data_2aiz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2aiz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -89.54 105.87 18.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 111.537 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.33 9.39 30.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.631 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.64 -36.56 2.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.442 -1.361 . . . . 0.0 113.817 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -121.08 169.88 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.74 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.12 155.15 20.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.7 t -39.25 -53.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.21 -18.24 9.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.36 -43.31 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 110.463 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.51 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 9.4 mt -63.18 -22.13 66.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.236 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -95.78 -14.92 22.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -131.61 -15.13 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -62.74 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 96.6 6.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -160.77 18.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.749 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 85.0 m -125.81 130.58 51.71 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.84 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.41 ' HA ' ' CD1' ' P' ' 45' ' ' TYR . 15.8 t -108.41 148.88 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -114.86 119.1 35.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.416 0.627 . . . . 0.0 112.185 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -103.63 169.22 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.823 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.54 -169.54 19.49 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.881 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' P' ' 36' ' ' PHE . 1.5 t80 -57.01 112.85 1.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 110.809 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.79 38.64 4.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -89.93 138.32 31.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -122.14 49.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.96 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.38 150.37 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 5.7 mt -98.01 163.18 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 11.1 p -110.65 143.41 41.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.091 0.472 . . . . 0.0 111.839 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.446 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.87 -32.21 8.46 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.225 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -33.97 74.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' P' ' 32' ' ' VAL . 77.2 m-85 -100.42 -0.24 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.446 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 48.1 t -65.22 -43.04 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.548 0.214 . . . . 0.0 111.444 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.447 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 1.0 OUTLIER -42.22 -43.45 3.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.531 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.7 -49.73 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.98 -45.76 61.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.474 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . 0.447 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 3.9 p30 -73.9 -32.21 63.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.59 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . 0.437 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.41 -49.48 22.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.531 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 20.0 m-70 -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.532 . . . . 0.0 109.643 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . 0.401 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -61.18 -44.42 97.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.58 98.48 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 0.0 110.587 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.75 -40.1 63.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.445 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 5.5 tp -63.95 -42.82 97.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.417 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.14 -39.84 78.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.68 -25.89 55.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.543 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.47 113.6 50.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 110.419 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.5 -46.81 27.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.627 2.218 . . . . 0.0 113.535 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.46 16.82 9.52 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.441 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.73 118.69 30.35 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -120.15 134.4 55.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.213 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.428 ' N ' HD13 ' P' ' 56' ' ' LEU . 4.5 p -97.43 134.39 35.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.404 0.621 . . . . 0.0 111.496 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' P' ' 133' ' ' ALA . 1.1 tt -109.56 103.32 12.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.8 120.08 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.5 mt-10 -103.69 117.63 34.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.609 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -103.29 140.91 15.07 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.582 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.581 ' O ' ' O ' ' P' ' 127' ' ' ASN . 77.4 m-20 -157.24 104.81 2.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.293 . . . . 0.0 110.824 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.407 ' CG2' ' NH1' ' P' ' 86' ' ' ARG . 72.1 p -101.9 -172.05 2.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -62.62 143.81 56.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.191 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 1.2 pp20? -63.43 -29.36 70.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.881 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.64 119.59 1.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.09 -113.46 2.95 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.96 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -167.21 147.56 4.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.157 0.479 . . . . 0.0 111.036 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 82.2 Cg_exo -41.68 -45.94 6.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.522 2.148 . . . . 0.0 112.919 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.12 -42.45 94.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.762 0.315 . . . . 0.0 110.761 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.27 -46.39 60.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.927 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' P' ' 80' ' ' ILE . 12.5 m120 -67.66 -75.45 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.68 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -29.7 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 O-C-N 123.141 0.276 . . . . 0.0 111.515 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' P' ' 85' ' ' ARG . . . -65.24 -59.75 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.436 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' P' ' 86' ' ' ARG . 0.3 OUTLIER -49.76 -44.6 48.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.922 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.409 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -71.54 -55.28 7.69 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.125 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 1.0 OUTLIER -45.51 -36.44 4.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 110.533 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.527 ' HB3' ' CE2' ' P' ' 39' ' ' TYR . 5.2 mtp180 -69.64 -51.84 31.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -52.82 -39.8 62.77 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.58 77.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.261 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -29.13 69.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.334 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.35 -52.0 56.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.417 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -70.75 -39.08 75.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.231 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -42.28 97.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.859 0.362 . . . . 0.0 110.204 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.94 -24.96 75.84 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -61.24 -61.18 2.74 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 39.9 mt -58.27 -30.83 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.445 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.23 96.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.48 -25.05 75.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.794 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . 0.401 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 2.9 mtpm? -76.84 -9.43 58.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 0.0 111.207 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.67 -1.98 23.25 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.193 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.445 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 25.0 t -75.58 127.26 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.418 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.9 146.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.253 0.549 . . . . 0.0 111.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.15 83.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.569 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.46 -21.9 50.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.666 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.6 mtpp -94.21 -5.84 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.85 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.73 149.08 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.57 140.99 8.47 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 35.1 p -136.21 153.41 51.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.422 ' CG2' HD22 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -163.5 171.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.041 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.68 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.5 OUTLIER -162.04 131.12 4.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.302 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' P' ' 110' ' ' GLY . 65.7 m-85 -115.84 23.11 12.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.847 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -8.47 -106.38 0.0 OUTLIER Glycine 0 C--N 1.34 0.779 0 O-C-N 123.474 0.484 . . . . 0.0 113.971 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.576 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 3.8 mt-10 -71.16 -18.52 62.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.703 0.252 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.65 -70.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.133 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -130.66 89.62 42.99 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 122.312 -0.242 . . . . 0.0 110.541 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.0 156.27 39.98 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.599 2.199 . . . . 0.0 112.461 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.68 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' P' ' 123' ' ' ALA . 2.6 t -88.79 114.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.056 0.455 . . . . 0.0 110.999 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.63 138.32 57.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.024 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.02 176.66 16.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.874 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.464 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 7.1 p80 -141.64 65.55 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.904 0.352 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.8 150.28 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' P' ' 121' ' ' GLU . 35.4 tp10 -38.44 -30.94 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.1 -59.73 2.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.875 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.412 ' HA ' HG13 ' P' ' 116' ' ' VAL . . . -67.66 -42.44 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.464 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 1.0 OUTLIER -60.66 -45.08 95.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.161 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 26.9 m -62.92 -36.83 84.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.801 0.334 . . . . 0.0 110.509 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -69.21 -25.02 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.549 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.581 ' O ' ' O ' ' P' ' 69' ' ' ASN . 4.6 m-20 -82.49 -33.89 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' P' ' 124' ' ' TYR . 4.7 mtp180 -69.64 83.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -158.02 148.29 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -121.12 109.29 14.83 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 t -87.78 115.6 28.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.19 102.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.744 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -100.76 127.04 47.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.307 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.973 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' P' P ' 16' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' P' ' 17' ' ' PHE . 15.3 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 0.1 OUTLIER -151.48 135.86 16.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.219 0.533 . . . . 0.0 112.283 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 2.88 33.27 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.205 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.95 -34.36 2.86 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.399 -1.381 . . . . 0.0 114.154 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -114.69 161.71 17.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.826 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 21' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' P' ' 16' ' ' THR . 0.8 OUTLIER -97.72 145.76 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 t -37.12 -58.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.84 -16.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -99.19 -43.02 6.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.324 0.583 . . . . 0.0 110.056 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.494 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 25.5 mt -54.67 -21.69 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -12.85 16.91 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.32 -23.63 5.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 ptm85 -122.89 -48.22 2.02 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.27 102.87 12.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.354 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 1.1 p30 179.66 22.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.405 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 72.8 m -125.22 126.84 45.83 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.103 -0.373 . . . . 0.0 111.386 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.496 HG12 ' CB ' ' P' ' 45' ' ' TYR . 0.8 OUTLIER -105.18 150.64 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.913 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -117.93 112.7 20.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.374 0.606 . . . . 0.0 112.167 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.56 ' CD2' ' CZ ' ' P' ' 86' ' ' ARG . 15.3 m-30 -92.13 167.0 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.226 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.14 174.05 15.47 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 142.45 57.27 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.54 -0.388 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.67 26.0 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.771 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.451 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -108.97 135.25 50.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.656 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.665 ' HA ' ' NE ' ' P' ' 86' ' ' ARG . 47.4 p90 -132.86 30.46 4.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.32 150.83 44.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.774 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 mt -87.7 166.38 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.589 0.233 . . . . 0.0 110.616 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 144.56 40.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.09 0.472 . . . . 0.0 111.779 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.451 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.73 -31.95 2.82 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.606 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -30.5 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.712 0.291 . . . . 0.0 111.497 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.496 ' CB ' HG12 ' P' ' 32' ' ' VAL . 72.6 m-85 -104.9 3.52 30.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 54.3 t -69.1 -37.22 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.21 -42.44 14.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.516 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.8 OUTLIER -55.96 -49.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.002 0.43 . . . . 0.0 110.412 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.77 -39.68 74.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -45.79 72.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.51 68.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.516 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 16.5 m-70 -72.27 -40.64 67.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.973 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.9 73.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.05 -36.05 59.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.481 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . 0.448 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 13.8 t80 -74.26 -38.89 63.31 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.153 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 1.2 tp -65.08 -43.95 90.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -69.96 -39.98 75.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.24 -24.43 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.055 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.97 89.92 51.86 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.009 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.46 -21.67 10.82 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.792 2.328 . . . . 0.0 113.354 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.78 -1.2 55.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.679 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.422 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.81 125.88 35.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 2.6 pttp -121.85 132.29 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.836 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.8 p -97.6 146.61 7.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.484 0.659 . . . . 0.0 111.713 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.9 OUTLIER -118.89 103.73 9.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.406 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.17 112.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.5 tt0 -101.3 114.99 29.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.104 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.35 146.54 16.08 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.878 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 127' ' ' ASN . 11.3 m-80 -155.76 107.49 2.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 79.1 p -105.35 -173.91 2.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.428 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 24.0 p-10 -54.76 139.1 40.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -61.51 -27.15 68.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.204 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -39.59 108.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.67 -175.17 15.9 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.406 -0.815 . . . . 0.0 113.437 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.6 147.69 34.18 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 122.223 0.209 . . . . 0.0 111.224 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 92.9 Cg_exo -39.56 -45.22 3.33 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.881 2.387 . . . . 0.0 113.172 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -40.88 90.84 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.902 0.382 . . . . 0.0 110.438 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -75.53 -37.45 60.04 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -70.51 -76.85 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.528 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -31.93 -40.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 O-C-N 123.101 0.251 . . . . 0.0 111.343 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.91 11.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.519 ' HA ' ' HD3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -47.32 -53.45 13.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.54 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' P' ' 86' ' ' ARG . . . -69.16 -42.62 75.44 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.334 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 7.3 tp-100 -45.68 -44.65 13.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.637 0.256 . . . . 0.0 110.656 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.519 ' HD3' ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -72.19 -32.88 67.2 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.552 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.665 ' NE ' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -62.04 -49.81 74.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.504 0.669 . . . . 0.0 109.302 177.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.33 -35.34 67.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.5 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -29.64 70.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.94 -59.69 4.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.537 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -64.9 -37.69 80.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -61.16 -47.39 86.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.299 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.9 -19.03 73.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -67.5 -64.18 0.91 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 75.6 mt -52.54 -33.71 46.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.095 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.91 97.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.201 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.47 -32.4 81.01 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -8.63 56.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.948 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.44 14.33 30.47 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.51 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 48.1 t -80.46 130.42 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.402 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.07 165.69 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 111.127 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.34 -30.07 17.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.474 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.32 58.27 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.813 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.87 -4.32 26.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.212 0.529 . . . . 0.0 111.093 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 38.4 mt -96.37 150.38 20.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.133 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.15 142.99 10.01 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.651 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 30.4 p -133.26 156.76 46.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.585 0.231 . . . . 0.0 110.451 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -171.13 129.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.347 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -119.25 130.55 55.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.736 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 82.6 m-85 -110.94 25.66 11.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.083 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.47 -112.36 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.718 -0.674 . . . . 0.0 114.445 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.479 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.03 6.88 47.84 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -53.89 -58.97 5.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.72 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 89.36 11.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.265 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.84 164.36 14.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.568 2.179 . . . . 0.0 112.424 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.38 -62.7 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.64 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' P' ' 126' ' ' LYS . 7.9 t -89.49 112.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.8 137.77 58.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.85 174.56 17.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.992 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.435 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 15.3 p-80 -141.99 68.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.28 . . . . 0.0 111.369 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.42 152.5 47.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -37.93 -32.36 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.58 -61.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' P' ' 116' ' ' VAL . . . -67.98 -43.24 79.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 0.7 OUTLIER -56.81 -50.17 73.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 87.7 p -60.66 -37.04 80.24 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.133 0.492 . . . . 0.0 110.056 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . 0.416 ' HB3' ' CG2' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -62.47 -32.92 73.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.294 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 69' ' ' ASN . 98.7 m-20 -81.58 -30.45 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.415 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -69.79 74.61 0.43 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.089 0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 146.18 40.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.509 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.77 90.01 3.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 t -80.2 114.17 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.2 OUTLIER -63.08 104.95 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.206 178.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -102.25 126.75 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.491 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.088 179.652 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.716 0.293 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.544 ' C ' ' H ' ' P' ' 19' ' ' GLY . 47.8 m-85 -137.92 85.62 2.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.771 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 50.6 4.98 0.07 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.726 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' P' ' 17' ' ' PHE . . . 171.53 97.2 0.11 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' P' ' 19' ' ' GLY . 0.8 OUTLIER 60.57 -178.34 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -107.99 160.49 15.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.49 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 t -39.13 -53.46 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 -15.92 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.7 -38.64 8.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.452 0.644 . . . . 0.0 110.142 178.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 14.4 mt -70.27 -22.47 62.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.464 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -85.25 -26.72 26.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -140.6 -3.49 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' P' ' 24' ' ' ASP . 5.4 mtm-85 -107.54 -68.03 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -109.52 96.39 6.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 112.061 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.77 27.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.024 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 95.3 m -128.33 129.61 46.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.882 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' P' ' 45' ' ' TYR . 1.0 OUTLIER -110.77 150.72 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -120.94 118.05 28.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.7 m-30 -100.99 171.65 7.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.383 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.76 -166.64 23.41 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.903 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.68 117.71 5.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 t70 45.45 29.04 0.55 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.342 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.404 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 24.5 mmtm -94.81 130.9 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.779 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -119.57 67.08 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.037 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.15 150.67 30.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.475 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mt -107.98 156.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -109.85 150.16 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.15 0.5 . . . . 0.0 112.065 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.447 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -48.92 -31.27 10.16 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.264 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.75 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.69 0.281 . . . . 0.0 111.389 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.44 ' CB ' HG11 ' P' ' 32' ' ' VAL . 77.0 m-85 -99.68 -4.61 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.447 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 64.9 t -62.82 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.403 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -44.46 -45.38 9.09 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.501 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -52.59 -49.67 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.941 0.401 . . . . 0.0 110.22 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -54.06 -45.36 71.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.904 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -40.29 96.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.343 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.66 67.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.856 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.501 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 59.7 m-70 -68.17 -41.47 81.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.03 99.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.437 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.66 0.267 . . . . 0.0 110.482 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -73.38 -36.88 66.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.646 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.425 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 5.0 tp -60.01 -47.9 83.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.191 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.27 -43.08 78.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.594 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.64 -26.38 22.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.684 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.402 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -114.88 113.63 44.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.491 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.14 -49.08 17.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.771 2.314 . . . . 0.0 113.849 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.64 17.5 8.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.416 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.39 114.6 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.094 0.473 . . . . 0.0 110.662 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.495 ' CG ' ' HA ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -117.32 133.45 55.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.806 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.2 p -98.88 143.53 13.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 121.43 0.633 . . . . 0.0 111.476 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' P' ' 133' ' ' ALA . 4.5 tt -113.55 101.16 9.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.627 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.13 106.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.234 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.426 ' HG2' ' CZ ' ' P' ' 109' ' ' TYR . 0.9 OUTLIER -100.59 119.37 38.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.68 144.04 17.09 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.621 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 127' ' ' ASN . 1.4 m-20 -140.19 102.43 4.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.625 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.419 ' CG2' HD13 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -95.0 -169.97 2.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.573 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.61 158.49 34.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -74.44 -33.96 63.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.259 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.03 116.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 -161.82 12.56 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.532 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.15 35.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.489 0.185 . . . . 0.0 110.751 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.439 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 46.6 Cg_exo -54.77 -31.87 74.0 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.231 1.954 . . . . 0.0 112.162 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.44 -43.02 82.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.706 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.89 -39.74 63.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.256 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -67.83 -76.7 0.08 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.569 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 1.8 tt -33.1 -38.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -56.87 6.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.749 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -55.4 -42.14 73.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.539 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -66.76 -40.51 93.83 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -52.55 -43.56 65.27 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.132 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -63.12 -35.87 81.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.498 ' N ' ' HG3' ' P' ' 85' ' ' ARG . 0.0 OUTLIER -65.22 -44.65 87.6 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.79 -36.85 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.219 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . 0.528 ' HA ' ' HB3' ' P' ' 91' ' ' LYS . 0.2 OUTLIER -67.57 -28.89 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.211 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.46 -66.36 0.5 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.11 -31.75 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.385 0.612 . . . . 0.0 109.892 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' P' ' 88' ' ' ASP . 0.3 OUTLIER -60.93 -47.62 85.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.351 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.85 79.39 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.112 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -68.04 -61.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.02 -31.3 64.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.283 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.43 84.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.591 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.09 -39.63 94.62 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -60.86 -35.23 76.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.88 27.43 1.9 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.556 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.442 HG12 ' N ' ' P' ' 100' ' ' ASP . 45.4 t -89.92 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.524 0.202 . . . . 0.0 110.483 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.442 ' N ' HG12 ' P' ' 99' ' ' VAL . 4.8 m-20 -66.31 165.22 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.245 0.545 . . . . 0.0 111.493 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.11 -29.91 18.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.297 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.97 -29.68 55.82 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.386 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.495 ' HA ' ' CG ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.14 -4.87 26.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 110.421 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.91 121.32 44.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.122 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.61 178.36 17.47 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.606 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' P' ' 107' ' ' VAL . 70.7 p -149.95 163.44 38.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' P' ' 106' ' ' THR . 93.5 t -160.85 161.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.21 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.569 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 5.6 t -159.66 129.05 5.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.471 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.426 ' CZ ' ' HG2' ' P' ' 67' ' ' GLU . 25.9 m-85 -88.85 -63.26 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.12 -127.92 8.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.079 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.439 ' HG3' ' HG3' ' P' ' 76' ' ' PRO . 0.3 OUTLIER -93.14 2.62 56.62 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.029 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.45 -66.14 0.45 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.831 0.348 . . . . 0.0 110.429 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -141.03 88.97 9.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.057 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.27 165.78 18.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.737 2.291 . . . . 0.0 112.434 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.54 -58.33 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.46 HG11 ' ND2' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -91.11 142.83 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.27 139.8 31.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.96 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.21 175.81 16.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.936 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.43 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 9.5 p-80 -141.3 68.27 1.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.749 0.274 . . . . 0.0 111.457 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -141.25 153.65 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 3.7 tp10 -40.37 -30.3 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.56 -65.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.992 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.459 ' O ' HG12 ' P' ' 116' ' ' VAL . . . -68.13 -41.42 81.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.698 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.43 ' CE2' ' HB2' ' P' ' 119' ' ' HIS . 1.6 m-85 -54.7 -52.96 60.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -59.09 -37.35 76.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -61.53 -31.62 71.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.292 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 69' ' ' ASN . 58.3 m-20 -84.42 -34.31 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.896 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 5.0 mtp180 -68.97 79.64 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.158 0.504 . . . . 0.0 111.135 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' P' ' 69' ' ' ASN . 0.1 OUTLIER -150.59 149.76 30.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -119.73 98.48 6.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.9 115.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.39 103.13 0.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.549 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -99.47 128.59 45.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 111.511 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.051 179.624 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.78 0.324 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' P' ' 20' ' ' TYR . 55.2 m-85 -89.51 106.65 18.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.994 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.01 35.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.412 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.41 -35.03 2.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.16 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -129.92 176.77 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 0.0 111.709 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -103.3 157.37 17.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 t -46.4 -51.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.18 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.53 -13.34 2.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.436 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.11 -44.66 6.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.573 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 3.9 mt -58.07 -19.78 34.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.703 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -109.02 -11.27 14.98 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.06 -31.08 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -122.83 -50.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.72 103.8 13.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.529 0.68 . . . . 0.0 112.403 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 0.3 OUTLIER -176.08 11.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.301 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.426 ' O ' ' CD1' ' P' ' 45' ' ' TYR . 85.0 m -113.77 128.12 56.29 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.838 -0.539 . . . . 0.0 112.097 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' P' ' 129' ' ' ARG . 5.3 t -108.06 151.16 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' P' ' 34' ' ' PHE . 6.9 m-85 -112.48 163.32 14.61 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' P' ' 33' ' ' TYR . 73.4 m-85 -152.06 168.55 24.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.221 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.49 -175.74 23.27 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.567 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.35 128.43 37.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.084 0.442 . . . . 0.0 110.884 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p30 43.59 29.76 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.801 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.431 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 2.3 tttp -101.02 137.71 39.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' P' ' 39' ' ' TYR . 48.5 p90 -125.37 60.71 1.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.306 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.63 150.85 31.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.232 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.76 163.44 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.652 0.263 . . . . 0.0 110.736 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 72.8 p -112.61 142.67 44.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.308 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.9 -29.74 4.6 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.346 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.05 -32.87 74.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.61 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' P' ' 33' ' ' TYR . 68.2 m-85 -102.8 3.65 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.82 -41.23 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.437 ' NE2' HG12 ' P' ' 48' ' ' ILE . 6.1 pm0 -45.77 -37.77 6.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.487 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.3 mt -57.74 -52.83 52.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -52.85 -33.09 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.437 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -40.78 62.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.3 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.45 -43.93 53.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.037 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 59.9 m-70 -62.9 -38.82 92.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.026 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.36 87.18 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -73.63 -41.51 62.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.434 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 5.6 tp -61.02 -45.06 96.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.397 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.79 -40.74 72.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.564 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.96 -26.64 37.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -114.54 114.33 44.95 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.374 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 -51.58 10.35 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.859 2.373 . . . . 0.0 113.931 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.06 19.69 5.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' P' ' 103' ' ' LYS . . . -90.19 119.68 30.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -119.5 132.51 55.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.724 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 8.8 p -98.65 144.87 10.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 121.294 0.569 . . . . 0.0 110.904 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.445 ' CD2' HG21 ' P' ' 107' ' ' VAL . 0.6 OUTLIER -116.56 108.31 15.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.943 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.53 113.96 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -99.07 120.36 39.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.29 144.01 21.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.708 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' P' ' 129' ' ' ARG . 0.3 OUTLIER -144.3 159.8 42.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 1.1 p -170.26 -173.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.445 ' CB ' ' CE2' ' P' ' 124' ' ' TYR . 10.0 p-10 -63.72 157.25 24.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.379 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.502 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 0.2 OUTLIER -70.55 -31.35 68.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . 0.441 ' HB2' ' OH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -49.86 119.74 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.37 -173.82 15.33 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.225 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.17 143.15 26.56 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.135 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.527 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -40.2 -43.1 3.73 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.017 2.478 . . . . 0.0 113.667 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -59.82 -45.17 93.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -70.89 -41.97 70.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.406 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.482 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 4.3 m-80 -67.5 -75.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.9 OUTLIER -29.48 -44.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 111.525 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.37 4.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.91 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -47.9 -51.9 21.42 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.279 -0.569 . . . . 0.0 109.92 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.447 ' HA2' ' CG ' ' P' ' 86' ' ' ARG . . . -61.52 -40.74 99.12 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.511 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -51.39 -40.51 59.4 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 8.1 ttp-105 -64.73 -38.82 92.29 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.453 ' CD ' ' HA ' ' P' ' 39' ' ' TYR . 0.3 OUTLIER -59.05 -40.08 84.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.776 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -34.69 78.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.1 68.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.86 -38.06 43.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.809 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -39.66 91.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.236 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.79 -27.43 64.91 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -59.87 -57.02 14.67 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 23.2 mt -61.45 -32.25 72.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.39 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.96 95.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.103 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.12 -26.97 74.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.759 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -72.38 -11.44 60.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.99 2.0 25.24 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.13 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . . . . . . . . . 26.9 t -81.95 131.95 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.368 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.404 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.5 OUTLIER -60.9 164.28 5.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.271 0.557 . . . . 0.0 111.324 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.26 -30.02 25.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.37 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.58 -22.78 53.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.895 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -98.84 -3.86 34.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.092 0.473 . . . . 0.0 111.25 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 8.7 mt -89.2 150.44 22.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.254 -0.279 . . . . 0.0 110.342 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.16 138.82 7.72 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 66.3 p -132.14 153.37 50.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.693 0.282 . . . . 0.0 111.014 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.445 HG21 ' CD2' ' P' ' 65' ' ' LEU . 0.2 OUTLIER -175.38 170.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.443 ' OG ' HG22 ' P' ' 80' ' ' ILE . 32.4 p -162.47 139.18 7.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.406 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' P' ' 110' ' ' GLY . 74.6 m-85 -123.57 19.77 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 7.4 -110.34 0.01 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.502 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -86.18 8.07 22.51 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -51.43 -59.74 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 109.961 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.17 89.81 22.72 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.686 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.18 160.11 11.32 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.709 2.273 . . . . 0.0 112.991 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -69.13 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.674 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 t -87.67 106.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.923 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.24 134.9 49.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.1 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.69 174.68 13.56 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.379 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.61 87.02 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.145 0.473 . . . . 0.0 111.692 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -173.2 165.98 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -47.79 -22.3 0.52 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.57 -60.84 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.912 0.386 . . . . 0.0 111.444 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.09 72.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.445 ' CE2' ' CB ' ' P' ' 71' ' ' ASP . 2.9 m-85 -60.55 -45.75 92.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.749 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 25.2 t -65.34 -32.02 73.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.174 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -75.06 -24.69 58.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.369 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -87.89 -29.0 21.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 111.262 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -67.25 87.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' P' ' 32' ' ' VAL . 3.3 ptt-85 -159.08 160.31 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.37 106.53 9.9 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.25 111.24 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.58 101.94 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.209 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' P' ' 65' ' ' LEU . . . -101.92 130.51 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.279 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.025 179.91 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.988 0.423 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.94 106.38 4.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.169 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.66 8.51 47.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.288 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.54 -35.67 2.24 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.575 -1.297 . . . . 0.0 114.127 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 2.9 m-85 -119.43 169.26 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.124 0.462 . . . . 0.0 111.468 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -101.27 145.3 29.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.992 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 t -43.27 -30.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 111.468 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' P' ' 27' ' ' GLN . . . -61.67 -21.96 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.69 -54.05 3.02 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.604 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.636 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 7.1 mt -44.59 -28.05 0.55 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.89 -31.22 12.31 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.157 0.503 . . . . 0.0 110.725 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.1 OUTLIER -148.5 77.68 1.4 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.532 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . 0.623 ' HB2' ' O ' ' P' ' 27' ' ' GLN . 0.0 OUTLIER 164.47 -68.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.205 177.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.429 ' CD1' ' HD3' ' P' ' 28' ' ' ARG . 6.7 m-85 -109.13 90.09 3.19 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.61 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 2.0 p30 -168.29 64.69 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.411 ' O ' ' CE1' ' P' ' 45' ' ' TYR . 97.6 m -164.11 126.68 2.44 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.818 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' P' ' 45' ' ' TYR . 1.2 t -99.75 150.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.652 0.263 . . . . 0.0 111.215 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -116.33 108.35 15.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.587 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -89.31 172.94 8.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.612 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.16 -173.98 19.92 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . 0.411 ' CE2' ' OD2' ' P' ' 37' ' ' ASP . 3.0 t80 -58.36 122.56 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.457 0.628 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . 0.411 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 2.7 p30 43.92 30.84 0.44 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.744 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 141.58 28.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.43 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 31.2 p90 -130.76 52.55 2.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.497 . . . . 0.0 110.833 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -149.97 150.14 31.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.448 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.27 163.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.924 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 69.4 p -109.45 150.59 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.41 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.86 -29.72 1.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.205 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -65.2 -30.47 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.436 ' HB3' HG11 ' P' ' 32' ' ' VAL . 68.0 m-85 -104.12 1.17 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.981 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.41 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 82.4 t -73.22 -37.56 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.41 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.62 -40.7 63.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' P' ' 45' ' ' TYR . 4.6 pt -67.25 -35.72 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.344 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.88 -40.12 96.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.95 -34.19 62.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.792 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.76 -53.58 8.27 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 23.0 m-70 -53.59 -35.35 60.75 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' P' ' 94' ' ' LEU . . . -67.37 -40.04 85.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.065 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 110.201 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.23 -37.87 63.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.73 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.465 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 1.7 tp -62.47 -42.74 99.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.294 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.64 -42.06 71.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.461 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.07 54.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.534 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.15 112.22 49.84 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.94 -48.74 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.842 2.361 . . . . 0.0 114.154 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.61 17.61 8.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.405 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.35 117.91 29.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -118.7 130.41 55.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.765 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.465 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 8.4 p -94.44 140.23 17.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.347 0.594 . . . . 0.0 111.422 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' P' ' 107' ' ' VAL . 0.6 OUTLIER -110.14 104.31 13.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.786 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.09 108.12 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.6 tt0 -102.01 118.06 36.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.03 152.34 20.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -148.55 170.7 17.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.871 0.367 . . . . 0.0 110.926 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.1 OUTLIER 176.2 174.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.147 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.517 ' HB2' ' CZ ' ' P' ' 124' ' ' TYR . 37.7 p-10 -54.46 142.64 26.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.253 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 2.2 pp20? -62.79 -25.98 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . 0.436 ' HD3' ' CE1' ' P' ' 119' ' ' HIS . 0.7 OUTLIER -39.33 110.74 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.545 -178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.22 -168.87 12.71 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.336 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.57 144.83 29.45 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.674 0.273 . . . . 0.0 111.066 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.06 -39.28 14.66 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.634 2.223 . . . . 0.0 112.488 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.8 -43.02 97.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.679 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -68.18 -41.81 80.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' P' ' 80' ' ' ILE . 3.1 m-80 -70.68 -75.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.813 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -30.15 -40.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -69.89 -57.06 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.82 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.4 -42.0 81.42 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.056 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.54 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -69.86 -52.32 20.19 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.765 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.437 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 1.9 tt0 -48.03 -35.67 11.52 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.92 -48.71 79.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.082 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.451 ' HB3' ' CE2' ' P' ' 34' ' ' PHE . 0.3 OUTLIER -54.98 -40.89 70.55 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.24 74.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.44 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -32.99 74.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.235 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.33 -53.44 57.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.426 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.37 -34.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -60.84 -52.75 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' P' ' 95' ' ' ALA . . . -65.06 -27.1 71.86 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -59.16 -58.4 8.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' P' ' 53' ' ' ALA . 92.6 mt -56.73 -29.91 62.98 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . 0.418 ' HB2' ' HA2' ' P' ' 92' ' ' GLY . . . -69.84 -38.99 76.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.84 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.31 -35.17 87.61 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.68 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -63.87 -36.56 84.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.63 26.15 2.22 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.247 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' P' ' 56' ' ' LEU . 24.4 t -91.15 146.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.568 0.223 . . . . 0.0 110.726 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.28 161.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.172 0.51 . . . . 0.0 111.562 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.29 -31.32 17.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.67 -12.91 65.11 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 12.9 mtpp -94.37 -10.91 31.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.27 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.79 150.01 22.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.74 144.58 11.8 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 17.6 p -124.57 159.09 31.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.722 0.296 . . . . 0.0 110.85 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' P' ' 65' ' ' LEU . 0.0 OUTLIER -175.28 117.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.151 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.813 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -99.77 143.78 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.526 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' P' ' 110' ' ' GLY . 2.8 m-85 -105.45 7.8 33.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 16.87 -127.25 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.276 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.08 12.75 37.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.53 0.205 . . . . 0.0 111.106 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -59.1 5.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 109.95 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.36 89.03 16.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . 0.419 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 31.9 Cg_exo -61.19 164.07 15.57 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.804 2.336 . . . . 0.0 112.982 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.3 -67.4 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.277 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' P' ' 123' ' ' ALA . 18.8 t -88.52 108.76 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.89 138.75 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.503 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.28 177.03 14.99 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.999 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.533 ' CD2' ' CE2' ' P' ' 124' ' ' TYR . 14.8 t-160 -141.03 61.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -127.14 154.69 44.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -49.38 -23.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.547 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' P' ' 126' ' ' LYS . . . -76.07 -58.1 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.938 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' P' ' 116' ' ' VAL . . . -63.77 -42.21 97.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.674 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.533 ' CE2' ' CD2' ' P' ' 119' ' ' HIS . 3.2 m-30 -66.59 -37.21 84.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.37 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 125' ' ' SER . . . . . 0.434 ' HA ' ' NE ' ' P' ' 128' ' ' ARG . 22.5 p -62.06 -37.61 85.64 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 110.682 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' P' ' 126' ' ' LYS . 0.0 OUTLIER -83.07 -11.84 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.713 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -80.71 -37.07 31.3 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -78.65 92.63 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.821 0.82 . . . . 0.0 110.756 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -146.68 146.35 30.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.362 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -115.53 93.91 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.03 112.84 16.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 1.4 mm? -63.71 100.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.282 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -97.38 122.53 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.806 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.053 179.568 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 7.0 m-85 -90.96 107.02 18.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.66 33.48 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.396 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.24 -35.43 2.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.593 -1.289 . . . . 0.0 113.466 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.87 43.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.599 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -60.07 152.37 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t -44.3 -40.07 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 112.029 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -14.83 25.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.316 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.54 -41.03 8.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.561 0.696 . . . . 0.0 109.895 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.491 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 14.7 mt -61.86 -19.8 63.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -98.66 -14.61 19.76 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.99 -17.9 2.11 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -67.96 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -105.36 81.89 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.634 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.24 10.17 2.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.006 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 23.5 m -134.81 137.12 43.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.421 HG13 ' CB ' ' P' ' 45' ' ' TYR . 11.3 t -106.89 149.71 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.437 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.548 ' CE2' ' NH2' ' P' ' 129' ' ' ARG . 3.3 m-85 -113.39 115.51 28.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.778 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.448 ' CG ' ' HD3' ' P' ' 86' ' ' ARG . 82.4 m-85 -104.69 168.9 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.078 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.99 179.73 19.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.384 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 3.6 t80 -61.4 137.48 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . 0.415 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 0.5 OUTLIER 46.91 28.05 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.407 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 5.5 mttm -109.12 136.07 49.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.742 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -130.86 49.82 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.75 150.44 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.958 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.98 164.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.519 0.199 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 28.0 p -109.5 144.22 38.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 111.299 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.84 -29.58 1.43 Allowed Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.219 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.43 -31.96 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.618 0.247 . . . . 0.0 111.655 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.421 ' CB ' HG13 ' P' ' 32' ' ' VAL . 76.0 m-85 -104.39 3.31 32.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.414 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 98.5 t -70.31 -38.32 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.318 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.24 -40.25 11.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.298 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.558 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.4 mt -55.39 -55.87 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.945 0.402 . . . . 0.0 110.333 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -52.04 -31.89 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.697 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -38.69 62.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.36 -45.98 35.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.558 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 65.8 m-70 -64.41 -37.73 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.67 95.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.76 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.22 98.34 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.032 0.444 . . . . 0.0 110.14 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 24.2 t80 -75.82 -37.6 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.66 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.454 ' CD2' HG11 ' P' ' 99' ' ' VAL . 10.1 tp -60.68 -49.02 79.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -70.1 -40.31 75.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.51 -27.29 37.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.423 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -113.63 115.37 46.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.667 0.27 . . . . 0.0 110.423 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.83 -59.6 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.915 2.41 . . . . 0.0 113.902 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 20.52 2.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.418 ' CB ' ' HB ' ' P' ' 59' ' ' THR . . . -88.46 114.6 25.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.017 0.437 . . . . 0.0 110.374 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.4 129.7 56.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.404 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.4 p -95.56 126.37 48.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.428 0.632 . . . . 0.0 110.921 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.8 OUTLIER -99.54 105.51 17.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.721 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.19 120.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.047 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' P' ' 109' ' ' TYR . 2.1 tt0 -106.52 116.05 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.97 142.97 18.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.735 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' P' ' 129' ' ' ARG . 0.6 OUTLIER -141.39 161.52 37.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.959 0.409 . . . . 0.0 110.751 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 1.3 p -170.16 -173.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.538 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.48 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 4.3 p30 -74.92 152.79 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.617 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -63.56 -32.63 74.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.935 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.75 109.41 0.11 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.96 178.62 19.17 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.14 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.97 146.51 31.43 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.511 0.196 . . . . 0.0 110.853 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' P' ' 80' ' ' ILE . 71.8 Cg_exo -41.23 -42.6 5.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.741 2.294 . . . . 0.0 113.197 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.34 -43.62 98.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.881 0.372 . . . . 0.0 110.568 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -43.56 78.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.6 OUTLIER -69.51 -76.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.687 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.62 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.46 -43.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.72 -56.49 9.09 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.573 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.551 ' O ' ' HG2' ' P' ' 85' ' ' ARG . 0.2 OUTLIER -48.9 -56.19 9.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.262 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.99 -39.34 97.45 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.526 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 3.8 mt-30 -48.41 -51.12 28.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 13.0 ptp180 -62.2 -32.67 73.35 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.448 ' HD3' ' CG ' ' P' ' 34' ' ' PHE . 0.4 OUTLIER -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.74 76.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.982 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.35 -29.73 70.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.638 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.9 -43.22 93.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.154 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 39.2 t -75.47 -42.7 42.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.365 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -38.93 93.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' P' ' 95' ' ' ALA . . . -71.75 -31.29 65.09 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.32 -57.01 14.79 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.63 -30.48 65.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.285 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . 0.405 ' HB2' ' HA2' ' P' ' 92' ' ' GLY . . . -68.9 -39.71 79.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.945 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.66 -36.21 91.15 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.873 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -35.36 78.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.05 26.53 2.05 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.454 HG11 ' CD2' ' P' ' 56' ' ' LEU . 57.5 t -90.77 144.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.595 0.236 . . . . 0.0 110.54 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.434 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -63.94 161.56 15.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.504 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.97 -32.3 16.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.423 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.41 -23.93 36.25 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.689 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.67 -3.25 33.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.29 0.567 . . . . 0.0 110.858 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.24 148.88 23.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.846 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -148.68 140.84 8.53 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.637 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.424 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 14.8 p -131.12 153.44 49.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.679 0.276 . . . . 0.0 110.832 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -174.26 117.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -105.65 137.8 42.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.368 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.513 ' O ' ' C ' ' P' ' 110' ' ' GLY . 91.9 m-85 -121.4 15.97 11.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.996 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -5.03 -106.3 0.0 OUTLIER Glycine 0 C--N 1.34 0.761 0 O-C-N 123.758 0.662 . . . . 0.0 114.523 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.61 0.7 56.76 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.589 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -54.73 -59.87 4.13 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 88.7 7.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.96 168.29 7.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.893 2.395 . . . . 0.0 113.163 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.51 -66.01 0.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.236 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' P' ' 123' ' ' ALA . 2.5 p -88.6 151.05 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -108.37 136.13 48.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.865 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.29 -178.9 20.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -140.23 43.53 1.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.443 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -130.07 156.13 45.02 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -27.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.617 0.246 . . . . 0.0 111.591 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.24 -58.84 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.386 . . . . 0.0 110.651 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' P' ' 116' ' ' VAL . . . -72.48 -39.6 67.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.549 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.48 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 5.9 m-85 -57.82 -49.77 75.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.956 0.408 . . . . 0.0 110.531 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 125' ' ' SER . . . . . 0.645 ' O ' ' NH2' ' P' ' 129' ' ' ARG . 8.3 t -62.7 -33.02 74.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . 0.605 ' O ' ' CZ ' ' P' ' 129' ' ' ARG . 0.1 OUTLIER -75.83 -14.41 60.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.325 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -94.18 -24.45 17.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.457 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.6 mtp180 -77.11 91.11 3.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.645 ' NH2' ' O ' ' P' ' 125' ' ' SER . 0.0 OUTLIER -160.88 154.85 22.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.05 103.96 9.73 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.03 109.44 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.82 100.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.28 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -98.0 123.08 41.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.92 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.915 179.707 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' P' ' 20' ' ' TYR . 40.4 m-85 -137.53 103.06 4.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.978 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.89 9.99 23.4 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.72 -1.229 . . . . 0.0 112.211 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.2 -33.89 2.71 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.651 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 18.0 m-85 -116.11 160.59 20.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.131 0.491 . . . . 0.0 112.286 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -97.56 142.0 29.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.327 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 t -40.86 -53.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.86 -16.54 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.393 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.29 -46.07 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 110.417 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.519 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 11.9 mt -56.12 -20.83 19.11 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.559 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -12.23 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -118.72 -28.15 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -117.13 -52.51 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -109.39 97.07 6.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 0.3 OUTLIER -164.68 13.02 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.439 HG23 ' CE1' ' P' ' 33' ' ' TYR . 90.3 m -120.41 130.09 54.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.916 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 5.3 t -108.84 141.72 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.102 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.439 ' CE1' HG23 ' P' ' 31' ' ' THR . 66.9 m-85 -116.28 117.7 30.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 20.4 m-30 -96.26 167.76 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.925 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -100.74 -170.11 28.81 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.76 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.43 115.74 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.52 31.63 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.534 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.433 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 15.5 mmtm -91.58 141.66 28.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 17.3 t80 -126.55 57.71 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.701 0.762 . . . . 0.0 110.116 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -150.96 150.85 31.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.893 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mt -100.81 160.33 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 42' ' ' THR . . . . . 0.414 ' O ' HG23 ' P' ' 46' ' ' VAL . 18.4 p -108.83 138.86 44.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 111.743 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.08 -28.64 1.35 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.926 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.35 -31.98 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.112 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.488 ' O ' HG13 ' P' ' 48' ' ' ILE . 65.9 m-85 -106.33 5.57 29.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.414 HG23 ' O ' ' P' ' 42' ' ' THR . 80.4 t -76.26 -28.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.53 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -36.46 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.67 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.532 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -58.95 -46.32 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.172 0.51 . . . . 0.0 109.899 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.75 -39.01 83.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.767 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.72 -44.69 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.345 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 -50.08 66.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.967 0.413 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.532 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 60.0 m-70 -59.75 -35.8 75.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.85 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.686 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.97 80.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.977 0.418 . . . . 0.0 110.435 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -78.03 -34.21 50.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.0 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.436 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 1.0 OUTLIER -67.0 -40.57 87.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.874 -179.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.99 -34.35 66.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.61 -22.63 67.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.569 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.403 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . 0.6 OUTLIER -110.8 115.29 53.55 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.592 0.235 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.12 -62.1 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.878 2.385 . . . . 0.0 114.065 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.6 25.16 1.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.14 122.13 33.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.166 0.508 . . . . 0.0 110.98 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.2 mttp -128.29 132.68 48.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 8.9 p -95.38 146.41 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-O 121.392 0.615 . . . . 0.0 111.54 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.22 103.68 12.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.69 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.32 95.02 3.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.542 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 22.3 tt0 -89.36 119.72 30.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.773 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.48 145.9 18.65 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.658 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.498 ' HB2' ' HG2' ' P' ' 129' ' ' ARG . 28.2 m120 -142.49 161.44 38.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 2.2 p -165.23 -169.98 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.0 111.889 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -58.17 158.48 6.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.926 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -77.63 -30.95 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.324 0.583 . . . . 0.0 109.741 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 129.09 38.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.697 0.761 . . . . 0.0 112.653 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -179.96 18.1 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.824 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.77 144.28 28.41 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.72 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.59 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 94.8 Cg_exo -39.39 -49.68 3.07 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.144 2.563 . . . . 0.0 113.603 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -43.41 76.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -71.79 -45.37 61.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' P' ' 80' ' ' ILE . 6.4 m120 -71.11 -76.59 0.1 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -31.94 -46.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -57.02 10.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.279 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -50.43 -46.59 56.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.037 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.55 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -67.9 -43.61 82.25 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.236 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -51.95 -37.38 52.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 109.842 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -51.1 63.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.708 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.55 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 0.8 OUTLIER -58.39 -39.59 80.06 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.96 -32.83 71.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.757 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -31.67 71.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.145 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.43 33.59 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.604 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 17.4 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.878 0.371 . . . . 0.0 111.088 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.31 -39.75 91.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.651 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.91 -24.39 69.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.16 -58.3 7.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.23 -32.46 72.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.686 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.46 98.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.389 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.32 -21.21 77.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.864 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -10.8 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.0 111.344 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -5.88 17.98 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.436 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.436 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 19.5 t -78.45 127.77 38.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.946 0.373 . . . . 0.0 111.097 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.4 143.08 57.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 111.494 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.81 -35.38 22.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.553 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -21.1 54.27 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.725 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.1 OUTLIER -94.02 -9.66 36.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.16 0.48 . . . . 0.0 111.387 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . 0.43 ' CB ' ' HG2' ' P' ' 91' ' ' LYS . 1.1 mt -106.76 140.13 40.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.674 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.09 143.44 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' P' ' 107' ' ' VAL . 15.9 p -115.7 159.87 20.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.676 0.274 . . . . 0.0 110.863 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' P' ' 106' ' ' THR . 46.4 t -164.57 114.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.415 ' OG ' HG23 ' P' ' 80' ' ' ILE . 58.5 p -111.82 134.71 53.2 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.433 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.524 ' O ' ' C ' ' P' ' 110' ' ' GLY . 95.2 m-85 -124.21 19.01 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.58 -109.79 0.01 OUTLIER Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 114.445 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -88.59 7.69 32.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.23 -60.35 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 110.327 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -142.09 89.18 8.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.941 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.99 166.99 9.6 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.692 2.261 . . . . 0.0 112.543 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.26 -63.08 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.46 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 36.7 t -89.04 112.19 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tp -65.0 137.97 58.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.14 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.37 176.19 14.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.82 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.407 ' CB ' ' OH ' ' P' ' 124' ' ' TYR . 17.8 p-80 -140.79 60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.886 0.343 . . . . 0.0 111.39 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.31 155.3 48.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.35 -30.79 0.11 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.78 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.11 79.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' P' ' 71' ' ' ASP . 5.2 m-85 -62.64 -39.29 93.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.054 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 14.2 m -65.14 -33.51 76.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.945 0.402 . . . . 0.0 109.971 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -73.98 -24.49 59.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.493 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -90.53 -30.87 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 76.2 mtm-85 -67.44 88.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.498 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.15 156.95 29.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.69 99.21 5.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 31.1 t -95.95 115.75 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' P' ' 65' ' ' LEU . 2.9 pp -85.72 123.59 31.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -131.68 151.8 51.35 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.015 179.653 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.94 0.4 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 67.2 m-85 -133.45 109.54 9.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.508 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.71 9.69 20.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.265 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.72 -36.06 2.23 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.593 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -121.34 162.4 20.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.431 . . . . 0.0 111.459 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 11.0 p -101.49 156.76 17.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.822 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 38.0 t -45.89 -41.55 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' P' ' 27' ' ' GLN . . . -66.2 -18.49 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' NE2' ' P' ' 27' ' ' GLN . 0.3 OUTLIER -99.26 -43.88 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.338 0.59 . . . . 0.0 110.008 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.525 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 1.9 mt -63.59 -19.2 64.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.557 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -25.04 22.35 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' P' ' 24' ' ' ASP . 2.9 pp0? -132.98 -8.66 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . 0.401 ' HD3' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -109.94 -66.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' P' ' 28' ' ' ARG . 67.3 m-85 -107.43 88.8 2.82 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.39 0.614 . . . . 0.0 111.513 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.511 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.2 OUTLIER -152.47 16.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.997 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.42 HG22 ' CE1' ' P' ' 33' ' ' TYR . 91.1 m -121.89 129.82 52.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 4.6 t -107.68 150.49 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.917 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.42 ' CE1' HG22 ' P' ' 31' ' ' THR . 37.5 m-85 -123.05 112.11 17.38 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -93.22 170.74 9.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.714 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.45 179.81 30.78 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.531 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.53 119.94 10.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 110.715 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t0 61.44 37.46 16.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.045 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -121.31 137.92 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.412 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 29.9 p90 -127.4 56.79 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 110.719 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.2 150.92 32.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.21 163.23 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.982 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 43.2 p -113.41 149.27 34.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.312 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.77 -32.4 3.03 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.31 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -64.17 -33.36 75.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.689 0.281 . . . . 0.0 111.614 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.424 ' CB ' HG12 ' P' ' 32' ' ' VAL . 78.4 m-85 -100.61 -3.71 29.93 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.408 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 70.2 t -61.79 -42.97 96.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.609 0.242 . . . . 0.0 111.351 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -43.83 -43.5 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.551 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.34 -46.8 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -58.27 -42.24 86.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.9 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -42.7 77.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.87 65.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.552 ' HA ' ' HD2' ' P' ' 55' ' ' TYR . 14.6 m-70 -62.5 -38.56 90.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 110.473 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . 0.419 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -68.58 -41.68 79.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.927 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.84 98.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.733 0.302 . . . . 0.0 111.147 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . 0.552 ' HD2' ' HA ' ' P' ' 52' ' ' HIS . 0.2 OUTLIER -71.84 -36.5 70.21 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.776 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.4 OUTLIER -75.14 -34.21 61.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.617 -178.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.55 -30.16 64.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.011 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 -17.85 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.376 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.402 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -112.58 111.79 51.69 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.301 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.93 -63.27 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.949 2.433 . . . . 0.0 114.421 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 22.59 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.403 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -89.5 112.96 24.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.349 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -117.01 132.87 56.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 14.4 p -98.64 146.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.547 0.689 . . . . 0.0 111.474 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.3 OUTLIER -107.3 103.65 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.462 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -83.59 100.2 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.387 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 5.5 tt0 -90.96 121.54 32.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.306 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.13 146.42 20.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.265 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' P' ' 129' ' ' ARG . 0.8 OUTLIER -145.33 161.08 40.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.632 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.416 ' CG2' ' NH1' ' P' ' 86' ' ' ARG . 0.5 OUTLIER -162.38 -172.99 3.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 111.638 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 6.0 p-10 -81.75 166.32 20.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.374 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 tm-20 -64.15 -39.0 93.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.932 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . 0.415 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 4.1 mmm180 -39.37 106.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -173.91 15.49 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.056 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.21 146.79 32.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.527 0.203 . . . . 0.0 110.646 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -45.46 -40.89 18.01 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.479 2.119 . . . . 0.0 112.644 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.37 -41.27 89.68 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -69.42 -44.2 71.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' P' ' 80' ' ' ILE . 27.8 m120 -61.84 -75.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.636 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.6 OUTLIER -30.01 -45.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 O-C-N 123.185 0.303 . . . . 0.0 111.737 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.13 -60.65 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.607 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.21 -45.98 8.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.767 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.9 -38.24 92.76 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.82 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -44.01 63.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.865 0.364 . . . . 0.0 110.226 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -39.72 90.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.416 ' NH1' ' CG2' ' P' ' 70' ' ' THR . 3.0 mtt180 -61.65 -39.85 92.84 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.52 81.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.143 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -32.01 73.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.495 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.53 -63.53 1.24 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.514 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.23 -37.09 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 111.403 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -61.73 2.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.8 -20.3 59.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.363 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.69 -58.78 5.83 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 mt -59.41 -30.04 68.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.373 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.63 94.82 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.243 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.12 -26.71 73.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.892 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . 0.419 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 1.2 mtpm? -78.23 -9.92 59.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.68 0.276 . . . . 0.0 111.26 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.12 -3.2 23.98 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.152 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.458 HG13 HD23 ' P' ' 56' ' ' LEU . 16.8 t -74.68 126.14 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.766 0.283 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.432 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.3 OUTLIER -62.37 139.23 58.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.0 111.566 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.99 -32.84 74.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.294 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.46 -19.99 58.39 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.189 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.99 -4.32 26.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.198 0.523 . . . . 0.0 111.035 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . 0.429 ' CD2' HG13 ' P' ' 99' ' ' VAL . 0.5 OUTLIER -110.8 120.48 42.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -124.94 -175.17 14.17 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.852 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.403 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 15.8 p -149.21 163.12 38.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.885 0.374 . . . . 0.0 111.279 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' P' ' 67' ' ' GLU . 0.1 OUTLIER -177.0 111.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.47 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.636 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 1.1 p -111.9 145.54 39.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 0.0 111.812 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' P' ' 110' ' ' GLY . 83.7 m-85 -121.16 23.83 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 11.56 -115.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.859 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.36 17.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.175 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -59.1 -54.42 47.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 110.113 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -141.33 89.74 9.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.364 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.53 165.73 10.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.712 2.275 . . . . 0.0 112.534 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -59.72 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 t -88.21 109.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -75.98 134.07 40.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.777 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.04 -179.15 27.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.616 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -142.51 73.89 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -168.53 161.89 11.84 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 0.0 OUTLIER -46.35 -24.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.83 -59.06 3.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 -40.29 67.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 25.4 m-85 -60.48 -43.26 97.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 95.4 p -68.21 -33.34 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -71.89 -22.85 61.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.218 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -87.41 -29.21 21.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.357 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -66.35 90.2 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.246 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.438 ' O ' ' CB ' ' P' ' 69' ' ' ASN . 0.8 OUTLIER -158.81 158.6 33.83 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.67 107.84 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.85 147.75 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -100.53 100.02 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.586 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -104.55 143.87 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . 0.511 ' CE1' ' OH ' ' P' ' 55' ' ' TYR . 8.1 m-85 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -89.74 106.48 18.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.75 9.4 26.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.552 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.26 -38.35 1.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.795 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.415 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 17.7 m-85 -121.67 170.93 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 111.822 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.36 150.69 23.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.887 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 t -38.26 -63.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.53 -13.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -46.35 5.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.552 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 12.5 mt -56.88 -22.24 35.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.506 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.64 -11.96 16.65 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -115.77 -27.32 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -55.91 2.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -108.21 81.83 1.54 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.174 0.512 . . . . 0.0 111.914 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.415 ' ND2' ' NE2' ' P' ' 52' ' ' HIS . 0.2 OUTLIER -140.39 13.71 2.37 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.918 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.432 HG21 ' CE1' ' P' ' 33' ' ' TYR . 53.8 m -134.56 136.63 43.15 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' P' ' 45' ' ' TYR . 10.5 t -108.6 150.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.077 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.432 ' CE1' HG21 ' P' ' 31' ' ' THR . 34.6 m-85 -123.75 114.54 20.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 22.3 m-30 -93.4 170.59 9.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.777 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.31 -172.25 31.01 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.98 126.34 27.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.27 0.535 . . . . 0.0 110.673 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 46.64 33.77 2.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -96.08 141.51 29.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.689 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 3.3 t80 -129.85 48.81 2.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.714 0.769 . . . . 0.0 109.767 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -150.29 151.01 32.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.955 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.08 161.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.559 0.219 . . . . 0.0 110.661 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 16.2 p -110.83 144.8 39.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.032 0.444 . . . . 0.0 111.755 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.58 -30.17 3.13 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 113.413 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . 0.438 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 0.6 OUTLIER -63.27 -31.34 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.689 0.281 . . . . 0.0 111.721 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.407 ' CB ' HG12 ' P' ' 32' ' ' VAL . 87.8 m-85 -105.7 4.71 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 72.0 t -70.9 -37.17 67.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' P' ' 44' ' ' GLU . 0.0 OUTLIER -52.42 -31.99 37.02 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.557 -178.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.549 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -62.86 -49.98 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.191 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mp -53.57 -37.45 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.62 -39.24 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.708 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.48 -57.32 4.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 20.0 m-70 -54.31 -37.85 65.29 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.49 95.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.729 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.98 96.81 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.865 0.364 . . . . 0.0 110.551 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -73.86 -38.33 64.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.447 HD12 ' N ' ' P' ' 64' ' ' VAL . 4.5 tp -65.48 -43.12 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.352 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.06 -37.67 78.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.445 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.85 -24.04 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.37 114.88 42.69 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.52 -48.6 19.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 113.894 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.7 18.48 7.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.446 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.64 116.57 28.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 0.0 110.711 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -118.19 133.96 55.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.953 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.447 ' N ' HD12 ' P' ' 56' ' ' LEU . 9.3 p -95.57 141.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.345 0.593 . . . . 0.0 111.259 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' P' ' 133' ' ' ALA . 5.1 tt -108.96 101.03 10.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.725 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -79.27 112.24 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.329 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 8.2 mt-10 -99.72 117.56 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.1 22.15 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.997 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' P' ' 129' ' ' ARG . 0.9 OUTLIER -145.5 157.92 43.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.814 0.34 . . . . 0.0 110.32 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 1.5 p -168.03 -176.65 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.059 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 6.1 p-10 -72.42 155.58 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.49 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pm0 -62.4 -34.23 76.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.018 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -39.68 106.92 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . 0.48 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.69 168.25 17.42 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.569 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 75' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' P' ' 79' ' ' ASN . 0.5 OUTLIER -83.03 146.16 51.11 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.653 0.263 . . . . 0.0 110.568 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.11 -36.36 84.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.957 2.438 . . . . 0.0 114.182 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . 0.402 ' O ' HG21 ' P' ' 80' ' ' ILE . 1.0 OUTLIER -64.12 -48.96 74.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.79 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -75.07 -30.25 60.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -65.38 -74.54 0.1 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.612 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.3 OUTLIER -32.27 -38.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 O-C-N 123.23 0.332 . . . . 0.0 111.231 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -61.41 -59.37 5.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.499 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.22 -50.85 20.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.922 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.472 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.72 -45.24 86.06 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.598 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -49.25 -38.69 27.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.281 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -67.65 -46.65 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.715 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.489 ' HG2' ' HA ' ' P' ' 39' ' ' TYR . 0.4 OUTLIER -58.27 -40.65 82.43 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.12 -31.98 70.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.124 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -32.13 70.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.429 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.53 -60.16 4.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.8 -35.62 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -42.83 97.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.502 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.77 -22.63 78.93 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.88 -62.09 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . 0.413 ' CD1' HG12 ' P' ' 64' ' ' VAL . 75.3 mt -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.501 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.62 92.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.753 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.37 -24.44 76.07 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -73.17 -10.06 59.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.79 36.41 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.934 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 22.2 t -75.8 128.8 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.24 138.64 57.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.28 -36.03 60.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.04 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.06 -15.53 60.71 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.043 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 7.0 mtpp -92.88 -11.44 33.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 mt -103.68 142.81 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.69 145.64 14.47 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 15.2 p -123.27 162.57 22.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.956 0.407 . . . . 0.0 111.313 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' CD2' ' P' ' 65' ' ' LEU . 0.0 OUTLIER 179.05 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.599 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -98.69 142.55 30.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.902 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.553 ' O ' ' HG3' ' P' ' 112' ' ' GLU . 34.7 m-85 -113.31 13.81 19.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.89 -109.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.045 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -107.96 15.31 24.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' P' ' 109' ' ' TYR . 0.2 OUTLIER -63.25 -45.02 93.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.633 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . 0.411 ' N ' ' OE2' ' P' ' 112' ' ' GLU . 20.9 mtmm -146.51 88.93 5.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.71 164.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 0.0 113.143 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.37 -61.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.507 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 t -88.41 109.79 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.27 136.12 47.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.109 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.56 173.17 13.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -140.88 92.89 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.068 0.434 . . . . 0.0 111.994 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -166.64 162.37 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . 0.416 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.2 OUTLIER -47.08 -25.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.578 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.02 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.725 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.64 69.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 12.9 m-85 -54.55 -50.52 67.73 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.072 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -65.99 -33.81 76.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -68.04 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.46 -29.75 21.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 5.4 mtp180 -65.49 88.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -158.3 157.46 32.5 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.71 95.26 4.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.44 112.62 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.409 ' HB2' ' ND2' ' P' ' 30' ' ' ASN . 0.3 OUTLIER -63.8 105.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.565 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -100.55 128.41 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.482 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.831 179.732 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 54.9 m-85 -136.04 108.42 7.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 111.282 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 9.95 32.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.424 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 -31.66 3.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.563 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.407 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 33.5 m-85 -117.29 161.8 18.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 16.7 t -111.15 160.57 16.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.755 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 17.2 t -40.06 -56.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.37 -19.94 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.76 -43.61 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.298 0.57 . . . . 0.0 110.283 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.468 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 47.1 mt -67.94 -22.0 65.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.44 -20.88 26.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -143.42 -3.57 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 -69.87 0.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -108.86 89.56 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 112.101 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -150.14 18.75 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 86.9 m -126.3 132.01 51.74 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.833 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.417 HG13 ' N ' ' P' ' 33' ' ' TYR . 23.6 t -108.36 149.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.417 ' N ' HG13 ' P' ' 32' ' ' VAL . 9.1 m-85 -113.41 113.44 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.623 0.725 . . . . 0.0 112.301 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.761 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 7.1 m-30 -90.29 174.49 7.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.567 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.89 -177.85 15.06 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -62.34 136.45 57.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.82 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.0 28.21 0.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.269 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.447 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -105.5 127.75 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.704 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.442 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 23.3 p90 -128.11 43.56 3.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.478 . . . . 0.0 110.2 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -148.06 150.51 34.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.345 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . 0.413 ' CG2' HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -89.06 166.32 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.78 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 47.1 p -111.09 150.1 29.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.125 0.488 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.427 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.56 -31.2 3.54 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.337 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . 0.425 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 2.2 mm-40 -63.03 -32.44 73.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.405 ' O ' HG13 ' P' ' 48' ' ' ILE . 92.1 m-85 -104.05 5.11 35.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.427 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 76.3 t -70.68 -39.92 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' P' ' 44' ' ' GLU . 0.0 OUTLIER -49.81 -33.74 17.51 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.681 -178.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.542 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -59.17 -52.56 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 110.065 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.57 -33.32 63.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.23 -43.04 68.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.9 -37.06 62.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.542 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 28.4 m-70 -69.04 -38.73 79.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.84 94.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.347 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.36 90.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.021 0.439 . . . . 0.0 110.311 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . 0.433 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 7.8 t80 -72.56 -40.4 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.474 HD13 ' N ' ' P' ' 64' ' ' VAL . 1.8 tp -61.64 -44.24 97.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -65.95 -41.8 90.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.94 3.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.412 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . 0.5 OUTLIER -113.77 118.05 43.48 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.483 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.56 -56.5 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.715 2.277 . . . . 0.0 113.727 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 23.42 1.59 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.453 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -91.5 131.82 36.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 110.547 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -137.35 137.72 39.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.997 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.474 ' N ' HD13 ' P' ' 56' ' ' LEU . 9.9 p -98.16 141.29 16.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.519 0.675 . . . . 0.0 111.533 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' P' ' 133' ' ' ALA . 4.9 tt -108.97 103.62 12.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.32 113.62 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 110.94 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.02 118.72 37.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -104.06 139.54 14.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.582 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 127' ' ' ASN . 57.0 m-80 -145.76 104.62 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.417 ' CG2' ' NH1' ' P' ' 86' ' ' ARG . 39.2 p -86.21 -176.54 5.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.423 ' HB2' ' CE1' ' P' ' 124' ' ' TYR . 10.4 p-10 -71.09 165.47 23.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.442 ' O ' ' CD ' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -66.68 -35.68 80.73 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.94 114.08 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.66 -142.12 17.3 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.807 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.29 146.11 52.65 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.512 0.196 . . . . 0.0 110.614 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.459 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 87.8 Cg_exo -44.68 -43.95 14.27 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.589 2.192 . . . . 0.0 113.715 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.72 -46.36 88.48 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -72.83 -36.56 67.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.949 0.404 . . . . 0.0 110.006 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' P' ' 80' ' ' ILE . 5.4 m120 -67.99 -74.33 0.12 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.619 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -29.98 -44.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.911 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -57.89 11.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.224 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.2 OUTLIER -46.53 -44.36 17.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.245 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.441 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -65.73 -38.13 94.17 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.564 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.34 -43.49 43.82 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -67.98 -33.72 75.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.466 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.447 ' NE ' ' O ' ' P' ' 38' ' ' LYS . 56.0 mtt180 -65.11 -49.23 70.75 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.543 0.687 . . . . 0.0 109.277 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.14 -34.81 74.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.704 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.45 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.89 -67.51 0.42 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.691 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 59.0 t -53.16 -43.35 49.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.112 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -40.98 85.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.546 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.77 -15.58 80.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.914 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -72.75 -64.27 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.78 -32.62 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.396 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.75 89.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.828 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.13 -22.75 77.41 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.605 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -76.04 -10.03 59.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.806 0.336 . . . . 0.0 110.975 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.3 35.73 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.148 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 18.2 t -75.63 125.81 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.852 0.326 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' P' ' 103' ' ' LYS . 2.5 p30 -62.34 139.54 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.335 0.588 . . . . 0.0 111.565 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.48 -36.35 10.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.449 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.99 -17.1 60.55 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.078 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' P' ' 63' ' ' LYS . 24.3 mtpp -91.49 -14.51 30.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.036 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mt -102.62 143.07 32.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -139.92 146.14 17.48 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 19.4 p -128.78 152.04 48.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.783 0.325 . . . . 0.0 110.652 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.445 ' CG2' ' CD2' ' P' ' 65' ' ' LEU . 0.0 OUTLIER -175.39 119.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.619 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -118.53 133.63 55.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.522 ' O ' ' C ' ' P' ' 110' ' ' GLY . 23.7 m-85 -102.01 32.48 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -103.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.539 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' P' ' 72' ' ' GLU . 41.7 mt-10 -113.89 16.87 18.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -47.21 66.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.66 89.34 11.78 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.6 163.39 15.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.683 2.255 . . . . 0.0 112.935 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.73 -64.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.85 108.74 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.89 135.83 54.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.46 173.94 14.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.085 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -140.74 60.95 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.05 152.14 51.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . 0.411 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.1 OUTLIER -37.78 -33.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.28 -61.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.84 -42.63 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.992 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.441 ' O ' ' HD3' ' P' ' 128' ' ' ARG . 4.7 m-85 -56.65 -54.0 51.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.196 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 125' ' ' SER . . . . . 0.542 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 4.8 m -55.68 -35.59 66.2 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -75.44 -21.22 58.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.56 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 69' ' ' ASN . 44.9 m-20 -80.95 -42.76 20.77 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.39 73.58 0.72 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.949 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.6 143.42 49.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.11 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.61 98.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.66 111.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 101.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.589 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -97.6 125.65 42.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.46 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.945 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 33.2 p . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 45.5 m-85 -129.98 112.08 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.678 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.35 9.62 61.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.584 -0.817 . . . . 0.0 114.08 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 -27.4 3.86 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.137 -1.506 . . . . 0.0 114.529 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.15 173.89 8.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.285 0.542 . . . . 0.0 111.726 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.89 151.52 21.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 t -44.5 -35.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.898 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.59 -13.04 38.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.612 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' P' ' 29' ' ' TYR . 0.4 OUTLIER -98.16 -44.37 6.63 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.849 0.833 . . . . 0.0 108.891 177.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 7.5 mt -58.89 -23.36 60.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.348 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -111.87 -19.19 12.48 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 -32.23 2.99 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -141.57 59.92 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 0.5 OUTLIER 157.5 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.974 0.416 . . . . 0.0 110.691 178.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 172.95 15.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.414 HG23 ' CE1' ' P' ' 33' ' ' TYR . 57.3 m -120.4 126.82 51.41 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.628 0.649 . . . . 0.0 112.203 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 3.4 t -108.18 145.35 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.414 ' CE1' HG23 ' P' ' 31' ' ' THR . 39.6 m-85 -119.49 115.19 23.54 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -96.04 168.28 10.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.766 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.53 -171.87 28.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.976 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.8 116.52 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.656 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 58.33 39.2 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.41 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 1.7 tptp -112.97 136.15 52.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -130.33 54.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.58 150.59 33.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.76 161.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.781 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 30.7 p -112.71 147.72 36.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.017 0.437 . . . . 0.0 111.385 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.77 -30.17 3.39 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.082 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.49 -33.89 75.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.562 0.22 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -104.49 3.36 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.57 -41.14 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' P' ' 47' ' ' GLN . 6.5 pm0 -47.6 -35.05 8.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.711 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.486 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -64.37 -46.78 92.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.536 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . 0.421 ' HB3' ' CE1' ' P' ' 93' ' ' TYR . 5.6 mp -56.87 -47.34 80.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.375 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . 0.44 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.3 OUTLIER -67.45 -33.52 75.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.428 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.9 -41.03 37.93 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.685 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 22.3 m-70 -64.21 -38.46 91.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.26 88.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . 0.438 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 21.6 t80 -79.2 -34.45 42.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.441 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 5.0 tp -66.51 -41.3 89.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -75.64 -34.54 60.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.653 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.93 -24.85 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.57 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.401 ' OG1' ' CB ' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -112.57 114.82 49.74 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.634 0.254 . . . . 0.0 110.389 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -48.94 -63.12 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.876 2.384 . . . . 0.0 114.039 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.27 18.85 2.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.447 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -84.56 113.57 21.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.9 mttp -115.59 128.46 55.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.51 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.6 p -96.2 139.98 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 121.305 0.574 . . . . 0.0 110.641 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.45 103.09 11.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.956 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.47 106.45 12.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.479 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.416 ' HA ' HG22 ' P' ' 107' ' ' VAL . 20.7 mt-10 -89.8 119.32 30.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.526 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 134.53 12.52 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' P' ' 129' ' ' ARG . 27.3 m120 -134.62 159.02 42.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.438 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.402 HG21 ' O ' ' P' ' 69' ' ' ASN . 7.6 p -164.42 -177.61 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.162 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.493 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 8.2 p-10 -73.55 155.6 38.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' P' ' 111' ' ' GLU . 2.6 pp20? -63.49 -34.86 78.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.962 0.41 . . . . 0.0 110.641 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . 0.408 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -41.8 165.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.438 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.4 -124.47 6.7 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.773 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -163.62 145.53 7.52 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.477 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 2.4 Cg_endo -39.61 -53.13 2.36 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.297 2.664 . . . . 0.0 113.25 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -40.73 93.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.37 -35.16 68.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.453 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.532 ' O ' HD13 ' P' ' 82' ' ' LEU . 5.6 m120 -76.94 -76.88 0.16 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.537 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.04 -43.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.3 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -68.86 -60.72 2.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.532 HD13 ' O ' ' P' ' 79' ' ' ASN . 0.0 OUTLIER -57.14 -38.42 73.49 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.272 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.521 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -68.46 -50.96 34.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.341 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.4 mt-30 -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -46.49 88.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.324 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.441 ' CD ' ' HA2' ' P' ' 83' ' ' GLY . 0.4 OUTLIER -57.27 -42.62 81.95 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.44 79.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.147 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -32.34 73.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.467 178.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.59 84.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.697 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.01 -34.69 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.702 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -38.69 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.525 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.96 -29.47 58.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . 0.46 ' CD1' ' HE3' ' P' ' 97' ' ' LYS . 7.6 t80 -62.87 -53.76 49.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . 0.574 ' HA ' ' HD2' ' P' ' 97' ' ' LYS . 20.3 mt -59.48 -28.62 67.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.263 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.57 -36.63 65.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.914 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.45 58.01 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.092 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . 0.574 ' HD2' ' HA ' ' P' ' 94' ' ' LEU . 0.0 OUTLIER -49.42 -34.76 17.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.92 28.94 1.6 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.386 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . . . . . . . . . 23.1 t -90.71 145.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.567 0.223 . . . . 0.0 110.822 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.5 160.45 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.283 0.563 . . . . 0.0 111.526 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.64 -32.52 16.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.316 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.1 -21.67 46.93 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.48 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.08 -4.57 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.22 0.533 . . . . 0.0 110.923 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.74 150.51 24.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.206 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.9 139.67 8.12 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 34.6 p -141.57 151.2 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' P' ' 67' ' ' GLU . 0.2 OUTLIER -166.95 170.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.855 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 1.3 t -157.38 126.93 6.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.726 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.3 m-85 -115.49 18.49 15.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -1.28 -113.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.597 -0.729 . . . . 0.0 114.804 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -85.35 2.54 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.91 -57.05 14.47 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 88.22 5.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.76 170.81 18.69 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.022 2.481 . . . . 0.0 112.838 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.46 -56.03 2.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.152 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.471 HG12 ' CA ' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -88.72 138.61 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.699 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.44 139.41 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.154 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.19 176.93 15.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.881 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.464 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 0.2 OUTLIER -141.06 62.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 0.249 . . . . 0.0 111.279 -179.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.92 154.91 49.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.81 -26.09 0.12 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.69 -62.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.97 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.471 ' CA ' HG12 ' P' ' 116' ' ' VAL . . . -69.79 -42.43 73.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 1.0 OUTLIER -55.65 -48.76 74.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.759 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 58.2 m -63.34 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.397 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -68.33 -27.13 66.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.325 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.431 ' ND2' HG11 ' P' ' 116' ' ' VAL . 92.0 m-20 -89.07 -28.95 19.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -70.16 86.89 0.57 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 7.6 ptt-85 -159.79 159.18 32.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -123.63 102.35 7.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -86.87 109.58 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.3 OUTLIER -59.68 102.19 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.572 178.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 126.92 48.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.678 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.874 179.624 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 CA--C 1.526 0.036 0 CA-C-O 120.805 0.336 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' P' ' 20' ' ' TYR . 63.4 m-85 -89.68 107.16 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.994 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.75 9.33 38.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.645 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.67 -37.1 1.87 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.349 -1.405 . . . . 0.0 114.037 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' P' ' 17' ' ' PHE . 5.3 m-85 -120.76 169.14 10.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.023 0.411 . . . . 0.0 111.586 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 26.0 t -102.78 152.99 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.439 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -40.07 -48.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.36 -17.27 28.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -42.61 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.284 0.564 . . . . 0.0 110.427 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 16.3 mt -59.27 -21.22 59.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.436 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . 0.425 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 4.5 mm-40 -103.26 -12.6 17.17 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -125.21 -22.72 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -109.78 -62.16 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -108.25 83.58 1.8 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.288 0.566 . . . . 0.0 112.162 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.536 HD21 ' HB2' ' P' ' 132' ' ' LEU . 0.1 OUTLIER -141.53 13.45 2.14 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.933 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 95.2 m -134.28 135.99 43.23 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.434 HG13 ' CB ' ' P' ' 45' ' ' TYR . 3.0 t -108.37 150.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.07 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.32 115.62 21.98 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.2 m-30 -96.18 169.87 9.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.512 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.56 -168.95 19.41 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.818 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.58 126.14 26.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 49.75 30.57 3.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.618 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.402 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -101.13 132.55 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -129.35 46.26 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 110.822 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.41 150.43 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.808 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.9 164.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.259 . . . . 0.0 110.896 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 67.2 p -112.8 149.98 32.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.213 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.4 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.48 -32.51 1.92 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.228 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.89 -33.06 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.415 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.434 ' CB ' HG13 ' P' ' 32' ' ' VAL . 81.4 m-85 -102.27 -1.02 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.4 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 79.4 t -65.59 -40.98 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.283 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.468 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -43.85 -43.44 6.3 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.536 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -57.39 -50.34 77.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 110.556 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 mt -53.32 -37.46 62.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -40.26 56.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.13 -54.22 11.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.03 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.536 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 22.7 m-70 -56.98 -36.8 70.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 109.904 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.53 97.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.903 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.07 95.51 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.854 0.359 . . . . 0.0 110.751 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.33 -36.43 53.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.437 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 8.0 tp -68.93 -39.42 79.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.935 0.398 . . . . 0.0 111.174 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.05 -36.74 66.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.192 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.45 -23.28 67.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.22 111.24 58.04 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.602 0.239 . . . . 0.0 110.363 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.17 -58.67 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.863 2.375 . . . . 0.0 113.927 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.65 2.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.41 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -89.18 116.95 27.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.77 131.12 57.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.038 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.419 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 3.9 p -95.98 133.69 36.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.433 0.635 . . . . 0.0 111.15 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.445 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.2 tt -109.79 103.67 12.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.793 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.41 108.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.73 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.408 ' HA ' HG23 ' P' ' 107' ' ' VAL . 2.4 tt0 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.773 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.77 128.58 8.87 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.722 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.412 ' O ' HG23 ' P' ' 70' ' ' THR . 1.8 m-80 -130.93 158.0 41.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.9 OUTLIER -170.25 -175.19 1.89 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 111.495 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.533 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 14.0 p-10 -77.43 149.39 35.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.302 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 9.2 pm0 -57.71 -31.63 66.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.883 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . 0.419 ' N ' ' HG2' ' P' ' 72' ' ' GLU . 2.9 tpp180 -40.74 107.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.36 -173.69 15.03 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.163 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.76 145.52 30.87 Favored Pre-proline 0 N--CA 1.466 0.355 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.409 ' HG3' ' OE2' ' P' ' 111' ' ' GLU . 81.4 Cg_exo -39.97 -46.79 3.91 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.916 2.411 . . . . 0.0 113.063 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.84 -40.99 94.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.99 -39.01 63.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -68.78 -76.75 0.09 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' P' ' 79' ' ' ASN . 1.0 OUTLIER -30.64 -45.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.433 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.37 -57.62 11.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.487 ' O ' ' HG2' ' P' ' 85' ' ' ARG . 0.2 OUTLIER -45.31 -51.86 10.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.779 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.454 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -62.23 -35.84 92.16 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.482 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -47.9 65.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.913 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 0.0 OUTLIER -68.1 -32.99 73.69 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.827 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.454 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 6.6 mtt180 -65.22 -45.99 82.46 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.555 0.693 . . . . 0.0 109.229 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' P' ' 106' ' ' THR . . . -60.35 -35.55 75.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.749 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.99 -30.74 71.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.87 -56.35 20.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.938 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.04 -36.17 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -43.77 98.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.21 -24.44 76.42 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.98 -64.04 1.0 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 85.2 mt -53.83 -32.82 54.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.6 88.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.053 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.72 -21.08 77.85 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -79.85 -9.52 59.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 122.74 0.416 . . . . 0.0 110.974 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.94 0.18 36.01 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.776 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.437 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 48.6 t -73.63 123.71 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.36 148.61 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.24 75.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.673 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.39 -22.1 55.44 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.045 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -100.05 -4.43 29.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.229 0.537 . . . . 0.0 111.133 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 37.2 mt -95.91 150.12 20.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.298 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -148.42 142.07 9.66 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.408 ' HB ' ' CB ' ' P' ' 87' ' ' ALA . 45.0 p -134.02 155.69 49.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.668 0.27 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.445 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.1 OUTLIER -170.77 171.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 108' ' ' SER . . . . . . . . . . . . . 14.7 p -162.62 134.54 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.633 0.254 . . . . 0.0 111.48 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.509 ' O ' ' C ' ' P' ' 110' ' ' GLY . 29.5 m-85 -123.62 23.59 8.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 1.25 -110.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 114.622 0.609 . . . . 0.0 114.622 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.498 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -84.05 5.06 27.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -54.71 -59.57 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 88.78 7.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.98 166.96 13.05 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.79 2.327 . . . . 0.0 113.018 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.72 -61.64 1.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.27 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.84 108.86 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.83 136.53 56.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.199 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.06 174.98 14.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.981 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.457 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 7.2 p-80 -141.12 61.09 1.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.765 0.283 . . . . 0.0 111.462 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.16 156.35 44.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -43.66 -25.82 0.19 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.13 -56.66 4.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.89 -43.19 68.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.666 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.533 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 2.0 m-85 -59.48 -47.38 85.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 94.6 p -63.36 -33.44 75.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 110.241 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -24.49 63.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.887 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.85 -30.8 18.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.335 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 3.0 mtp180 -65.82 87.25 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.32 157.17 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.06 96.23 4.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.02 109.71 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.536 ' HB2' HD21 ' P' ' 30' ' ' ASN . 0.3 OUTLIER -60.92 101.81 0.17 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.031 178.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -100.22 127.84 46.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.755 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.889 179.758 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -137.04 107.17 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.18 9.64 12.26 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.358 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.79 -41.41 1.32 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.819 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -126.65 172.59 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.967 0.413 . . . . 0.0 111.504 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -99.72 152.26 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.949 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t -42.13 -53.85 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.315 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.46 -14.94 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -44.79 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 109.483 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 2.6 mt -59.06 -21.98 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.997 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -100.75 -11.93 19.51 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -121.86 -21.82 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . 0.457 ' HD3' ' CZ ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -118.39 -55.44 2.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.457 ' CZ ' ' HD3' ' P' ' 28' ' ' ARG . 53.0 m-85 -108.78 101.41 10.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.179 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 1.4 p30 -170.44 20.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.247 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.429 HG22 ' CE1' ' P' ' 33' ' ' TYR . 82.7 m -128.88 131.29 47.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.178 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.98 143.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.211 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.429 ' CE1' HG22 ' P' ' 31' ' ' THR . 45.3 m-85 -117.28 118.55 32.59 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.51 170.73 7.86 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.132 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.45 -165.77 15.34 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.433 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . 0.407 ' CE2' ' OD2' ' P' ' 37' ' ' ASP . 2.7 t80 -57.65 123.74 16.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.51 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . 0.407 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 3.2 p30 42.01 28.61 0.1 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.002 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -90.44 130.14 36.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.626 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 9.1 t80 -125.03 59.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.52 149.98 29.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.91 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 8.6 mt -96.83 161.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 3.9 p -110.47 140.72 44.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 112.025 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.6 -30.03 3.1 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.095 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.84 -33.49 76.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.55 0.214 . . . . 0.0 111.552 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.403 ' O ' HG13 ' P' ' 48' ' ' ILE . 83.1 m-85 -101.26 0.17 36.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.42 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 75.6 t -66.87 -40.81 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.401 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -45.11 -43.52 9.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.423 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.52 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -54.08 -52.46 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.292 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 mp -50.92 -40.27 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.385 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -38.29 64.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.928 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.02 -58.89 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.821 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 18.8 m-70 -51.54 -37.0 47.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.171 0.51 . . . . 0.0 109.784 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . 0.443 ' CB ' ' CE ' ' P' ' 97' ' ' LYS . . . -60.98 -48.16 83.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.289 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.85 76.86 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.926 0.394 . . . . 0.0 110.372 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -71.47 -42.12 68.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.676 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.446 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.4 OUTLIER -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.301 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -67.29 -43.06 82.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.09 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.331 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.41 95.64 45.02 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.88 -24.61 39.58 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 113.29 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.9 5.27 51.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.411 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.55 127.03 36.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.8 mttp -121.51 130.56 53.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.046 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.446 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.1 p -97.38 147.34 6.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.502 0.668 . . . . 0.0 111.536 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.5 tt -119.78 104.24 10.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.665 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.15 109.87 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.618 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 1.6 mm-40 -89.7 121.55 31.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.54 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.25 133.84 11.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.881 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -145.82 100.98 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.778 0.323 . . . . 0.0 110.754 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -168.68 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.407 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 13.0 p-10 -81.79 164.91 21.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.974 0.416 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.506 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 10.1 tm-20 -66.93 -40.59 87.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.246 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . 0.407 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -44.97 106.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.037 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.27 -164.83 12.01 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.479 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.27 146.02 34.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.657 0.265 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 71.8 Cg_exo -50.78 -38.22 56.39 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.13 2.553 . . . . 0.0 114.158 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.55 -42.8 83.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . 0.466 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 40.5 t80 -81.73 -29.26 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.482 ' HB2' ' OE1' ' P' ' 111' ' ' GLU . 2.0 m-80 -90.62 -11.54 39.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -87.58 -40.74 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.2 -48.67 64.59 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.269 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -60.24 -38.46 83.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.126 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.544 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -69.4 -44.52 64.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.139 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.7 OUTLIER -50.63 -41.3 54.88 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.65 -35.42 80.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -64.24 -52.39 58.95 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.98 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.476 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -29.43 69.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.49 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.75 -50.77 63.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.629 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.15 -38.76 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' P' ' 92' ' ' GLY . 0.0 OUTLIER -61.97 -40.68 96.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.234 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -72.09 -28.3 68.66 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . 0.439 ' CD1' ' HD2' ' P' ' 97' ' ' LYS . 4.3 t80 -59.97 -62.24 2.02 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . 0.626 ' HA ' ' HD3' ' P' ' 97' ' ' LYS . 95.4 mt -54.43 -32.42 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.55 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.18 76.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.169 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.78 -29.75 75.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.547 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' P' ' 94' ' ' LEU . 0.7 OUTLIER -74.13 -11.6 60.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.11 3.49 15.24 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 28.2 t -80.98 131.82 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.897 0.349 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.416 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -60.31 158.02 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.333 0.587 . . . . 0.0 111.556 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.42 -29.94 22.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.71 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.53 50.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.807 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.93 -3.77 31.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.145 0.497 . . . . 0.0 111.163 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mt -91.68 149.21 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.336 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.89 139.79 8.45 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 43.5 p -138.45 151.43 47.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.767 0.318 . . . . 0.0 110.975 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.441 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -161.27 169.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.133 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.441 ' O ' HG12 ' P' ' 80' ' ' ILE . 51.6 p -162.68 130.04 3.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.506 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.552 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.0 OUTLIER -114.19 31.55 6.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.234 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.77 -113.12 0.01 OUTLIER Glycine 0 C--N 1.34 0.796 0 O-C-N 123.679 0.612 . . . . 0.0 114.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 2.7 mp0 -97.71 13.18 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' P' ' 76' ' ' PRO . 26.0 mt-10 -61.72 -55.23 32.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.679 0.276 . . . . 0.0 110.378 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -134.19 89.83 27.24 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 161.2 8.98 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.641 2.227 . . . . 0.0 112.967 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.92 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.712 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -88.61 108.82 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.98 135.04 57.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.388 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.93 173.3 14.72 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.787 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CD1' ' P' ' 124' ' ' TYR . 0.6 OUTLIER -141.21 64.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.787 0.294 . . . . 0.0 111.492 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.82 152.88 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -38.0 -32.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -60.93 2.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -43.93 74.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.471 ' CD1' ' HA ' ' P' ' 119' ' ' HIS . 0.8 OUTLIER -57.71 -52.99 63.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.316 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 11.2 t -59.33 -33.96 71.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -27.84 67.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.572 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 69' ' ' ASN . 74.3 m-20 -82.96 -33.48 26.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.88 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -69.74 80.21 0.44 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.815 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -156.56 150.86 25.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.95 115.91 25.35 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.8 112.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.3 OUTLIER -59.41 98.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.632 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -102.36 129.1 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.009 179.773 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.81 0.338 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 94.2 m-85 -89.48 108.1 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.498 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.97 9.14 38.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.333 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -32.97 2.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.488 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' P' ' 17' ' ' PHE . 2.1 m-85 -115.41 160.61 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.025 0.441 . . . . 0.0 111.611 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 9.4 t -103.2 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.262 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t -43.3 -41.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -17.27 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 -40.58 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.568 0.699 . . . . 0.0 110.012 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' P' ' 29' ' ' TYR . 6.3 mt -64.27 -15.34 59.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.564 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . 0.466 ' HG3' ' CD2' ' P' ' 134' ' ' TYR . 2.0 tt0 -92.78 -25.47 18.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.39 -9.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -117.12 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 54.0 m-85 -107.12 99.49 9.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 111.961 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 1.3 p30 -178.38 27.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.22 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.425 HG21 ' CE1' ' P' ' 33' ' ' TYR . 78.6 m -126.48 127.08 44.81 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.791 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 1.9 t -104.19 150.13 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.157 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' P' ' 31' ' ' THR . 53.0 m-85 -124.63 112.64 17.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.243 0.544 . . . . 0.0 112.429 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -91.51 166.66 12.73 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.97 -167.64 19.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.064 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.54 126.32 26.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.016 0.436 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t0 53.09 27.92 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.568 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -100.97 136.8 40.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.478 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 46.4 p90 -135.72 36.05 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.22 150.63 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.799 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.26 164.66 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.933 0.397 . . . . 0.0 111.069 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.38 149.06 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.427 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -41.18 -33.96 0.85 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.527 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.2 -31.79 72.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.644 0.259 . . . . 0.0 111.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.487 ' O ' HG13 ' P' ' 48' ' ' ILE . 71.2 m-85 -99.99 1.54 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.427 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 56.0 t -65.05 -44.72 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.604 ' NE2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -40.01 -43.97 1.65 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.487 HG13 ' O ' ' P' ' 45' ' ' TYR . 0.1 OUTLIER -62.14 -47.4 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.066 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.61 -51.77 67.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.801 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . 0.554 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.9 OUTLIER -61.13 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.14 -37.06 72.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.854 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CD2' ' P' ' 55' ' ' TYR . 5.6 m-70 -66.21 -33.44 75.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.241 0.543 . . . . 0.0 110.321 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . 0.407 ' CB ' ' HG2' ' P' ' 97' ' ' LYS . . . -75.38 -31.14 60.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.826 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.25 69.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 111.356 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HE1' ' P' ' 134' ' ' TYR . 1.8 p90 -74.28 -34.41 63.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.444 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 0.4 OUTLIER -72.4 -35.64 68.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -178.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.77 -31.7 65.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.98 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.89 61.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.38 111.79 57.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.819 0.342 . . . . 0.0 110.503 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.69 -62.49 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.079 2.519 . . . . 0.0 114.481 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.35 22.93 2.7 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.406 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.65 116.34 28.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.711 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -122.21 132.28 54.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.892 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 10.0 p -95.36 137.34 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 121.41 0.624 . . . . 0.0 111.466 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -105.15 106.39 16.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.682 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.88 104.39 12.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 10.4 mt-10 -89.59 119.88 30.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.596 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.16 95.92 1.88 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.094 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.58 155.22 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.283 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.7 OUTLIER -173.43 176.25 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.165 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -73.88 148.16 42.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.249 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.417 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 0.5 OUTLIER -55.36 -28.3 52.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.957 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . 0.438 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 19.1 ttm180 -39.82 104.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.312 0.577 . . . . 0.0 112.263 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . 0.477 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.29 163.28 16.54 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.109 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.16 146.71 71.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.463 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 68.7 Cg_exo -50.53 -42.63 48.54 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.744 2.296 . . . . 0.0 113.95 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.99 -46.66 86.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . 0.576 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -77.49 -32.31 54.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' P' ' 82' ' ' LEU . 1.5 m120 -63.56 -74.94 0.09 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' P' ' 79' ' ' ASN . 0.7 OUTLIER -32.16 -40.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 120.779 0.323 . . . . 0.0 110.707 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' P' ' 84' ' ' GLN . . . -62.16 -55.3 30.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.039 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.3 OUTLIER -43.72 -52.65 6.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.595 177.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.433 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -68.62 -34.4 78.49 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.108 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' P' ' 81' ' ' ALA . 0.0 OUTLIER -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -64.09 -40.26 95.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.478 ' CG ' ' HA ' ' P' ' 39' ' ' TYR . 9.1 mtt180 -60.26 -39.58 87.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.64 94.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.431 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.29 -34.89 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.51 -61.06 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.429 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.88 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.354 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -47.17 87.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.634 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.56 -23.01 76.79 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.839 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . 0.451 ' CE1' ' HD3' ' P' ' 97' ' ' LYS . 5.2 t80 -64.43 -63.69 1.07 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -55.47 -31.68 62.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.497 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.12 95.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.82 -24.08 75.64 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.447 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -74.98 -9.49 58.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.068 179.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.21 6.04 48.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.868 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.444 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 39.3 t -76.86 130.39 36.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.064 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.47 140.68 58.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.456 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.0 70.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.35 -17.9 57.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.929 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 12.6 mtpp -91.65 -13.38 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.999 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mt -101.99 143.83 31.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.355 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.23 147.07 17.77 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 17.4 p -127.93 154.71 45.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.728 0.299 . . . . 0.0 110.663 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -176.02 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.769 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.429 ' O ' ' CG1' ' P' ' 80' ' ' ILE . 52.5 p -112.79 137.46 51.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.771 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.531 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.7 m-85 -113.22 26.85 10.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.707 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 5.8 -111.37 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.224 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -101.38 14.89 30.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -62.52 -55.16 30.09 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.24 88.83 5.69 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.95 169.89 12.56 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.026 2.484 . . . . 0.0 112.928 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.84 -61.69 1.33 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.224 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' P' ' 123' ' ' ALA . 38.9 t -89.44 114.17 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.601 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.04 138.7 57.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.8 178.19 18.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.053 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.505 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 0.5 OUTLIER -142.04 67.53 1.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.639 0.219 . . . . 0.0 111.305 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.09 153.13 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -38.98 -32.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.14 -52.65 13.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.874 0.368 . . . . 0.0 111.291 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.421 ' HB2' ' CG1' ' P' ' 116' ' ' VAL . . . -71.08 -43.53 67.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.187 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.505 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 2.1 m-30 -63.91 -40.5 96.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 91.5 p -65.85 -35.75 81.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.026 0.441 . . . . 0.0 109.888 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -69.59 -25.3 63.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.743 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.63 -30.68 19.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 7.4 mtp180 -66.18 82.41 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -159.23 162.42 36.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -128.42 102.45 6.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 t -91.21 117.52 34.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.1 OUTLIER -71.48 104.92 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.081 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -115.21 145.19 42.66 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.543 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . 0.697 ' HE1' ' OH ' ' P' ' 55' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.922 0.391 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' P' ' 20' ' ' TYR . 57.1 m-85 -91.06 108.71 20.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.32 9.38 42.46 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.818 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.51 2.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.02 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' P' ' 17' ' ' PHE . 0.5 OUTLIER -120.62 164.89 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.021 0.439 . . . . 0.0 111.58 -179.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.3 t -98.27 152.32 19.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 15.7 t -39.9 -49.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.72 -15.98 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' P' ' 29' ' ' TYR . 0.2 OUTLIER -99.6 -47.58 5.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.233 0.539 . . . . 0.0 110.233 178.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.539 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 42.0 mt -54.62 -22.64 14.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.783 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -12.93 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -111.9 -29.69 7.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -129.79 -38.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.412 ' HB2' ' OD1' ' P' ' 24' ' ' ASP . 27.7 m-85 -109.91 104.78 13.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.614 0.721 . . . . 0.0 112.366 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 179.44 22.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.464 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.41 HG22 ' CE1' ' P' ' 33' ' ' TYR . 91.7 m -126.88 128.79 47.05 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.065 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 16.7 t -108.95 150.29 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.309 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.41 ' CE1' HG22 ' P' ' 31' ' ' THR . 54.2 m-85 -122.46 116.19 23.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.0 m-85 -95.66 168.63 10.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.67 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.77 -166.84 29.49 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.185 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -58.68 114.89 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 50.12 30.46 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.6 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.416 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -95.97 142.84 27.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.984 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -130.0 55.77 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.09 150.39 31.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.562 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.38 161.93 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 42.6 p -112.59 147.11 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.394 . . . . 0.0 111.251 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.63 -31.13 2.43 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.0 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.76 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 111.259 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -105.26 3.75 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.946 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.66 -38.4 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -52.27 -32.81 39.04 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.615 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.475 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -63.51 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.158 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' P' ' 93' ' ' TYR . 8.2 mt -59.33 -34.13 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.194 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.68 -39.16 52.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.924 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' P' ' 25' ' ' LEU . . . -74.45 -46.45 39.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.949 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 19.5 m-70 -62.28 -38.23 88.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.04 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.007 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.88 95.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.063 0.459 . . . . 0.0 110.203 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -75.38 -35.82 61.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.903 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.452 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.8 OUTLIER -63.56 -43.22 97.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.036 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -69.97 -41.22 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.264 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.38 -26.56 61.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -111.73 110.49 54.84 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.447 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.55 -51.03 11.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.795 2.33 . . . . 0.0 114.0 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 18.32 6.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.449 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -89.2 112.79 23.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.451 . . . . 0.0 110.658 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 7.5 mttt -115.96 130.11 56.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.722 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.9 p -99.04 146.59 8.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.569 0.7 . . . . 0.0 111.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.494 ' HB3' ' O ' ' P' ' 133' ' ' ALA . 2.8 tt -117.63 105.26 11.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.38 103.46 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.153 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.44 119.38 31.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.787 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.64 143.28 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.098 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.5 ' O ' ' CG2' ' P' ' 70' ' ' THR . 1.5 m-80 -138.96 157.52 45.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 68.1 p -164.73 -165.29 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.474 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' P' ' 124' ' ' TYR . 24.0 p30 -90.89 158.8 16.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.492 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 2.3 pm0 -60.85 -33.55 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.845 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -45.32 111.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.15 -174.84 15.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.052 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.82 145.09 31.28 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 111.639 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.484 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 85.1 Cg_exo -38.57 -46.92 2.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.117 2.545 . . . . 0.0 113.723 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.37 -44.47 92.72 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.743 0.306 . . . . 0.0 111.024 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -70.1 -44.83 68.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' P' ' 80' ' ' ILE . 7.1 m120 -70.94 -76.02 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.584 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.67 -43.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.39 -55.88 11.96 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.65 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -49.43 -50.36 41.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 178.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -63.07 -42.59 99.54 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.9 tp60 -47.84 -40.44 21.34 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.204 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.3 ptm180 -67.6 -37.71 82.95 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.557 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 15.9 mtt180 -62.72 -47.67 82.58 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.24 69.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.829 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -32.66 73.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.497 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.62 -56.51 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.511 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.08 -34.61 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.248 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -44.81 96.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.763 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.46 -23.66 77.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . 0.411 ' CE2' HD12 ' P' ' 49' ' ' LEU . 6.2 t80 -64.5 -60.81 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 91.0 mt -55.91 -31.93 63.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.25 -39.08 82.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.032 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.04 95.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.04 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -34.66 74.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.02 26.59 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.095 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.451 ' CG1' ' HD3' ' P' ' 103' ' ' LYS . 49.6 t -90.53 143.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.179 0.191 . . . . 0.0 110.572 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.444 ' N ' HG13 ' P' ' 99' ' ' VAL . 2.8 m-20 -62.8 162.6 10.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 111.455 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.13 -31.5 16.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.548 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.93 -23.82 47.39 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.829 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.541 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -100.63 -4.32 28.66 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.114 0.483 . . . . 0.0 111.059 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.92 147.26 24.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.87 144.13 11.43 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.812 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' P' ' 107' ' ' VAL . 39.8 p -124.21 157.46 34.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.727 0.298 . . . . 0.0 110.533 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' P' ' 106' ' ' THR . 92.7 t -161.14 162.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.584 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 2.3 t -155.74 123.25 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.493 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' P' ' 110' ' ' GLY . 92.6 m-85 -116.75 17.76 15.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -3.68 -113.54 0.0 OUTLIER Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.492 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -78.77 -2.33 38.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.02 -63.39 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.679 0.275 . . . . 0.0 110.753 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 89.49 20.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.7 163.44 13.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.706 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.37 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.655 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.415 ' CG1' ' HB1' ' P' ' 123' ' ' ALA . 46.5 t -88.78 113.95 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.78 136.53 52.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.28 175.67 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.721 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.443 ' HB3' ' CE2' ' P' ' 124' ' ' TYR . 5.8 m80 -141.56 100.31 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.873 0.336 . . . . 0.0 111.629 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -170.83 161.56 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -47.33 -24.59 0.8 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.36 -60.73 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.934 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.415 ' HB1' ' CG1' ' P' ' 116' ' ' VAL . . . -69.18 -41.05 77.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.817 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' P' ' 119' ' ' HIS . 13.2 m-85 -59.01 -50.38 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.239 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 8.4 t -62.38 -32.57 73.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -73.56 -24.36 60.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -88.94 -31.48 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.25 88.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.3 OUTLIER -158.78 157.88 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.86 100.68 7.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -84.32 113.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -62.63 102.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.662 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -106.91 132.95 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.086 179.694 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' P' ' 20' ' ' TYR . 81.9 m-85 -89.86 106.39 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.45 9.05 22.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.523 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.21 -40.71 1.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.509 ' OH ' ' HG2' ' P' ' 47' ' ' GLN . 0.1 OUTLIER -128.89 -179.7 5.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.262 0.553 . . . . 0.0 111.899 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -118.28 175.81 5.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 t -42.94 -53.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.07 -21.12 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.77 -43.95 6.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.961 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.452 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 30.0 mt -56.85 -21.77 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.657 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.63 -11.3 15.89 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.31 -25.35 4.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -111.14 -64.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -105.2 81.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.68 9.61 2.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.989 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 67.8 m -135.21 138.32 43.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.423 HG13 ' CB ' ' P' ' 45' ' ' TYR . 10.3 t -109.62 149.89 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.031 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -117.42 116.46 27.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.804 0.811 . . . . 0.0 112.885 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.68 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -92.72 174.81 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.891 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.17 -176.45 14.83 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 2.7 t80 -61.84 131.8 51.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.703 0.751 . . . . 0.0 110.613 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 2.7 p30 44.68 29.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.445 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -94.53 119.86 33.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.65 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.766 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.4 OUTLIER -118.73 46.12 1.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.751 0.786 . . . . 0.0 110.053 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.41 150.47 31.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.433 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 mt -93.03 165.88 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.348 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.32 141.09 43.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.09 0.472 . . . . 0.0 111.828 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.09 -31.72 4.53 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.055 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -33.01 74.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 111.015 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.423 ' CB ' HG13 ' P' ' 32' ' ' VAL . 74.8 m-85 -100.13 -6.85 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.865 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.3 -42.09 94.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 120.88 0.371 . . . . 0.0 111.44 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.509 ' HG2' ' OH ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -44.91 -42.55 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.522 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 5.6 mt -50.67 -55.5 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.368 0.604 . . . . 0.0 109.783 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.18 -32.93 25.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.906 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -41.21 67.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.682 0.277 . . . . 0.0 110.834 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . 0.404 ' CB ' HD23 ' P' ' 25' ' ' LEU . . . -73.1 -42.68 62.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.522 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 46.3 m-70 -65.97 -39.31 90.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.921 0.391 . . . . 0.0 110.122 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . 0.408 ' HB2' ' CD2' ' P' ' 94' ' ' LEU . . . -61.97 -50.63 71.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.415 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.47 -40.55 78.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -76.09 -38.34 57.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.433 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 1.2 tp -70.57 -35.73 73.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -73.67 -33.97 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.031 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.387 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.7 114.29 49.75 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.24 -50.17 11.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.611 2.207 . . . . 0.0 113.543 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.88 17.46 4.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.439 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.46 122.76 33.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.972 0.415 . . . . 0.0 110.182 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -124.78 135.71 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.583 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.8 p -100.88 150.05 5.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.489 0.661 . . . . 0.0 111.535 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.8 OUTLIER -121.76 107.81 12.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.55 104.22 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -89.75 122.62 33.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.18 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -116.35 141.32 16.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.497 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.6 OUTLIER -148.32 113.99 5.68 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.496 ' CG2' ' NH1' ' P' ' 86' ' ' ARG . 45.5 p -99.69 176.28 5.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -58.96 138.62 57.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -50.48 -28.07 7.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.656 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.21 106.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 0.0 112.774 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.86 -178.94 18.62 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.46 143.89 27.12 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.983 0.391 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.593 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -48.02 -27.94 9.72 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.775 2.317 . . . . 0.0 113.22 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -45.38 92.84 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.299 0.571 . . . . 0.0 110.752 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' P' ' 82' ' ' LEU . 14.1 t80 -90.12 -17.34 27.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.566 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -85.6 -21.76 28.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.263 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -83.58 -35.59 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.81 -49.56 61.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.605 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' P' ' 78' ' ' TYR . 0.2 OUTLIER -52.32 -45.81 65.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.211 177.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -74.84 -53.91 6.13 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.282 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -46.0 -36.56 5.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.083 0.468 . . . . 0.0 109.875 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 34.8 mtp85 -67.68 -46.85 71.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.346 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.496 ' NH1' ' CG2' ' P' ' 70' ' ' THR . 31.1 mtt180 -58.07 -38.98 77.37 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.18 84.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.107 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -30.68 71.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.325 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.31 -60.81 2.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.05 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.91 -41.41 92.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.601 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -38.88 78.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.043 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.68 79.03 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.573 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.83 -60.19 2.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' P' ' 99' ' ' VAL . 90.3 mt -57.84 -34.13 69.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.053 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.64 81.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.988 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.17 -26.92 74.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.504 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.99 -9.03 59.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 111.366 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.77 -6.75 17.84 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.251 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.433 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 80.0 t -67.96 112.97 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.829 0.314 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.99 144.97 56.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.215 0.531 . . . . 0.0 111.401 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.51 -36.77 74.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.738 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.86 -24.95 55.31 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.766 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.12 -3.76 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.309 0.576 . . . . 0.0 110.798 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.3 150.48 20.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.097 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -142.5 141.72 10.98 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 78.3 p -142.89 145.9 33.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.414 ' CG2' HD23 ' P' ' 65' ' ' LEU . 0.2 OUTLIER -160.63 173.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.591 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -162.49 129.07 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.291 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.5 OUTLIER -114.21 27.12 9.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.683 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -4.59 -115.44 0.0 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.6 0.562 . . . . 0.0 114.23 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 3.2 mp0 -83.09 -2.05 54.38 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.761 -0.258 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.64 -63.1 1.31 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.662 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -139.96 89.4 11.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 164.77 11.28 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.652 2.235 . . . . 0.0 112.705 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.39 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.22 111.08 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.783 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.48 135.24 47.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.89 172.88 12.9 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.951 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.414 ' CE1' ' OH ' ' P' ' 124' ' ' TYR . 3.9 t60 -138.08 48.76 1.96 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.365 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.02 157.66 42.4 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 15.3 tp10 -42.99 -37.43 1.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.45 -60.29 3.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.94 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.26 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.414 ' OH ' ' CE1' ' P' ' 119' ' ' HIS . 2.8 m-85 -57.17 -56.21 24.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.381 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 125' ' ' SER . . . . . 0.482 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 0.3 OUTLIER -55.91 -35.55 66.7 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -73.29 -22.52 60.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.201 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 69' ' ' ASN . 37.2 m-20 -81.21 -43.74 18.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.68 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.97 71.61 0.81 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.515 0.674 . . . . 0.0 110.804 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.13 145.29 51.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.225 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -117.33 93.21 4.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.08 115.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.73 100.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.309 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -102.77 130.17 49.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 111.557 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.87 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 C--O 1.231 0.101 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -88.82 102.91 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.569 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.26 10.09 56.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.145 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.98 17.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.336 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.501 ' CE2' ' CD2' ' P' ' 29' ' ' TYR . 1.7 m-85 -107.04 147.13 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -104.14 144.38 31.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -38.31 -56.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.23 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -45.38 5.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 0.0 110.628 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.499 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 34.3 mt -56.54 -20.82 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.956 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.58 -12.3 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -123.38 -25.38 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . 0.445 ' HG2' ' CZ ' ' P' ' 29' ' ' TYR . 4.7 tpm_? -110.9 -62.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' P' ' 20' ' ' TYR . 22.2 m-85 -107.19 91.66 3.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 19.2 p-10 -155.07 13.77 0.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.369 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -125.94 130.82 52.03 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 3.6 t -111.19 148.45 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.5 118.31 26.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' P' ' 86' ' ' ARG . 21.9 m-85 -95.49 168.28 10.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.604 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.64 -166.69 27.37 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.158 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -60.88 122.03 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.23 25.51 1.83 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.749 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.467 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -93.14 138.58 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.469 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.431 ' HA ' ' HB3' ' P' ' 86' ' ' ARG . 44.6 p90 -131.42 49.93 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -147.62 150.74 34.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.917 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mt -95.36 161.8 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.647 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 135.58 50.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 111.327 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.73 -27.38 2.19 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.024 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -32.1 72.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.407 ' O ' HG13 ' P' ' 48' ' ' ILE . 31.1 m-85 -105.54 11.44 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.522 ' HA ' ' HG ' ' P' ' 49' ' ' LEU . 0.9 OUTLIER -72.7 -34.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.264 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.36 -45.58 6.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.95 0.405 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.574 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.11 -50.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 0.0 109.196 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . 0.566 ' HB3' ' CE2' ' P' ' 93' ' ' TYR . 6.2 mt -53.4 -62.41 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.726 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.5 -49.67 71.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.47 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.588 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.574 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 7.5 m-70 -72.17 -42.87 65.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.75 0.31 . . . . 0.0 110.821 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.59 -25.79 67.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.016 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.18 -36.93 46.84 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.04 0.448 . . . . 0.0 109.926 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -75.91 -34.68 59.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.452 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.7 OUTLIER -72.18 -36.06 69.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -32.72 66.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.153 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.09 -19.7 63.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.403 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . 0.6 OUTLIER -110.02 111.7 58.21 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 120.615 0.245 . . . . 0.0 110.481 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.89 -63.09 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.884 2.389 . . . . 0.0 114.213 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.17 24.09 1.66 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.413 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.53 122.58 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.145 0.498 . . . . 0.0 110.777 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -126.38 131.29 51.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.84 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 8.7 p -96.05 143.74 11.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.62 0.724 . . . . 0.0 111.754 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.449 HD23 ' CG2' ' P' ' 107' ' ' VAL . 4.8 tt -116.7 104.49 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.47 113.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.675 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.6 mm-40 -89.53 119.87 30.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.638 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.7 86.96 1.47 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.817 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' P' ' 70' ' ' THR . 7.6 t30 -98.65 158.49 15.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 110.354 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 61.0 p -165.29 -165.55 0.88 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 19.8 p-10 -83.77 154.56 23.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.617 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -64.85 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.624 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.91 110.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 -173.17 14.8 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.36 145.3 29.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 72.1 Cg_exo -48.16 -44.74 27.74 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.458 2.106 . . . . 0.0 112.465 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -41.1 98.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.24 -42.96 78.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' P' ' 80' ' ' ILE . 31.4 m120 -69.92 -75.49 0.11 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.385 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -29.63 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.62 11.34 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.796 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.549 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -54.22 -43.77 71.11 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.752 178.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.638 ' HA2' ' HD3' ' P' ' 86' ' ' ARG . . . -68.11 -41.9 85.71 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.959 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.96 -31.57 65.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' P' ' 88' ' ' ASP . 10.5 tpt85 -65.67 -60.35 2.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.38 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.638 ' HD3' ' HA2' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -56.42 -41.5 76.47 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.242 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.63 65.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.3 OUTLIER -65.27 -31.63 72.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.09 178.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.17 -42.49 98.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.011 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . 0.477 ' O ' ' CD1' ' P' ' 93' ' ' TYR . 32.9 t -70.53 -38.65 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.925 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' P' ' 88' ' ' ASP . 0.0 OUTLIER -74.22 -27.84 60.98 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.019 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.71 -53.94 6.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.48 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . 0.566 ' CE2' ' HB3' ' P' ' 49' ' ' LEU . 0.7 OUTLIER -57.59 -44.16 85.2 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . 0.524 ' HG ' ' CE1' ' P' ' 93' ' ' TYR . 4.5 mt -58.87 -35.19 72.57 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' P' ' 99' ' ' VAL . . . -61.45 -43.17 99.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.577 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.81 -13.07 78.71 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.393 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -88.98 -8.44 54.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.667 0.27 . . . . 0.0 111.061 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.69 -12.62 11.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.763 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.443 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 60.9 t -70.65 114.64 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.593 0.235 . . . . 0.0 110.716 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.8 144.58 52.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.388 0.613 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.48 49.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.807 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.35 45.12 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.8 mtmt -96.07 -6.08 39.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.161 0.505 . . . . 0.0 110.9 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . 0.418 ' HG ' HG12 ' P' ' 99' ' ' VAL . 19.8 mt -89.4 149.88 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.916 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.41 135.37 4.69 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 70.2 p -133.55 156.24 48.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.813 0.34 . . . . 0.0 110.645 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.449 ' CG2' HD23 ' P' ' 65' ' ' LEU . 0.1 OUTLIER -172.85 121.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -111.87 137.85 49.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.751 0.31 . . . . 0.0 110.976 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 90.3 m-85 -116.68 24.51 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -111.82 0.01 OUTLIER Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.569 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.89 14.4 31.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.506 0.193 . . . . 0.0 111.514 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -54.84 41.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.96 89.16 8.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.423 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.05 166.89 9.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.692 2.262 . . . . 0.0 112.756 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.48 -67.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.606 ' HB ' ' HE3' ' P' ' 126' ' ' LYS . 38.5 t -89.61 111.8 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.342 0.592 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.73 138.54 58.44 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.923 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.76 174.15 14.11 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.8 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.44 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 14.2 p-80 -140.39 58.77 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -127.04 157.85 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' P' ' 125' ' ' SER . 0.2 OUTLIER -43.39 -27.55 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.615 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' P' ' 126' ' ' LYS . . . -64.76 -59.38 4.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.602 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -66.36 -42.44 88.02 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.44 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 11.9 m-30 -65.37 -44.28 88.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 125' ' ' SER . . . . . 0.425 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 51.8 p -73.28 -38.92 65.75 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.623 0.249 . . . . 0.0 111.416 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . 0.606 ' HE3' ' HB ' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -82.05 -16.77 49.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.038 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' P' ' 123' ' ' ALA . 39.1 m-20 -85.33 -29.55 24.41 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.425 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.1 mtp180 -70.32 94.97 0.98 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.521 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.7 OUTLIER -158.85 156.02 28.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.11 99.78 7.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 15.1 t -83.08 110.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' P' ' 30' ' ' ASN . 0.3 OUTLIER -61.31 98.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.19 178.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -101.21 126.67 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.623 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.982 179.693 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' P' ' 55' ' ' TYR . 4.5 m-85 -92.27 106.86 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 8.99 32.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.388 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.98 -38.57 1.69 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.887 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' P' ' 17' ' ' PHE . 0.5 OUTLIER -124.15 171.76 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.359 . . . . 0.0 111.341 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.75 150.77 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.436 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.8 t -43.26 -43.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.15 -15.76 48.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.43 -40.05 8.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.559 0.695 . . . . 0.0 109.887 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 5.0 mt -61.96 -21.13 64.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . 0.405 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 55.3 mt-30 -98.32 -14.85 20.01 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.4 -18.32 3.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 -66.74 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -105.9 83.67 1.95 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.282 0.563 . . . . 0.0 111.836 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' P' ' 26' ' ' GLN . 0.1 OUTLIER -138.52 12.77 2.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 79.8 m -134.98 137.91 43.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . 0.442 HG11 ' CG ' ' P' ' 45' ' ' TYR . 3.3 t -112.55 147.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.248 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -117.44 123.15 45.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.476 0.655 . . . . 0.0 112.573 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 75.3 m-85 -108.97 172.6 6.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.876 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.37 -169.27 16.4 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.488 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' P' ' 37' ' ' ASP . 2.0 t80 -60.17 125.9 25.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 110.748 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . 0.436 ' HB2' ' CE1' ' P' ' 36' ' ' PHE . 2.3 t0 44.59 29.43 0.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.86 126.65 41.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.738 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 11.2 t80 -125.9 57.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.731 0.777 . . . . 0.0 110.191 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -151.09 150.71 31.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.715 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -98.64 162.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.604 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 7.5 p -112.76 144.89 41.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.118 0.485 . . . . 0.0 111.574 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.63 -31.94 3.96 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.313 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -63.82 -33.89 76.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.442 ' CG ' HG11 ' P' ' 32' ' ' VAL . 78.0 m-85 -99.11 -2.52 36.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.439 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 77.0 t -63.07 -43.69 99.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.506 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -39.63 -45.64 1.68 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.638 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.582 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.58 -53.26 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mp -47.14 -46.49 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.549 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 2.6 p30 -73.46 -33.22 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.657 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.32 -51.48 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.582 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 12.0 m-70 -57.57 -37.79 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 109.936 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.3 94.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.24 84.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.523 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . 0.457 ' HA ' ' CE2' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -70.1 -43.01 71.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.604 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.511 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.4 OUTLIER -69.57 -36.75 76.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.03 -178.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.83 -36.33 78.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.13 66.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.604 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.85 112.87 47.51 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 -44.0 45.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.653 2.235 . . . . 0.0 113.575 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 17.51 11.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.42 123.74 34.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.271 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 30.9 mttt -123.12 132.72 54.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.683 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.2 p -96.42 143.54 12.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.417 0.627 . . . . 0.0 110.983 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' P' ' 133' ' ' ALA . 0.5 OUTLIER -113.39 108.65 17.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.796 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.39 109.67 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.7 mt-10 -99.39 120.24 39.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.392 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 146.34 18.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.354 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' P' ' 129' ' ' ARG . 52.9 m-80 -139.54 167.52 21.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 2.4 p -168.98 174.8 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.983 0.42 . . . . 0.0 111.448 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 15.4 p-10 -60.01 151.8 25.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.617 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.506 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 1.4 pp20? -66.26 -31.83 72.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 111.666 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 113.61 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.67 -169.41 12.91 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.266 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 75' ' ' THR . . . . . 0.449 ' HB ' ' HG3' ' P' ' 77' ' ' GLU . 0.6 OUTLIER -107.82 146.72 34.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 111.48 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.52 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 41.0 Cg_exo -54.96 -35.98 91.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.793 2.329 . . . . 0.0 113.929 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . 0.449 ' HG3' ' HB ' ' P' ' 75' ' ' THR . 0.0 OUTLIER -44.12 -55.35 4.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 0.1 OUTLIER -93.69 -13.93 26.94 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.602 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.455 ' CB ' ' HG2' ' P' ' 111' ' ' GLU . 2.1 m-20 -84.17 -25.76 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.539 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.5 OUTLIER -90.89 -36.42 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.43 -49.93 61.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.434 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -68.9 -34.35 75.27 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.976 178.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.535 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -69.55 -56.72 8.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.796 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -50.46 -33.53 21.46 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -49.31 78.2 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.474 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 0.1 OUTLIER -55.43 -38.19 68.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.31 79.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.241 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -31.32 69.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.341 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.84 88.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.968 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.33 -31.39 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.429 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' P' ' 92' ' ' GLY . 0.0 OUTLIER -62.73 -44.03 97.26 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . 0.486 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -74.32 -26.86 67.09 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -59.52 -57.1 14.44 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 47.2 mt -61.04 -32.28 71.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.332 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.53 99.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.561 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.96 -19.97 78.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.014 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -10.79 59.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.663 0.268 . . . . 0.0 111.269 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -7.52 16.96 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.065 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.412 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 31.8 t -78.8 127.41 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.732 0.301 . . . . 0.0 110.99 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.417 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -58.58 163.53 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.548 . . . . 0.0 111.322 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' P' ' 104' ' ' LEU . . . -80.87 -31.65 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.198 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.18 -24.14 35.19 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.782 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -95.5 -4.55 44.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 111.224 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' P' ' 101' ' ' ALA . 7.2 mt -95.1 139.55 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.129 -0.228 . . . . 0.0 110.403 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.45 141.77 10.72 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.416 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 68.4 p -133.21 153.22 51.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.929 0.395 . . . . 0.0 111.106 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -176.15 119.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.43 ' O ' HG12 ' P' ' 80' ' ' ILE . 90.3 p -117.51 140.11 50.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.416 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' P' ' 110' ' ' GLY . 33.1 m-85 -121.08 28.07 8.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.581 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -23.22 -71.07 0.01 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.874 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.506 ' OE1' ' HA ' ' P' ' 72' ' ' GLU . 4.4 mm-40 -106.78 -2.1 21.86 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.01 -57.01 6.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 118.474 0.579 . . . . 0.0 110.422 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -134.71 90.04 24.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -57.94 163.05 10.06 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.521 2.147 . . . . 0.0 112.564 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.45 -68.63 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.11 119.83 36.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.1 136.82 44.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.57 175.21 14.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.791 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' P' ' 119' ' ' HIS . 0.1 OUTLIER -140.53 97.52 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.825 0.312 . . . . 0.0 111.587 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -175.9 165.83 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -48.46 -26.29 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.05 -63.49 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.01 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.621 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 7.0 m-30 -56.97 -46.53 82.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.624 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -68.55 -36.85 79.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.329 . . . . 0.0 111.29 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -68.22 -26.93 65.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.292 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' P' ' 70' ' ' THR . 84.1 m-20 -87.19 -28.84 22.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.481 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 6.5 mtp180 -69.35 81.05 0.37 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.89 152.39 21.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.122 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.51 105.11 10.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 16.0 t -86.73 113.41 24.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' P' ' 30' ' ' ASN . 0.4 OUTLIER -61.05 99.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.194 178.178 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' P' ' 65' ' ' LEU . . . -99.55 124.39 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.635 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.917 179.685 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.031 0.443 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.431 ' N ' ' O ' ' P' ' 20' ' ' TYR . 70.6 m-85 -90.55 107.08 18.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.611 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.81 9.87 35.5 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.297 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 134.21 -35.75 2.19 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.793 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' P' ' 17' ' ' PHE . 22.2 m-85 -117.81 161.9 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.715 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.15 153.65 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.425 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 17.3 t -39.26 -51.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.43 16.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.38 -40.35 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.421 0.629 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.485 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 20.1 mt -69.32 -20.82 63.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.206 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -88.7 -20.89 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -142.71 -6.59 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -69.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.426 ' O ' HG23 ' P' ' 48' ' ' ILE . 67.6 m-85 -108.98 85.69 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.201 0.524 . . . . 0.0 112.244 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.2 19.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.329 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 31' ' ' THR . . . . . 0.43 HG21 ' CE1' ' P' ' 33' ' ' TYR . 98.4 m -126.42 129.35 48.56 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.86 150.38 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.978 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . 0.43 ' CE1' HG21 ' P' ' 31' ' ' THR . 48.9 m-85 -121.39 116.16 24.25 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.514 ' CE2' ' HG2' ' P' ' 86' ' ' ARG . 21.7 m-85 -98.09 167.11 11.09 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.68 -167.38 17.23 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -66.18 123.34 19.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.079 0.439 . . . . 0.0 110.835 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.67 15.34 7.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.728 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.463 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 2.2 mptt -91.17 125.64 36.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.475 ' HB3' ' NH1' ' P' ' 86' ' ' ARG . 52.1 p90 -128.04 37.46 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.796 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.05 149.74 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 mp -87.57 164.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.283 . . . . 0.0 110.975 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 49.3 p -112.35 150.63 30.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.405 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -42.45 -32.95 1.32 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.14 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.05 -33.37 75.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.727 0.299 . . . . 0.0 111.416 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -102.82 3.6 36.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 74.2 t -69.16 -40.49 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.41 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -44.07 -44.35 7.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.533 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.6 OUTLIER -56.47 -51.1 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.818 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mp -53.36 -34.5 57.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.595 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -39.04 53.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.867 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.79 26.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.533 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 54.6 m-70 -59.92 -35.95 75.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.987 0.422 . . . . 0.0 110.139 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.45 98.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.302 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.79 91.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.978 0.418 . . . . 0.0 110.723 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.38 -38.79 63.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.97 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.435 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 2.9 tp -62.2 -41.68 98.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.139 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.16 -40.92 71.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.73 -27.92 31.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.683 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 59' ' ' THR . . . . . 0.419 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -109.6 115.1 56.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.566 0.222 . . . . 0.0 110.488 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.8 -59.03 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 113.858 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.72 22.91 2.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.456 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.76 123.38 34.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 110.707 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -128.07 134.16 49.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.435 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.8 p -97.0 146.13 7.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.502 0.668 . . . . 0.0 111.758 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -117.41 105.37 12.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.527 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.14 108.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.636 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.3 tt0 -99.2 117.61 34.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -107.51 149.67 16.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.968 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.8 OUTLIER -152.96 108.57 3.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.811 0.339 . . . . 0.0 110.712 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -100.65 -171.67 2.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.416 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 21.2 p-10 -64.27 144.85 56.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.396 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -64.08 -27.09 68.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.542 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . 0.416 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.9 OUTLIER -39.55 110.91 0.16 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.326 0.584 . . . . 0.0 112.037 -178.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.01 -150.91 18.65 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.902 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.05 148.46 51.71 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 122.0 0.12 . . . . 0.0 110.822 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 1.3 Cg_endo -41.85 -38.91 4.98 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.616 2.211 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.9 -40.84 96.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.88 -47.53 45.18 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.681 178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.589 ' O ' HD11 ' P' ' 82' ' ' LEU . 11.1 m120 -64.62 -76.27 0.07 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.692 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -35.42 -38.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.37 -64.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.043 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.617 ' CD2' ' CZ ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -63.48 -33.63 75.99 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.285 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . 0.492 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.89 -52.47 28.58 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.447 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 1.2 tp-100 -50.79 -34.73 28.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -59.93 -43.02 95.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.617 ' CZ ' ' CD2' ' P' ' 82' ' ' LEU . 6.8 mtt85 -56.37 -43.41 79.16 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.05 -32.58 68.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.4 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.419 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.27 -56.67 18.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.642 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.34 -34.42 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.4 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -59.45 -51.81 68.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.39 -26.09 74.44 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.115 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -59.96 -61.27 2.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . 0.403 ' HB2' ' CD2' ' P' ' 104' ' ' LEU . 23.1 mt -59.83 -29.8 68.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.88 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.11 98.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.33 -21.08 78.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.626 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -11.29 59.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 111.179 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.28 -3.63 22.08 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.308 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 21.5 t -81.98 131.65 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.831 0.315 . . . . 0.0 111.423 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' CG ' ' P' ' 103' ' ' LYS . 31.3 p30 -58.95 166.37 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.208 0.527 . . . . 0.0 111.306 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.87 -31.83 51.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.314 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.7 -21.36 62.85 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.297 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 23.4 mtpp -90.45 -12.65 36.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.064 0.459 . . . . 0.0 111.067 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' P' ' 94' ' ' LEU . 6.3 mt -92.23 149.76 21.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.93 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.78 137.01 6.7 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' P' ' 107' ' ' VAL . 18.7 p -117.63 156.24 28.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.065 0.46 . . . . 0.0 111.275 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' P' ' 106' ' ' THR . 97.2 t -160.49 157.75 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.608 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.692 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 3.3 t -161.09 128.18 4.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.993 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.31 -68.46 0.79 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.349 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.7 -121.51 6.37 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.615 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.588 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 1.2 mm-40 -75.62 -19.89 58.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.859 0.33 . . . . 0.0 111.091 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.47 -74.09 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -142.09 102.45 5.71 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.323 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.34 167.49 20.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.745 2.297 . . . . 0.0 112.248 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.55 -77.66 0.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.618 ' HB ' ' NZ ' ' P' ' 126' ' ' LYS . 2.0 t -96.94 130.6 45.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.461 0.648 . . . . 0.0 111.137 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 141.13 52.34 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.745 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.73 172.09 12.99 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.764 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -141.09 91.64 2.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.793 0.296 . . . . 0.0 111.411 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' P' ' 124' ' ' TYR . 37.5 t70 -178.86 167.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' P' ' 125' ' ' SER . 1.1 mm-40 -44.45 -26.83 0.38 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -66.54 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.672 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.631 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -70.4 -35.67 73.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.7 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' P' ' 120' ' ' ASP . 2.2 m-85 -65.85 -46.43 78.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 125' ' ' SER . . . . . 0.415 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 6.9 t -71.56 -37.06 71.11 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . 0.631 ' CE ' ' HA ' ' P' ' 123' ' ' ALA . 0.0 OUTLIER -79.77 -16.16 56.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.993 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' P' ' 123' ' ' ALA . 7.9 m-20 -86.53 -31.51 21.23 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 120.581 0.229 . . . . 0.0 110.495 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.415 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.7 mtp180 -70.3 83.62 0.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.25 153.33 34.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -119.66 99.18 6.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.67 112.73 21.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.55 101.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.669 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.72 122.1 39.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.733 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.947 179.596 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.791 0.329 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' P' P ' 17' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' P' ' 20' ' ' TYR . 61.1 m-85 -88.83 105.87 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.992 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.82 10.33 38.02 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.129 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.96 -30.61 3.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.384 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' CE2' ' P' ' 29' ' ' TYR . 20.3 m-85 -114.22 158.75 20.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 150.98 23.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.014 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 16.5 t -39.5 -48.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.59 -17.89 57.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.42 -43.93 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.456 0.646 . . . . 0.0 110.441 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 17.5 mt -58.35 -21.38 49.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.152 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 26' ' ' GLN . . . . . 0.429 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 4.3 mt-30 -101.92 -12.4 18.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.93 -21.52 4.34 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -112.64 -60.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 29' ' ' TYR . . . . . 0.452 ' CE2' ' CE1' ' P' ' 20' ' ' TYR . 28.3 m-85 -102.29 85.9 2.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.933 0.397 . . . . 0.0 111.735 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 30' ' ' ASN . . . . . 0.469 HD21 ' HB2' ' P' ' 132' ' ' LEU . 0.0 OUTLIER -144.6 6.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 51.9 m -136.86 138.8 41.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 t -111.82 150.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.507 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -120.37 119.11 32.13 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 34' ' ' PHE . . . . . 0.425 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 16.3 m-85 -95.69 170.24 9.46 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.52 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 -179.65 23.01 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.634 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 36' ' ' PHE . . . . . 0.415 ' CE2' ' CE2' ' P' ' 124' ' ' TYR . 0.6 OUTLIER -64.22 117.3 6.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 111.049 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.51 24.77 7.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 38' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' P' ' 40' ' ' ASP . 0.0 OUTLIER -111.06 127.33 55.51 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.903 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 39' ' ' TYR . . . . . 0.684 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -117.65 77.5 1.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.599 0.714 . . . . 0.0 111.058 -178.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 40' ' ' ASP . . . . . 0.487 ' HB2' ' HD3' ' P' ' 38' ' ' LYS . 0.2 OUTLIER -153.28 150.36 28.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.223 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 mt -99.0 155.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -108.48 143.73 37.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.481 . . . . 0.0 112.056 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.59 -29.26 5.57 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.121 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 44' ' ' GLU . . . . . 0.43 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 3.4 mm-40 -66.16 -28.98 69.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 45' ' ' TYR . . . . . 0.4 ' O ' HG13 ' P' ' 48' ' ' ILE . 75.6 m-85 -103.27 -1.06 29.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 46' ' ' VAL . . . . . 0.439 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 94.8 t -65.26 -41.42 91.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 47' ' ' GLN . . . . . 0.432 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 0.0 OUTLIER -49.24 -29.49 5.82 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.588 -178.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 48' ' ' ILE . . . . . 0.541 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 2.9 mt -64.71 -52.85 49.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.391 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mp -51.9 -47.83 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.3 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 50' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -70.07 -35.75 74.45 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.609 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.43 -47.76 39.08 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.171 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 52' ' ' HIS . . . . . 0.541 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 8.9 m-70 -61.04 -38.04 84.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.8 92.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.019 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.93 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.935 0.397 . . . . 0.0 110.618 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -71.01 -40.28 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.691 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 56' ' ' LEU . . . . . 0.523 HD11 ' N ' ' P' ' 64' ' ' VAL . 2.0 tp -62.88 -45.18 93.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.73 -40.49 96.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.336 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.39 9.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.669 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.5 115.74 41.86 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.601 0.239 . . . . 0.0 110.599 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.46 -50.91 11.24 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.694 2.263 . . . . 0.0 113.506 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.75 19.66 3.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 62' ' ' ALA . . . . . 0.418 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -92.61 134.74 34.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 63' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -138.02 141.49 40.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 64' ' ' VAL . . . . . 0.523 ' N ' HD11 ' P' ' 56' ' ' LEU . 9.6 p -100.4 150.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.519 0.675 . . . . 0.0 111.795 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tt -120.69 101.45 7.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.342 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 1.3 t -83.51 101.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 67' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 29.6 tt0 -90.41 123.47 34.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 68' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -106.71 148.05 16.34 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.521 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 69' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -160.91 106.19 1.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.317 . . . . 0.0 110.508 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 70' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 26.7 p -106.26 -170.85 1.79 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 71' ' ' ASP . . . . . 0.485 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 21.4 p-10 -57.28 138.12 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 72' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' P' ' 124' ' ' TYR . 0.7 OUTLIER -59.83 -22.84 62.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.454 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -38.13 108.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.12 -144.69 18.34 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.635 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.97 146.82 60.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.727 0.264 . . . . 0.0 110.772 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 76' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 1.9 Cg_endo -39.99 -44.79 3.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.009 2.473 . . . . 0.0 112.445 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -42.72 99.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -71.46 -40.25 70.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.679 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 79' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -67.15 -75.12 0.1 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 80' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -29.4 -41.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 123.254 0.346 . . . . 0.0 111.475 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -64.47 -59.74 3.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.597 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' P' ' 85' ' ' ARG . 0.2 OUTLIER -48.69 -46.71 40.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.256 178.35 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.83 -46.01 85.08 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.52 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 84' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -47.12 -43.14 20.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.388 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 85' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -65.54 -36.0 82.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.777 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 86' ' ' ARG . . . . . 0.473 ' HA ' ' CD1' ' P' ' 39' ' ' TYR . 17.0 mtt180 -68.5 -48.61 63.95 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.334 0.588 . . . . 0.0 109.445 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 87' ' ' ALA . . . . . 0.429 ' CB ' ' HB ' ' P' ' 106' ' ' THR . . . -62.4 -40.31 96.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.562 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 88' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -56.21 -35.25 67.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.844 178.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.33 -64.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.5 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 90' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' P' ' 93' ' ' TYR . 20.3 t -55.14 -39.67 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.371 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 91' ' ' LYS . . . . . 0.478 ' HA ' ' CD2' ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.49 -43.1 99.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 110.153 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 92' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -71.81 -11.12 73.29 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 93' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' P' ' 90' ' ' VAL . 4.4 t80 -75.95 -62.9 1.44 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 94' ' ' LEU . . . . . 0.423 ' HB2' ' HG ' ' P' ' 104' ' ' LEU . 72.2 mt -53.51 -31.38 45.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 95' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' P' ' 99' ' ' VAL . . . -63.38 -40.26 96.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.394 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.31 -24.7 75.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.455 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.33 -9.18 59.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 111.248 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.86 14.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.947 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 99' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' P' ' 95' ' ' ALA . 21.8 t -70.57 114.88 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -55.84 141.63 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.89 40.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.246 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.88 64.99 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.689 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 103' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 2.1 mtpp -93.59 -19.13 21.46 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 120.522 0.201 . . . . 0.0 111.399 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 104' ' ' LEU . . . . . 0.594 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -136.27 132.01 35.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.782 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.72 -169.07 12.68 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.534 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 106' ' ' THR . . . . . 0.429 ' HB ' ' CB ' ' P' ' 87' ' ' ALA . 49.6 p -147.36 168.53 21.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.087 0.47 . . . . 0.0 111.272 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 107' ' ' VAL . . . . . 0.429 HG13 ' CZ ' ' P' ' 109' ' ' TYR . 48.7 t -158.32 163.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.509 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 108' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' P' ' 80' ' ' ILE . 3.2 t -160.28 113.58 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.963 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 109' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' P' ' 110' ' ' GLY . 60.0 m-85 -108.36 27.33 9.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.194 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -12.08 -109.26 0.0 OUTLIER Glycine 0 CA--C 1.526 0.744 0 O-C-N 123.684 0.615 . . . . 0.0 114.581 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 111' ' ' GLU . . . . . 0.535 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 6.3 mt-10 -63.29 -18.31 63.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 112' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 3.7 tm-20 -48.18 -69.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.527 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -130.25 95.04 28.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.69 0.281 . . . . 0.0 111.034 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.34 155.93 54.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.705 2.27 . . . . 0.0 112.454 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.97 -71.47 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 116' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' P' ' 126' ' ' LYS . 3.5 t -88.76 114.29 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.49 136.59 49.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.75 175.4 14.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.118 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 119' ' ' HIS . . . . . 0.463 ' CE1' ' OH ' ' P' ' 124' ' ' TYR . 18.5 t60 -140.16 52.94 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.627 0.251 . . . . 0.0 111.184 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.31 154.69 48.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -45.42 -26.41 0.55 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.25 -58.18 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 110.72 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 123' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' P' ' 116' ' ' VAL . . . -69.59 -40.36 76.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.638 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 124' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -59.7 -49.89 76.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.462 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 125' ' ' SER . . . . . 0.409 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 3.3 t -64.26 -34.89 79.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 126' ' ' LYS . . . . . 0.411 ' HB3' ' CG2' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -68.74 -27.08 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' P' P ' 127' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' P' ' 69' ' ' ASN . 1.7 m-20 -82.21 -31.82 30.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 128' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 1.8 mpp_? -68.85 85.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.051 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 129' ' ' ARG . . . . . 0.419 ' HG2' ' OD1' ' P' ' 69' ' ' ASN . 3.9 ptt180 -154.65 147.16 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 130' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -113.29 108.53 17.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 t -88.27 108.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 132' ' ' LEU . . . . . 0.469 ' HB2' HD21 ' P' ' 30' ' ' ASN . 1.2 mm? -62.51 101.92 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.571 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.93 135.14 45.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 111.48 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' P' P ' 134' ' ' TYR . . . . . 0.404 ' OH ' ' ND1' ' P' ' 52' ' ' HIS . 6.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.932 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 12.1 p 58.7 163.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 12.7 p 58.73 38.41 24.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.92 -28.55 32.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.59 138.83 44.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.61 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -120.41 130.24 54.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.66 -66.33 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' P' ' 9' ' ' ALA . . . -143.24 17.95 1.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.337 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' P' ' 8' ' ' ALA . . . 81.94 -17.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.27 -67.74 1.73 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.823 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -178.33 168.69 1.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.268 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.08 -11.78 62.7 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.839 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' P' ' 14' ' ' ALA . . . -43.57 -24.26 0.1 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' P' ' 13' ' ' ALA . . . -30.53 142.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -67.41 105.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.527 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p -149.76 92.27 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.043 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -89.54 105.87 18.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 111.537 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.33 9.39 30.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.631 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.64 -36.56 2.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.442 -1.361 . . . . 0.0 113.817 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -121.08 169.88 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.74 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.12 155.15 20.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.7 t -39.25 -53.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.21 -18.24 9.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.36 -43.31 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 110.463 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.51 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 9.4 mt -63.18 -22.13 66.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.236 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -95.78 -14.92 22.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -131.61 -15.13 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -62.74 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 96.6 6.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -160.77 18.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.749 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 85.0 m -125.81 130.58 51.71 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.84 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.41 ' HA ' ' CD1' ' P' ' 45' ' ' TYR . 15.8 t -108.41 148.88 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -114.86 119.1 35.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.416 0.627 . . . . 0.0 112.185 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -103.63 169.22 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.823 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.54 -169.54 19.49 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.881 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' P' ' 36' ' ' PHE . 1.5 t80 -57.01 112.85 1.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 110.809 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.79 38.64 4.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -89.93 138.32 31.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.527 ' CE2' ' HB3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -122.14 49.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.96 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.38 150.37 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 5.7 mt -98.01 163.18 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 11.1 p -110.65 143.41 41.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.091 0.472 . . . . 0.0 111.839 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.446 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.87 -32.21 8.46 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.225 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -33.97 74.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.41 ' CD1' ' HA ' ' P' ' 32' ' ' VAL . 77.2 m-85 -100.42 -0.24 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.446 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 48.1 t -65.22 -43.04 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.548 0.214 . . . . 0.0 111.444 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.447 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 1.0 OUTLIER -42.22 -43.45 3.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.531 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.7 -49.73 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.98 -45.76 61.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.474 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . 0.447 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 3.9 p30 -73.9 -32.21 63.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.59 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . 0.437 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.41 -49.48 22.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.531 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 20.0 m-70 -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.532 . . . . 0.0 109.643 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . 0.401 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -61.18 -44.42 97.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.58 98.48 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 0.0 110.587 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.75 -40.1 63.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.445 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 5.5 tp -63.95 -42.82 97.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.417 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.14 -39.84 78.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.68 -25.89 55.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.543 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -112.47 113.6 50.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 110.419 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.5 -46.81 27.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.627 2.218 . . . . 0.0 113.535 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.46 16.82 9.52 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.441 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.73 118.69 30.35 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -120.15 134.4 55.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.213 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.428 ' N ' HD13 ' P' ' 56' ' ' LEU . 4.5 p -97.43 134.39 35.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.404 0.621 . . . . 0.0 111.496 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.455 ' N ' ' O ' ' P' ' 133' ' ' ALA . 1.1 tt -109.56 103.32 12.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.8 120.08 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.5 mt-10 -103.69 117.63 34.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.609 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -103.29 140.91 15.07 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.582 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.581 ' O ' ' O ' ' P' ' 127' ' ' ASN . 77.4 m-20 -157.24 104.81 2.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.293 . . . . 0.0 110.824 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.407 ' CG2' ' NH1' ' P' ' 86' ' ' ARG . 72.1 p -101.9 -172.05 2.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -62.62 143.81 56.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.191 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 1.2 pp20? -63.43 -29.36 70.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.881 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.405 ' HG3' ' HB1' ' U' ' 7' ' ' DAL . 0.0 OUTLIER -41.64 119.59 1.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.09 -113.46 2.95 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.96 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -167.21 147.56 4.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.157 0.479 . . . . 0.0 111.036 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 82.2 Cg_exo -41.68 -45.94 6.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.522 2.148 . . . . 0.0 112.919 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.12 -42.45 94.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.762 0.315 . . . . 0.0 110.761 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.517 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 1.6 t80 -71.27 -46.39 60.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' P' ' 80' ' ' ILE . 12.5 m120 -67.66 -75.45 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.68 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -29.7 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 O-C-N 123.141 0.276 . . . . 0.0 111.515 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' P' ' 85' ' ' ARG . . . -65.24 -59.75 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.436 179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' P' ' 86' ' ' ARG . 0.3 OUTLIER -49.76 -44.6 48.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.922 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.409 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -71.54 -55.28 7.69 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.125 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 1.0 OUTLIER -45.51 -36.44 4.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 110.533 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.527 ' HB3' ' CE2' ' P' ' 39' ' ' TYR . 5.2 mtp180 -69.64 -51.84 31.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -52.82 -39.8 62.77 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.58 77.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.261 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -29.13 69.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.334 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.35 -52.0 56.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.417 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -70.75 -39.08 75.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.231 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -42.28 97.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.859 0.362 . . . . 0.0 110.204 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.94 -24.96 75.84 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -61.24 -61.18 2.74 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 39.9 mt -58.27 -30.83 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.445 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.23 96.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.48 -25.05 75.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.794 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . 0.401 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 2.9 mtpm? -76.84 -9.43 58.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 0.0 111.207 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.67 -1.98 23.25 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.193 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.445 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 25.0 t -75.58 127.26 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.418 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.9 146.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.253 0.549 . . . . 0.0 111.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.1 -36.15 83.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.569 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.46 -21.9 50.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.666 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.6 mtpp -94.21 -5.84 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.85 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -96.73 149.08 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.57 140.99 8.47 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 35.1 p -136.21 153.41 51.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.422 ' CG2' HD22 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -163.5 171.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.041 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.68 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.5 OUTLIER -162.04 131.12 4.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.302 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' P' ' 110' ' ' GLY . 65.7 m-85 -115.84 23.11 12.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.847 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -8.47 -106.38 0.0 OUTLIER Glycine 0 C--N 1.34 0.779 0 O-C-N 123.474 0.484 . . . . 0.0 113.971 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.576 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 3.8 mt-10 -71.16 -18.52 62.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.703 0.252 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.65 -70.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.133 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -130.66 89.62 42.99 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 122.312 -0.242 . . . . 0.0 110.541 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.0 156.27 39.98 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.599 2.199 . . . . 0.0 112.461 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.68 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.095 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.412 HG13 ' HA ' ' P' ' 123' ' ' ALA . 2.6 t -88.79 114.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.056 0.455 . . . . 0.0 110.999 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.63 138.32 57.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.024 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.02 176.66 16.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.874 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.464 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 7.1 p80 -141.64 65.55 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.904 0.352 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.8 150.28 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' P' ' 121' ' ' GLU . 35.4 tp10 -38.44 -30.94 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.1 -59.73 2.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.875 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.412 ' HA ' HG13 ' P' ' 116' ' ' VAL . . . -67.66 -42.44 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.464 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 1.0 OUTLIER -60.66 -45.08 95.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.161 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 26.9 m -62.92 -36.83 84.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.801 0.334 . . . . 0.0 110.509 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -69.21 -25.02 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.549 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.581 ' O ' ' O ' ' P' ' 69' ' ' ASN . 4.6 m-20 -82.49 -33.89 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' P' ' 124' ' ' TYR . 4.7 mtp180 -69.64 83.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -158.02 148.29 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -121.12 109.29 14.83 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 t -87.78 115.6 28.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.19 102.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.744 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -100.76 127.04 47.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.307 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.973 179.807 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.455 ' HB3' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.517 ' HB3' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.405 ' HB1' ' HG3' ' P' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.844 0.354 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 72.4 m -77.96 -32.89 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 99.5 p -61.14 -173.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -82.59 -57.35 3.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -121.1 110.7 16.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.997 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -150.08 132.3 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.05 -49.55 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -174.57 -88.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.756 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 69.81 -55.96 0.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.19 -23.64 31.51 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.618 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.2 135.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.14 -12.76 61.33 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.917 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.21 -72.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.543 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.74 69.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . 0.452 ' O ' ' CZ ' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -118.66 -109.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 16' ' ' THR . . . . . 0.443 ' O ' ' CD1' ' P' ' 17' ' ' PHE . 15.3 p -88.86 150.34 22.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.452 ' CZ ' ' O ' ' P' ' 15' ' ' GLN . 0.1 OUTLIER -151.48 135.86 16.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.219 0.533 . . . . 0.0 112.283 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 2.88 33.27 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.205 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.95 -34.36 2.86 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.399 -1.381 . . . . 0.0 114.154 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -114.69 161.71 17.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.826 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 21' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' P' ' 16' ' ' THR . 0.8 OUTLIER -97.72 145.76 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 14.5 t -37.12 -58.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.84 -16.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -99.19 -43.02 6.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.324 0.583 . . . . 0.0 110.056 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.494 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 25.5 mt -54.67 -21.69 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -12.85 16.91 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.32 -23.63 5.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 ptm85 -122.89 -48.22 2.02 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.27 102.87 12.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.354 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 1.1 p30 179.66 22.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.405 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 72.8 m -125.22 126.84 45.83 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.103 -0.373 . . . . 0.0 111.386 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.496 HG12 ' CB ' ' P' ' 45' ' ' TYR . 0.8 OUTLIER -105.18 150.64 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.913 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -117.93 112.7 20.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.374 0.606 . . . . 0.0 112.167 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.56 ' CD2' ' CZ ' ' P' ' 86' ' ' ARG . 15.3 m-30 -92.13 167.0 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.226 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.14 174.05 15.47 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.507 ' CD1' ' HB3' ' U' ' 7' ' ' DAL . 0.3 OUTLIER -61.76 142.45 57.27 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.54 -0.388 . . . . 0.0 110.946 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.67 26.0 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.771 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.451 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -108.97 135.25 50.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.656 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.665 ' HA ' ' NE ' ' P' ' 86' ' ' ARG . 47.4 p90 -132.86 30.46 4.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.32 150.83 44.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.774 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 mt -87.7 166.38 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.589 0.233 . . . . 0.0 110.616 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.07 144.56 40.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.09 0.472 . . . . 0.0 111.779 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.451 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.73 -31.95 2.82 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.606 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -30.5 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.712 0.291 . . . . 0.0 111.497 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.496 ' CB ' HG12 ' P' ' 32' ' ' VAL . 72.6 m-85 -104.9 3.52 30.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 54.3 t -69.1 -37.22 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.21 -42.44 14.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.516 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.8 OUTLIER -55.96 -49.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.002 0.43 . . . . 0.0 110.412 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.77 -39.68 74.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -45.79 72.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.51 68.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.516 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 16.5 m-70 -72.27 -40.64 67.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.973 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.9 73.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.05 -36.05 59.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.481 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . 0.448 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 13.8 t80 -74.26 -38.89 63.31 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.153 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 1.2 tp -65.08 -43.95 90.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -69.96 -39.98 75.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.24 -24.43 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.055 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.97 89.92 51.86 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.009 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.46 -21.67 10.82 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.792 2.328 . . . . 0.0 113.354 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.78 -1.2 55.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.679 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.422 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.81 125.88 35.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 2.6 pttp -121.85 132.29 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.836 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.8 p -97.6 146.61 7.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.484 0.659 . . . . 0.0 111.713 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.9 OUTLIER -118.89 103.73 9.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.406 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.17 112.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.5 tt0 -101.3 114.99 29.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.104 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.35 146.54 16.08 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.878 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 127' ' ' ASN . 11.3 m-80 -155.76 107.49 2.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 79.1 p -105.35 -173.91 2.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.428 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 24.0 p-10 -54.76 139.1 40.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.479 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -61.51 -27.15 68.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.204 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -39.59 108.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.67 -175.17 15.9 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.406 -0.815 . . . . 0.0 113.437 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.6 147.69 34.18 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 122.223 0.209 . . . . 0.0 111.224 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.433 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 92.9 Cg_exo -39.56 -45.22 3.33 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.881 2.387 . . . . 0.0 113.172 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -40.88 90.84 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.902 0.382 . . . . 0.0 110.438 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.485 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 5.7 t80 -75.53 -37.45 60.04 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -70.51 -76.85 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.528 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -31.93 -40.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 O-C-N 123.101 0.251 . . . . 0.0 111.343 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.91 11.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.519 ' HA ' ' HD3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -47.32 -53.45 13.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.54 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' P' ' 86' ' ' ARG . . . -69.16 -42.62 75.44 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.334 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 7.3 tp-100 -45.68 -44.65 13.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.637 0.256 . . . . 0.0 110.656 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.519 ' HD3' ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -72.19 -32.88 67.2 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.552 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.665 ' NE ' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -62.04 -49.81 74.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.504 0.669 . . . . 0.0 109.302 177.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.33 -35.34 67.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.5 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -29.64 70.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.94 -59.69 4.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.537 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.1 t -64.9 -37.69 80.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -61.16 -47.39 86.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.299 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.9 -19.03 73.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -67.5 -64.18 0.91 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 75.6 mt -52.54 -33.71 46.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.095 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.91 97.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.201 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.47 -32.4 81.01 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -8.63 56.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.948 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.44 14.33 30.47 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.51 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.428 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 48.1 t -80.46 130.42 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.402 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.07 165.69 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 111.127 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.34 -30.07 17.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.474 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.32 58.27 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.813 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.87 -4.32 26.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.212 0.529 . . . . 0.0 111.093 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 38.4 mt -96.37 150.38 20.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.133 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.15 142.99 10.01 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.651 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 30.4 p -133.26 156.76 46.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.585 0.231 . . . . 0.0 110.451 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -171.13 129.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.347 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -119.25 130.55 55.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.736 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 82.6 m-85 -110.94 25.66 11.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.083 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.47 -112.36 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.718 -0.674 . . . . 0.0 114.445 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.479 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.03 6.88 47.84 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -53.89 -58.97 5.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.72 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 89.36 11.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.265 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.84 164.36 14.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.568 2.179 . . . . 0.0 112.424 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.38 -62.7 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.64 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' P' ' 126' ' ' LYS . 7.9 t -89.49 112.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.8 137.77 58.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.85 174.56 17.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.992 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.435 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 15.3 p-80 -141.99 68.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.28 . . . . 0.0 111.369 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.42 152.5 47.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -37.93 -32.36 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.58 -61.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.403 ' HB1' HG11 ' P' ' 116' ' ' VAL . . . -67.98 -43.24 79.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 0.7 OUTLIER -56.81 -50.17 73.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 87.7 p -60.66 -37.04 80.24 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.133 0.492 . . . . 0.0 110.056 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . 0.416 ' HB3' ' CG2' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -62.47 -32.92 73.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.294 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 69' ' ' ASN . 98.7 m-20 -81.58 -30.45 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.415 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -69.79 74.61 0.43 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.089 0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 146.18 40.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.509 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.77 90.01 3.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 t -80.2 114.17 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.2 OUTLIER -63.08 104.95 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.206 178.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -102.25 126.75 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.491 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.088 179.652 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.441 ' O4 ' ' N2 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.712 0.292 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.485 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.439 ' OH2' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.507 ' HB3' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 87.0 p -107.14 -22.12 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t 67.92 61.44 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -88.02 -58.74 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.753 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -116.26 90.29 3.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -96.93 143.59 27.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.17 -12.71 61.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 77.55 -166.77 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.51 126.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.95 -73.06 0.41 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.84 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -160.48 134.0 6.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.952 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.03 -71.38 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.538 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.42 -47.12 9.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 0.0 111.193 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 63.41 31.56 14.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.08 17.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -88.83 152.29 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.544 ' C ' ' H ' ' P' ' 19' ' ' GLY . 47.8 m-85 -137.92 85.62 2.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.771 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 50.6 4.98 0.07 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.726 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' P' ' 17' ' ' PHE . . . 171.53 97.2 0.11 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' P' ' 19' ' ' GLY . 0.8 OUTLIER 60.57 -178.34 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -107.99 160.49 15.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.49 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 t -39.13 -53.46 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 -15.92 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.7 -38.64 8.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.452 0.644 . . . . 0.0 110.142 178.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 14.4 mt -70.27 -22.47 62.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.464 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -85.25 -26.72 26.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -140.6 -3.49 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' P' ' 24' ' ' ASP . 5.4 mtm-85 -107.54 -68.03 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -109.52 96.39 6.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 112.061 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.77 27.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.024 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 95.3 m -128.33 129.61 46.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.882 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.44 HG11 ' CB ' ' P' ' 45' ' ' TYR . 1.0 OUTLIER -110.77 150.72 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -120.94 118.05 28.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.7 m-30 -100.99 171.65 7.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.383 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.76 -166.64 23.41 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.903 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.68 117.71 5.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 t70 45.45 29.04 0.55 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.342 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.404 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 24.5 mmtm -94.81 130.9 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.779 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -119.57 67.08 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.037 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.15 150.67 30.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.475 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mt -107.98 156.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -109.85 150.16 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.15 0.5 . . . . 0.0 112.065 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.447 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -48.92 -31.27 10.16 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.264 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.75 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.69 0.281 . . . . 0.0 111.389 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.44 ' CB ' HG11 ' P' ' 32' ' ' VAL . 77.0 m-85 -99.68 -4.61 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.447 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 64.9 t -62.82 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.403 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -44.46 -45.38 9.09 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.501 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -52.59 -49.67 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.941 0.401 . . . . 0.0 110.22 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -54.06 -45.36 71.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.904 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -40.29 96.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.343 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.66 67.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.856 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.501 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 59.7 m-70 -68.17 -41.47 81.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.03 99.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.437 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.66 0.267 . . . . 0.0 110.482 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -73.38 -36.88 66.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.646 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.425 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 5.0 tp -60.01 -47.9 83.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.191 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.27 -43.08 78.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.594 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.64 -26.38 22.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.684 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.402 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -114.88 113.63 44.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.491 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.14 -49.08 17.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.771 2.314 . . . . 0.0 113.849 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.64 17.5 8.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.416 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.39 114.6 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.094 0.473 . . . . 0.0 110.662 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.495 ' CG ' ' HA ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -117.32 133.45 55.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.806 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.2 p -98.88 143.53 13.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 121.43 0.633 . . . . 0.0 111.476 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' P' ' 133' ' ' ALA . 4.5 tt -113.55 101.16 9.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.627 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.13 106.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.234 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.426 ' HG2' ' CZ ' ' P' ' 109' ' ' TYR . 0.9 OUTLIER -100.59 119.37 38.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.68 144.04 17.09 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.621 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 127' ' ' ASN . 1.4 m-20 -140.19 102.43 4.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.625 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.419 ' CG2' HD13 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -95.0 -169.97 2.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.573 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.61 158.49 34.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -74.44 -33.96 63.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.259 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.03 116.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 -161.82 12.56 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.532 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.15 35.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.489 0.185 . . . . 0.0 110.751 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.439 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 46.6 Cg_exo -54.77 -31.87 74.0 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.231 1.954 . . . . 0.0 112.162 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.44 -43.02 82.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.706 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.492 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 29.2 t80 -73.89 -39.74 63.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.256 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -67.83 -76.7 0.08 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.569 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 1.8 tt -33.1 -38.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -56.87 6.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.749 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -55.4 -42.14 73.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.539 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -66.76 -40.51 93.83 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -52.55 -43.56 65.27 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.132 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -63.12 -35.87 81.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.498 ' N ' ' HG3' ' P' ' 85' ' ' ARG . 0.0 OUTLIER -65.22 -44.65 87.6 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.79 -36.85 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.219 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . 0.528 ' HA ' ' HB3' ' P' ' 91' ' ' LYS . 0.2 OUTLIER -67.57 -28.89 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.211 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.46 -66.36 0.5 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.11 -31.75 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.385 0.612 . . . . 0.0 109.892 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' P' ' 88' ' ' ASP . 0.3 OUTLIER -60.93 -47.62 85.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.351 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.85 79.39 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.112 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -68.04 -61.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 63.4 mt -57.02 -31.3 64.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.283 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.43 84.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.591 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.09 -39.63 94.62 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -60.86 -35.23 76.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.88 27.43 1.9 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.556 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.442 HG12 ' N ' ' P' ' 100' ' ' ASP . 45.4 t -89.92 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.524 0.202 . . . . 0.0 110.483 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.442 ' N ' HG12 ' P' ' 99' ' ' VAL . 4.8 m-20 -66.31 165.22 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.245 0.545 . . . . 0.0 111.493 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.11 -29.91 18.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.297 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.97 -29.68 55.82 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.386 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.495 ' HA ' ' CG ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.14 -4.87 26.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 110.421 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.91 121.32 44.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.122 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.61 178.36 17.47 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.606 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' P' ' 107' ' ' VAL . 70.7 p -149.95 163.44 38.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' P' ' 106' ' ' THR . 93.5 t -160.85 161.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.21 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.569 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 5.6 t -159.66 129.05 5.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.471 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.426 ' CZ ' ' HG2' ' P' ' 67' ' ' GLU . 25.9 m-85 -88.85 -63.26 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.12 -127.92 8.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.079 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.439 ' HG3' ' HG3' ' P' ' 76' ' ' PRO . 0.3 OUTLIER -93.14 2.62 56.62 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.029 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.45 -66.14 0.45 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.831 0.348 . . . . 0.0 110.429 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -141.03 88.97 9.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.057 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.27 165.78 18.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.737 2.291 . . . . 0.0 112.434 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.54 -58.33 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.46 HG11 ' ND2' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -91.11 142.83 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.27 139.8 31.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.96 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.21 175.81 16.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.936 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.43 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 9.5 p-80 -141.3 68.27 1.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.749 0.274 . . . . 0.0 111.457 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -141.25 153.65 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 3.7 tp10 -40.37 -30.3 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.56 -65.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.992 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.459 ' O ' HG12 ' P' ' 116' ' ' VAL . . . -68.13 -41.42 81.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.698 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.43 ' CE2' ' HB2' ' P' ' 119' ' ' HIS . 1.6 m-85 -54.7 -52.96 60.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -59.09 -37.35 76.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -61.53 -31.62 71.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.292 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 69' ' ' ASN . 58.3 m-20 -84.42 -34.31 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.896 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 5.0 mtp180 -68.97 79.64 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.158 0.504 . . . . 0.0 111.135 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' P' ' 69' ' ' ASN . 0.1 OUTLIER -150.59 149.76 30.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.114 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -119.73 98.48 6.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -83.9 115.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.39 103.13 0.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.549 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -99.47 128.59 45.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 111.511 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.051 179.624 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.548 ' O10' ' CB ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.548 ' CB ' ' O10' ' U' ' 2' ' ' AMU . . . . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.492 ' HB3' ' CE2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.627 0.251 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 31.9 p -126.79 30.72 5.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.841 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -138.01 20.06 2.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 3.5 t -90.15 -54.94 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.772 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -140.85 117.87 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -142.74 141.39 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.03 -62.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -172.95 -176.46 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.39 138.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.05 85.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.332 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . 0.418 ' HB3' ' CB ' ' P' ' 14' ' ' ALA . 1.1 t-20 178.68 124.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.711 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.46 -57.4 3.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.659 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.75 -24.8 24.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . 0.418 ' CB ' ' HB3' ' P' ' 11' ' ' ASN . . . -55.64 133.27 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -109.16 -164.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -130.49 90.54 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 111.12 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' P' ' 20' ' ' TYR . 55.2 m-85 -89.51 106.65 18.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.994 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.01 35.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.412 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.41 -35.03 2.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.16 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -129.92 176.77 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 0.0 111.709 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -103.3 157.37 17.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 17.4 t -46.4 -51.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.18 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.53 -13.34 2.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.436 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.11 -44.66 6.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.573 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 3.9 mt -58.07 -19.78 34.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.703 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -109.02 -11.27 14.98 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.06 -31.08 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -122.83 -50.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.72 103.8 13.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.529 0.68 . . . . 0.0 112.403 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 0.3 OUTLIER -176.08 11.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.301 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.426 ' O ' ' CD1' ' P' ' 45' ' ' TYR . 85.0 m -113.77 128.12 56.29 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.838 -0.539 . . . . 0.0 112.097 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' P' ' 129' ' ' ARG . 5.3 t -108.06 151.16 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' P' ' 34' ' ' PHE . 6.9 m-85 -112.48 163.32 14.61 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' P' ' 33' ' ' TYR . 73.4 m-85 -152.06 168.55 24.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.221 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.49 -175.74 23.27 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.567 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.35 128.43 37.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.084 0.442 . . . . 0.0 110.884 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p30 43.59 29.76 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.801 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.431 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 2.3 tttp -101.02 137.71 39.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' P' ' 39' ' ' TYR . 48.5 p90 -125.37 60.71 1.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.306 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.63 150.85 31.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.232 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.76 163.44 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.652 0.263 . . . . 0.0 110.736 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 72.8 p -112.61 142.67 44.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.308 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.9 -29.74 4.6 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.346 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.05 -32.87 74.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.61 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' P' ' 33' ' ' TYR . 68.2 m-85 -102.8 3.65 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.82 -41.23 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.437 ' NE2' HG12 ' P' ' 48' ' ' ILE . 6.1 pm0 -45.77 -37.77 6.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.487 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.3 mt -57.74 -52.83 52.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -52.85 -33.09 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.437 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -40.78 62.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.3 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.45 -43.93 53.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.037 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 59.9 m-70 -62.9 -38.82 92.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.026 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.36 87.18 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -73.63 -41.51 62.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.434 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 5.6 tp -61.02 -45.06 96.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.397 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.79 -40.74 72.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.564 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.96 -26.64 37.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -114.54 114.33 44.95 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.374 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 -51.58 10.35 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.859 2.373 . . . . 0.0 113.931 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.06 19.69 5.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' P' ' 103' ' ' LYS . . . -90.19 119.68 30.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.497 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -119.5 132.51 55.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.724 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 8.8 p -98.65 144.87 10.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 121.294 0.569 . . . . 0.0 110.904 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.445 ' CD2' HG21 ' P' ' 107' ' ' VAL . 0.6 OUTLIER -116.56 108.31 15.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.943 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.53 113.96 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -99.07 120.36 39.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.29 144.01 21.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.708 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.43 ' CB ' ' O ' ' P' ' 129' ' ' ARG . 0.3 OUTLIER -144.3 159.8 42.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 1.1 p -170.26 -173.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.445 ' CB ' ' CE2' ' P' ' 124' ' ' TYR . 10.0 p-10 -63.72 157.25 24.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.379 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.502 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 0.2 OUTLIER -70.55 -31.35 68.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.441 ' HB2' ' OH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -49.86 119.74 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.37 -173.82 15.33 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.225 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.17 143.15 26.56 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.135 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.527 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -40.2 -43.1 3.73 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.017 2.478 . . . . 0.0 113.667 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -59.82 -45.17 93.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 14.1 t80 -70.89 -41.97 70.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.482 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 4.3 m-80 -67.5 -75.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.527 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.9 OUTLIER -29.48 -44.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 111.525 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.37 4.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.91 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -47.9 -51.9 21.42 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.279 -0.569 . . . . 0.0 109.92 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.447 ' HA2' ' CG ' ' P' ' 86' ' ' ARG . . . -61.52 -40.74 99.12 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.511 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -51.39 -40.51 59.4 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 8.1 ttp-105 -64.73 -38.82 92.29 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.453 ' CD ' ' HA ' ' P' ' 39' ' ' TYR . 0.3 OUTLIER -59.05 -40.08 84.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.776 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.87 -34.69 78.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.1 68.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.86 -38.06 43.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.809 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -39.66 91.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.236 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.79 -27.43 64.91 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -59.87 -57.02 14.67 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 23.2 mt -61.45 -32.25 72.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.39 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.96 95.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.103 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.12 -26.97 74.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.759 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -72.38 -11.44 60.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.99 2.0 25.24 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.13 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . . . . . . . . . 26.9 t -81.95 131.95 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.368 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.404 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.5 OUTLIER -60.9 164.28 5.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.271 0.557 . . . . 0.0 111.324 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.26 -30.02 25.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.37 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.58 -22.78 53.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.895 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.497 ' HB2' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -98.84 -3.86 34.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.092 0.473 . . . . 0.0 111.25 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 8.7 mt -89.2 150.44 22.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.254 -0.279 . . . . 0.0 110.342 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.16 138.82 7.72 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.434 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 66.3 p -132.14 153.37 50.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.693 0.282 . . . . 0.0 111.014 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.445 HG21 ' CD2' ' P' ' 65' ' ' LEU . 0.2 OUTLIER -175.38 170.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.443 ' OG ' HG22 ' P' ' 80' ' ' ILE . 32.4 p -162.47 139.18 7.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.406 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' P' ' 110' ' ' GLY . 74.6 m-85 -123.57 19.77 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 7.4 -110.34 0.01 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.502 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -86.18 8.07 22.51 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -51.43 -59.74 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 109.961 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.17 89.81 22.72 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.686 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.18 160.11 11.32 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.709 2.273 . . . . 0.0 112.991 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -69.13 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.674 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 t -87.67 106.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.923 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.24 134.9 49.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.1 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.69 174.68 13.56 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.379 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.61 87.02 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.145 0.473 . . . . 0.0 111.692 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -173.2 165.98 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -47.79 -22.3 0.52 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.57 -60.84 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.912 0.386 . . . . 0.0 111.444 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.09 72.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.445 ' CE2' ' CB ' ' P' ' 71' ' ' ASP . 2.9 m-85 -60.55 -45.75 92.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.749 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 25.2 t -65.34 -32.02 73.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.174 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -75.06 -24.69 58.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.369 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -87.89 -29.0 21.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 111.262 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -67.25 87.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' P' ' 32' ' ' VAL . 3.3 ptt-85 -159.08 160.31 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.37 106.53 9.9 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.25 111.24 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.58 101.94 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.209 178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' P' ' 65' ' ' LEU . . . -101.92 130.51 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.279 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.025 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.466 H5'1 ' O4 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.466 ' O4 ' H5'1 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.668 0.747 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.506 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 90.9 p -172.33 -172.33 0.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.04 89.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 37.8 p -88.39 -27.6 21.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 148.31 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.712 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.95 146.94 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -91.09 -55.29 3.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.719 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 63.27 137.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.194 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.83 3.24 38.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.38 -28.23 72.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 11.7 p30 43.09 31.73 0.37 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.405 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 -45.81 40.49 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.02 -73.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 111.185 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -179.86 176.0 0.79 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . 0.41 ' O ' ' CB ' ' P' ' 21' ' ' SER . 0.0 OUTLIER -129.85 148.05 51.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.493 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.5 p -129.24 150.35 50.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 111.688 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.94 106.38 4.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.169 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.66 8.51 47.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.288 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.54 -35.67 2.24 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.575 -1.297 . . . . 0.0 114.127 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.41 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 2.9 m-85 -119.43 169.26 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.124 0.462 . . . . 0.0 111.468 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 21' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' P' ' 15' ' ' GLN . 5.0 m -101.27 145.3 29.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.992 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 10.3 t -43.27 -30.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 111.468 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' P' ' 27' ' ' GLN . . . -61.67 -21.96 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . 0.457 ' HA ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.69 -54.05 3.02 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.604 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.636 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 7.1 mt -44.59 -28.05 0.55 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.89 -31.22 12.31 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.157 0.503 . . . . 0.0 110.725 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.1 OUTLIER -148.5 77.68 1.4 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.532 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . 0.623 ' HB2' ' O ' ' P' ' 27' ' ' GLN . 0.0 OUTLIER 164.47 -68.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.205 177.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.429 ' CD1' ' HD3' ' P' ' 28' ' ' ARG . 6.7 m-85 -109.13 90.09 3.19 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.61 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.509 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 2.0 p30 -168.29 64.69 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.411 ' O ' ' CE1' ' P' ' 45' ' ' TYR . 97.6 m -164.11 126.68 2.44 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.818 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' P' ' 45' ' ' TYR . 1.2 t -99.75 150.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.652 0.263 . . . . 0.0 111.215 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -116.33 108.35 15.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.587 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -89.31 172.94 8.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.612 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.16 -173.98 19.92 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 3.0 t80 -58.36 122.56 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.457 0.628 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . 0.411 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 2.7 p30 43.92 30.84 0.44 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.744 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 141.58 28.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.43 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 31.2 p90 -130.76 52.55 2.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.497 . . . . 0.0 110.833 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -149.97 150.14 31.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.448 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.27 163.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.924 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 69.4 p -109.45 150.59 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.41 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.86 -29.72 1.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.205 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -65.2 -30.47 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.436 ' HB3' HG11 ' P' ' 32' ' ' VAL . 68.0 m-85 -104.12 1.17 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.981 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.41 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 82.4 t -73.22 -37.56 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.41 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.62 -40.7 63.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' P' ' 45' ' ' TYR . 4.6 pt -67.25 -35.72 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.344 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.88 -40.12 96.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.95 -34.19 62.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.792 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.76 -53.58 8.27 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.636 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 23.0 m-70 -53.59 -35.35 60.75 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' P' ' 94' ' ' LEU . . . -67.37 -40.04 85.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.065 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 110.201 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.23 -37.87 63.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.73 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.465 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 1.7 tp -62.47 -42.74 99.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.294 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.64 -42.06 71.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.461 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.07 54.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.534 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.15 112.22 49.84 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.94 -48.74 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.842 2.361 . . . . 0.0 114.154 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.61 17.61 8.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.405 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.35 117.91 29.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -118.7 130.41 55.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.765 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.465 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 8.4 p -94.44 140.23 17.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.347 0.594 . . . . 0.0 111.422 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' P' ' 107' ' ' VAL . 0.6 OUTLIER -110.14 104.31 13.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.786 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.09 108.12 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.6 tt0 -102.01 118.06 36.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.03 152.34 20.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -148.55 170.7 17.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.871 0.367 . . . . 0.0 110.926 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.1 OUTLIER 176.2 174.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.147 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.517 ' HB2' ' CZ ' ' P' ' 124' ' ' TYR . 37.7 p-10 -54.46 142.64 26.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.253 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 2.2 pp20? -62.79 -25.98 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.436 ' HD3' ' CE1' ' P' ' 119' ' ' HIS . 0.7 OUTLIER -39.33 110.74 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.545 -178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.22 -168.87 12.71 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.336 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.57 144.83 29.45 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.674 0.273 . . . . 0.0 111.066 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.06 -39.28 14.66 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.634 2.223 . . . . 0.0 112.488 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.8 -43.02 97.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.679 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 12.3 t80 -68.18 -41.81 80.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.44 ' O ' ' C ' ' P' ' 80' ' ' ILE . 3.1 m-80 -70.68 -75.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.813 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -30.15 -40.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -69.89 -57.06 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.82 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.4 -42.0 81.42 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.056 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.54 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -69.86 -52.32 20.19 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.765 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.437 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 1.9 tt0 -48.03 -35.67 11.52 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.92 -48.71 79.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.082 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.451 ' HB3' ' CE2' ' P' ' 34' ' ' PHE . 0.3 OUTLIER -54.98 -40.89 70.55 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.24 74.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.44 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -32.99 74.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.235 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.33 -53.44 57.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.426 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.37 -34.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -60.84 -52.75 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' P' ' 95' ' ' ALA . . . -65.06 -27.1 71.86 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -59.16 -58.4 8.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' P' ' 53' ' ' ALA . 92.6 mt -56.73 -29.91 62.98 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . 0.418 ' HB2' ' HA2' ' P' ' 92' ' ' GLY . . . -69.84 -38.99 76.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.84 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.31 -35.17 87.61 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.68 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -63.87 -36.56 84.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.63 26.15 2.22 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.247 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.401 HG13 ' CD2' ' P' ' 56' ' ' LEU . 24.4 t -91.15 146.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.568 0.223 . . . . 0.0 110.726 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.28 161.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.172 0.51 . . . . 0.0 111.562 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.29 -31.32 17.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.67 -12.91 65.11 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 12.9 mtpp -94.37 -10.91 31.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.27 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mt -99.79 150.01 22.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.74 144.58 11.8 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 17.6 p -124.57 159.09 31.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.722 0.296 . . . . 0.0 110.85 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.42 HG22 ' CD2' ' P' ' 65' ' ' LEU . 0.0 OUTLIER -175.28 117.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.151 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.813 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -99.77 143.78 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.526 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' P' ' 110' ' ' GLY . 2.8 m-85 -105.45 7.8 33.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 16.87 -127.25 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.276 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.08 12.75 37.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.53 0.205 . . . . 0.0 111.106 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -59.1 5.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 109.95 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.36 89.03 16.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . 0.419 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 31.9 Cg_exo -61.19 164.07 15.57 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.804 2.336 . . . . 0.0 112.982 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.3 -67.4 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.277 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' P' ' 123' ' ' ALA . 18.8 t -88.52 108.76 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.89 138.75 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.503 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.28 177.03 14.99 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.999 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.533 ' CD2' ' CE2' ' P' ' 124' ' ' TYR . 14.8 t-160 -141.03 61.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -127.14 154.69 44.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -49.38 -23.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.547 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' P' ' 126' ' ' LYS . . . -76.07 -58.1 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.938 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.413 ' HA ' HG13 ' P' ' 116' ' ' VAL . . . -63.77 -42.21 97.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.674 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.533 ' CE2' ' CD2' ' P' ' 119' ' ' HIS . 3.2 m-30 -66.59 -37.21 84.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.37 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 125' ' ' SER . . . . . 0.434 ' HA ' ' NE ' ' P' ' 128' ' ' ARG . 22.5 p -62.06 -37.61 85.64 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 110.682 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' P' ' 126' ' ' LYS . 0.0 OUTLIER -83.07 -11.84 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.713 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -80.71 -37.07 31.3 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -78.65 92.63 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.821 0.82 . . . . 0.0 110.756 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -146.68 146.35 30.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.362 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -115.53 93.91 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.03 112.84 16.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 1.4 mm? -63.71 100.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.282 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -97.38 122.53 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.806 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.053 179.568 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.441 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.763 ' O ' ' O ' ' U' ' 4' ' ' DGL . . . . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.763 ' O ' ' O ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.431 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t -174.69 133.7 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 5.8 p -98.62 35.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -74.75 -23.25 58.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -105.33 139.11 40.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -110.35 150.03 29.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.42 -42.21 54.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 65.52 -76.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.02 124.78 24.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.8 -72.74 0.37 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.096 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 61.9 31.1 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 0.0 110.823 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.3 -21.33 53.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.727 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.96 42.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.21 106.71 18.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.007 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -151.41 103.74 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.46 123.57 50.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.426 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 7.0 m-85 -90.96 107.02 18.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.66 33.48 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.396 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.24 -35.43 2.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.593 -1.289 . . . . 0.0 113.466 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.87 43.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.599 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -60.07 152.37 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t -44.3 -40.07 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 112.029 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -14.83 25.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.316 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.54 -41.03 8.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.561 0.696 . . . . 0.0 109.895 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.491 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 14.7 mt -61.86 -19.8 63.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -98.66 -14.61 19.76 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.99 -17.9 2.11 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -67.96 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -105.36 81.89 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.634 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.24 10.17 2.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.006 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 23.5 m -134.81 137.12 43.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.421 HG13 ' CB ' ' P' ' 45' ' ' TYR . 11.3 t -106.89 149.71 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.437 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.548 ' CE2' ' NH2' ' P' ' 129' ' ' ARG . 3.3 m-85 -113.39 115.51 28.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.778 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.448 ' CG ' ' HD3' ' P' ' 86' ' ' ARG . 82.4 m-85 -104.69 168.9 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.078 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.99 179.73 19.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.384 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.535 ' CE1' ' O ' ' U' ' 6' ' ' DAL . 3.6 t80 -61.4 137.48 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . 0.415 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 0.5 OUTLIER 46.91 28.05 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.407 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 5.5 mttm -109.12 136.07 49.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.742 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -130.86 49.82 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.75 150.44 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.958 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 2.2 mp -92.98 164.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.519 0.199 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 28.0 p -109.5 144.22 38.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 111.299 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.84 -29.58 1.43 Allowed Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.219 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.43 -31.96 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.618 0.247 . . . . 0.0 111.655 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.421 ' CB ' HG13 ' P' ' 32' ' ' VAL . 76.0 m-85 -104.39 3.31 32.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.414 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 98.5 t -70.31 -38.32 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.318 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.24 -40.25 11.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.298 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.558 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.4 mt -55.39 -55.87 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.945 0.402 . . . . 0.0 110.333 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -52.04 -31.89 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.697 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -38.69 62.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.36 -45.98 35.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.558 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 65.8 m-70 -64.41 -37.73 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.67 95.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.76 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.22 98.34 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.032 0.444 . . . . 0.0 110.14 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . 0.426 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 24.2 t80 -75.82 -37.6 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.66 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.454 ' CD2' HG11 ' P' ' 99' ' ' VAL . 10.1 tp -60.68 -49.02 79.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -70.1 -40.31 75.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.51 -27.29 37.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.423 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -113.63 115.37 46.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.667 0.27 . . . . 0.0 110.423 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.83 -59.6 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.915 2.41 . . . . 0.0 113.902 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 20.52 2.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.418 ' CB ' ' HB ' ' P' ' 59' ' ' THR . . . -88.46 114.6 25.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.017 0.437 . . . . 0.0 110.374 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.4 129.7 56.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.404 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.4 p -95.56 126.37 48.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.428 0.632 . . . . 0.0 110.921 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.8 OUTLIER -99.54 105.51 17.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.721 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.19 120.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.047 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.413 ' OE2' ' CE2' ' P' ' 109' ' ' TYR . 2.1 tt0 -106.52 116.05 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.97 142.97 18.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.735 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' P' ' 129' ' ' ARG . 0.6 OUTLIER -141.39 161.52 37.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.959 0.409 . . . . 0.0 110.751 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 1.3 p -170.16 -173.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.538 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.48 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 4.3 p30 -74.92 152.79 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.617 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -63.56 -32.63 74.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.935 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -39.75 109.41 0.11 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.96 178.62 19.17 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.14 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.97 146.51 31.43 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.511 0.196 . . . . 0.0 110.853 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' P' ' 80' ' ' ILE . 71.8 Cg_exo -41.23 -42.6 5.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.741 2.294 . . . . 0.0 113.197 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.34 -43.62 98.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.881 0.372 . . . . 0.0 110.568 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.543 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 0.3 OUTLIER -67.94 -43.56 78.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.6 OUTLIER -69.51 -76.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.687 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.62 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.46 -43.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.72 -56.49 9.09 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.573 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.551 ' O ' ' HG2' ' P' ' 85' ' ' ARG . 0.2 OUTLIER -48.9 -56.19 9.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.262 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.99 -39.34 97.45 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.526 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 3.8 mt-30 -48.41 -51.12 28.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 13.0 ptp180 -62.2 -32.67 73.35 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.448 ' HD3' ' CG ' ' P' ' 34' ' ' PHE . 0.4 OUTLIER -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.74 76.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.982 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.35 -29.73 70.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.638 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.9 -43.22 93.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.154 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 39.2 t -75.47 -42.7 42.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.365 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -38.93 93.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' P' ' 95' ' ' ALA . . . -71.75 -31.29 65.09 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.32 -57.01 14.79 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 83.5 mt -57.63 -30.48 65.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.285 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . 0.405 ' HB2' ' HA2' ' P' ' 92' ' ' GLY . . . -68.9 -39.71 79.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.945 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.66 -36.21 91.15 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.873 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -35.36 78.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.05 26.53 2.05 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.454 HG11 ' CD2' ' P' ' 56' ' ' LEU . 57.5 t -90.77 144.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.595 0.236 . . . . 0.0 110.54 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.434 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -63.94 161.56 15.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.504 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.97 -32.3 16.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.423 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.41 -23.93 36.25 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.689 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.67 -3.25 33.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.29 0.567 . . . . 0.0 110.858 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.24 148.88 23.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.846 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -148.68 140.84 8.53 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.637 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.424 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 14.8 p -131.12 153.44 49.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.679 0.276 . . . . 0.0 110.832 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.424 ' CG1' ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -174.26 117.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.62 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -105.65 137.8 42.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.368 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.513 ' O ' ' C ' ' P' ' 110' ' ' GLY . 91.9 m-85 -121.4 15.97 11.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.996 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -5.03 -106.3 0.0 OUTLIER Glycine 0 C--N 1.34 0.761 0 O-C-N 123.758 0.662 . . . . 0.0 114.523 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.61 0.7 56.76 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.589 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -54.73 -59.87 4.13 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 88.7 7.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.96 168.29 7.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.893 2.395 . . . . 0.0 113.163 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.51 -66.01 0.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.236 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' P' ' 123' ' ' ALA . 2.5 p -88.6 151.05 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -108.37 136.13 48.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.865 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.29 -178.9 20.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -140.23 43.53 1.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.443 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -130.07 156.13 45.02 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -27.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.617 0.246 . . . . 0.0 111.591 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.24 -58.84 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.386 . . . . 0.0 110.651 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' P' ' 116' ' ' VAL . . . -72.48 -39.6 67.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.549 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.48 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 5.9 m-85 -57.82 -49.77 75.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.956 0.408 . . . . 0.0 110.531 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 125' ' ' SER . . . . . 0.645 ' O ' ' NH2' ' P' ' 129' ' ' ARG . 8.3 t -62.7 -33.02 74.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . 0.605 ' O ' ' CZ ' ' P' ' 129' ' ' ARG . 0.1 OUTLIER -75.83 -14.41 60.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.325 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -94.18 -24.45 17.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.457 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.6 mtp180 -77.11 91.11 3.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.645 ' NH2' ' O ' ' P' ' 125' ' ' SER . 0.0 OUTLIER -160.88 154.85 22.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.05 103.96 9.73 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.03 109.44 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.82 100.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.28 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -98.0 123.08 41.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.92 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.915 179.707 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.51 H5'1 ' O2 ' ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.422 ' O10' ' HB2' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' U' ' 6' ' ' DAL . . . . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.42 0.629 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.526 ' C ' ' H ' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.577 ' O ' ' HG3' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.535 ' O ' ' CE1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.451 ' C ' ' HB2' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.331 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -143.64 85.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 31.4 p -177.48 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.59 -23.01 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.31 149.96 26.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -111.64 150.73 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' P' ' 8' ' ' ALA . 1.2 p30 -62.83 -12.85 27.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.431 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' P' ' 7' ' ' ASP . . . 84.81 -178.66 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.88 -19.64 20.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.788 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.65 -69.39 1.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.258 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 64.14 129.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 110.531 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.77 -73.3 0.34 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.57 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.45 -73.26 0.53 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.775 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 174.05 53.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 61.35 110.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.269 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 77.2 p -123.74 149.61 45.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' P' ' 20' ' ' TYR . 40.4 m-85 -137.53 103.06 4.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.978 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.89 9.99 23.4 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.72 -1.229 . . . . 0.0 112.211 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.2 -33.89 2.71 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.651 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.492 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 18.0 m-85 -116.11 160.59 20.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.131 0.491 . . . . 0.0 112.286 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -97.56 142.0 29.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.327 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 t -40.86 -53.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.86 -16.54 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.393 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.29 -46.07 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 110.417 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.519 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 11.9 mt -56.12 -20.83 19.11 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.559 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -12.23 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -118.72 -28.15 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -117.13 -52.51 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -109.39 97.07 6.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.423 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 0.3 OUTLIER -164.68 13.02 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.439 HG23 ' CE1' ' P' ' 33' ' ' TYR . 90.3 m -120.41 130.09 54.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.916 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 5.3 t -108.84 141.72 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.102 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.439 ' CE1' HG23 ' P' ' 31' ' ' THR . 66.9 m-85 -116.28 117.7 30.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.473 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 20.4 m-30 -96.26 167.76 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.925 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -100.74 -170.11 28.81 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.76 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.515 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 1.8 t80 -56.43 115.74 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.52 31.63 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.534 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.433 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 15.5 mmtm -91.58 141.66 28.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 17.3 t80 -126.55 57.71 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.701 0.762 . . . . 0.0 110.116 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -150.96 150.85 31.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.893 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mt -100.81 160.33 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 42' ' ' THR . . . . . 0.414 ' O ' HG23 ' P' ' 46' ' ' VAL . 18.4 p -108.83 138.86 44.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 111.743 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.08 -28.64 1.35 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.926 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.35 -31.98 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.112 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.488 ' O ' HG13 ' P' ' 48' ' ' ILE . 65.9 m-85 -106.33 5.57 29.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.414 HG23 ' O ' ' P' ' 42' ' ' THR . 80.4 t -76.26 -28.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.53 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -36.46 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.67 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.532 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -58.95 -46.32 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.172 0.51 . . . . 0.0 109.899 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mt -59.75 -39.01 83.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.767 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.72 -44.69 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.345 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 -50.08 66.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.967 0.413 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.532 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 60.0 m-70 -59.75 -35.8 75.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.85 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.686 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.97 80.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.977 0.418 . . . . 0.0 110.435 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -78.03 -34.21 50.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.0 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.436 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 1.0 OUTLIER -67.0 -40.57 87.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.874 -179.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.99 -34.35 66.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.61 -22.63 67.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.569 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.403 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . 0.6 OUTLIER -110.8 115.29 53.55 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.592 0.235 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.12 -62.1 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.878 2.385 . . . . 0.0 114.065 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.6 25.16 1.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.14 122.13 33.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.166 0.508 . . . . 0.0 110.98 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.2 mttp -128.29 132.68 48.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 8.9 p -95.38 146.41 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-O 121.392 0.615 . . . . 0.0 111.54 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.22 103.68 12.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.69 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -84.32 95.02 3.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.542 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 22.3 tt0 -89.36 119.72 30.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.773 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.48 145.9 18.65 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.658 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.498 ' HB2' ' HG2' ' P' ' 129' ' ' ARG . 28.2 m120 -142.49 161.44 38.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 2.2 p -165.23 -169.98 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.0 111.889 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -58.17 158.48 6.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.926 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -77.63 -30.95 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.324 0.583 . . . . 0.0 109.741 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 129.09 38.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.697 0.761 . . . . 0.0 112.653 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -179.96 18.1 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.824 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.77 144.28 28.41 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.72 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.59 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 94.8 Cg_exo -39.39 -49.68 3.07 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.144 2.563 . . . . 0.0 113.603 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -43.41 76.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -71.79 -45.37 61.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' P' ' 80' ' ' ILE . 6.4 m120 -71.11 -76.59 0.1 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -31.94 -46.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -57.02 10.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.279 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -50.43 -46.59 56.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.037 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.55 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -67.9 -43.61 82.25 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.236 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -51.95 -37.38 52.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 109.842 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -51.1 63.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.708 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.55 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 0.8 OUTLIER -58.39 -39.59 80.06 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.96 -32.83 71.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.757 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -31.67 71.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.145 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.43 33.59 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.604 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 17.4 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.878 0.371 . . . . 0.0 111.088 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.31 -39.75 91.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.651 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.91 -24.39 69.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.16 -58.3 7.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.23 -32.46 72.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.686 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.46 98.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.389 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.32 -21.21 77.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.864 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -10.8 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.0 111.344 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -5.88 17.98 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.436 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.436 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 19.5 t -78.45 127.77 38.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.946 0.373 . . . . 0.0 111.097 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.4 143.08 57.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 111.494 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.81 -35.38 22.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.553 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -21.1 54.27 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.725 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.1 OUTLIER -94.02 -9.66 36.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.16 0.48 . . . . 0.0 111.387 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . 0.43 ' CB ' ' HG2' ' P' ' 91' ' ' LYS . 1.1 mt -106.76 140.13 40.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.674 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.09 143.44 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.459 ' O ' ' CG2' ' P' ' 107' ' ' VAL . 15.9 p -115.7 159.87 20.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.676 0.274 . . . . 0.0 110.863 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' P' ' 106' ' ' THR . 46.4 t -164.57 114.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.415 ' OG ' HG23 ' P' ' 80' ' ' ILE . 58.5 p -111.82 134.71 53.2 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.433 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.524 ' O ' ' C ' ' P' ' 110' ' ' GLY . 95.2 m-85 -124.21 19.01 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.58 -109.79 0.01 OUTLIER Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 114.445 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.564 ' OE1' ' HA ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -88.59 7.69 32.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.23 -60.35 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 110.327 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -142.09 89.18 8.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.941 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.99 166.99 9.6 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.692 2.261 . . . . 0.0 112.543 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.26 -63.08 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.46 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 36.7 t -89.04 112.19 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.812 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tp -65.0 137.97 58.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.14 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.37 176.19 14.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.82 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.407 ' CB ' ' OH ' ' P' ' 124' ' ' TYR . 17.8 p-80 -140.79 60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.886 0.343 . . . . 0.0 111.39 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.31 155.3 48.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.35 -30.79 0.11 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.78 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.11 79.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' P' ' 71' ' ' ASP . 5.2 m-85 -62.64 -39.29 93.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.054 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 14.2 m -65.14 -33.51 76.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.945 0.402 . . . . 0.0 109.971 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 21.1 mtmt -73.98 -24.49 59.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.493 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -90.53 -30.87 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 76.2 mtm-85 -67.44 88.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.498 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.15 156.95 29.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.69 99.21 5.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 31.1 t -95.95 115.75 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' P' ' 65' ' ' LEU . 2.9 pp -85.72 123.59 31.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -131.68 151.8 51.35 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.015 179.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.447 ' O4 ' ' N2 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.458 ' CZ ' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.515 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -121.5 -47.2 2.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -76.4 63.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 34.2 p -90.05 -48.43 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -150.97 99.3 2.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.933 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.59 124.07 30.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.12 -38.83 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 62.92 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.66 28.06 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.904 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.96 -42.7 60.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.625 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -178.95 -178.86 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.71 -28.13 67.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.487 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -67.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.093 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.21 56.3 5.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.152 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -137.49 161.02 37.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.08 150.87 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 67.2 m-85 -133.45 109.54 9.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.508 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.71 9.69 20.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.265 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.72 -36.06 2.23 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.593 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -121.34 162.4 20.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.431 . . . . 0.0 111.459 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 11.0 p -101.49 156.76 17.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.822 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 38.0 t -45.89 -41.55 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' P' ' 27' ' ' GLN . . . -66.2 -18.49 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . 0.408 ' HA ' ' NE2' ' P' ' 27' ' ' GLN . 0.3 OUTLIER -99.26 -43.88 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.338 0.59 . . . . 0.0 110.008 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.525 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 1.9 mt -63.59 -19.2 64.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.557 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.88 -25.04 22.35 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' P' ' 24' ' ' ASP . 2.9 pp0? -132.98 -8.66 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . 0.401 ' HD3' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -109.94 -66.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' P' ' 28' ' ' ARG . 67.3 m-85 -107.43 88.8 2.82 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.39 0.614 . . . . 0.0 111.513 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.511 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.2 OUTLIER -152.47 16.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.997 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.42 HG22 ' CE1' ' P' ' 33' ' ' TYR . 91.1 m -121.89 129.82 52.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 4.6 t -107.68 150.49 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.917 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.42 ' CE1' HG22 ' P' ' 31' ' ' THR . 37.5 m-85 -123.05 112.11 17.38 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -93.22 170.74 9.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.714 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.45 179.81 30.78 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.531 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.537 ' CE1' ' HB3' ' U' ' 7' ' ' DAL . 0.6 OUTLIER -63.53 119.94 10.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 110.715 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t0 61.44 37.46 16.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.045 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -121.31 137.92 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.412 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 29.9 p90 -127.4 56.79 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 110.719 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.2 150.92 32.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.21 163.23 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.982 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 43.2 p -113.41 149.27 34.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.312 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.77 -32.4 3.03 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.31 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -64.17 -33.36 75.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.689 0.281 . . . . 0.0 111.614 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.424 ' CB ' HG12 ' P' ' 32' ' ' VAL . 78.4 m-85 -100.61 -3.71 29.93 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.408 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 70.2 t -61.79 -42.97 96.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.609 0.242 . . . . 0.0 111.351 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -43.83 -43.5 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.551 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.34 -46.8 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -58.27 -42.24 86.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.9 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -42.7 77.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.87 65.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.552 ' HA ' ' HD2' ' P' ' 55' ' ' TYR . 14.6 m-70 -62.5 -38.56 90.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 110.473 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . 0.419 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -68.58 -41.68 79.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.927 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.84 98.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.733 0.302 . . . . 0.0 111.147 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . 0.552 ' HD2' ' HA ' ' P' ' 52' ' ' HIS . 0.2 OUTLIER -71.84 -36.5 70.21 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.776 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.487 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.4 OUTLIER -75.14 -34.21 61.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.617 -178.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.55 -30.16 64.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.011 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 -17.85 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.376 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.402 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -112.58 111.79 51.69 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.301 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.93 -63.27 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.949 2.433 . . . . 0.0 114.421 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 22.59 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.403 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -89.5 112.96 24.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.349 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -117.01 132.87 56.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.487 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 14.4 p -98.64 146.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.547 0.689 . . . . 0.0 111.474 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.468 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.3 OUTLIER -107.3 103.65 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.462 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -83.59 100.2 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.387 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 5.5 tt0 -90.96 121.54 32.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.306 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.13 146.42 20.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.265 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' P' ' 129' ' ' ARG . 0.8 OUTLIER -145.33 161.08 40.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.632 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.416 ' CG2' ' NH1' ' P' ' 86' ' ' ARG . 0.5 OUTLIER -162.38 -172.99 3.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 111.638 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 6.0 p-10 -81.75 166.32 20.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.374 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 tm-20 -64.15 -39.0 93.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.932 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.415 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 4.1 mmm180 -39.37 106.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -173.91 15.49 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.056 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.21 146.79 32.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.527 0.203 . . . . 0.0 110.646 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -45.46 -40.89 18.01 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.479 2.119 . . . . 0.0 112.644 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.37 -41.27 89.68 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.498 ' CZ ' ' C ' ' U' ' 4' ' ' DGL . 3.1 t80 -69.42 -44.2 71.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' P' ' 80' ' ' ILE . 27.8 m120 -61.84 -75.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.636 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.6 OUTLIER -30.01 -45.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 O-C-N 123.185 0.303 . . . . 0.0 111.737 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.13 -60.65 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.607 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.21 -45.98 8.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.767 178.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.9 -38.24 92.76 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.82 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -44.01 63.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.865 0.364 . . . . 0.0 110.226 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -39.72 90.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.416 ' NH1' ' CG2' ' P' ' 70' ' ' THR . 3.0 mtt180 -61.65 -39.85 92.84 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.52 81.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.143 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -32.01 73.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.495 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.53 -63.53 1.24 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.514 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.23 -37.09 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 111.403 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -61.73 2.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.8 -20.3 59.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.363 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.69 -58.78 5.83 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 24.2 mt -59.41 -30.04 68.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.373 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.63 94.82 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.243 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.12 -26.71 73.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.892 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . 0.419 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 1.2 mtpm? -78.23 -9.92 59.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.68 0.276 . . . . 0.0 111.26 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.12 -3.2 23.98 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.152 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.458 HG13 HD23 ' P' ' 56' ' ' LEU . 16.8 t -74.68 126.14 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.766 0.283 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.432 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.3 OUTLIER -62.37 139.23 58.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.0 111.566 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.99 -32.84 74.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.294 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.46 -19.99 58.39 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.189 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.99 -4.32 26.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.198 0.523 . . . . 0.0 111.035 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . 0.429 ' CD2' HG13 ' P' ' 99' ' ' VAL . 0.5 OUTLIER -110.8 120.48 42.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -124.94 -175.17 14.17 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.852 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.403 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 15.8 p -149.21 163.12 38.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.885 0.374 . . . . 0.0 111.279 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' P' ' 67' ' ' GLU . 0.1 OUTLIER -177.0 111.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.47 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.636 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 1.1 p -111.9 145.54 39.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 0.0 111.812 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' P' ' 110' ' ' GLY . 83.7 m-85 -121.16 23.83 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 11.56 -115.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.859 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.451 ' HB2' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.36 17.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.175 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -59.1 -54.42 47.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 110.113 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -141.33 89.74 9.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.364 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.53 165.73 10.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.712 2.275 . . . . 0.0 112.534 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -59.72 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 11.4 t -88.21 109.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -75.98 134.07 40.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.777 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.04 -179.15 27.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.616 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -142.51 73.89 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -168.53 161.89 11.84 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . 0.416 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 0.0 OUTLIER -46.35 -24.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.83 -59.06 3.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 -40.29 67.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 25.4 m-85 -60.48 -43.26 97.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 95.4 p -68.21 -33.34 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -71.89 -22.85 61.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.218 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -87.41 -29.21 21.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.357 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -66.35 90.2 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.246 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.438 ' O ' ' CB ' ' P' ' 69' ' ' ASN . 0.8 OUTLIER -158.81 158.6 33.83 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.67 107.84 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.85 147.75 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -100.53 100.02 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.586 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -104.55 143.87 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . 0.511 ' CE1' ' OH ' ' P' ' 55' ' ' TYR . 8.1 m-85 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.453 HO3' ' HA ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.621 ' O10' ' CB ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.621 ' CB ' ' O10' ' U' ' 2' ' ' AMU . . . . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.536 ' HB3' ' O ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.464 ' CZ ' ' CE1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.537 ' HB3' ' CE1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.829 0.347 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.16 154.74 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 10.1 m -84.58 114.25 21.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 20.3 m -90.08 -54.1 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -150.23 150.21 31.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -89.88 137.55 32.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.29 -23.14 21.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.201 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.63 -81.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.99 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.83 163.12 3.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.46 -57.98 1.49 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.418 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 43.95 56.06 4.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 111.335 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.24 -66.71 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.604 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.15 -54.67 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 0.0 111.374 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.94 151.4 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.05 109.85 21.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p -132.04 118.82 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -89.74 106.48 18.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.75 9.4 26.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.552 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.26 -38.35 1.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.795 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.415 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 17.7 m-85 -121.67 170.93 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 111.822 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.36 150.69 23.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.887 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 t -38.26 -63.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.53 -13.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -46.35 5.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.552 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 12.5 mt -56.88 -22.24 35.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.506 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.64 -11.96 16.65 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -115.77 -27.32 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -55.91 2.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -108.21 81.83 1.54 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.174 0.512 . . . . 0.0 111.914 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.415 ' ND2' ' NE2' ' P' ' 52' ' ' HIS . 0.2 OUTLIER -140.39 13.71 2.37 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.918 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.432 HG21 ' CE1' ' P' ' 33' ' ' TYR . 53.8 m -134.56 136.63 43.15 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' P' ' 45' ' ' TYR . 10.5 t -108.6 150.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.077 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.432 ' CE1' HG21 ' P' ' 31' ' ' THR . 34.6 m-85 -123.75 114.54 20.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 22.3 m-30 -93.4 170.59 9.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.777 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.31 -172.25 31.01 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.517 ' CD1' ' HB3' ' U' ' 7' ' ' DAL . 1.0 OUTLIER -60.98 126.34 27.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.27 0.535 . . . . 0.0 110.673 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 46.64 33.77 2.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -96.08 141.51 29.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.689 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 3.3 t80 -129.85 48.81 2.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.714 0.769 . . . . 0.0 109.767 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -150.29 151.01 32.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.955 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 2.5 mt -96.08 161.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.559 0.219 . . . . 0.0 110.661 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 16.2 p -110.83 144.8 39.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.032 0.444 . . . . 0.0 111.755 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.58 -30.17 3.13 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 113.413 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . 0.438 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 0.6 OUTLIER -63.27 -31.34 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.689 0.281 . . . . 0.0 111.721 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.407 ' CB ' HG12 ' P' ' 32' ' ' VAL . 87.8 m-85 -105.7 4.71 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 72.0 t -70.9 -37.17 67.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' P' ' 44' ' ' GLU . 0.0 OUTLIER -52.42 -31.99 37.02 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.557 -178.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.549 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -62.86 -49.98 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.191 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 mp -53.57 -37.45 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.62 -39.24 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.708 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.48 -57.32 4.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.552 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 20.0 m-70 -54.31 -37.85 65.29 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.15 -43.49 95.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.729 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.98 96.81 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.865 0.364 . . . . 0.0 110.551 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -73.86 -38.33 64.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.447 HD12 ' N ' ' P' ' 64' ' ' VAL . 4.5 tp -65.48 -43.12 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.352 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.06 -37.67 78.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.445 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.85 -24.04 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.37 114.88 42.69 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.52 -48.6 19.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 113.894 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.7 18.48 7.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.446 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.64 116.57 28.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 0.0 110.711 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -118.19 133.96 55.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.953 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.447 ' N ' HD12 ' P' ' 56' ' ' LEU . 9.3 p -95.57 141.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.345 0.593 . . . . 0.0 111.259 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' P' ' 133' ' ' ALA . 5.1 tt -108.96 101.03 10.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.725 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -79.27 112.24 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.329 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 8.2 mt-10 -99.72 117.56 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.1 22.15 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.997 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' P' ' 129' ' ' ARG . 0.9 OUTLIER -145.5 157.92 43.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.814 0.34 . . . . 0.0 110.32 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 1.5 p -168.03 -176.65 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.059 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 6.1 p-10 -72.42 155.58 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.49 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pm0 -62.4 -34.23 76.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.018 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -39.68 106.92 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . 0.48 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.69 168.25 17.42 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.569 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 75' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' P' ' 79' ' ' ASN . 0.5 OUTLIER -83.03 146.16 51.11 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.653 0.263 . . . . 0.0 110.568 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.11 -36.36 84.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.957 2.438 . . . . 0.0 114.182 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . 0.402 ' O ' HG21 ' P' ' 80' ' ' ILE . 1.0 OUTLIER -64.12 -48.96 74.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.79 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -75.07 -30.25 60.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -65.38 -74.54 0.1 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.612 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.3 OUTLIER -32.27 -38.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 O-C-N 123.23 0.332 . . . . 0.0 111.231 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -61.41 -59.37 5.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.499 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.22 -50.85 20.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.922 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.472 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.72 -45.24 86.06 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.598 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -49.25 -38.69 27.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.281 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -67.65 -46.65 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.715 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.489 ' HG2' ' HA ' ' P' ' 39' ' ' TYR . 0.4 OUTLIER -58.27 -40.65 82.43 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.12 -31.98 70.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.124 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -32.13 70.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.429 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.53 -60.16 4.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.8 -35.62 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -42.83 97.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.502 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.77 -22.63 78.93 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.88 -62.09 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . 0.413 ' CD1' HG12 ' P' ' 64' ' ' VAL . 75.3 mt -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.501 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.62 92.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.753 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.37 -24.44 76.07 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -73.17 -10.06 59.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.79 36.41 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.934 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 22.2 t -75.8 128.8 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.24 138.64 57.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.28 -36.03 60.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.04 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.06 -15.53 60.71 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.043 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 7.0 mtpp -92.88 -11.44 33.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 mt -103.68 142.81 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -147.69 145.64 14.47 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 15.2 p -123.27 162.57 22.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.956 0.407 . . . . 0.0 111.313 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' CD2' ' P' ' 65' ' ' LEU . 0.0 OUTLIER 179.05 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.599 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.612 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -98.69 142.55 30.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.902 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.553 ' O ' ' HG3' ' P' ' 112' ' ' GLU . 34.7 m-85 -113.31 13.81 19.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.89 -109.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.045 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.421 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -107.96 15.31 24.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' P' ' 109' ' ' TYR . 0.2 OUTLIER -63.25 -45.02 93.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.633 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . 0.411 ' N ' ' OE2' ' P' ' 112' ' ' GLU . 20.9 mtmm -146.51 88.93 5.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.71 164.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 0.0 113.143 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.37 -61.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.507 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 15.3 t -88.41 109.79 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.27 136.12 47.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.109 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.56 173.17 13.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -140.88 92.89 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.068 0.434 . . . . 0.0 111.994 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -166.64 162.37 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . 0.416 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.2 OUTLIER -47.08 -25.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.578 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.02 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.725 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.64 69.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 12.9 m-85 -54.55 -50.52 67.73 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.072 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -65.99 -33.81 76.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -68.04 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.46 -29.75 21.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 5.4 mtp180 -65.49 88.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -158.3 157.46 32.5 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.71 95.26 4.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 13.6 t -82.44 112.62 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.409 ' HB2' ' ND2' ' P' ' 30' ' ' ASN . 0.3 OUTLIER -63.8 105.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.565 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -100.55 128.41 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.482 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.831 179.732 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.457 " H3'" ' O2 ' ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.422 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.855 0.359 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.422 ' N ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.483 ' HA ' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.517 ' HB3' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 89.9 p -161.32 -173.0 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m 70.35 -63.47 0.4 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -47.53 -59.93 2.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -139.58 123.29 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -147.75 134.97 20.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.91 -70.41 0.68 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -179.08 168.0 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.53 24.83 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -29.43 49.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -178.08 49.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.82 -56.53 3.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.414 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.12 37.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.404 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.44 82.04 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.318 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 53.33 48.56 21.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.289 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.13 147.61 52.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 54.9 m-85 -136.04 108.42 7.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 111.282 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 9.95 32.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.424 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 -31.66 3.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.563 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.407 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 33.5 m-85 -117.29 161.8 18.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 16.7 t -111.15 160.57 16.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.755 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 17.2 t -40.06 -56.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.37 -19.94 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.76 -43.61 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.298 0.57 . . . . 0.0 110.283 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.468 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 47.1 mt -67.94 -22.0 65.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.44 -20.88 26.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -143.42 -3.57 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 -69.87 0.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -108.86 89.56 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 112.101 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -150.14 18.75 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 86.9 m -126.3 132.01 51.74 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.833 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.417 HG13 ' N ' ' P' ' 33' ' ' TYR . 23.6 t -108.36 149.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.417 ' N ' HG13 ' P' ' 32' ' ' VAL . 9.1 m-85 -113.41 113.44 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.623 0.725 . . . . 0.0 112.301 -179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.761 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 7.1 m-30 -90.29 174.49 7.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.567 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.89 -177.85 15.06 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.511 ' CZ ' ' HA ' ' U' ' 7' ' ' DAL . 12.9 t80 -62.34 136.45 57.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.82 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.0 28.21 0.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.269 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.447 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -105.5 127.75 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.704 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.442 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 23.3 p90 -128.11 43.56 3.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.478 . . . . 0.0 110.2 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -148.06 150.51 34.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.345 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . 0.413 ' CG2' HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -89.06 166.32 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.78 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 47.1 p -111.09 150.1 29.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.125 0.488 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.427 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.56 -31.2 3.54 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.337 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . 0.425 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 2.2 mm-40 -63.03 -32.44 73.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.405 ' O ' HG13 ' P' ' 48' ' ' ILE . 92.1 m-85 -104.05 5.11 35.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.427 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 76.3 t -70.68 -39.92 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' P' ' 44' ' ' GLU . 0.0 OUTLIER -49.81 -33.74 17.51 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.681 -178.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.542 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -59.17 -52.56 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 110.065 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.57 -33.32 63.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.681 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.23 -43.04 68.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.9 -37.06 62.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.542 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 28.4 m-70 -69.04 -38.73 79.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.84 94.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.347 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.36 90.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.021 0.439 . . . . 0.0 110.311 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . 0.433 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 7.8 t80 -72.56 -40.4 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.474 HD13 ' N ' ' P' ' 64' ' ' VAL . 1.8 tp -61.64 -44.24 97.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -65.95 -41.8 90.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.94 3.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.412 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . 0.5 OUTLIER -113.77 118.05 43.48 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.483 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.56 -56.5 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.715 2.277 . . . . 0.0 113.727 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 23.42 1.59 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.453 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -91.5 131.82 36.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 110.547 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -137.35 137.72 39.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.997 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.474 ' N ' HD13 ' P' ' 56' ' ' LEU . 9.9 p -98.16 141.29 16.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.519 0.675 . . . . 0.0 111.533 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' P' ' 133' ' ' ALA . 4.9 tt -108.97 103.62 12.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.32 113.62 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 110.94 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.02 118.72 37.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -104.06 139.54 14.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.582 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 127' ' ' ASN . 57.0 m-80 -145.76 104.62 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.417 ' CG2' ' NH1' ' P' ' 86' ' ' ARG . 39.2 p -86.21 -176.54 5.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.423 ' HB2' ' CE1' ' P' ' 124' ' ' TYR . 10.4 p-10 -71.09 165.47 23.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.442 ' O ' ' CD ' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -66.68 -35.68 80.73 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.94 114.08 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.66 -142.12 17.3 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.807 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.29 146.11 52.65 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.512 0.196 . . . . 0.0 110.614 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.459 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 87.8 Cg_exo -44.68 -43.95 14.27 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.589 2.192 . . . . 0.0 113.715 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.72 -46.36 88.48 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.508 ' CE1' ' CB ' ' U' ' 3' ' ' ALA . 22.7 t80 -72.83 -36.56 67.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.949 0.404 . . . . 0.0 110.006 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' P' ' 80' ' ' ILE . 5.4 m120 -67.99 -74.33 0.12 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.619 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -29.98 -44.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.911 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -57.89 11.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.224 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.2 OUTLIER -46.53 -44.36 17.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.245 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.441 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -65.73 -38.13 94.17 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.564 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.34 -43.49 43.82 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -67.98 -33.72 75.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.466 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.447 ' NE ' ' O ' ' P' ' 38' ' ' LYS . 56.0 mtt180 -65.11 -49.23 70.75 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.543 0.687 . . . . 0.0 109.277 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.14 -34.81 74.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.704 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.45 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.89 -67.51 0.42 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.691 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 59.0 t -53.16 -43.35 49.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.112 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -40.98 85.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.546 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.77 -15.58 80.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.914 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -72.75 -64.27 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.78 -32.62 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.396 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.75 89.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.828 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.13 -22.75 77.41 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.605 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -76.04 -10.03 59.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.806 0.336 . . . . 0.0 110.975 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.3 35.73 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.148 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 18.2 t -75.63 125.81 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.852 0.326 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' P' ' 103' ' ' LYS . 2.5 p30 -62.34 139.54 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.335 0.588 . . . . 0.0 111.565 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.48 -36.35 10.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.449 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.99 -17.1 60.55 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.078 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.454 ' HA ' ' HB3' ' P' ' 63' ' ' LYS . 24.3 mtpp -91.49 -14.51 30.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.036 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mt -102.62 143.07 32.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -139.92 146.14 17.48 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 19.4 p -128.78 152.04 48.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.783 0.325 . . . . 0.0 110.652 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.445 ' CG2' ' CD2' ' P' ' 65' ' ' LEU . 0.0 OUTLIER -175.39 119.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.619 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -118.53 133.63 55.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.522 ' O ' ' C ' ' P' ' 110' ' ' GLY . 23.7 m-85 -102.01 32.48 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -103.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.539 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' P' ' 72' ' ' GLU . 41.7 mt-10 -113.89 16.87 18.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -47.21 66.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.66 89.34 11.78 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.6 163.39 15.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.683 2.255 . . . . 0.0 112.935 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.73 -64.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 2.4 t -88.85 108.74 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -66.89 135.83 54.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.46 173.94 14.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.085 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -140.74 60.95 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.05 152.14 51.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . 0.411 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.1 OUTLIER -37.78 -33.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.28 -61.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.84 -42.63 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.992 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.441 ' O ' ' HD3' ' P' ' 128' ' ' ARG . 4.7 m-85 -56.65 -54.0 51.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.196 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 125' ' ' SER . . . . . 0.542 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 4.8 m -55.68 -35.59 66.2 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -75.44 -21.22 58.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.56 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 69' ' ' ASN . 44.9 m-20 -80.95 -42.76 20.77 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.761 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.39 73.58 0.72 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.949 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.6 143.42 49.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.11 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.61 98.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.66 111.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 101.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.589 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -97.6 125.65 42.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.46 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.945 179.705 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.447 ' PB ' ' O7 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.447 ' O7 ' ' PB ' ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.508 ' CB ' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.429 ' O ' ' O ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.511 ' HA ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 28.3 t 63.07 -79.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.039 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -156.29 168.9 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -72.61 -51.24 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -122.25 104.29 9.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.25 109.2 16.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.67 -15.47 45.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 63.83 22.92 13.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.787 0.327 . . . . 0.0 111.188 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.16 32.51 13.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.308 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' P' ' 14' ' ' ALA . . . -91.55 -71.34 1.2 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.329 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 16.1 m120 64.85 -107.36 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.184 0.194 . . . . 0.0 111.4 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.12 -73.64 1.27 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.665 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.45 -55.24 3.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . 0.442 ' CB ' ' HA2' ' P' ' 10' ' ' GLY . . . 76.48 124.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.431 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -143.46 -178.4 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.087 0.47 . . . . 0.0 111.763 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 33.2 p -125.88 151.43 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.237 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.438 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 45.5 m-85 -129.98 112.08 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.678 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.35 9.62 61.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.584 -0.817 . . . . 0.0 114.08 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 -27.4 3.86 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.137 -1.506 . . . . 0.0 114.529 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.15 173.89 8.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.285 0.542 . . . . 0.0 111.726 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.89 151.52 21.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 13.1 t -44.5 -35.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.898 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.59 -13.04 38.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.612 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' P' ' 29' ' ' TYR . 0.4 OUTLIER -98.16 -44.37 6.63 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.849 0.833 . . . . 0.0 108.891 177.385 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 7.5 mt -58.89 -23.36 60.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.348 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -111.87 -19.19 12.48 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 -32.23 2.99 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -141.57 59.92 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 0.5 OUTLIER 157.5 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.974 0.416 . . . . 0.0 110.691 178.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 172.95 15.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.414 HG23 ' CE1' ' P' ' 33' ' ' TYR . 57.3 m -120.4 126.82 51.41 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.628 0.649 . . . . 0.0 112.203 -179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 3.4 t -108.18 145.35 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.414 ' CE1' HG23 ' P' ' 31' ' ' THR . 39.6 m-85 -119.49 115.19 23.54 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -96.04 168.28 10.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.766 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.53 -171.87 28.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.976 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 12.0 t80 -61.8 116.52 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.656 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 58.33 39.2 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.41 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 1.7 tptp -112.97 136.15 52.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -130.33 54.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.58 150.59 33.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -96.76 161.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.781 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 30.7 p -112.71 147.72 36.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.017 0.437 . . . . 0.0 111.385 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.77 -30.17 3.39 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.082 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.49 -33.89 75.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.562 0.22 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -104.49 3.36 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.57 -41.14 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' P' ' 47' ' ' GLN . 6.5 pm0 -47.6 -35.05 8.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.711 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.486 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -64.37 -46.78 92.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.536 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . 0.421 ' HB3' ' CE1' ' P' ' 93' ' ' TYR . 5.6 mp -56.87 -47.34 80.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.375 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . 0.44 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.3 OUTLIER -67.45 -33.52 75.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.428 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.9 -41.03 37.93 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.685 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.592 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 22.3 m-70 -64.21 -38.46 91.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.26 88.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . 0.438 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 21.6 t80 -79.2 -34.45 42.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.441 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 5.0 tp -66.51 -41.3 89.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -75.64 -34.54 60.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.653 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.93 -24.85 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.57 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.401 ' OG1' ' CB ' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -112.57 114.82 49.74 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.634 0.254 . . . . 0.0 110.389 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -48.94 -63.12 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.876 2.384 . . . . 0.0 114.039 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.27 18.85 2.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.447 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -84.56 113.57 21.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.549 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.9 mttp -115.59 128.46 55.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.51 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.441 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.6 p -96.2 139.98 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 121.305 0.574 . . . . 0.0 110.641 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tt -112.45 103.09 11.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.956 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.47 106.45 12.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.479 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.416 ' HA ' HG22 ' P' ' 107' ' ' VAL . 20.7 mt-10 -89.8 119.32 30.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.526 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 134.53 12.52 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' P' ' 129' ' ' ARG . 27.3 m120 -134.62 159.02 42.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.438 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.402 HG21 ' O ' ' P' ' 69' ' ' ASN . 7.6 p -164.42 -177.61 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.162 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.493 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 8.2 p-10 -73.55 155.6 38.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' P' ' 111' ' ' GLU . 2.6 pp20? -63.49 -34.86 78.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.962 0.41 . . . . 0.0 110.641 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.408 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -41.8 165.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.438 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.4 -124.47 6.7 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.773 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -163.62 145.53 7.52 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.477 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 2.4 Cg_endo -39.61 -53.13 2.36 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.297 2.664 . . . . 0.0 113.25 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -40.73 93.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.609 ' OH ' ' HB3' ' U' ' 4' ' ' DGL . 1.1 t80 -72.37 -35.16 68.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.453 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.532 ' O ' HD13 ' P' ' 82' ' ' LEU . 5.6 m120 -76.94 -76.88 0.16 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.537 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.04 -43.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.3 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -68.86 -60.72 2.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.532 HD13 ' O ' ' P' ' 79' ' ' ASN . 0.0 OUTLIER -57.14 -38.42 73.49 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.272 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.521 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -68.46 -50.96 34.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.341 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.4 mt-30 -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -46.49 88.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.324 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.441 ' CD ' ' HA2' ' P' ' 83' ' ' GLY . 0.4 OUTLIER -57.27 -42.62 81.95 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.87 -37.44 79.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.147 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.63 -32.34 73.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.467 178.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.59 -47.59 84.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.697 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.01 -34.69 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.702 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.94 -38.69 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.525 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.96 -29.47 58.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . 0.46 ' CD1' ' HE3' ' P' ' 97' ' ' LYS . 7.6 t80 -62.87 -53.76 49.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . 0.574 ' HA ' ' HD2' ' P' ' 97' ' ' LYS . 20.3 mt -59.48 -28.62 67.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.263 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.57 -36.63 65.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.914 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.45 58.01 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.092 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . 0.574 ' HD2' ' HA ' ' P' ' 94' ' ' LEU . 0.0 OUTLIER -49.42 -34.76 17.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.92 28.94 1.6 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.386 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . . . . . . . . . 23.1 t -90.71 145.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.567 0.223 . . . . 0.0 110.822 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.5 160.45 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.283 0.563 . . . . 0.0 111.526 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.64 -32.52 16.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.316 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.1 -21.67 46.93 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.48 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.549 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.08 -4.57 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.22 0.533 . . . . 0.0 110.923 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 4.6 mt -85.74 150.51 24.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.206 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.9 139.67 8.12 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 34.6 p -141.57 151.2 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' P' ' 67' ' ' GLU . 0.2 OUTLIER -166.95 170.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.855 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 1.3 t -157.38 126.93 6.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.726 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.3 m-85 -115.49 18.49 15.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -1.28 -113.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.597 -0.729 . . . . 0.0 114.804 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -85.35 2.54 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.91 -57.05 14.47 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 88.22 5.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.76 170.81 18.69 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.022 2.481 . . . . 0.0 112.838 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.46 -56.03 2.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.152 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.471 HG12 ' CA ' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -88.72 138.61 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.699 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.44 139.41 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.154 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.19 176.93 15.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.881 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.464 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 0.2 OUTLIER -141.06 62.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 0.249 . . . . 0.0 111.279 -179.36 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -132.92 154.91 49.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.81 -26.09 0.12 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.69 -62.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.97 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.471 ' CA ' HG12 ' P' ' 116' ' ' VAL . . . -69.79 -42.43 73.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 1.0 OUTLIER -55.65 -48.76 74.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.759 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 58.2 m -63.34 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.397 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -68.33 -27.13 66.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.325 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.431 ' ND2' HG11 ' P' ' 116' ' ' VAL . 92.0 m-20 -89.07 -28.95 19.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -70.16 86.89 0.57 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 7.6 ptt-85 -159.79 159.18 32.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -123.63 102.35 7.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -86.87 109.58 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.3 OUTLIER -59.68 102.19 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.572 178.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 126.92 48.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.678 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.874 179.624 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.524 ' H6 ' " O5'" ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.499 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' U' ' 4' ' ' DGL . . . . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.609 ' HB3' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.454 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 36.7 p -104.19 -54.22 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.62 68.63 4.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -90.0 -36.35 15.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -150.17 127.97 11.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -90.01 149.43 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.09 -52.96 4.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.03 116.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 15.72 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.392 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.33 80.49 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 68.34 -68.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -26.79 68.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.5 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 111.186 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.24 -168.65 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.202 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -102.33 176.23 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 39.1 p -127.68 110.68 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.944 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' P' ' 20' ' ' TYR . 63.4 m-85 -89.68 107.16 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.994 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.75 9.33 38.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.645 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.67 -37.1 1.87 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.349 -1.405 . . . . 0.0 114.037 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' P' ' 17' ' ' PHE . 5.3 m-85 -120.76 169.14 10.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.023 0.411 . . . . 0.0 111.586 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 26.0 t -102.78 152.99 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.439 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -40.07 -48.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.36 -17.27 28.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -42.61 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.284 0.564 . . . . 0.0 110.427 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 16.3 mt -59.27 -21.22 59.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.436 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . 0.425 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 4.5 mm-40 -103.26 -12.6 17.17 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -125.21 -22.72 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -109.78 -62.16 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -108.25 83.58 1.8 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.288 0.566 . . . . 0.0 112.162 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.536 HD21 ' HB2' ' P' ' 132' ' ' LEU . 0.1 OUTLIER -141.53 13.45 2.14 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.933 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 95.2 m -134.28 135.99 43.23 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.434 HG13 ' CB ' ' P' ' 45' ' ' TYR . 3.0 t -108.37 150.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.07 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.32 115.62 21.98 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.453 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.2 m-30 -96.18 169.87 9.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.512 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.56 -168.95 19.41 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.818 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.418 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 4.0 t80 -61.58 126.14 26.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 49.75 30.57 3.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.618 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.402 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -101.13 132.55 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -129.35 46.26 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 110.822 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.41 150.43 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.808 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.9 164.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.259 . . . . 0.0 110.896 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 67.2 p -112.8 149.98 32.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.213 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.4 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.48 -32.51 1.92 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.228 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.89 -33.06 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.415 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.434 ' CB ' HG13 ' P' ' 32' ' ' VAL . 81.4 m-85 -102.27 -1.02 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.4 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 79.4 t -65.59 -40.98 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.283 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.468 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -43.85 -43.44 6.3 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.536 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -57.39 -50.34 77.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 110.556 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 5.1 mt -53.32 -37.46 62.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -40.26 56.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.13 -54.22 11.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.03 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.536 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 22.7 m-70 -56.98 -36.8 70.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 109.904 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -60.76 -42.53 97.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.903 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.07 95.51 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.854 0.359 . . . . 0.0 110.751 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.33 -36.43 53.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.437 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 8.0 tp -68.93 -39.42 79.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.935 0.398 . . . . 0.0 111.174 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.05 -36.74 66.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.192 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.45 -23.28 67.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.22 111.24 58.04 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.602 0.239 . . . . 0.0 110.363 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.17 -58.67 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.863 2.375 . . . . 0.0 113.927 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.65 2.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.41 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -89.18 116.95 27.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.77 131.12 57.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.038 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.419 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 3.9 p -95.98 133.69 36.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.433 0.635 . . . . 0.0 111.15 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.445 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.2 tt -109.79 103.67 12.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.793 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.41 108.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.73 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.408 ' HA ' HG23 ' P' ' 107' ' ' VAL . 2.4 tt0 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.773 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.77 128.58 8.87 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.722 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.412 ' O ' HG23 ' P' ' 70' ' ' THR . 1.8 m-80 -130.93 158.0 41.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.9 OUTLIER -170.25 -175.19 1.89 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 111.495 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.533 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 14.0 p-10 -77.43 149.39 35.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.302 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.498 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 9.2 pm0 -57.71 -31.63 66.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.883 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.419 ' N ' ' HG2' ' P' ' 72' ' ' GLU . 2.9 tpp180 -40.74 107.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.36 -173.69 15.03 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.163 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.76 145.52 30.87 Favored Pre-proline 0 N--CA 1.466 0.355 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.409 ' HG3' ' OE2' ' P' ' 111' ' ' GLU . 81.4 Cg_exo -39.97 -46.79 3.91 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.916 2.411 . . . . 0.0 113.063 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.84 -40.99 94.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.4 t80 -73.99 -39.01 63.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -68.78 -76.75 0.09 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' P' ' 79' ' ' ASN . 1.0 OUTLIER -30.64 -45.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.433 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.37 -57.62 11.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.487 ' O ' ' HG2' ' P' ' 85' ' ' ARG . 0.2 OUTLIER -45.31 -51.86 10.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.779 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.454 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -62.23 -35.84 92.16 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.482 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -47.9 65.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.913 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 0.0 OUTLIER -68.1 -32.99 73.69 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.827 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.454 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 6.6 mtt180 -65.22 -45.99 82.46 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.555 0.693 . . . . 0.0 109.229 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' P' ' 106' ' ' THR . . . -60.35 -35.55 75.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.749 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.99 -30.74 71.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.87 -56.35 20.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.938 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.04 -36.17 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -43.77 98.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.21 -24.44 76.42 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.98 -64.04 1.0 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 85.2 mt -53.83 -32.82 54.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.6 88.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.053 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.72 -21.08 77.85 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . 0.408 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -79.85 -9.52 59.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 122.74 0.416 . . . . 0.0 110.974 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.94 0.18 36.01 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.776 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.437 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 48.6 t -73.63 123.71 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.36 148.61 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.48 -34.24 75.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.673 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.39 -22.1 55.44 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.045 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.514 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -100.05 -4.43 29.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.229 0.537 . . . . 0.0 111.133 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 37.2 mt -95.91 150.12 20.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.298 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -148.42 142.07 9.66 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.408 ' HB ' ' CB ' ' P' ' 87' ' ' ALA . 45.0 p -134.02 155.69 49.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.668 0.27 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.445 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.1 OUTLIER -170.77 171.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 108' ' ' SER . . . . . . . . . . . . . 14.7 p -162.62 134.54 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.633 0.254 . . . . 0.0 111.48 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.509 ' O ' ' C ' ' P' ' 110' ' ' GLY . 29.5 m-85 -123.62 23.59 8.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 1.25 -110.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 114.622 0.609 . . . . 0.0 114.622 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.498 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -84.05 5.06 27.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -54.71 -59.57 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 88.78 7.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.98 166.96 13.05 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.79 2.327 . . . . 0.0 113.018 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.72 -61.64 1.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.27 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 5.6 t -88.84 108.86 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.83 136.53 56.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.199 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.06 174.98 14.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.981 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.457 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 7.2 p-80 -141.12 61.09 1.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.765 0.283 . . . . 0.0 111.462 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -130.16 156.35 44.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -43.66 -25.82 0.19 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.13 -56.66 4.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.89 -43.19 68.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.666 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.533 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 2.0 m-85 -59.48 -47.38 85.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 94.6 p -63.36 -33.44 75.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 110.241 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -24.49 63.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.887 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.85 -30.8 18.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.335 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 3.0 mtp180 -65.82 87.25 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.32 157.17 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.06 96.23 4.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.02 109.71 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.536 ' HB2' HD21 ' P' ' 30' ' ' ASN . 0.3 OUTLIER -60.92 101.81 0.17 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.031 178.144 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -100.22 127.84 46.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.755 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.889 179.758 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.569 ' H6 ' " O5'" ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.569 ' C10' ' H ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.569 ' H ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.512 ' HB3' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.418 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 77.5 p -143.27 98.47 3.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 28.9 t -141.6 -77.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 5.0 t -90.14 -31.5 17.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -150.9 150.36 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -89.68 138.65 31.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.33 -12.31 61.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.396 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.29 121.14 32.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.08 -154.1 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.54 -69.82 1.21 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.436 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -177.59 111.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 110.77 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -28.61 73.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.681 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.14 -64.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.232 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.65 43.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 166.77 22.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 5.5 p -130.59 150.62 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -137.04 107.17 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.18 9.64 12.26 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.358 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.79 -41.41 1.32 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.819 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -126.65 172.59 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.967 0.413 . . . . 0.0 111.504 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -99.72 152.26 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.949 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 16.7 t -42.13 -53.85 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.315 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.46 -14.94 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -44.79 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 109.483 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 2.6 mt -59.06 -21.98 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.997 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -100.75 -11.93 19.51 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -121.86 -21.82 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . 0.457 ' HD3' ' CZ ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -118.39 -55.44 2.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.457 ' CZ ' ' HD3' ' P' ' 28' ' ' ARG . 53.0 m-85 -108.78 101.41 10.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.179 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 1.4 p30 -170.44 20.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.247 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.429 HG22 ' CE1' ' P' ' 33' ' ' TYR . 82.7 m -128.88 131.29 47.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.178 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -110.98 143.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.211 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.429 ' CE1' HG22 ' P' ' 31' ' ' THR . 45.3 m-85 -117.28 118.55 32.59 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.51 170.73 7.86 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.132 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.45 -165.77 15.34 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.433 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.523 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 2.7 t80 -57.65 123.74 16.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.51 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . 0.407 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 3.2 p30 42.01 28.61 0.1 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.002 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -90.44 130.14 36.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.626 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 9.1 t80 -125.03 59.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.52 149.98 29.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.91 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 8.6 mt -96.83 161.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 3.9 p -110.47 140.72 44.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 112.025 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.6 -30.03 3.1 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.095 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.84 -33.49 76.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.55 0.214 . . . . 0.0 111.552 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.403 ' O ' HG13 ' P' ' 48' ' ' ILE . 83.1 m-85 -101.26 0.17 36.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.42 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 75.6 t -66.87 -40.81 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.401 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -45.11 -43.52 9.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.423 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.52 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -54.08 -52.46 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.292 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.6 mp -50.92 -40.27 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.385 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -38.29 64.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.928 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.02 -58.89 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.821 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 18.8 m-70 -51.54 -37.0 47.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.171 0.51 . . . . 0.0 109.784 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . 0.443 ' CB ' ' CE ' ' P' ' 97' ' ' LYS . . . -60.98 -48.16 83.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.289 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.85 76.86 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.926 0.394 . . . . 0.0 110.372 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -71.47 -42.12 68.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.676 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.446 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.4 OUTLIER -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.301 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -67.29 -43.06 82.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.09 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.331 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.41 95.64 45.02 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.88 -24.61 39.58 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 113.29 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.9 5.27 51.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.411 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.55 127.03 36.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.8 mttp -121.51 130.56 53.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.046 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.446 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.1 p -97.38 147.34 6.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.502 0.668 . . . . 0.0 111.536 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.441 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.5 tt -119.78 104.24 10.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.665 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.15 109.87 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.618 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 1.6 mm-40 -89.7 121.55 31.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.54 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.25 133.84 11.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.881 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -145.82 100.98 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.778 0.323 . . . . 0.0 110.754 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -168.68 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.407 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 13.0 p-10 -81.79 164.91 21.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.974 0.416 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.506 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 10.1 tm-20 -66.93 -40.59 87.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.246 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.418 ' O ' ' NZ ' ' U' ' 5' ' ' 6CL . 0.0 OUTLIER -44.97 106.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.037 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.27 -164.83 12.01 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.479 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.27 146.02 34.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.657 0.265 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 71.8 Cg_exo -50.78 -38.22 56.39 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.13 2.553 . . . . 0.0 114.158 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.55 -42.8 83.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.466 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 40.5 t80 -81.73 -29.26 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.482 ' HB2' ' OE1' ' P' ' 111' ' ' GLU . 2.0 m-80 -90.62 -11.54 39.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -87.58 -40.74 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.2 -48.67 64.59 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.269 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -60.24 -38.46 83.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.126 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.544 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -69.4 -44.52 64.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.139 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.7 OUTLIER -50.63 -41.3 54.88 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.454 ' HG3' ' CE1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.65 -35.42 80.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -64.24 -52.39 58.95 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.55 -34.98 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.476 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -29.43 69.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.49 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.75 -50.77 63.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.629 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.15 -38.76 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . 0.411 ' HG3' ' N ' ' P' ' 92' ' ' GLY . 0.0 OUTLIER -61.97 -40.68 96.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.234 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . 0.411 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -72.09 -28.3 68.66 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . 0.439 ' CD1' ' HD2' ' P' ' 97' ' ' LYS . 4.3 t80 -59.97 -62.24 2.02 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . 0.626 ' HA ' ' HD3' ' P' ' 97' ' ' LYS . 95.4 mt -54.43 -32.42 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.55 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.18 76.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.169 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.78 -29.75 75.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.547 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' P' ' 94' ' ' LEU . 0.7 OUTLIER -74.13 -11.6 60.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.11 3.49 15.24 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 28.2 t -80.98 131.82 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.897 0.349 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.416 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -60.31 158.02 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.333 0.587 . . . . 0.0 111.556 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -86.42 -29.94 22.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.71 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.53 50.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.807 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.93 -3.77 31.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.145 0.497 . . . . 0.0 111.163 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 7.3 mt -91.68 149.21 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.336 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.89 139.79 8.45 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 43.5 p -138.45 151.43 47.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.767 0.318 . . . . 0.0 110.975 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.441 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -161.27 169.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.133 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.441 ' O ' HG12 ' P' ' 80' ' ' ILE . 51.6 p -162.68 130.04 3.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.506 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.552 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.0 OUTLIER -114.19 31.55 6.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.234 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.77 -113.12 0.01 OUTLIER Glycine 0 C--N 1.34 0.796 0 O-C-N 123.679 0.612 . . . . 0.0 114.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 2.7 mp0 -97.71 13.18 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . 0.409 ' CG ' ' HB3' ' P' ' 76' ' ' PRO . 26.0 mt-10 -61.72 -55.23 32.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.679 0.276 . . . . 0.0 110.378 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -134.19 89.83 27.24 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 161.2 8.98 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.641 2.227 . . . . 0.0 112.967 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.92 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.712 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 3.6 t -88.61 108.82 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.98 135.04 57.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.388 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.93 173.3 14.72 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.787 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.471 ' HA ' ' CD1' ' P' ' 124' ' ' TYR . 0.6 OUTLIER -141.21 64.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.787 0.294 . . . . 0.0 111.492 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.82 152.88 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -38.0 -32.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -60.93 2.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -43.93 74.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.471 ' CD1' ' HA ' ' P' ' 119' ' ' HIS . 0.8 OUTLIER -57.71 -52.99 63.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.316 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 11.2 t -59.33 -33.96 71.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -27.84 67.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.572 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 69' ' ' ASN . 74.3 m-20 -82.96 -33.48 26.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.88 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -69.74 80.21 0.44 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.815 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -156.56 150.86 25.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.95 115.91 25.35 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.8 112.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.3 OUTLIER -59.41 98.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.632 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -102.36 129.1 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.009 179.773 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.418 ' PB ' ' HB3' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.418 ' HB3' ' PB ' ' U' ' 1' ' ' UDP . . . . . . . . 0 C--O 1.23 0.078 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.418 ' NZ ' ' O ' ' P' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.523 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.417 ' CB ' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.833 0.349 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 65.9 m 61.43 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -97.09 145.5 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 31.6 p -87.04 -45.48 10.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -119.9 114.86 22.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.59 100.35 13.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -90.94 -23.71 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.78 -170.96 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.086 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.33 126.97 31.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.194 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.06 -39.96 5.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.444 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.16 11.55 7.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.441 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.68 -24.98 26.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.566 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 111.372 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.08 52.86 9.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.006 0.432 . . . . 0.0 110.99 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -177.49 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.358 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -119.5 106.24 12.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 94.2 m-85 -89.48 108.1 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.498 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.97 9.14 38.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.333 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -32.97 2.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.488 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' P' ' 17' ' ' PHE . 2.1 m-85 -115.41 160.61 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.025 0.441 . . . . 0.0 111.611 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 9.4 t -103.2 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.262 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.5 t -43.3 -41.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -17.27 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 -40.58 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.568 0.699 . . . . 0.0 110.012 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' P' ' 29' ' ' TYR . 6.3 mt -64.27 -15.34 59.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.564 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . 0.466 ' HG3' ' CD2' ' P' ' 134' ' ' TYR . 2.0 tt0 -92.78 -25.47 18.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.39 -9.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -117.12 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.429 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 54.0 m-85 -107.12 99.49 9.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 111.961 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 1.3 p30 -178.38 27.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.22 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.425 HG21 ' CE1' ' P' ' 33' ' ' TYR . 78.6 m -126.48 127.08 44.81 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.791 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 1.9 t -104.19 150.13 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.157 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.425 ' CE1' HG21 ' P' ' 31' ' ' THR . 53.0 m-85 -124.63 112.64 17.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.243 0.544 . . . . 0.0 112.429 -179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -91.51 166.66 12.73 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.97 -167.64 19.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.064 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.54 126.32 26.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.016 0.436 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t0 53.09 27.92 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.568 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -100.97 136.8 40.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.478 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 46.4 p90 -135.72 36.05 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.22 150.63 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.799 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.26 164.66 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.933 0.397 . . . . 0.0 111.069 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.38 149.06 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.941 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.427 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -41.18 -33.96 0.85 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.527 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.2 -31.79 72.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.644 0.259 . . . . 0.0 111.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.487 ' O ' HG13 ' P' ' 48' ' ' ILE . 71.2 m-85 -99.99 1.54 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.427 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 56.0 t -65.05 -44.72 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.604 ' NE2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -40.01 -43.97 1.65 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.487 HG13 ' O ' ' P' ' 45' ' ' TYR . 0.1 OUTLIER -62.14 -47.4 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.066 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.61 -51.77 67.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.801 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . 0.554 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.9 OUTLIER -61.13 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.14 -37.06 72.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.854 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.618 ' HA ' ' CD2' ' P' ' 55' ' ' TYR . 5.6 m-70 -66.21 -33.44 75.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.241 0.543 . . . . 0.0 110.321 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . 0.407 ' CB ' ' HG2' ' P' ' 97' ' ' LYS . . . -75.38 -31.14 60.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.826 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.25 69.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 111.356 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HE1' ' P' ' 134' ' ' TYR . 1.8 p90 -74.28 -34.41 63.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.444 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 0.4 OUTLIER -72.4 -35.64 68.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -178.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.77 -31.7 65.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.98 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.89 61.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.38 111.79 57.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.819 0.342 . . . . 0.0 110.503 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.69 -62.49 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.079 2.519 . . . . 0.0 114.481 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.35 22.93 2.7 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.406 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.65 116.34 28.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.711 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -122.21 132.28 54.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.892 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 10.0 p -95.36 137.34 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 121.41 0.624 . . . . 0.0 111.466 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.499 ' CB ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -105.15 106.39 16.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.682 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.88 104.39 12.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 10.4 mt-10 -89.59 119.88 30.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.596 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.16 95.92 1.88 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.094 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -97.58 155.22 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.283 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.7 OUTLIER -173.43 176.25 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.165 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -73.88 148.16 42.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.249 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.417 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 0.5 OUTLIER -55.36 -28.3 52.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.957 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.455 ' HD3' ' CB ' ' U' ' 7' ' ' DAL . 19.1 ttm180 -39.82 104.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.312 0.577 . . . . 0.0 112.263 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . 0.477 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.29 163.28 16.54 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.109 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.16 146.71 71.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.463 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 68.7 Cg_exo -50.53 -42.63 48.54 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.744 2.296 . . . . 0.0 113.95 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.99 -46.66 86.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.582 ' CE1' ' HA ' ' U' ' 5' ' ' 6CL . 0.0 OUTLIER -77.49 -32.31 54.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.512 ' O ' ' N ' ' P' ' 82' ' ' LEU . 1.5 m120 -63.56 -74.94 0.09 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.444 ' C ' ' O ' ' P' ' 79' ' ' ASN . 0.7 OUTLIER -32.16 -40.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 120.779 0.323 . . . . 0.0 110.707 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' P' ' 84' ' ' GLN . . . -62.16 -55.3 30.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.039 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.3 OUTLIER -43.72 -52.65 6.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.595 177.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.433 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -68.62 -34.4 78.49 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.108 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.424 ' HB2' ' HA ' ' P' ' 81' ' ' ALA . 0.0 OUTLIER -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -64.09 -40.26 95.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.478 ' CG ' ' HA ' ' P' ' 39' ' ' TYR . 9.1 mtt180 -60.26 -39.58 87.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.64 94.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.431 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.29 -34.89 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.51 -61.06 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.429 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.88 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.354 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -47.17 87.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.634 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.56 -23.01 76.79 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.839 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . 0.451 ' CE1' ' HD3' ' P' ' 97' ' ' LYS . 5.2 t80 -64.43 -63.69 1.07 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 33.5 mt -55.47 -31.68 62.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.497 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.12 95.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.82 -24.08 75.64 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.447 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -74.98 -9.49 58.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.068 179.384 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.21 6.04 48.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.868 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.444 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 39.3 t -76.86 130.39 36.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.064 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.47 140.68 58.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.456 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.0 70.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.35 -17.9 57.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.929 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 12.6 mtpp -91.65 -13.38 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.999 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 mt -101.99 143.83 31.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.355 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -146.23 147.07 17.77 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 17.4 p -127.93 154.71 45.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.728 0.299 . . . . 0.0 110.663 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -176.02 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.769 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.429 ' O ' ' CG1' ' P' ' 80' ' ' ILE . 52.5 p -112.79 137.46 51.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.771 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.531 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.7 m-85 -113.22 26.85 10.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.707 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.531 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 5.8 -111.37 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.224 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.463 ' HG3' ' HG3' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -101.38 14.89 30.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -62.52 -55.16 30.09 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.24 88.83 5.69 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.95 169.89 12.56 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.026 2.484 . . . . 0.0 112.928 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.84 -61.69 1.33 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.224 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' P' ' 123' ' ' ALA . 38.9 t -89.44 114.17 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.601 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.04 138.7 57.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.8 178.19 18.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.053 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.505 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 0.5 OUTLIER -142.04 67.53 1.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.639 0.219 . . . . 0.0 111.305 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.09 153.13 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -38.98 -32.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.14 -52.65 13.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.874 0.368 . . . . 0.0 111.291 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.421 ' HB2' ' CG1' ' P' ' 116' ' ' VAL . . . -71.08 -43.53 67.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.187 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.505 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 2.1 m-30 -63.91 -40.5 96.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 91.5 p -65.85 -35.75 81.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.026 0.441 . . . . 0.0 109.888 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -69.59 -25.3 63.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.743 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.63 -30.68 19.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 7.4 mtp180 -66.18 82.41 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -159.23 162.42 36.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -128.42 102.45 6.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 t -91.21 117.52 34.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.1 OUTLIER -71.48 104.92 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.081 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -115.21 145.19 42.66 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.543 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . 0.697 ' HE1' ' OH ' ' P' ' 55' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . 0.571 H5'1 ' O2 ' ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.465 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.409 ' N ' ' O1B' ' U' ' 1' ' ' UDP . . . . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.818 0.342 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.465 ' N ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.582 ' HA ' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.455 ' CB ' ' HD3' ' P' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 96.0 p -93.35 86.11 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 59.8 p -174.47 -41.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -71.82 -55.87 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -145.98 111.76 5.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -149.99 130.68 14.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.36 -52.61 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 59.12 103.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.32 60.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.62 -73.19 1.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.463 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 62.89 127.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 111.023 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.05 -46.7 4.09 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -50.45 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.12 -160.25 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 67.14 154.46 0.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.828 0.347 . . . . 0.0 111.194 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.9 121.17 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.757 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' P' ' 20' ' ' TYR . 57.1 m-85 -91.06 108.71 20.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.32 9.38 42.46 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.818 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.51 2.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.02 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' P' ' 17' ' ' PHE . 0.5 OUTLIER -120.62 164.89 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.021 0.439 . . . . 0.0 111.58 -179.272 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.3 t -98.27 152.32 19.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 15.7 t -39.9 -49.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.72 -15.98 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' P' ' 29' ' ' TYR . 0.2 OUTLIER -99.6 -47.58 5.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.233 0.539 . . . . 0.0 110.233 178.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.539 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 42.0 mt -54.62 -22.64 14.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.783 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -12.93 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -111.9 -29.69 7.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -129.79 -38.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.412 ' HB2' ' OD1' ' P' ' 24' ' ' ASP . 27.7 m-85 -109.91 104.78 13.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.614 0.721 . . . . 0.0 112.366 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 179.44 22.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.464 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.41 HG22 ' CE1' ' P' ' 33' ' ' TYR . 91.7 m -126.88 128.79 47.05 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.065 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 16.7 t -108.95 150.29 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.309 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.41 ' CE1' HG22 ' P' ' 31' ' ' THR . 54.2 m-85 -122.46 116.19 23.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.0 m-85 -95.66 168.63 10.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.67 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.77 -166.84 29.49 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.185 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -58.68 114.89 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 50.12 30.46 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.6 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.416 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -95.97 142.84 27.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.984 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -130.0 55.77 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.09 150.39 31.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.562 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.38 161.93 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 110.836 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 42.6 p -112.59 147.11 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.394 . . . . 0.0 111.251 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.63 -31.13 2.43 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.0 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.76 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 111.259 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -105.26 3.75 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.946 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.66 -38.4 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -52.27 -32.81 39.04 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.615 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.475 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -63.51 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.158 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' P' ' 93' ' ' TYR . 8.2 mt -59.33 -34.13 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.194 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.68 -39.16 52.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.924 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . 0.406 ' HB3' HD21 ' P' ' 25' ' ' LEU . . . -74.45 -46.45 39.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.949 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.539 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 19.5 m-70 -62.28 -38.23 88.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.04 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.007 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.88 95.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.063 0.459 . . . . 0.0 110.203 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -75.38 -35.82 61.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.903 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.452 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.8 OUTLIER -63.56 -43.22 97.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.036 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -69.97 -41.22 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.264 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.38 -26.56 61.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -111.73 110.49 54.84 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.447 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.55 -51.03 11.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.795 2.33 . . . . 0.0 114.0 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 18.32 6.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.449 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -89.2 112.79 23.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.451 . . . . 0.0 110.658 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 7.5 mttt -115.96 130.11 56.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.722 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.9 p -99.04 146.59 8.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.569 0.7 . . . . 0.0 111.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.494 ' HB3' ' O ' ' P' ' 133' ' ' ALA . 2.8 tt -117.63 105.26 11.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -82.38 103.46 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.153 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.44 119.38 31.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.787 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.64 143.28 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.098 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.5 ' O ' ' CG2' ' P' ' 70' ' ' THR . 1.5 m-80 -138.96 157.52 45.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 68.1 p -164.73 -165.29 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.474 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' P' ' 124' ' ' TYR . 24.0 p30 -90.89 158.8 16.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.492 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 2.3 pm0 -60.85 -33.55 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.845 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -45.32 111.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.15 -174.84 15.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.052 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.82 145.09 31.28 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 111.639 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.484 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 85.1 Cg_exo -38.57 -46.92 2.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.117 2.545 . . . . 0.0 113.723 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.37 -44.47 92.72 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.743 0.306 . . . . 0.0 111.024 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.7 t80 -70.1 -44.83 68.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' P' ' 80' ' ' ILE . 7.1 m120 -70.94 -76.02 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.584 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.67 -43.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.39 -55.88 11.96 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.65 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.54 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -49.43 -50.36 41.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 178.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -63.07 -42.59 99.54 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.9 tp60 -47.84 -40.44 21.34 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.204 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.475 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.3 ptm180 -67.6 -37.71 82.95 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.557 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 15.9 mtt180 -62.72 -47.67 82.58 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.45 -33.24 69.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.829 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -32.66 73.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.497 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.62 -56.51 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.511 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -66.08 -34.61 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.248 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -44.81 96.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.763 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.46 -23.66 77.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . 0.411 ' CE2' HD12 ' P' ' 49' ' ' LEU . 6.2 t80 -64.5 -60.81 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 91.0 mt -55.91 -31.93 63.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.25 -39.08 82.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.032 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.04 95.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.04 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -34.66 74.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.02 26.59 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.095 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.451 ' CG1' ' HD3' ' P' ' 103' ' ' LYS . 49.6 t -90.53 143.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.179 0.191 . . . . 0.0 110.572 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.444 ' N ' HG13 ' P' ' 99' ' ' VAL . 2.8 m-20 -62.8 162.6 10.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 111.455 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.13 -31.5 16.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.548 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.93 -23.82 47.39 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.829 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.541 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -100.63 -4.32 28.66 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.114 0.483 . . . . 0.0 111.059 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 47.0 mt -96.92 147.26 24.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.87 144.13 11.43 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.812 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.443 ' O ' ' CG2' ' P' ' 107' ' ' VAL . 39.8 p -124.21 157.46 34.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.727 0.298 . . . . 0.0 110.533 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' P' ' 106' ' ' THR . 92.7 t -161.14 162.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.584 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 2.3 t -155.74 123.25 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.493 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' P' ' 110' ' ' GLY . 92.6 m-85 -116.75 17.76 15.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -3.68 -113.54 0.0 OUTLIER Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.492 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -78.77 -2.33 38.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.02 -63.39 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.679 0.275 . . . . 0.0 110.753 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 89.49 20.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.7 163.44 13.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.706 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.37 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.655 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.415 ' CG1' ' HB1' ' P' ' 123' ' ' ALA . 46.5 t -88.78 113.95 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.772 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.78 136.53 52.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.28 175.67 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.721 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.443 ' HB3' ' CE2' ' P' ' 124' ' ' TYR . 5.8 m80 -141.56 100.31 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.873 0.336 . . . . 0.0 111.629 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -170.83 161.56 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -47.33 -24.59 0.8 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.36 -60.73 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.934 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.415 ' HB1' ' CG1' ' P' ' 116' ' ' VAL . . . -69.18 -41.05 77.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.817 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' P' ' 119' ' ' HIS . 13.2 m-85 -59.01 -50.38 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.239 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 8.4 t -62.38 -32.57 73.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -73.56 -24.36 60.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -88.94 -31.48 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.25 88.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.3 OUTLIER -158.78 157.88 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.86 100.68 7.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -84.32 113.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -62.63 102.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.662 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -106.91 132.95 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.086 179.694 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.401 ' H2 ' ' N ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . 0.401 ' N ' ' H2 ' ' U' ' 2' ' ' AMU . . . . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.123 0.487 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.548 ' HB3' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.815 0.341 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -113.15 -35.73 5.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t 60.16 109.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -90.04 -39.76 12.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.073 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -150.98 150.07 30.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -100.35 131.33 46.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.21 -28.12 19.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.242 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 62.95 32.08 15.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.875 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.49 -157.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.45 -73.17 1.26 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.673 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.01 165.97 33.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 0.0 111.047 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.15 -12.91 61.12 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.758 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.48 -29.38 4.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.78 0.324 . . . . 0.0 111.489 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.88 170.45 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 62.72 134.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -132.3 104.76 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' P' ' 20' ' ' TYR . 81.9 m-85 -89.86 106.39 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.45 9.05 22.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.523 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.21 -40.71 1.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.509 ' OH ' ' HG2' ' P' ' 47' ' ' GLN . 0.1 OUTLIER -128.89 -179.7 5.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.262 0.553 . . . . 0.0 111.899 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -118.28 175.81 5.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 t -42.94 -53.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.07 -21.12 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.77 -43.95 6.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.961 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.452 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 30.0 mt -56.85 -21.77 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.657 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.63 -11.3 15.89 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.31 -25.35 4.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -111.14 -64.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -105.2 81.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.68 9.61 2.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.989 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 67.8 m -135.21 138.32 43.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.423 HG13 ' CB ' ' P' ' 45' ' ' TYR . 10.3 t -109.62 149.89 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.031 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -117.42 116.46 27.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.804 0.811 . . . . 0.0 112.885 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.68 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -92.72 174.81 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.891 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.17 -176.45 14.83 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 2.7 t80 -61.84 131.8 51.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.703 0.751 . . . . 0.0 110.613 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 2.7 p30 44.68 29.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.445 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -94.53 119.86 33.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.65 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.766 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.4 OUTLIER -118.73 46.12 1.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.751 0.786 . . . . 0.0 110.053 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.41 150.47 31.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.433 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 2.6 mt -93.03 165.88 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.348 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.32 141.09 43.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.09 0.472 . . . . 0.0 111.828 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.09 -31.72 4.53 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.055 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -33.01 74.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 111.015 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.423 ' CB ' HG13 ' P' ' 32' ' ' VAL . 74.8 m-85 -100.13 -6.85 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.865 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.3 -42.09 94.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 120.88 0.371 . . . . 0.0 111.44 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.509 ' HG2' ' OH ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -44.91 -42.55 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.522 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 5.6 mt -50.67 -55.5 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.368 0.604 . . . . 0.0 109.783 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.18 -32.93 25.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.906 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -41.21 67.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.682 0.277 . . . . 0.0 110.834 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . 0.404 ' CB ' HD23 ' P' ' 25' ' ' LEU . . . -73.1 -42.68 62.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.522 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 46.3 m-70 -65.97 -39.31 90.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.921 0.391 . . . . 0.0 110.122 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . 0.408 ' HB2' ' CD2' ' P' ' 94' ' ' LEU . . . -61.97 -50.63 71.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.415 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.47 -40.55 78.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -76.09 -38.34 57.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.433 ' CD2' ' CG1' ' P' ' 99' ' ' VAL . 1.2 tp -70.57 -35.73 73.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -73.67 -33.97 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.031 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.387 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.7 114.29 49.75 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.24 -50.17 11.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.611 2.207 . . . . 0.0 113.543 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.88 17.46 4.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.439 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.46 122.76 33.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.972 0.415 . . . . 0.0 110.182 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -124.78 135.71 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.583 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.8 p -100.88 150.05 5.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.489 0.661 . . . . 0.0 111.535 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.443 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.8 OUTLIER -121.76 107.81 12.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.55 104.22 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -89.75 122.62 33.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.18 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -116.35 141.32 16.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.497 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.6 OUTLIER -148.32 113.99 5.68 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.496 ' CG2' ' NH1' ' P' ' 86' ' ' ARG . 45.5 p -99.69 176.28 5.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -58.96 138.62 57.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.448 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -50.48 -28.07 7.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.656 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.439 ' HB3' ' HB1' ' U' ' 7' ' ' DAL . 0.0 OUTLIER -46.21 106.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 0.0 112.774 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.86 -178.94 18.62 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.46 143.89 27.12 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.983 0.391 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.593 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -48.02 -27.94 9.72 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.775 2.317 . . . . 0.0 113.22 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -45.38 92.84 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.299 0.571 . . . . 0.0 110.752 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.509 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 14.1 t80 -90.12 -17.34 27.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.566 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -85.6 -21.76 28.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.263 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -83.58 -35.59 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.81 -49.56 61.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.605 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' P' ' 78' ' ' TYR . 0.2 OUTLIER -52.32 -45.81 65.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.211 177.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.465 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -74.84 -53.91 6.13 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.282 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -46.0 -36.56 5.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.083 0.468 . . . . 0.0 109.875 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 34.8 mtp85 -67.68 -46.85 71.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.346 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.496 ' NH1' ' CG2' ' P' ' 70' ' ' THR . 31.1 mtt180 -58.07 -38.98 77.37 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.57 -37.18 84.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.107 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -30.68 71.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.325 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.31 -60.81 2.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.05 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.91 -41.41 92.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.601 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -38.88 78.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.043 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.68 79.03 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.573 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.83 -60.19 2.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . 0.413 ' HB3' ' CG2' ' P' ' 99' ' ' VAL . 90.3 mt -57.84 -34.13 69.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.053 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.64 81.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.988 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.17 -26.92 74.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.504 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.99 -9.03 59.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 111.366 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.77 -6.75 17.84 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.251 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.433 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 80.0 t -67.96 112.97 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.829 0.314 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.99 144.97 56.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.215 0.531 . . . . 0.0 111.401 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.51 -36.77 74.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.738 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.86 -24.95 55.31 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.766 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.12 -3.76 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.309 0.576 . . . . 0.0 110.798 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.3 150.48 20.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.097 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -142.5 141.72 10.98 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 78.3 p -142.89 145.9 33.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.414 ' CG2' HD23 ' P' ' 65' ' ' LEU . 0.2 OUTLIER -160.63 173.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.591 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -162.49 129.07 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.291 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.5 OUTLIER -114.21 27.12 9.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.683 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -4.59 -115.44 0.0 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.6 0.562 . . . . 0.0 114.23 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 3.2 mp0 -83.09 -2.05 54.38 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.761 -0.258 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.64 -63.1 1.31 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.662 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -139.96 89.4 11.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 164.77 11.28 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.652 2.235 . . . . 0.0 112.705 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.39 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.22 111.08 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.783 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.48 135.24 47.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.89 172.88 12.9 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.951 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.414 ' CE1' ' OH ' ' P' ' 124' ' ' TYR . 3.9 t60 -138.08 48.76 1.96 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.365 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.02 157.66 42.4 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 15.3 tp10 -42.99 -37.43 1.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.45 -60.29 3.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.94 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.26 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.414 ' OH ' ' CE1' ' P' ' 119' ' ' HIS . 2.8 m-85 -57.17 -56.21 24.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.381 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 125' ' ' SER . . . . . 0.482 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 0.3 OUTLIER -55.91 -35.55 66.7 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -73.29 -22.52 60.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.201 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 69' ' ' ASN . 37.2 m-20 -81.21 -43.74 18.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.68 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.97 71.61 0.81 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.515 0.674 . . . . 0.0 110.804 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.13 145.29 51.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.225 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -117.33 93.21 4.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.08 115.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.73 100.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.309 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -102.77 130.17 49.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 111.557 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.87 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.509 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.501 ' HD3' ' O ' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.439 ' HB1' ' HB3' ' P' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -99.04 -64.35 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.812 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.3 -177.26 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 33.5 t -66.27 -27.84 68.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -108.47 113.36 26.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.908 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.92 137.07 33.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.01 -51.26 5.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 179.83 143.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 61.19 153.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.199 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.32 -12.56 62.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.94 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 m120 62.95 -177.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.713 0.292 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.19 -73.28 1.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -45.68 -45.2 14.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.702 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . 0.471 ' O ' ' CG ' ' P' ' 15' ' ' GLN . . . -64.11 -139.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' P' ' 14' ' ' ALA . 15.0 pt20 50.0 53.73 12.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.165 0.507 . . . . 0.0 111.721 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 74.6 p -130.94 93.47 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.695 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -88.82 102.91 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.569 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.26 10.09 56.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.145 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.98 17.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.336 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.501 ' CE2' ' CD2' ' P' ' 29' ' ' TYR . 1.7 m-85 -107.04 147.13 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -104.14 144.38 31.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -38.31 -56.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.23 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -45.38 5.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 0.0 110.628 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.499 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 34.3 mt -56.54 -20.82 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.956 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.58 -12.3 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -123.38 -25.38 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . 0.445 ' HG2' ' CZ ' ' P' ' 29' ' ' TYR . 4.7 tpm_? -110.9 -62.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' P' ' 20' ' ' TYR . 22.2 m-85 -107.19 91.66 3.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 19.2 p-10 -155.07 13.77 0.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.369 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -125.94 130.82 52.03 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 3.6 t -111.19 148.45 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.5 118.31 26.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' P' ' 86' ' ' ARG . 21.9 m-85 -95.49 168.28 10.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.604 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.64 -166.69 27.37 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.158 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.445 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 8.2 t80 -60.88 122.03 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.23 25.51 1.83 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.749 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.467 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -93.14 138.58 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.469 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.431 ' HA ' ' HB3' ' P' ' 86' ' ' ARG . 44.6 p90 -131.42 49.93 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -147.62 150.74 34.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.917 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mt -95.36 161.8 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.647 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 135.58 50.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 111.327 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.73 -27.38 2.19 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.024 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -32.1 72.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.407 ' O ' HG13 ' P' ' 48' ' ' ILE . 31.1 m-85 -105.54 11.44 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.522 ' HA ' ' HG ' ' P' ' 49' ' ' LEU . 0.9 OUTLIER -72.7 -34.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.264 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.36 -45.58 6.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.95 0.405 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.574 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.11 -50.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 0.0 109.196 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . 0.566 ' HB3' ' CE2' ' P' ' 93' ' ' TYR . 6.2 mt -53.4 -62.41 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.726 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.5 -49.67 71.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.47 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.588 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.574 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 7.5 m-70 -72.17 -42.87 65.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.75 0.31 . . . . 0.0 110.821 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.59 -25.79 67.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.016 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.18 -36.93 46.84 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.04 0.448 . . . . 0.0 109.926 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -75.91 -34.68 59.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.452 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.7 OUTLIER -72.18 -36.06 69.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -32.72 66.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.153 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.09 -19.7 63.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.403 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . 0.6 OUTLIER -110.02 111.7 58.21 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 120.615 0.245 . . . . 0.0 110.481 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.89 -63.09 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.884 2.389 . . . . 0.0 114.213 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.17 24.09 1.66 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.413 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.53 122.58 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.145 0.498 . . . . 0.0 110.777 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -126.38 131.29 51.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.84 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.452 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 8.7 p -96.05 143.74 11.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.62 0.724 . . . . 0.0 111.754 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.449 HD23 ' CG2' ' P' ' 107' ' ' VAL . 4.8 tt -116.7 104.49 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.47 113.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.675 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.6 mm-40 -89.53 119.87 30.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.638 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.7 86.96 1.47 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.817 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' P' ' 70' ' ' THR . 7.6 t30 -98.65 158.49 15.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 110.354 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 61.0 p -165.29 -165.55 0.88 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.433 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 19.8 p-10 -83.77 154.56 23.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.617 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -64.85 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.624 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.91 110.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 -173.17 14.8 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.36 145.3 29.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 72.1 Cg_exo -48.16 -44.74 27.74 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.458 2.106 . . . . 0.0 112.465 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -41.1 98.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.6 t80 -68.24 -42.96 78.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' P' ' 80' ' ' ILE . 31.4 m120 -69.92 -75.49 0.11 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.385 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -29.63 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.62 11.34 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.796 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.549 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -54.22 -43.77 71.11 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.752 178.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.638 ' HA2' ' HD3' ' P' ' 86' ' ' ARG . . . -68.11 -41.9 85.71 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.959 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.96 -31.57 65.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' P' ' 88' ' ' ASP . 10.5 tpt85 -65.67 -60.35 2.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.38 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.638 ' HD3' ' HA2' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -56.42 -41.5 76.47 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.242 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.63 65.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . 0.499 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.3 OUTLIER -65.27 -31.63 72.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.09 178.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.17 -42.49 98.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.011 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . 0.477 ' O ' ' CD1' ' P' ' 93' ' ' TYR . 32.9 t -70.53 -38.65 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.925 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' P' ' 88' ' ' ASP . 0.0 OUTLIER -74.22 -27.84 60.98 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.019 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.71 -53.94 6.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.48 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . 0.566 ' CE2' ' HB3' ' P' ' 49' ' ' LEU . 0.7 OUTLIER -57.59 -44.16 85.2 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . 0.524 ' HG ' ' CE1' ' P' ' 93' ' ' TYR . 4.5 mt -58.87 -35.19 72.57 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' P' ' 99' ' ' VAL . . . -61.45 -43.17 99.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.577 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.81 -13.07 78.71 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.393 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -88.98 -8.44 54.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.667 0.27 . . . . 0.0 111.061 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.69 -12.62 11.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.763 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.443 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 60.9 t -70.65 114.64 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.593 0.235 . . . . 0.0 110.716 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.8 144.58 52.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.388 0.613 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.51 -37.48 49.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.807 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.35 45.12 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.8 mtmt -96.07 -6.08 39.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.161 0.505 . . . . 0.0 110.9 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . 0.418 ' HG ' HG12 ' P' ' 99' ' ' VAL . 19.8 mt -89.4 149.88 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.916 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.41 135.37 4.69 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 106' ' ' THR . . . . . . . . . . . . . 70.2 p -133.55 156.24 48.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.813 0.34 . . . . 0.0 110.645 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.449 ' CG2' HD23 ' P' ' 65' ' ' LEU . 0.1 OUTLIER -172.85 121.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -111.87 137.85 49.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.751 0.31 . . . . 0.0 110.976 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 90.3 m-85 -116.68 24.51 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -111.82 0.01 OUTLIER Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.569 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.89 14.4 31.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.506 0.193 . . . . 0.0 111.514 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -54.84 41.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.96 89.16 8.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.423 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.05 166.89 9.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.692 2.262 . . . . 0.0 112.756 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.48 -67.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.606 ' HB ' ' HE3' ' P' ' 126' ' ' LYS . 38.5 t -89.61 111.8 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.342 0.592 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.73 138.54 58.44 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.923 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.76 174.15 14.11 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.8 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.44 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 14.2 p-80 -140.39 58.77 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -127.04 157.85 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' P' ' 125' ' ' SER . 0.2 OUTLIER -43.39 -27.55 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.615 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' P' ' 126' ' ' LYS . . . -64.76 -59.38 4.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.602 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -66.36 -42.44 88.02 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.44 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 11.9 m-30 -65.37 -44.28 88.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 125' ' ' SER . . . . . 0.425 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 51.8 p -73.28 -38.92 65.75 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.623 0.249 . . . . 0.0 111.416 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . 0.606 ' HE3' ' HB ' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -82.05 -16.77 49.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.038 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' P' ' 123' ' ' ALA . 39.1 m-20 -85.33 -29.55 24.41 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.425 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.1 mtp180 -70.32 94.97 0.98 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.521 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.7 OUTLIER -158.85 156.02 28.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.11 99.78 7.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 15.1 t -83.08 110.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' P' ' 30' ' ' ASN . 0.3 OUTLIER -61.31 98.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.19 178.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.443 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -101.21 126.67 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.623 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.982 179.693 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.42 ' N2 ' ' O4 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.477 0.18 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.479 ' HB3' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.445 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.607 0.241 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -146.64 117.67 7.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.14 -174.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 4.7 t -83.15 -30.78 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.96 92.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.906 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -139.74 139.57 36.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.714 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -60.44 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 57.69 163.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.054 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 75.33 -53.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' P' ' 11' ' ' ASN . . . -90.19 -66.55 1.21 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.617 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' P' ' 10' ' ' GLY . 76.0 m-20 66.81 -65.86 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' P' ' 10' ' ' GLY . . . -90.02 -64.07 1.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.11 -73.23 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 111.69 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.16 144.46 7.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.611 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.09 110.02 3.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 30.0 p -122.35 115.83 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' P' ' 55' ' ' TYR . 4.5 m-85 -92.27 106.86 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 8.99 32.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.388 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.98 -38.57 1.69 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.887 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' P' ' 17' ' ' PHE . 0.5 OUTLIER -124.15 171.76 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.359 . . . . 0.0 111.341 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.75 150.77 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.436 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.8 t -43.26 -43.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.15 -15.76 48.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.43 -40.05 8.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.559 0.695 . . . . 0.0 109.887 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 5.0 mt -61.96 -21.13 64.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . 0.405 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 55.3 mt-30 -98.32 -14.85 20.01 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.4 -18.32 3.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 -66.74 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -105.9 83.67 1.95 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.282 0.563 . . . . 0.0 111.836 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.405 ' OD1' ' HA ' ' P' ' 26' ' ' GLN . 0.1 OUTLIER -138.52 12.77 2.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 79.8 m -134.98 137.91 43.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . 0.442 HG11 ' CG ' ' P' ' 45' ' ' TYR . 3.3 t -112.55 147.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.248 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -117.44 123.15 45.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.476 0.655 . . . . 0.0 112.573 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 75.3 m-85 -108.97 172.6 6.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.876 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.37 -169.27 16.4 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.488 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 2.0 t80 -60.17 125.9 25.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 110.748 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . 0.436 ' HB2' ' CE1' ' P' ' 36' ' ' PHE . 2.3 t0 44.59 29.43 0.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.86 126.65 41.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.738 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 11.2 t80 -125.9 57.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.731 0.777 . . . . 0.0 110.191 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -151.09 150.71 31.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.715 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -98.64 162.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.604 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 7.5 p -112.76 144.89 41.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.118 0.485 . . . . 0.0 111.574 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.63 -31.94 3.96 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.313 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -63.82 -33.89 76.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.442 ' CG ' HG11 ' P' ' 32' ' ' VAL . 78.0 m-85 -99.11 -2.52 36.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.439 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 77.0 t -63.07 -43.69 99.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.506 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -39.63 -45.64 1.68 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.638 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.582 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.58 -53.26 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mp -47.14 -46.49 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.549 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . 0.453 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 2.6 p30 -73.46 -33.22 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.657 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.32 -51.48 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.582 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 12.0 m-70 -57.57 -37.79 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 109.936 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.66 -45.3 94.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.24 84.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.523 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . 0.457 ' HA ' ' CE2' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -70.1 -43.01 71.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.604 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.511 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 0.4 OUTLIER -69.57 -36.75 76.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.03 -178.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.83 -36.33 78.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.13 66.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.604 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.85 112.87 47.51 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 -44.0 45.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.653 2.235 . . . . 0.0 113.575 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 17.51 11.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.42 123.74 34.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.271 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.514 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 30.9 mttt -123.12 132.72 54.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.683 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.2 p -96.42 143.54 12.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.417 0.627 . . . . 0.0 110.983 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' P' ' 133' ' ' ALA . 0.5 OUTLIER -113.39 108.65 17.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.796 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.39 109.67 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.7 mt-10 -99.39 120.24 39.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.392 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 146.34 18.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.354 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' P' ' 129' ' ' ARG . 52.9 m-80 -139.54 167.52 21.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 2.4 p -168.98 174.8 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.983 0.42 . . . . 0.0 111.448 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 15.4 p-10 -60.01 151.8 25.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.617 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.506 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 1.4 pp20? -66.26 -31.83 72.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 111.666 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 113.61 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.67 -169.41 12.91 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.266 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 75' ' ' THR . . . . . 0.449 ' HB ' ' HG3' ' P' ' 77' ' ' GLU . 0.6 OUTLIER -107.82 146.72 34.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 111.48 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.52 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 41.0 Cg_exo -54.96 -35.98 91.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.793 2.329 . . . . 0.0 113.929 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . 0.449 ' HG3' ' HB ' ' P' ' 75' ' ' THR . 0.0 OUTLIER -44.12 -55.35 4.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.497 ' CD2' ' CG ' ' U' ' 4' ' ' DGL . 0.1 OUTLIER -93.69 -13.93 26.94 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.602 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.455 ' CB ' ' HG2' ' P' ' 111' ' ' GLU . 2.1 m-20 -84.17 -25.76 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.539 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.52 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.5 OUTLIER -90.89 -36.42 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.43 -49.93 61.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.434 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -68.9 -34.35 75.27 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.976 178.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.535 ' N ' ' CD1' ' P' ' 82' ' ' LEU . . . -69.55 -56.72 8.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.796 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -50.46 -33.53 21.46 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -49.31 78.2 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.474 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 0.1 OUTLIER -55.43 -38.19 68.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.0 -35.31 79.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.241 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -31.32 69.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.341 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.84 88.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.968 179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.33 -31.39 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.429 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . 0.486 ' HG3' ' N ' ' P' ' 92' ' ' GLY . 0.0 OUTLIER -62.73 -44.03 97.26 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . 0.486 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -74.32 -26.86 67.09 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -59.52 -57.1 14.44 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 47.2 mt -61.04 -32.28 71.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.332 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.53 99.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.561 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.96 -19.97 78.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.014 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -10.79 59.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.663 0.268 . . . . 0.0 111.269 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -7.52 16.96 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.065 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.412 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 31.8 t -78.8 127.41 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.732 0.301 . . . . 0.0 110.99 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.417 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -58.58 163.53 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.548 . . . . 0.0 111.322 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . 0.407 ' HA ' ' CD1' ' P' ' 104' ' ' LEU . . . -80.87 -31.65 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.198 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.18 -24.14 35.19 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.782 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.514 ' HB2' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -95.5 -4.55 44.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 111.224 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . 0.407 ' CD1' ' HA ' ' P' ' 101' ' ' ALA . 7.2 mt -95.1 139.55 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.129 -0.228 . . . . 0.0 110.403 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -143.45 141.77 10.72 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.416 ' O ' ' CG1' ' P' ' 107' ' ' VAL . 68.4 p -133.21 153.22 51.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.929 0.395 . . . . 0.0 111.106 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -176.15 119.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.43 ' O ' HG12 ' P' ' 80' ' ' ILE . 90.3 p -117.51 140.11 50.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.416 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' P' ' 110' ' ' GLY . 33.1 m-85 -121.08 28.07 8.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.581 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -23.22 -71.07 0.01 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.874 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.506 ' OE1' ' HA ' ' P' ' 72' ' ' GLU . 4.4 mm-40 -106.78 -2.1 21.86 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.01 -57.01 6.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 118.474 0.579 . . . . 0.0 110.422 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -134.71 90.04 24.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -57.94 163.05 10.06 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.521 2.147 . . . . 0.0 112.564 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.45 -68.63 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.11 119.83 36.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.1 136.82 44.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.57 175.21 14.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.791 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' P' ' 119' ' ' HIS . 0.1 OUTLIER -140.53 97.52 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.825 0.312 . . . . 0.0 111.587 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -175.9 165.83 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -48.46 -26.29 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.05 -63.49 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.01 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.621 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 7.0 m-30 -56.97 -46.53 82.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.624 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -68.55 -36.85 79.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.329 . . . . 0.0 111.29 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -68.22 -26.93 65.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.292 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' P' ' 70' ' ' THR . 84.1 m-20 -87.19 -28.84 22.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.481 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 6.5 mtp180 -69.35 81.05 0.37 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.89 152.39 21.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.122 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.51 105.11 10.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 16.0 t -86.73 113.41 24.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' P' ' 30' ' ' ASN . 0.4 OUTLIER -61.05 99.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.194 178.178 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' P' ' 65' ' ' LEU . . . -99.55 124.39 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.635 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.917 179.685 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . 0.556 ' HN2' ' H5 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.891 0.377 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.497 ' CG ' ' CD2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.415 ' HE ' ' O ' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.45 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.418 ' HA ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.813 0.34 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.45 139.87 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -156.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.608 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -68.52 -35.7 77.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.511 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -149.91 116.82 5.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.462 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.32 150.13 31.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.713 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -73.41 -52.37 13.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 46.49 -169.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.625 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.38 65.16 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.957 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.64 -20.52 31.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.843 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.5 128.7 44.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.53 -22.2 51.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.23 -28.82 59.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.834 0.35 . . . . 0.0 111.251 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.15 97.43 5.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -176.72 114.83 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.711 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.76 119.82 30.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.443 . . . . 0.0 111.184 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.431 ' N ' ' O ' ' P' ' 20' ' ' TYR . 70.6 m-85 -90.55 107.08 18.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.611 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.81 9.87 35.5 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.297 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 134.21 -35.75 2.19 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.793 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' P' ' 17' ' ' PHE . 22.2 m-85 -117.81 161.9 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.715 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.15 153.65 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.425 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 17.3 t -39.26 -51.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.43 16.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.38 -40.35 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.421 0.629 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.485 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 20.1 mt -69.32 -20.82 63.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.206 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -88.7 -20.89 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -142.71 -6.59 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -69.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.426 ' O ' HG23 ' P' ' 48' ' ' ILE . 67.6 m-85 -108.98 85.69 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.201 0.524 . . . . 0.0 112.244 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.2 19.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.329 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 31' ' ' THR . . . . . 0.43 HG21 ' CE1' ' P' ' 33' ' ' TYR . 98.4 m -126.42 129.35 48.56 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 t -107.86 150.38 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.978 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . 0.43 ' CE1' HG21 ' P' ' 31' ' ' THR . 48.9 m-85 -121.39 116.16 24.25 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.514 ' CE2' ' HG2' ' P' ' 86' ' ' ARG . 21.7 m-85 -98.09 167.11 11.09 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.68 -167.38 17.23 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.603 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 6.2 t80 -66.18 123.34 19.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.079 0.439 . . . . 0.0 110.835 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.67 15.34 7.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.728 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.463 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 2.2 mptt -91.17 125.64 36.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.475 ' HB3' ' NH1' ' P' ' 86' ' ' ARG . 52.1 p90 -128.04 37.46 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.796 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.05 149.74 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 1.2 mp -87.57 164.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.283 . . . . 0.0 110.975 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 49.3 p -112.35 150.63 30.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.405 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -42.45 -32.95 1.32 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.14 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.05 -33.37 75.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.727 0.299 . . . . 0.0 111.416 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -102.82 3.6 36.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 74.2 t -69.16 -40.49 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.41 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -44.07 -44.35 7.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.533 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 0.6 OUTLIER -56.47 -51.1 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.818 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mp -53.36 -34.5 57.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.595 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -39.04 53.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.867 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.79 26.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.533 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 54.6 m-70 -59.92 -35.95 75.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.987 0.422 . . . . 0.0 110.139 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.45 98.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.302 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.79 91.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.978 0.418 . . . . 0.0 110.723 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.38 -38.79 63.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.97 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.435 ' CD1' ' HB ' ' P' ' 64' ' ' VAL . 2.9 tp -62.2 -41.68 98.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.139 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.16 -40.92 71.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.73 -27.92 31.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.683 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 59' ' ' THR . . . . . 0.419 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -109.6 115.1 56.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.566 0.222 . . . . 0.0 110.488 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.8 -59.03 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 113.858 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.72 22.91 2.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.456 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -90.76 123.38 34.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 110.707 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -128.07 134.16 49.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.435 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.8 p -97.0 146.13 7.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.502 0.668 . . . . 0.0 111.758 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt -117.41 105.37 12.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.527 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.14 108.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.636 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.3 tt0 -99.2 117.61 34.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -107.51 149.67 16.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.968 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.8 OUTLIER -152.96 108.57 3.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.811 0.339 . . . . 0.0 110.712 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -100.65 -171.67 2.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.416 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 21.2 p-10 -64.27 144.85 56.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.396 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -64.08 -27.09 68.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.542 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . 0.416 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.9 OUTLIER -39.55 110.91 0.16 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.326 0.584 . . . . 0.0 112.037 -178.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.01 -150.91 18.65 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.902 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.05 148.46 51.71 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 122.0 0.12 . . . . 0.0 110.822 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 1.3 Cg_endo -41.85 -38.91 4.98 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.616 2.211 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.9 -40.84 96.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.88 -47.53 45.18 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.681 178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.589 ' O ' HD11 ' P' ' 82' ' ' LEU . 11.1 m120 -64.62 -76.27 0.07 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.692 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -35.42 -38.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.37 -64.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.043 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.617 ' CD2' ' CZ ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -63.48 -33.63 75.99 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.285 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . 0.492 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.89 -52.47 28.58 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.447 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 1.2 tp-100 -50.79 -34.73 28.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -59.93 -43.02 95.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.617 ' CZ ' ' CD2' ' P' ' 82' ' ' LEU . 6.8 mtt85 -56.37 -43.41 79.16 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.05 -32.58 68.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.4 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.419 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.27 -56.67 18.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.642 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.34 -34.42 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.4 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -59.45 -51.81 68.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.39 -26.09 74.44 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.115 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -59.96 -61.27 2.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . 0.403 ' HB2' ' CD2' ' P' ' 104' ' ' LEU . 23.1 mt -59.83 -29.8 68.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.88 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.11 98.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.33 -21.08 78.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.626 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -11.29 59.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 111.179 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.28 -3.63 22.08 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.308 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' P' ' 56' ' ' LEU . 21.5 t -81.98 131.65 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.831 0.315 . . . . 0.0 111.423 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' CG ' ' P' ' 103' ' ' LYS . 31.3 p30 -58.95 166.37 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.208 0.527 . . . . 0.0 111.306 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.87 -31.83 51.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.314 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.7 -21.36 62.85 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.297 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 23.4 mtpp -90.45 -12.65 36.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.064 0.459 . . . . 0.0 111.067 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' P' ' 94' ' ' LEU . 6.3 mt -92.23 149.76 21.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.93 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.78 137.01 6.7 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.406 ' O ' ' CG2' ' P' ' 107' ' ' VAL . 18.7 p -117.63 156.24 28.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.065 0.46 . . . . 0.0 111.275 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' P' ' 106' ' ' THR . 97.2 t -160.49 157.75 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.608 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.692 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 3.3 t -161.09 128.18 4.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.993 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.31 -68.46 0.79 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.349 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.7 -121.51 6.37 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.615 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.588 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 1.2 mm-40 -75.62 -19.89 58.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.859 0.33 . . . . 0.0 111.091 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.47 -74.09 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -142.09 102.45 5.71 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.323 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.34 167.49 20.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.745 2.297 . . . . 0.0 112.248 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -88.55 -77.66 0.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.618 ' HB ' ' NZ ' ' P' ' 126' ' ' LYS . 2.0 t -96.94 130.6 45.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.461 0.648 . . . . 0.0 111.137 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 141.13 52.34 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.745 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.73 172.09 12.99 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.764 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -141.09 91.64 2.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.793 0.296 . . . . 0.0 111.411 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' P' ' 124' ' ' TYR . 37.5 t70 -178.86 167.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' P' ' 125' ' ' SER . 1.1 mm-40 -44.45 -26.83 0.38 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -66.54 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.672 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.631 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -70.4 -35.67 73.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.7 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' P' ' 120' ' ' ASP . 2.2 m-85 -65.85 -46.43 78.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 125' ' ' SER . . . . . 0.415 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 6.9 t -71.56 -37.06 71.11 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . 0.631 ' CE ' ' HA ' ' P' ' 123' ' ' ALA . 0.0 OUTLIER -79.77 -16.16 56.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.993 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' P' ' 123' ' ' ALA . 7.9 m-20 -86.53 -31.51 21.23 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 120.581 0.229 . . . . 0.0 110.495 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.415 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.7 mtp180 -70.3 83.62 0.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.25 153.33 34.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -119.66 99.18 6.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.67 112.73 21.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.55 101.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.669 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.72 122.1 39.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.733 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.947 179.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.815 0.34 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . 0.603 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.478 ' HA ' ' CE1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.881 0.372 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -139.8 90.43 2.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 68.6 p -163.81 -176.67 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -70.77 -45.22 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -150.2 136.56 18.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.878 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.74 150.04 52.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.82 -66.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.25 -76.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.39 174.73 14.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 -44.71 7.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.269 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -163.32 30.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.17 -12.83 61.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.808 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.73 -27.4 2.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.7 0.286 . . . . 0.0 111.513 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.73 -165.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.158 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.86 162.77 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.023 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 75.5 p -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 17' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' P' ' 20' ' ' TYR . 61.1 m-85 -88.83 105.87 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.992 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.82 10.33 38.02 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.129 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.96 -30.61 3.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.384 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' CE2' ' P' ' 29' ' ' TYR . 20.3 m-85 -114.22 158.75 20.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 150.98 23.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.014 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 16.5 t -39.5 -48.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.59 -17.89 57.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.42 -43.93 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.456 0.646 . . . . 0.0 110.441 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 17.5 mt -58.35 -21.38 49.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.152 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 26' ' ' GLN . . . . . 0.429 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 4.3 mt-30 -101.92 -12.4 18.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.93 -21.52 4.34 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -112.64 -60.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 29' ' ' TYR . . . . . 0.452 ' CE2' ' CE1' ' P' ' 20' ' ' TYR . 28.3 m-85 -102.29 85.9 2.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.933 0.397 . . . . 0.0 111.735 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 30' ' ' ASN . . . . . 0.469 HD21 ' HB2' ' P' ' 132' ' ' LEU . 0.0 OUTLIER -144.6 6.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 51.9 m -136.86 138.8 41.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 32' ' ' VAL . . . . . . . . . . . . . 12.0 t -111.82 150.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.507 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -120.37 119.11 32.13 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 34' ' ' PHE . . . . . 0.425 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 16.3 m-85 -95.69 170.24 9.46 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.52 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 -179.65 23.01 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.634 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 36' ' ' PHE . . . . . 0.515 ' CD1' ' HB1' ' U' ' 7' ' ' DAL . 0.6 OUTLIER -64.22 117.3 6.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 111.049 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.51 24.77 7.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 38' ' ' LYS . . . . . 0.487 ' HD3' ' HB2' ' P' ' 40' ' ' ASP . 0.0 OUTLIER -111.06 127.33 55.51 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.903 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 39' ' ' TYR . . . . . 0.684 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -117.65 77.5 1.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.599 0.714 . . . . 0.0 111.058 -178.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 40' ' ' ASP . . . . . 0.487 ' HB2' ' HD3' ' P' ' 38' ' ' LYS . 0.2 OUTLIER -153.28 150.36 28.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.223 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 mt -99.0 155.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -108.48 143.73 37.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.481 . . . . 0.0 112.056 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.59 -29.26 5.57 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.121 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 44' ' ' GLU . . . . . 0.43 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 3.4 mm-40 -66.16 -28.98 69.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 45' ' ' TYR . . . . . 0.4 ' O ' HG13 ' P' ' 48' ' ' ILE . 75.6 m-85 -103.27 -1.06 29.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 46' ' ' VAL . . . . . 0.439 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 94.8 t -65.26 -41.42 91.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 47' ' ' GLN . . . . . 0.432 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 0.0 OUTLIER -49.24 -29.49 5.82 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.588 -178.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 48' ' ' ILE . . . . . 0.541 ' CG2' ' CD2' ' P' ' 52' ' ' HIS . 2.9 mt -64.71 -52.85 49.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.391 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mp -51.9 -47.83 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.3 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 50' ' ' ASP . . . . . 0.432 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -70.07 -35.75 74.45 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.609 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.43 -47.76 39.08 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.171 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 52' ' ' HIS . . . . . 0.541 ' CD2' ' CG2' ' P' ' 48' ' ' ILE . 8.9 m-70 -61.04 -38.04 84.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.8 92.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.019 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.93 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.935 0.397 . . . . 0.0 110.618 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -71.01 -40.28 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.691 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 56' ' ' LEU . . . . . 0.523 HD11 ' N ' ' P' ' 64' ' ' VAL . 2.0 tp -62.88 -45.18 93.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.73 -40.49 96.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.336 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.39 9.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.669 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.5 115.74 41.86 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.601 0.239 . . . . 0.0 110.599 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.46 -50.91 11.24 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.694 2.263 . . . . 0.0 113.506 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.75 19.66 3.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 62' ' ' ALA . . . . . 0.418 ' O ' ' NZ ' ' P' ' 103' ' ' LYS . . . -92.61 134.74 34.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 63' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -138.02 141.49 40.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 64' ' ' VAL . . . . . 0.523 ' N ' HD11 ' P' ' 56' ' ' LEU . 9.6 p -100.4 150.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.519 0.675 . . . . 0.0 111.795 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tt -120.69 101.45 7.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.342 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 1.3 t -83.51 101.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 67' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 29.6 tt0 -90.41 123.47 34.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 68' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -106.71 148.05 16.34 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.521 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 69' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -160.91 106.19 1.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.317 . . . . 0.0 110.508 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 70' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 26.7 p -106.26 -170.85 1.79 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 71' ' ' ASP . . . . . 0.485 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 21.4 p-10 -57.28 138.12 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 72' ' ' GLU . . . . . 0.407 ' OE2' ' CE1' ' P' ' 124' ' ' TYR . 0.7 OUTLIER -59.83 -22.84 62.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.454 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -38.13 108.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.12 -144.69 18.34 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.635 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.97 146.82 60.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.727 0.264 . . . . 0.0 110.772 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 76' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 1.9 Cg_endo -39.99 -44.79 3.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.009 2.473 . . . . 0.0 112.445 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -42.72 99.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 78' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 9.8 t80 -71.46 -40.25 70.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.679 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 79' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -67.15 -75.12 0.1 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 80' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -29.4 -41.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 123.254 0.346 . . . . 0.0 111.475 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -64.47 -59.74 3.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.597 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' P' ' 85' ' ' ARG . 0.2 OUTLIER -48.69 -46.71 40.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.256 178.35 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.83 -46.01 85.08 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.52 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 84' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -47.12 -43.14 20.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.388 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 85' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -65.54 -36.0 82.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.777 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 86' ' ' ARG . . . . . 0.473 ' HA ' ' CD1' ' P' ' 39' ' ' TYR . 17.0 mtt180 -68.5 -48.61 63.95 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.334 0.588 . . . . 0.0 109.445 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 87' ' ' ALA . . . . . 0.429 ' CB ' ' HB ' ' P' ' 106' ' ' THR . . . -62.4 -40.31 96.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.562 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 88' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -56.21 -35.25 67.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.844 178.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.33 -64.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.5 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 90' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' P' ' 93' ' ' TYR . 20.3 t -55.14 -39.67 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.371 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 91' ' ' LYS . . . . . 0.478 ' HA ' ' CD2' ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.49 -43.1 99.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 110.153 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 92' ' ' GLY . . . . . 0.442 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -71.81 -11.12 73.29 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 93' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' P' ' 90' ' ' VAL . 4.4 t80 -75.95 -62.9 1.44 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 94' ' ' LEU . . . . . 0.423 ' HB2' ' HG ' ' P' ' 104' ' ' LEU . 72.2 mt -53.51 -31.38 45.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 95' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' P' ' 99' ' ' VAL . . . -63.38 -40.26 96.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.394 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.31 -24.7 75.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.455 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.33 -9.18 59.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 111.248 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.86 14.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.947 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 99' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' P' ' 95' ' ' ALA . 21.8 t -70.57 114.88 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -55.84 141.63 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.89 40.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.246 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.88 64.99 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.689 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 103' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 2.1 mtpp -93.59 -19.13 21.46 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 120.522 0.201 . . . . 0.0 111.399 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 104' ' ' LEU . . . . . 0.594 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -136.27 132.01 35.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.782 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -126.72 -169.07 12.68 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.534 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 106' ' ' THR . . . . . 0.429 ' HB ' ' CB ' ' P' ' 87' ' ' ALA . 49.6 p -147.36 168.53 21.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.087 0.47 . . . . 0.0 111.272 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 107' ' ' VAL . . . . . 0.429 HG13 ' CZ ' ' P' ' 109' ' ' TYR . 48.7 t -158.32 163.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.509 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 108' ' ' SER . . . . . 0.502 ' O ' ' CD1' ' P' ' 80' ' ' ILE . 3.2 t -160.28 113.58 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.963 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 109' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' P' ' 110' ' ' GLY . 60.0 m-85 -108.36 27.33 9.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.194 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -12.08 -109.26 0.0 OUTLIER Glycine 0 CA--C 1.526 0.744 0 O-C-N 123.684 0.615 . . . . 0.0 114.581 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 111' ' ' GLU . . . . . 0.535 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 6.3 mt-10 -63.29 -18.31 63.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 112' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 3.7 tm-20 -48.18 -69.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.527 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -130.25 95.04 28.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.69 0.281 . . . . 0.0 111.034 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.34 155.93 54.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.705 2.27 . . . . 0.0 112.454 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -101.97 -71.47 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 116' ' ' VAL . . . . . 0.411 ' CG2' ' HB3' ' P' ' 126' ' ' LYS . 3.5 t -88.76 114.29 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.49 136.59 49.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.75 175.4 14.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.118 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 119' ' ' HIS . . . . . 0.463 ' CE1' ' OH ' ' P' ' 124' ' ' TYR . 18.5 t60 -140.16 52.94 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.627 0.251 . . . . 0.0 111.184 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -131.31 154.69 48.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -45.42 -26.41 0.55 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.25 -58.18 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 110.72 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 123' ' ' ALA . . . . . 0.402 ' HB3' HG13 ' P' ' 116' ' ' VAL . . . -69.59 -40.36 76.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.638 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 124' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -59.7 -49.89 76.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.462 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 125' ' ' SER . . . . . 0.409 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 3.3 t -64.26 -34.89 79.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 126' ' ' LYS . . . . . 0.411 ' HB3' ' CG2' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -68.74 -27.08 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' P' P ' 127' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' P' ' 69' ' ' ASN . 1.7 m-20 -82.21 -31.82 30.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 128' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 1.8 mpp_? -68.85 85.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.051 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 129' ' ' ARG . . . . . 0.419 ' HG2' ' OD1' ' P' ' 69' ' ' ASN . 3.9 ptt180 -154.65 147.16 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 130' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -113.29 108.53 17.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 t -88.27 108.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 132' ' ' LEU . . . . . 0.469 ' HB2' HD21 ' P' ' 30' ' ' ASN . 1.2 mm? -62.51 101.92 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.571 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.93 135.14 45.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 111.48 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' P' P ' 134' ' ' TYR . . . . . 0.404 ' OH ' ' ND1' ' P' ' 52' ' ' HIS . 6.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.932 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' U' U ' 4' ' ' DGL . . . . . 0.428 ' HB3' ' CE2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' U' U ' 5' ' ' 6CL . . . . . 0.448 ' OH2' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' U' U ' 7' ' ' DAL . . . . . 0.515 ' HB1' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -89.54 105.87 18.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 111.537 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.33 9.39 30.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.631 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.64 -36.56 2.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.442 -1.361 . . . . 0.0 113.817 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -121.08 169.88 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.74 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.12 155.15 20.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.406 HG23 ' H ' ' P' ' 22' ' ' VAL . 20.7 t -39.25 -53.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.21 -18.24 9.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.36 -43.31 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 110.463 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.523 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 9.4 mt -63.18 -22.13 66.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.236 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -95.78 -14.92 22.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -131.61 -15.13 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -62.74 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 96.6 6.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.475 ' HA ' HG21 ' P' ' 48' ' ' ILE . 1.6 p30 -160.77 18.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.749 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.454 ' OG1' HG13 ' P' ' 131' ' ' VAL . 85.0 m -125.81 130.58 51.71 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.436 HG11 HG23 ' P' ' 41' ' ' ILE . 15.8 t -108.41 148.88 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -114.86 119.1 35.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.416 0.627 . . . . 0.0 112.185 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 73.1 m-85 -103.63 169.22 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.823 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.54 -169.54 19.49 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.881 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 36' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' P' ' 36' ' ' PHE . 1.5 t80 -57.01 112.85 1.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 110.809 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.79 38.64 4.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -89.93 138.32 31.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -122.14 49.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.96 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.38 150.37 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.521 HG22 ' N ' ' P' ' 42' ' ' THR . 5.7 mt -98.01 163.18 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.521 ' N ' HG22 ' P' ' 41' ' ' ILE . 11.1 p -110.65 143.41 41.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.091 0.472 . . . . 0.0 111.839 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.451 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.87 -32.21 8.46 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.225 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -33.97 74.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' P' ' 32' ' ' VAL . 77.2 m-85 -100.42 -0.24 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 48.1 t -65.22 -43.04 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.548 0.214 . . . . 0.0 111.444 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.458 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 1.0 OUTLIER -42.22 -43.45 3.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.002 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.7 -49.73 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.98 -45.76 61.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.474 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 50' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 3.9 p30 -73.9 -32.21 63.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.59 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 51' ' ' ALA . . . . . 0.437 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.41 -49.48 22.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.002 ' CD2' HG22 ' P' ' 48' ' ' ILE . 20.0 m-70 -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.532 . . . . 0.0 109.643 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 53' ' ' ALA . . . . . 0.411 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -61.18 -44.42 97.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.58 98.48 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 0.0 110.587 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.75 -40.1 63.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.9 HD23 HG11 ' P' ' 99' ' ' VAL . 5.5 tp -63.95 -42.82 97.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.417 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.14 -39.84 78.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.68 -25.89 55.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.543 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.4 OUTLIER -112.47 113.6 50.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 110.419 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.5 -46.81 27.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.627 2.218 . . . . 0.0 113.535 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.46 16.82 9.52 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.73 118.69 30.35 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -120.15 134.4 55.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.213 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' P' ' 56' ' ' LEU . 4.5 p -97.43 134.39 35.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.404 0.621 . . . . 0.0 111.496 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.481 HD21 HG22 ' P' ' 107' ' ' VAL . 1.1 tt -109.56 103.32 12.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.648 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.5 OUTLIER -79.8 120.08 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.5 mt-10 -103.69 117.63 34.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.609 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 68' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -103.29 140.91 15.07 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.582 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.581 ' O ' ' O ' ' P' ' 127' ' ' ASN . 77.4 m-20 -157.24 104.81 2.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.293 . . . . 0.0 110.824 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.566 HG22 ' NH1' ' P' ' 86' ' ' ARG . 72.1 p -101.9 -172.05 2.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -62.62 143.81 56.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.191 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 1.2 pp20? -63.43 -29.36 70.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.881 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.64 119.59 1.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 74' ' ' GLY . . . . . 0.577 ' O ' HG23 ' P' ' 75' ' ' THR . . . 115.09 -113.46 2.95 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.96 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 75' ' ' THR . . . . . 0.577 HG23 ' O ' ' P' ' 74' ' ' GLY . 0.6 OUTLIER -167.21 147.56 4.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.157 0.479 . . . . 0.0 111.036 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 82.2 Cg_exo -41.68 -45.94 6.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.522 2.148 . . . . 0.0 112.919 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.12 -42.45 94.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.762 0.315 . . . . 0.0 110.761 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.27 -46.39 60.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.927 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' P' ' 80' ' ' ILE . 12.5 m120 -67.66 -75.45 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.695 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -29.7 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 O-C-N 123.141 0.276 . . . . 0.0 111.515 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.24 -59.75 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.436 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' P' ' 86' ' ' ARG . 0.3 OUTLIER -49.76 -44.6 48.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.922 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -71.54 -55.28 7.69 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.125 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.52 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 1.0 OUTLIER -45.51 -36.44 4.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 110.533 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.557 ' HB3' ' CE2' ' P' ' 39' ' ' TYR . 5.2 mtp180 -69.64 -51.84 31.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.566 ' NH1' HG22 ' P' ' 70' ' ' THR . 0.2 OUTLIER -52.82 -39.8 62.77 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.58 77.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.261 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -29.13 69.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.334 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.35 -52.0 56.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.417 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -70.75 -39.08 75.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.231 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.494 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -60.78 -42.28 97.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.859 0.362 . . . . 0.0 110.204 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.94 -24.96 75.84 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -61.24 -61.18 2.74 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' P' ' 104' ' ' LEU . 39.9 mt -58.27 -30.83 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.445 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.23 96.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.48 -25.05 75.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.794 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.411 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 2.9 mtpm? -76.84 -9.43 58.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 0.0 111.207 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.67 -1.98 23.25 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.193 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.9 HG11 HD23 ' P' ' 56' ' ' LEU . 25.0 t -75.58 127.26 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.418 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.9 146.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.253 0.549 . . . . 0.0 111.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.89 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -64.1 -36.15 83.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.569 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.46 -21.9 50.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.666 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.6 mtpp -94.21 -5.84 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.85 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' P' ' 101' ' ' ALA . 5.3 mt -96.73 149.08 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.648 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -149.57 140.99 8.47 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.505 ' O ' HG13 ' P' ' 107' ' ' VAL . 35.1 p -136.21 153.41 51.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.505 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -163.5 171.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.041 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.5 OUTLIER -162.04 131.12 4.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.302 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' P' ' 110' ' ' GLY . 65.7 m-85 -115.84 23.11 12.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.847 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -8.47 -106.38 0.0 OUTLIER Glycine 0 C--N 1.34 0.779 0 O-C-N 123.474 0.484 . . . . 0.0 113.971 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 3.8 mt-10 -71.16 -18.52 62.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.703 0.252 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.65 -70.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.133 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -130.66 89.62 42.99 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 122.312 -0.242 . . . . 0.0 110.541 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.0 156.27 39.98 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.599 2.199 . . . . 0.0 112.461 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 115' ' ' ALA . . . . . 0.712 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -97.68 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.095 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.673 HG21 ' CB ' ' P' ' 126' ' ' LYS . 2.6 t -88.79 114.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.056 0.455 . . . . 0.0 110.999 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.63 138.32 57.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.024 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.02 176.66 16.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.874 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.468 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 7.1 p80 -141.64 65.55 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.904 0.352 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.8 150.28 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -38.44 -30.94 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.1 -59.73 2.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.875 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.66 -42.44 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 1.0 OUTLIER -60.66 -45.08 95.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.161 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 26.9 m -62.92 -36.83 84.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.801 0.334 . . . . 0.0 110.509 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.673 ' CB ' HG21 ' P' ' 116' ' ' VAL . 27.0 mtmt -69.21 -25.02 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.549 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.712 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 4.6 m-20 -82.49 -33.89 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 4.7 mtp180 -69.64 83.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -158.02 148.29 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -121.12 109.29 14.83 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.454 HG13 ' OG1' ' P' ' 31' ' ' THR . 4.4 t -87.78 115.6 28.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.587 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -59.19 102.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.744 178.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -100.76 127.04 47.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.307 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.973 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' P' P ' 16' ' ' THR . . . . . 0.531 HG22 ' HB3' ' P' ' 21' ' ' SER . 15.3 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 0.1 OUTLIER -151.48 135.86 16.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.219 0.533 . . . . 0.0 112.283 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 2.88 33.27 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.205 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.95 -34.36 2.86 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.399 -1.381 . . . . 0.0 114.154 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -114.69 161.71 17.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.826 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 21' ' ' SER . . . . . 0.531 ' HB3' HG22 ' P' ' 16' ' ' THR . 0.8 OUTLIER -97.72 145.76 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.425 HG23 ' H ' ' P' ' 22' ' ' VAL . 14.5 t -37.12 -58.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.84 -16.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -99.19 -43.02 6.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.324 0.583 . . . . 0.0 110.056 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 25.5 mt -54.67 -21.69 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -12.85 16.91 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.32 -23.63 5.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 ptm85 -122.89 -48.22 2.02 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.27 102.87 12.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.354 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.522 ' HA ' HG21 ' P' ' 48' ' ' ILE . 12.5 p-10 179.66 22.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.405 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.773 HG23 HG22 ' P' ' 131' ' ' VAL . 72.8 m -125.22 126.84 45.83 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.103 -0.373 . . . . 0.0 111.386 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.676 HG11 HG23 ' P' ' 41' ' ' ILE . 0.8 OUTLIER -105.18 150.64 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.913 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -117.93 112.7 20.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.374 0.606 . . . . 0.0 112.167 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.56 ' CD2' ' CZ ' ' P' ' 86' ' ' ARG . 15.3 m-30 -92.13 167.0 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.226 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.14 174.05 15.47 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 142.45 57.27 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.54 -0.388 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.67 26.0 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.771 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.451 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -108.97 135.25 50.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.656 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.669 ' HA ' ' NE ' ' P' ' 86' ' ' ARG . 47.4 p90 -132.86 30.46 4.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.32 150.83 44.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.774 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.757 HD11 HG22 ' P' ' 90' ' ' VAL . 1.5 mt -87.7 166.38 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.589 0.233 . . . . 0.0 110.616 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.479 ' N ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -111.07 144.56 40.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.09 0.472 . . . . 0.0 111.779 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.73 -31.95 2.82 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.606 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -30.5 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.712 0.291 . . . . 0.0 111.497 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.591 ' HB3' HG13 ' P' ' 32' ' ' VAL . 72.6 m-85 -104.9 3.52 30.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.454 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 54.3 t -69.1 -37.22 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.21 -42.44 14.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.035 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.8 OUTLIER -55.96 -49.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.002 0.43 . . . . 0.0 110.412 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.77 -39.68 74.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -45.79 72.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.51 68.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.035 ' CD2' HG22 ' P' ' 48' ' ' ILE . 16.5 m-70 -72.27 -40.64 67.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.973 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.9 73.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.05 -36.05 59.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.481 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 55' ' ' TYR . . . . . 0.456 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 13.8 t80 -74.26 -38.89 63.31 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.153 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.736 HD23 ' CG1' ' P' ' 99' ' ' VAL . 1.2 tp -65.08 -43.95 90.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -69.96 -39.98 75.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.24 -24.43 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.055 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.97 89.92 51.86 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.009 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.46 -21.67 10.82 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.792 2.328 . . . . 0.0 113.354 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.78 -1.2 55.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.679 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.81 125.88 35.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 2.6 pttp -121.85 132.29 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.836 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -97.6 146.61 7.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.484 0.659 . . . . 0.0 111.713 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.509 HD21 HG22 ' P' ' 107' ' ' VAL . 0.9 OUTLIER -118.89 103.73 9.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.406 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.613 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.6 OUTLIER -79.17 112.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.5 tt0 -101.3 114.99 29.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.104 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.35 146.54 16.08 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.878 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 127' ' ' ASN . 11.3 m-80 -155.76 107.49 2.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 79.1 p -105.35 -173.91 2.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 24.0 p-10 -54.76 139.1 40.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -61.51 -27.15 68.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.204 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -39.59 108.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.67 -175.17 15.9 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.406 -0.815 . . . . 0.0 113.437 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.6 147.69 34.18 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 122.223 0.209 . . . . 0.0 111.224 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 92.9 Cg_exo -39.56 -45.22 3.33 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.881 2.387 . . . . 0.0 113.172 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -40.88 90.84 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.902 0.382 . . . . 0.0 110.438 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -75.53 -37.45 60.04 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -70.51 -76.85 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.543 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -31.93 -40.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 O-C-N 123.101 0.251 . . . . 0.0 111.343 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.91 11.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.534 ' HA ' ' HD3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -47.32 -53.45 13.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.54 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' P' ' 86' ' ' ARG . . . -69.16 -42.62 75.44 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.334 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 7.3 tp-100 -45.68 -44.65 13.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.637 0.256 . . . . 0.0 110.656 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -72.19 -32.88 67.2 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.552 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.669 ' NE ' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -62.04 -49.81 74.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.504 0.669 . . . . 0.0 109.302 177.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -56.33 -35.34 67.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.5 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -29.64 70.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -62.94 -59.69 4.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.537 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.757 HG22 HD11 ' P' ' 41' ' ' ILE . 23.1 t -64.9 -37.69 80.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -61.16 -47.39 86.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.299 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.9 -19.03 73.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -67.5 -64.18 0.91 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.44 ' O ' HG23 ' P' ' 99' ' ' VAL . 75.6 mt -52.54 -33.71 46.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.095 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.91 97.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.201 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.47 -32.4 81.01 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -8.63 56.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.948 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.44 14.33 30.47 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.51 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.736 ' CG1' HD23 ' P' ' 56' ' ' LEU . 48.1 t -80.46 130.42 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.402 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.07 165.69 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 111.127 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.34 -30.07 17.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.474 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.32 58.27 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.813 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.644 ' HD3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -101.87 -4.32 26.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.212 0.529 . . . . 0.0 111.093 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' P' ' 101' ' ' ALA . 38.4 mt -96.37 150.38 20.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.133 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.613 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -151.15 142.99 10.01 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.651 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.74 ' O ' HG13 ' P' ' 107' ' ' VAL . 30.4 p -133.26 156.76 46.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.585 0.231 . . . . 0.0 110.451 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.74 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -171.13 129.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.347 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -119.25 130.55 55.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.736 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 82.6 m-85 -110.94 25.66 11.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.083 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.47 -112.36 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.718 -0.674 . . . . 0.0 114.445 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.509 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.03 6.88 47.84 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -53.89 -58.97 5.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.72 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 89.36 11.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.265 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.84 164.36 14.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.568 2.179 . . . . 0.0 112.424 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.38 -62.7 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.64 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' P' ' 126' ' ' LYS . 7.9 t -89.49 112.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.8 137.77 58.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.85 174.56 17.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.992 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.438 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 15.3 p-80 -141.99 68.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.28 . . . . 0.0 111.369 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.42 152.5 47.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -37.93 -32.36 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.58 -61.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.24 79.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -56.81 -50.17 73.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 87.7 p -60.66 -37.04 80.24 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.133 0.492 . . . . 0.0 110.056 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.856 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -62.47 -32.92 73.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.294 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 69' ' ' ASN . 98.7 m-20 -81.58 -30.45 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.415 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 4.5 mtp180 -69.79 74.61 0.43 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.089 0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 146.18 40.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.509 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.77 90.01 3.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.773 HG22 HG23 ' P' ' 31' ' ' THR . 15.4 t -80.2 114.17 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.468 HD22 HG13 ' P' ' 66' ' ' VAL . 0.2 OUTLIER -63.08 104.95 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.206 178.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -102.25 126.75 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.491 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.088 179.652 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.716 0.293 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' P' ' 19' ' ' GLY . 47.8 m-85 -137.92 85.62 2.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.771 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 50.6 4.98 0.07 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.726 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 19' ' ' GLY . . . . . 0.72 ' O ' HD21 ' P' ' 25' ' ' LEU . . . 171.53 97.2 0.11 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' P' ' 19' ' ' GLY . 0.8 OUTLIER 60.57 -178.34 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -107.99 160.49 15.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.49 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' P' ' 26' ' ' GLN . 20.6 t -39.13 -53.46 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 -15.92 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 24' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.7 -38.64 8.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.452 0.644 . . . . 0.0 110.142 178.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.72 HD21 ' O ' ' P' ' 19' ' ' GLY . 14.4 mt -70.27 -22.47 62.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.464 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 26' ' ' GLN . . . . . 0.404 ' HG3' HG12 ' P' ' 22' ' ' VAL . 12.6 mt-30 -85.25 -26.72 26.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.6 -3.49 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 28' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' P' ' 24' ' ' ASP . 5.4 mtm-85 -107.54 -68.03 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -109.52 96.39 6.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 112.061 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.579 ' HA ' HG21 ' P' ' 48' ' ' ILE . 2.6 p30 -162.77 27.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.024 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.571 HG23 HG22 ' P' ' 131' ' ' VAL . 95.3 m -128.33 129.61 46.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.882 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.483 HG11 HG23 ' P' ' 41' ' ' ILE . 1.0 OUTLIER -110.77 150.72 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -120.94 118.05 28.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.7 m-30 -100.99 171.65 7.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.383 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.76 -166.64 23.41 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.903 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.68 117.71 5.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 t70 45.45 29.04 0.55 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.342 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.404 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 24.5 mmtm -94.81 130.9 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.779 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -119.57 67.08 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.037 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.15 150.67 30.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.475 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.483 HG23 HG11 ' P' ' 32' ' ' VAL . 3.6 mt -107.98 156.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -109.85 150.16 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.15 0.5 . . . . 0.0 112.065 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.449 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -48.92 -31.27 10.16 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.264 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.75 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.69 0.281 . . . . 0.0 111.389 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.464 ' CB ' HG13 ' P' ' 32' ' ' VAL . 77.0 m-85 -99.68 -4.61 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.449 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 64.9 t -62.82 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.432 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -44.46 -45.38 9.09 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.008 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -52.59 -49.67 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.941 0.401 . . . . 0.0 110.22 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.859 HD11 HG13 ' P' ' 90' ' ' VAL . 2.7 mm? -54.06 -45.36 71.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -40.29 96.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.343 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 51' ' ' ALA . . . . . 0.444 ' HB2' ' HA3' ' P' ' 19' ' ' GLY . . . -68.95 -46.66 67.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.856 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.008 ' CD2' HG22 ' P' ' 48' ' ' ILE . 59.7 m-70 -68.17 -41.47 81.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.03 99.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.437 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.66 0.267 . . . . 0.0 110.482 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -73.38 -36.88 66.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.646 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 1.074 HD23 HG11 ' P' ' 99' ' ' VAL . 5.0 tp -60.01 -47.9 83.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.191 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.27 -43.08 78.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.594 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.64 -26.38 22.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.684 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -114.88 113.63 44.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.491 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.14 -49.08 17.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.771 2.314 . . . . 0.0 113.849 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.64 17.5 8.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.39 114.6 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.094 0.473 . . . . 0.0 110.662 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.518 ' CG ' ' HA ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -117.32 133.45 55.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.806 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.537 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.2 p -98.88 143.53 13.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 121.43 0.633 . . . . 0.0 111.476 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.765 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.5 tt -113.55 101.16 9.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.627 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.63 HG11 ' HB ' ' P' ' 90' ' ' VAL . 0.8 OUTLIER -80.13 106.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.477 ' OE2' HG11 ' P' ' 107' ' ' VAL . 0.9 OUTLIER -100.59 119.37 38.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 68' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' P' ' 130' ' ' ALA . . . -96.68 144.04 17.09 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.621 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 127' ' ' ASN . 1.4 m-20 -140.19 102.43 4.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.625 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 70' ' ' THR . . . . . 1.081 HG21 HD11 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -95.0 -169.97 2.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.573 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.61 158.49 34.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 pp20? -74.44 -33.96 63.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.259 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.03 116.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 -161.82 12.56 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.532 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.15 35.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.489 0.185 . . . . 0.0 110.751 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.431 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 46.6 Cg_exo -54.77 -31.87 74.0 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.231 1.954 . . . . 0.0 112.162 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.44 -43.02 82.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.706 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.89 -39.74 63.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.256 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -67.83 -76.7 0.08 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.58 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 1.8 tt -33.1 -38.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -56.87 6.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.749 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 1.081 HD11 HG21 ' P' ' 70' ' ' THR . 0.0 OUTLIER -55.4 -42.14 73.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 1.011 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -66.76 -40.51 93.83 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -52.55 -43.56 65.27 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.132 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.521 ' HD3' ' CD1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.12 -35.87 81.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.637 ' NH1' HG23 ' P' ' 70' ' ' THR . 0.0 OUTLIER -65.22 -44.65 87.6 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.745 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -57.79 -36.85 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.219 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 88' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' P' ' 91' ' ' LYS . 0.2 OUTLIER -67.57 -28.89 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.211 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -58.46 -66.36 0.5 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.859 HG13 HD11 ' P' ' 49' ' ' LEU . 84.3 t -57.11 -31.75 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.385 0.612 . . . . 0.0 109.892 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' P' ' 88' ' ' ASP . 0.3 OUTLIER -60.93 -47.62 85.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.351 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.85 79.39 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.112 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -68.04 -61.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' P' ' 104' ' ' LEU . 63.4 mt -57.02 -31.3 64.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.283 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.43 84.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.591 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.09 -39.63 94.62 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -60.86 -35.23 76.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.88 27.43 1.9 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.556 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 1.074 HG11 HD23 ' P' ' 56' ' ' LEU . 45.4 t -89.92 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.524 0.202 . . . . 0.0 110.483 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.31 165.22 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.245 0.545 . . . . 0.0 111.493 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.11 -29.91 18.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.297 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.97 -29.68 55.82 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.386 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.518 ' HA ' ' CG ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.14 -4.87 26.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 110.421 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' P' ' 94' ' ' LEU . 0.2 OUTLIER -106.91 121.32 44.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.122 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.557 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -129.61 178.36 17.47 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.606 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.745 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 70.7 p -149.95 163.44 38.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.765 ' CG2' HD21 ' P' ' 65' ' ' LEU . 93.5 t -160.85 161.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.21 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 5.6 t -159.66 129.05 5.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.471 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.433 ' CZ ' ' HG2' ' P' ' 67' ' ' GLU . 25.9 m-85 -88.85 -63.26 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.12 -127.92 8.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.079 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' P' ' 72' ' ' GLU . 0.3 OUTLIER -93.14 2.62 56.62 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.029 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.45 -66.14 0.45 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.831 0.348 . . . . 0.0 110.429 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -141.03 88.97 9.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.057 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 114' ' ' PRO . . . . . 0.4 ' CG ' ' HB3' ' P' ' 72' ' ' GLU . 24.2 Cg_exo -64.27 165.78 18.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.737 2.291 . . . . 0.0 112.434 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.54 -58.33 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.886 HG13 ' HB1' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -91.11 142.83 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.27 139.8 31.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.96 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.21 175.81 16.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.936 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.448 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 9.5 p-80 -141.3 68.27 1.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.749 0.274 . . . . 0.0 111.457 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -141.25 153.65 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 121' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 3.7 tp10 -40.37 -30.3 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.56 -65.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.992 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 123' ' ' ALA . . . . . 0.886 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -68.13 -41.42 81.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.698 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' P' ' 119' ' ' HIS . 1.6 m-85 -54.7 -52.96 60.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -59.09 -37.35 76.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -61.53 -31.62 71.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.292 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 69' ' ' ASN . 58.3 m-20 -84.42 -34.31 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.896 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 5.0 mtp180 -68.97 79.64 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.158 0.504 . . . . 0.0 111.135 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' P' ' 69' ' ' ASN . 0.1 OUTLIER -150.59 149.76 30.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.114 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.43 ' HA ' ' HA2' ' P' ' 68' ' ' GLY . . . -119.73 98.48 6.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.571 HG22 HG23 ' P' ' 31' ' ' THR . 21.8 t -83.9 115.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.467 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -65.39 103.13 0.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.549 178.233 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -99.47 128.59 45.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 111.511 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.051 179.624 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.78 0.324 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -89.51 106.65 18.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.994 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.01 35.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.412 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.41 -35.03 2.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.16 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -129.92 176.77 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 0.0 111.709 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -103.3 157.37 17.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.795 ' HA ' HD12 ' P' ' 25' ' ' LEU . 17.4 t -46.4 -51.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.18 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.53 -13.34 2.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.436 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.11 -44.66 6.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' P' ' 22' ' ' VAL . 3.9 mt -58.07 -19.78 34.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.703 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -109.02 -11.27 14.98 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.06 -31.08 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -122.83 -50.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.72 103.8 13.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.529 0.68 . . . . 0.0 112.403 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.601 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -176.08 11.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.301 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.426 ' O ' ' CD1' ' P' ' 45' ' ' TYR . 85.0 m -113.77 128.12 56.29 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.838 -0.539 . . . . 0.0 112.097 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.631 ' CG1' HG23 ' P' ' 41' ' ' ILE . 5.3 t -108.06 151.16 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 33' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' P' ' 34' ' ' PHE . 6.9 m-85 -112.48 163.32 14.61 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' P' ' 33' ' ' TYR . 73.4 m-85 -152.06 168.55 24.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.221 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.49 -175.74 23.27 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.567 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.35 128.43 37.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.084 0.442 . . . . 0.0 110.884 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p30 43.59 29.76 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.801 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.431 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 2.3 tttp -101.02 137.71 39.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' P' ' 39' ' ' TYR . 48.5 p90 -125.37 60.71 1.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.306 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.63 150.85 31.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.232 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.631 HG23 ' CG1' ' P' ' 32' ' ' VAL . 3.3 mt -94.76 163.44 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.652 0.263 . . . . 0.0 110.736 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.518 ' N ' HG22 ' P' ' 41' ' ' ILE . 72.8 p -112.61 142.67 44.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.308 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.9 -29.74 4.6 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.346 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.05 -32.87 74.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.61 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' P' ' 33' ' ' TYR . 68.2 m-85 -102.8 3.65 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.82 -41.23 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.46 ' NE2' HG12 ' P' ' 48' ' ' ILE . 6.1 pm0 -45.77 -37.77 6.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.0 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.3 mt -57.74 -52.83 52.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -52.85 -33.09 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.437 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -40.78 62.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.3 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 51' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -74.45 -43.93 53.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.0 ' CD2' HG22 ' P' ' 48' ' ' ILE . 59.9 m-70 -62.9 -38.82 92.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.026 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.36 87.18 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 55' ' ' TYR . . . . . 0.47 ' HD2' ' HH ' ' P' ' 134' ' ' TYR . 8.9 t80 -73.63 -41.51 62.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 1.069 HD23 HG11 ' P' ' 99' ' ' VAL . 5.6 tp -61.02 -45.06 96.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.397 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.79 -40.74 72.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.564 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.96 -26.64 37.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -114.54 114.33 44.95 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.374 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 -51.58 10.35 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.859 2.373 . . . . 0.0 113.931 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.06 19.69 5.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.627 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.19 119.68 30.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.503 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -119.5 132.51 55.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.724 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.691 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.8 p -98.65 144.87 10.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 121.294 0.569 . . . . 0.0 110.904 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.634 HD21 HG22 ' P' ' 107' ' ' VAL . 0.6 OUTLIER -116.56 108.31 15.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.943 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.2 OUTLIER -85.53 113.96 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' P' ' 107' ' ' VAL . 21.0 tt0 -99.07 120.36 39.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.29 144.01 21.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.708 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.743 ' O ' HG23 ' P' ' 70' ' ' THR . 0.3 OUTLIER -144.3 159.8 42.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.743 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.1 p -170.26 -173.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.445 ' CB ' ' CE2' ' P' ' 124' ' ' TYR . 10.0 p-10 -63.72 157.25 24.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.379 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.519 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 0.2 OUTLIER -70.55 -31.35 68.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.441 ' HB2' ' OH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -49.86 119.74 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.37 -173.82 15.33 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.225 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.17 143.15 26.56 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.135 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.537 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -40.2 -43.1 3.73 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.017 2.478 . . . . 0.0 113.667 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -59.82 -45.17 93.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -70.89 -41.97 70.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.406 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 4.3 m-80 -67.5 -75.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.9 OUTLIER -29.48 -44.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 111.525 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.37 4.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.91 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.572 HD12 ' NH1' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -47.9 -51.9 21.42 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.279 -0.569 . . . . 0.0 109.92 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' P' ' 86' ' ' ARG . . . -61.52 -40.74 99.12 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.511 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -51.39 -40.51 59.4 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.523 HH12 HD22 ' P' ' 82' ' ' LEU . 8.1 ttp-105 -64.73 -38.82 92.29 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.572 ' NH1' HD12 ' P' ' 82' ' ' LEU . 0.3 OUTLIER -59.05 -40.08 84.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' P' ' 106' ' ' THR . . . -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 88' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.5 OUTLIER -65.87 -34.69 78.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 178.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.1 68.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.86 -38.06 43.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.809 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.583 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.2 -39.66 91.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.236 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.79 -27.43 64.91 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -59.87 -57.02 14.67 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.463 ' HB2' HD21 ' P' ' 104' ' ' LEU . 23.2 mt -61.45 -32.25 72.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.39 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.96 95.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.103 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.12 -26.97 74.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.759 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -72.38 -11.44 60.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.99 2.0 25.24 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.13 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 1.069 HG11 HD23 ' P' ' 56' ' ' LEU . 26.9 t -81.95 131.95 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.368 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 100' ' ' ASP . . . . . 0.427 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.5 OUTLIER -60.9 164.28 5.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.271 0.557 . . . . 0.0 111.324 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.921 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -84.26 -30.02 25.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.58 -22.78 53.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.895 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.644 ' HE3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -98.84 -3.86 34.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.092 0.473 . . . . 0.0 111.25 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.921 HD12 ' HA ' ' P' ' 101' ' ' ALA . 8.7 mt -89.2 150.44 22.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.254 -0.279 . . . . 0.0 110.342 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.652 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.16 138.82 7.72 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.827 ' O ' HG13 ' P' ' 107' ' ' VAL . 66.3 p -132.14 153.37 50.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.693 0.282 . . . . 0.0 111.014 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.827 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -175.38 170.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.493 ' OG ' HG23 ' P' ' 80' ' ' ILE . 32.4 p -162.47 139.18 7.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.406 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' P' ' 110' ' ' GLY . 74.6 m-85 -123.57 19.77 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 7.4 -110.34 0.01 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -86.18 8.07 22.51 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 112' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 8.4 tp10 -51.43 -59.74 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 109.961 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.17 89.81 22.72 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.686 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.18 160.11 11.32 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.709 2.273 . . . . 0.0 112.991 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -69.13 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.674 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.69 HG21 ' HB3' ' P' ' 126' ' ' LYS . 19.6 t -87.67 106.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.923 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.24 134.9 49.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.1 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.69 174.68 13.56 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.379 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.61 87.02 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.145 0.473 . . . . 0.0 111.692 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -173.2 165.98 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -47.79 -22.3 0.52 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.57 -60.84 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.912 0.386 . . . . 0.0 111.444 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.09 72.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.445 ' CE2' ' CB ' ' P' ' 71' ' ' ASP . 2.9 m-85 -60.55 -45.75 92.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.749 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 25.2 t -65.34 -32.02 73.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.174 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.69 ' HB3' HG21 ' P' ' 116' ' ' VAL . 1.9 mtmt -75.06 -24.69 58.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.369 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -87.89 -29.0 21.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 111.262 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -67.25 87.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 3.3 ptt-85 -159.08 160.31 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -125.37 106.53 9.9 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.25 111.24 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.646 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -61.58 101.94 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.209 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 130.51 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.279 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' P' P ' 134' ' ' TYR . . . . . 0.47 ' HH ' ' HD2' ' P' ' 55' ' ' TYR . 5.8 m-85 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.025 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.988 0.423 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.94 106.38 4.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.169 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.66 8.51 47.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.288 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.54 -35.67 2.24 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.575 -1.297 . . . . 0.0 114.127 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.71 ' HB2' HD21 ' P' ' 25' ' ' LEU . 2.9 m-85 -119.43 169.26 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.124 0.462 . . . . 0.0 111.468 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -101.27 145.3 29.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.992 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.508 ' HA ' HD12 ' P' ' 25' ' ' LEU . 10.3 t -43.27 -30.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 111.468 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 23' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' P' ' 27' ' ' GLN . . . -61.67 -21.96 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 24' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.69 -54.05 3.02 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.604 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.71 HD21 ' HB2' ' P' ' 20' ' ' TYR . 7.1 mt -44.59 -28.05 0.55 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.89 -31.22 12.31 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.157 0.503 . . . . 0.0 110.725 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 27' ' ' GLN . . . . . 0.634 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.1 OUTLIER -148.5 77.68 1.4 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.532 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 28' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' P' ' 27' ' ' GLN . 0.0 OUTLIER 164.47 -68.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.205 177.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.449 ' CD1' ' HD3' ' P' ' 28' ' ' ARG . 6.7 m-85 -109.13 90.09 3.19 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.61 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 10.5 p-10 -168.29 64.69 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.411 ' O ' ' CE1' ' P' ' 45' ' ' TYR . 97.6 m -164.11 126.68 2.44 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.818 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.921 HG11 HG23 ' P' ' 41' ' ' ILE . 1.2 t -99.75 150.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.652 0.263 . . . . 0.0 111.215 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -116.33 108.35 15.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -89.31 172.94 8.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.612 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.16 -173.98 19.92 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 36' ' ' PHE . . . . . 0.411 ' CE2' ' OD2' ' P' ' 37' ' ' ASP . 3.0 t80 -58.36 122.56 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.457 0.628 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 37' ' ' ASP . . . . . 0.411 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 2.7 p30 43.92 30.84 0.44 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.744 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 141.58 28.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.467 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 31.2 p90 -130.76 52.55 2.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.497 . . . . 0.0 110.833 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -149.97 150.14 31.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.448 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.921 HG23 HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -100.27 163.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.924 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 69.4 p -109.45 150.59 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.86 -29.72 1.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.205 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -65.2 -30.47 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.503 ' CB ' HG13 ' P' ' 32' ' ' VAL . 68.0 m-85 -104.12 1.17 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.981 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 82.4 t -73.22 -37.56 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.41 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.62 -40.7 63.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' P' ' 45' ' ' TYR . 4.6 pt -67.25 -35.72 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.344 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.88 -40.12 96.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.95 -34.19 62.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.792 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.76 -53.58 8.27 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 0.651 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 23.0 m-70 -53.59 -35.35 60.75 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.04 85.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.065 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 110.201 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.23 -37.87 63.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.73 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 1.017 HD23 HG11 ' P' ' 99' ' ' VAL . 1.7 tp -62.47 -42.74 99.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.294 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.64 -42.06 71.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.461 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.07 54.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.534 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.3 OUTLIER -113.15 112.22 49.84 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.94 -48.74 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.842 2.361 . . . . 0.0 114.154 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.61 17.61 8.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.585 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.35 117.91 29.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -118.7 130.41 55.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.765 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.638 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.4 p -94.44 140.23 17.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.347 0.594 . . . . 0.0 111.422 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.14 104.31 13.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.786 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.09 108.12 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.6 tt0 -102.01 118.06 36.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.03 152.34 20.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.55 170.7 17.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.871 0.367 . . . . 0.0 110.926 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.1 OUTLIER 176.2 174.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.147 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.533 ' HB2' ' CZ ' ' P' ' 124' ' ' TYR . 37.7 p-10 -54.46 142.64 26.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.253 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 2.2 pp20? -62.79 -25.98 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.417 ' HD3' ' CD2' ' P' ' 119' ' ' HIS . 0.7 OUTLIER -39.33 110.74 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.545 -178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.22 -168.87 12.71 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.336 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.57 144.83 29.45 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.674 0.273 . . . . 0.0 111.066 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.06 -39.28 14.66 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.634 2.223 . . . . 0.0 112.488 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.8 -43.02 97.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.679 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -68.18 -41.81 80.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.467 ' OD1' HG23 ' P' ' 70' ' ' THR . 3.1 m-80 -70.68 -75.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.823 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -30.15 -40.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 81' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -69.89 -57.06 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.82 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 1.016 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.4 -42.0 81.42 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.056 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 1.016 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.86 -52.32 20.19 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.765 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 1.9 tt0 -48.03 -35.67 11.52 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.92 -48.71 79.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.082 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 0.3 OUTLIER -54.98 -40.89 70.55 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.556 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.78 -34.24 74.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.44 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -32.99 74.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.235 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.33 -53.44 57.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.426 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.37 -34.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -60.84 -52.75 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 92' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -65.06 -27.1 71.86 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -59.16 -58.4 8.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.485 ' CD1' HG11 ' P' ' 64' ' ' VAL . 92.6 mt -56.73 -29.91 62.98 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 95' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -69.84 -38.99 76.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.84 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.31 -35.17 87.61 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.68 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -63.87 -36.56 84.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.63 26.15 2.22 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.247 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 1.017 HG11 HD23 ' P' ' 56' ' ' LEU . 24.4 t -91.15 146.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.568 0.223 . . . . 0.0 110.726 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.28 161.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.172 0.51 . . . . 0.0 111.562 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.29 -31.32 17.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.67 -12.91 65.11 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 12.9 mtpp -94.37 -10.91 31.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.27 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' P' ' 101' ' ' ALA . 1.9 mt -99.79 150.01 22.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.74 144.58 11.8 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.777 ' O ' HG13 ' P' ' 107' ' ' VAL . 17.6 p -124.57 159.09 31.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.722 0.296 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.777 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -175.28 117.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.151 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.823 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -99.77 143.78 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.526 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' P' ' 110' ' ' GLY . 2.8 m-85 -105.45 7.8 33.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 16.87 -127.25 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.276 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -101.08 12.75 37.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.53 0.205 . . . . 0.0 111.106 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -59.1 5.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 109.95 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.36 89.03 16.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 114' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 31.9 Cg_exo -61.19 164.07 15.57 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.804 2.336 . . . . 0.0 112.982 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.3 -67.4 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.277 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.769 HG21 ' HG3' ' P' ' 126' ' ' LYS . 18.8 t -88.52 108.76 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.89 138.75 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.503 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.28 177.03 14.99 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.999 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.537 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 0.3 OUTLIER -141.03 61.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 120' ' ' ASP . . . . . 0.824 ' OD2' ' HB3' ' P' ' 122' ' ' ALA . 7.9 p-10 -127.14 154.69 44.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -49.38 -23.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.547 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 122' ' ' ALA . . . . . 0.824 ' HB3' ' OD2' ' P' ' 120' ' ' ASP . . . -76.07 -58.1 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.938 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.21 97.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.674 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.537 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 3.2 m-30 -66.59 -37.21 84.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.37 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 125' ' ' SER . . . . . 0.444 ' HA ' ' NE ' ' P' ' 128' ' ' ARG . 22.5 p -62.06 -37.61 85.64 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 110.682 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.769 ' HG3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -83.07 -11.84 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.713 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -80.71 -37.07 31.3 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.628 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -78.65 92.63 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.821 0.82 . . . . 0.0 110.756 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -146.68 146.35 30.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.362 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -115.53 93.91 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.03 112.84 16.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 1.4 mm? -63.71 100.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.282 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -97.38 122.53 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.806 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.053 179.568 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.43 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 7.0 m-85 -90.96 107.02 18.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.66 33.48 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.396 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.24 -35.43 2.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.593 -1.289 . . . . 0.0 113.466 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.87 43.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.599 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -60.07 152.37 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' P' ' 25' ' ' LEU . 21.5 t -44.3 -40.07 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 112.029 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -14.83 25.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.316 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.54 -41.03 8.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.561 0.696 . . . . 0.0 109.895 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.522 HD21 ' HB1' ' P' ' 51' ' ' ALA . 14.7 mt -61.86 -19.8 63.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -98.66 -14.61 19.76 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.99 -17.9 2.11 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -67.96 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -105.36 81.89 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.634 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.24 10.17 2.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.006 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.678 ' OG1' HG13 ' P' ' 131' ' ' VAL . 23.5 m -134.81 137.12 43.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.65 HG11 HG23 ' P' ' 41' ' ' ILE . 11.3 t -106.89 149.71 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.437 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 33' ' ' TYR . . . . . 0.548 ' CE2' ' NH2' ' P' ' 129' ' ' ARG . 3.3 m-85 -113.39 115.51 28.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.778 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.462 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 82.4 m-85 -104.69 168.9 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.078 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.99 179.73 19.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.384 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 3.6 t80 -61.4 137.48 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 37' ' ' ASP . . . . . 0.415 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 0.5 OUTLIER 46.91 28.05 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.407 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 5.5 mttm -109.12 136.07 49.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.742 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -130.86 49.82 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.75 150.44 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.958 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.65 HG23 HG11 ' P' ' 32' ' ' VAL . 2.2 mp -92.98 164.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.519 0.199 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.529 ' N ' HG22 ' P' ' 41' ' ' ILE . 28.0 p -109.5 144.22 38.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.84 -29.58 1.43 Allowed Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.219 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.43 -31.96 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.618 0.247 . . . . 0.0 111.655 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.562 ' CB ' HG13 ' P' ' 32' ' ' VAL . 76.0 m-85 -104.39 3.31 32.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.414 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 98.5 t -70.31 -38.32 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.318 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.24 -40.25 11.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.298 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.05 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.4 mt -55.39 -55.87 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.945 0.402 . . . . 0.0 110.333 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.687 HD11 HG13 ' P' ' 90' ' ' VAL . 2.8 mm? -52.04 -31.89 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.697 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -38.69 62.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 51' ' ' ALA . . . . . 0.522 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -75.36 -45.98 35.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.05 ' CD2' HG22 ' P' ' 48' ' ' ILE . 65.8 m-70 -64.41 -37.73 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.67 95.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.76 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.22 98.34 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.032 0.444 . . . . 0.0 110.14 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 55' ' ' TYR . . . . . 0.43 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 24.2 t80 -75.82 -37.6 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.66 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.944 HD23 HG11 ' P' ' 99' ' ' VAL . 10.1 tp -60.68 -49.02 79.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -70.1 -40.31 75.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.51 -27.29 37.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.423 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -113.63 115.37 46.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.667 0.27 . . . . 0.0 110.423 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.83 -59.6 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.915 2.41 . . . . 0.0 113.902 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 20.52 2.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.663 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -88.46 114.6 25.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.017 0.437 . . . . 0.0 110.374 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.4 129.7 56.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.687 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.4 p -95.56 126.37 48.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.428 0.632 . . . . 0.0 110.921 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.588 HD21 HG22 ' P' ' 107' ' ' VAL . 0.8 OUTLIER -99.54 105.51 17.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.721 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.557 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.4 t -82.19 120.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.047 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.1 tt0 -106.52 116.05 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.97 142.97 18.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.735 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.726 ' O ' HG23 ' P' ' 70' ' ' THR . 0.6 OUTLIER -141.39 161.52 37.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.959 0.409 . . . . 0.0 110.751 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.726 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.3 p -170.16 -173.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.538 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.48 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 4.3 p30 -74.92 152.79 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.617 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.414 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pp20? -63.56 -32.63 74.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.935 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.404 ' HB3' ' OD1' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -39.75 109.41 0.11 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.96 178.62 19.17 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.14 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.97 146.51 31.43 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.511 0.196 . . . . 0.0 110.853 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 71.8 Cg_exo -41.23 -42.6 5.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.741 2.294 . . . . 0.0 113.197 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.34 -43.62 98.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.881 0.372 . . . . 0.0 110.568 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -43.56 78.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.6 OUTLIER -69.51 -76.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.687 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.635 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.46 -43.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.72 -56.49 9.09 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.573 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.766 HD12 ' C ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -48.9 -56.19 9.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.262 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.99 -39.34 97.45 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.526 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 3.8 mt-30 -48.41 -51.12 28.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 13.0 ptp180 -62.2 -32.67 73.35 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 0.4 OUTLIER -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.74 76.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.982 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 88' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.5 OUTLIER -63.35 -29.73 70.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.638 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -64.9 -43.22 93.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.154 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.687 HG13 HD11 ' P' ' 49' ' ' LEU . 39.2 t -75.47 -42.7 42.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.365 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' P' ' 88' ' ' ASP . 0.0 OUTLIER -63.1 -38.93 93.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 92' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -71.75 -31.29 65.09 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.32 -57.01 14.79 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' P' ' 64' ' ' VAL . 83.5 mt -57.63 -30.48 65.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.285 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 95' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -68.9 -39.71 79.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.945 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.66 -36.21 91.15 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.873 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -35.36 78.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.05 26.53 2.05 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.944 HG11 HD23 ' P' ' 56' ' ' LEU . 57.5 t -90.77 144.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.595 0.236 . . . . 0.0 110.54 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 100' ' ' ASP . . . . . 0.457 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -63.94 161.56 15.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.504 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.97 -32.3 16.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.423 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.41 -23.93 36.25 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.689 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.67 -3.25 33.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.29 0.567 . . . . 0.0 110.858 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.8 mt -89.24 148.88 23.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.846 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.557 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -148.68 140.84 8.53 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.637 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.806 ' O ' HG13 ' P' ' 107' ' ' VAL . 14.8 p -131.12 153.44 49.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.679 0.276 . . . . 0.0 110.832 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.806 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -174.26 117.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.635 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -105.65 137.8 42.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.368 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.513 ' O ' ' C ' ' P' ' 110' ' ' GLY . 91.9 m-85 -121.4 15.97 11.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.996 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -5.03 -106.3 0.0 OUTLIER Glycine 0 C--N 1.34 0.761 0 O-C-N 123.758 0.662 . . . . 0.0 114.523 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -89.61 0.7 56.76 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.589 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -54.73 -59.87 4.13 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 88.7 7.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.96 168.29 7.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.893 2.395 . . . . 0.0 113.163 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.51 -66.01 0.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.236 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.823 HG13 ' HB1' ' P' ' 123' ' ' ALA . 2.5 p -88.6 151.05 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -108.37 136.13 48.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.865 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.29 -178.9 20.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -140.23 43.53 1.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.443 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -130.07 156.13 45.02 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -27.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.617 0.246 . . . . 0.0 111.591 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.24 -58.84 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.386 . . . . 0.0 110.651 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 123' ' ' ALA . . . . . 0.823 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -72.48 -39.6 67.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.549 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.48 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 5.9 m-85 -57.82 -49.77 75.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.956 0.408 . . . . 0.0 110.531 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 125' ' ' SER . . . . . 0.645 ' O ' ' NH2' ' P' ' 129' ' ' ARG . 8.3 t -62.7 -33.02 74.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.605 ' O ' ' CZ ' ' P' ' 129' ' ' ARG . 0.1 OUTLIER -75.83 -14.41 60.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.325 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -94.18 -24.45 17.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.457 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.6 mtp180 -77.11 91.11 3.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.645 ' NH2' ' O ' ' P' ' 125' ' ' SER . 0.0 OUTLIER -160.88 154.85 22.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.05 103.96 9.73 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.678 HG13 ' OG1' ' P' ' 31' ' ' THR . 2.6 t -82.03 109.44 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.82 100.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.28 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -98.0 123.08 41.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.92 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.915 179.707 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' P' ' 20' ' ' TYR . 40.4 m-85 -137.53 103.06 4.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.978 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.89 9.99 23.4 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.72 -1.229 . . . . 0.0 112.211 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.2 -33.89 2.71 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.651 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.821 ' HB2' HD21 ' P' ' 25' ' ' LEU . 18.0 m-85 -116.11 160.59 20.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.131 0.491 . . . . 0.0 112.286 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -97.56 142.0 29.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.327 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 t -40.86 -53.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.86 -16.54 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.393 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.29 -46.07 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 110.417 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' P' ' 20' ' ' TYR . 11.9 mt -56.12 -20.83 19.11 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.559 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -12.23 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -118.72 -28.15 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -117.13 -52.51 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -109.39 97.07 6.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.865 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -164.68 13.02 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 31' ' ' THR . . . . . 1.004 HG23 HG22 ' P' ' 131' ' ' VAL . 90.3 m -120.41 130.09 54.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.916 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.648 HG11 HG23 ' P' ' 41' ' ' ILE . 5.3 t -108.84 141.72 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.102 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.28 117.7 30.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 20.4 m-30 -96.26 167.76 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.925 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 35' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' P' ' 128' ' ' ARG . . . -100.74 -170.11 28.81 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.76 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.43 115.74 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.52 31.63 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.534 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.433 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 15.5 mmtm -91.58 141.66 28.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 17.3 t80 -126.55 57.71 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.701 0.762 . . . . 0.0 110.116 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -150.96 150.85 31.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.893 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.648 HG23 HG11 ' P' ' 32' ' ' VAL . 3.0 mt -100.81 160.33 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.467 ' O ' HG23 ' P' ' 46' ' ' VAL . 18.4 p -108.83 138.86 44.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 111.743 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.08 -28.64 1.35 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.926 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.35 -31.98 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.112 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.494 ' O ' HG13 ' P' ' 48' ' ' ILE . 65.9 m-85 -106.33 5.57 29.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' P' ' 42' ' ' THR . 80.4 t -76.26 -28.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.53 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -36.46 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.67 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.074 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -58.95 -46.32 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.172 0.51 . . . . 0.0 109.899 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.434 HD23 ' N ' ' P' ' 49' ' ' LEU . 3.3 mt -59.75 -39.01 83.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.767 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.72 -44.69 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.345 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 -50.08 66.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.967 0.413 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.074 ' CD2' HG22 ' P' ' 48' ' ' ILE . 60.0 m-70 -59.75 -35.8 75.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.85 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.686 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.97 80.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.977 0.418 . . . . 0.0 110.435 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -78.03 -34.21 50.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.0 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.823 ' CD2' HG11 ' P' ' 99' ' ' VAL . 1.0 OUTLIER -67.0 -40.57 87.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.874 -179.234 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.99 -34.35 66.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.61 -22.63 67.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.569 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -110.8 115.29 53.55 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.592 0.235 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.12 -62.1 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.878 2.385 . . . . 0.0 114.065 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.6 25.16 1.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.602 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -91.14 122.13 33.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.166 0.508 . . . . 0.0 110.98 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.2 mttp -128.29 132.68 48.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.533 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.9 p -95.38 146.41 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-O 121.392 0.615 . . . . 0.0 111.54 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.22 103.68 12.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.69 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.631 HG11 ' HB ' ' P' ' 90' ' ' VAL . 0.2 OUTLIER -84.32 95.02 3.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.542 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 22.3 tt0 -89.36 119.72 30.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.773 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.48 145.9 18.65 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.658 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.674 ' O ' HG23 ' P' ' 70' ' ' THR . 81.5 m-20 -142.49 161.44 38.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.674 HG23 ' O ' ' P' ' 69' ' ' ASN . 2.2 p -165.23 -169.98 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.0 111.889 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.505 ' HB3' ' CE1' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -58.17 158.48 6.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.926 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -77.63 -30.95 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.324 0.583 . . . . 0.0 109.741 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.404 ' HD2' ' OH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -65.89 129.09 38.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.697 0.761 . . . . 0.0 112.653 -178.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -179.96 18.1 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.824 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.77 144.28 28.41 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.72 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.605 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 94.8 Cg_exo -39.39 -49.68 3.07 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.144 2.563 . . . . 0.0 113.603 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -43.41 76.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -71.79 -45.37 61.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' P' ' 80' ' ' ILE . 6.4 m120 -71.11 -76.59 0.1 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -31.94 -46.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -57.02 10.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.279 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.986 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -50.43 -46.59 56.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.037 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.986 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.9 -43.61 82.25 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.236 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -51.95 -37.38 52.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 109.842 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -51.1 63.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.708 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.58 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 0.8 OUTLIER -58.39 -39.59 80.06 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -59.96 -32.83 71.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.757 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -31.67 71.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.145 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.45 -55.43 33.59 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.604 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.631 ' HB ' HG11 ' P' ' 66' ' ' VAL . 17.4 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.878 0.371 . . . . 0.0 111.088 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.616 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.31 -39.75 91.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.651 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.91 -24.39 69.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.16 -58.3 7.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.515 ' CD1' HG11 ' P' ' 64' ' ' VAL . 95.3 mt -61.23 -32.46 72.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.686 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.46 98.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.389 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.32 -21.21 77.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.864 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -10.8 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.0 111.344 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -5.88 17.98 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.436 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.823 HG11 ' CD2' ' P' ' 56' ' ' LEU . 19.5 t -78.45 127.77 38.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.946 0.373 . . . . 0.0 111.097 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.4 143.08 57.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 111.494 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.81 -35.38 22.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.553 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -21.1 54.27 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.725 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.1 OUTLIER -94.02 -9.66 36.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.16 0.48 . . . . 0.0 111.387 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.616 HD13 ' O ' ' P' ' 91' ' ' LYS . 1.1 mt -106.76 140.13 40.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.674 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.402 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -149.09 143.44 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.55 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 15.9 p -115.7 159.87 20.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.676 0.274 . . . . 0.0 110.863 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.58 HG12 ' CE2' ' P' ' 109' ' ' TYR . 46.4 t -164.57 114.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.489 ' OG ' HG23 ' P' ' 80' ' ' ILE . 58.5 p -111.82 134.71 53.2 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.433 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.58 ' CE2' HG12 ' P' ' 107' ' ' VAL . 95.2 m-85 -124.21 19.01 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.58 -109.79 0.01 OUTLIER Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 114.445 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' HA ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -88.59 7.69 32.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.23 -60.35 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 110.327 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -142.09 89.18 8.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.941 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.99 166.99 9.6 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.692 2.261 . . . . 0.0 112.543 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.26 -63.08 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.46 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.775 HG21 ' HD2' ' P' ' 126' ' ' LYS . 36.7 t -89.04 112.19 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.812 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tp -65.0 137.97 58.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.14 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.37 176.19 14.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.82 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.407 ' CB ' ' OH ' ' P' ' 124' ' ' TYR . 17.8 p-80 -140.79 60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.886 0.343 . . . . 0.0 111.39 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.31 155.3 48.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.35 -30.79 0.11 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.78 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.11 79.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' P' ' 71' ' ' ASP . 5.2 m-85 -62.64 -39.29 93.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.054 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 14.2 m -65.14 -33.51 76.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.945 0.402 . . . . 0.0 109.971 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.775 ' HD2' HG21 ' P' ' 116' ' ' VAL . 21.1 mtmt -73.98 -24.49 59.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.493 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -90.53 -30.87 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 76.2 mtm-85 -67.44 88.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.53 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.15 156.95 29.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.69 99.21 5.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 1.004 HG22 HG23 ' P' ' 31' ' ' THR . 31.1 t -95.95 115.75 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.846 ' O ' HD12 ' P' ' 132' ' ' LEU . 2.9 pp -85.72 123.59 31.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -131.68 151.8 51.35 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' P' P ' 134' ' ' TYR . . . . . 0.48 ' HE2' HD12 ' P' ' 56' ' ' LEU . 57.1 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.015 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.94 0.4 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 67.2 m-85 -133.45 109.54 9.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.508 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.71 9.69 20.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.265 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.72 -36.06 2.23 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.593 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.403 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 5.7 m-85 -121.34 162.4 20.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.431 . . . . 0.0 111.459 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 11.0 p -101.49 156.76 17.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.822 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.696 HG13 ' OH ' ' P' ' 134' ' ' TYR . 38.0 t -45.89 -41.55 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 23' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' P' ' 27' ' ' GLN . . . -66.2 -18.49 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' NE2' ' P' ' 27' ' ' GLN . 0.3 OUTLIER -99.26 -43.88 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.338 0.59 . . . . 0.0 110.008 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.542 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 1.9 mt -63.59 -19.2 64.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.557 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 26' ' ' GLN . . . . . 0.41 ' HG3' ' HG3' ' P' ' 27' ' ' GLN . 0.0 OUTLIER -88.88 -25.04 22.35 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 27' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' P' ' 23' ' ' ALA . 2.9 pp0? -132.98 -8.66 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 28' ' ' ARG . . . . . 0.403 ' HD3' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -109.94 -66.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.403 ' CE2' ' HD3' ' P' ' 28' ' ' ARG . 67.3 m-85 -107.43 88.8 2.82 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.39 0.614 . . . . 0.0 111.513 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.2 OUTLIER -152.47 16.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.997 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 91.1 m -121.89 129.82 52.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.716 HG11 HG23 ' P' ' 41' ' ' ILE . 4.6 t -107.68 150.49 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.917 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -123.05 112.11 17.38 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.411 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 23.3 m-85 -93.22 170.74 9.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.714 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.45 179.81 30.78 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.531 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.53 119.94 10.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 110.715 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t0 61.44 37.46 16.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.045 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -121.31 137.92 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 29.9 p90 -127.4 56.79 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 110.719 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.2 150.92 32.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.716 HG23 HG11 ' P' ' 32' ' ' VAL . 1.4 mp -94.21 163.23 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.982 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.481 ' N ' HG22 ' P' ' 41' ' ' ILE . 43.2 p -113.41 149.27 34.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.312 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.77 -32.4 3.03 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.31 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -64.17 -33.36 75.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.689 0.281 . . . . 0.0 111.614 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.541 ' CB ' HG13 ' P' ' 32' ' ' VAL . 78.4 m-85 -100.61 -3.71 29.93 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.408 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 70.2 t -61.79 -42.97 96.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.609 0.242 . . . . 0.0 111.351 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.413 ' NE2' HG12 ' P' ' 48' ' ' ILE . 0.9 OUTLIER -43.83 -43.5 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.063 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.34 -46.8 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -58.27 -42.24 86.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.9 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -42.7 77.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.87 65.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.063 ' CD2' HG22 ' P' ' 48' ' ' ILE . 14.6 m-70 -62.5 -38.56 90.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 110.473 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 53' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -68.58 -41.68 79.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.927 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.84 98.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.733 0.302 . . . . 0.0 111.147 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 55' ' ' TYR . . . . . 0.605 ' HE2' ' HD1' ' P' ' 52' ' ' HIS . 0.2 OUTLIER -71.84 -36.5 70.21 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.776 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.71 HD21 ' HG3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -75.14 -34.21 61.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.617 -178.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.55 -30.16 64.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.011 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 -17.85 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.376 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -112.58 111.79 51.69 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.301 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.93 -63.27 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.949 2.433 . . . . 0.0 114.421 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 22.59 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.646 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.5 112.96 24.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.349 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -117.01 132.87 56.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.546 ' HB ' HD13 ' P' ' 56' ' ' LEU . 14.4 p -98.64 146.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.547 0.689 . . . . 0.0 111.474 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.461 HD22 HG21 ' P' ' 107' ' ' VAL . 0.3 OUTLIER -107.3 103.65 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.462 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.458 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.5 t -83.59 100.2 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.387 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 5.5 tt0 -90.96 121.54 32.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.306 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.13 146.42 20.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.265 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' HG23 ' P' ' 70' ' ' THR . 0.8 OUTLIER -145.33 161.08 40.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.632 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.447 HG23 ' NH1' ' P' ' 86' ' ' ARG . 0.5 OUTLIER -162.38 -172.99 3.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 111.638 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 6.0 p-10 -81.75 166.32 20.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.374 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 tm-20 -64.15 -39.0 93.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.932 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.434 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 4.1 mmm180 -39.37 106.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -173.91 15.49 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.056 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.21 146.79 32.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.527 0.203 . . . . 0.0 110.646 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.432 ' O ' HD12 ' P' ' 80' ' ' ILE . 88.1 Cg_exo -45.46 -40.89 18.01 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.479 2.119 . . . . 0.0 112.644 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.37 -41.27 89.68 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -69.42 -44.2 71.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' P' ' 80' ' ' ILE . 27.8 m120 -61.84 -75.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.618 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.6 OUTLIER -30.01 -45.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 O-C-N 123.185 0.303 . . . . 0.0 111.737 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.13 -60.65 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.607 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -44.21 -45.98 8.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.767 178.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.409 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.9 -38.24 92.76 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.82 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -44.01 63.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.865 0.364 . . . . 0.0 110.226 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -39.72 90.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.528 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 3.0 mtt180 -61.65 -39.85 92.84 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.52 81.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.143 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -32.01 73.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.495 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.53 -63.53 1.24 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.514 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.23 -37.09 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 111.403 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -61.73 2.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.8 -20.3 59.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.363 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.69 -58.78 5.83 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.519 HD12 HD22 ' P' ' 104' ' ' LEU . 24.2 mt -59.41 -30.04 68.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.373 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.63 94.82 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.243 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.12 -26.71 73.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.892 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 1.2 mtpm? -78.23 -9.92 59.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.68 0.276 . . . . 0.0 111.26 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.12 -3.2 23.98 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.152 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.839 HG11 HD21 ' P' ' 104' ' ' LEU . 16.8 t -74.68 126.14 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.766 0.283 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 100' ' ' ASP . . . . . 0.45 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.3 OUTLIER -62.37 139.23 58.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.0 111.566 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.862 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -62.99 -32.84 74.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.294 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.46 -19.99 58.39 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.189 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.71 ' HG3' HD21 ' P' ' 56' ' ' LEU . 0.0 OUTLIER -101.99 -4.32 26.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.198 0.523 . . . . 0.0 111.035 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' P' ' 101' ' ' ALA . 0.5 OUTLIER -110.8 120.48 42.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.458 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -124.94 -175.17 14.17 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.852 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.781 ' O ' HG13 ' P' ' 107' ' ' VAL . 15.8 p -149.21 163.12 38.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.885 0.374 . . . . 0.0 111.279 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.781 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -177.0 111.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.47 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 1.1 p -111.9 145.54 39.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 0.0 111.812 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' P' ' 110' ' ' GLY . 83.7 m-85 -121.16 23.83 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 11.56 -115.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.859 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.36 17.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.175 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -59.1 -54.42 47.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 110.113 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -141.33 89.74 9.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.364 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.53 165.73 10.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.712 2.275 . . . . 0.0 112.534 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -59.72 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.814 HG21 ' HB3' ' P' ' 126' ' ' LYS . 11.4 t -88.21 109.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -75.98 134.07 40.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.777 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.04 -179.15 27.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.616 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -142.51 73.89 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -168.53 161.89 11.84 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 121' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 0.0 OUTLIER -46.35 -24.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.83 -59.06 3.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 -40.29 67.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 25.4 m-85 -60.48 -43.26 97.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 95.4 p -68.21 -33.34 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.814 ' HB3' HG21 ' P' ' 116' ' ' VAL . 23.7 mtmt -71.89 -22.85 61.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.218 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -87.41 -29.21 21.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.357 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.8 mtp180 -66.35 90.2 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.246 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.8 OUTLIER -158.81 158.6 33.83 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.67 107.84 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.85 147.75 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -100.53 100.02 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.586 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' P' ' 65' ' ' LEU . . . -104.55 143.87 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' P' P ' 134' ' ' TYR . . . . . 0.696 ' OH ' HG13 ' P' ' 22' ' ' VAL . 8.1 m-85 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -89.74 106.48 18.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.75 9.4 26.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.552 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.26 -38.35 1.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.795 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 17.7 m-85 -121.67 170.93 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 111.822 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.36 150.69 23.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.887 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 t -38.26 -63.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.53 -13.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -46.35 5.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 12.5 mt -56.88 -22.24 35.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.506 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 26' ' ' GLN . . . . . 0.541 ' HA ' ' ND2' ' P' ' 30' ' ' ASN . 0.1 OUTLIER -104.64 -11.96 16.65 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -115.77 -27.32 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -55.91 2.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -108.21 81.83 1.54 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.174 0.512 . . . . 0.0 111.914 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.541 ' ND2' ' HA ' ' P' ' 26' ' ' GLN . 5.0 t-20 -140.39 13.71 2.37 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.918 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.665 ' OG1' HG13 ' P' ' 131' ' ' VAL . 53.8 m -134.56 136.63 43.15 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.722 HG11 HG23 ' P' ' 41' ' ' ILE . 10.5 t -108.6 150.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.077 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -123.75 114.54 20.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 22.3 m-30 -93.4 170.59 9.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.777 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.31 -172.25 31.01 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.98 126.34 27.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.27 0.535 . . . . 0.0 110.673 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 46.64 33.77 2.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -96.08 141.51 29.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.689 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 3.3 t80 -129.85 48.81 2.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.714 0.769 . . . . 0.0 109.767 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -150.29 151.01 32.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.955 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.722 HG23 HG11 ' P' ' 32' ' ' VAL . 2.5 mt -96.08 161.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.559 0.219 . . . . 0.0 110.661 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.465 ' N ' HG22 ' P' ' 41' ' ' ILE . 16.2 p -110.83 144.8 39.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.032 0.444 . . . . 0.0 111.755 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.58 -30.17 3.13 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 113.413 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -31.34 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.689 0.281 . . . . 0.0 111.721 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.585 ' CB ' HG13 ' P' ' 32' ' ' VAL . 87.8 m-85 -105.7 4.71 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 72.0 t -70.9 -37.17 67.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -31.99 37.02 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.557 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 0.986 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -62.86 -49.98 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.191 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.554 HD23 ' CD2' ' P' ' 93' ' ' TYR . 1.6 mp -53.57 -37.45 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.62 -39.24 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.708 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.48 -57.32 4.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 0.986 ' CD2' HG22 ' P' ' 48' ' ' ILE . 20.0 m-70 -54.31 -37.85 65.29 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 53' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' P' ' 49' ' ' LEU . . . -60.15 -43.49 95.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.729 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.98 96.81 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.865 0.364 . . . . 0.0 110.551 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -73.86 -38.33 64.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.825 ' CD2' HG11 ' P' ' 99' ' ' VAL . 4.5 tp -65.48 -43.12 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.352 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.06 -37.67 78.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.445 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.85 -24.04 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -115.37 114.88 42.69 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.52 -48.6 19.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 113.894 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.7 18.48 7.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.612 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.64 116.57 28.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 0.0 110.711 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -118.19 133.96 55.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.953 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.656 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.3 p -95.57 141.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.345 0.593 . . . . 0.0 111.259 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.841 HD21 ' CG2' ' P' ' 107' ' ' VAL . 5.1 tt -108.96 101.03 10.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.725 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.468 HG13 HD22 ' P' ' 132' ' ' LEU . 0.7 OUTLIER -79.27 112.24 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.329 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.517 ' HG3' HD22 ' P' ' 65' ' ' LEU . 8.2 mt-10 -99.72 117.56 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.1 22.15 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.997 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.691 ' O ' HG23 ' P' ' 70' ' ' THR . 0.9 OUTLIER -145.5 157.92 43.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.814 0.34 . . . . 0.0 110.32 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.691 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.5 p -168.03 -176.65 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.059 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 6.1 p-10 -72.42 155.58 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.49 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pm0 -62.4 -34.23 76.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.018 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -39.68 106.92 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 74' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.69 168.25 17.42 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.569 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 75' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' P' ' 79' ' ' ASN . 0.5 OUTLIER -83.03 146.16 51.11 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.653 0.263 . . . . 0.0 110.568 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.11 -36.36 84.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.957 2.438 . . . . 0.0 114.182 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 77' ' ' GLU . . . . . 0.416 ' O ' HG22 ' P' ' 80' ' ' ILE . 1.0 OUTLIER -64.12 -48.96 74.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.79 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 78' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -75.07 -30.25 60.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -65.38 -74.54 0.1 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.627 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.3 OUTLIER -32.27 -38.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 O-C-N 123.23 0.332 . . . . 0.0 111.231 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 81' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -61.41 -59.37 5.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.499 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -47.22 -50.85 20.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.922 178.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.478 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.72 -45.24 86.06 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.598 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 4.2 tp60 -49.25 -38.69 27.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.281 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -67.65 -46.65 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.715 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.579 ' NH1' HG21 ' P' ' 70' ' ' THR . 0.4 OUTLIER -58.27 -40.65 82.43 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.595 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.12 -31.98 70.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.124 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -32.13 70.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.429 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.53 -60.16 4.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.8 -35.62 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -42.83 97.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.502 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.77 -22.63 78.93 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 93' ' ' TYR . . . . . 0.554 ' CD2' HD23 ' P' ' 49' ' ' LEU . 5.2 t80 -63.88 -62.09 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.6 ' CD1' HG11 ' P' ' 64' ' ' VAL . 75.3 mt -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.501 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.62 92.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.753 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.37 -24.44 76.07 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -73.17 -10.06 59.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.79 36.41 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.934 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.825 HG11 ' CD2' ' P' ' 56' ' ' LEU . 22.2 t -75.8 128.8 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.24 138.64 57.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -53.28 -36.03 60.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.04 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.06 -15.53 60.71 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.043 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.686 ' HE3' HG13 ' P' ' 99' ' ' VAL . 7.0 mtpp -92.88 -11.44 33.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' P' ' 101' ' ' ALA . 1.8 mt -103.68 142.81 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.451 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -147.69 145.64 14.47 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.771 ' O ' HG13 ' P' ' 107' ' ' VAL . 15.2 p -123.27 162.57 22.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.956 0.407 . . . . 0.0 111.313 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.841 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER 179.05 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.599 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -98.69 142.55 30.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.902 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' P' ' 112' ' ' GLU . 34.7 m-85 -113.31 13.81 19.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.89 -109.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.045 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -107.96 15.31 24.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 112' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' P' ' 109' ' ' TYR . 0.2 OUTLIER -63.25 -45.02 93.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.633 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 113' ' ' LYS . . . . . 0.411 ' N ' ' OE2' ' P' ' 112' ' ' GLU . 20.9 mtmm -146.51 88.93 5.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.71 164.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 0.0 113.143 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.37 -61.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.507 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.776 HG21 ' HB3' ' P' ' 126' ' ' LYS . 15.3 t -88.41 109.79 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.27 136.12 47.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.109 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.56 173.17 13.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -140.88 92.89 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.068 0.434 . . . . 0.0 111.994 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -166.64 162.37 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 121' ' ' GLU . . . . . 0.416 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.2 OUTLIER -47.08 -25.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.578 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.02 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.725 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.64 69.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 12.9 m-85 -54.55 -50.52 67.73 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.072 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -65.99 -33.81 76.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.776 ' HB3' HG21 ' P' ' 116' ' ' VAL . 3.6 mtmt -68.04 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.915 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.46 -29.75 21.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 5.4 mtp180 -65.49 88.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -158.3 157.46 32.5 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.71 95.26 4.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.665 HG13 ' OG1' ' P' ' 31' ' ' THR . 13.6 t -82.44 112.62 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.468 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -63.8 105.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.565 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -100.55 128.41 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.482 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.831 179.732 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 54.9 m-85 -136.04 108.42 7.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 111.282 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 9.95 32.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.424 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 -31.66 3.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.563 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.628 ' HB2' HD21 ' P' ' 25' ' ' LEU . 33.5 m-85 -117.29 161.8 18.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 16.7 t -111.15 160.57 16.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.755 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.436 HG23 ' H ' ' P' ' 22' ' ' VAL . 17.2 t -40.06 -56.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.37 -19.94 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.76 -43.61 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.298 0.57 . . . . 0.0 110.283 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' P' ' 20' ' ' TYR . 47.1 mt -67.94 -22.0 65.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.44 -20.88 26.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -143.42 -3.57 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 28' ' ' ARG . . . . . 0.41 ' HD2' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -107.26 -69.87 0.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.41 ' CE2' ' HD2' ' P' ' 28' ' ' ARG . 58.3 m-85 -108.86 89.56 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 112.101 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -150.14 18.75 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 86.9 m -126.3 132.01 51.74 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.833 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 1.065 HG11 HG23 ' P' ' 41' ' ' ILE . 23.6 t -108.36 149.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -113.41 113.44 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.623 0.725 . . . . 0.0 112.301 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.802 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 7.1 m-30 -90.29 174.49 7.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.567 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.89 -177.85 15.06 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -62.34 136.45 57.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.82 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.0 28.21 0.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.269 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.447 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -105.5 127.75 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.704 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.45 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 23.3 p90 -128.11 43.56 3.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.478 . . . . 0.0 110.2 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -148.06 150.51 34.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.345 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 1.065 HG23 HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -89.06 166.32 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.78 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.467 ' H ' HG22 ' P' ' 41' ' ' ILE . 47.1 p -111.09 150.1 29.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.125 0.488 . . . . 0.0 111.568 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.56 -31.2 3.54 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.337 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.03 -32.44 73.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.404 ' O ' HG13 ' P' ' 48' ' ' ILE . 92.1 m-85 -104.05 5.11 35.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.43 HG13 ' OH ' ' P' ' 93' ' ' TYR . 76.3 t -70.68 -39.92 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.81 -33.74 17.51 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.681 -178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.058 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -59.17 -52.56 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 110.065 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.753 HD11 HG13 ' P' ' 90' ' ' VAL . 3.1 mm? -55.57 -33.32 63.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.681 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.23 -43.04 68.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.9 -37.06 62.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.058 ' CD2' HG22 ' P' ' 48' ' ' ILE . 28.4 m-70 -69.04 -38.73 79.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.84 94.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.347 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.36 90.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.021 0.439 . . . . 0.0 110.311 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 55' ' ' TYR . . . . . 0.444 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 7.8 t80 -72.56 -40.4 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.768 ' CD2' HG11 ' P' ' 99' ' ' VAL . 1.8 tp -61.64 -44.24 97.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -65.95 -41.8 90.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.94 3.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -113.77 118.05 43.48 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.483 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.56 -56.5 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.715 2.277 . . . . 0.0 113.727 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 23.42 1.59 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.475 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -91.5 131.82 36.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 110.547 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -137.35 137.72 39.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.997 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.9 p -98.16 141.29 16.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.519 0.675 . . . . 0.0 111.533 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.878 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.9 tt -108.97 103.62 12.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.565 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.8 OUTLIER -81.32 113.62 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.02 118.72 37.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -104.06 139.54 14.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.582 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 127' ' ' ASN . 57.0 m-80 -145.76 104.62 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.915 HG22 ' NH1' ' P' ' 86' ' ' ARG . 39.2 p -86.21 -176.54 5.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 10.4 p-10 -71.09 165.47 23.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.442 ' O ' ' CD ' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -66.68 -35.68 80.73 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.94 114.08 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.66 -142.12 17.3 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.807 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.29 146.11 52.65 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.512 0.196 . . . . 0.0 110.614 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.483 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 87.8 Cg_exo -44.68 -43.95 14.27 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.589 2.192 . . . . 0.0 113.715 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.72 -46.36 88.48 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -72.83 -36.56 67.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.949 0.404 . . . . 0.0 110.006 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' P' ' 80' ' ' ILE . 5.4 m120 -67.99 -74.33 0.12 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.621 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -29.98 -44.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.911 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -57.89 11.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.224 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.2 OUTLIER -46.53 -44.36 17.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.245 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.464 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -65.73 -38.13 94.17 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.564 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.34 -43.49 43.82 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.2 ptm180 -67.98 -33.72 75.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.466 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.915 ' NH1' HG22 ' P' ' 70' ' ' THR . 56.0 mtt180 -65.11 -49.23 70.75 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.543 0.687 . . . . 0.0 109.277 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.14 -34.81 74.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.704 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.45 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -63.89 -67.51 0.42 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.691 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.753 HG13 HD11 ' P' ' 49' ' ' LEU . 59.0 t -53.16 -43.35 49.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.112 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -40.98 85.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.546 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.77 -15.58 80.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.914 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 93' ' ' TYR . . . . . 0.43 ' OH ' HG13 ' P' ' 46' ' ' VAL . 2.6 t80 -72.75 -64.27 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.58 ' CD1' HG11 ' P' ' 64' ' ' VAL . 28.7 mt -55.78 -32.62 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.396 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.75 89.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.828 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.13 -22.75 77.41 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.605 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -76.04 -10.03 59.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.806 0.336 . . . . 0.0 110.975 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.3 35.73 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.148 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' P' ' 56' ' ' LEU . 18.2 t -75.63 125.81 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.852 0.326 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' P' ' 103' ' ' LYS . 2.5 p30 -62.34 139.54 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.335 0.588 . . . . 0.0 111.565 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.48 -36.35 10.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.449 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.99 -17.1 60.55 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.078 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' P' ' 63' ' ' LYS . 24.3 mtpp -91.49 -14.51 30.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.036 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' P' ' 94' ' ' LEU . 1.3 mt -102.62 143.07 32.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.565 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -139.92 146.14 17.48 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.776 ' O ' HG13 ' P' ' 107' ' ' VAL . 19.4 p -128.78 152.04 48.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.783 0.325 . . . . 0.0 110.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -175.39 119.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -118.53 133.63 55.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.522 ' O ' ' C ' ' P' ' 110' ' ' GLY . 23.7 m-85 -102.01 32.48 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -103.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.539 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' P' ' 72' ' ' GLU . 41.7 mt-10 -113.89 16.87 18.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -47.21 66.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.66 89.34 11.78 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.6 163.39 15.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.683 2.255 . . . . 0.0 112.935 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.73 -64.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' P' ' 126' ' ' LYS . 2.4 t -88.85 108.74 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 117' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' P' ' 117' ' ' LEU . 3.6 mm? -66.89 135.83 54.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.46 173.94 14.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.085 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -140.74 60.95 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.05 152.14 51.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 121' ' ' GLU . . . . . 0.411 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.1 OUTLIER -37.78 -33.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.28 -61.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.84 -42.63 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.992 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.466 ' O ' ' HD3' ' P' ' 128' ' ' ARG . 4.7 m-85 -56.65 -54.0 51.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.196 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 125' ' ' SER . . . . . 0.552 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 4.8 m -55.68 -35.59 66.2 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.664 ' HB3' HG21 ' P' ' 116' ' ' VAL . 33.9 mtmt -75.44 -21.22 58.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.56 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 69' ' ' ASN . 44.9 m-20 -80.95 -42.76 20.77 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.802 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.39 73.58 0.72 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.949 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.6 143.42 49.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.11 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.61 98.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.66 111.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 101.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.589 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -97.6 125.65 42.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.46 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.945 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 33.2 p . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 45.5 m-85 -129.98 112.08 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.678 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.35 9.62 61.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.584 -0.817 . . . . 0.0 114.08 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 -27.4 3.86 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.137 -1.506 . . . . 0.0 114.529 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.15 173.89 8.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.285 0.542 . . . . 0.0 111.726 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.89 151.52 21.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' P' ' 25' ' ' LEU . 13.1 t -44.5 -35.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.898 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.59 -13.04 38.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.612 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 24' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' P' ' 29' ' ' TYR . 0.4 OUTLIER -98.16 -44.37 6.63 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.849 0.833 . . . . 0.0 108.891 177.385 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' P' ' 22' ' ' VAL . 7.5 mt -58.89 -23.36 60.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.348 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -111.87 -19.19 12.48 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 -32.23 2.99 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 28' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -141.57 59.92 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 0.5 OUTLIER 157.5 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.974 0.416 . . . . 0.0 110.691 178.484 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 2.3 p30 172.95 15.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 57.3 m -120.4 126.82 51.41 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.628 0.649 . . . . 0.0 112.203 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.745 HG11 HG23 ' P' ' 41' ' ' ILE . 3.4 t -108.18 145.35 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.49 115.19 23.54 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.7 m-85 -96.04 168.28 10.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.766 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.53 -171.87 28.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.976 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.8 116.52 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.656 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 58.33 39.2 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.41 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 1.7 tptp -112.97 136.15 52.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.416 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 27.5 p90 -130.33 54.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.58 150.59 33.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.745 HG23 HG11 ' P' ' 32' ' ' VAL . 1.6 mp -96.76 161.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.781 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.468 ' N ' HG22 ' P' ' 41' ' ' ILE . 30.7 p -112.71 147.72 36.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.017 0.437 . . . . 0.0 111.385 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.77 -30.17 3.39 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.082 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.49 -33.89 75.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.562 0.22 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.403 ' CB ' HG13 ' P' ' 32' ' ' VAL . 96.9 m-85 -104.49 3.36 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.57 -41.14 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' P' ' 47' ' ' GLN . 6.5 pm0 -47.6 -35.05 8.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.711 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.003 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -64.37 -46.78 92.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.536 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.437 ' HB3' ' CE1' ' P' ' 93' ' ' TYR . 5.6 mp -56.87 -47.34 80.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.375 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 50' ' ' ASP . . . . . 0.449 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.3 OUTLIER -67.45 -33.52 75.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.428 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.9 -41.03 37.93 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.685 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.003 ' CD2' HG22 ' P' ' 48' ' ' ILE . 22.3 m-70 -64.21 -38.46 91.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.26 88.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 55' ' ' TYR . . . . . 0.448 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 21.6 t80 -79.2 -34.45 42.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 1.023 HD23 HG11 ' P' ' 99' ' ' VAL . 5.0 tp -66.51 -41.3 89.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -75.64 -34.54 60.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.653 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.93 -24.85 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.57 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -112.57 114.82 49.74 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.634 0.254 . . . . 0.0 110.389 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -48.94 -63.12 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.876 2.384 . . . . 0.0 114.039 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.27 18.85 2.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -84.56 113.57 21.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.9 mttp -115.59 128.46 55.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.51 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.7 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.6 p -96.2 139.98 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 121.305 0.574 . . . . 0.0 110.641 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.618 HD21 HG22 ' P' ' 107' ' ' VAL . 1.1 tt -112.45 103.09 11.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.956 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.689 HG13 HD22 ' P' ' 132' ' ' LEU . 0.6 OUTLIER -81.47 106.45 12.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.479 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.58 ' HA ' HG23 ' P' ' 107' ' ' VAL . 20.7 mt-10 -89.8 119.32 30.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.526 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 134.53 12.52 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.607 ' O ' HG23 ' P' ' 70' ' ' THR . 27.3 m120 -134.62 159.02 42.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.438 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.607 HG23 ' O ' ' P' ' 69' ' ' ASN . 7.6 p -164.42 -177.61 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.162 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.518 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 8.2 p-10 -73.55 155.6 38.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' P' ' 111' ' ' GLU . 2.6 pp20? -63.49 -34.86 78.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.962 0.41 . . . . 0.0 110.641 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -41.8 165.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.438 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 74' ' ' GLY . . . . . 0.529 ' O ' HG23 ' P' ' 75' ' ' THR . . . 78.4 -124.47 6.7 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.773 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 75' ' ' THR . . . . . 0.529 HG23 ' O ' ' P' ' 74' ' ' GLY . 0.8 OUTLIER -163.62 145.53 7.52 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.437 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 2.4 Cg_endo -39.61 -53.13 2.36 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.297 2.664 . . . . 0.0 113.25 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -40.73 93.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.37 -35.16 68.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.453 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.74 ' HA ' HD12 ' P' ' 82' ' ' LEU . 5.6 m120 -76.94 -76.88 0.16 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.573 HD11 ' O ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.04 -43.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.3 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 81' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -68.86 -60.72 2.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 1.028 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.14 -38.42 73.49 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.272 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 1.028 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -68.46 -50.96 34.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.341 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.4 mt-30 -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -46.49 88.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.324 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.615 ' HD2' HD22 ' P' ' 82' ' ' LEU . 0.4 OUTLIER -57.27 -42.62 81.95 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -59.87 -37.44 79.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.147 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 88' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -64.63 -32.34 73.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.467 178.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.59 -47.59 84.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.697 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.01 -34.69 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.702 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.567 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -66.94 -38.69 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.525 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.96 -29.47 58.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 93' ' ' TYR . . . . . 0.451 ' CD1' ' HE3' ' P' ' 97' ' ' LYS . 7.6 t80 -62.87 -53.76 49.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.596 ' HB2' HD21 ' P' ' 104' ' ' LEU . 20.3 mt -59.48 -28.62 67.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.263 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.57 -36.63 65.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.914 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.45 58.01 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.092 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.575 ' HD2' ' HA ' ' P' ' 94' ' ' LEU . 0.0 OUTLIER -49.42 -34.76 17.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.92 28.94 1.6 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.386 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 1.023 HG11 HD23 ' P' ' 56' ' ' LEU . 23.1 t -90.71 145.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.567 0.223 . . . . 0.0 110.822 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 100' ' ' ASP . . . . . 0.405 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -61.5 160.45 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.283 0.563 . . . . 0.0 111.526 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.772 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.64 -32.52 16.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.1 -21.67 46.93 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.48 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.08 -4.57 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.22 0.533 . . . . 0.0 110.923 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' P' ' 101' ' ' ALA . 4.6 mt -85.74 150.51 24.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.206 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.619 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.9 139.67 8.12 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.685 ' O ' HG13 ' P' ' 107' ' ' VAL . 34.6 p -141.57 151.2 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.685 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -166.95 170.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.855 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.573 ' O ' HD11 ' P' ' 80' ' ' ILE . 1.3 t -157.38 126.93 6.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.726 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.3 m-85 -115.49 18.49 15.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -1.28 -113.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.597 -0.729 . . . . 0.0 114.804 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -85.35 2.54 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.91 -57.05 14.47 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 88.22 5.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.76 170.81 18.69 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.022 2.481 . . . . 0.0 112.838 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.46 -56.03 2.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.152 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.892 HG13 ' HB1' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -88.72 138.61 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.699 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.44 139.41 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.154 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.19 176.93 15.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.881 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.464 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 0.1 OUTLIER -141.06 62.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 0.249 . . . . 0.0 111.279 -179.36 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 120' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 1.4 p30 -132.92 154.91 49.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.81 -26.09 0.12 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 122' ' ' ALA . . . . . 0.517 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -72.69 -62.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.97 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 123' ' ' ALA . . . . . 0.892 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -69.79 -42.43 73.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 1.0 OUTLIER -55.65 -48.76 74.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.759 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 58.2 m -63.34 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.397 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -68.33 -27.13 66.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.325 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.443 ' ND2' HG12 ' P' ' 116' ' ' VAL . 92.0 m-20 -89.07 -28.95 19.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -70.16 86.89 0.57 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 7.6 ptt-85 -159.79 159.18 32.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -123.63 102.35 7.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -86.87 109.58 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.689 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -59.68 102.19 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.572 178.354 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 126.92 48.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.678 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.874 179.624 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 CA--C 1.526 0.036 0 CA-C-O 120.805 0.336 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' P' ' 20' ' ' TYR . 63.4 m-85 -89.68 107.16 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.994 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.75 9.33 38.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.645 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.67 -37.1 1.87 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.349 -1.405 . . . . 0.0 114.037 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' P' ' 17' ' ' PHE . 5.3 m-85 -120.76 169.14 10.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.023 0.411 . . . . 0.0 111.586 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 26.0 t -102.78 152.99 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.439 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -40.07 -48.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.36 -17.27 28.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -42.61 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.284 0.564 . . . . 0.0 110.427 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.509 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 16.3 mt -59.27 -21.22 59.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.436 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 26' ' ' GLN . . . . . 0.771 ' HA ' HD21 ' P' ' 30' ' ' ASN . 4.5 mm-40 -103.26 -12.6 17.17 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -125.21 -22.72 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -109.78 -62.16 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -108.25 83.58 1.8 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.288 0.566 . . . . 0.0 112.162 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.771 HD21 ' HA ' ' P' ' 26' ' ' GLN . 2.6 t-20 -141.53 13.45 2.14 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.933 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.477 HG23 HG22 ' P' ' 131' ' ' VAL . 95.2 m -134.28 135.99 43.23 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.719 HG11 HG23 ' P' ' 41' ' ' ILE . 3.0 t -108.37 150.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.07 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.32 115.62 21.98 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.2 m-30 -96.18 169.87 9.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.512 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.56 -168.95 19.41 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.818 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.58 126.14 26.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 49.75 30.57 3.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.618 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.402 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -101.13 132.55 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.423 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 40.1 p90 -129.35 46.26 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 110.822 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.41 150.43 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.808 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.719 HG23 HG11 ' P' ' 32' ' ' VAL . 1.2 mp -90.9 164.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.259 . . . . 0.0 110.896 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.465 ' N ' HG22 ' P' ' 41' ' ' ILE . 67.2 p -112.8 149.98 32.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.213 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -43.48 -32.51 1.92 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.228 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.89 -33.06 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.415 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.502 ' CB ' HG13 ' P' ' 32' ' ' VAL . 81.4 m-85 -102.27 -1.02 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.59 -40.98 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -43.44 6.3 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.008 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -57.39 -50.34 77.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 110.556 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' P' ' 53' ' ' ALA . 5.1 mt -53.32 -37.46 62.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -40.26 56.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.13 -54.22 11.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.03 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.008 ' CD2' HG22 ' P' ' 48' ' ' ILE . 22.7 m-70 -56.98 -36.8 70.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 109.904 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 53' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' P' ' 49' ' ' LEU . . . -60.76 -42.53 97.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.07 95.51 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.854 0.359 . . . . 0.0 110.751 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.33 -36.43 53.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.707 ' CD2' HG11 ' P' ' 99' ' ' VAL . 8.0 tp -68.93 -39.42 79.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.935 0.398 . . . . 0.0 111.174 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.05 -36.74 66.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.192 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.45 -23.28 67.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.22 111.24 58.04 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.602 0.239 . . . . 0.0 110.363 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.17 -58.67 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.863 2.375 . . . . 0.0 113.927 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.65 2.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.638 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.18 116.95 27.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.77 131.12 57.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.038 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.661 ' HB ' HD13 ' P' ' 56' ' ' LEU . 3.9 p -95.98 133.69 36.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.433 0.635 . . . . 0.0 111.15 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.452 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.2 tt -109.79 103.67 12.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.793 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.73 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -82.41 108.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.73 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.47 ' HA ' HG23 ' P' ' 107' ' ' VAL . 2.4 tt0 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.773 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.77 128.58 8.87 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.722 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.721 ' O ' HG23 ' P' ' 70' ' ' THR . 1.8 m-80 -130.93 158.0 41.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.721 HG23 ' O ' ' P' ' 69' ' ' ASN . 0.9 OUTLIER -170.25 -175.19 1.89 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 111.495 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.563 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 14.0 p-10 -77.43 149.39 35.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.302 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 9.2 pm0 -57.71 -31.63 66.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.883 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.423 ' N ' ' HG2' ' P' ' 72' ' ' GLU . 2.9 tpp180 -40.74 107.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.36 -173.69 15.03 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.163 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.76 145.52 30.87 Favored Pre-proline 0 N--CA 1.466 0.355 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 81.4 Cg_exo -39.97 -46.79 3.91 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.916 2.411 . . . . 0.0 113.063 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.84 -40.99 94.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.99 -39.01 63.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.457 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 0.4 OUTLIER -68.78 -76.75 0.09 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' P' ' 79' ' ' ASN . 1.0 OUTLIER -30.64 -45.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.433 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.37 -57.62 11.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -45.31 -51.86 10.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.779 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -62.23 -35.84 92.16 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.482 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -47.9 65.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.913 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 0.0 OUTLIER -68.1 -32.99 73.69 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.827 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.494 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 6.6 mtt180 -65.22 -45.99 82.46 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.555 0.693 . . . . 0.0 109.229 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' P' ' 106' ' ' THR . . . -60.35 -35.55 75.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.749 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.99 -30.74 71.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.87 -56.35 20.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.938 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.04 -36.17 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -43.77 98.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -72.21 -24.44 76.42 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.98 -64.04 1.0 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.464 ' CD1' HG11 ' P' ' 64' ' ' VAL . 85.2 mt -53.83 -32.82 54.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 95' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -59.02 -41.6 88.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.053 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.72 -21.08 77.85 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -79.85 -9.52 59.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 122.74 0.416 . . . . 0.0 110.974 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.94 0.18 36.01 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.776 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.707 HG11 ' CD2' ' P' ' 56' ' ' LEU . 48.6 t -73.63 123.71 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.36 148.61 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -68.48 -34.24 75.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.673 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.39 -22.1 55.44 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.045 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.622 ' HD3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -100.05 -4.43 29.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.229 0.537 . . . . 0.0 111.133 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' P' ' 101' ' ' ALA . 37.2 mt -95.91 150.12 20.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.298 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.616 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -148.42 142.07 9.66 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.755 ' O ' HG13 ' P' ' 107' ' ' VAL . 45.0 p -134.02 155.69 49.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.668 0.27 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.755 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -170.77 171.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.424 ' OG ' HG23 ' P' ' 80' ' ' ILE . 14.7 p -162.62 134.54 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.633 0.254 . . . . 0.0 111.48 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.509 ' O ' ' C ' ' P' ' 110' ' ' GLY . 29.5 m-85 -123.62 23.59 8.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 1.25 -110.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 114.622 0.609 . . . . 0.0 114.622 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -84.05 5.06 27.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -54.71 -59.57 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 88.78 7.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.98 166.96 13.05 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.79 2.327 . . . . 0.0 113.018 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.72 -61.64 1.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.27 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' P' ' 126' ' ' LYS . 5.6 t -88.84 108.86 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.83 136.53 56.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.199 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.06 174.98 14.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.981 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.457 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 7.2 p-80 -141.12 61.09 1.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.765 0.283 . . . . 0.0 111.462 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 120' ' ' ASP . . . . . 0.724 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 2.7 p30 -130.16 156.35 44.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -43.66 -25.82 0.19 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 122' ' ' ALA . . . . . 0.724 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -75.13 -56.66 4.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.89 -43.19 68.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.666 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 2.0 m-85 -59.48 -47.38 85.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 94.6 p -63.36 -33.44 75.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 110.241 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.784 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -69.79 -24.49 63.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.887 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.85 -30.8 18.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.335 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 3.0 mtp180 -65.82 87.25 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.2 OUTLIER -159.32 157.17 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.248 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.06 96.23 4.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.477 HG22 HG23 ' P' ' 31' ' ' THR . 21.5 t -82.02 109.71 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.73 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -60.92 101.81 0.17 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.031 178.144 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.22 127.84 46.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.755 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.889 179.758 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -137.04 107.17 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.18 9.64 12.26 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.358 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.79 -41.41 1.32 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.819 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -126.65 172.59 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.967 0.413 . . . . 0.0 111.504 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -99.72 152.26 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.949 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.672 ' HA ' HD12 ' P' ' 25' ' ' LEU . 16.7 t -42.13 -53.85 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.315 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.46 -14.94 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -44.79 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 109.483 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' P' ' 22' ' ' VAL . 2.6 mt -59.06 -21.98 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.997 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -100.75 -11.93 19.51 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -121.86 -21.82 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 28' ' ' ARG . . . . . 0.483 ' HD3' ' CZ ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -118.39 -55.44 2.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.483 ' CZ ' ' HD3' ' P' ' 28' ' ' ARG . 53.0 m-85 -108.78 101.41 10.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.179 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 11.2 p-10 -170.44 20.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.247 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 82.7 m -128.88 131.29 47.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 2.6 t -110.98 143.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.211 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -117.28 118.55 32.59 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.51 170.73 7.86 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.132 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.45 -165.77 15.34 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.433 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 36' ' ' PHE . . . . . 0.407 ' CE2' ' OD2' ' P' ' 37' ' ' ASP . 2.7 t80 -57.65 123.74 16.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.51 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 37' ' ' ASP . . . . . 0.407 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 3.2 p30 42.01 28.61 0.1 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.002 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -90.44 130.14 36.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.626 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 9.1 t80 -125.03 59.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.52 149.98 29.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.91 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.482 HG22 ' N ' ' P' ' 42' ' ' THR . 8.6 mt -96.83 161.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.482 ' N ' HG22 ' P' ' 41' ' ' ILE . 3.9 p -110.47 140.72 44.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 112.025 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.6 -30.03 3.1 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.095 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.84 -33.49 76.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.55 0.214 . . . . 0.0 111.552 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.403 ' O ' HG13 ' P' ' 48' ' ' ILE . 83.1 m-85 -101.26 0.17 36.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.42 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 75.6 t -66.87 -40.81 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.43 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -45.11 -43.52 9.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.423 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 0.953 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -54.08 -52.46 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.292 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' P' ' 53' ' ' ALA . 2.6 mp -50.92 -40.27 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.385 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -38.29 64.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.928 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.02 -58.89 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.821 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 0.953 ' CD2' HG22 ' P' ' 48' ' ' ILE . 18.8 m-70 -51.54 -37.0 47.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.171 0.51 . . . . 0.0 109.784 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 53' ' ' ALA . . . . . 0.566 ' HB1' ' NZ ' ' P' ' 97' ' ' LYS . . . -60.98 -48.16 83.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.289 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.85 76.86 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.926 0.394 . . . . 0.0 110.372 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -71.47 -42.12 68.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.676 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.75 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.301 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -67.29 -43.06 82.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.09 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.331 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -123.41 95.64 45.02 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.88 -24.61 39.58 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 113.29 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.9 5.27 51.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.55 127.03 36.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.8 mttp -121.51 130.56 53.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.046 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.1 p -97.38 147.34 6.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.502 0.668 . . . . 0.0 111.536 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.5 tt -119.78 104.24 10.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.665 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.683 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -83.15 109.87 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.618 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 1.6 mm-40 -89.7 121.55 31.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.54 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.25 133.84 11.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.881 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.2 OUTLIER -145.82 100.98 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.778 0.323 . . . . 0.0 110.754 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.862 HG21 HD11 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -88.05 -168.68 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 13.0 p-10 -81.79 164.91 21.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.974 0.416 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 10.1 tm-20 -66.93 -40.59 87.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.246 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.432 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -44.97 106.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.037 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.27 -164.83 12.01 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.479 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.27 146.02 34.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.657 0.265 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.68 ' O ' HD12 ' P' ' 80' ' ' ILE . 71.8 Cg_exo -50.78 -38.22 56.39 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.13 2.553 . . . . 0.0 114.158 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.55 -42.8 83.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 78' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 40.5 t80 -81.73 -29.26 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.66 ' HA ' HD12 ' P' ' 82' ' ' LEU . 2.0 m-80 -90.62 -11.54 39.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.68 HD12 ' O ' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -87.58 -40.74 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.496 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.2 -48.67 64.59 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.269 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 1.029 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -60.24 -38.46 83.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.126 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 1.029 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.4 -44.52 64.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.139 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.7 OUTLIER -50.63 -41.3 54.88 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.477 ' HG3' ' CE1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.65 -35.42 80.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.294 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -64.24 -52.39 58.95 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.55 -34.98 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.476 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -29.43 69.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.49 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.75 -50.77 63.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.629 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.15 -38.76 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.424 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.97 -40.68 96.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.234 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 -28.3 68.66 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 93' ' ' TYR . . . . . 0.466 ' CD1' ' HD2' ' P' ' 97' ' ' LYS . 4.3 t80 -59.97 -62.24 2.02 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.639 ' HA ' ' HD3' ' P' ' 97' ' ' LYS . 95.4 mt -54.43 -32.42 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.55 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.18 76.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.169 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.78 -29.75 75.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.547 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.639 ' HD3' ' HA ' ' P' ' 94' ' ' LEU . 0.7 OUTLIER -74.13 -11.6 60.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.11 3.49 15.24 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.75 HG11 ' CD2' ' P' ' 56' ' ' LEU . 28.2 t -80.98 131.82 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.897 0.349 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 100' ' ' ASP . . . . . 0.438 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -60.31 158.02 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.333 0.587 . . . . 0.0 111.556 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.876 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -86.42 -29.94 22.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.71 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.53 50.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.807 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.631 ' HE3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -99.93 -3.77 31.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.145 0.497 . . . . 0.0 111.163 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.3 mt -91.68 149.21 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.336 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.634 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -145.89 139.79 8.45 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.488 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 43.5 p -138.45 151.43 47.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.767 0.318 . . . . 0.0 110.975 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.511 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -161.27 169.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.133 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.478 ' OG ' HG23 ' P' ' 80' ' ' ILE . 51.6 p -162.68 130.04 3.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.506 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.552 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.0 OUTLIER -114.19 31.55 6.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.234 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.77 -113.12 0.01 OUTLIER Glycine 0 C--N 1.34 0.796 0 O-C-N 123.679 0.612 . . . . 0.0 114.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 2.7 mp0 -97.71 13.18 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 112' ' ' GLU . . . . . 0.436 ' CG ' ' HB3' ' P' ' 76' ' ' PRO . 26.0 mt-10 -61.72 -55.23 32.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.679 0.276 . . . . 0.0 110.378 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -134.19 89.83 27.24 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 161.2 8.98 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.641 2.227 . . . . 0.0 112.967 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.92 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.712 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.878 HG21 ' HB3' ' P' ' 126' ' ' LYS . 3.6 t -88.61 108.82 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.98 135.04 57.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.388 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.93 173.3 14.72 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.787 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.487 ' HA ' ' CD1' ' P' ' 124' ' ' TYR . 0.1 OUTLIER -141.21 64.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.787 0.294 . . . . 0.0 111.492 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.82 152.88 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -38.0 -32.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -60.93 2.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -43.93 74.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' P' ' 119' ' ' HIS . 0.8 OUTLIER -57.71 -52.99 63.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.316 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 125' ' ' SER . . . . . 0.403 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 11.2 t -59.33 -33.96 71.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.878 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -67.86 -27.84 67.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.572 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 69' ' ' ASN . 74.3 m-20 -82.96 -33.48 26.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.88 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.3 mpp_? -69.74 80.21 0.44 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.815 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 4.1 ptt180 -156.56 150.86 25.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.95 115.91 25.35 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.8 112.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.683 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -59.41 98.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.632 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -102.36 129.1 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.009 179.773 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.81 0.338 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.525 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 94.2 m-85 -89.48 108.1 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.498 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.97 9.14 38.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.333 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -32.97 2.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.488 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' P' ' 17' ' ' PHE . 2.1 m-85 -115.41 160.61 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.025 0.441 . . . . 0.0 111.611 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 9.4 t -103.2 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.262 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.614 ' HA ' HD12 ' P' ' 25' ' ' LEU . 21.5 t -43.3 -41.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -17.27 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 -40.58 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.568 0.699 . . . . 0.0 110.012 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' P' ' 22' ' ' VAL . 6.3 mt -64.27 -15.34 59.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.564 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 26' ' ' GLN . . . . . 0.491 ' HG3' ' CD2' ' P' ' 134' ' ' TYR . 2.0 tt0 -92.78 -25.47 18.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.39 -9.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -117.12 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 54.0 m-85 -107.12 99.49 9.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 111.961 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.622 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 12.2 p-10 -178.38 27.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.22 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.508 HG23 HG22 ' P' ' 131' ' ' VAL . 78.6 m -126.48 127.08 44.81 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.791 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.745 HG11 HG23 ' P' ' 41' ' ' ILE . 1.9 t -104.19 150.13 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.157 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -124.63 112.64 17.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.243 0.544 . . . . 0.0 112.429 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -91.51 166.66 12.73 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.97 -167.64 19.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.064 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.54 126.32 26.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.016 0.436 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t0 53.09 27.92 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.568 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -100.97 136.8 40.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.485 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 46.4 p90 -135.72 36.05 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.22 150.63 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.799 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.745 HG23 HG11 ' P' ' 32' ' ' VAL . 0.8 OUTLIER -88.26 164.66 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.933 0.397 . . . . 0.0 111.069 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.456 ' H ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -114.38 149.06 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' P' ' 46' ' ' VAL . . . -41.18 -33.96 0.85 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.527 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.2 -31.79 72.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.644 0.259 . . . . 0.0 111.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.491 ' O ' HG13 ' P' ' 48' ' ' ILE . 71.2 m-85 -99.99 1.54 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' P' ' 43' ' ' GLY . 56.0 t -65.05 -44.72 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -40.01 -43.97 1.65 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 0.89 HG22 ' HD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -62.14 -47.4 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.066 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.41 HD22 HG13 ' P' ' 90' ' ' VAL . 16.2 mt -56.61 -51.77 67.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.801 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 50' ' ' ASP . . . . . 0.576 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.9 OUTLIER -61.13 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 51' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' P' ' 17' ' ' PHE . . . -71.14 -37.06 72.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 0.89 ' HD2' HG22 ' P' ' 48' ' ' ILE . 5.6 m-70 -66.21 -33.44 75.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.241 0.543 . . . . 0.0 110.321 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 53' ' ' ALA . . . . . 0.416 ' CB ' ' HG2' ' P' ' 97' ' ' LYS . . . -75.38 -31.14 60.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.826 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.25 69.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 111.356 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 55' ' ' TYR . . . . . 0.772 ' HH ' ' HE1' ' P' ' 134' ' ' TYR . 1.8 p90 -74.28 -34.41 63.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.577 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -72.4 -35.64 68.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -178.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.77 -31.7 65.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.98 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.89 61.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.38 111.79 57.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.819 0.342 . . . . 0.0 110.503 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.69 -62.49 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.079 2.519 . . . . 0.0 114.481 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.35 22.93 2.7 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.65 116.34 28.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.711 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -122.21 132.28 54.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.892 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.512 ' HB ' HD13 ' P' ' 56' ' ' LEU . 10.0 p -95.36 137.34 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 121.41 0.624 . . . . 0.0 111.466 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' P' ' 107' ' ' VAL . 0.6 OUTLIER -105.15 106.39 16.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.682 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.577 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.6 OUTLIER -84.88 104.39 12.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 10.4 mt-10 -89.59 119.88 30.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.596 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.16 95.92 1.88 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.094 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.708 ' O ' HG23 ' P' ' 70' ' ' THR . 0.4 OUTLIER -97.58 155.22 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.283 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.708 HG23 ' O ' ' P' ' 69' ' ' ASN . 0.7 OUTLIER -173.43 176.25 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.165 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -73.88 148.16 42.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.249 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' P' ' 114' ' ' PRO . 0.5 OUTLIER -55.36 -28.3 52.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.957 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.456 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 19.1 ttm180 -39.82 104.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.312 0.577 . . . . 0.0 112.263 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 74' ' ' GLY . . . . . 0.489 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.29 163.28 16.54 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.109 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.16 146.71 71.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.479 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 68.7 Cg_exo -50.53 -42.63 48.54 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.744 2.296 . . . . 0.0 113.95 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.99 -46.66 86.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 78' ' ' TYR . . . . . 0.576 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -77.49 -32.31 54.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.547 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 1.5 m120 -63.56 -74.94 0.09 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.445 HG23 ' OG ' ' P' ' 108' ' ' SER . 0.7 OUTLIER -32.16 -40.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 120.779 0.323 . . . . 0.0 110.707 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 81' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' P' ' 84' ' ' GLN . . . -62.16 -55.3 30.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.039 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.3 OUTLIER -43.72 -52.65 6.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.595 177.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.44 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -68.62 -34.4 78.49 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.108 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.442 ' HB2' ' HA ' ' P' ' 81' ' ' ALA . 0.0 OUTLIER -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -64.09 -40.26 95.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.571 ' NH1' HG21 ' P' ' 70' ' ' THR . 9.1 mtt180 -60.26 -39.58 87.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.64 94.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.431 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.29 -34.89 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.51 -61.06 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.429 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.41 HG13 HD22 ' P' ' 49' ' ' LEU . 26.3 t -64.88 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.354 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -47.17 87.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.634 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.56 -23.01 76.79 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.839 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 93' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' P' ' 97' ' ' LYS . 5.2 t80 -64.43 -63.69 1.07 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' P' ' 64' ' ' VAL . 33.5 mt -55.47 -31.68 62.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.12 95.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.82 -24.08 75.64 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.447 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -74.98 -9.49 58.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.068 179.384 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.21 6.04 48.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.868 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' P' ' 56' ' ' LEU . 39.3 t -76.86 130.39 36.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.064 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.47 140.68 58.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.456 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.0 70.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.35 -17.9 57.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.929 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 12.6 mtpp -91.65 -13.38 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.999 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.423 HD21 ' CG1' ' P' ' 99' ' ' VAL . 2.8 mt -101.99 143.83 31.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.355 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.577 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.23 147.07 17.77 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.812 ' O ' HG13 ' P' ' 107' ' ' VAL . 17.4 p -127.93 154.71 45.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.728 0.299 . . . . 0.0 110.663 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.812 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -176.02 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.769 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.445 ' OG ' HG23 ' P' ' 80' ' ' ILE . 52.5 p -112.79 137.46 51.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.771 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.531 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.7 m-85 -113.22 26.85 10.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.707 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 5.8 -111.37 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.224 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.479 ' HG3' ' HG3' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -101.38 14.89 30.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -62.52 -55.16 30.09 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.24 88.83 5.69 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 114' ' ' PRO . . . . . 0.433 ' HG2' ' HG2' ' P' ' 72' ' ' GLU . 21.6 Cg_exo -65.95 169.89 12.56 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.026 2.484 . . . . 0.0 112.928 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.84 -61.69 1.33 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.224 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.44 114.17 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.601 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.04 138.7 57.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.8 178.19 18.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.053 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.512 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 0.5 OUTLIER -142.04 67.53 1.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.639 0.219 . . . . 0.0 111.305 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.09 153.13 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -38.98 -32.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.14 -52.65 13.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.874 0.368 . . . . 0.0 111.291 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.53 67.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.512 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 2.1 m-30 -63.91 -40.5 96.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 91.5 p -65.85 -35.75 81.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.026 0.441 . . . . 0.0 109.888 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -69.59 -25.3 63.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.743 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.63 -30.68 19.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 7.4 mtp180 -66.18 82.41 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -159.23 162.42 36.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -128.42 102.45 6.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.508 HG22 HG23 ' P' ' 31' ' ' THR . 14.1 t -91.21 117.52 34.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.1 OUTLIER -71.48 104.92 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.081 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -115.21 145.19 42.66 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.543 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' P' P ' 134' ' ' TYR . . . . . 0.772 ' HE1' ' HH ' ' P' ' 55' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.922 0.391 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' P' ' 20' ' ' TYR . 57.1 m-85 -91.06 108.71 20.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.32 9.38 42.46 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.818 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.51 2.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.02 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.551 ' HD2' HD21 ' P' ' 25' ' ' LEU . 0.5 OUTLIER -120.62 164.89 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.021 0.439 . . . . 0.0 111.58 -179.272 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.3 t -98.27 152.32 19.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 15.7 t -39.9 -49.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.72 -15.98 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' P' ' 29' ' ' TYR . 0.2 OUTLIER -99.6 -47.58 5.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.233 0.539 . . . . 0.0 110.233 178.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' P' ' 20' ' ' TYR . 42.0 mt -54.62 -22.64 14.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.783 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -12.93 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -111.9 -29.69 7.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -129.79 -38.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.415 ' HB2' ' OD1' ' P' ' 24' ' ' ASP . 27.7 m-85 -109.91 104.78 13.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.614 0.721 . . . . 0.0 112.366 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 179.44 22.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.464 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 91.7 m -126.88 128.79 47.05 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.065 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.738 HG11 HG23 ' P' ' 41' ' ' ILE . 16.7 t -108.95 150.29 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.309 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -122.46 116.19 23.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.0 m-85 -95.66 168.63 10.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.67 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.77 -166.84 29.49 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.185 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -58.68 114.89 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 50.12 30.46 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.6 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.416 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -95.97 142.84 27.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.984 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -130.0 55.77 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.09 150.39 31.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.562 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.738 HG23 HG11 ' P' ' 32' ' ' VAL . 1.5 mp -97.38 161.93 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 110.836 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.466 ' N ' HG22 ' P' ' 41' ' ' ILE . 42.6 p -112.59 147.11 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.394 . . . . 0.0 111.251 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.63 -31.13 2.43 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.0 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.76 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 111.259 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.439 ' CB ' HG13 ' P' ' 32' ' ' VAL . 94.5 m-85 -105.26 3.75 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.946 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.66 -38.4 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -52.27 -32.81 39.04 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.615 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 0.962 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -63.51 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.158 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -59.33 -34.13 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.194 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.68 -39.16 52.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.924 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.45 -46.45 39.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 0.962 ' CD2' HG22 ' P' ' 48' ' ' ILE . 19.5 m-70 -62.28 -38.23 88.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.04 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.007 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.88 95.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.063 0.459 . . . . 0.0 110.203 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -75.38 -35.82 61.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.903 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.852 HD23 HG11 ' P' ' 99' ' ' VAL . 0.8 OUTLIER -63.56 -43.22 97.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.036 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -69.97 -41.22 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.264 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.38 -26.56 61.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -111.73 110.49 54.84 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.447 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.55 -51.03 11.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.795 2.33 . . . . 0.0 114.0 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 18.32 6.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.2 112.79 23.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.451 . . . . 0.0 110.658 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 7.5 mttt -115.96 130.11 56.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.722 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.9 p -99.04 146.59 8.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.569 0.7 . . . . 0.0 111.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.724 HD21 ' CG2' ' P' ' 107' ' ' VAL . 2.8 tt -117.63 105.26 11.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.486 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.4 OUTLIER -82.38 103.46 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.153 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.44 119.38 31.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.787 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.64 143.28 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.098 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.535 ' O ' HG23 ' P' ' 70' ' ' THR . 1.5 m-80 -138.96 157.52 45.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.535 HG23 ' O ' ' P' ' 69' ' ' ASN . 68.1 p -164.73 -165.29 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.474 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' P' ' 124' ' ' TYR . 24.0 p30 -90.89 158.8 16.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.517 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 2.3 pm0 -60.85 -33.55 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.845 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.408 ' HG2' ' OH ' ' P' ' 124' ' ' TYR . 5.3 mmm180 -45.32 111.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.15 -174.84 15.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.052 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.82 145.09 31.28 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 111.639 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.466 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 85.1 Cg_exo -38.57 -46.92 2.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.117 2.545 . . . . 0.0 113.723 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.37 -44.47 92.72 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.743 0.306 . . . . 0.0 111.024 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -70.1 -44.83 68.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' P' ' 80' ' ' ILE . 7.1 m120 -70.94 -76.02 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.6 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.67 -43.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.39 -55.88 11.96 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.65 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 1.011 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -49.43 -50.36 41.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 178.139 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 1.011 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -63.07 -42.59 99.54 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.9 tp60 -47.84 -40.44 21.34 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.204 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.3 ptm180 -67.6 -37.71 82.95 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.578 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 15.9 mtt180 -62.72 -47.67 82.58 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.616 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.45 -33.24 69.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.829 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -32.66 73.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.497 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -59.62 -56.51 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.511 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.413 ' HB ' HG11 ' P' ' 66' ' ' VAL . 21.4 t -66.08 -34.61 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.248 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -44.81 96.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.763 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.46 -23.66 77.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.5 -60.81 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 91.0 mt -55.91 -31.93 63.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.25 -39.08 82.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.032 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.04 95.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.04 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -34.66 74.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.02 26.59 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.095 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.852 HG11 HD23 ' P' ' 56' ' ' LEU . 49.6 t -90.53 143.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.179 0.191 . . . . 0.0 110.572 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.8 162.6 10.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 111.455 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -91.13 -31.5 16.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.548 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.93 -23.82 47.39 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.829 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.558 ' HG3' HD21 ' P' ' 56' ' ' LEU . 0.0 OUTLIER -100.63 -4.32 28.66 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.114 0.483 . . . . 0.0 111.059 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' P' ' 101' ' ' ALA . 47.0 mt -96.92 147.26 24.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.486 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -150.87 144.13 11.43 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.812 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.616 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 39.8 p -124.21 157.46 34.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.727 0.298 . . . . 0.0 110.533 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.724 ' CG2' HD21 ' P' ' 65' ' ' LEU . 92.7 t -161.14 162.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.6 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 2.3 t -155.74 123.25 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.493 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' P' ' 110' ' ' GLY . 92.6 m-85 -116.75 17.76 15.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -3.68 -113.54 0.0 OUTLIER Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -78.77 -2.33 38.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.02 -63.39 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.679 0.275 . . . . 0.0 110.753 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 89.49 20.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.7 163.44 13.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.706 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.37 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.655 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.78 113.95 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.78 136.53 52.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.28 175.67 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.721 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.455 ' HB3' ' CE2' ' P' ' 124' ' ' TYR . 11.0 m-70 -141.56 100.31 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.873 0.336 . . . . 0.0 111.629 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -170.83 161.56 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -47.33 -24.59 0.8 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.36 -60.73 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.934 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.05 77.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.817 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' P' ' 119' ' ' HIS . 13.2 m-85 -59.01 -50.38 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.239 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 8.4 t -62.38 -32.57 73.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -73.56 -24.36 60.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -88.94 -31.48 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.25 88.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.3 OUTLIER -158.78 157.88 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.86 100.68 7.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -84.32 113.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -62.63 102.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.662 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -106.91 132.95 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.086 179.694 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' P' ' 20' ' ' TYR . 81.9 m-85 -89.86 106.39 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.45 9.05 22.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.523 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.21 -40.71 1.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.518 ' OH ' ' HG2' ' P' ' 47' ' ' GLN . 0.1 OUTLIER -128.89 -179.7 5.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.262 0.553 . . . . 0.0 111.899 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -118.28 175.81 5.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 t -42.94 -53.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.07 -21.12 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.77 -43.95 6.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.961 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' P' ' 51' ' ' ALA . 30.0 mt -56.85 -21.77 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.657 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 26' ' ' GLN . . . . . 0.476 ' HA ' HD21 ' P' ' 30' ' ' ASN . 45.2 mt-30 -106.63 -11.3 15.89 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.31 -25.35 4.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -111.14 -64.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -105.2 81.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.476 HD21 ' HA ' ' P' ' 26' ' ' GLN . 3.4 t-20 -139.68 9.61 2.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.989 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.612 HG23 HG22 ' P' ' 131' ' ' VAL . 67.8 m -135.21 138.32 43.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.738 HG11 HG23 ' P' ' 41' ' ' ILE . 10.3 t -109.62 149.89 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.031 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -117.42 116.46 27.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.804 0.811 . . . . 0.0 112.885 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.724 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -92.72 174.81 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.891 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.17 -176.45 14.83 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 36' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 2.7 t80 -61.84 131.8 51.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.703 0.751 . . . . 0.0 110.613 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 37' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 2.7 p30 44.68 29.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.445 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -94.53 119.86 33.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.65 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.766 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.4 OUTLIER -118.73 46.12 1.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.751 0.786 . . . . 0.0 110.053 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.41 150.47 31.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.433 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.741 HD11 HG22 ' P' ' 90' ' ' VAL . 2.6 mt -93.03 165.88 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.348 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.465 ' H ' HG22 ' P' ' 41' ' ' ILE . 0.3 OUTLIER -110.32 141.09 43.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.09 0.472 . . . . 0.0 111.828 -179.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.09 -31.72 4.53 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.055 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -33.01 74.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 111.015 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.5 ' CB ' HG13 ' P' ' 32' ' ' VAL . 74.8 m-85 -100.13 -6.85 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.865 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.3 -42.09 94.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 120.88 0.371 . . . . 0.0 111.44 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.518 ' HG2' ' OH ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -44.91 -42.55 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 0.965 HG22 ' CD2' ' P' ' 52' ' ' HIS . 5.6 mt -50.67 -55.5 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.368 0.604 . . . . 0.0 109.783 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.18 -32.93 25.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.906 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -41.21 67.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.682 0.277 . . . . 0.0 110.834 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 51' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -73.1 -42.68 62.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 0.965 ' CD2' HG22 ' P' ' 48' ' ' ILE . 46.3 m-70 -65.97 -39.31 90.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.921 0.391 . . . . 0.0 110.122 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.97 -50.63 71.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.47 -40.55 78.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -76.09 -38.34 57.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.72 HD13 ' HB ' ' P' ' 64' ' ' VAL . 1.2 tp -70.57 -35.73 73.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -73.67 -33.97 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.031 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.387 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -112.7 114.29 49.75 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.24 -50.17 11.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.611 2.207 . . . . 0.0 113.543 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.88 17.46 4.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.594 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.46 122.76 33.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.972 0.415 . . . . 0.0 110.182 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -124.78 135.71 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.583 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.72 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -100.88 150.05 5.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.489 0.661 . . . . 0.0 111.535 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.523 HD21 HG22 ' P' ' 107' ' ' VAL . 0.8 OUTLIER -121.76 107.81 12.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.763 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.2 OUTLIER -86.55 104.22 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' P' ' 133' ' ' ALA . 55.5 mt-10 -89.75 122.62 33.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.18 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 68' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -116.35 141.32 16.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.497 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.6 OUTLIER -148.32 113.99 5.68 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.972 HG22 ' NH1' ' P' ' 86' ' ' ARG . 45.5 p -99.69 176.28 5.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -58.96 138.62 57.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -50.48 -28.07 7.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.656 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.402 ' HE ' ' HH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -46.21 106.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 0.0 112.774 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.86 -178.94 18.62 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.46 143.89 27.12 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.983 0.391 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.614 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -48.02 -27.94 9.72 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.775 2.317 . . . . 0.0 113.22 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -45.38 92.84 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.299 0.571 . . . . 0.0 110.752 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 78' ' ' TYR . . . . . 0.474 ' CE2' HD23 ' P' ' 82' ' ' LEU . 14.1 t80 -90.12 -17.34 27.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.566 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' P' ' 76' ' ' PRO . 5.1 m-80 -85.6 -21.76 28.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.263 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -83.58 -35.59 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.81 -49.56 61.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.605 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.474 HD23 ' CE2' ' P' ' 78' ' ' TYR . 0.2 OUTLIER -52.32 -45.81 65.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.211 177.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.488 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -74.84 -53.91 6.13 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.282 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -46.0 -36.56 5.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.083 0.468 . . . . 0.0 109.875 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 34.8 mtp85 -67.68 -46.85 71.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.346 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.972 ' NH1' HG22 ' P' ' 70' ' ' THR . 31.1 mtt180 -58.07 -38.98 77.37 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.592 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -66.57 -37.18 84.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.107 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -30.68 71.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.325 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.31 -60.81 2.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.05 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.741 HG22 HD11 ' P' ' 41' ' ' ILE . 20.7 t -62.91 -41.41 92.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.601 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.603 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -58.44 -38.88 78.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.043 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.68 79.03 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.573 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.83 -60.19 2.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.582 ' HB3' HG21 ' P' ' 99' ' ' VAL . 90.3 mt -57.84 -34.13 69.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.053 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.64 81.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.988 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.17 -26.92 74.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.504 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.99 -9.03 59.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 111.366 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.77 -6.75 17.84 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.251 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.582 HG21 ' HB3' ' P' ' 94' ' ' LEU . 80.0 t -67.96 112.97 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.829 0.314 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.99 144.97 56.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.215 0.531 . . . . 0.0 111.401 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.51 -36.77 74.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.738 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.86 -24.95 55.31 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.766 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.12 -3.76 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.309 0.576 . . . . 0.0 110.798 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' P' ' 91' ' ' LYS . 0.7 OUTLIER -94.3 150.48 20.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.097 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.763 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -142.5 141.72 10.98 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.592 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 78.3 p -142.89 145.9 33.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.536 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -160.63 173.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.591 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -162.49 129.07 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.291 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.5 OUTLIER -114.21 27.12 9.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.683 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -4.59 -115.44 0.0 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.6 0.562 . . . . 0.0 114.23 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 3.2 mp0 -83.09 -2.05 54.38 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.761 -0.258 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.64 -63.1 1.31 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.662 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -139.96 89.4 11.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 164.77 11.28 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.652 2.235 . . . . 0.0 112.705 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.39 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.757 HG21 ' HB3' ' P' ' 126' ' ' LYS . 2.8 t -89.22 111.08 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.783 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.48 135.24 47.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.89 172.88 12.9 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.951 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.518 ' CE1' ' HH ' ' P' ' 124' ' ' TYR . 3.9 t60 -138.08 48.76 1.96 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.365 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.02 157.66 42.4 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 121' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 15.3 tp10 -42.99 -37.43 1.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.45 -60.29 3.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.94 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.26 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.518 ' HH ' ' CE1' ' P' ' 119' ' ' HIS . 2.8 m-85 -57.17 -56.21 24.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.381 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 125' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 0.3 OUTLIER -55.91 -35.55 66.7 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.757 ' HB3' HG21 ' P' ' 116' ' ' VAL . 25.5 mtmt -73.29 -22.52 60.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.201 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 69' ' ' ASN . 37.2 m-20 -81.21 -43.74 18.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.97 71.61 0.81 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.515 0.674 . . . . 0.0 110.804 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.13 145.29 51.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.225 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -117.33 93.21 4.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.612 HG22 HG23 ' P' ' 31' ' ' THR . 24.7 t -83.08 115.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.634 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -63.73 100.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.309 178.303 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.539 ' HB2' ' OE1' ' P' ' 67' ' ' GLU . . . -102.77 130.17 49.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 111.557 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.87 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 C--O 1.231 0.101 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -88.82 102.91 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.569 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.26 10.09 56.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.145 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.98 17.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.336 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.644 ' HB2' HD21 ' P' ' 25' ' ' LEU . 1.7 m-85 -107.04 147.13 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -104.14 144.38 31.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -38.31 -56.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.23 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -45.38 5.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 0.0 110.628 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' P' ' 20' ' ' TYR . 34.3 mt -56.54 -20.82 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.956 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.58 -12.3 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -123.38 -25.38 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 28' ' ' ARG . . . . . 0.475 ' HG2' ' CZ ' ' P' ' 29' ' ' TYR . 4.7 tpm_? -110.9 -62.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' P' ' 20' ' ' TYR . 22.2 m-85 -107.19 91.66 3.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 19.2 p-10 -155.07 13.77 0.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.369 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -125.94 130.82 52.03 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.758 HG11 HG23 ' P' ' 41' ' ' ILE . 3.6 t -111.19 148.45 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.5 118.31 26.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' P' ' 86' ' ' ARG . 21.9 m-85 -95.49 168.28 10.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.604 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.64 -166.69 27.37 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.158 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -60.88 122.03 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.23 25.51 1.83 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.749 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.467 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -93.14 138.58 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.469 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.451 ' HA ' ' HB3' ' P' ' 86' ' ' ARG . 44.6 p90 -131.42 49.93 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -147.62 150.74 34.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.917 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.758 HG23 HG11 ' P' ' 32' ' ' VAL . 1.9 mt -95.36 161.8 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.647 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.478 ' N ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -109.96 135.58 50.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 111.327 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.73 -27.38 2.19 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.024 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -32.1 72.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.406 ' O ' HG13 ' P' ' 48' ' ' ILE . 31.1 m-85 -105.54 11.44 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.546 ' HA ' ' HG ' ' P' ' 49' ' ' LEU . 0.9 OUTLIER -72.7 -34.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.264 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.36 -45.58 6.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.95 0.405 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.121 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.11 -50.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 0.0 109.196 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' P' ' 93' ' ' TYR . 6.2 mt -53.4 -62.41 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.726 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.5 -49.67 71.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.47 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.588 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.121 ' CD2' HG22 ' P' ' 48' ' ' ILE . 7.5 m-70 -72.17 -42.87 65.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.75 0.31 . . . . 0.0 110.821 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' P' ' 94' ' ' LEU . . . -65.59 -25.79 67.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.18 -36.93 46.84 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.04 0.448 . . . . 0.0 109.926 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -75.91 -34.68 59.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.642 HD13 ' HB ' ' P' ' 64' ' ' VAL . 0.7 OUTLIER -72.18 -36.06 69.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -32.72 66.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.153 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.09 -19.7 63.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -110.02 111.7 58.21 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 120.615 0.245 . . . . 0.0 110.481 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.89 -63.09 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.884 2.389 . . . . 0.0 114.213 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.17 24.09 1.66 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.622 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.53 122.58 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.145 0.498 . . . . 0.0 110.777 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -126.38 131.29 51.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.84 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.642 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.7 p -96.05 143.74 11.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.62 0.724 . . . . 0.0 111.754 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.823 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.8 tt -116.7 104.49 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.518 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -84.47 113.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.675 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.6 mm-40 -89.53 119.87 30.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.638 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.7 86.96 1.47 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.817 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' P' ' 70' ' ' THR . 7.6 t30 -98.65 158.49 15.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 110.354 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 61.0 p -165.29 -165.55 0.88 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 19.8 p-10 -83.77 154.56 23.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.617 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 3.1 pp20? -64.85 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.624 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.91 110.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 -173.17 14.8 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.36 145.3 29.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.463 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 72.1 Cg_exo -48.16 -44.74 27.74 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.458 2.106 . . . . 0.0 112.465 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -41.1 98.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.24 -42.96 78.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.472 ' HB2' ' HA3' ' P' ' 110' ' ' GLY . 31.4 m120 -69.92 -75.49 0.11 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.385 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -29.63 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.62 11.34 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.796 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 1.03 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -54.22 -43.77 71.11 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.752 178.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 1.03 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -68.11 -41.9 85.71 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.959 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.96 -31.57 65.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' P' ' 88' ' ' ASP . 10.5 tpt85 -65.67 -60.35 2.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.38 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.646 ' HD3' ' HA2' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -56.42 -41.5 76.47 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.242 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.63 65.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 88' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.3 OUTLIER -65.27 -31.63 72.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.09 178.063 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.17 -42.49 98.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.011 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.477 ' O ' ' CD1' ' P' ' 93' ' ' TYR . 32.9 t -70.53 -38.65 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.925 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.595 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -74.22 -27.84 60.98 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.019 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 92' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -74.71 -53.94 6.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.48 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 93' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' P' ' 49' ' ' LEU . 0.7 OUTLIER -57.59 -44.16 85.2 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.543 ' HG ' ' CE1' ' P' ' 93' ' ' TYR . 4.5 mt -58.87 -35.19 72.57 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 95' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -61.45 -43.17 99.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.577 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.81 -13.07 78.71 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.393 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 97' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 15.1 mttm -88.98 -8.44 54.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.667 0.27 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.69 -12.62 11.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.763 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.589 HG13 ' CD2' ' P' ' 56' ' ' LEU . 60.9 t -70.65 114.64 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.593 0.235 . . . . 0.0 110.716 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.8 144.58 52.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.388 0.613 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -51.51 -37.48 49.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.807 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.35 45.12 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.8 mtmt -96.07 -6.08 39.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.161 0.505 . . . . 0.0 110.9 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' P' ' 91' ' ' LYS . 19.8 mt -89.4 149.88 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.916 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.41 135.37 4.69 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.765 ' O ' HG13 ' P' ' 107' ' ' VAL . 70.2 p -133.55 156.24 48.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.813 0.34 . . . . 0.0 110.645 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.823 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.1 OUTLIER -172.85 121.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -111.87 137.85 49.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.751 0.31 . . . . 0.0 110.976 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 90.3 m-85 -116.68 24.51 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -111.82 0.01 OUTLIER Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.569 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.89 14.4 31.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.506 0.193 . . . . 0.0 111.514 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -54.84 41.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.96 89.16 8.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.423 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 114' ' ' PRO . . . . . 0.415 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 35.2 Cg_exo -61.05 166.89 9.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.692 2.262 . . . . 0.0 112.756 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.48 -67.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.911 HG21 ' HD3' ' P' ' 126' ' ' LYS . 38.5 t -89.61 111.8 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.342 0.592 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.73 138.54 58.44 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.923 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.76 174.15 14.11 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.8 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.449 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 14.2 p-80 -140.39 58.77 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -127.04 157.85 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 121' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' P' ' 125' ' ' SER . 0.2 OUTLIER -43.39 -27.55 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.615 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 122' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' P' ' 126' ' ' LYS . . . -64.76 -59.38 4.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 123' ' ' ALA . . . . . 0.617 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -66.36 -42.44 88.02 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 11.9 m-30 -65.37 -44.28 88.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 125' ' ' SER . . . . . 0.435 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 51.8 p -73.28 -38.92 65.75 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.623 0.249 . . . . 0.0 111.416 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.911 ' HD3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -82.05 -16.77 49.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.038 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' P' ' 123' ' ' ALA . 39.1 m-20 -85.33 -29.55 24.41 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.435 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.1 mtp180 -70.32 94.97 0.98 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.521 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.7 OUTLIER -158.85 156.02 28.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.11 99.78 7.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 15.1 t -83.08 110.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.518 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -61.31 98.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.19 178.317 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -101.21 126.67 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.623 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' P' P ' 134' ' ' TYR . . . . . 0.429 ' HH ' ' HD1' ' P' ' 52' ' ' HIS . 20.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.982 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' P' ' 55' ' ' TYR . 4.5 m-85 -92.27 106.86 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 8.99 32.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.388 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.98 -38.57 1.69 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.887 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' P' ' 17' ' ' PHE . 0.5 OUTLIER -124.15 171.76 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.359 . . . . 0.0 111.341 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.75 150.77 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.436 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.709 ' HA ' HD12 ' P' ' 25' ' ' LEU . 18.8 t -43.26 -43.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.15 -15.76 48.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.43 -40.05 8.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.559 0.695 . . . . 0.0 109.887 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.709 HD12 ' HA ' ' P' ' 22' ' ' VAL . 5.0 mt -61.96 -21.13 64.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 26' ' ' GLN . . . . . 0.621 ' OE1' HG12 ' P' ' 22' ' ' VAL . 55.3 mt-30 -98.32 -14.85 20.01 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.4 -18.32 3.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 -66.74 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -105.9 83.67 1.95 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.282 0.563 . . . . 0.0 111.836 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' P' ' 26' ' ' GLN . 1.7 t-20 -138.52 12.77 2.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.555 ' OG1' HG13 ' P' ' 131' ' ' VAL . 79.8 m -134.98 137.91 43.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 3.3 t -112.55 147.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.248 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -117.44 123.15 45.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.476 0.655 . . . . 0.0 112.573 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.454 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 75.3 m-85 -108.97 172.6 6.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.876 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.37 -169.27 16.4 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.488 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 36' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' P' ' 37' ' ' ASP . 2.0 t80 -60.17 125.9 25.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 110.748 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 37' ' ' ASP . . . . . 0.448 ' HB2' ' CE1' ' P' ' 36' ' ' PHE . 2.3 t0 44.59 29.43 0.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.86 126.65 41.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.738 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 11.2 t80 -125.9 57.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.731 0.777 . . . . 0.0 110.191 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -151.09 150.71 31.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.715 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.679 HD13 HD21 ' P' ' 49' ' ' LEU . 10.6 mt -98.64 162.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.604 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.517 ' N ' HG22 ' P' ' 41' ' ' ILE . 7.5 p -112.76 144.89 41.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.118 0.485 . . . . 0.0 111.574 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.63 -31.94 3.96 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.313 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -63.82 -33.89 76.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.432 ' CB ' HG13 ' P' ' 32' ' ' VAL . 78.0 m-85 -99.11 -2.52 36.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.441 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 77.0 t -63.07 -43.69 99.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.474 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 0.0 OUTLIER -39.63 -45.64 1.68 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.638 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.004 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.58 -53.26 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.679 HD21 HD13 ' P' ' 41' ' ' ILE . 3.5 mp -47.14 -46.49 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.549 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 50' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 2.6 p30 -73.46 -33.22 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.657 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 51' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.32 -51.48 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.004 ' CD2' HG22 ' P' ' 48' ' ' ILE . 12.0 m-70 -57.57 -37.79 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 109.936 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 53' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' P' ' 94' ' ' LEU . . . -61.66 -45.3 94.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.24 84.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.523 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 55' ' ' TYR . . . . . 0.467 ' HA ' ' CE2' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -70.1 -43.01 71.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.604 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.684 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -69.57 -36.75 76.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.03 -178.668 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.83 -36.33 78.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.13 66.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.604 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -113.85 112.87 47.51 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 -44.0 45.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.653 2.235 . . . . 0.0 113.575 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 17.51 11.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.591 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.42 123.74 34.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.271 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 30.9 mttt -123.12 132.72 54.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.683 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.2 p -96.42 143.54 12.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.417 0.627 . . . . 0.0 110.983 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.64 HD21 HG22 ' P' ' 107' ' ' VAL . 0.5 OUTLIER -113.39 108.65 17.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.796 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.684 HG13 HD22 ' P' ' 132' ' ' LEU . 0.2 OUTLIER -88.39 109.67 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.7 mt-10 -99.39 120.24 39.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.392 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 146.34 18.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.354 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.722 ' O ' HG23 ' P' ' 70' ' ' THR . 52.9 m-80 -139.54 167.52 21.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.722 HG23 ' O ' ' P' ' 69' ' ' ASN . 2.4 p -168.98 174.8 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.983 0.42 . . . . 0.0 111.448 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.508 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 15.4 p-10 -60.01 151.8 25.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.617 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.53 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 1.4 pp20? -66.26 -31.83 72.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 111.666 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 113.61 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.67 -169.41 12.91 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.266 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 75' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' P' ' 77' ' ' GLU . 0.6 OUTLIER -107.82 146.72 34.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 111.48 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.657 ' HB3' HD13 ' P' ' 80' ' ' ILE . 41.0 Cg_exo -54.96 -35.98 91.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.793 2.329 . . . . 0.0 113.929 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 77' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' P' ' 77' ' ' GLU . 0.0 OUTLIER -44.12 -55.35 4.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 78' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 0.1 OUTLIER -93.69 -13.93 26.94 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.602 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.748 ' HA ' HD12 ' P' ' 82' ' ' LEU . 0.3 OUTLIER -84.17 -25.76 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.539 179.746 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.657 HD13 ' HB3' ' P' ' 76' ' ' PRO . 0.5 OUTLIER -90.89 -36.42 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.43 -49.93 61.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.434 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 1.05 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -68.9 -34.35 75.27 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.976 178.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 1.05 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.55 -56.72 8.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.796 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 45.6 tt0 -50.46 -33.53 21.46 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -49.31 78.2 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.532 ' HD2' HD22 ' P' ' 82' ' ' LEU . 0.1 OUTLIER -55.43 -38.19 68.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' P' ' 84' ' ' GLN . . . -63.0 -35.31 79.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.241 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -31.32 69.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.341 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' P' ' 39' ' ' TYR . . . -61.1 -46.84 88.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.968 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.33 -31.39 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.429 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.587 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -62.73 -44.03 97.26 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 92' ' ' GLY . . . . . 0.49 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -74.32 -26.86 67.09 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -59.52 -57.1 14.44 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' P' ' 53' ' ' ALA . 47.2 mt -61.04 -32.28 71.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.332 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 95' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -61.83 -42.53 99.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.561 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.96 -19.97 78.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.014 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -10.79 59.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.663 0.268 . . . . 0.0 111.269 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -7.52 16.96 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.065 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.684 HG11 ' CD2' ' P' ' 56' ' ' LEU . 31.8 t -78.8 127.41 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.732 0.301 . . . . 0.0 110.99 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 100' ' ' ASP . . . . . 0.425 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -58.58 163.53 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.548 . . . . 0.0 111.322 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.957 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -80.87 -31.65 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.198 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.18 -24.14 35.19 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.782 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -95.5 -4.55 44.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 111.224 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.957 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.2 mt -95.1 139.55 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.129 -0.228 . . . . 0.0 110.403 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.576 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -143.45 141.77 10.72 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.805 ' O ' HG13 ' P' ' 107' ' ' VAL . 68.4 p -133.21 153.22 51.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.929 0.395 . . . . 0.0 111.106 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.805 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -176.15 119.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.457 ' O ' HG12 ' P' ' 80' ' ' ILE . 90.3 p -117.51 140.11 50.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.416 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' P' ' 110' ' ' GLY . 33.1 m-85 -121.08 28.07 8.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.581 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -23.22 -71.07 0.01 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.874 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.53 ' OE1' ' HA ' ' P' ' 72' ' ' GLU . 4.4 mm-40 -106.78 -2.1 21.86 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.01 -57.01 6.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 118.474 0.579 . . . . 0.0 110.422 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -134.71 90.04 24.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -57.94 163.05 10.06 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.521 2.147 . . . . 0.0 112.564 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.45 -68.63 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.11 119.83 36.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.1 136.82 44.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.57 175.21 14.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.791 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 119' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' P' ' 119' ' ' HIS . 0.1 OUTLIER -140.53 97.52 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.825 0.312 . . . . 0.0 111.587 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -175.9 165.83 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -48.46 -26.29 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.05 -63.49 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.01 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.621 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 7.0 m-30 -56.97 -46.53 82.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.624 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -68.55 -36.85 79.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.329 . . . . 0.0 111.29 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -68.22 -26.93 65.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.292 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' P' ' 70' ' ' THR . 84.1 m-20 -87.19 -28.84 22.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.481 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 6.5 mtp180 -69.35 81.05 0.37 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.89 152.39 21.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.122 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.51 105.11 10.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.555 HG13 ' OG1' ' P' ' 31' ' ' THR . 16.0 t -86.73 113.41 24.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.684 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -61.05 99.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.194 178.178 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' P' P ' 133' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -99.55 124.39 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.635 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' P' P ' 134' ' ' TYR . . . . . 0.463 ' HE1' HD12 ' P' ' 56' ' ' LEU . 22.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.917 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.031 0.443 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' P' ' 20' ' ' TYR . 70.6 m-85 -90.55 107.08 18.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.611 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.81 9.87 35.5 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.297 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 134.21 -35.75 2.19 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.793 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.595 ' HB2' HD21 ' P' ' 25' ' ' LEU . 22.2 m-85 -117.81 161.9 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.715 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.15 153.65 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.425 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.414 HG23 ' H ' ' P' ' 22' ' ' VAL . 17.3 t -39.26 -51.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.43 16.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.38 -40.35 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.421 0.629 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' P' ' 20' ' ' TYR . 20.1 mt -69.32 -20.82 63.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.206 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -88.7 -20.89 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -142.71 -6.59 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -69.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -108.98 85.69 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.201 0.524 . . . . 0.0 112.244 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.2 19.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.329 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 98.4 m -126.42 129.35 48.56 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.754 HG11 HG23 ' P' ' 41' ' ' ILE . 3.2 t -107.86 150.38 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.978 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -121.39 116.16 24.25 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' HG2' ' P' ' 86' ' ' ARG . 21.7 m-85 -98.09 167.11 11.09 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.68 -167.38 17.23 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -66.18 123.34 19.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.079 0.439 . . . . 0.0 110.835 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.67 15.34 7.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.728 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.463 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 2.2 mptt -91.17 125.64 36.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.504 ' HB3' ' NH1' ' P' ' 86' ' ' ARG . 52.1 p90 -128.04 37.46 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.796 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.05 149.74 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.754 HG23 HG11 ' P' ' 32' ' ' VAL . 1.2 mp -87.57 164.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.283 . . . . 0.0 110.975 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 42' ' ' THR . . . . . 0.444 ' N ' HG22 ' P' ' 41' ' ' ILE . 49.3 p -112.35 150.63 30.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.405 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -42.45 -32.95 1.32 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.14 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.05 -33.37 75.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.727 0.299 . . . . 0.0 111.416 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 45' ' ' TYR . . . . . 0.403 ' CB ' HG13 ' P' ' 32' ' ' VAL . 87.7 m-85 -102.82 3.6 36.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 74.2 t -69.16 -40.49 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.41 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.07 -44.35 7.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 1.035 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.6 OUTLIER -56.47 -51.1 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.818 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.581 HD23 ' CD2' ' P' ' 93' ' ' TYR . 2.1 mp -53.36 -34.5 57.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.595 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -39.04 53.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.867 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.79 26.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 1.035 ' CD2' HG22 ' P' ' 48' ' ' ILE . 54.6 m-70 -59.92 -35.95 75.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.987 0.422 . . . . 0.0 110.139 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.45 98.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.302 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.79 91.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.978 0.418 . . . . 0.0 110.723 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.38 -38.79 63.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.97 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 1.043 HD23 HG11 ' P' ' 99' ' ' VAL . 2.9 tp -62.2 -41.68 98.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.139 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.16 -40.92 71.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.73 -27.92 31.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.683 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.4 OUTLIER -109.6 115.1 56.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.566 0.222 . . . . 0.0 110.488 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.8 -59.03 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 113.858 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.72 22.91 2.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.633 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.76 123.38 34.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 110.707 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -128.07 134.16 49.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -97.0 146.13 7.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.502 0.668 . . . . 0.0 111.758 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.8 HD21 ' CG2' ' P' ' 107' ' ' VAL . 5.1 tt -117.41 105.37 12.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.452 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -83.14 108.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.636 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.3 tt0 -99.2 117.61 34.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 68' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -107.51 149.67 16.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.968 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.8 OUTLIER -152.96 108.57 3.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.811 0.339 . . . . 0.0 110.712 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -100.65 -171.67 2.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 21.2 p-10 -64.27 144.85 56.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.396 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -64.08 -27.09 68.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.542 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 73' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.9 OUTLIER -39.55 110.91 0.16 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.326 0.584 . . . . 0.0 112.037 -178.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.01 -150.91 18.65 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.902 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.05 148.46 51.71 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 122.0 0.12 . . . . 0.0 110.822 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 1.3 Cg_endo -41.85 -38.91 4.98 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.616 2.211 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 77' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' P' ' 81' ' ' ALA . 0.5 OUTLIER -61.9 -40.84 96.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.88 -47.53 45.18 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.681 178.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' P' ' 82' ' ' LEU . 11.1 m120 -64.62 -76.27 0.07 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.711 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -35.42 -38.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 81' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' P' ' 77' ' ' GLU . . . -66.37 -64.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.043 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.931 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -63.48 -33.63 75.99 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.285 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 83' ' ' GLY . . . . . 0.931 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.89 -52.47 28.58 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 1.2 tp-100 -50.79 -34.73 28.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -59.93 -43.02 95.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.617 ' CZ ' ' CD2' ' P' ' 82' ' ' LEU . 6.8 mtt85 -56.37 -43.41 79.16 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.05 -32.58 68.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.4 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.419 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.27 -56.67 18.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.642 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.34 -34.42 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.4 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.44 ' HD3' HD13 ' P' ' 104' ' ' LEU . 3.1 tmtt? -59.45 -51.81 68.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.39 -26.09 74.44 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.115 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 93' ' ' TYR . . . . . 0.581 ' CD2' HD23 ' P' ' 49' ' ' LEU . 5.8 t80 -59.96 -61.27 2.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.489 ' HB2' HD21 ' P' ' 104' ' ' LEU . 23.1 mt -59.83 -29.8 68.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.88 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.11 98.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.33 -21.08 78.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.626 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -11.29 59.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 111.179 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.28 -3.63 22.08 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.308 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 1.043 HG11 HD23 ' P' ' 56' ' ' LEU . 21.5 t -81.98 131.65 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.831 0.315 . . . . 0.0 111.423 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' CG ' ' P' ' 103' ' ' LYS . 31.3 p30 -58.95 166.37 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.208 0.527 . . . . 0.0 111.306 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 101' ' ' ALA . . . . . 0.803 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -77.87 -31.83 51.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.7 -21.36 62.85 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.297 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 23.4 mtpp -90.45 -12.65 36.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.064 0.459 . . . . 0.0 111.067 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.803 HD12 ' HA ' ' P' ' 101' ' ' ALA . 6.3 mt -92.23 149.76 21.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.93 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.444 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -145.78 137.01 6.7 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.573 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 18.7 p -117.63 156.24 28.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.065 0.46 . . . . 0.0 111.275 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.8 ' CG2' HD21 ' P' ' 65' ' ' LEU . 97.2 t -160.49 157.75 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.608 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.711 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 3.3 t -161.09 128.18 4.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.993 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.31 -68.46 0.79 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.349 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.7 -121.51 6.37 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.615 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 1.2 mm-40 -75.62 -19.89 58.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.859 0.33 . . . . 0.0 111.091 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.47 -74.09 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -142.09 102.45 5.71 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.323 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.34 167.49 20.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.745 2.297 . . . . 0.0 112.248 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 115' ' ' ALA . . . . . 0.779 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -88.55 -77.66 0.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.66 ' HB ' ' NZ ' ' P' ' 126' ' ' LYS . 2.0 t -96.94 130.6 45.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.461 0.648 . . . . 0.0 111.137 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 141.13 52.34 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.745 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.73 172.09 12.99 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.764 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -141.09 91.64 2.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.793 0.296 . . . . 0.0 111.411 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 120' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' P' ' 124' ' ' TYR . 37.5 t70 -178.86 167.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 121' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' P' ' 125' ' ' SER . 1.1 mm-40 -44.45 -26.83 0.38 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -66.54 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.672 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 123' ' ' ALA . . . . . 0.646 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -70.4 -35.67 73.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.7 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' P' ' 120' ' ' ASP . 2.2 m-85 -65.85 -46.43 78.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 125' ' ' SER . . . . . 0.424 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 6.9 t -71.56 -37.06 71.11 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.66 ' NZ ' ' HB ' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -79.77 -16.16 56.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.993 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.779 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 7.9 m-20 -86.53 -31.51 21.23 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 120.581 0.229 . . . . 0.0 110.495 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.424 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.7 mtp180 -70.3 83.62 0.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.25 153.33 34.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -119.66 99.18 6.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.67 112.73 21.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.452 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -61.55 101.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.669 178.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.72 122.1 39.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.733 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.947 179.596 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.791 0.329 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' P' P ' 17' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' P' ' 20' ' ' TYR . 61.1 m-85 -88.83 105.87 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.992 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.82 10.33 38.02 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.129 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.96 -30.61 3.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.384 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' CE2' ' P' ' 29' ' ' TYR . 20.3 m-85 -114.22 158.75 20.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 150.98 23.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.014 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 22' ' ' VAL . . . . . 0.42 HG23 ' H ' ' P' ' 22' ' ' VAL . 16.5 t -39.5 -48.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.59 -17.89 57.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.42 -43.93 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.456 0.646 . . . . 0.0 110.441 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 25' ' ' LEU . . . . . 0.481 ' O ' ' ND2' ' P' ' 30' ' ' ASN . 17.5 mt -58.35 -21.38 49.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.152 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 26' ' ' GLN . . . . . 0.605 ' HA ' ' ND2' ' P' ' 30' ' ' ASN . 4.3 mt-30 -101.92 -12.4 18.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.93 -21.52 4.34 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -112.64 -60.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 29' ' ' TYR . . . . . 0.452 ' CE2' ' CE1' ' P' ' 20' ' ' TYR . 28.3 m-85 -102.29 85.9 2.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.933 0.397 . . . . 0.0 111.735 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 30' ' ' ASN . . . . . 0.605 ' ND2' ' HA ' ' P' ' 26' ' ' GLN . 1.2 t-20 -144.6 6.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 31' ' ' THR . . . . . 0.422 ' OG1' HG13 ' P' ' 131' ' ' VAL . 51.9 m -136.86 138.8 41.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 32' ' ' VAL . . . . . 0.694 HG11 HG23 ' P' ' 41' ' ' ILE . 12.0 t -111.82 150.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.507 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -120.37 119.11 32.13 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 34' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 16.3 m-85 -95.69 170.24 9.46 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.52 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 -179.65 23.01 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.634 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 36' ' ' PHE . . . . . 0.415 ' CE2' ' CE2' ' P' ' 124' ' ' TYR . 0.6 OUTLIER -64.22 117.3 6.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 111.049 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.51 24.77 7.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 38' ' ' LYS . . . . . 0.515 ' HD3' ' HB2' ' P' ' 40' ' ' ASP . 0.0 OUTLIER -111.06 127.33 55.51 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.903 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 39' ' ' TYR . . . . . 0.684 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -117.65 77.5 1.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.599 0.714 . . . . 0.0 111.058 -178.457 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 40' ' ' ASP . . . . . 0.515 ' HB2' ' HD3' ' P' ' 38' ' ' LYS . 0.2 OUTLIER -153.28 150.36 28.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.223 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 41' ' ' ILE . . . . . 0.694 HG23 HG11 ' P' ' 32' ' ' VAL . 7.5 mt -99.0 155.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -108.48 143.73 37.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.481 . . . . 0.0 112.056 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.59 -29.26 5.57 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.121 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -66.16 -28.98 69.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.27 -1.06 29.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 94.8 t -65.26 -41.42 91.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 47' ' ' GLN . . . . . 0.434 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 0.0 OUTLIER -49.24 -29.49 5.82 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.588 -178.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 48' ' ' ILE . . . . . 0.939 HG22 ' CD2' ' P' ' 52' ' ' HIS . 2.9 mt -64.71 -52.85 49.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.391 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 49' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' P' ' 93' ' ' TYR . 2.7 mp -51.9 -47.83 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.3 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 50' ' ' ASP . . . . . 0.434 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -70.07 -35.75 74.45 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.609 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 51' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -73.43 -47.76 39.08 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.171 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 52' ' ' HIS . . . . . 0.939 ' CD2' HG22 ' P' ' 48' ' ' ILE . 8.9 m-70 -61.04 -38.04 84.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.8 92.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.019 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.93 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.935 0.397 . . . . 0.0 110.618 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -71.01 -40.28 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.691 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 56' ' ' LEU . . . . . 0.623 HD13 ' HB ' ' P' ' 64' ' ' VAL . 2.0 tp -62.88 -45.18 93.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.73 -40.49 96.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.336 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.39 9.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.669 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 59' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -115.5 115.74 41.86 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.601 0.239 . . . . 0.0 110.599 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.46 -50.91 11.24 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.694 2.263 . . . . 0.0 113.506 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 61' ' ' ALA . . . . . 0.406 ' O ' ' HD2' ' P' ' 63' ' ' LYS . . . -88.75 19.66 3.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 62' ' ' ALA . . . . . 0.594 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -92.61 134.74 34.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 63' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -138.02 141.49 40.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 64' ' ' VAL . . . . . 0.782 HG11 ' CD1' ' P' ' 94' ' ' LEU . 9.6 p -100.4 150.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.519 0.675 . . . . 0.0 111.795 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 65' ' ' LEU . . . . . 0.705 HD21 ' CG2' ' P' ' 107' ' ' VAL . 3.4 tt -120.69 101.45 7.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.342 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 66' ' ' VAL . . . . . 0.647 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.3 t -83.51 101.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 67' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 29.6 tt0 -90.41 123.47 34.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 68' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -106.71 148.05 16.34 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.521 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 69' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -160.91 106.19 1.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.317 . . . . 0.0 110.508 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 70' ' ' THR . . . . . 0.801 HG21 ' NH1' ' P' ' 86' ' ' ARG . 26.7 p -106.26 -170.85 1.79 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 71' ' ' ASP . . . . . 0.501 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 21.4 p-10 -57.28 138.12 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 72' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -59.83 -22.84 62.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.454 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -38.13 108.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.12 -144.69 18.34 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.635 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.97 146.82 60.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.727 0.264 . . . . 0.0 110.772 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 76' ' ' PRO . . . . . 0.526 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 1.9 Cg_endo -39.99 -44.79 3.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.009 2.473 . . . . 0.0 112.445 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -42.72 99.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -71.46 -40.25 70.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.679 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 79' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -67.15 -75.12 0.1 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.497 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 80' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -29.4 -41.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 123.254 0.346 . . . . 0.0 111.475 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -64.47 -59.74 3.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.597 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 82' ' ' LEU . . . . . 0.804 HD12 ' NH1' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -48.69 -46.71 40.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.256 178.35 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.83 -46.01 85.08 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.52 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 84' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -47.12 -43.14 20.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.388 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 85' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -65.54 -36.0 82.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.777 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 86' ' ' ARG . . . . . 0.804 ' NH1' HD12 ' P' ' 82' ' ' LEU . 17.0 mtt180 -68.5 -48.61 63.95 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.334 0.588 . . . . 0.0 109.445 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 87' ' ' ALA . . . . . 0.713 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -62.4 -40.31 96.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.562 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -56.21 -35.25 67.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.844 178.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 89' ' ' ALA . . . . . 0.51 ' HB2' ' HE1' ' P' ' 39' ' ' TYR . . . -64.33 -64.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 90' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' P' ' 93' ' ' TYR . 20.3 t -55.14 -39.67 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.371 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 91' ' ' LYS . . . . . 0.517 ' HA ' ' CD2' ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.49 -43.1 99.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 110.153 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 92' ' ' GLY . . . . . 0.432 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -71.81 -11.12 73.29 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 93' ' ' TYR . . . . . 0.43 ' CD2' HD23 ' P' ' 49' ' ' LEU . 4.4 t80 -75.95 -62.9 1.44 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 94' ' ' LEU . . . . . 0.782 ' CD1' HG11 ' P' ' 64' ' ' VAL . 72.2 mt -53.51 -31.38 45.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 95' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' P' ' 99' ' ' VAL . . . -63.38 -40.26 96.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.394 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.31 -24.7 75.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.455 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.33 -9.18 59.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 111.248 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.86 14.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.947 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 99' ' ' VAL . . . . . 0.577 ' CG1' HD23 ' P' ' 56' ' ' LEU . 21.8 t -70.57 114.88 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -55.84 141.63 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.89 40.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.246 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.88 64.99 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.689 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 103' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 2.1 mtpp -93.59 -19.13 21.46 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 120.522 0.201 . . . . 0.0 111.399 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 104' ' ' LEU . . . . . 0.73 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -136.27 132.01 35.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.782 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 105' ' ' GLY . . . . . 0.647 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -126.72 -169.07 12.68 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.534 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 106' ' ' THR . . . . . 0.713 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 49.6 p -147.36 168.53 21.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.087 0.47 . . . . 0.0 111.272 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 107' ' ' VAL . . . . . 0.705 ' CG2' HD21 ' P' ' 65' ' ' LEU . 48.7 t -158.32 163.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.509 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 108' ' ' SER . . . . . 0.542 ' N ' HG12 ' P' ' 107' ' ' VAL . 3.2 t -160.28 113.58 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.963 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 109' ' ' TYR . . . . . 0.599 ' CZ ' HG11 ' P' ' 107' ' ' VAL . 60.0 m-85 -108.36 27.33 9.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.194 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -12.08 -109.26 0.0 OUTLIER Glycine 0 CA--C 1.526 0.744 0 O-C-N 123.684 0.615 . . . . 0.0 114.581 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 111' ' ' GLU . . . . . 0.504 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 6.3 mt-10 -63.29 -18.31 63.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 112' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 3.7 tm-20 -48.18 -69.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.527 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -130.25 95.04 28.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.69 0.281 . . . . 0.0 111.034 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.34 155.93 54.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.705 2.27 . . . . 0.0 112.454 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 115' ' ' ALA . . . . . 0.661 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -101.97 -71.47 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 116' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' P' ' 126' ' ' LYS . 3.5 t -88.76 114.29 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.49 136.59 49.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.75 175.4 14.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.118 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -140.16 52.94 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.627 0.251 . . . . 0.0 111.184 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 1.7 p30 -131.31 154.69 48.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -45.42 -26.41 0.55 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 122' ' ' ALA . . . . . 0.504 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -70.25 -58.18 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 110.72 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.59 -40.36 76.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.638 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 124' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -59.7 -49.89 76.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.462 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 125' ' ' SER . . . . . 0.414 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 3.3 t -64.26 -34.89 79.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 126' ' ' LYS . . . . . 0.977 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -68.74 -27.08 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' P' P ' 127' ' ' ASN . . . . . 0.661 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 1.7 m-20 -82.21 -31.82 30.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 128' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 1.8 mpp_? -68.85 85.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.051 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 129' ' ' ARG . . . . . 0.445 ' HG2' ' OD1' ' P' ' 69' ' ' ASN . 3.9 ptt180 -154.65 147.16 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 130' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -113.29 108.53 17.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 131' ' ' VAL . . . . . 0.422 HG13 ' OG1' ' P' ' 31' ' ' THR . 3.6 t -88.27 108.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 132' ' ' LEU . . . . . 0.596 HD22 HG13 ' P' ' 66' ' ' VAL . 1.2 mm? -62.51 101.92 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.571 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.93 135.14 45.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 111.48 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.932 179.818 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 12.1 p 58.7 163.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 12.7 p 58.73 38.41 24.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.92 -28.55 32.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.59 138.83 44.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.61 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -120.41 130.24 54.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.66 -66.33 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 8' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' P' ' 9' ' ' ALA . . . -143.24 17.95 1.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.337 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 9' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' P' ' 8' ' ' ALA . . . 81.94 -17.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.27 -67.74 1.73 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.823 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -178.33 168.69 1.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.268 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.08 -11.78 62.7 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.839 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 13' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' P' ' 14' ' ' ALA . . . -43.57 -24.26 0.1 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' P' ' 13' ' ' ALA . . . -30.53 142.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -67.41 105.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.527 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p -149.76 92.27 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.043 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -89.54 105.87 18.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 111.537 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.33 9.39 30.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.631 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.64 -36.56 2.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.442 -1.361 . . . . 0.0 113.817 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -121.08 169.88 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.74 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.12 155.15 20.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.406 HG23 ' H ' ' P' ' 22' ' ' VAL . 20.7 t -39.25 -53.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.21 -18.24 9.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.36 -43.31 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 110.463 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.523 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 9.4 mt -63.18 -22.13 66.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.236 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -95.78 -14.92 22.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -131.61 -15.13 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -62.74 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 96.6 6.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.475 ' HA ' HG21 ' P' ' 48' ' ' ILE . 1.6 p30 -160.77 18.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.749 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.454 ' OG1' HG13 ' P' ' 131' ' ' VAL . 85.0 m -125.81 130.58 51.71 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.436 HG11 HG23 ' P' ' 41' ' ' ILE . 15.8 t -108.41 148.88 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -114.86 119.1 35.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.416 0.627 . . . . 0.0 112.185 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 73.1 m-85 -103.63 169.22 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.823 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.54 -169.54 19.49 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.881 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' P' ' 36' ' ' PHE . 1.5 t80 -57.01 112.85 1.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 110.809 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.79 38.64 4.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -89.93 138.32 31.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -122.14 49.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.96 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.38 150.37 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.521 HG22 ' N ' ' P' ' 42' ' ' THR . 5.7 mt -98.01 163.18 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.521 ' N ' HG22 ' P' ' 41' ' ' ILE . 11.1 p -110.65 143.41 41.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.091 0.472 . . . . 0.0 111.839 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.451 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.87 -32.21 8.46 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.225 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -33.97 74.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' P' ' 32' ' ' VAL . 77.2 m-85 -100.42 -0.24 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 48.1 t -65.22 -43.04 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.548 0.214 . . . . 0.0 111.444 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.458 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 1.0 OUTLIER -42.22 -43.45 3.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.002 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.7 -49.73 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.98 -45.76 61.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.474 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 50' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 3.9 p30 -73.9 -32.21 63.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.59 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 51' ' ' ALA . . . . . 0.437 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.41 -49.48 22.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.002 ' CD2' HG22 ' P' ' 48' ' ' ILE . 20.0 m-70 -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.532 . . . . 0.0 109.643 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 53' ' ' ALA . . . . . 0.411 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -61.18 -44.42 97.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.58 98.48 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 0.0 110.587 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.75 -40.1 63.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.9 HD23 HG11 ' P' ' 99' ' ' VAL . 5.5 tp -63.95 -42.82 97.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.417 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.14 -39.84 78.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.68 -25.89 55.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.543 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.4 OUTLIER -112.47 113.6 50.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 110.419 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.5 -46.81 27.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.627 2.218 . . . . 0.0 113.535 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.46 16.82 9.52 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.73 118.69 30.35 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -120.15 134.4 55.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.213 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' P' ' 56' ' ' LEU . 4.5 p -97.43 134.39 35.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.404 0.621 . . . . 0.0 111.496 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.481 HD21 HG22 ' P' ' 107' ' ' VAL . 1.1 tt -109.56 103.32 12.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.648 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.5 OUTLIER -79.8 120.08 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.5 mt-10 -103.69 117.63 34.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.609 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 68' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -103.29 140.91 15.07 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.582 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.581 ' O ' ' O ' ' P' ' 127' ' ' ASN . 77.4 m-20 -157.24 104.81 2.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.293 . . . . 0.0 110.824 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.566 HG22 ' NH1' ' P' ' 86' ' ' ARG . 72.1 p -101.9 -172.05 2.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -62.62 143.81 56.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.191 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 1.2 pp20? -63.43 -29.36 70.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.881 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' U' ' 7' ' ' DAL . 0.0 OUTLIER -41.64 119.59 1.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 74' ' ' GLY . . . . . 0.577 ' O ' HG23 ' P' ' 75' ' ' THR . . . 115.09 -113.46 2.95 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.96 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 75' ' ' THR . . . . . 0.577 HG23 ' O ' ' P' ' 74' ' ' GLY . 0.6 OUTLIER -167.21 147.56 4.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.157 0.479 . . . . 0.0 111.036 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 82.2 Cg_exo -41.68 -45.94 6.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.522 2.148 . . . . 0.0 112.919 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.12 -42.45 94.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.762 0.315 . . . . 0.0 110.761 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 1.6 t80 -71.27 -46.39 60.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' P' ' 80' ' ' ILE . 12.5 m120 -67.66 -75.45 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.695 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -29.7 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 O-C-N 123.141 0.276 . . . . 0.0 111.515 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.24 -59.75 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.436 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' P' ' 86' ' ' ARG . 0.3 OUTLIER -49.76 -44.6 48.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.922 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -71.54 -55.28 7.69 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.125 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.52 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 1.0 OUTLIER -45.51 -36.44 4.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 110.533 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.557 ' HB3' ' CE2' ' P' ' 39' ' ' TYR . 5.2 mtp180 -69.64 -51.84 31.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.566 ' NH1' HG22 ' P' ' 70' ' ' THR . 0.2 OUTLIER -52.82 -39.8 62.77 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.58 77.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.261 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -29.13 69.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.334 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.35 -52.0 56.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.417 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -70.75 -39.08 75.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.231 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.494 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -60.78 -42.28 97.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.859 0.362 . . . . 0.0 110.204 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.94 -24.96 75.84 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -61.24 -61.18 2.74 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' P' ' 104' ' ' LEU . 39.9 mt -58.27 -30.83 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.445 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.23 96.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.48 -25.05 75.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.794 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.411 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 2.9 mtpm? -76.84 -9.43 58.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 0.0 111.207 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.67 -1.98 23.25 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.193 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.9 HG11 HD23 ' P' ' 56' ' ' LEU . 25.0 t -75.58 127.26 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.418 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.9 146.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.253 0.549 . . . . 0.0 111.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.89 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -64.1 -36.15 83.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.569 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.46 -21.9 50.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.666 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.6 mtpp -94.21 -5.84 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.85 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' P' ' 101' ' ' ALA . 5.3 mt -96.73 149.08 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.648 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -149.57 140.99 8.47 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.505 ' O ' HG13 ' P' ' 107' ' ' VAL . 35.1 p -136.21 153.41 51.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.505 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -163.5 171.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.041 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.5 OUTLIER -162.04 131.12 4.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.302 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' P' ' 110' ' ' GLY . 65.7 m-85 -115.84 23.11 12.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.847 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -8.47 -106.38 0.0 OUTLIER Glycine 0 C--N 1.34 0.779 0 O-C-N 123.474 0.484 . . . . 0.0 113.971 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 3.8 mt-10 -71.16 -18.52 62.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.703 0.252 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.65 -70.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.133 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -130.66 89.62 42.99 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 122.312 -0.242 . . . . 0.0 110.541 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.0 156.27 39.98 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.599 2.199 . . . . 0.0 112.461 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 115' ' ' ALA . . . . . 0.712 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -97.68 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.095 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.673 HG21 ' CB ' ' P' ' 126' ' ' LYS . 2.6 t -88.79 114.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.056 0.455 . . . . 0.0 110.999 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.63 138.32 57.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.024 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.02 176.66 16.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.874 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.468 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 7.1 p80 -141.64 65.55 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.904 0.352 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.8 150.28 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -38.44 -30.94 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.1 -59.73 2.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.875 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.66 -42.44 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 1.0 OUTLIER -60.66 -45.08 95.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.161 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 26.9 m -62.92 -36.83 84.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.801 0.334 . . . . 0.0 110.509 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.673 ' CB ' HG21 ' P' ' 116' ' ' VAL . 27.0 mtmt -69.21 -25.02 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.549 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.712 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 4.6 m-20 -82.49 -33.89 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 4.7 mtp180 -69.64 83.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -158.02 148.29 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -121.12 109.29 14.83 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.454 HG13 ' OG1' ' P' ' 31' ' ' THR . 4.4 t -87.78 115.6 28.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.587 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -59.19 102.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.744 178.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -100.76 127.04 47.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.307 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.973 179.807 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.451 ' HB3' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.597 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.597 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.844 0.354 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 72.4 m -77.96 -32.89 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 99.5 p -61.14 -173.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -82.59 -57.35 3.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -121.1 110.7 16.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.997 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -150.08 132.3 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.05 -49.55 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 8' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' P' ' 9' ' ' ALA . . . -174.57 -88.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.756 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 9' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' P' ' 8' ' ' ALA . . . 69.81 -55.96 0.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.19 -23.64 31.51 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.618 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.2 135.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.14 -12.76 61.33 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.917 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.21 -72.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.543 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.74 69.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 15' ' ' GLN . . . . . 0.452 ' O ' ' CZ ' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -118.66 -109.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 16' ' ' THR . . . . . 0.531 HG22 ' HB3' ' P' ' 21' ' ' SER . 15.3 p -88.86 150.34 22.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 0.1 OUTLIER -151.48 135.86 16.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.219 0.533 . . . . 0.0 112.283 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 2.88 33.27 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.205 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.95 -34.36 2.86 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.399 -1.381 . . . . 0.0 114.154 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -114.69 161.71 17.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.826 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 21' ' ' SER . . . . . 0.531 ' HB3' HG22 ' P' ' 16' ' ' THR . 0.8 OUTLIER -97.72 145.76 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.428 HG23 ' O ' ' P' ' 15' ' ' GLN . 14.5 t -37.12 -58.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.84 -16.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -99.19 -43.02 6.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.324 0.583 . . . . 0.0 110.056 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 25.5 mt -54.67 -21.69 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -12.85 16.91 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.32 -23.63 5.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 ptm85 -122.89 -48.22 2.02 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.27 102.87 12.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.354 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.522 ' HA ' HG21 ' P' ' 48' ' ' ILE . 12.5 p-10 179.66 22.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.405 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.773 HG23 HG22 ' P' ' 131' ' ' VAL . 72.8 m -125.22 126.84 45.83 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.103 -0.373 . . . . 0.0 111.386 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.676 HG11 HG23 ' P' ' 41' ' ' ILE . 0.8 OUTLIER -105.18 150.64 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.913 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -117.93 112.7 20.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.374 0.606 . . . . 0.0 112.167 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.56 ' CD2' ' CZ ' ' P' ' 86' ' ' ARG . 15.3 m-30 -92.13 167.0 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.226 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.14 174.05 15.47 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.89 ' CE1' ' HB2' ' U' ' 7' ' ' DAL . 0.3 OUTLIER -61.76 142.45 57.27 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.54 -0.388 . . . . 0.0 110.946 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.67 26.0 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.771 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.451 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -108.97 135.25 50.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.656 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.669 ' HA ' ' NE ' ' P' ' 86' ' ' ARG . 47.4 p90 -132.86 30.46 4.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.32 150.83 44.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.774 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.757 HD11 HG22 ' P' ' 90' ' ' VAL . 1.5 mt -87.7 166.38 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.589 0.233 . . . . 0.0 110.616 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.479 ' N ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -111.07 144.56 40.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.09 0.472 . . . . 0.0 111.779 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.73 -31.95 2.82 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.606 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -30.5 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.712 0.291 . . . . 0.0 111.497 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.591 ' HB3' HG13 ' P' ' 32' ' ' VAL . 72.6 m-85 -104.9 3.52 30.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.454 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 54.3 t -69.1 -37.22 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.21 -42.44 14.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.035 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.8 OUTLIER -55.96 -49.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.002 0.43 . . . . 0.0 110.412 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.77 -39.68 74.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -45.79 72.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.51 68.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.035 ' CD2' HG22 ' P' ' 48' ' ' ILE . 16.5 m-70 -72.27 -40.64 67.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.973 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.9 73.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.05 -36.05 59.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.481 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 55' ' ' TYR . . . . . 0.456 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 13.8 t80 -74.26 -38.89 63.31 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.153 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.736 HD23 ' CG1' ' P' ' 99' ' ' VAL . 1.2 tp -65.08 -43.95 90.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -69.96 -39.98 75.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.24 -24.43 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.055 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.97 89.92 51.86 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.009 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.46 -21.67 10.82 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.792 2.328 . . . . 0.0 113.354 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.78 -1.2 55.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.679 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.81 125.88 35.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 2.6 pttp -121.85 132.29 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.836 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -97.6 146.61 7.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.484 0.659 . . . . 0.0 111.713 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.509 HD21 HG22 ' P' ' 107' ' ' VAL . 0.9 OUTLIER -118.89 103.73 9.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.406 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.613 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.6 OUTLIER -79.17 112.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.5 tt0 -101.3 114.99 29.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.104 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.35 146.54 16.08 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.878 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 127' ' ' ASN . 11.3 m-80 -155.76 107.49 2.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 79.1 p -105.35 -173.91 2.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 24.0 p-10 -54.76 139.1 40.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -61.51 -27.15 68.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.204 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -39.59 108.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.67 -175.17 15.9 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.406 -0.815 . . . . 0.0 113.437 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.6 147.69 34.18 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 122.223 0.209 . . . . 0.0 111.224 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 92.9 Cg_exo -39.56 -45.22 3.33 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.881 2.387 . . . . 0.0 113.172 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -40.88 90.84 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.902 0.382 . . . . 0.0 110.438 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 5.7 t80 -75.53 -37.45 60.04 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -70.51 -76.85 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.543 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -31.93 -40.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 O-C-N 123.101 0.251 . . . . 0.0 111.343 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.91 11.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.534 ' HA ' ' HD3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -47.32 -53.45 13.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.54 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' P' ' 86' ' ' ARG . . . -69.16 -42.62 75.44 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.334 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 7.3 tp-100 -45.68 -44.65 13.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.637 0.256 . . . . 0.0 110.656 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -72.19 -32.88 67.2 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.552 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.669 ' NE ' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -62.04 -49.81 74.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.504 0.669 . . . . 0.0 109.302 177.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -56.33 -35.34 67.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.5 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -29.64 70.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -62.94 -59.69 4.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.537 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.757 HG22 HD11 ' P' ' 41' ' ' ILE . 23.1 t -64.9 -37.69 80.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -61.16 -47.39 86.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.299 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.9 -19.03 73.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -67.5 -64.18 0.91 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.44 ' O ' HG23 ' P' ' 99' ' ' VAL . 75.6 mt -52.54 -33.71 46.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.095 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.91 97.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.201 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.47 -32.4 81.01 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -8.63 56.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.948 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.44 14.33 30.47 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.51 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.736 ' CG1' HD23 ' P' ' 56' ' ' LEU . 48.1 t -80.46 130.42 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.402 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.07 165.69 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 111.127 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.34 -30.07 17.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.474 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.32 58.27 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.813 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.644 ' HD3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -101.87 -4.32 26.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.212 0.529 . . . . 0.0 111.093 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' P' ' 101' ' ' ALA . 38.4 mt -96.37 150.38 20.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.133 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.613 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -151.15 142.99 10.01 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.651 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.74 ' O ' HG13 ' P' ' 107' ' ' VAL . 30.4 p -133.26 156.76 46.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.585 0.231 . . . . 0.0 110.451 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.74 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -171.13 129.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.347 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -119.25 130.55 55.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.736 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 82.6 m-85 -110.94 25.66 11.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.083 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.47 -112.36 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.718 -0.674 . . . . 0.0 114.445 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.509 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.03 6.88 47.84 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -53.89 -58.97 5.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.72 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 89.36 11.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.265 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.84 164.36 14.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.568 2.179 . . . . 0.0 112.424 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.38 -62.7 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.64 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' P' ' 126' ' ' LYS . 7.9 t -89.49 112.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.8 137.77 58.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.85 174.56 17.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.992 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.438 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 15.3 p-80 -141.99 68.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.28 . . . . 0.0 111.369 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.42 152.5 47.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -37.93 -32.36 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.58 -61.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.24 79.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -56.81 -50.17 73.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 87.7 p -60.66 -37.04 80.24 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.133 0.492 . . . . 0.0 110.056 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.856 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -62.47 -32.92 73.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.294 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 69' ' ' ASN . 98.7 m-20 -81.58 -30.45 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.415 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 4.5 mtp180 -69.79 74.61 0.43 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.089 0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 146.18 40.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.509 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.77 90.01 3.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.773 HG22 HG23 ' P' ' 31' ' ' THR . 15.4 t -80.2 114.17 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.468 HD22 HG13 ' P' ' 66' ' ' VAL . 0.2 OUTLIER -63.08 104.95 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.206 178.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -102.25 126.75 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.491 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.088 179.652 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.451 ' O4 ' ' N2 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.712 0.292 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.488 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.89 ' HB2' ' CE1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 87.0 p -107.14 -22.12 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t 67.92 61.44 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -88.02 -58.74 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.753 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -116.26 90.29 3.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -96.93 143.59 27.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 7' ' ' ASP . . . . . 0.545 ' O ' ' HB3' ' P' ' 8' ' ' ALA . 2.4 m-20 -69.17 -12.71 61.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 8' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' P' ' 7' ' ' ASP . . . 77.55 -166.77 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.51 126.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.95 -73.06 0.41 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.84 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 11' ' ' ASN . . . . . 0.41 HD22 ' HB2' ' P' ' 14' ' ' ALA . 7.4 p-10 -160.48 134.0 6.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.952 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.03 -71.38 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.538 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.42 -47.12 9.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 0.0 111.193 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' P' ' 11' ' ' ASN . . . 63.41 31.56 14.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.08 17.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -88.83 152.29 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' P' ' 19' ' ' GLY . 47.8 m-85 -137.92 85.62 2.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.771 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 50.6 4.98 0.07 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.726 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 19' ' ' GLY . . . . . 0.72 ' O ' HD21 ' P' ' 25' ' ' LEU . . . 171.53 97.2 0.11 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' P' ' 19' ' ' GLY . 0.8 OUTLIER 60.57 -178.34 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -107.99 160.49 15.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.49 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' P' ' 26' ' ' GLN . 20.6 t -39.13 -53.46 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 -15.92 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 24' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.7 -38.64 8.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.452 0.644 . . . . 0.0 110.142 178.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.72 HD21 ' O ' ' P' ' 19' ' ' GLY . 14.4 mt -70.27 -22.47 62.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.464 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 26' ' ' GLN . . . . . 0.404 ' HG3' HG12 ' P' ' 22' ' ' VAL . 12.6 mt-30 -85.25 -26.72 26.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.6 -3.49 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 28' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' P' ' 24' ' ' ASP . 5.4 mtm-85 -107.54 -68.03 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -109.52 96.39 6.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 112.061 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.579 ' HA ' HG21 ' P' ' 48' ' ' ILE . 2.6 p30 -162.77 27.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.024 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.571 HG23 HG22 ' P' ' 131' ' ' VAL . 95.3 m -128.33 129.61 46.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.882 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.483 HG11 HG23 ' P' ' 41' ' ' ILE . 1.0 OUTLIER -110.77 150.72 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -120.94 118.05 28.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.7 m-30 -100.99 171.65 7.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.383 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.76 -166.64 23.41 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.903 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.68 117.71 5.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 t70 45.45 29.04 0.55 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.342 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.404 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 24.5 mmtm -94.81 130.9 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.779 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -119.57 67.08 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.037 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.15 150.67 30.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.475 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.483 HG23 HG11 ' P' ' 32' ' ' VAL . 3.6 mt -107.98 156.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -109.85 150.16 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.15 0.5 . . . . 0.0 112.065 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.449 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -48.92 -31.27 10.16 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.264 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.75 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.69 0.281 . . . . 0.0 111.389 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.464 ' CB ' HG13 ' P' ' 32' ' ' VAL . 77.0 m-85 -99.68 -4.61 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.449 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 64.9 t -62.82 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.432 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -44.46 -45.38 9.09 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.008 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -52.59 -49.67 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.941 0.401 . . . . 0.0 110.22 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.859 HD11 HG13 ' P' ' 90' ' ' VAL . 2.7 mm? -54.06 -45.36 71.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -40.29 96.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.343 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 51' ' ' ALA . . . . . 0.444 ' HB2' ' HA3' ' P' ' 19' ' ' GLY . . . -68.95 -46.66 67.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.856 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.008 ' CD2' HG22 ' P' ' 48' ' ' ILE . 59.7 m-70 -68.17 -41.47 81.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.03 99.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.437 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.66 0.267 . . . . 0.0 110.482 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -73.38 -36.88 66.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.646 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 1.074 HD23 HG11 ' P' ' 99' ' ' VAL . 5.0 tp -60.01 -47.9 83.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.191 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.27 -43.08 78.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.594 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.64 -26.38 22.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.684 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -114.88 113.63 44.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.491 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.14 -49.08 17.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.771 2.314 . . . . 0.0 113.849 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.64 17.5 8.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.39 114.6 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.094 0.473 . . . . 0.0 110.662 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.518 ' CG ' ' HA ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -117.32 133.45 55.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.806 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.537 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.2 p -98.88 143.53 13.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 121.43 0.633 . . . . 0.0 111.476 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.765 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.5 tt -113.55 101.16 9.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.627 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.63 HG11 ' HB ' ' P' ' 90' ' ' VAL . 0.8 OUTLIER -80.13 106.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.477 ' OE2' HG11 ' P' ' 107' ' ' VAL . 0.9 OUTLIER -100.59 119.37 38.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 68' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' P' ' 130' ' ' ALA . . . -96.68 144.04 17.09 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.621 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 127' ' ' ASN . 1.4 m-20 -140.19 102.43 4.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.625 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 70' ' ' THR . . . . . 1.081 HG21 HD11 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -95.0 -169.97 2.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.573 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.61 158.49 34.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 pp20? -74.44 -33.96 63.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.259 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.03 116.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 -161.82 12.56 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.532 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.15 35.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.489 0.185 . . . . 0.0 110.751 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.431 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 46.6 Cg_exo -54.77 -31.87 74.0 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.231 1.954 . . . . 0.0 112.162 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.44 -43.02 82.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.706 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.492 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 29.2 t80 -73.89 -39.74 63.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.256 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -67.83 -76.7 0.08 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.58 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 1.8 tt -33.1 -38.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -56.87 6.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.749 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 1.081 HD11 HG21 ' P' ' 70' ' ' THR . 0.0 OUTLIER -55.4 -42.14 73.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 1.011 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -66.76 -40.51 93.83 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -52.55 -43.56 65.27 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.132 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.521 ' HD3' ' CD1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.12 -35.87 81.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.637 ' NH1' HG23 ' P' ' 70' ' ' THR . 0.0 OUTLIER -65.22 -44.65 87.6 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.745 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -57.79 -36.85 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.219 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 88' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' P' ' 91' ' ' LYS . 0.2 OUTLIER -67.57 -28.89 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.211 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -58.46 -66.36 0.5 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.859 HG13 HD11 ' P' ' 49' ' ' LEU . 84.3 t -57.11 -31.75 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.385 0.612 . . . . 0.0 109.892 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' P' ' 88' ' ' ASP . 0.3 OUTLIER -60.93 -47.62 85.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.351 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.85 79.39 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.112 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -68.04 -61.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' P' ' 104' ' ' LEU . 63.4 mt -57.02 -31.3 64.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.283 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.43 84.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.591 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.09 -39.63 94.62 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -60.86 -35.23 76.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.88 27.43 1.9 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.556 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 1.074 HG11 HD23 ' P' ' 56' ' ' LEU . 45.4 t -89.92 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.524 0.202 . . . . 0.0 110.483 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.31 165.22 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.245 0.545 . . . . 0.0 111.493 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.11 -29.91 18.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.297 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.97 -29.68 55.82 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.386 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.518 ' HA ' ' CG ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.14 -4.87 26.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 110.421 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' P' ' 94' ' ' LEU . 0.2 OUTLIER -106.91 121.32 44.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.122 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.557 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -129.61 178.36 17.47 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.606 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.745 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 70.7 p -149.95 163.44 38.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.765 ' CG2' HD21 ' P' ' 65' ' ' LEU . 93.5 t -160.85 161.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.21 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 5.6 t -159.66 129.05 5.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.471 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.433 ' CZ ' ' HG2' ' P' ' 67' ' ' GLU . 25.9 m-85 -88.85 -63.26 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.12 -127.92 8.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.079 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' P' ' 72' ' ' GLU . 0.3 OUTLIER -93.14 2.62 56.62 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.029 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.45 -66.14 0.45 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.831 0.348 . . . . 0.0 110.429 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -141.03 88.97 9.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.057 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 114' ' ' PRO . . . . . 0.4 ' CG ' ' HB3' ' P' ' 72' ' ' GLU . 24.2 Cg_exo -64.27 165.78 18.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.737 2.291 . . . . 0.0 112.434 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.54 -58.33 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.886 HG13 ' HB1' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -91.11 142.83 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.27 139.8 31.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.96 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.21 175.81 16.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.936 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.448 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 9.5 p-80 -141.3 68.27 1.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.749 0.274 . . . . 0.0 111.457 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -141.25 153.65 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 121' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 3.7 tp10 -40.37 -30.3 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.56 -65.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.992 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 123' ' ' ALA . . . . . 0.886 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -68.13 -41.42 81.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.698 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' P' ' 119' ' ' HIS . 1.6 m-85 -54.7 -52.96 60.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -59.09 -37.35 76.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -61.53 -31.62 71.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.292 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 69' ' ' ASN . 58.3 m-20 -84.42 -34.31 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.896 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 5.0 mtp180 -68.97 79.64 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.158 0.504 . . . . 0.0 111.135 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' P' ' 69' ' ' ASN . 0.1 OUTLIER -150.59 149.76 30.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.114 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.43 ' HA ' ' HA2' ' P' ' 68' ' ' GLY . . . -119.73 98.48 6.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.571 HG22 HG23 ' P' ' 31' ' ' THR . 21.8 t -83.9 115.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.467 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -65.39 103.13 0.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.549 178.233 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -99.47 128.59 45.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 111.511 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.051 179.624 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.599 ' O10' ' HB2' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' U' U ' 3' ' ' ALA . . . . . 0.599 ' HB2' ' O10' ' U' ' 2' ' ' AMU . . . . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.492 ' HB3' ' CE2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.768 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.768 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.627 0.251 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 31.9 p -126.79 30.72 5.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.841 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -138.01 20.06 2.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 3.5 t -90.15 -54.94 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.772 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -140.85 117.87 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -142.74 141.39 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.03 -62.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -172.95 -176.46 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.39 138.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.05 85.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.332 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 11' ' ' ASN . . . . . 0.49 ' HB3' ' HB2' ' P' ' 14' ' ' ALA . 1.1 t-20 178.68 124.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.711 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.46 -57.4 3.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.659 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.75 -24.8 24.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' P' ' 11' ' ' ASN . . . -55.64 133.27 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -109.16 -164.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -130.49 90.54 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 111.12 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -89.51 106.65 18.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.994 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.01 35.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.412 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.41 -35.03 2.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.16 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -129.92 176.77 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 0.0 111.709 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 21' ' ' SER . . . . . 0.431 ' OG ' ' HB1' ' P' ' 14' ' ' ALA . 8.9 t -103.3 157.37 17.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.795 ' HA ' HD12 ' P' ' 25' ' ' LEU . 17.4 t -46.4 -51.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.18 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.53 -13.34 2.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.436 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.11 -44.66 6.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' P' ' 22' ' ' VAL . 3.9 mt -58.07 -19.78 34.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.703 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -109.02 -11.27 14.98 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.06 -31.08 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -122.83 -50.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.72 103.8 13.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.529 0.68 . . . . 0.0 112.403 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.601 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -176.08 11.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.301 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.426 ' O ' ' CD1' ' P' ' 45' ' ' TYR . 85.0 m -113.77 128.12 56.29 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.838 -0.539 . . . . 0.0 112.097 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.631 ' CG1' HG23 ' P' ' 41' ' ' ILE . 5.3 t -108.06 151.16 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 33' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' P' ' 34' ' ' PHE . 6.9 m-85 -112.48 163.32 14.61 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' P' ' 33' ' ' TYR . 73.4 m-85 -152.06 168.55 24.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.221 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.49 -175.74 23.27 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.567 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.35 128.43 37.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.084 0.442 . . . . 0.0 110.884 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p30 43.59 29.76 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.801 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.431 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 2.3 tttp -101.02 137.71 39.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' P' ' 39' ' ' TYR . 48.5 p90 -125.37 60.71 1.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.306 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.63 150.85 31.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.232 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.631 HG23 ' CG1' ' P' ' 32' ' ' VAL . 3.3 mt -94.76 163.44 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.652 0.263 . . . . 0.0 110.736 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.518 ' N ' HG22 ' P' ' 41' ' ' ILE . 72.8 p -112.61 142.67 44.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.308 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.9 -29.74 4.6 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.346 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.05 -32.87 74.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.61 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' P' ' 33' ' ' TYR . 68.2 m-85 -102.8 3.65 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.82 -41.23 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.46 ' NE2' HG12 ' P' ' 48' ' ' ILE . 6.1 pm0 -45.77 -37.77 6.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.0 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.3 mt -57.74 -52.83 52.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -52.85 -33.09 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.437 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -40.78 62.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.3 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 51' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -74.45 -43.93 53.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.0 ' CD2' HG22 ' P' ' 48' ' ' ILE . 59.9 m-70 -62.9 -38.82 92.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.026 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.36 87.18 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 55' ' ' TYR . . . . . 0.47 ' HD2' ' HH ' ' P' ' 134' ' ' TYR . 8.9 t80 -73.63 -41.51 62.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 1.069 HD23 HG11 ' P' ' 99' ' ' VAL . 5.6 tp -61.02 -45.06 96.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.397 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.79 -40.74 72.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.564 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.96 -26.64 37.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -114.54 114.33 44.95 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.374 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 -51.58 10.35 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.859 2.373 . . . . 0.0 113.931 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.06 19.69 5.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.627 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.19 119.68 30.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.503 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -119.5 132.51 55.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.724 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.691 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.8 p -98.65 144.87 10.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 121.294 0.569 . . . . 0.0 110.904 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.634 HD21 HG22 ' P' ' 107' ' ' VAL . 0.6 OUTLIER -116.56 108.31 15.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.943 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.2 OUTLIER -85.53 113.96 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' P' ' 107' ' ' VAL . 21.0 tt0 -99.07 120.36 39.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.29 144.01 21.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.708 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.743 ' O ' HG23 ' P' ' 70' ' ' THR . 0.3 OUTLIER -144.3 159.8 42.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.743 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.1 p -170.26 -173.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.445 ' CB ' ' CE2' ' P' ' 124' ' ' TYR . 10.0 p-10 -63.72 157.25 24.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.379 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.519 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 0.2 OUTLIER -70.55 -31.35 68.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.441 ' HB2' ' OH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -49.86 119.74 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.37 -173.82 15.33 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.225 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.17 143.15 26.56 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.135 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.537 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -40.2 -43.1 3.73 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.017 2.478 . . . . 0.0 113.667 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -59.82 -45.17 93.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.511 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 14.1 t80 -70.89 -41.97 70.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 4.3 m-80 -67.5 -75.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.9 OUTLIER -29.48 -44.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 111.525 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.37 4.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.91 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.572 HD12 ' NH1' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -47.9 -51.9 21.42 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.279 -0.569 . . . . 0.0 109.92 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' P' ' 86' ' ' ARG . . . -61.52 -40.74 99.12 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.511 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -51.39 -40.51 59.4 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.523 HH12 HD22 ' P' ' 82' ' ' LEU . 8.1 ttp-105 -64.73 -38.82 92.29 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.572 ' NH1' HD12 ' P' ' 82' ' ' LEU . 0.3 OUTLIER -59.05 -40.08 84.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' P' ' 106' ' ' THR . . . -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 88' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.5 OUTLIER -65.87 -34.69 78.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 178.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.1 68.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.86 -38.06 43.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.809 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.583 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.2 -39.66 91.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.236 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.79 -27.43 64.91 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -59.87 -57.02 14.67 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.463 ' HB2' HD21 ' P' ' 104' ' ' LEU . 23.2 mt -61.45 -32.25 72.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.39 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.96 95.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.103 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.12 -26.97 74.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.759 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -72.38 -11.44 60.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.99 2.0 25.24 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.13 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 1.069 HG11 HD23 ' P' ' 56' ' ' LEU . 26.9 t -81.95 131.95 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.368 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 100' ' ' ASP . . . . . 0.427 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.5 OUTLIER -60.9 164.28 5.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.271 0.557 . . . . 0.0 111.324 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.921 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -84.26 -30.02 25.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.58 -22.78 53.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.895 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.644 ' HE3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -98.84 -3.86 34.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.092 0.473 . . . . 0.0 111.25 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.921 HD12 ' HA ' ' P' ' 101' ' ' ALA . 8.7 mt -89.2 150.44 22.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.254 -0.279 . . . . 0.0 110.342 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.652 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.16 138.82 7.72 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.827 ' O ' HG13 ' P' ' 107' ' ' VAL . 66.3 p -132.14 153.37 50.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.693 0.282 . . . . 0.0 111.014 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.827 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -175.38 170.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.493 ' OG ' HG23 ' P' ' 80' ' ' ILE . 32.4 p -162.47 139.18 7.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.406 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' P' ' 110' ' ' GLY . 74.6 m-85 -123.57 19.77 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 7.4 -110.34 0.01 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -86.18 8.07 22.51 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 112' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 8.4 tp10 -51.43 -59.74 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 109.961 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.17 89.81 22.72 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.686 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.18 160.11 11.32 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.709 2.273 . . . . 0.0 112.991 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -69.13 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.674 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.69 HG21 ' HB3' ' P' ' 126' ' ' LYS . 19.6 t -87.67 106.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.923 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.24 134.9 49.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.1 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.69 174.68 13.56 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.379 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.61 87.02 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.145 0.473 . . . . 0.0 111.692 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -173.2 165.98 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -47.79 -22.3 0.52 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.57 -60.84 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.912 0.386 . . . . 0.0 111.444 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.09 72.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.445 ' CE2' ' CB ' ' P' ' 71' ' ' ASP . 2.9 m-85 -60.55 -45.75 92.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.749 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 25.2 t -65.34 -32.02 73.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.174 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.69 ' HB3' HG21 ' P' ' 116' ' ' VAL . 1.9 mtmt -75.06 -24.69 58.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.369 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -87.89 -29.0 21.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 111.262 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -67.25 87.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 3.3 ptt-85 -159.08 160.31 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -125.37 106.53 9.9 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.25 111.24 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.646 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -61.58 101.94 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.209 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 130.51 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.279 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' P' P ' 134' ' ' TYR . . . . . 0.47 ' HH ' ' HD2' ' P' ' 55' ' ' TYR . 5.8 m-85 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.025 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.466 H5'2 ' O4 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.466 ' O4 ' H5'2 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.668 0.747 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.511 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 90.9 p -172.33 -172.33 0.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.04 89.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 37.8 p -88.39 -27.6 21.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 148.31 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.712 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.95 146.94 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -91.09 -55.29 3.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.719 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 63.27 137.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.194 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.83 3.24 38.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.38 -28.23 72.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 11.7 p30 43.09 31.73 0.37 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.405 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 -45.81 40.49 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.02 -73.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 111.185 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -179.86 176.0 0.79 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 15' ' ' GLN . . . . . 0.41 ' O ' ' CB ' ' P' ' 21' ' ' SER . 0.0 OUTLIER -129.85 148.05 51.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.493 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.5 p -129.24 150.35 50.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 111.688 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.94 106.38 4.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.169 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.66 8.51 47.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.288 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.54 -35.67 2.24 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.575 -1.297 . . . . 0.0 114.127 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.71 ' HB2' HD21 ' P' ' 25' ' ' LEU . 2.9 m-85 -119.43 169.26 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.124 0.462 . . . . 0.0 111.468 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 21' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' P' ' 15' ' ' GLN . 5.0 m -101.27 145.3 29.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.992 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.508 ' HA ' HD12 ' P' ' 25' ' ' LEU . 10.3 t -43.27 -30.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 111.468 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 23' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' P' ' 27' ' ' GLN . . . -61.67 -21.96 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 24' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.69 -54.05 3.02 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.604 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.71 HD21 ' HB2' ' P' ' 20' ' ' TYR . 7.1 mt -44.59 -28.05 0.55 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.89 -31.22 12.31 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.157 0.503 . . . . 0.0 110.725 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 27' ' ' GLN . . . . . 0.634 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.1 OUTLIER -148.5 77.68 1.4 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.532 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 28' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' P' ' 27' ' ' GLN . 0.0 OUTLIER 164.47 -68.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.205 177.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.449 ' CD1' ' HD3' ' P' ' 28' ' ' ARG . 6.7 m-85 -109.13 90.09 3.19 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.61 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 10.5 p-10 -168.29 64.69 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.411 ' O ' ' CE1' ' P' ' 45' ' ' TYR . 97.6 m -164.11 126.68 2.44 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.818 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.921 HG11 HG23 ' P' ' 41' ' ' ILE . 1.2 t -99.75 150.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.652 0.263 . . . . 0.0 111.215 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -116.33 108.35 15.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -89.31 172.94 8.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.612 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.16 -173.98 19.92 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 3.0 t80 -58.36 122.56 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.457 0.628 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 37' ' ' ASP . . . . . 0.411 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 2.7 p30 43.92 30.84 0.44 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.744 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 141.58 28.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.467 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 31.2 p90 -130.76 52.55 2.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.497 . . . . 0.0 110.833 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -149.97 150.14 31.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.448 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.921 HG23 HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -100.27 163.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.924 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 69.4 p -109.45 150.59 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.86 -29.72 1.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.205 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -65.2 -30.47 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.503 ' CB ' HG13 ' P' ' 32' ' ' VAL . 68.0 m-85 -104.12 1.17 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.981 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 82.4 t -73.22 -37.56 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.41 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.62 -40.7 63.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' P' ' 45' ' ' TYR . 4.6 pt -67.25 -35.72 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.344 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.88 -40.12 96.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.95 -34.19 62.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.792 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.76 -53.58 8.27 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 0.651 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 23.0 m-70 -53.59 -35.35 60.75 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.04 85.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.065 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 110.201 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.23 -37.87 63.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.73 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 1.017 HD23 HG11 ' P' ' 99' ' ' VAL . 1.7 tp -62.47 -42.74 99.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.294 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.64 -42.06 71.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.461 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.07 54.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.534 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.3 OUTLIER -113.15 112.22 49.84 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.94 -48.74 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.842 2.361 . . . . 0.0 114.154 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.61 17.61 8.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.585 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.35 117.91 29.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -118.7 130.41 55.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.765 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.638 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.4 p -94.44 140.23 17.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.347 0.594 . . . . 0.0 111.422 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.14 104.31 13.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.786 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.09 108.12 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.6 tt0 -102.01 118.06 36.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.03 152.34 20.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 69' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -148.55 170.7 17.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.871 0.367 . . . . 0.0 110.926 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.1 OUTLIER 176.2 174.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.147 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.533 ' HB2' ' CZ ' ' P' ' 124' ' ' TYR . 37.7 p-10 -54.46 142.64 26.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.253 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 2.2 pp20? -62.79 -25.98 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.417 ' HD3' ' CD2' ' P' ' 119' ' ' HIS . 0.7 OUTLIER -39.33 110.74 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.545 -178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.22 -168.87 12.71 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.336 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.57 144.83 29.45 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.674 0.273 . . . . 0.0 111.066 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.06 -39.28 14.66 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.634 2.223 . . . . 0.0 112.488 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.8 -43.02 97.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.679 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 12.3 t80 -68.18 -41.81 80.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.467 ' OD1' HG23 ' P' ' 70' ' ' THR . 3.1 m-80 -70.68 -75.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.823 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -30.15 -40.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 81' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -69.89 -57.06 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.82 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 1.016 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.4 -42.0 81.42 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.056 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 1.016 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.86 -52.32 20.19 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.765 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 1.9 tt0 -48.03 -35.67 11.52 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.92 -48.71 79.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.082 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 0.3 OUTLIER -54.98 -40.89 70.55 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.556 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.78 -34.24 74.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.44 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -32.99 74.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.235 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.33 -53.44 57.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.426 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.37 -34.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -60.84 -52.75 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 92' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -65.06 -27.1 71.86 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -59.16 -58.4 8.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.485 ' CD1' HG11 ' P' ' 64' ' ' VAL . 92.6 mt -56.73 -29.91 62.98 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 95' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -69.84 -38.99 76.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.84 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.31 -35.17 87.61 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.68 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -63.87 -36.56 84.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.63 26.15 2.22 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.247 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 1.017 HG11 HD23 ' P' ' 56' ' ' LEU . 24.4 t -91.15 146.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.568 0.223 . . . . 0.0 110.726 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.28 161.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.172 0.51 . . . . 0.0 111.562 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.29 -31.32 17.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.67 -12.91 65.11 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 12.9 mtpp -94.37 -10.91 31.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.27 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' P' ' 101' ' ' ALA . 1.9 mt -99.79 150.01 22.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.74 144.58 11.8 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.777 ' O ' HG13 ' P' ' 107' ' ' VAL . 17.6 p -124.57 159.09 31.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.722 0.296 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.777 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -175.28 117.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.151 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.823 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -99.77 143.78 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.526 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' P' ' 110' ' ' GLY . 2.8 m-85 -105.45 7.8 33.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 16.87 -127.25 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.276 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -101.08 12.75 37.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.53 0.205 . . . . 0.0 111.106 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -59.1 5.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 109.95 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.36 89.03 16.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 114' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 31.9 Cg_exo -61.19 164.07 15.57 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.804 2.336 . . . . 0.0 112.982 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.3 -67.4 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.277 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.769 HG21 ' HG3' ' P' ' 126' ' ' LYS . 18.8 t -88.52 108.76 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.89 138.75 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.503 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.28 177.03 14.99 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.999 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.537 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 0.3 OUTLIER -141.03 61.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 120' ' ' ASP . . . . . 0.824 ' OD2' ' HB3' ' P' ' 122' ' ' ALA . 7.9 p-10 -127.14 154.69 44.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -49.38 -23.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.547 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 122' ' ' ALA . . . . . 0.824 ' HB3' ' OD2' ' P' ' 120' ' ' ASP . . . -76.07 -58.1 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.938 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.21 97.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.674 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.537 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 3.2 m-30 -66.59 -37.21 84.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.37 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 125' ' ' SER . . . . . 0.444 ' HA ' ' NE ' ' P' ' 128' ' ' ARG . 22.5 p -62.06 -37.61 85.64 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 110.682 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.769 ' HG3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -83.07 -11.84 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.713 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -80.71 -37.07 31.3 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.628 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -78.65 92.63 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.821 0.82 . . . . 0.0 110.756 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -146.68 146.35 30.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.362 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -115.53 93.91 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.03 112.84 16.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 1.4 mm? -63.71 100.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.282 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -97.38 122.53 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.806 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.053 179.568 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.441 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' U' U ' 3' ' ' ALA . . . . . 0.763 ' O ' ' O ' ' U' ' 4' ' ' DGL . . . . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.763 ' O ' ' O ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.709 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.431 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.709 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t -174.69 133.7 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 5.8 p -98.62 35.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -74.75 -23.25 58.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -105.33 139.11 40.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -110.35 150.03 29.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.42 -42.21 54.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 65.52 -76.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.02 124.78 24.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.8 -72.74 0.37 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.096 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 61.9 31.1 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 0.0 110.823 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.3 -21.33 53.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.727 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.96 42.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.21 106.71 18.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.007 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -151.41 103.74 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.46 123.57 50.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.43 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 7.0 m-85 -90.96 107.02 18.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.66 33.48 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.396 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.24 -35.43 2.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.593 -1.289 . . . . 0.0 113.466 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.87 43.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.599 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -60.07 152.37 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' P' ' 25' ' ' LEU . 21.5 t -44.3 -40.07 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 112.029 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -14.83 25.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.316 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.54 -41.03 8.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.561 0.696 . . . . 0.0 109.895 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.522 HD21 ' HB1' ' P' ' 51' ' ' ALA . 14.7 mt -61.86 -19.8 63.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -98.66 -14.61 19.76 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.99 -17.9 2.11 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -67.96 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -105.36 81.89 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.634 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.24 10.17 2.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.006 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.678 ' OG1' HG13 ' P' ' 131' ' ' VAL . 23.5 m -134.81 137.12 43.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.65 HG11 HG23 ' P' ' 41' ' ' ILE . 11.3 t -106.89 149.71 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.437 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 33' ' ' TYR . . . . . 0.548 ' CE2' ' NH2' ' P' ' 129' ' ' ARG . 3.3 m-85 -113.39 115.51 28.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.778 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.462 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 82.4 m-85 -104.69 168.9 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.078 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.99 179.73 19.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.384 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' U' ' 3' ' ' ALA . 3.6 t80 -61.4 137.48 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 37' ' ' ASP . . . . . 0.415 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 0.5 OUTLIER 46.91 28.05 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.407 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 5.5 mttm -109.12 136.07 49.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.742 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -130.86 49.82 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.75 150.44 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.958 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.65 HG23 HG11 ' P' ' 32' ' ' VAL . 2.2 mp -92.98 164.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.519 0.199 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.529 ' N ' HG22 ' P' ' 41' ' ' ILE . 28.0 p -109.5 144.22 38.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.84 -29.58 1.43 Allowed Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.219 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.43 -31.96 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.618 0.247 . . . . 0.0 111.655 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.562 ' CB ' HG13 ' P' ' 32' ' ' VAL . 76.0 m-85 -104.39 3.31 32.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.414 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 98.5 t -70.31 -38.32 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.318 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.24 -40.25 11.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.298 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.05 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.4 mt -55.39 -55.87 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.945 0.402 . . . . 0.0 110.333 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.687 HD11 HG13 ' P' ' 90' ' ' VAL . 2.8 mm? -52.04 -31.89 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.697 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -38.69 62.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 51' ' ' ALA . . . . . 0.522 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -75.36 -45.98 35.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.05 ' CD2' HG22 ' P' ' 48' ' ' ILE . 65.8 m-70 -64.41 -37.73 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.67 95.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.76 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.22 98.34 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.032 0.444 . . . . 0.0 110.14 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 55' ' ' TYR . . . . . 0.43 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 24.2 t80 -75.82 -37.6 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.66 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.944 HD23 HG11 ' P' ' 99' ' ' VAL . 10.1 tp -60.68 -49.02 79.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -70.1 -40.31 75.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.51 -27.29 37.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.423 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -113.63 115.37 46.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.667 0.27 . . . . 0.0 110.423 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.83 -59.6 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.915 2.41 . . . . 0.0 113.902 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 20.52 2.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.663 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -88.46 114.6 25.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.017 0.437 . . . . 0.0 110.374 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.4 129.7 56.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.687 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.4 p -95.56 126.37 48.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.428 0.632 . . . . 0.0 110.921 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.588 HD21 HG22 ' P' ' 107' ' ' VAL . 0.8 OUTLIER -99.54 105.51 17.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.721 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.557 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.4 t -82.19 120.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.047 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.1 tt0 -106.52 116.05 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.97 142.97 18.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.735 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.726 ' O ' HG23 ' P' ' 70' ' ' THR . 0.6 OUTLIER -141.39 161.52 37.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.959 0.409 . . . . 0.0 110.751 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.726 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.3 p -170.16 -173.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.538 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.48 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 4.3 p30 -74.92 152.79 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.617 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.414 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pp20? -63.56 -32.63 74.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.935 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.404 ' HB3' ' OD1' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -39.75 109.41 0.11 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.96 178.62 19.17 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.14 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.97 146.51 31.43 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.511 0.196 . . . . 0.0 110.853 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 71.8 Cg_exo -41.23 -42.6 5.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.741 2.294 . . . . 0.0 113.197 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.34 -43.62 98.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.881 0.372 . . . . 0.0 110.568 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 0.3 OUTLIER -67.94 -43.56 78.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.6 OUTLIER -69.51 -76.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.687 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.635 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.46 -43.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.72 -56.49 9.09 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.573 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.766 HD12 ' C ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -48.9 -56.19 9.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.262 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.99 -39.34 97.45 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.526 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 3.8 mt-30 -48.41 -51.12 28.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 13.0 ptp180 -62.2 -32.67 73.35 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 0.4 OUTLIER -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.74 76.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.982 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 88' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.5 OUTLIER -63.35 -29.73 70.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.638 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -64.9 -43.22 93.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.154 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.687 HG13 HD11 ' P' ' 49' ' ' LEU . 39.2 t -75.47 -42.7 42.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.365 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' P' ' 88' ' ' ASP . 0.0 OUTLIER -63.1 -38.93 93.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 92' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -71.75 -31.29 65.09 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.32 -57.01 14.79 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' P' ' 64' ' ' VAL . 83.5 mt -57.63 -30.48 65.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.285 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 95' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -68.9 -39.71 79.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.945 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.66 -36.21 91.15 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.873 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -35.36 78.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.05 26.53 2.05 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.944 HG11 HD23 ' P' ' 56' ' ' LEU . 57.5 t -90.77 144.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.595 0.236 . . . . 0.0 110.54 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 100' ' ' ASP . . . . . 0.457 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -63.94 161.56 15.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.504 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.97 -32.3 16.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.423 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.41 -23.93 36.25 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.689 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.67 -3.25 33.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.29 0.567 . . . . 0.0 110.858 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.8 mt -89.24 148.88 23.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.846 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.557 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -148.68 140.84 8.53 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.637 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.806 ' O ' HG13 ' P' ' 107' ' ' VAL . 14.8 p -131.12 153.44 49.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.679 0.276 . . . . 0.0 110.832 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.806 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -174.26 117.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.635 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -105.65 137.8 42.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.368 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.513 ' O ' ' C ' ' P' ' 110' ' ' GLY . 91.9 m-85 -121.4 15.97 11.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.996 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -5.03 -106.3 0.0 OUTLIER Glycine 0 C--N 1.34 0.761 0 O-C-N 123.758 0.662 . . . . 0.0 114.523 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -89.61 0.7 56.76 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.589 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -54.73 -59.87 4.13 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 88.7 7.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.96 168.29 7.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.893 2.395 . . . . 0.0 113.163 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.51 -66.01 0.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.236 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.823 HG13 ' HB1' ' P' ' 123' ' ' ALA . 2.5 p -88.6 151.05 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -108.37 136.13 48.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.865 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.29 -178.9 20.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -140.23 43.53 1.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.443 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -130.07 156.13 45.02 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -27.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.617 0.246 . . . . 0.0 111.591 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.24 -58.84 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.386 . . . . 0.0 110.651 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 123' ' ' ALA . . . . . 0.823 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -72.48 -39.6 67.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.549 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.48 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 5.9 m-85 -57.82 -49.77 75.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.956 0.408 . . . . 0.0 110.531 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 125' ' ' SER . . . . . 0.645 ' O ' ' NH2' ' P' ' 129' ' ' ARG . 8.3 t -62.7 -33.02 74.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.605 ' O ' ' CZ ' ' P' ' 129' ' ' ARG . 0.1 OUTLIER -75.83 -14.41 60.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.325 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -94.18 -24.45 17.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.457 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.6 mtp180 -77.11 91.11 3.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.645 ' NH2' ' O ' ' P' ' 125' ' ' SER . 0.0 OUTLIER -160.88 154.85 22.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.05 103.96 9.73 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.678 HG13 ' OG1' ' P' ' 31' ' ' THR . 2.6 t -82.03 109.44 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.82 100.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.28 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -98.0 123.08 41.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.92 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.915 179.707 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.513 ' O2 ' H5'2 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.738 ' O10' ' HB2' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' U' U ' 3' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.42 0.629 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.548 ' C ' ' H ' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.631 ' HD2' HD23 ' P' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.738 ' HB2' ' O10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.45 ' C ' ' HB2' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.331 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -143.64 85.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 31.4 p -177.48 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.59 -23.01 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.31 149.96 26.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -111.64 150.73 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 7' ' ' ASP . . . . . 0.617 ' O ' ' HB3' ' P' ' 8' ' ' ALA . 1.2 p30 -62.83 -12.85 27.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.431 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 8' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' P' ' 7' ' ' ASP . . . 84.81 -178.66 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.88 -19.64 20.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.788 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.65 -69.39 1.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.258 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 64.14 129.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 110.531 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.77 -73.3 0.34 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.57 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 13' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' P' ' 14' ' ' ALA . . . -90.45 -73.26 0.53 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.775 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' P' ' 13' ' ' ALA . . . 174.05 53.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 61.35 110.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.269 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 77.2 p -123.74 149.61 45.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' P' ' 20' ' ' TYR . 40.4 m-85 -137.53 103.06 4.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.978 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.89 9.99 23.4 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.72 -1.229 . . . . 0.0 112.211 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.2 -33.89 2.71 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.651 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.821 ' HB2' HD21 ' P' ' 25' ' ' LEU . 18.0 m-85 -116.11 160.59 20.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.131 0.491 . . . . 0.0 112.286 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -97.56 142.0 29.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.327 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 t -40.86 -53.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.86 -16.54 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.393 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.29 -46.07 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 110.417 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' P' ' 20' ' ' TYR . 11.9 mt -56.12 -20.83 19.11 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.559 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -12.23 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -118.72 -28.15 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -117.13 -52.51 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -109.39 97.07 6.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.865 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -164.68 13.02 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 31' ' ' THR . . . . . 1.004 HG23 HG22 ' P' ' 131' ' ' VAL . 90.3 m -120.41 130.09 54.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.916 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.648 HG11 HG23 ' P' ' 41' ' ' ILE . 5.3 t -108.84 141.72 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.102 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.28 117.7 30.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 20.4 m-30 -96.26 167.76 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.925 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 35' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' P' ' 128' ' ' ARG . . . -100.74 -170.11 28.81 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.76 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.515 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 1.8 t80 -56.43 115.74 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.52 31.63 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.534 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.433 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 15.5 mmtm -91.58 141.66 28.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 17.3 t80 -126.55 57.71 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.701 0.762 . . . . 0.0 110.116 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -150.96 150.85 31.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.893 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.648 HG23 HG11 ' P' ' 32' ' ' VAL . 3.0 mt -100.81 160.33 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.467 ' O ' HG23 ' P' ' 46' ' ' VAL . 18.4 p -108.83 138.86 44.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 111.743 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.08 -28.64 1.35 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.926 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.35 -31.98 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.112 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.494 ' O ' HG13 ' P' ' 48' ' ' ILE . 65.9 m-85 -106.33 5.57 29.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' P' ' 42' ' ' THR . 80.4 t -76.26 -28.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.53 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -36.46 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.67 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.074 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -58.95 -46.32 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.172 0.51 . . . . 0.0 109.899 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.434 HD23 ' N ' ' P' ' 49' ' ' LEU . 3.3 mt -59.75 -39.01 83.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.767 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.72 -44.69 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.345 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 -50.08 66.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.967 0.413 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.074 ' CD2' HG22 ' P' ' 48' ' ' ILE . 60.0 m-70 -59.75 -35.8 75.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.85 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.686 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.97 80.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.977 0.418 . . . . 0.0 110.435 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -78.03 -34.21 50.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.0 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.823 ' CD2' HG11 ' P' ' 99' ' ' VAL . 1.0 OUTLIER -67.0 -40.57 87.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.874 -179.234 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.99 -34.35 66.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.61 -22.63 67.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.569 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -110.8 115.29 53.55 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.592 0.235 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.12 -62.1 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.878 2.385 . . . . 0.0 114.065 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.6 25.16 1.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.602 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -91.14 122.13 33.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.166 0.508 . . . . 0.0 110.98 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.2 mttp -128.29 132.68 48.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.533 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.9 p -95.38 146.41 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-O 121.392 0.615 . . . . 0.0 111.54 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.22 103.68 12.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.69 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.631 HG11 ' HB ' ' P' ' 90' ' ' VAL . 0.2 OUTLIER -84.32 95.02 3.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.542 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 22.3 tt0 -89.36 119.72 30.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.773 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.48 145.9 18.65 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.658 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.674 ' O ' HG23 ' P' ' 70' ' ' THR . 81.5 m-20 -142.49 161.44 38.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.674 HG23 ' O ' ' P' ' 69' ' ' ASN . 2.2 p -165.23 -169.98 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.0 111.889 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.505 ' HB3' ' CE1' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -58.17 158.48 6.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.926 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -77.63 -30.95 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.324 0.583 . . . . 0.0 109.741 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.419 ' NE ' ' H82' ' U' ' 2' ' ' AMU . 0.0 OUTLIER -65.89 129.09 38.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.697 0.761 . . . . 0.0 112.653 -178.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -179.96 18.1 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.824 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.77 144.28 28.41 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.72 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.605 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 94.8 Cg_exo -39.39 -49.68 3.07 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.144 2.563 . . . . 0.0 113.603 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -43.41 76.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -71.79 -45.37 61.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' P' ' 80' ' ' ILE . 6.4 m120 -71.11 -76.59 0.1 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -31.94 -46.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -57.02 10.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.279 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.986 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -50.43 -46.59 56.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.037 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.986 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.9 -43.61 82.25 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.236 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -51.95 -37.38 52.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 109.842 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -51.1 63.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.708 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.58 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 0.8 OUTLIER -58.39 -39.59 80.06 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -59.96 -32.83 71.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.757 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -31.67 71.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.145 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.45 -55.43 33.59 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.604 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.631 ' HB ' HG11 ' P' ' 66' ' ' VAL . 17.4 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.878 0.371 . . . . 0.0 111.088 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.616 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.31 -39.75 91.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.651 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.91 -24.39 69.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.16 -58.3 7.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.515 ' CD1' HG11 ' P' ' 64' ' ' VAL . 95.3 mt -61.23 -32.46 72.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.686 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.46 98.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.389 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.32 -21.21 77.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.864 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -10.8 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.0 111.344 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -5.88 17.98 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.436 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.823 HG11 ' CD2' ' P' ' 56' ' ' LEU . 19.5 t -78.45 127.77 38.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.946 0.373 . . . . 0.0 111.097 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.4 143.08 57.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 111.494 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.81 -35.38 22.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.553 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -21.1 54.27 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.725 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.1 OUTLIER -94.02 -9.66 36.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.16 0.48 . . . . 0.0 111.387 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.616 HD13 ' O ' ' P' ' 91' ' ' LYS . 1.1 mt -106.76 140.13 40.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.674 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.402 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -149.09 143.44 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.55 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 15.9 p -115.7 159.87 20.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.676 0.274 . . . . 0.0 110.863 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.58 HG12 ' CE2' ' P' ' 109' ' ' TYR . 46.4 t -164.57 114.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.489 ' OG ' HG23 ' P' ' 80' ' ' ILE . 58.5 p -111.82 134.71 53.2 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.433 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.58 ' CE2' HG12 ' P' ' 107' ' ' VAL . 95.2 m-85 -124.21 19.01 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.58 -109.79 0.01 OUTLIER Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 114.445 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' HA ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -88.59 7.69 32.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.23 -60.35 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 110.327 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -142.09 89.18 8.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.941 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.99 166.99 9.6 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.692 2.261 . . . . 0.0 112.543 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.26 -63.08 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.46 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.775 HG21 ' HD2' ' P' ' 126' ' ' LYS . 36.7 t -89.04 112.19 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.812 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tp -65.0 137.97 58.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.14 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.37 176.19 14.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.82 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.407 ' CB ' ' OH ' ' P' ' 124' ' ' TYR . 17.8 p-80 -140.79 60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.886 0.343 . . . . 0.0 111.39 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.31 155.3 48.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.35 -30.79 0.11 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.78 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.11 79.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' P' ' 71' ' ' ASP . 5.2 m-85 -62.64 -39.29 93.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.054 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 14.2 m -65.14 -33.51 76.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.945 0.402 . . . . 0.0 109.971 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.775 ' HD2' HG21 ' P' ' 116' ' ' VAL . 21.1 mtmt -73.98 -24.49 59.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.493 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -90.53 -30.87 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 76.2 mtm-85 -67.44 88.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.53 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.15 156.95 29.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.69 99.21 5.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 1.004 HG22 HG23 ' P' ' 31' ' ' THR . 31.1 t -95.95 115.75 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.846 ' O ' HD12 ' P' ' 132' ' ' LEU . 2.9 pp -85.72 123.59 31.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -131.68 151.8 51.35 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' P' P ' 134' ' ' TYR . . . . . 0.48 ' HE2' HD12 ' P' ' 56' ' ' LEU . 57.1 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.015 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.563 ' H9 ' ' HB2' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.482 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.563 ' HB2' ' H9 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.482 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -121.5 -47.2 2.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -76.4 63.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 34.2 p -90.05 -48.43 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -150.97 99.3 2.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.933 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.59 124.07 30.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.12 -38.83 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 62.92 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.66 28.06 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.904 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.96 -42.7 60.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.625 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -178.95 -178.86 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.71 -28.13 67.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.487 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -67.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.093 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.21 56.3 5.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.152 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -137.49 161.02 37.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.08 150.87 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 67.2 m-85 -133.45 109.54 9.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.508 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.71 9.69 20.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.265 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.72 -36.06 2.23 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.593 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.403 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 5.7 m-85 -121.34 162.4 20.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.431 . . . . 0.0 111.459 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 11.0 p -101.49 156.76 17.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.822 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.696 HG13 ' OH ' ' P' ' 134' ' ' TYR . 38.0 t -45.89 -41.55 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 23' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' P' ' 27' ' ' GLN . . . -66.2 -18.49 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' NE2' ' P' ' 27' ' ' GLN . 0.3 OUTLIER -99.26 -43.88 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.338 0.59 . . . . 0.0 110.008 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.542 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 1.9 mt -63.59 -19.2 64.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.557 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 26' ' ' GLN . . . . . 0.41 ' HG3' ' HG3' ' P' ' 27' ' ' GLN . 0.0 OUTLIER -88.88 -25.04 22.35 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 27' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' P' ' 23' ' ' ALA . 2.9 pp0? -132.98 -8.66 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 28' ' ' ARG . . . . . 0.403 ' HD3' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -109.94 -66.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.403 ' CE2' ' HD3' ' P' ' 28' ' ' ARG . 67.3 m-85 -107.43 88.8 2.82 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.39 0.614 . . . . 0.0 111.513 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.2 OUTLIER -152.47 16.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.997 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 91.1 m -121.89 129.82 52.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.716 HG11 HG23 ' P' ' 41' ' ' ILE . 4.6 t -107.68 150.49 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.917 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -123.05 112.11 17.38 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.411 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 23.3 m-85 -93.22 170.74 9.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.714 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.45 179.81 30.78 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.531 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.924 ' CD1' ' HB2' ' U' ' 7' ' ' DAL . 0.6 OUTLIER -63.53 119.94 10.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 110.715 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t0 61.44 37.46 16.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.045 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -121.31 137.92 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 29.9 p90 -127.4 56.79 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 110.719 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.2 150.92 32.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.716 HG23 HG11 ' P' ' 32' ' ' VAL . 1.4 mp -94.21 163.23 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.982 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.481 ' N ' HG22 ' P' ' 41' ' ' ILE . 43.2 p -113.41 149.27 34.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.312 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.77 -32.4 3.03 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.31 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -64.17 -33.36 75.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.689 0.281 . . . . 0.0 111.614 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.541 ' CB ' HG13 ' P' ' 32' ' ' VAL . 78.4 m-85 -100.61 -3.71 29.93 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.408 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 70.2 t -61.79 -42.97 96.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.609 0.242 . . . . 0.0 111.351 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.413 ' NE2' HG12 ' P' ' 48' ' ' ILE . 0.9 OUTLIER -43.83 -43.5 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.063 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.34 -46.8 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -58.27 -42.24 86.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.9 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -42.7 77.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.87 65.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.063 ' CD2' HG22 ' P' ' 48' ' ' ILE . 14.6 m-70 -62.5 -38.56 90.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 110.473 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 53' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -68.58 -41.68 79.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.927 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.84 98.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.733 0.302 . . . . 0.0 111.147 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 55' ' ' TYR . . . . . 0.605 ' HE2' ' HD1' ' P' ' 52' ' ' HIS . 0.2 OUTLIER -71.84 -36.5 70.21 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.776 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.71 HD21 ' HG3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -75.14 -34.21 61.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.617 -178.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.55 -30.16 64.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.011 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 -17.85 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.376 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -112.58 111.79 51.69 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.301 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.93 -63.27 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.949 2.433 . . . . 0.0 114.421 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 22.59 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.646 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.5 112.96 24.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.349 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -117.01 132.87 56.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.546 ' HB ' HD13 ' P' ' 56' ' ' LEU . 14.4 p -98.64 146.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.547 0.689 . . . . 0.0 111.474 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.461 HD22 HG21 ' P' ' 107' ' ' VAL . 0.3 OUTLIER -107.3 103.65 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.462 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.458 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.5 t -83.59 100.2 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.387 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 5.5 tt0 -90.96 121.54 32.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.306 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.13 146.42 20.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.265 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' HG23 ' P' ' 70' ' ' THR . 0.8 OUTLIER -145.33 161.08 40.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.632 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.447 HG23 ' NH1' ' P' ' 86' ' ' ARG . 0.5 OUTLIER -162.38 -172.99 3.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 111.638 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 6.0 p-10 -81.75 166.32 20.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.374 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 tm-20 -64.15 -39.0 93.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.932 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.434 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 4.1 mmm180 -39.37 106.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -173.91 15.49 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.056 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.21 146.79 32.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.527 0.203 . . . . 0.0 110.646 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.432 ' O ' HD12 ' P' ' 80' ' ' ILE . 88.1 Cg_exo -45.46 -40.89 18.01 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.479 2.119 . . . . 0.0 112.644 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.37 -41.27 89.68 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.498 ' CZ ' ' C ' ' U' ' 4' ' ' DGL . 3.1 t80 -69.42 -44.2 71.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' P' ' 80' ' ' ILE . 27.8 m120 -61.84 -75.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.618 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.6 OUTLIER -30.01 -45.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 O-C-N 123.185 0.303 . . . . 0.0 111.737 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.13 -60.65 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.607 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -44.21 -45.98 8.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.767 178.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.409 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.9 -38.24 92.76 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.82 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -44.01 63.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.865 0.364 . . . . 0.0 110.226 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -39.72 90.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.528 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 3.0 mtt180 -61.65 -39.85 92.84 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.52 81.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.143 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -32.01 73.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.495 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.53 -63.53 1.24 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.514 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.23 -37.09 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 111.403 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -61.73 2.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.8 -20.3 59.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.363 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.69 -58.78 5.83 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.519 HD12 HD22 ' P' ' 104' ' ' LEU . 24.2 mt -59.41 -30.04 68.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.373 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.63 94.82 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.243 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.12 -26.71 73.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.892 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 1.2 mtpm? -78.23 -9.92 59.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.68 0.276 . . . . 0.0 111.26 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.12 -3.2 23.98 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.152 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.839 HG11 HD21 ' P' ' 104' ' ' LEU . 16.8 t -74.68 126.14 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.766 0.283 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 100' ' ' ASP . . . . . 0.45 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.3 OUTLIER -62.37 139.23 58.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.0 111.566 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.862 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -62.99 -32.84 74.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.294 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.46 -19.99 58.39 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.189 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.71 ' HG3' HD21 ' P' ' 56' ' ' LEU . 0.0 OUTLIER -101.99 -4.32 26.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.198 0.523 . . . . 0.0 111.035 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' P' ' 101' ' ' ALA . 0.5 OUTLIER -110.8 120.48 42.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.458 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -124.94 -175.17 14.17 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.852 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.781 ' O ' HG13 ' P' ' 107' ' ' VAL . 15.8 p -149.21 163.12 38.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.885 0.374 . . . . 0.0 111.279 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.781 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -177.0 111.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.47 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 1.1 p -111.9 145.54 39.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 0.0 111.812 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' P' ' 110' ' ' GLY . 83.7 m-85 -121.16 23.83 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 11.56 -115.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.859 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.36 17.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.175 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -59.1 -54.42 47.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 110.113 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -141.33 89.74 9.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.364 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.53 165.73 10.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.712 2.275 . . . . 0.0 112.534 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -59.72 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.814 HG21 ' HB3' ' P' ' 126' ' ' LYS . 11.4 t -88.21 109.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -75.98 134.07 40.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.777 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.04 -179.15 27.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.616 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -142.51 73.89 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -168.53 161.89 11.84 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 121' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 0.0 OUTLIER -46.35 -24.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.83 -59.06 3.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 -40.29 67.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 25.4 m-85 -60.48 -43.26 97.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 95.4 p -68.21 -33.34 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.814 ' HB3' HG21 ' P' ' 116' ' ' VAL . 23.7 mtmt -71.89 -22.85 61.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.218 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -87.41 -29.21 21.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.357 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.8 mtp180 -66.35 90.2 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.246 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.8 OUTLIER -158.81 158.6 33.83 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.67 107.84 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.85 147.75 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -100.53 100.02 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.586 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' P' ' 65' ' ' LEU . . . -104.55 143.87 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' P' P ' 134' ' ' TYR . . . . . 0.696 ' OH ' HG13 ' P' ' 22' ' ' VAL . 8.1 m-85 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.621 ' O10' ' CB ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' U' U ' 3' ' ' ALA . . . . . 0.621 ' CB ' ' O10' ' U' ' 2' ' ' AMU . . . . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.534 ' HB3' ' O ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.464 ' CZ ' ' CE1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.924 ' HB2' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.829 0.347 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.16 154.74 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 10.1 m -84.58 114.25 21.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 20.3 m -90.08 -54.1 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -150.23 150.21 31.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -89.88 137.55 32.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.29 -23.14 21.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.201 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.63 -81.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.99 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.83 163.12 3.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.46 -57.98 1.49 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.418 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 43.95 56.06 4.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 111.335 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.24 -66.71 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.604 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.15 -54.67 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 0.0 111.374 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.94 151.4 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -107.05 109.85 21.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p -132.04 118.82 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -89.74 106.48 18.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.75 9.4 26.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.552 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.26 -38.35 1.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.795 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 17.7 m-85 -121.67 170.93 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 111.822 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.36 150.69 23.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.887 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 t -38.26 -63.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.53 -13.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -46.35 5.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 12.5 mt -56.88 -22.24 35.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.506 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 26' ' ' GLN . . . . . 0.541 ' HA ' ' ND2' ' P' ' 30' ' ' ASN . 0.1 OUTLIER -104.64 -11.96 16.65 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -115.77 -27.32 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -55.91 2.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -108.21 81.83 1.54 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.174 0.512 . . . . 0.0 111.914 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.541 ' ND2' ' HA ' ' P' ' 26' ' ' GLN . 5.0 t-20 -140.39 13.71 2.37 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.918 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.665 ' OG1' HG13 ' P' ' 131' ' ' VAL . 53.8 m -134.56 136.63 43.15 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.722 HG11 HG23 ' P' ' 41' ' ' ILE . 10.5 t -108.6 150.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.077 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -123.75 114.54 20.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 22.3 m-30 -93.4 170.59 9.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.777 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.31 -172.25 31.01 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.725 ' CD1' ' HB2' ' U' ' 7' ' ' DAL . 1.0 OUTLIER -60.98 126.34 27.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.27 0.535 . . . . 0.0 110.673 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 46.64 33.77 2.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -96.08 141.51 29.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.689 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 3.3 t80 -129.85 48.81 2.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.714 0.769 . . . . 0.0 109.767 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -150.29 151.01 32.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.955 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.722 HG23 HG11 ' P' ' 32' ' ' VAL . 2.5 mt -96.08 161.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.559 0.219 . . . . 0.0 110.661 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.465 ' N ' HG22 ' P' ' 41' ' ' ILE . 16.2 p -110.83 144.8 39.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.032 0.444 . . . . 0.0 111.755 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.58 -30.17 3.13 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 113.413 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -31.34 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.689 0.281 . . . . 0.0 111.721 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.585 ' CB ' HG13 ' P' ' 32' ' ' VAL . 87.8 m-85 -105.7 4.71 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 72.0 t -70.9 -37.17 67.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -31.99 37.02 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.557 -178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 0.986 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -62.86 -49.98 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.191 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.554 HD23 ' CD2' ' P' ' 93' ' ' TYR . 1.6 mp -53.57 -37.45 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.62 -39.24 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.708 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.48 -57.32 4.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 0.986 ' CD2' HG22 ' P' ' 48' ' ' ILE . 20.0 m-70 -54.31 -37.85 65.29 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 53' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' P' ' 49' ' ' LEU . . . -60.15 -43.49 95.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.729 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.98 96.81 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.865 0.364 . . . . 0.0 110.551 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -73.86 -38.33 64.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.825 ' CD2' HG11 ' P' ' 99' ' ' VAL . 4.5 tp -65.48 -43.12 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.352 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.06 -37.67 78.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.445 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.85 -24.04 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -115.37 114.88 42.69 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.52 -48.6 19.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 113.894 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.7 18.48 7.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.612 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.64 116.57 28.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 0.0 110.711 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -118.19 133.96 55.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.953 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.656 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.3 p -95.57 141.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.345 0.593 . . . . 0.0 111.259 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.841 HD21 ' CG2' ' P' ' 107' ' ' VAL . 5.1 tt -108.96 101.03 10.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.725 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.468 HG13 HD22 ' P' ' 132' ' ' LEU . 0.7 OUTLIER -79.27 112.24 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.329 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.517 ' HG3' HD22 ' P' ' 65' ' ' LEU . 8.2 mt-10 -99.72 117.56 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.1 22.15 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.997 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.691 ' O ' HG23 ' P' ' 70' ' ' THR . 0.9 OUTLIER -145.5 157.92 43.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.814 0.34 . . . . 0.0 110.32 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.691 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.5 p -168.03 -176.65 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.059 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 6.1 p-10 -72.42 155.58 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.49 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pm0 -62.4 -34.23 76.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.018 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -39.68 106.92 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 74' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.69 168.25 17.42 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.569 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 75' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' P' ' 79' ' ' ASN . 0.5 OUTLIER -83.03 146.16 51.11 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.653 0.263 . . . . 0.0 110.568 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.11 -36.36 84.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.957 2.438 . . . . 0.0 114.182 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 77' ' ' GLU . . . . . 0.416 ' O ' HG22 ' P' ' 80' ' ' ILE . 1.0 OUTLIER -64.12 -48.96 74.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.79 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -75.07 -30.25 60.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -65.38 -74.54 0.1 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.627 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.3 OUTLIER -32.27 -38.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 O-C-N 123.23 0.332 . . . . 0.0 111.231 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 81' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -61.41 -59.37 5.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.499 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -47.22 -50.85 20.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.922 178.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.478 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.72 -45.24 86.06 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.598 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 4.2 tp60 -49.25 -38.69 27.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.281 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -67.65 -46.65 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.715 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.579 ' NH1' HG21 ' P' ' 70' ' ' THR . 0.4 OUTLIER -58.27 -40.65 82.43 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.595 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.12 -31.98 70.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.124 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -32.13 70.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.429 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.53 -60.16 4.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.8 -35.62 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -42.83 97.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.502 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.77 -22.63 78.93 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 93' ' ' TYR . . . . . 0.554 ' CD2' HD23 ' P' ' 49' ' ' LEU . 5.2 t80 -63.88 -62.09 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.6 ' CD1' HG11 ' P' ' 64' ' ' VAL . 75.3 mt -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.501 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.62 92.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.753 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.37 -24.44 76.07 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -73.17 -10.06 59.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.79 36.41 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.934 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.825 HG11 ' CD2' ' P' ' 56' ' ' LEU . 22.2 t -75.8 128.8 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.24 138.64 57.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -53.28 -36.03 60.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.04 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.06 -15.53 60.71 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.043 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.686 ' HE3' HG13 ' P' ' 99' ' ' VAL . 7.0 mtpp -92.88 -11.44 33.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' P' ' 101' ' ' ALA . 1.8 mt -103.68 142.81 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.451 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -147.69 145.64 14.47 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.771 ' O ' HG13 ' P' ' 107' ' ' VAL . 15.2 p -123.27 162.57 22.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.956 0.407 . . . . 0.0 111.313 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.841 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER 179.05 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.599 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -98.69 142.55 30.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.902 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' P' ' 112' ' ' GLU . 34.7 m-85 -113.31 13.81 19.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.89 -109.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.045 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -107.96 15.31 24.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 112' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' P' ' 109' ' ' TYR . 0.2 OUTLIER -63.25 -45.02 93.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.633 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 113' ' ' LYS . . . . . 0.411 ' N ' ' OE2' ' P' ' 112' ' ' GLU . 20.9 mtmm -146.51 88.93 5.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.71 164.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 0.0 113.143 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.37 -61.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.507 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.776 HG21 ' HB3' ' P' ' 126' ' ' LYS . 15.3 t -88.41 109.79 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.27 136.12 47.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.109 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.56 173.17 13.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -140.88 92.89 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.068 0.434 . . . . 0.0 111.994 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -166.64 162.37 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 121' ' ' GLU . . . . . 0.416 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.2 OUTLIER -47.08 -25.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.578 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.02 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.725 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.64 69.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 12.9 m-85 -54.55 -50.52 67.73 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.072 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -65.99 -33.81 76.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.776 ' HB3' HG21 ' P' ' 116' ' ' VAL . 3.6 mtmt -68.04 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.915 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.46 -29.75 21.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 5.4 mtp180 -65.49 88.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -158.3 157.46 32.5 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.71 95.26 4.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.665 HG13 ' OG1' ' P' ' 31' ' ' THR . 13.6 t -82.44 112.62 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.468 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -63.8 105.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.565 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -100.55 128.41 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.482 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.831 179.732 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.457 ' O2 ' H5'2 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.422 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.855 0.359 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.422 ' N ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.49 ' HA ' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.725 ' HB2' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 89.9 p -161.32 -173.0 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m 70.35 -63.47 0.4 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -47.53 -59.93 2.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -139.58 123.29 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -147.75 134.97 20.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.91 -70.41 0.68 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -179.08 168.0 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.53 24.83 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -29.43 49.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 11' ' ' ASN . . . . . 0.417 ' CG ' ' HB3' ' P' ' 14' ' ' ALA . 2.5 t30 -178.08 49.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.82 -56.53 3.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.414 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.12 37.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.404 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.417 ' HB3' ' CG ' ' P' ' 11' ' ' ASN . . . -62.44 82.04 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.318 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 53.33 48.56 21.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.289 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.13 147.61 52.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 54.9 m-85 -136.04 108.42 7.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 111.282 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 9.95 32.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.424 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 -31.66 3.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.563 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.628 ' HB2' HD21 ' P' ' 25' ' ' LEU . 33.5 m-85 -117.29 161.8 18.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 16.7 t -111.15 160.57 16.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.755 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.436 HG23 ' H ' ' P' ' 22' ' ' VAL . 17.2 t -40.06 -56.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.37 -19.94 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.76 -43.61 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.298 0.57 . . . . 0.0 110.283 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' P' ' 20' ' ' TYR . 47.1 mt -67.94 -22.0 65.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.44 -20.88 26.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -143.42 -3.57 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 28' ' ' ARG . . . . . 0.41 ' HD2' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -107.26 -69.87 0.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.41 ' CE2' ' HD2' ' P' ' 28' ' ' ARG . 58.3 m-85 -108.86 89.56 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 112.101 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -150.14 18.75 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 86.9 m -126.3 132.01 51.74 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.833 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 1.065 HG11 HG23 ' P' ' 41' ' ' ILE . 23.6 t -108.36 149.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -113.41 113.44 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.623 0.725 . . . . 0.0 112.301 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.802 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 7.1 m-30 -90.29 174.49 7.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.567 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.89 -177.85 15.06 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.514 ' CZ ' ' HA ' ' U' ' 7' ' ' DAL . 12.9 t80 -62.34 136.45 57.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.82 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.0 28.21 0.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.269 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.447 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -105.5 127.75 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.704 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.45 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 23.3 p90 -128.11 43.56 3.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.478 . . . . 0.0 110.2 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -148.06 150.51 34.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.345 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 1.065 HG23 HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -89.06 166.32 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.78 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.467 ' H ' HG22 ' P' ' 41' ' ' ILE . 47.1 p -111.09 150.1 29.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.125 0.488 . . . . 0.0 111.568 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.56 -31.2 3.54 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.337 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.03 -32.44 73.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.404 ' O ' HG13 ' P' ' 48' ' ' ILE . 92.1 m-85 -104.05 5.11 35.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.43 HG13 ' OH ' ' P' ' 93' ' ' TYR . 76.3 t -70.68 -39.92 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.81 -33.74 17.51 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.681 -178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.058 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -59.17 -52.56 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 110.065 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.753 HD11 HG13 ' P' ' 90' ' ' VAL . 3.1 mm? -55.57 -33.32 63.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.681 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.23 -43.04 68.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.9 -37.06 62.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.058 ' CD2' HG22 ' P' ' 48' ' ' ILE . 28.4 m-70 -69.04 -38.73 79.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.84 94.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.347 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.36 90.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.021 0.439 . . . . 0.0 110.311 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 55' ' ' TYR . . . . . 0.444 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 7.8 t80 -72.56 -40.4 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.768 ' CD2' HG11 ' P' ' 99' ' ' VAL . 1.8 tp -61.64 -44.24 97.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -65.95 -41.8 90.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.94 3.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -113.77 118.05 43.48 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.483 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.56 -56.5 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.715 2.277 . . . . 0.0 113.727 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 23.42 1.59 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.475 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -91.5 131.82 36.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 110.547 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -137.35 137.72 39.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.997 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.9 p -98.16 141.29 16.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.519 0.675 . . . . 0.0 111.533 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.878 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.9 tt -108.97 103.62 12.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.565 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.8 OUTLIER -81.32 113.62 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.02 118.72 37.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -104.06 139.54 14.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.582 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 127' ' ' ASN . 57.0 m-80 -145.76 104.62 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.915 HG22 ' NH1' ' P' ' 86' ' ' ARG . 39.2 p -86.21 -176.54 5.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 10.4 p-10 -71.09 165.47 23.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.442 ' O ' ' CD ' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -66.68 -35.68 80.73 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.94 114.08 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.66 -142.12 17.3 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.807 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.29 146.11 52.65 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.512 0.196 . . . . 0.0 110.614 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.483 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 87.8 Cg_exo -44.68 -43.95 14.27 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.589 2.192 . . . . 0.0 113.715 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.72 -46.36 88.48 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' U' ' 3' ' ' ALA . 22.7 t80 -72.83 -36.56 67.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.949 0.404 . . . . 0.0 110.006 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' P' ' 80' ' ' ILE . 5.4 m120 -67.99 -74.33 0.12 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.621 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -29.98 -44.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.911 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -57.89 11.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.224 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.2 OUTLIER -46.53 -44.36 17.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.245 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.464 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -65.73 -38.13 94.17 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.564 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.34 -43.49 43.82 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.2 ptm180 -67.98 -33.72 75.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.466 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.915 ' NH1' HG22 ' P' ' 70' ' ' THR . 56.0 mtt180 -65.11 -49.23 70.75 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.543 0.687 . . . . 0.0 109.277 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.14 -34.81 74.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.704 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.45 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -63.89 -67.51 0.42 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.691 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.753 HG13 HD11 ' P' ' 49' ' ' LEU . 59.0 t -53.16 -43.35 49.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.112 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -40.98 85.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.546 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.77 -15.58 80.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.914 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 93' ' ' TYR . . . . . 0.43 ' OH ' HG13 ' P' ' 46' ' ' VAL . 2.6 t80 -72.75 -64.27 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.58 ' CD1' HG11 ' P' ' 64' ' ' VAL . 28.7 mt -55.78 -32.62 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.396 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.75 89.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.828 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.13 -22.75 77.41 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.605 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -76.04 -10.03 59.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.806 0.336 . . . . 0.0 110.975 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.3 35.73 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.148 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' P' ' 56' ' ' LEU . 18.2 t -75.63 125.81 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.852 0.326 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' P' ' 103' ' ' LYS . 2.5 p30 -62.34 139.54 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.335 0.588 . . . . 0.0 111.565 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.48 -36.35 10.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.449 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.99 -17.1 60.55 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.078 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' P' ' 63' ' ' LYS . 24.3 mtpp -91.49 -14.51 30.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.036 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' P' ' 94' ' ' LEU . 1.3 mt -102.62 143.07 32.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.565 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -139.92 146.14 17.48 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.776 ' O ' HG13 ' P' ' 107' ' ' VAL . 19.4 p -128.78 152.04 48.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.783 0.325 . . . . 0.0 110.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -175.39 119.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -118.53 133.63 55.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.522 ' O ' ' C ' ' P' ' 110' ' ' GLY . 23.7 m-85 -102.01 32.48 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -103.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.539 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' P' ' 72' ' ' GLU . 41.7 mt-10 -113.89 16.87 18.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -47.21 66.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.66 89.34 11.78 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.6 163.39 15.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.683 2.255 . . . . 0.0 112.935 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.73 -64.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' P' ' 126' ' ' LYS . 2.4 t -88.85 108.74 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 117' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' P' ' 117' ' ' LEU . 3.6 mm? -66.89 135.83 54.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.46 173.94 14.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.085 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -140.74 60.95 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.05 152.14 51.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 121' ' ' GLU . . . . . 0.411 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.1 OUTLIER -37.78 -33.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.28 -61.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.84 -42.63 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.992 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.466 ' O ' ' HD3' ' P' ' 128' ' ' ARG . 4.7 m-85 -56.65 -54.0 51.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.196 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 125' ' ' SER . . . . . 0.552 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 4.8 m -55.68 -35.59 66.2 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.664 ' HB3' HG21 ' P' ' 116' ' ' VAL . 33.9 mtmt -75.44 -21.22 58.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.56 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 69' ' ' ASN . 44.9 m-20 -80.95 -42.76 20.77 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.802 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.39 73.58 0.72 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.949 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.6 143.42 49.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.11 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.61 98.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.66 111.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 101.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.589 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -97.6 125.65 42.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.46 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.945 179.705 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.447 ' PB ' ' O7 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.515 H111 ' H3 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' U' U ' 3' ' ' ALA . . . . . 0.53 ' HB3' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.657 ' CG ' ' H2 ' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.657 ' H2 ' ' CG ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.514 ' HA ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 28.3 t 63.07 -79.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.039 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -156.29 168.9 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -72.61 -51.24 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -122.25 104.29 9.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.25 109.2 16.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.67 -15.47 45.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 63.83 22.92 13.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.787 0.327 . . . . 0.0 111.188 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 9' ' ' ALA . . . . . 0.785 ' CB ' ' HB2' ' P' ' 23' ' ' ALA . . . 53.16 32.51 13.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.308 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 10' ' ' GLY . . . . . 0.639 ' HA2' ' HB2' ' P' ' 14' ' ' ALA . . . -91.55 -71.34 1.2 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.329 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 16.1 m120 64.85 -107.36 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.184 0.194 . . . . 0.0 111.4 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.12 -73.64 1.27 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.665 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 13' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' P' ' 14' ' ' ALA . . . -90.45 -55.24 3.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.639 ' HB2' ' HA2' ' P' ' 10' ' ' GLY . . . 76.48 124.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.431 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -143.46 -178.4 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.087 0.47 . . . . 0.0 111.763 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 33.2 p -125.88 151.43 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.237 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 45.5 m-85 -129.98 112.08 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.678 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.35 9.62 61.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.584 -0.817 . . . . 0.0 114.08 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 -27.4 3.86 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.137 -1.506 . . . . 0.0 114.529 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.15 173.89 8.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.285 0.542 . . . . 0.0 111.726 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.89 151.52 21.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' P' ' 25' ' ' LEU . 13.1 t -44.5 -35.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.898 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 23' ' ' ALA . . . . . 0.785 ' HB2' ' CB ' ' P' ' 9' ' ' ALA . . . -63.59 -13.04 38.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.612 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 24' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' P' ' 29' ' ' TYR . 0.4 OUTLIER -98.16 -44.37 6.63 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.849 0.833 . . . . 0.0 108.891 177.385 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' P' ' 22' ' ' VAL . 7.5 mt -58.89 -23.36 60.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.348 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -111.87 -19.19 12.48 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 -32.23 2.99 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 28' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -141.57 59.92 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 0.5 OUTLIER 157.5 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.974 0.416 . . . . 0.0 110.691 178.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 2.3 p30 172.95 15.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 57.3 m -120.4 126.82 51.41 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.628 0.649 . . . . 0.0 112.203 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.745 HG11 HG23 ' P' ' 41' ' ' ILE . 3.4 t -108.18 145.35 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.49 115.19 23.54 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.7 m-85 -96.04 168.28 10.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.766 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.53 -171.87 28.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.976 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 12.0 t80 -61.8 116.52 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.656 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 58.33 39.2 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.41 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 1.7 tptp -112.97 136.15 52.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.416 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 27.5 p90 -130.33 54.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.58 150.59 33.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.745 HG23 HG11 ' P' ' 32' ' ' VAL . 1.6 mp -96.76 161.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.781 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.468 ' N ' HG22 ' P' ' 41' ' ' ILE . 30.7 p -112.71 147.72 36.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.017 0.437 . . . . 0.0 111.385 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.77 -30.17 3.39 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.082 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.49 -33.89 75.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.562 0.22 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.403 ' CB ' HG13 ' P' ' 32' ' ' VAL . 96.9 m-85 -104.49 3.36 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.57 -41.14 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' P' ' 47' ' ' GLN . 6.5 pm0 -47.6 -35.05 8.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.711 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.003 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -64.37 -46.78 92.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.536 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.437 ' HB3' ' CE1' ' P' ' 93' ' ' TYR . 5.6 mp -56.87 -47.34 80.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.375 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 50' ' ' ASP . . . . . 0.449 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.3 OUTLIER -67.45 -33.52 75.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.428 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.9 -41.03 37.93 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.685 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.003 ' CD2' HG22 ' P' ' 48' ' ' ILE . 22.3 m-70 -64.21 -38.46 91.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.26 88.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 55' ' ' TYR . . . . . 0.448 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 21.6 t80 -79.2 -34.45 42.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 1.023 HD23 HG11 ' P' ' 99' ' ' VAL . 5.0 tp -66.51 -41.3 89.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -75.64 -34.54 60.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.653 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.93 -24.85 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.57 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -112.57 114.82 49.74 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.634 0.254 . . . . 0.0 110.389 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -48.94 -63.12 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.876 2.384 . . . . 0.0 114.039 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.27 18.85 2.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -84.56 113.57 21.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.9 mttp -115.59 128.46 55.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.51 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.7 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.6 p -96.2 139.98 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 121.305 0.574 . . . . 0.0 110.641 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.618 HD21 HG22 ' P' ' 107' ' ' VAL . 1.1 tt -112.45 103.09 11.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.956 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.689 HG13 HD22 ' P' ' 132' ' ' LEU . 0.6 OUTLIER -81.47 106.45 12.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.479 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.58 ' HA ' HG23 ' P' ' 107' ' ' VAL . 20.7 mt-10 -89.8 119.32 30.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.526 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 134.53 12.52 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.607 ' O ' HG23 ' P' ' 70' ' ' THR . 27.3 m120 -134.62 159.02 42.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.438 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.607 HG23 ' O ' ' P' ' 69' ' ' ASN . 7.6 p -164.42 -177.61 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.162 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.518 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 8.2 p-10 -73.55 155.6 38.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' P' ' 111' ' ' GLU . 2.6 pp20? -63.49 -34.86 78.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.962 0.41 . . . . 0.0 110.641 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -41.8 165.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.438 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 74' ' ' GLY . . . . . 0.529 ' O ' HG23 ' P' ' 75' ' ' THR . . . 78.4 -124.47 6.7 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.773 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 75' ' ' THR . . . . . 0.529 HG23 ' O ' ' P' ' 74' ' ' GLY . 0.8 OUTLIER -163.62 145.53 7.52 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.437 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 2.4 Cg_endo -39.61 -53.13 2.36 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.297 2.664 . . . . 0.0 113.25 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -40.73 93.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.621 ' OH ' ' HB3' ' U' ' 4' ' ' DGL . 1.1 t80 -72.37 -35.16 68.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.453 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.74 ' HA ' HD12 ' P' ' 82' ' ' LEU . 5.6 m120 -76.94 -76.88 0.16 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.573 HD11 ' O ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.04 -43.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.3 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 81' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -68.86 -60.72 2.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 1.028 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.14 -38.42 73.49 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.272 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 1.028 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -68.46 -50.96 34.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.341 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.4 mt-30 -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -46.49 88.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.324 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.615 ' HD2' HD22 ' P' ' 82' ' ' LEU . 0.4 OUTLIER -57.27 -42.62 81.95 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -59.87 -37.44 79.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.147 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 88' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -64.63 -32.34 73.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.467 178.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.59 -47.59 84.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.697 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.01 -34.69 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.702 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.567 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -66.94 -38.69 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.525 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.96 -29.47 58.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 93' ' ' TYR . . . . . 0.451 ' CD1' ' HE3' ' P' ' 97' ' ' LYS . 7.6 t80 -62.87 -53.76 49.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.596 ' HB2' HD21 ' P' ' 104' ' ' LEU . 20.3 mt -59.48 -28.62 67.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.263 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.57 -36.63 65.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.914 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.45 58.01 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.092 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.575 ' HD2' ' HA ' ' P' ' 94' ' ' LEU . 0.0 OUTLIER -49.42 -34.76 17.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.92 28.94 1.6 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.386 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 1.023 HG11 HD23 ' P' ' 56' ' ' LEU . 23.1 t -90.71 145.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.567 0.223 . . . . 0.0 110.822 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 100' ' ' ASP . . . . . 0.405 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -61.5 160.45 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.283 0.563 . . . . 0.0 111.526 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.772 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.64 -32.52 16.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.1 -21.67 46.93 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.48 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.08 -4.57 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.22 0.533 . . . . 0.0 110.923 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' P' ' 101' ' ' ALA . 4.6 mt -85.74 150.51 24.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.206 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.619 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.9 139.67 8.12 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.685 ' O ' HG13 ' P' ' 107' ' ' VAL . 34.6 p -141.57 151.2 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.685 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -166.95 170.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.855 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.573 ' O ' HD11 ' P' ' 80' ' ' ILE . 1.3 t -157.38 126.93 6.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.726 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.3 m-85 -115.49 18.49 15.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -1.28 -113.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.597 -0.729 . . . . 0.0 114.804 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -85.35 2.54 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.91 -57.05 14.47 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 88.22 5.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.76 170.81 18.69 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.022 2.481 . . . . 0.0 112.838 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.46 -56.03 2.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.152 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.892 HG13 ' HB1' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -88.72 138.61 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.699 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.44 139.41 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.154 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.19 176.93 15.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.881 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.464 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 0.1 OUTLIER -141.06 62.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 0.249 . . . . 0.0 111.279 -179.36 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 120' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 1.4 p30 -132.92 154.91 49.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.81 -26.09 0.12 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 122' ' ' ALA . . . . . 0.517 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -72.69 -62.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.97 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 123' ' ' ALA . . . . . 0.892 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -69.79 -42.43 73.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 1.0 OUTLIER -55.65 -48.76 74.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.759 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 58.2 m -63.34 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.397 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -68.33 -27.13 66.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.325 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.443 ' ND2' HG12 ' P' ' 116' ' ' VAL . 92.0 m-20 -89.07 -28.95 19.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -70.16 86.89 0.57 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 7.6 ptt-85 -159.79 159.18 32.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -123.63 102.35 7.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -86.87 109.58 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.689 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -59.68 102.19 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.572 178.354 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 126.92 48.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.678 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.874 179.624 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.595 ' PA ' ' HB2' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.499 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' U' U ' 3' ' ' ALA . . . . . 0.595 ' HB2' ' PA ' ' U' ' 1' ' ' UDP . . . . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.621 ' HB3' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.696 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.454 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.696 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 36.7 p -104.19 -54.22 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.62 68.63 4.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -90.0 -36.35 15.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -150.17 127.97 11.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -90.01 149.43 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.09 -52.96 4.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.03 116.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 15.72 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.392 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.33 80.49 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 68.34 -68.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -26.79 68.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.5 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 111.186 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.24 -168.65 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.202 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -102.33 176.23 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 39.1 p -127.68 110.68 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.944 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' P' ' 20' ' ' TYR . 63.4 m-85 -89.68 107.16 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.994 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.75 9.33 38.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.645 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.67 -37.1 1.87 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.349 -1.405 . . . . 0.0 114.037 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' P' ' 17' ' ' PHE . 5.3 m-85 -120.76 169.14 10.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.023 0.411 . . . . 0.0 111.586 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 26.0 t -102.78 152.99 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.439 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -40.07 -48.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.36 -17.27 28.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -42.61 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.284 0.564 . . . . 0.0 110.427 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.509 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 16.3 mt -59.27 -21.22 59.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.436 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 26' ' ' GLN . . . . . 0.771 ' HA ' HD21 ' P' ' 30' ' ' ASN . 4.5 mm-40 -103.26 -12.6 17.17 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -125.21 -22.72 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -109.78 -62.16 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -108.25 83.58 1.8 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.288 0.566 . . . . 0.0 112.162 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.771 HD21 ' HA ' ' P' ' 26' ' ' GLN . 2.6 t-20 -141.53 13.45 2.14 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.933 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.477 HG23 HG22 ' P' ' 131' ' ' VAL . 95.2 m -134.28 135.99 43.23 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.719 HG11 HG23 ' P' ' 41' ' ' ILE . 3.0 t -108.37 150.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.07 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.32 115.62 21.98 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.2 m-30 -96.18 169.87 9.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.512 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.56 -168.95 19.41 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.818 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.418 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 4.0 t80 -61.58 126.14 26.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 49.75 30.57 3.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.618 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.402 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -101.13 132.55 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.423 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 40.1 p90 -129.35 46.26 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 110.822 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.41 150.43 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.808 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.719 HG23 HG11 ' P' ' 32' ' ' VAL . 1.2 mp -90.9 164.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.259 . . . . 0.0 110.896 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.465 ' N ' HG22 ' P' ' 41' ' ' ILE . 67.2 p -112.8 149.98 32.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.213 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -43.48 -32.51 1.92 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.228 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.89 -33.06 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.415 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.502 ' CB ' HG13 ' P' ' 32' ' ' VAL . 81.4 m-85 -102.27 -1.02 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.59 -40.98 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -43.44 6.3 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.008 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -57.39 -50.34 77.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 110.556 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' P' ' 53' ' ' ALA . 5.1 mt -53.32 -37.46 62.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -40.26 56.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.13 -54.22 11.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.03 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.008 ' CD2' HG22 ' P' ' 48' ' ' ILE . 22.7 m-70 -56.98 -36.8 70.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 109.904 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 53' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' P' ' 49' ' ' LEU . . . -60.76 -42.53 97.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.07 95.51 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.854 0.359 . . . . 0.0 110.751 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.33 -36.43 53.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.707 ' CD2' HG11 ' P' ' 99' ' ' VAL . 8.0 tp -68.93 -39.42 79.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.935 0.398 . . . . 0.0 111.174 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.05 -36.74 66.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.192 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.45 -23.28 67.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.22 111.24 58.04 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.602 0.239 . . . . 0.0 110.363 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.17 -58.67 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.863 2.375 . . . . 0.0 113.927 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.65 2.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.638 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.18 116.95 27.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.77 131.12 57.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.038 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.661 ' HB ' HD13 ' P' ' 56' ' ' LEU . 3.9 p -95.98 133.69 36.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.433 0.635 . . . . 0.0 111.15 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.452 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.2 tt -109.79 103.67 12.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.793 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.73 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -82.41 108.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.73 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.47 ' HA ' HG23 ' P' ' 107' ' ' VAL . 2.4 tt0 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.773 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.77 128.58 8.87 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.722 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.721 ' O ' HG23 ' P' ' 70' ' ' THR . 1.8 m-80 -130.93 158.0 41.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.721 HG23 ' O ' ' P' ' 69' ' ' ASN . 0.9 OUTLIER -170.25 -175.19 1.89 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 111.495 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.563 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 14.0 p-10 -77.43 149.39 35.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.302 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 9.2 pm0 -57.71 -31.63 66.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.883 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.423 ' N ' ' HG2' ' P' ' 72' ' ' GLU . 2.9 tpp180 -40.74 107.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.36 -173.69 15.03 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.163 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.76 145.52 30.87 Favored Pre-proline 0 N--CA 1.466 0.355 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 81.4 Cg_exo -39.97 -46.79 3.91 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.916 2.411 . . . . 0.0 113.063 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.84 -40.99 94.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.508 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.4 t80 -73.99 -39.01 63.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.457 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 0.4 OUTLIER -68.78 -76.75 0.09 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' P' ' 79' ' ' ASN . 1.0 OUTLIER -30.64 -45.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.433 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.37 -57.62 11.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -45.31 -51.86 10.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.779 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -62.23 -35.84 92.16 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.482 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -47.9 65.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.913 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 0.0 OUTLIER -68.1 -32.99 73.69 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.827 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.494 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 6.6 mtt180 -65.22 -45.99 82.46 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.555 0.693 . . . . 0.0 109.229 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' P' ' 106' ' ' THR . . . -60.35 -35.55 75.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.749 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.99 -30.74 71.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.87 -56.35 20.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.938 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.04 -36.17 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -43.77 98.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -72.21 -24.44 76.42 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.98 -64.04 1.0 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.464 ' CD1' HG11 ' P' ' 64' ' ' VAL . 85.2 mt -53.83 -32.82 54.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 95' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -59.02 -41.6 88.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.053 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.72 -21.08 77.85 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -79.85 -9.52 59.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 122.74 0.416 . . . . 0.0 110.974 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.94 0.18 36.01 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.776 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.707 HG11 ' CD2' ' P' ' 56' ' ' LEU . 48.6 t -73.63 123.71 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.36 148.61 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -68.48 -34.24 75.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.673 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.39 -22.1 55.44 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.045 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.622 ' HD3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -100.05 -4.43 29.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.229 0.537 . . . . 0.0 111.133 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' P' ' 101' ' ' ALA . 37.2 mt -95.91 150.12 20.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.298 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.616 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -148.42 142.07 9.66 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.755 ' O ' HG13 ' P' ' 107' ' ' VAL . 45.0 p -134.02 155.69 49.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.668 0.27 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.755 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -170.77 171.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.424 ' OG ' HG23 ' P' ' 80' ' ' ILE . 14.7 p -162.62 134.54 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.633 0.254 . . . . 0.0 111.48 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.509 ' O ' ' C ' ' P' ' 110' ' ' GLY . 29.5 m-85 -123.62 23.59 8.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 1.25 -110.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 114.622 0.609 . . . . 0.0 114.622 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -84.05 5.06 27.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -54.71 -59.57 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 88.78 7.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.98 166.96 13.05 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.79 2.327 . . . . 0.0 113.018 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.72 -61.64 1.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.27 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' P' ' 126' ' ' LYS . 5.6 t -88.84 108.86 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.83 136.53 56.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.199 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.06 174.98 14.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.981 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.457 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 7.2 p-80 -141.12 61.09 1.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.765 0.283 . . . . 0.0 111.462 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 120' ' ' ASP . . . . . 0.724 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 2.7 p30 -130.16 156.35 44.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -43.66 -25.82 0.19 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 122' ' ' ALA . . . . . 0.724 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -75.13 -56.66 4.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.89 -43.19 68.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.666 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 2.0 m-85 -59.48 -47.38 85.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 94.6 p -63.36 -33.44 75.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 110.241 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.784 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -69.79 -24.49 63.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.887 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.85 -30.8 18.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.335 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 3.0 mtp180 -65.82 87.25 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.2 OUTLIER -159.32 157.17 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.248 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.06 96.23 4.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.477 HG22 HG23 ' P' ' 31' ' ' THR . 21.5 t -82.02 109.71 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.73 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -60.92 101.81 0.17 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.031 178.144 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.22 127.84 46.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.755 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.889 179.758 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.568 ' H6 ' " O5'" ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.576 ' C10' ' H ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.576 ' H ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.536 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.418 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.536 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 77.5 p -143.27 98.47 3.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 28.9 t -141.6 -77.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 5.0 t -90.14 -31.5 17.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -150.9 150.36 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -89.68 138.65 31.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.33 -12.31 61.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.396 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.29 121.14 32.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.08 -154.1 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.54 -69.82 1.21 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.436 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -177.59 111.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 110.77 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -28.61 73.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.681 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.14 -64.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.232 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.65 43.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 166.77 22.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 5.5 p -130.59 150.62 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -137.04 107.17 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.18 9.64 12.26 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.358 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.79 -41.41 1.32 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.819 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -126.65 172.59 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.967 0.413 . . . . 0.0 111.504 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -99.72 152.26 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.949 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.672 ' HA ' HD12 ' P' ' 25' ' ' LEU . 16.7 t -42.13 -53.85 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.315 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.46 -14.94 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -44.79 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 109.483 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' P' ' 22' ' ' VAL . 2.6 mt -59.06 -21.98 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.997 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -100.75 -11.93 19.51 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -121.86 -21.82 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 28' ' ' ARG . . . . . 0.483 ' HD3' ' CZ ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -118.39 -55.44 2.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.483 ' CZ ' ' HD3' ' P' ' 28' ' ' ARG . 53.0 m-85 -108.78 101.41 10.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.179 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 11.2 p-10 -170.44 20.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.247 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 82.7 m -128.88 131.29 47.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 2.6 t -110.98 143.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.211 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -117.28 118.55 32.59 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.51 170.73 7.86 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.132 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.45 -165.77 15.34 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.433 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.523 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 2.7 t80 -57.65 123.74 16.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.51 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 37' ' ' ASP . . . . . 0.407 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 3.2 p30 42.01 28.61 0.1 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.002 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -90.44 130.14 36.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.626 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 9.1 t80 -125.03 59.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.52 149.98 29.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.91 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.482 HG22 ' N ' ' P' ' 42' ' ' THR . 8.6 mt -96.83 161.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.482 ' N ' HG22 ' P' ' 41' ' ' ILE . 3.9 p -110.47 140.72 44.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 112.025 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.6 -30.03 3.1 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.095 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.84 -33.49 76.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.55 0.214 . . . . 0.0 111.552 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.403 ' O ' HG13 ' P' ' 48' ' ' ILE . 83.1 m-85 -101.26 0.17 36.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.42 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 75.6 t -66.87 -40.81 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.43 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -45.11 -43.52 9.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.423 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 0.953 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -54.08 -52.46 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.292 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' P' ' 53' ' ' ALA . 2.6 mp -50.92 -40.27 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.385 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -38.29 64.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.928 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.02 -58.89 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.821 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 0.953 ' CD2' HG22 ' P' ' 48' ' ' ILE . 18.8 m-70 -51.54 -37.0 47.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.171 0.51 . . . . 0.0 109.784 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 53' ' ' ALA . . . . . 0.566 ' HB1' ' NZ ' ' P' ' 97' ' ' LYS . . . -60.98 -48.16 83.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.289 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.85 76.86 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.926 0.394 . . . . 0.0 110.372 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -71.47 -42.12 68.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.676 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.75 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.301 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -67.29 -43.06 82.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.09 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.331 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -123.41 95.64 45.02 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.88 -24.61 39.58 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 113.29 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.9 5.27 51.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.55 127.03 36.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.8 mttp -121.51 130.56 53.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.046 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.1 p -97.38 147.34 6.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.502 0.668 . . . . 0.0 111.536 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.5 tt -119.78 104.24 10.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.665 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.683 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -83.15 109.87 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.618 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 1.6 mm-40 -89.7 121.55 31.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.54 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.25 133.84 11.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.881 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.2 OUTLIER -145.82 100.98 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.778 0.323 . . . . 0.0 110.754 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.862 HG21 HD11 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -88.05 -168.68 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 13.0 p-10 -81.79 164.91 21.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.974 0.416 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 10.1 tm-20 -66.93 -40.59 87.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.246 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.432 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -44.97 106.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.037 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.27 -164.83 12.01 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.479 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.27 146.02 34.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.657 0.265 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.68 ' O ' HD12 ' P' ' 80' ' ' ILE . 71.8 Cg_exo -50.78 -38.22 56.39 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.13 2.553 . . . . 0.0 114.158 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.55 -42.8 83.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 40.5 t80 -81.73 -29.26 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.66 ' HA ' HD12 ' P' ' 82' ' ' LEU . 2.0 m-80 -90.62 -11.54 39.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.68 HD12 ' O ' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -87.58 -40.74 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.2 -48.67 64.59 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.269 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 1.029 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -60.24 -38.46 83.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.126 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 1.029 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.4 -44.52 64.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.139 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.7 OUTLIER -50.63 -41.3 54.88 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.477 ' HG3' ' CE1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.65 -35.42 80.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.294 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -64.24 -52.39 58.95 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.55 -34.98 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.476 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -29.43 69.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.49 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.75 -50.77 63.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.629 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.15 -38.76 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.424 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.97 -40.68 96.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.234 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 -28.3 68.66 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 93' ' ' TYR . . . . . 0.466 ' CD1' ' HD2' ' P' ' 97' ' ' LYS . 4.3 t80 -59.97 -62.24 2.02 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.639 ' HA ' ' HD3' ' P' ' 97' ' ' LYS . 95.4 mt -54.43 -32.42 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.55 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.18 76.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.169 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.78 -29.75 75.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.547 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.639 ' HD3' ' HA ' ' P' ' 94' ' ' LEU . 0.7 OUTLIER -74.13 -11.6 60.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.11 3.49 15.24 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.75 HG11 ' CD2' ' P' ' 56' ' ' LEU . 28.2 t -80.98 131.82 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.897 0.349 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 100' ' ' ASP . . . . . 0.438 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -60.31 158.02 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.333 0.587 . . . . 0.0 111.556 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.876 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -86.42 -29.94 22.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.71 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.53 50.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.807 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.631 ' HE3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -99.93 -3.77 31.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.145 0.497 . . . . 0.0 111.163 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.3 mt -91.68 149.21 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.336 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.634 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -145.89 139.79 8.45 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.488 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 43.5 p -138.45 151.43 47.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.767 0.318 . . . . 0.0 110.975 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.511 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -161.27 169.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.133 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.478 ' OG ' HG23 ' P' ' 80' ' ' ILE . 51.6 p -162.68 130.04 3.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.506 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.552 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.0 OUTLIER -114.19 31.55 6.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.234 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.77 -113.12 0.01 OUTLIER Glycine 0 C--N 1.34 0.796 0 O-C-N 123.679 0.612 . . . . 0.0 114.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 2.7 mp0 -97.71 13.18 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 112' ' ' GLU . . . . . 0.436 ' CG ' ' HB3' ' P' ' 76' ' ' PRO . 26.0 mt-10 -61.72 -55.23 32.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.679 0.276 . . . . 0.0 110.378 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -134.19 89.83 27.24 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 161.2 8.98 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.641 2.227 . . . . 0.0 112.967 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.92 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.712 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.878 HG21 ' HB3' ' P' ' 126' ' ' LYS . 3.6 t -88.61 108.82 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.98 135.04 57.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.388 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.93 173.3 14.72 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.787 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.487 ' HA ' ' CD1' ' P' ' 124' ' ' TYR . 0.1 OUTLIER -141.21 64.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.787 0.294 . . . . 0.0 111.492 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.82 152.88 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -38.0 -32.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -60.93 2.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -43.93 74.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' P' ' 119' ' ' HIS . 0.8 OUTLIER -57.71 -52.99 63.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.316 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 125' ' ' SER . . . . . 0.403 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 11.2 t -59.33 -33.96 71.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.878 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -67.86 -27.84 67.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.572 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 69' ' ' ASN . 74.3 m-20 -82.96 -33.48 26.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.88 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.3 mpp_? -69.74 80.21 0.44 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.815 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 4.1 ptt180 -156.56 150.86 25.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.95 115.91 25.35 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.8 112.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.683 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -59.41 98.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.632 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -102.36 129.1 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.009 179.773 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.483 ' O2B' ' HB3' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' U' U ' 3' ' ' ALA . . . . . 0.483 ' HB3' ' O2B' ' U' ' 1' ' ' UDP . . . . . . . . 0 C--O 1.23 0.078 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.66 ' CG ' ' H2 ' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.68 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.523 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.68 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.833 0.349 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 65.9 m 61.43 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -97.09 145.5 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 31.6 p -87.04 -45.48 10.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -119.9 114.86 22.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.59 100.35 13.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 7' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' P' ' 8' ' ' ALA . 12.7 t70 -90.94 -23.71 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 8' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' P' ' 7' ' ' ASP . . . 67.78 -170.96 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.086 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.33 126.97 31.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.194 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.06 -39.96 5.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.444 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.16 11.55 7.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.441 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.68 -24.98 26.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.566 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 111.372 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.08 52.86 9.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.006 0.432 . . . . 0.0 110.99 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -177.49 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.358 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -119.5 106.24 12.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.525 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 94.2 m-85 -89.48 108.1 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.498 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.97 9.14 38.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.333 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -32.97 2.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.488 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' P' ' 17' ' ' PHE . 2.1 m-85 -115.41 160.61 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.025 0.441 . . . . 0.0 111.611 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 9.4 t -103.2 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.262 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.614 ' HA ' HD12 ' P' ' 25' ' ' LEU . 21.5 t -43.3 -41.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -17.27 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 -40.58 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.568 0.699 . . . . 0.0 110.012 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' P' ' 22' ' ' VAL . 6.3 mt -64.27 -15.34 59.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.564 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 26' ' ' GLN . . . . . 0.491 ' HG3' ' CD2' ' P' ' 134' ' ' TYR . 2.0 tt0 -92.78 -25.47 18.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.39 -9.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -117.12 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 54.0 m-85 -107.12 99.49 9.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 111.961 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.622 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 12.2 p-10 -178.38 27.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.22 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.508 HG23 HG22 ' P' ' 131' ' ' VAL . 78.6 m -126.48 127.08 44.81 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.791 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.745 HG11 HG23 ' P' ' 41' ' ' ILE . 1.9 t -104.19 150.13 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.157 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -124.63 112.64 17.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.243 0.544 . . . . 0.0 112.429 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -91.51 166.66 12.73 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.97 -167.64 19.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.064 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.54 126.32 26.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.016 0.436 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t0 53.09 27.92 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.568 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -100.97 136.8 40.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.485 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 46.4 p90 -135.72 36.05 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.22 150.63 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.799 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.745 HG23 HG11 ' P' ' 32' ' ' VAL . 0.8 OUTLIER -88.26 164.66 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.933 0.397 . . . . 0.0 111.069 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.456 ' H ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -114.38 149.06 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' P' ' 46' ' ' VAL . . . -41.18 -33.96 0.85 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.527 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.2 -31.79 72.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.644 0.259 . . . . 0.0 111.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.491 ' O ' HG13 ' P' ' 48' ' ' ILE . 71.2 m-85 -99.99 1.54 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' P' ' 43' ' ' GLY . 56.0 t -65.05 -44.72 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -40.01 -43.97 1.65 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 0.89 HG22 ' HD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -62.14 -47.4 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.066 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.41 HD22 HG13 ' P' ' 90' ' ' VAL . 16.2 mt -56.61 -51.77 67.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.801 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 50' ' ' ASP . . . . . 0.576 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.9 OUTLIER -61.13 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 51' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' P' ' 17' ' ' PHE . . . -71.14 -37.06 72.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 0.89 ' HD2' HG22 ' P' ' 48' ' ' ILE . 5.6 m-70 -66.21 -33.44 75.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.241 0.543 . . . . 0.0 110.321 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 53' ' ' ALA . . . . . 0.416 ' CB ' ' HG2' ' P' ' 97' ' ' LYS . . . -75.38 -31.14 60.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.826 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.25 69.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 111.356 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 55' ' ' TYR . . . . . 0.772 ' HH ' ' HE1' ' P' ' 134' ' ' TYR . 1.8 p90 -74.28 -34.41 63.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.577 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -72.4 -35.64 68.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -178.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.77 -31.7 65.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.98 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.89 61.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.38 111.79 57.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.819 0.342 . . . . 0.0 110.503 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.69 -62.49 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.079 2.519 . . . . 0.0 114.481 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.35 22.93 2.7 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.65 116.34 28.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.711 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -122.21 132.28 54.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.892 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.512 ' HB ' HD13 ' P' ' 56' ' ' LEU . 10.0 p -95.36 137.34 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 121.41 0.624 . . . . 0.0 111.466 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' P' ' 107' ' ' VAL . 0.6 OUTLIER -105.15 106.39 16.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.682 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.577 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.6 OUTLIER -84.88 104.39 12.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 10.4 mt-10 -89.59 119.88 30.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.596 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.16 95.92 1.88 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.094 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.708 ' O ' HG23 ' P' ' 70' ' ' THR . 0.4 OUTLIER -97.58 155.22 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.283 179.235 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.708 HG23 ' O ' ' P' ' 69' ' ' ASN . 0.7 OUTLIER -173.43 176.25 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.165 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -73.88 148.16 42.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.249 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' P' ' 114' ' ' PRO . 0.5 OUTLIER -55.36 -28.3 52.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.957 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.897 ' HD3' ' HB2' ' U' ' 7' ' ' DAL . 19.1 ttm180 -39.82 104.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.312 0.577 . . . . 0.0 112.263 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 74' ' ' GLY . . . . . 0.489 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.29 163.28 16.54 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.109 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.16 146.71 71.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.479 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 68.7 Cg_exo -50.53 -42.63 48.54 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.744 2.296 . . . . 0.0 113.95 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.99 -46.66 86.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.591 ' CE1' ' HA ' ' U' ' 5' ' ' 6CL . 0.0 OUTLIER -77.49 -32.31 54.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.547 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 1.5 m120 -63.56 -74.94 0.09 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.445 HG23 ' OG ' ' P' ' 108' ' ' SER . 0.7 OUTLIER -32.16 -40.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 120.779 0.323 . . . . 0.0 110.707 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 81' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' P' ' 84' ' ' GLN . . . -62.16 -55.3 30.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.039 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.3 OUTLIER -43.72 -52.65 6.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.595 177.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.44 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -68.62 -34.4 78.49 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.108 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.442 ' HB2' ' HA ' ' P' ' 81' ' ' ALA . 0.0 OUTLIER -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -64.09 -40.26 95.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.571 ' NH1' HG21 ' P' ' 70' ' ' THR . 9.1 mtt180 -60.26 -39.58 87.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.64 94.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.431 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.29 -34.89 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.51 -61.06 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.429 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.41 HG13 HD22 ' P' ' 49' ' ' LEU . 26.3 t -64.88 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.354 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -47.17 87.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.634 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.56 -23.01 76.79 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.839 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 93' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' P' ' 97' ' ' LYS . 5.2 t80 -64.43 -63.69 1.07 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' P' ' 64' ' ' VAL . 33.5 mt -55.47 -31.68 62.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.12 95.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.82 -24.08 75.64 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.447 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -74.98 -9.49 58.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.068 179.384 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.21 6.04 48.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.868 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' P' ' 56' ' ' LEU . 39.3 t -76.86 130.39 36.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.064 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.47 140.68 58.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.456 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.0 70.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.35 -17.9 57.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.929 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 12.6 mtpp -91.65 -13.38 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.999 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.423 HD21 ' CG1' ' P' ' 99' ' ' VAL . 2.8 mt -101.99 143.83 31.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.355 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.577 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.23 147.07 17.77 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.812 ' O ' HG13 ' P' ' 107' ' ' VAL . 17.4 p -127.93 154.71 45.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.728 0.299 . . . . 0.0 110.663 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.812 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -176.02 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.769 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.445 ' OG ' HG23 ' P' ' 80' ' ' ILE . 52.5 p -112.79 137.46 51.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.771 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.531 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.7 m-85 -113.22 26.85 10.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.707 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 5.8 -111.37 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.224 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.479 ' HG3' ' HG3' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -101.38 14.89 30.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -62.52 -55.16 30.09 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.24 88.83 5.69 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 114' ' ' PRO . . . . . 0.433 ' HG2' ' HG2' ' P' ' 72' ' ' GLU . 21.6 Cg_exo -65.95 169.89 12.56 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.026 2.484 . . . . 0.0 112.928 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.84 -61.69 1.33 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.224 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.44 114.17 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.601 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.04 138.7 57.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.8 178.19 18.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.053 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.512 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 0.5 OUTLIER -142.04 67.53 1.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.639 0.219 . . . . 0.0 111.305 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.09 153.13 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -38.98 -32.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.14 -52.65 13.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.874 0.368 . . . . 0.0 111.291 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.53 67.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.512 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 2.1 m-30 -63.91 -40.5 96.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 91.5 p -65.85 -35.75 81.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.026 0.441 . . . . 0.0 109.888 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -69.59 -25.3 63.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.743 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.63 -30.68 19.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 7.4 mtp180 -66.18 82.41 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -159.23 162.42 36.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -128.42 102.45 6.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.508 HG22 HG23 ' P' ' 31' ' ' THR . 14.1 t -91.21 117.52 34.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.1 OUTLIER -71.48 104.92 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.081 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -115.21 145.19 42.66 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.543 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' P' P ' 134' ' ' TYR . . . . . 0.772 ' HE1' ' HH ' ' P' ' 55' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.576 ' O2 ' H5'2 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.465 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' U' U ' 3' ' ' ALA . . . . . 0.409 ' N ' ' O1B' ' U' ' 1' ' ' UDP . . . . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.818 0.342 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.465 ' N ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.591 ' HA ' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.897 ' HB2' ' HD3' ' P' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 96.0 p -93.35 86.11 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 59.8 p -174.47 -41.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -71.82 -55.87 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -145.98 111.76 5.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -149.99 130.68 14.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.36 -52.61 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 59.12 103.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.32 60.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.62 -73.19 1.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.463 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 62.89 127.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 111.023 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.05 -46.7 4.09 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -50.45 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.12 -160.25 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 67.14 154.46 0.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.828 0.347 . . . . 0.0 111.194 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.9 121.17 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.757 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' P' ' 20' ' ' TYR . 57.1 m-85 -91.06 108.71 20.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.32 9.38 42.46 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.818 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.51 2.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.02 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.551 ' HD2' HD21 ' P' ' 25' ' ' LEU . 0.5 OUTLIER -120.62 164.89 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.021 0.439 . . . . 0.0 111.58 -179.272 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.3 t -98.27 152.32 19.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 15.7 t -39.9 -49.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.72 -15.98 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' P' ' 29' ' ' TYR . 0.2 OUTLIER -99.6 -47.58 5.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.233 0.539 . . . . 0.0 110.233 178.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' P' ' 20' ' ' TYR . 42.0 mt -54.62 -22.64 14.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.783 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -12.93 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -111.9 -29.69 7.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -129.79 -38.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.415 ' HB2' ' OD1' ' P' ' 24' ' ' ASP . 27.7 m-85 -109.91 104.78 13.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.614 0.721 . . . . 0.0 112.366 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 179.44 22.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.464 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 91.7 m -126.88 128.79 47.05 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.065 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.738 HG11 HG23 ' P' ' 41' ' ' ILE . 16.7 t -108.95 150.29 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.309 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -122.46 116.19 23.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.0 m-85 -95.66 168.63 10.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.67 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.77 -166.84 29.49 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.185 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -58.68 114.89 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 50.12 30.46 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.6 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.416 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -95.97 142.84 27.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.984 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -130.0 55.77 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.09 150.39 31.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.562 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.738 HG23 HG11 ' P' ' 32' ' ' VAL . 1.5 mp -97.38 161.93 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 110.836 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.466 ' N ' HG22 ' P' ' 41' ' ' ILE . 42.6 p -112.59 147.11 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.394 . . . . 0.0 111.251 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.63 -31.13 2.43 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.0 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.76 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 111.259 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.439 ' CB ' HG13 ' P' ' 32' ' ' VAL . 94.5 m-85 -105.26 3.75 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.946 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.66 -38.4 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -52.27 -32.81 39.04 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.615 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 0.962 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -63.51 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.158 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -59.33 -34.13 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.194 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.68 -39.16 52.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.924 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.45 -46.45 39.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 0.962 ' CD2' HG22 ' P' ' 48' ' ' ILE . 19.5 m-70 -62.28 -38.23 88.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.04 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.007 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.88 95.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.063 0.459 . . . . 0.0 110.203 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -75.38 -35.82 61.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.903 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.852 HD23 HG11 ' P' ' 99' ' ' VAL . 0.8 OUTLIER -63.56 -43.22 97.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.036 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -69.97 -41.22 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.264 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.38 -26.56 61.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -111.73 110.49 54.84 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.447 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.55 -51.03 11.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.795 2.33 . . . . 0.0 114.0 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 18.32 6.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.2 112.79 23.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.451 . . . . 0.0 110.658 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 7.5 mttt -115.96 130.11 56.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.722 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.9 p -99.04 146.59 8.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.569 0.7 . . . . 0.0 111.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.724 HD21 ' CG2' ' P' ' 107' ' ' VAL . 2.8 tt -117.63 105.26 11.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.486 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.4 OUTLIER -82.38 103.46 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.153 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.44 119.38 31.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.787 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.64 143.28 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.098 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.535 ' O ' HG23 ' P' ' 70' ' ' THR . 1.5 m-80 -138.96 157.52 45.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.535 HG23 ' O ' ' P' ' 69' ' ' ASN . 68.1 p -164.73 -165.29 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.474 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' P' ' 124' ' ' TYR . 24.0 p30 -90.89 158.8 16.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.517 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 2.3 pm0 -60.85 -33.55 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.845 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.408 ' HG2' ' OH ' ' P' ' 124' ' ' TYR . 5.3 mmm180 -45.32 111.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.15 -174.84 15.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.052 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.82 145.09 31.28 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 111.639 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.466 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 85.1 Cg_exo -38.57 -46.92 2.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.117 2.545 . . . . 0.0 113.723 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.37 -44.47 92.72 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.743 0.306 . . . . 0.0 111.024 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.7 t80 -70.1 -44.83 68.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' P' ' 80' ' ' ILE . 7.1 m120 -70.94 -76.02 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.6 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.67 -43.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.39 -55.88 11.96 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.65 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 1.011 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -49.43 -50.36 41.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 178.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 1.011 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -63.07 -42.59 99.54 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.9 tp60 -47.84 -40.44 21.34 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.204 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.3 ptm180 -67.6 -37.71 82.95 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.578 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 15.9 mtt180 -62.72 -47.67 82.58 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.616 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.45 -33.24 69.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.829 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -32.66 73.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.497 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -59.62 -56.51 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.511 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.413 ' HB ' HG11 ' P' ' 66' ' ' VAL . 21.4 t -66.08 -34.61 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.248 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -44.81 96.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.763 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.46 -23.66 77.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.5 -60.81 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 91.0 mt -55.91 -31.93 63.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.25 -39.08 82.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.032 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.04 95.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.04 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -34.66 74.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.02 26.59 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.095 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.852 HG11 HD23 ' P' ' 56' ' ' LEU . 49.6 t -90.53 143.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.179 0.191 . . . . 0.0 110.572 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.8 162.6 10.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 111.455 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -91.13 -31.5 16.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.548 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.93 -23.82 47.39 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.829 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.558 ' HG3' HD21 ' P' ' 56' ' ' LEU . 0.0 OUTLIER -100.63 -4.32 28.66 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.114 0.483 . . . . 0.0 111.059 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' P' ' 101' ' ' ALA . 47.0 mt -96.92 147.26 24.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.486 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -150.87 144.13 11.43 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.812 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.616 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 39.8 p -124.21 157.46 34.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.727 0.298 . . . . 0.0 110.533 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.724 ' CG2' HD21 ' P' ' 65' ' ' LEU . 92.7 t -161.14 162.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.6 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 2.3 t -155.74 123.25 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.493 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' P' ' 110' ' ' GLY . 92.6 m-85 -116.75 17.76 15.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -3.68 -113.54 0.0 OUTLIER Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -78.77 -2.33 38.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.02 -63.39 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.679 0.275 . . . . 0.0 110.753 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 89.49 20.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.7 163.44 13.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.706 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.37 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.655 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.78 113.95 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.78 136.53 52.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.28 175.67 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.721 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.455 ' HB3' ' CE2' ' P' ' 124' ' ' TYR . 11.0 m-70 -141.56 100.31 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.873 0.336 . . . . 0.0 111.629 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -170.83 161.56 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -47.33 -24.59 0.8 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.36 -60.73 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.934 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.05 77.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.817 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' P' ' 119' ' ' HIS . 13.2 m-85 -59.01 -50.38 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.239 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 8.4 t -62.38 -32.57 73.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -73.56 -24.36 60.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -88.94 -31.48 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.25 88.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.3 OUTLIER -158.78 157.88 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.86 100.68 7.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -84.32 113.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -62.63 102.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.662 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -106.91 132.95 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.086 179.694 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.123 0.487 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.548 ' HB3' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.544 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.815 0.341 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -113.15 -35.73 5.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t 60.16 109.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -90.04 -39.76 12.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.073 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -150.98 150.07 30.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -100.35 131.33 46.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.21 -28.12 19.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.242 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 62.95 32.08 15.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.875 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.49 -157.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.45 -73.17 1.26 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.673 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.01 165.97 33.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 0.0 111.047 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.15 -12.91 61.12 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.758 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.48 -29.38 4.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.78 0.324 . . . . 0.0 111.489 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.88 170.45 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 62.72 134.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -132.3 104.76 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' P' ' 20' ' ' TYR . 81.9 m-85 -89.86 106.39 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.45 9.05 22.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.523 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.21 -40.71 1.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.518 ' OH ' ' HG2' ' P' ' 47' ' ' GLN . 0.1 OUTLIER -128.89 -179.7 5.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.262 0.553 . . . . 0.0 111.899 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -118.28 175.81 5.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 t -42.94 -53.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.07 -21.12 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.77 -43.95 6.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.961 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' P' ' 51' ' ' ALA . 30.0 mt -56.85 -21.77 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.657 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 26' ' ' GLN . . . . . 0.476 ' HA ' HD21 ' P' ' 30' ' ' ASN . 45.2 mt-30 -106.63 -11.3 15.89 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.31 -25.35 4.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -111.14 -64.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -105.2 81.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.476 HD21 ' HA ' ' P' ' 26' ' ' GLN . 3.4 t-20 -139.68 9.61 2.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.989 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.612 HG23 HG22 ' P' ' 131' ' ' VAL . 67.8 m -135.21 138.32 43.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.738 HG11 HG23 ' P' ' 41' ' ' ILE . 10.3 t -109.62 149.89 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.031 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -117.42 116.46 27.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.804 0.811 . . . . 0.0 112.885 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.724 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -92.72 174.81 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.891 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.17 -176.45 14.83 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 2.7 t80 -61.84 131.8 51.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.703 0.751 . . . . 0.0 110.613 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 37' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 2.7 p30 44.68 29.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.445 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -94.53 119.86 33.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.65 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.766 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.4 OUTLIER -118.73 46.12 1.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.751 0.786 . . . . 0.0 110.053 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.41 150.47 31.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.433 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.741 HD11 HG22 ' P' ' 90' ' ' VAL . 2.6 mt -93.03 165.88 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.348 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.465 ' H ' HG22 ' P' ' 41' ' ' ILE . 0.3 OUTLIER -110.32 141.09 43.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.09 0.472 . . . . 0.0 111.828 -179.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.09 -31.72 4.53 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.055 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -33.01 74.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 111.015 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.5 ' CB ' HG13 ' P' ' 32' ' ' VAL . 74.8 m-85 -100.13 -6.85 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.865 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.3 -42.09 94.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 120.88 0.371 . . . . 0.0 111.44 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.518 ' HG2' ' OH ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -44.91 -42.55 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 0.965 HG22 ' CD2' ' P' ' 52' ' ' HIS . 5.6 mt -50.67 -55.5 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.368 0.604 . . . . 0.0 109.783 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.18 -32.93 25.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.906 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -41.21 67.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.682 0.277 . . . . 0.0 110.834 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 51' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -73.1 -42.68 62.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 0.965 ' CD2' HG22 ' P' ' 48' ' ' ILE . 46.3 m-70 -65.97 -39.31 90.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.921 0.391 . . . . 0.0 110.122 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.97 -50.63 71.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.47 -40.55 78.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -76.09 -38.34 57.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.72 HD13 ' HB ' ' P' ' 64' ' ' VAL . 1.2 tp -70.57 -35.73 73.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -73.67 -33.97 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.031 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.387 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -112.7 114.29 49.75 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.24 -50.17 11.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.611 2.207 . . . . 0.0 113.543 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.88 17.46 4.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.594 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.46 122.76 33.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.972 0.415 . . . . 0.0 110.182 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -124.78 135.71 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.583 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.72 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -100.88 150.05 5.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.489 0.661 . . . . 0.0 111.535 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.523 HD21 HG22 ' P' ' 107' ' ' VAL . 0.8 OUTLIER -121.76 107.81 12.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.763 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.2 OUTLIER -86.55 104.22 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' P' ' 133' ' ' ALA . 55.5 mt-10 -89.75 122.62 33.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.18 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 68' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -116.35 141.32 16.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.497 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.6 OUTLIER -148.32 113.99 5.68 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.972 HG22 ' NH1' ' P' ' 86' ' ' ARG . 45.5 p -99.69 176.28 5.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -58.96 138.62 57.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -50.48 -28.07 7.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.656 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.907 ' HG2' ' HB3' ' U' ' 7' ' ' DAL . 0.0 OUTLIER -46.21 106.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 0.0 112.774 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.86 -178.94 18.62 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.46 143.89 27.12 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.983 0.391 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.614 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -48.02 -27.94 9.72 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.775 2.317 . . . . 0.0 113.22 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -45.38 92.84 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.299 0.571 . . . . 0.0 110.752 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 14.1 t80 -90.12 -17.34 27.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.566 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' P' ' 76' ' ' PRO . 5.1 m-80 -85.6 -21.76 28.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.263 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -83.58 -35.59 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.81 -49.56 61.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.605 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.474 HD23 ' CE2' ' P' ' 78' ' ' TYR . 0.2 OUTLIER -52.32 -45.81 65.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.211 177.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.488 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -74.84 -53.91 6.13 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.282 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -46.0 -36.56 5.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.083 0.468 . . . . 0.0 109.875 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 34.8 mtp85 -67.68 -46.85 71.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.346 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.972 ' NH1' HG22 ' P' ' 70' ' ' THR . 31.1 mtt180 -58.07 -38.98 77.37 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.592 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -66.57 -37.18 84.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.107 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -30.68 71.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.325 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.31 -60.81 2.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.05 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.741 HG22 HD11 ' P' ' 41' ' ' ILE . 20.7 t -62.91 -41.41 92.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.601 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.603 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -58.44 -38.88 78.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.043 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.68 79.03 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.573 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.83 -60.19 2.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.582 ' HB3' HG21 ' P' ' 99' ' ' VAL . 90.3 mt -57.84 -34.13 69.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.053 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.64 81.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.988 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.17 -26.92 74.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.504 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.99 -9.03 59.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 111.366 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.77 -6.75 17.84 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.251 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.582 HG21 ' HB3' ' P' ' 94' ' ' LEU . 80.0 t -67.96 112.97 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.829 0.314 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.99 144.97 56.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.215 0.531 . . . . 0.0 111.401 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.51 -36.77 74.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.738 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.86 -24.95 55.31 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.766 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.12 -3.76 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.309 0.576 . . . . 0.0 110.798 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' P' ' 91' ' ' LYS . 0.7 OUTLIER -94.3 150.48 20.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.097 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.763 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -142.5 141.72 10.98 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.592 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 78.3 p -142.89 145.9 33.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.536 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -160.63 173.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.591 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -162.49 129.07 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.291 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.5 OUTLIER -114.21 27.12 9.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.683 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -4.59 -115.44 0.0 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.6 0.562 . . . . 0.0 114.23 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 3.2 mp0 -83.09 -2.05 54.38 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.761 -0.258 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.64 -63.1 1.31 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.662 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -139.96 89.4 11.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 164.77 11.28 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.652 2.235 . . . . 0.0 112.705 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.39 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.757 HG21 ' HB3' ' P' ' 126' ' ' LYS . 2.8 t -89.22 111.08 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.783 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.48 135.24 47.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.89 172.88 12.9 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.951 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.518 ' CE1' ' HH ' ' P' ' 124' ' ' TYR . 3.9 t60 -138.08 48.76 1.96 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.365 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.02 157.66 42.4 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 121' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 15.3 tp10 -42.99 -37.43 1.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.45 -60.29 3.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.94 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.26 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.518 ' HH ' ' CE1' ' P' ' 119' ' ' HIS . 2.8 m-85 -57.17 -56.21 24.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.381 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 125' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 0.3 OUTLIER -55.91 -35.55 66.7 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.757 ' HB3' HG21 ' P' ' 116' ' ' VAL . 25.5 mtmt -73.29 -22.52 60.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.201 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 69' ' ' ASN . 37.2 m-20 -81.21 -43.74 18.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.97 71.61 0.81 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.515 0.674 . . . . 0.0 110.804 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.13 145.29 51.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.225 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -117.33 93.21 4.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.612 HG22 HG23 ' P' ' 31' ' ' THR . 24.7 t -83.08 115.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.634 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -63.73 100.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.309 178.303 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.539 ' HB2' ' OE1' ' P' ' 67' ' ' GLU . . . -102.77 130.17 49.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 111.557 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.87 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.517 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.493 ' HD3' ' O ' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.907 ' HB3' ' HG2' ' P' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -99.04 -64.35 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.812 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.3 -177.26 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 33.5 t -66.27 -27.84 68.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -108.47 113.36 26.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.908 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.92 137.07 33.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.01 -51.26 5.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 179.83 143.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 61.19 153.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.199 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.32 -12.56 62.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.94 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 m120 62.95 -177.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.713 0.292 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.19 -73.28 1.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -45.68 -45.2 14.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.702 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.471 ' O ' ' CG ' ' P' ' 15' ' ' GLN . . . -64.11 -139.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 15' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' P' ' 14' ' ' ALA . 15.0 pt20 50.0 53.73 12.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.165 0.507 . . . . 0.0 111.721 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 74.6 p -130.94 93.47 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.695 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -88.82 102.91 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.569 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.26 10.09 56.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.145 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.98 17.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.336 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.644 ' HB2' HD21 ' P' ' 25' ' ' LEU . 1.7 m-85 -107.04 147.13 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -104.14 144.38 31.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -38.31 -56.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.23 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -45.38 5.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 0.0 110.628 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' P' ' 20' ' ' TYR . 34.3 mt -56.54 -20.82 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.956 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.58 -12.3 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -123.38 -25.38 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 28' ' ' ARG . . . . . 0.475 ' HG2' ' CZ ' ' P' ' 29' ' ' TYR . 4.7 tpm_? -110.9 -62.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' P' ' 20' ' ' TYR . 22.2 m-85 -107.19 91.66 3.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 19.2 p-10 -155.07 13.77 0.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.369 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -125.94 130.82 52.03 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.758 HG11 HG23 ' P' ' 41' ' ' ILE . 3.6 t -111.19 148.45 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.5 118.31 26.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' P' ' 86' ' ' ARG . 21.9 m-85 -95.49 168.28 10.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.604 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.64 -166.69 27.37 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.158 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.445 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 8.2 t80 -60.88 122.03 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.23 25.51 1.83 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.749 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.467 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -93.14 138.58 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.469 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.451 ' HA ' ' HB3' ' P' ' 86' ' ' ARG . 44.6 p90 -131.42 49.93 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -147.62 150.74 34.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.917 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.758 HG23 HG11 ' P' ' 32' ' ' VAL . 1.9 mt -95.36 161.8 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.647 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.478 ' N ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -109.96 135.58 50.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 111.327 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.73 -27.38 2.19 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.024 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -32.1 72.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.406 ' O ' HG13 ' P' ' 48' ' ' ILE . 31.1 m-85 -105.54 11.44 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.546 ' HA ' ' HG ' ' P' ' 49' ' ' LEU . 0.9 OUTLIER -72.7 -34.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.264 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.36 -45.58 6.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.95 0.405 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.121 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.11 -50.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 0.0 109.196 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' P' ' 93' ' ' TYR . 6.2 mt -53.4 -62.41 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.726 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.5 -49.67 71.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.47 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.588 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.121 ' CD2' HG22 ' P' ' 48' ' ' ILE . 7.5 m-70 -72.17 -42.87 65.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.75 0.31 . . . . 0.0 110.821 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' P' ' 94' ' ' LEU . . . -65.59 -25.79 67.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.18 -36.93 46.84 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.04 0.448 . . . . 0.0 109.926 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -75.91 -34.68 59.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.642 HD13 ' HB ' ' P' ' 64' ' ' VAL . 0.7 OUTLIER -72.18 -36.06 69.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -32.72 66.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.153 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.09 -19.7 63.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -110.02 111.7 58.21 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 120.615 0.245 . . . . 0.0 110.481 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.89 -63.09 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.884 2.389 . . . . 0.0 114.213 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.17 24.09 1.66 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.622 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.53 122.58 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.145 0.498 . . . . 0.0 110.777 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -126.38 131.29 51.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.84 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.642 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.7 p -96.05 143.74 11.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.62 0.724 . . . . 0.0 111.754 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.823 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.8 tt -116.7 104.49 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.518 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -84.47 113.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.675 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.6 mm-40 -89.53 119.87 30.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.638 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.7 86.96 1.47 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.817 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' P' ' 70' ' ' THR . 7.6 t30 -98.65 158.49 15.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 110.354 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 61.0 p -165.29 -165.55 0.88 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 19.8 p-10 -83.77 154.56 23.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.617 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 3.1 pp20? -64.85 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.624 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.91 110.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 -173.17 14.8 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.36 145.3 29.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.463 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 72.1 Cg_exo -48.16 -44.74 27.74 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.458 2.106 . . . . 0.0 112.465 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -41.1 98.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.476 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.6 t80 -68.24 -42.96 78.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.472 ' HB2' ' HA3' ' P' ' 110' ' ' GLY . 31.4 m120 -69.92 -75.49 0.11 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.385 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -29.63 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.62 11.34 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.796 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 1.03 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -54.22 -43.77 71.11 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.752 178.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 1.03 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -68.11 -41.9 85.71 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.959 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.96 -31.57 65.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' P' ' 88' ' ' ASP . 10.5 tpt85 -65.67 -60.35 2.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.38 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.646 ' HD3' ' HA2' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -56.42 -41.5 76.47 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.242 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.63 65.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 88' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.3 OUTLIER -65.27 -31.63 72.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.09 178.063 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.17 -42.49 98.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.011 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.477 ' O ' ' CD1' ' P' ' 93' ' ' TYR . 32.9 t -70.53 -38.65 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.925 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.595 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -74.22 -27.84 60.98 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.019 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 92' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -74.71 -53.94 6.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.48 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 93' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' P' ' 49' ' ' LEU . 0.7 OUTLIER -57.59 -44.16 85.2 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.543 ' HG ' ' CE1' ' P' ' 93' ' ' TYR . 4.5 mt -58.87 -35.19 72.57 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 95' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -61.45 -43.17 99.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.577 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.81 -13.07 78.71 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.393 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 97' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 15.1 mttm -88.98 -8.44 54.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.667 0.27 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.69 -12.62 11.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.763 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.589 HG13 ' CD2' ' P' ' 56' ' ' LEU . 60.9 t -70.65 114.64 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.593 0.235 . . . . 0.0 110.716 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.8 144.58 52.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.388 0.613 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -51.51 -37.48 49.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.807 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.35 45.12 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.8 mtmt -96.07 -6.08 39.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.161 0.505 . . . . 0.0 110.9 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' P' ' 91' ' ' LYS . 19.8 mt -89.4 149.88 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.916 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.41 135.37 4.69 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.765 ' O ' HG13 ' P' ' 107' ' ' VAL . 70.2 p -133.55 156.24 48.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.813 0.34 . . . . 0.0 110.645 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.823 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.1 OUTLIER -172.85 121.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -111.87 137.85 49.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.751 0.31 . . . . 0.0 110.976 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 90.3 m-85 -116.68 24.51 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -111.82 0.01 OUTLIER Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.569 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.89 14.4 31.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.506 0.193 . . . . 0.0 111.514 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -54.84 41.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.96 89.16 8.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.423 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 114' ' ' PRO . . . . . 0.415 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 35.2 Cg_exo -61.05 166.89 9.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.692 2.262 . . . . 0.0 112.756 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.48 -67.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.911 HG21 ' HD3' ' P' ' 126' ' ' LYS . 38.5 t -89.61 111.8 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.342 0.592 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.73 138.54 58.44 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.923 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.76 174.15 14.11 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.8 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.449 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 14.2 p-80 -140.39 58.77 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -127.04 157.85 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 121' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' P' ' 125' ' ' SER . 0.2 OUTLIER -43.39 -27.55 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.615 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 122' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' P' ' 126' ' ' LYS . . . -64.76 -59.38 4.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 123' ' ' ALA . . . . . 0.617 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -66.36 -42.44 88.02 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 11.9 m-30 -65.37 -44.28 88.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 125' ' ' SER . . . . . 0.435 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 51.8 p -73.28 -38.92 65.75 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.623 0.249 . . . . 0.0 111.416 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.911 ' HD3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -82.05 -16.77 49.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.038 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' P' ' 123' ' ' ALA . 39.1 m-20 -85.33 -29.55 24.41 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.435 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.1 mtp180 -70.32 94.97 0.98 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.521 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.7 OUTLIER -158.85 156.02 28.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.11 99.78 7.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 15.1 t -83.08 110.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.518 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -61.31 98.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.19 178.317 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -101.21 126.67 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.623 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' P' P ' 134' ' ' TYR . . . . . 0.429 ' HH ' ' HD1' ' P' ' 52' ' ' HIS . 20.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.982 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.42 ' O4 ' ' N2 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.477 0.18 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.629 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.445 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.629 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.607 0.241 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -146.64 117.67 7.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.14 -174.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 4.7 t -83.15 -30.78 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.96 92.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.906 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -139.74 139.57 36.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.714 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -60.44 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 8' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' P' ' 9' ' ' ALA . . . 57.69 163.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.054 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 9' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' P' ' 8' ' ' ALA . . . 75.33 -53.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 10' ' ' GLY . . . . . 0.871 ' CA ' ' HB3' ' P' ' 14' ' ' ALA . . . -90.19 -66.55 1.21 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.617 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 11' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' P' ' 10' ' ' GLY . 76.0 m-20 66.81 -65.86 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 12' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' P' ' 10' ' ' GLY . . . -90.02 -64.07 1.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.11 -73.23 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 111.69 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.871 ' HB3' ' CA ' ' P' ' 10' ' ' GLY . . . -50.16 144.46 7.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.611 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.09 110.02 3.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 30.0 p -122.35 115.83 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' P' ' 55' ' ' TYR . 4.5 m-85 -92.27 106.86 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 8.99 32.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.388 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.98 -38.57 1.69 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.887 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' P' ' 17' ' ' PHE . 0.5 OUTLIER -124.15 171.76 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.359 . . . . 0.0 111.341 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.75 150.77 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.436 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.709 ' HA ' HD12 ' P' ' 25' ' ' LEU . 18.8 t -43.26 -43.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.15 -15.76 48.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.43 -40.05 8.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.559 0.695 . . . . 0.0 109.887 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.709 HD12 ' HA ' ' P' ' 22' ' ' VAL . 5.0 mt -61.96 -21.13 64.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 26' ' ' GLN . . . . . 0.621 ' OE1' HG12 ' P' ' 22' ' ' VAL . 55.3 mt-30 -98.32 -14.85 20.01 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.4 -18.32 3.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 -66.74 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -105.9 83.67 1.95 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.282 0.563 . . . . 0.0 111.836 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.583 ' ND2' ' HA ' ' P' ' 26' ' ' GLN . 1.7 t-20 -138.52 12.77 2.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.555 ' OG1' HG13 ' P' ' 131' ' ' VAL . 79.8 m -134.98 137.91 43.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 3.3 t -112.55 147.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.248 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -117.44 123.15 45.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.476 0.655 . . . . 0.0 112.573 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.454 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 75.3 m-85 -108.97 172.6 6.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.876 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.37 -169.27 16.4 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.488 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 2.0 t80 -60.17 125.9 25.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 110.748 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 37' ' ' ASP . . . . . 0.448 ' HB2' ' CE1' ' P' ' 36' ' ' PHE . 2.3 t0 44.59 29.43 0.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.86 126.65 41.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.738 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 11.2 t80 -125.9 57.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.731 0.777 . . . . 0.0 110.191 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -151.09 150.71 31.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.715 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.679 HD13 HD21 ' P' ' 49' ' ' LEU . 10.6 mt -98.64 162.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.604 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.517 ' N ' HG22 ' P' ' 41' ' ' ILE . 7.5 p -112.76 144.89 41.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.118 0.485 . . . . 0.0 111.574 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.63 -31.94 3.96 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.313 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -63.82 -33.89 76.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.432 ' CB ' HG13 ' P' ' 32' ' ' VAL . 78.0 m-85 -99.11 -2.52 36.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.441 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 77.0 t -63.07 -43.69 99.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.474 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 0.0 OUTLIER -39.63 -45.64 1.68 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.638 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.004 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.58 -53.26 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.679 HD21 HD13 ' P' ' 41' ' ' ILE . 3.5 mp -47.14 -46.49 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.549 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 50' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 2.6 p30 -73.46 -33.22 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.657 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 51' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.32 -51.48 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.004 ' CD2' HG22 ' P' ' 48' ' ' ILE . 12.0 m-70 -57.57 -37.79 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 109.936 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 53' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' P' ' 94' ' ' LEU . . . -61.66 -45.3 94.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.24 84.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.523 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 55' ' ' TYR . . . . . 0.467 ' HA ' ' CE2' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -70.1 -43.01 71.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.604 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.684 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -69.57 -36.75 76.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.03 -178.668 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.83 -36.33 78.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.13 66.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.604 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -113.85 112.87 47.51 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 -44.0 45.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.653 2.235 . . . . 0.0 113.575 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 17.51 11.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.591 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.42 123.74 34.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.271 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 30.9 mttt -123.12 132.72 54.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.683 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.2 p -96.42 143.54 12.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.417 0.627 . . . . 0.0 110.983 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.64 HD21 HG22 ' P' ' 107' ' ' VAL . 0.5 OUTLIER -113.39 108.65 17.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.796 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.684 HG13 HD22 ' P' ' 132' ' ' LEU . 0.2 OUTLIER -88.39 109.67 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.7 mt-10 -99.39 120.24 39.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.392 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 146.34 18.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.354 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.722 ' O ' HG23 ' P' ' 70' ' ' THR . 52.9 m-80 -139.54 167.52 21.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.722 HG23 ' O ' ' P' ' 69' ' ' ASN . 2.4 p -168.98 174.8 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.983 0.42 . . . . 0.0 111.448 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.508 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 15.4 p-10 -60.01 151.8 25.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.617 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.53 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 1.4 pp20? -66.26 -31.83 72.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 111.666 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 113.61 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.67 -169.41 12.91 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.266 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 75' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' P' ' 77' ' ' GLU . 0.6 OUTLIER -107.82 146.72 34.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 111.48 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.657 ' HB3' HD13 ' P' ' 80' ' ' ILE . 41.0 Cg_exo -54.96 -35.98 91.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.793 2.329 . . . . 0.0 113.929 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 77' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' P' ' 77' ' ' GLU . 0.0 OUTLIER -44.12 -55.35 4.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.497 ' CD2' ' CG ' ' U' ' 4' ' ' DGL . 0.1 OUTLIER -93.69 -13.93 26.94 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.602 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.748 ' HA ' HD12 ' P' ' 82' ' ' LEU . 2.1 m-20 -84.17 -25.76 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.539 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.657 HD13 ' HB3' ' P' ' 76' ' ' PRO . 0.5 OUTLIER -90.89 -36.42 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.43 -49.93 61.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.434 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 1.05 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -68.9 -34.35 75.27 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.976 178.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 1.05 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.55 -56.72 8.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.796 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 45.6 tt0 -50.46 -33.53 21.46 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -49.31 78.2 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.532 ' HD2' HD22 ' P' ' 82' ' ' LEU . 0.1 OUTLIER -55.43 -38.19 68.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' P' ' 84' ' ' GLN . . . -63.0 -35.31 79.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.241 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -31.32 69.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.341 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' P' ' 39' ' ' TYR . . . -61.1 -46.84 88.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.968 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.33 -31.39 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.429 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.587 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -62.73 -44.03 97.26 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 92' ' ' GLY . . . . . 0.49 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -74.32 -26.86 67.09 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -59.52 -57.1 14.44 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' P' ' 53' ' ' ALA . 47.2 mt -61.04 -32.28 71.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.332 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 95' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -61.83 -42.53 99.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.561 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.96 -19.97 78.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.014 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -10.79 59.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.663 0.268 . . . . 0.0 111.269 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -7.52 16.96 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.065 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.684 HG11 ' CD2' ' P' ' 56' ' ' LEU . 31.8 t -78.8 127.41 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.732 0.301 . . . . 0.0 110.99 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 100' ' ' ASP . . . . . 0.425 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -58.58 163.53 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.548 . . . . 0.0 111.322 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.957 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -80.87 -31.65 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.198 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.18 -24.14 35.19 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.782 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -95.5 -4.55 44.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 111.224 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.957 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.2 mt -95.1 139.55 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.129 -0.228 . . . . 0.0 110.403 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.576 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -143.45 141.77 10.72 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.805 ' O ' HG13 ' P' ' 107' ' ' VAL . 68.4 p -133.21 153.22 51.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.929 0.395 . . . . 0.0 111.106 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.805 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -176.15 119.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.457 ' O ' HG12 ' P' ' 80' ' ' ILE . 90.3 p -117.51 140.11 50.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.416 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' P' ' 110' ' ' GLY . 33.1 m-85 -121.08 28.07 8.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.581 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -23.22 -71.07 0.01 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.874 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.53 ' OE1' ' HA ' ' P' ' 72' ' ' GLU . 4.4 mm-40 -106.78 -2.1 21.86 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.01 -57.01 6.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 118.474 0.579 . . . . 0.0 110.422 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -134.71 90.04 24.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -57.94 163.05 10.06 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.521 2.147 . . . . 0.0 112.564 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.45 -68.63 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.11 119.83 36.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.1 136.82 44.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.57 175.21 14.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.791 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 119' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' P' ' 119' ' ' HIS . 0.1 OUTLIER -140.53 97.52 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.825 0.312 . . . . 0.0 111.587 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -175.9 165.83 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -48.46 -26.29 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.05 -63.49 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.01 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.621 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 7.0 m-30 -56.97 -46.53 82.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.624 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -68.55 -36.85 79.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.329 . . . . 0.0 111.29 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -68.22 -26.93 65.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.292 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' P' ' 70' ' ' THR . 84.1 m-20 -87.19 -28.84 22.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.481 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 6.5 mtp180 -69.35 81.05 0.37 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.89 152.39 21.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.122 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.51 105.11 10.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.555 HG13 ' OG1' ' P' ' 31' ' ' THR . 16.0 t -86.73 113.41 24.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.684 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -61.05 99.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.194 178.178 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' P' P ' 133' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -99.55 124.39 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.635 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' P' P ' 134' ' ' TYR . . . . . 0.463 ' HE1' HD12 ' P' ' 56' ' ' LEU . 22.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.917 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.465 ' H82' ' HB3' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.891 0.377 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.497 ' CG ' ' CD2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.561 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.45 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.561 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.813 0.34 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.45 139.87 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -156.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.608 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -68.52 -35.7 77.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.511 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -149.91 116.82 5.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.462 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -150.32 150.13 31.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.713 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -73.41 -52.37 13.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 46.49 -169.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.625 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 9' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' P' ' 14' ' ' ALA . . . -131.38 65.16 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.957 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.64 -20.52 31.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.843 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.5 128.7 44.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.53 -22.2 51.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.23 -28.82 59.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.834 0.35 . . . . 0.0 111.251 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 14' ' ' ALA . . . . . 0.58 ' HB3' ' HB1' ' P' ' 9' ' ' ALA . . . -78.15 97.43 5.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -176.72 114.83 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.711 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.76 119.82 30.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.443 . . . . 0.0 111.184 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' P' ' 20' ' ' TYR . 70.6 m-85 -90.55 107.08 18.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.611 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.81 9.87 35.5 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.297 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 134.21 -35.75 2.19 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.793 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.595 ' HB2' HD21 ' P' ' 25' ' ' LEU . 22.2 m-85 -117.81 161.9 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.715 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.15 153.65 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.425 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.414 HG23 ' H ' ' P' ' 22' ' ' VAL . 17.3 t -39.26 -51.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.43 16.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.38 -40.35 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.421 0.629 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' P' ' 20' ' ' TYR . 20.1 mt -69.32 -20.82 63.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.206 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -88.7 -20.89 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -142.71 -6.59 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -69.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -108.98 85.69 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.201 0.524 . . . . 0.0 112.244 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.2 19.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.329 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 98.4 m -126.42 129.35 48.56 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.754 HG11 HG23 ' P' ' 41' ' ' ILE . 3.2 t -107.86 150.38 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.978 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -121.39 116.16 24.25 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' HG2' ' P' ' 86' ' ' ARG . 21.7 m-85 -98.09 167.11 11.09 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.68 -167.38 17.23 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.603 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 6.2 t80 -66.18 123.34 19.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.079 0.439 . . . . 0.0 110.835 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.67 15.34 7.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.728 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.463 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 2.2 mptt -91.17 125.64 36.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.504 ' HB3' ' NH1' ' P' ' 86' ' ' ARG . 52.1 p90 -128.04 37.46 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.796 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.05 149.74 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.754 HG23 HG11 ' P' ' 32' ' ' VAL . 1.2 mp -87.57 164.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.283 . . . . 0.0 110.975 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 42' ' ' THR . . . . . 0.444 ' N ' HG22 ' P' ' 41' ' ' ILE . 49.3 p -112.35 150.63 30.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.405 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -42.45 -32.95 1.32 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.14 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.05 -33.37 75.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.727 0.299 . . . . 0.0 111.416 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 45' ' ' TYR . . . . . 0.403 ' CB ' HG13 ' P' ' 32' ' ' VAL . 87.7 m-85 -102.82 3.6 36.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 74.2 t -69.16 -40.49 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.41 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.07 -44.35 7.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 1.035 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.6 OUTLIER -56.47 -51.1 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.818 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.581 HD23 ' CD2' ' P' ' 93' ' ' TYR . 2.1 mp -53.36 -34.5 57.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.595 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -39.04 53.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.867 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.79 26.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 1.035 ' CD2' HG22 ' P' ' 48' ' ' ILE . 54.6 m-70 -59.92 -35.95 75.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.987 0.422 . . . . 0.0 110.139 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.45 98.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.302 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.79 91.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.978 0.418 . . . . 0.0 110.723 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.38 -38.79 63.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.97 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 1.043 HD23 HG11 ' P' ' 99' ' ' VAL . 2.9 tp -62.2 -41.68 98.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.139 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.16 -40.92 71.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.73 -27.92 31.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.683 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.4 OUTLIER -109.6 115.1 56.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.566 0.222 . . . . 0.0 110.488 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.8 -59.03 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 113.858 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.72 22.91 2.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.633 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.76 123.38 34.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 110.707 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -128.07 134.16 49.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -97.0 146.13 7.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.502 0.668 . . . . 0.0 111.758 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.8 HD21 ' CG2' ' P' ' 107' ' ' VAL . 5.1 tt -117.41 105.37 12.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.452 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -83.14 108.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.636 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.3 tt0 -99.2 117.61 34.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 68' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -107.51 149.67 16.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.968 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.8 OUTLIER -152.96 108.57 3.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.811 0.339 . . . . 0.0 110.712 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -100.65 -171.67 2.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 21.2 p-10 -64.27 144.85 56.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.396 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -64.08 -27.09 68.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.542 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 73' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.9 OUTLIER -39.55 110.91 0.16 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.326 0.584 . . . . 0.0 112.037 -178.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.01 -150.91 18.65 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.902 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.05 148.46 51.71 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 122.0 0.12 . . . . 0.0 110.822 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 1.3 Cg_endo -41.85 -38.91 4.98 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.616 2.211 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 77' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' P' ' 81' ' ' ALA . 0.5 OUTLIER -61.9 -40.84 96.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.88 -47.53 45.18 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.681 178.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' P' ' 82' ' ' LEU . 11.1 m120 -64.62 -76.27 0.07 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.711 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -35.42 -38.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 81' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' P' ' 77' ' ' GLU . . . -66.37 -64.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.043 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.931 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -63.48 -33.63 75.99 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.285 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 83' ' ' GLY . . . . . 0.931 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.89 -52.47 28.58 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 1.2 tp-100 -50.79 -34.73 28.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -59.93 -43.02 95.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.617 ' CZ ' ' CD2' ' P' ' 82' ' ' LEU . 6.8 mtt85 -56.37 -43.41 79.16 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.05 -32.58 68.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.4 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.419 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.27 -56.67 18.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.642 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.34 -34.42 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.4 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.44 ' HD3' HD13 ' P' ' 104' ' ' LEU . 3.1 tmtt? -59.45 -51.81 68.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.39 -26.09 74.44 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.115 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 93' ' ' TYR . . . . . 0.581 ' CD2' HD23 ' P' ' 49' ' ' LEU . 5.8 t80 -59.96 -61.27 2.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.489 ' HB2' HD21 ' P' ' 104' ' ' LEU . 23.1 mt -59.83 -29.8 68.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.88 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.11 98.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.33 -21.08 78.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.626 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -11.29 59.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 111.179 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.28 -3.63 22.08 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.308 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 1.043 HG11 HD23 ' P' ' 56' ' ' LEU . 21.5 t -81.98 131.65 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.831 0.315 . . . . 0.0 111.423 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' CG ' ' P' ' 103' ' ' LYS . 31.3 p30 -58.95 166.37 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.208 0.527 . . . . 0.0 111.306 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 101' ' ' ALA . . . . . 0.803 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -77.87 -31.83 51.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.7 -21.36 62.85 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.297 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 23.4 mtpp -90.45 -12.65 36.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.064 0.459 . . . . 0.0 111.067 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.803 HD12 ' HA ' ' P' ' 101' ' ' ALA . 6.3 mt -92.23 149.76 21.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.93 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.444 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -145.78 137.01 6.7 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.573 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 18.7 p -117.63 156.24 28.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.065 0.46 . . . . 0.0 111.275 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.8 ' CG2' HD21 ' P' ' 65' ' ' LEU . 97.2 t -160.49 157.75 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.608 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.711 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 3.3 t -161.09 128.18 4.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.993 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.31 -68.46 0.79 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.349 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.7 -121.51 6.37 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.615 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 1.2 mm-40 -75.62 -19.89 58.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.859 0.33 . . . . 0.0 111.091 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.47 -74.09 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -142.09 102.45 5.71 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.323 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.34 167.49 20.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.745 2.297 . . . . 0.0 112.248 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 115' ' ' ALA . . . . . 0.779 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -88.55 -77.66 0.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.66 ' HB ' ' NZ ' ' P' ' 126' ' ' LYS . 2.0 t -96.94 130.6 45.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.461 0.648 . . . . 0.0 111.137 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 141.13 52.34 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.745 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.73 172.09 12.99 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.764 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -141.09 91.64 2.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.793 0.296 . . . . 0.0 111.411 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 120' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' P' ' 124' ' ' TYR . 37.5 t70 -178.86 167.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 121' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' P' ' 125' ' ' SER . 1.1 mm-40 -44.45 -26.83 0.38 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -66.54 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.672 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 123' ' ' ALA . . . . . 0.646 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -70.4 -35.67 73.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.7 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.485 ' HE2' ' HB3' ' U' ' 7' ' ' DAL . 2.2 m-85 -65.85 -46.43 78.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 125' ' ' SER . . . . . 0.424 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 6.9 t -71.56 -37.06 71.11 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.66 ' NZ ' ' HB ' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -79.77 -16.16 56.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.993 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.779 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 7.9 m-20 -86.53 -31.51 21.23 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 120.581 0.229 . . . . 0.0 110.495 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.424 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.7 mtp180 -70.3 83.62 0.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.25 153.33 34.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -119.66 99.18 6.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.67 112.73 21.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.452 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -61.55 101.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.669 178.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.72 122.1 39.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.733 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.947 179.596 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.815 0.34 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.59 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.603 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.59 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.881 0.372 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -139.8 90.43 2.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 68.6 p -163.81 -176.67 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -70.77 -45.22 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -150.2 136.56 18.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.878 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.74 150.04 52.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.82 -66.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.25 -76.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.39 174.73 14.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 -44.71 7.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.269 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -163.32 30.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.17 -12.83 61.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.808 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.73 -27.4 2.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.7 0.286 . . . . 0.0 111.513 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.73 -165.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.158 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.86 162.77 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.023 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 75.5 p -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 17' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' P' ' 20' ' ' TYR . 61.1 m-85 -88.83 105.87 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.992 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.82 10.33 38.02 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.129 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.96 -30.61 3.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.384 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' CE2' ' P' ' 29' ' ' TYR . 20.3 m-85 -114.22 158.75 20.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 150.98 23.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.014 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 22' ' ' VAL . . . . . 0.42 HG23 ' H ' ' P' ' 22' ' ' VAL . 16.5 t -39.5 -48.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.59 -17.89 57.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.42 -43.93 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.456 0.646 . . . . 0.0 110.441 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 25' ' ' LEU . . . . . 0.481 ' O ' ' ND2' ' P' ' 30' ' ' ASN . 17.5 mt -58.35 -21.38 49.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.152 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 26' ' ' GLN . . . . . 0.605 ' HA ' ' ND2' ' P' ' 30' ' ' ASN . 4.3 mt-30 -101.92 -12.4 18.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.93 -21.52 4.34 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -112.64 -60.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 29' ' ' TYR . . . . . 0.452 ' CE2' ' CE1' ' P' ' 20' ' ' TYR . 28.3 m-85 -102.29 85.9 2.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.933 0.397 . . . . 0.0 111.735 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 30' ' ' ASN . . . . . 0.605 ' ND2' ' HA ' ' P' ' 26' ' ' GLN . 1.2 t-20 -144.6 6.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 31' ' ' THR . . . . . 0.422 ' OG1' HG13 ' P' ' 131' ' ' VAL . 51.9 m -136.86 138.8 41.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 32' ' ' VAL . . . . . 0.694 HG11 HG23 ' P' ' 41' ' ' ILE . 12.0 t -111.82 150.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.507 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -120.37 119.11 32.13 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 34' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 16.3 m-85 -95.69 170.24 9.46 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.52 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 -179.65 23.01 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.634 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 36' ' ' PHE . . . . . 0.806 ' CD1' ' HB2' ' U' ' 7' ' ' DAL . 0.6 OUTLIER -64.22 117.3 6.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 111.049 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.51 24.77 7.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 38' ' ' LYS . . . . . 0.515 ' HD3' ' HB2' ' P' ' 40' ' ' ASP . 0.0 OUTLIER -111.06 127.33 55.51 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.903 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 39' ' ' TYR . . . . . 0.684 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -117.65 77.5 1.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.599 0.714 . . . . 0.0 111.058 -178.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 40' ' ' ASP . . . . . 0.515 ' HB2' ' HD3' ' P' ' 38' ' ' LYS . 0.2 OUTLIER -153.28 150.36 28.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.223 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 41' ' ' ILE . . . . . 0.694 HG23 HG11 ' P' ' 32' ' ' VAL . 7.5 mt -99.0 155.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -108.48 143.73 37.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.481 . . . . 0.0 112.056 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.59 -29.26 5.57 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.121 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -66.16 -28.98 69.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.27 -1.06 29.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 94.8 t -65.26 -41.42 91.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 47' ' ' GLN . . . . . 0.434 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 0.0 OUTLIER -49.24 -29.49 5.82 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.588 -178.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 48' ' ' ILE . . . . . 0.939 HG22 ' CD2' ' P' ' 52' ' ' HIS . 2.9 mt -64.71 -52.85 49.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.391 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 49' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' P' ' 93' ' ' TYR . 2.7 mp -51.9 -47.83 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.3 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 50' ' ' ASP . . . . . 0.434 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -70.07 -35.75 74.45 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.609 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 51' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -73.43 -47.76 39.08 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.171 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 52' ' ' HIS . . . . . 0.939 ' CD2' HG22 ' P' ' 48' ' ' ILE . 8.9 m-70 -61.04 -38.04 84.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.8 92.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.019 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.93 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.935 0.397 . . . . 0.0 110.618 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -71.01 -40.28 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.691 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 56' ' ' LEU . . . . . 0.623 HD13 ' HB ' ' P' ' 64' ' ' VAL . 2.0 tp -62.88 -45.18 93.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.73 -40.49 96.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.336 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.39 9.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.669 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 59' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -115.5 115.74 41.86 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.601 0.239 . . . . 0.0 110.599 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.46 -50.91 11.24 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.694 2.263 . . . . 0.0 113.506 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 61' ' ' ALA . . . . . 0.406 ' O ' ' HD2' ' P' ' 63' ' ' LYS . . . -88.75 19.66 3.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 62' ' ' ALA . . . . . 0.594 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -92.61 134.74 34.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 63' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -138.02 141.49 40.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 64' ' ' VAL . . . . . 0.782 HG11 ' CD1' ' P' ' 94' ' ' LEU . 9.6 p -100.4 150.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.519 0.675 . . . . 0.0 111.795 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 65' ' ' LEU . . . . . 0.705 HD21 ' CG2' ' P' ' 107' ' ' VAL . 3.4 tt -120.69 101.45 7.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.342 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 66' ' ' VAL . . . . . 0.647 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.3 t -83.51 101.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 67' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 29.6 tt0 -90.41 123.47 34.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 68' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -106.71 148.05 16.34 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.521 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 69' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -160.91 106.19 1.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.317 . . . . 0.0 110.508 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 70' ' ' THR . . . . . 0.801 HG21 ' NH1' ' P' ' 86' ' ' ARG . 26.7 p -106.26 -170.85 1.79 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 71' ' ' ASP . . . . . 0.501 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 21.4 p-10 -57.28 138.12 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 72' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -59.83 -22.84 62.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.454 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -38.13 108.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.12 -144.69 18.34 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.635 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.97 146.82 60.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.727 0.264 . . . . 0.0 110.772 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 76' ' ' PRO . . . . . 0.526 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 1.9 Cg_endo -39.99 -44.79 3.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.009 2.473 . . . . 0.0 112.445 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -42.72 99.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 78' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 9.8 t80 -71.46 -40.25 70.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.679 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 79' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -67.15 -75.12 0.1 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 80' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -29.4 -41.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 123.254 0.346 . . . . 0.0 111.475 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -64.47 -59.74 3.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.597 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 82' ' ' LEU . . . . . 0.804 HD12 ' NH1' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -48.69 -46.71 40.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.256 178.35 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.83 -46.01 85.08 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.52 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 84' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -47.12 -43.14 20.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.388 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 85' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -65.54 -36.0 82.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.777 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 86' ' ' ARG . . . . . 0.804 ' NH1' HD12 ' P' ' 82' ' ' LEU . 17.0 mtt180 -68.5 -48.61 63.95 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.334 0.588 . . . . 0.0 109.445 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 87' ' ' ALA . . . . . 0.713 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -62.4 -40.31 96.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.562 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -56.21 -35.25 67.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.844 178.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 89' ' ' ALA . . . . . 0.51 ' HB2' ' HE1' ' P' ' 39' ' ' TYR . . . -64.33 -64.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 90' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' P' ' 93' ' ' TYR . 20.3 t -55.14 -39.67 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.371 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 91' ' ' LYS . . . . . 0.517 ' HA ' ' CD2' ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.49 -43.1 99.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 110.153 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 92' ' ' GLY . . . . . 0.432 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -71.81 -11.12 73.29 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 93' ' ' TYR . . . . . 0.43 ' CD2' HD23 ' P' ' 49' ' ' LEU . 4.4 t80 -75.95 -62.9 1.44 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 94' ' ' LEU . . . . . 0.782 ' CD1' HG11 ' P' ' 64' ' ' VAL . 72.2 mt -53.51 -31.38 45.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 95' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' P' ' 99' ' ' VAL . . . -63.38 -40.26 96.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.394 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.31 -24.7 75.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.455 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.33 -9.18 59.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 111.248 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.86 14.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.947 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 99' ' ' VAL . . . . . 0.577 ' CG1' HD23 ' P' ' 56' ' ' LEU . 21.8 t -70.57 114.88 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -55.84 141.63 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.89 40.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.246 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.88 64.99 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.689 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 103' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 2.1 mtpp -93.59 -19.13 21.46 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 120.522 0.201 . . . . 0.0 111.399 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 104' ' ' LEU . . . . . 0.73 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -136.27 132.01 35.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.782 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 105' ' ' GLY . . . . . 0.647 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -126.72 -169.07 12.68 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.534 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 106' ' ' THR . . . . . 0.713 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 49.6 p -147.36 168.53 21.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.087 0.47 . . . . 0.0 111.272 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 107' ' ' VAL . . . . . 0.705 ' CG2' HD21 ' P' ' 65' ' ' LEU . 48.7 t -158.32 163.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.509 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 108' ' ' SER . . . . . 0.542 ' N ' HG12 ' P' ' 107' ' ' VAL . 3.2 t -160.28 113.58 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.963 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 109' ' ' TYR . . . . . 0.599 ' CZ ' HG11 ' P' ' 107' ' ' VAL . 60.0 m-85 -108.36 27.33 9.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.194 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -12.08 -109.26 0.0 OUTLIER Glycine 0 CA--C 1.526 0.744 0 O-C-N 123.684 0.615 . . . . 0.0 114.581 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 111' ' ' GLU . . . . . 0.504 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 6.3 mt-10 -63.29 -18.31 63.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 112' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 3.7 tm-20 -48.18 -69.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.527 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -130.25 95.04 28.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.69 0.281 . . . . 0.0 111.034 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.34 155.93 54.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.705 2.27 . . . . 0.0 112.454 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 115' ' ' ALA . . . . . 0.661 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -101.97 -71.47 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 116' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' P' ' 126' ' ' LYS . 3.5 t -88.76 114.29 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.49 136.59 49.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.75 175.4 14.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.118 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -140.16 52.94 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.627 0.251 . . . . 0.0 111.184 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 1.7 p30 -131.31 154.69 48.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -45.42 -26.41 0.55 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 122' ' ' ALA . . . . . 0.504 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -70.25 -58.18 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 110.72 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.59 -40.36 76.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.638 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 124' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -59.7 -49.89 76.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.462 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 125' ' ' SER . . . . . 0.414 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 3.3 t -64.26 -34.89 79.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 126' ' ' LYS . . . . . 0.977 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -68.74 -27.08 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' P' P ' 127' ' ' ASN . . . . . 0.661 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 1.7 m-20 -82.21 -31.82 30.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 128' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 1.8 mpp_? -68.85 85.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.051 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 129' ' ' ARG . . . . . 0.445 ' HG2' ' OD1' ' P' ' 69' ' ' ASN . 3.9 ptt180 -154.65 147.16 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 130' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -113.29 108.53 17.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 131' ' ' VAL . . . . . 0.422 HG13 ' OG1' ' P' ' 31' ' ' THR . 3.6 t -88.27 108.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 132' ' ' LEU . . . . . 0.596 HD22 HG13 ' P' ' 66' ' ' VAL . 1.2 mm? -62.51 101.92 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.571 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.93 135.14 45.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 111.48 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.932 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' U' U ' 1' ' ' UDP . . . . . 0.465 " H3'" ' H83' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' U' U ' 2' ' ' AMU . . . . . 0.686 H113 ' CB ' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' U' U ' 4' ' ' DGL . . . . . 0.433 ' HB3' ' CE2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' U' U ' 5' ' ' 6CL . . . . . 0.422 ' CZ ' ' OD1' ' P' ' 71' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' U' U ' 6' ' ' DAL . . . . . 0.686 ' CB ' H113 ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' U' U ' 7' ' ' DAL . . . . . 0.806 ' HB2' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -89.54 105.87 18.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 111.537 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.33 9.39 30.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.631 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.64 -36.56 2.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.442 -1.361 . . . . 0.0 113.817 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -121.08 169.88 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.74 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.12 155.15 20.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.406 HG23 ' H ' ' P' ' 22' ' ' VAL . 20.7 t -39.25 -53.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.21 -18.24 9.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.36 -43.31 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 110.463 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.523 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 9.4 mt -63.18 -22.13 66.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.236 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -95.78 -14.92 22.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -131.61 -15.13 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -62.74 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 96.6 6.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.475 ' HA ' HG21 ' P' ' 48' ' ' ILE . 1.6 p30 -160.77 18.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.749 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.454 ' OG1' HG13 ' P' ' 131' ' ' VAL . 85.0 m -125.81 130.58 51.71 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.436 HG11 HG23 ' P' ' 41' ' ' ILE . 15.8 t -108.41 148.88 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -114.86 119.1 35.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.416 0.627 . . . . 0.0 112.185 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 73.1 m-85 -103.63 169.22 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.823 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.54 -169.54 19.49 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.881 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' P' ' 36' ' ' PHE . 1.5 t80 -57.01 112.85 1.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 110.809 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.79 38.64 4.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -89.93 138.32 31.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -122.14 49.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.96 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.38 150.37 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.521 HG22 ' N ' ' P' ' 42' ' ' THR . 5.7 mt -98.01 163.18 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.521 ' N ' HG22 ' P' ' 41' ' ' ILE . 11.1 p -110.65 143.41 41.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.091 0.472 . . . . 0.0 111.839 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.451 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.87 -32.21 8.46 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.225 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -33.97 74.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' P' ' 32' ' ' VAL . 77.2 m-85 -100.42 -0.24 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 48.1 t -65.22 -43.04 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.548 0.214 . . . . 0.0 111.444 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.458 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 1.0 OUTLIER -42.22 -43.45 3.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.002 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.7 -49.73 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.98 -45.76 61.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.474 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 3.9 p30 -73.9 -32.21 63.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.59 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . 0.437 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.41 -49.48 22.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.002 ' CD2' HG22 ' P' ' 48' ' ' ILE . 20.0 m-70 -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.532 . . . . 0.0 109.643 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . 0.411 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -61.18 -44.42 97.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.58 98.48 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 0.0 110.587 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.75 -40.1 63.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.9 HD23 HG11 ' P' ' 99' ' ' VAL . 5.5 tp -63.95 -42.82 97.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.417 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.14 -39.84 78.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.68 -25.89 55.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.543 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.4 OUTLIER -112.47 113.6 50.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 110.419 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.5 -46.81 27.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.627 2.218 . . . . 0.0 113.535 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.46 16.82 9.52 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.73 118.69 30.35 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -120.15 134.4 55.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.213 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' P' ' 56' ' ' LEU . 4.5 p -97.43 134.39 35.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.404 0.621 . . . . 0.0 111.496 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.481 HD21 HG22 ' P' ' 107' ' ' VAL . 1.1 tt -109.56 103.32 12.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.648 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.5 OUTLIER -79.8 120.08 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.5 mt-10 -103.69 117.63 34.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.609 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -103.29 140.91 15.07 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.582 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.581 ' O ' ' O ' ' P' ' 127' ' ' ASN . 77.4 m-20 -157.24 104.81 2.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.293 . . . . 0.0 110.824 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.566 HG22 ' NH1' ' P' ' 86' ' ' ARG . 72.1 p -101.9 -172.05 2.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -62.62 143.81 56.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.191 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 1.2 pp20? -63.43 -29.36 70.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.881 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.64 119.59 1.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . 0.577 ' O ' HG23 ' P' ' 75' ' ' THR . . . 115.09 -113.46 2.95 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.96 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . 0.577 HG23 ' O ' ' P' ' 74' ' ' GLY . 0.6 OUTLIER -167.21 147.56 4.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.157 0.479 . . . . 0.0 111.036 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 82.2 Cg_exo -41.68 -45.94 6.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.522 2.148 . . . . 0.0 112.919 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.12 -42.45 94.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.762 0.315 . . . . 0.0 110.761 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -71.27 -46.39 60.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.927 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' P' ' 80' ' ' ILE . 12.5 m120 -67.66 -75.45 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.695 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -29.7 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 O-C-N 123.141 0.276 . . . . 0.0 111.515 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.24 -59.75 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.436 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' P' ' 86' ' ' ARG . 0.3 OUTLIER -49.76 -44.6 48.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.922 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -71.54 -55.28 7.69 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.125 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.52 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 1.0 OUTLIER -45.51 -36.44 4.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 110.533 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.557 ' HB3' ' CE2' ' P' ' 39' ' ' TYR . 5.2 mtp180 -69.64 -51.84 31.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.566 ' NH1' HG22 ' P' ' 70' ' ' THR . 0.2 OUTLIER -52.82 -39.8 62.77 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.58 77.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.261 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -29.13 69.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.334 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.35 -52.0 56.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.417 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -70.75 -39.08 75.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.231 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.494 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -60.78 -42.28 97.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.859 0.362 . . . . 0.0 110.204 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.94 -24.96 75.84 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -61.24 -61.18 2.74 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' P' ' 104' ' ' LEU . 39.9 mt -58.27 -30.83 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.445 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.23 96.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.48 -25.05 75.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.794 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.411 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 2.9 mtpm? -76.84 -9.43 58.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 0.0 111.207 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.67 -1.98 23.25 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.193 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.9 HG11 HD23 ' P' ' 56' ' ' LEU . 25.0 t -75.58 127.26 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.418 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.9 146.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.253 0.549 . . . . 0.0 111.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.89 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -64.1 -36.15 83.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.569 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.46 -21.9 50.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.666 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.6 mtpp -94.21 -5.84 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.85 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' P' ' 101' ' ' ALA . 5.3 mt -96.73 149.08 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.648 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -149.57 140.99 8.47 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.505 ' O ' HG13 ' P' ' 107' ' ' VAL . 35.1 p -136.21 153.41 51.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.505 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -163.5 171.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.041 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.5 OUTLIER -162.04 131.12 4.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.302 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' P' ' 110' ' ' GLY . 65.7 m-85 -115.84 23.11 12.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.847 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -8.47 -106.38 0.0 OUTLIER Glycine 0 C--N 1.34 0.779 0 O-C-N 123.474 0.484 . . . . 0.0 113.971 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 3.8 mt-10 -71.16 -18.52 62.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.703 0.252 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.65 -70.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.133 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -130.66 89.62 42.99 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 122.312 -0.242 . . . . 0.0 110.541 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.0 156.27 39.98 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.599 2.199 . . . . 0.0 112.461 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . 0.712 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -97.68 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.095 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.673 HG21 ' CB ' ' P' ' 126' ' ' LYS . 2.6 t -88.79 114.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.056 0.455 . . . . 0.0 110.999 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.63 138.32 57.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.024 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.02 176.66 16.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.874 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.468 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 7.1 p80 -141.64 65.55 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.904 0.352 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.8 150.28 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -38.44 -30.94 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.1 -59.73 2.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.875 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.66 -42.44 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 1.0 OUTLIER -60.66 -45.08 95.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.161 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 26.9 m -62.92 -36.83 84.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.801 0.334 . . . . 0.0 110.509 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.673 ' CB ' HG21 ' P' ' 116' ' ' VAL . 27.0 mtmt -69.21 -25.02 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.549 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.712 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 4.6 m-20 -82.49 -33.89 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 4.7 mtp180 -69.64 83.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -158.02 148.29 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -121.12 109.29 14.83 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.454 HG13 ' OG1' ' P' ' 31' ' ' THR . 4.4 t -87.78 115.6 28.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.587 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -59.19 102.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.744 178.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -100.76 127.04 47.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.307 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.973 179.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . 0.531 HG22 ' HB3' ' P' ' 21' ' ' SER . 15.3 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 0.1 OUTLIER -151.48 135.86 16.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.219 0.533 . . . . 0.0 112.283 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 2.88 33.27 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.205 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.95 -34.36 2.86 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.399 -1.381 . . . . 0.0 114.154 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -114.69 161.71 17.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.826 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . 0.531 ' HB3' HG22 ' P' ' 16' ' ' THR . 0.8 OUTLIER -97.72 145.76 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.425 HG23 ' H ' ' P' ' 22' ' ' VAL . 14.5 t -37.12 -58.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.84 -16.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -99.19 -43.02 6.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.324 0.583 . . . . 0.0 110.056 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 25.5 mt -54.67 -21.69 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -12.85 16.91 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.32 -23.63 5.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 ptm85 -122.89 -48.22 2.02 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.27 102.87 12.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.354 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.522 ' HA ' HG21 ' P' ' 48' ' ' ILE . 1.1 p30 179.66 22.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.405 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.773 HG23 HG22 ' P' ' 131' ' ' VAL . 72.8 m -125.22 126.84 45.83 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.103 -0.373 . . . . 0.0 111.386 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.676 HG11 HG23 ' P' ' 41' ' ' ILE . 0.8 OUTLIER -105.18 150.64 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.913 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -117.93 112.7 20.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.374 0.606 . . . . 0.0 112.167 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.56 ' CD2' ' CZ ' ' P' ' 86' ' ' ARG . 15.3 m-30 -92.13 167.0 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.226 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.14 174.05 15.47 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -61.76 142.45 57.27 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.54 -0.388 . . . . 0.0 110.946 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.67 26.0 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.771 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.451 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -108.97 135.25 50.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.656 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.669 ' HA ' ' NE ' ' P' ' 86' ' ' ARG . 47.4 p90 -132.86 30.46 4.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.32 150.83 44.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.774 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.757 HD11 HG22 ' P' ' 90' ' ' VAL . 1.5 mt -87.7 166.38 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.589 0.233 . . . . 0.0 110.616 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.479 ' N ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -111.07 144.56 40.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.09 0.472 . . . . 0.0 111.779 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.73 -31.95 2.82 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.606 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -30.5 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.712 0.291 . . . . 0.0 111.497 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.591 ' HB3' HG13 ' P' ' 32' ' ' VAL . 72.6 m-85 -104.9 3.52 30.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.454 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 54.3 t -69.1 -37.22 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.21 -42.44 14.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.035 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.8 OUTLIER -55.96 -49.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.002 0.43 . . . . 0.0 110.412 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.77 -39.68 74.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -45.79 72.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.51 68.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.035 ' CD2' HG22 ' P' ' 48' ' ' ILE . 16.5 m-70 -72.27 -40.64 67.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.973 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.9 73.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.05 -36.05 59.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.481 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . 0.456 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 13.8 t80 -74.26 -38.89 63.31 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.153 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.736 HD23 ' CG1' ' P' ' 99' ' ' VAL . 1.2 tp -65.08 -43.95 90.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -69.96 -39.98 75.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.24 -24.43 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.055 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.97 89.92 51.86 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.009 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.46 -21.67 10.82 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.792 2.328 . . . . 0.0 113.354 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.78 -1.2 55.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.679 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.81 125.88 35.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 2.6 pttp -121.85 132.29 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.836 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -97.6 146.61 7.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.484 0.659 . . . . 0.0 111.713 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.509 HD21 HG22 ' P' ' 107' ' ' VAL . 0.9 OUTLIER -118.89 103.73 9.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.406 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.613 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.6 OUTLIER -79.17 112.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.5 tt0 -101.3 114.99 29.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.104 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.35 146.54 16.08 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.878 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 127' ' ' ASN . 11.3 m-80 -155.76 107.49 2.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 79.1 p -105.35 -173.91 2.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 24.0 p-10 -54.76 139.1 40.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -61.51 -27.15 68.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.204 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -39.59 108.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.67 -175.17 15.9 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.406 -0.815 . . . . 0.0 113.437 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.6 147.69 34.18 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 122.223 0.209 . . . . 0.0 111.224 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 92.9 Cg_exo -39.56 -45.22 3.33 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.881 2.387 . . . . 0.0 113.172 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -40.88 90.84 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.902 0.382 . . . . 0.0 110.438 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -75.53 -37.45 60.04 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -70.51 -76.85 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.543 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -31.93 -40.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 O-C-N 123.101 0.251 . . . . 0.0 111.343 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.91 11.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.534 ' HA ' ' HD3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -47.32 -53.45 13.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.54 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' P' ' 86' ' ' ARG . . . -69.16 -42.62 75.44 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.334 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 7.3 tp-100 -45.68 -44.65 13.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.637 0.256 . . . . 0.0 110.656 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -72.19 -32.88 67.2 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.552 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.669 ' NE ' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -62.04 -49.81 74.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.504 0.669 . . . . 0.0 109.302 177.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -56.33 -35.34 67.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.5 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -29.64 70.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -62.94 -59.69 4.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.537 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.757 HG22 HD11 ' P' ' 41' ' ' ILE . 23.1 t -64.9 -37.69 80.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -61.16 -47.39 86.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.299 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.9 -19.03 73.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -67.5 -64.18 0.91 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.44 ' O ' HG23 ' P' ' 99' ' ' VAL . 75.6 mt -52.54 -33.71 46.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.095 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.91 97.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.201 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.47 -32.4 81.01 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -8.63 56.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.948 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.44 14.33 30.47 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.51 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.736 ' CG1' HD23 ' P' ' 56' ' ' LEU . 48.1 t -80.46 130.42 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.402 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.07 165.69 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 111.127 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.34 -30.07 17.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.474 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.32 58.27 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.813 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.644 ' HD3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -101.87 -4.32 26.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.212 0.529 . . . . 0.0 111.093 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' P' ' 101' ' ' ALA . 38.4 mt -96.37 150.38 20.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.133 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.613 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -151.15 142.99 10.01 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.651 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.74 ' O ' HG13 ' P' ' 107' ' ' VAL . 30.4 p -133.26 156.76 46.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.585 0.231 . . . . 0.0 110.451 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.74 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -171.13 129.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.347 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -119.25 130.55 55.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.736 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 82.6 m-85 -110.94 25.66 11.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.083 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.47 -112.36 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.718 -0.674 . . . . 0.0 114.445 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.509 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.03 6.88 47.84 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -53.89 -58.97 5.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.72 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 89.36 11.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.265 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.84 164.36 14.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.568 2.179 . . . . 0.0 112.424 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.38 -62.7 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.64 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' P' ' 126' ' ' LYS . 7.9 t -89.49 112.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.8 137.77 58.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.85 174.56 17.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.992 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.438 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 15.3 p-80 -141.99 68.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.28 . . . . 0.0 111.369 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.42 152.5 47.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -37.93 -32.36 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.58 -61.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.24 79.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -56.81 -50.17 73.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 87.7 p -60.66 -37.04 80.24 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.133 0.492 . . . . 0.0 110.056 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.856 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -62.47 -32.92 73.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.294 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 69' ' ' ASN . 98.7 m-20 -81.58 -30.45 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.415 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 4.5 mtp180 -69.79 74.61 0.43 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.089 0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 146.18 40.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.509 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.77 90.01 3.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.773 HG22 HG23 ' P' ' 31' ' ' THR . 15.4 t -80.2 114.17 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.468 HD22 HG13 ' P' ' 66' ' ' VAL . 0.2 OUTLIER -63.08 104.95 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.206 178.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -102.25 126.75 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.491 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.088 179.652 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.716 0.293 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' P' ' 19' ' ' GLY . 47.8 m-85 -137.92 85.62 2.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.771 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 50.6 4.98 0.07 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.726 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . 0.72 ' O ' HD21 ' P' ' 25' ' ' LEU . . . 171.53 97.2 0.11 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' P' ' 19' ' ' GLY . 0.8 OUTLIER 60.57 -178.34 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -107.99 160.49 15.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.49 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' P' ' 26' ' ' GLN . 20.6 t -39.13 -53.46 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 -15.92 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.7 -38.64 8.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.452 0.644 . . . . 0.0 110.142 178.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.72 HD21 ' O ' ' P' ' 19' ' ' GLY . 14.4 mt -70.27 -22.47 62.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.464 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . 0.404 ' HG3' HG12 ' P' ' 22' ' ' VAL . 12.6 mt-30 -85.25 -26.72 26.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -140.6 -3.49 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' P' ' 24' ' ' ASP . 5.4 mtm-85 -107.54 -68.03 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -109.52 96.39 6.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 112.061 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.579 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -162.77 27.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.024 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.571 HG23 HG22 ' P' ' 131' ' ' VAL . 95.3 m -128.33 129.61 46.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.882 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.483 HG11 HG23 ' P' ' 41' ' ' ILE . 1.0 OUTLIER -110.77 150.72 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -120.94 118.05 28.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.7 m-30 -100.99 171.65 7.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.383 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.76 -166.64 23.41 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.903 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.68 117.71 5.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 t70 45.45 29.04 0.55 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.342 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.404 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 24.5 mmtm -94.81 130.9 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.779 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -119.57 67.08 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.037 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.15 150.67 30.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.475 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.483 HG23 HG11 ' P' ' 32' ' ' VAL . 3.6 mt -107.98 156.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -109.85 150.16 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.15 0.5 . . . . 0.0 112.065 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.449 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -48.92 -31.27 10.16 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.264 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.75 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.69 0.281 . . . . 0.0 111.389 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.464 ' CB ' HG13 ' P' ' 32' ' ' VAL . 77.0 m-85 -99.68 -4.61 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.449 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 64.9 t -62.82 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.432 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -44.46 -45.38 9.09 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.008 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -52.59 -49.67 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.941 0.401 . . . . 0.0 110.22 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.859 HD11 HG13 ' P' ' 90' ' ' VAL . 2.7 mm? -54.06 -45.36 71.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -40.29 96.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.343 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . 0.444 ' HB2' ' HA3' ' P' ' 19' ' ' GLY . . . -68.95 -46.66 67.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.856 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.008 ' CD2' HG22 ' P' ' 48' ' ' ILE . 59.7 m-70 -68.17 -41.47 81.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.03 99.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.437 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.66 0.267 . . . . 0.0 110.482 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -73.38 -36.88 66.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.646 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 1.074 HD23 HG11 ' P' ' 99' ' ' VAL . 5.0 tp -60.01 -47.9 83.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.191 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.27 -43.08 78.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.594 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.64 -26.38 22.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.684 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -114.88 113.63 44.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.491 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.14 -49.08 17.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.771 2.314 . . . . 0.0 113.849 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.64 17.5 8.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.39 114.6 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.094 0.473 . . . . 0.0 110.662 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.518 ' CG ' ' HA ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -117.32 133.45 55.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.806 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.537 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.2 p -98.88 143.53 13.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 121.43 0.633 . . . . 0.0 111.476 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.765 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.5 tt -113.55 101.16 9.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.627 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.63 HG11 ' HB ' ' P' ' 90' ' ' VAL . 0.8 OUTLIER -80.13 106.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.477 ' OE2' HG11 ' P' ' 107' ' ' VAL . 0.9 OUTLIER -100.59 119.37 38.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' P' ' 130' ' ' ALA . . . -96.68 144.04 17.09 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.621 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 127' ' ' ASN . 1.4 m-20 -140.19 102.43 4.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.625 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 1.081 HG21 HD11 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -95.0 -169.97 2.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.573 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.61 158.49 34.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 pp20? -74.44 -33.96 63.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.259 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.03 116.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 -161.82 12.56 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.532 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.15 35.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.489 0.185 . . . . 0.0 110.751 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.431 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 46.6 Cg_exo -54.77 -31.87 74.0 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.231 1.954 . . . . 0.0 112.162 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.44 -43.02 82.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.706 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -73.89 -39.74 63.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.256 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -67.83 -76.7 0.08 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.58 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 1.8 tt -33.1 -38.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -56.87 6.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.749 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 1.081 HD11 HG21 ' P' ' 70' ' ' THR . 0.0 OUTLIER -55.4 -42.14 73.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 1.011 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -66.76 -40.51 93.83 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -52.55 -43.56 65.27 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.132 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.521 ' HD3' ' CD1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.12 -35.87 81.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.637 ' NH1' HG23 ' P' ' 70' ' ' THR . 0.0 OUTLIER -65.22 -44.65 87.6 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.745 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -57.79 -36.85 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.219 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' P' ' 91' ' ' LYS . 0.2 OUTLIER -67.57 -28.89 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.211 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -58.46 -66.36 0.5 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.859 HG13 HD11 ' P' ' 49' ' ' LEU . 84.3 t -57.11 -31.75 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.385 0.612 . . . . 0.0 109.892 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' P' ' 88' ' ' ASP . 0.3 OUTLIER -60.93 -47.62 85.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.351 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.85 79.39 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.112 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -68.04 -61.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' P' ' 104' ' ' LEU . 63.4 mt -57.02 -31.3 64.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.283 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.43 84.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.591 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.09 -39.63 94.62 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -60.86 -35.23 76.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.88 27.43 1.9 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.556 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 1.074 HG11 HD23 ' P' ' 56' ' ' LEU . 45.4 t -89.92 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.524 0.202 . . . . 0.0 110.483 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.31 165.22 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.245 0.545 . . . . 0.0 111.493 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.11 -29.91 18.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.297 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.97 -29.68 55.82 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.386 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.518 ' HA ' ' CG ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.14 -4.87 26.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 110.421 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' P' ' 94' ' ' LEU . 0.2 OUTLIER -106.91 121.32 44.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.122 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.557 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -129.61 178.36 17.47 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.606 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.745 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 70.7 p -149.95 163.44 38.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.765 ' CG2' HD21 ' P' ' 65' ' ' LEU . 93.5 t -160.85 161.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.21 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 5.6 t -159.66 129.05 5.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.471 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.433 ' CZ ' ' HG2' ' P' ' 67' ' ' GLU . 25.9 m-85 -88.85 -63.26 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.12 -127.92 8.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.079 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' P' ' 72' ' ' GLU . 0.3 OUTLIER -93.14 2.62 56.62 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.029 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.45 -66.14 0.45 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.831 0.348 . . . . 0.0 110.429 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -141.03 88.97 9.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.057 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . 0.4 ' CG ' ' HB3' ' P' ' 72' ' ' GLU . 24.2 Cg_exo -64.27 165.78 18.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.737 2.291 . . . . 0.0 112.434 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.54 -58.33 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.886 HG13 ' HB1' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -91.11 142.83 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.27 139.8 31.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.96 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.21 175.81 16.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.936 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.448 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 9.5 p-80 -141.3 68.27 1.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.749 0.274 . . . . 0.0 111.457 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -141.25 153.65 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 3.7 tp10 -40.37 -30.3 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.56 -65.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.992 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . 0.886 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -68.13 -41.42 81.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.698 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' P' ' 119' ' ' HIS . 1.6 m-85 -54.7 -52.96 60.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -59.09 -37.35 76.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -61.53 -31.62 71.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.292 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 69' ' ' ASN . 58.3 m-20 -84.42 -34.31 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.896 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 5.0 mtp180 -68.97 79.64 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.158 0.504 . . . . 0.0 111.135 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' P' ' 69' ' ' ASN . 0.1 OUTLIER -150.59 149.76 30.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.43 ' HA ' ' HA2' ' P' ' 68' ' ' GLY . . . -119.73 98.48 6.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.571 HG22 HG23 ' P' ' 31' ' ' THR . 21.8 t -83.9 115.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.467 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -65.39 103.13 0.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.549 178.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -99.47 128.59 45.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 111.511 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.051 179.624 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.78 0.324 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -89.51 106.65 18.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.994 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.01 35.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.412 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.41 -35.03 2.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.16 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -129.92 176.77 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 0.0 111.709 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.9 t -103.3 157.37 17.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.795 ' HA ' HD12 ' P' ' 25' ' ' LEU . 17.4 t -46.4 -51.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.18 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.53 -13.34 2.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.436 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.11 -44.66 6.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' P' ' 22' ' ' VAL . 3.9 mt -58.07 -19.78 34.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.703 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -109.02 -11.27 14.98 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.06 -31.08 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -122.83 -50.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.72 103.8 13.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.529 0.68 . . . . 0.0 112.403 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.601 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -176.08 11.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.301 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.426 ' O ' ' CD1' ' P' ' 45' ' ' TYR . 85.0 m -113.77 128.12 56.29 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.838 -0.539 . . . . 0.0 112.097 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.631 ' CG1' HG23 ' P' ' 41' ' ' ILE . 5.3 t -108.06 151.16 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' P' ' 34' ' ' PHE . 6.9 m-85 -112.48 163.32 14.61 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' P' ' 33' ' ' TYR . 73.4 m-85 -152.06 168.55 24.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.221 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.49 -175.74 23.27 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.567 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.35 128.43 37.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.084 0.442 . . . . 0.0 110.884 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p30 43.59 29.76 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.801 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.431 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 2.3 tttp -101.02 137.71 39.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' P' ' 39' ' ' TYR . 48.5 p90 -125.37 60.71 1.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.306 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.63 150.85 31.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.232 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.631 HG23 ' CG1' ' P' ' 32' ' ' VAL . 3.3 mt -94.76 163.44 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.652 0.263 . . . . 0.0 110.736 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.518 ' N ' HG22 ' P' ' 41' ' ' ILE . 72.8 p -112.61 142.67 44.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.308 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.9 -29.74 4.6 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.346 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.05 -32.87 74.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.61 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' P' ' 33' ' ' TYR . 68.2 m-85 -102.8 3.65 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.82 -41.23 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.46 ' NE2' HG12 ' P' ' 48' ' ' ILE . 6.1 pm0 -45.77 -37.77 6.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.0 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.3 mt -57.74 -52.83 52.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -52.85 -33.09 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.437 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -40.78 62.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.3 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -74.45 -43.93 53.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.0 ' CD2' HG22 ' P' ' 48' ' ' ILE . 59.9 m-70 -62.9 -38.82 92.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.026 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.36 87.18 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . 0.47 ' HD2' ' HH ' ' P' ' 134' ' ' TYR . 8.9 t80 -73.63 -41.51 62.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 1.069 HD23 HG11 ' P' ' 99' ' ' VAL . 5.6 tp -61.02 -45.06 96.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.397 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.79 -40.74 72.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.564 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.96 -26.64 37.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -114.54 114.33 44.95 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.374 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 -51.58 10.35 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.859 2.373 . . . . 0.0 113.931 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.06 19.69 5.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.627 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.19 119.68 30.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.503 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -119.5 132.51 55.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.724 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.691 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.8 p -98.65 144.87 10.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 121.294 0.569 . . . . 0.0 110.904 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.634 HD21 HG22 ' P' ' 107' ' ' VAL . 0.6 OUTLIER -116.56 108.31 15.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.943 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.2 OUTLIER -85.53 113.96 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' P' ' 107' ' ' VAL . 21.0 tt0 -99.07 120.36 39.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.29 144.01 21.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.708 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.743 ' O ' HG23 ' P' ' 70' ' ' THR . 0.3 OUTLIER -144.3 159.8 42.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.743 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.1 p -170.26 -173.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.445 ' CB ' ' CE2' ' P' ' 124' ' ' TYR . 10.0 p-10 -63.72 157.25 24.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.379 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.519 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 0.2 OUTLIER -70.55 -31.35 68.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.441 ' HB2' ' OH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -49.86 119.74 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.37 -173.82 15.33 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.225 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.17 143.15 26.56 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.135 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.537 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -40.2 -43.1 3.73 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.017 2.478 . . . . 0.0 113.667 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -59.82 -45.17 93.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -70.89 -41.97 70.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.406 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 4.3 m-80 -67.5 -75.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.9 OUTLIER -29.48 -44.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 111.525 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.37 4.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.91 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.572 HD12 ' NH1' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -47.9 -51.9 21.42 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.279 -0.569 . . . . 0.0 109.92 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' P' ' 86' ' ' ARG . . . -61.52 -40.74 99.12 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.511 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -51.39 -40.51 59.4 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.523 HH12 HD22 ' P' ' 82' ' ' LEU . 8.1 ttp-105 -64.73 -38.82 92.29 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.572 ' NH1' HD12 ' P' ' 82' ' ' LEU . 0.3 OUTLIER -59.05 -40.08 84.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' P' ' 106' ' ' THR . . . -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.5 OUTLIER -65.87 -34.69 78.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 178.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.1 68.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.86 -38.06 43.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.809 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.583 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.2 -39.66 91.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.236 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.79 -27.43 64.91 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -59.87 -57.02 14.67 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.463 ' HB2' HD21 ' P' ' 104' ' ' LEU . 23.2 mt -61.45 -32.25 72.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.39 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.96 95.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.103 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.12 -26.97 74.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.759 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -72.38 -11.44 60.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.99 2.0 25.24 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.13 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 1.069 HG11 HD23 ' P' ' 56' ' ' LEU . 26.9 t -81.95 131.95 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.368 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . 0.427 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.5 OUTLIER -60.9 164.28 5.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.271 0.557 . . . . 0.0 111.324 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.921 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -84.26 -30.02 25.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.58 -22.78 53.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.895 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.644 ' HE3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -98.84 -3.86 34.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.092 0.473 . . . . 0.0 111.25 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.921 HD12 ' HA ' ' P' ' 101' ' ' ALA . 8.7 mt -89.2 150.44 22.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.254 -0.279 . . . . 0.0 110.342 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.652 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.16 138.82 7.72 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.827 ' O ' HG13 ' P' ' 107' ' ' VAL . 66.3 p -132.14 153.37 50.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.693 0.282 . . . . 0.0 111.014 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.827 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -175.38 170.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.493 ' OG ' HG23 ' P' ' 80' ' ' ILE . 32.4 p -162.47 139.18 7.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.406 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' P' ' 110' ' ' GLY . 74.6 m-85 -123.57 19.77 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 7.4 -110.34 0.01 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -86.18 8.07 22.51 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 8.4 tp10 -51.43 -59.74 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 109.961 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.17 89.81 22.72 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.686 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.18 160.11 11.32 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.709 2.273 . . . . 0.0 112.991 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -69.13 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.674 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.69 HG21 ' HB3' ' P' ' 126' ' ' LYS . 19.6 t -87.67 106.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.923 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.24 134.9 49.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.1 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.69 174.68 13.56 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.379 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.61 87.02 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.145 0.473 . . . . 0.0 111.692 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -173.2 165.98 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -47.79 -22.3 0.52 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.57 -60.84 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.912 0.386 . . . . 0.0 111.444 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.09 72.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.445 ' CE2' ' CB ' ' P' ' 71' ' ' ASP . 2.9 m-85 -60.55 -45.75 92.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.749 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 25.2 t -65.34 -32.02 73.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.174 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.69 ' HB3' HG21 ' P' ' 116' ' ' VAL . 1.9 mtmt -75.06 -24.69 58.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.369 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -87.89 -29.0 21.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 111.262 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -67.25 87.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 3.3 ptt-85 -159.08 160.31 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -125.37 106.53 9.9 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.25 111.24 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.646 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -61.58 101.94 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.209 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 130.51 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.279 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . 0.47 ' HH ' ' HD2' ' P' ' 55' ' ' TYR . 5.8 m-85 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.025 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.988 0.423 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.94 106.38 4.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.169 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.66 8.51 47.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.288 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.54 -35.67 2.24 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.575 -1.297 . . . . 0.0 114.127 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.71 ' HB2' HD21 ' P' ' 25' ' ' LEU . 2.9 m-85 -119.43 169.26 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.124 0.462 . . . . 0.0 111.468 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 5.0 m -101.27 145.3 29.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.992 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.508 ' HA ' HD12 ' P' ' 25' ' ' LEU . 10.3 t -43.27 -30.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 111.468 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' P' ' 27' ' ' GLN . . . -61.67 -21.96 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.69 -54.05 3.02 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.604 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.71 HD21 ' HB2' ' P' ' 20' ' ' TYR . 7.1 mt -44.59 -28.05 0.55 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.89 -31.22 12.31 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.157 0.503 . . . . 0.0 110.725 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . 0.634 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.1 OUTLIER -148.5 77.68 1.4 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.532 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' P' ' 27' ' ' GLN . 0.0 OUTLIER 164.47 -68.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.205 177.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.449 ' CD1' ' HD3' ' P' ' 28' ' ' ARG . 6.7 m-85 -109.13 90.09 3.19 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.61 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 2.0 p30 -168.29 64.69 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.411 ' O ' ' CE1' ' P' ' 45' ' ' TYR . 97.6 m -164.11 126.68 2.44 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.818 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.921 HG11 HG23 ' P' ' 41' ' ' ILE . 1.2 t -99.75 150.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.652 0.263 . . . . 0.0 111.215 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -116.33 108.35 15.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -89.31 172.94 8.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.612 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.16 -173.98 19.92 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . 0.411 ' CE2' ' OD2' ' P' ' 37' ' ' ASP . 3.0 t80 -58.36 122.56 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.457 0.628 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . 0.411 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 2.7 p30 43.92 30.84 0.44 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.744 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 141.58 28.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.467 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 31.2 p90 -130.76 52.55 2.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.497 . . . . 0.0 110.833 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -149.97 150.14 31.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.448 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.921 HG23 HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -100.27 163.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.924 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 69.4 p -109.45 150.59 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.86 -29.72 1.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.205 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -65.2 -30.47 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.503 ' CB ' HG13 ' P' ' 32' ' ' VAL . 68.0 m-85 -104.12 1.17 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.981 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 82.4 t -73.22 -37.56 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.41 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.62 -40.7 63.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' P' ' 45' ' ' TYR . 4.6 pt -67.25 -35.72 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.344 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.88 -40.12 96.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.95 -34.19 62.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.792 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.76 -53.58 8.27 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 0.651 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 23.0 m-70 -53.59 -35.35 60.75 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.04 85.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.065 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 110.201 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.23 -37.87 63.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.73 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 1.017 HD23 HG11 ' P' ' 99' ' ' VAL . 1.7 tp -62.47 -42.74 99.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.294 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.64 -42.06 71.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.461 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.07 54.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.534 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.3 OUTLIER -113.15 112.22 49.84 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.94 -48.74 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.842 2.361 . . . . 0.0 114.154 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.61 17.61 8.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.585 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.35 117.91 29.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -118.7 130.41 55.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.765 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.638 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.4 p -94.44 140.23 17.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.347 0.594 . . . . 0.0 111.422 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.14 104.31 13.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.786 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.09 108.12 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.6 tt0 -102.01 118.06 36.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.03 152.34 20.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -148.55 170.7 17.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.871 0.367 . . . . 0.0 110.926 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.1 OUTLIER 176.2 174.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.147 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.533 ' HB2' ' CZ ' ' P' ' 124' ' ' TYR . 37.7 p-10 -54.46 142.64 26.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.253 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 2.2 pp20? -62.79 -25.98 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.429 ' HD3' ' CE1' ' P' ' 119' ' ' HIS . 0.7 OUTLIER -39.33 110.74 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.545 -178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.22 -168.87 12.71 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.336 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.57 144.83 29.45 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.674 0.273 . . . . 0.0 111.066 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.06 -39.28 14.66 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.634 2.223 . . . . 0.0 112.488 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.8 -43.02 97.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.679 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -68.18 -41.81 80.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.467 ' OD1' HG23 ' P' ' 70' ' ' THR . 3.1 m-80 -70.68 -75.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.823 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -30.15 -40.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -69.89 -57.06 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.82 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 1.016 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.4 -42.0 81.42 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.056 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 1.016 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.86 -52.32 20.19 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.765 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 1.9 tt0 -48.03 -35.67 11.52 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.92 -48.71 79.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.082 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 0.3 OUTLIER -54.98 -40.89 70.55 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.556 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.78 -34.24 74.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.44 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -32.99 74.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.235 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.33 -53.44 57.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.426 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.37 -34.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -60.84 -52.75 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -65.06 -27.1 71.86 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -59.16 -58.4 8.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.485 ' CD1' HG11 ' P' ' 64' ' ' VAL . 92.6 mt -56.73 -29.91 62.98 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -69.84 -38.99 76.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.84 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.31 -35.17 87.61 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.68 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -63.87 -36.56 84.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.63 26.15 2.22 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.247 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 1.017 HG11 HD23 ' P' ' 56' ' ' LEU . 24.4 t -91.15 146.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.568 0.223 . . . . 0.0 110.726 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.28 161.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.172 0.51 . . . . 0.0 111.562 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.29 -31.32 17.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.67 -12.91 65.11 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 12.9 mtpp -94.37 -10.91 31.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.27 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' P' ' 101' ' ' ALA . 1.9 mt -99.79 150.01 22.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.74 144.58 11.8 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.777 ' O ' HG13 ' P' ' 107' ' ' VAL . 17.6 p -124.57 159.09 31.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.722 0.296 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.777 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -175.28 117.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.151 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.823 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -99.77 143.78 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.526 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' P' ' 110' ' ' GLY . 2.8 m-85 -105.45 7.8 33.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 16.87 -127.25 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.276 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -101.08 12.75 37.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.53 0.205 . . . . 0.0 111.106 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -59.1 5.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 109.95 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.36 89.03 16.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 31.9 Cg_exo -61.19 164.07 15.57 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.804 2.336 . . . . 0.0 112.982 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.3 -67.4 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.277 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.769 HG21 ' HG3' ' P' ' 126' ' ' LYS . 18.8 t -88.52 108.76 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.89 138.75 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.503 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.28 177.03 14.99 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.999 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.537 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 14.8 t-160 -141.03 61.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . 0.824 ' OD2' ' HB3' ' P' ' 122' ' ' ALA . 7.9 p-10 -127.14 154.69 44.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -49.38 -23.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.547 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . 0.824 ' HB3' ' OD2' ' P' ' 120' ' ' ASP . . . -76.07 -58.1 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.938 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.21 97.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.674 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.537 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 3.2 m-30 -66.59 -37.21 84.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.37 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . 0.444 ' HA ' ' NE ' ' P' ' 128' ' ' ARG . 22.5 p -62.06 -37.61 85.64 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 110.682 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.769 ' HG3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -83.07 -11.84 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.713 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -80.71 -37.07 31.3 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.628 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -78.65 92.63 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.821 0.82 . . . . 0.0 110.756 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -146.68 146.35 30.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.362 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -115.53 93.91 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.03 112.84 16.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 1.4 mm? -63.71 100.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.282 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -97.38 122.53 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.806 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.053 179.568 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.806 0.336 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.43 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 7.0 m-85 -90.96 107.02 18.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.66 33.48 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.396 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.24 -35.43 2.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.593 -1.289 . . . . 0.0 113.466 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.87 43.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.599 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -60.07 152.37 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' P' ' 25' ' ' LEU . 21.5 t -44.3 -40.07 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 112.029 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -14.83 25.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.316 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.54 -41.03 8.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.561 0.696 . . . . 0.0 109.895 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.522 HD21 ' HB1' ' P' ' 51' ' ' ALA . 14.7 mt -61.86 -19.8 63.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -98.66 -14.61 19.76 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.99 -17.9 2.11 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -67.96 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -105.36 81.89 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.634 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.24 10.17 2.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.006 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.678 ' OG1' HG13 ' P' ' 131' ' ' VAL . 23.5 m -134.81 137.12 43.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.65 HG11 HG23 ' P' ' 41' ' ' ILE . 11.3 t -106.89 149.71 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.437 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . 0.548 ' CE2' ' NH2' ' P' ' 129' ' ' ARG . 3.3 m-85 -113.39 115.51 28.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.778 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.462 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 82.4 m-85 -104.69 168.9 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.078 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.99 179.73 19.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.384 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 3.6 t80 -61.4 137.48 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . 0.415 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 0.5 OUTLIER 46.91 28.05 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.407 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 5.5 mttm -109.12 136.07 49.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.742 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -130.86 49.82 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.75 150.44 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.958 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.65 HG23 HG11 ' P' ' 32' ' ' VAL . 2.2 mp -92.98 164.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.519 0.199 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.529 ' N ' HG22 ' P' ' 41' ' ' ILE . 28.0 p -109.5 144.22 38.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.84 -29.58 1.43 Allowed Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.219 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.43 -31.96 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.618 0.247 . . . . 0.0 111.655 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.562 ' CB ' HG13 ' P' ' 32' ' ' VAL . 76.0 m-85 -104.39 3.31 32.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.414 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 98.5 t -70.31 -38.32 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.318 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.24 -40.25 11.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.298 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.05 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.4 mt -55.39 -55.87 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.945 0.402 . . . . 0.0 110.333 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.687 HD11 HG13 ' P' ' 90' ' ' VAL . 2.8 mm? -52.04 -31.89 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.697 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -38.69 62.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . 0.522 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -75.36 -45.98 35.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.05 ' CD2' HG22 ' P' ' 48' ' ' ILE . 65.8 m-70 -64.41 -37.73 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.67 95.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.76 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.22 98.34 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.032 0.444 . . . . 0.0 110.14 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . 0.43 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 24.2 t80 -75.82 -37.6 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.66 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.944 HD23 HG11 ' P' ' 99' ' ' VAL . 10.1 tp -60.68 -49.02 79.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -70.1 -40.31 75.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.51 -27.29 37.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.423 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -113.63 115.37 46.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.667 0.27 . . . . 0.0 110.423 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.83 -59.6 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.915 2.41 . . . . 0.0 113.902 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 20.52 2.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.663 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -88.46 114.6 25.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.017 0.437 . . . . 0.0 110.374 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.4 129.7 56.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.687 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.4 p -95.56 126.37 48.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.428 0.632 . . . . 0.0 110.921 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.588 HD21 HG22 ' P' ' 107' ' ' VAL . 0.8 OUTLIER -99.54 105.51 17.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.721 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.557 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.4 t -82.19 120.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.047 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.1 tt0 -106.52 116.05 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.97 142.97 18.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.735 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.726 ' O ' HG23 ' P' ' 70' ' ' THR . 0.6 OUTLIER -141.39 161.52 37.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.959 0.409 . . . . 0.0 110.751 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.726 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.3 p -170.16 -173.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.538 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.48 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 4.3 p30 -74.92 152.79 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.617 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.414 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pp20? -63.56 -32.63 74.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.935 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.404 ' HB3' ' OD1' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -39.75 109.41 0.11 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.96 178.62 19.17 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.14 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.97 146.51 31.43 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.511 0.196 . . . . 0.0 110.853 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 71.8 Cg_exo -41.23 -42.6 5.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.741 2.294 . . . . 0.0 113.197 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.34 -43.62 98.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.881 0.372 . . . . 0.0 110.568 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.94 -43.56 78.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.6 OUTLIER -69.51 -76.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.687 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.635 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.46 -43.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.72 -56.49 9.09 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.573 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.766 HD12 ' C ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -48.9 -56.19 9.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.262 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.99 -39.34 97.45 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.526 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 3.8 mt-30 -48.41 -51.12 28.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 13.0 ptp180 -62.2 -32.67 73.35 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 0.4 OUTLIER -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.74 76.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.982 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.5 OUTLIER -63.35 -29.73 70.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.638 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -64.9 -43.22 93.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.154 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.687 HG13 HD11 ' P' ' 49' ' ' LEU . 39.2 t -75.47 -42.7 42.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.365 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' P' ' 88' ' ' ASP . 0.0 OUTLIER -63.1 -38.93 93.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -71.75 -31.29 65.09 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.32 -57.01 14.79 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' P' ' 64' ' ' VAL . 83.5 mt -57.63 -30.48 65.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.285 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -68.9 -39.71 79.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.945 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.66 -36.21 91.15 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.873 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -35.36 78.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.05 26.53 2.05 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.944 HG11 HD23 ' P' ' 56' ' ' LEU . 57.5 t -90.77 144.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.595 0.236 . . . . 0.0 110.54 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . 0.457 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -63.94 161.56 15.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.504 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.97 -32.3 16.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.423 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.41 -23.93 36.25 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.689 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.67 -3.25 33.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.29 0.567 . . . . 0.0 110.858 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.8 mt -89.24 148.88 23.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.846 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.557 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -148.68 140.84 8.53 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.637 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.806 ' O ' HG13 ' P' ' 107' ' ' VAL . 14.8 p -131.12 153.44 49.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.679 0.276 . . . . 0.0 110.832 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.806 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -174.26 117.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.635 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -105.65 137.8 42.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.368 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.513 ' O ' ' C ' ' P' ' 110' ' ' GLY . 91.9 m-85 -121.4 15.97 11.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.996 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -5.03 -106.3 0.0 OUTLIER Glycine 0 C--N 1.34 0.761 0 O-C-N 123.758 0.662 . . . . 0.0 114.523 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -89.61 0.7 56.76 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.589 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -54.73 -59.87 4.13 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 88.7 7.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.96 168.29 7.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.893 2.395 . . . . 0.0 113.163 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.51 -66.01 0.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.236 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.823 HG13 ' HB1' ' P' ' 123' ' ' ALA . 2.5 p -88.6 151.05 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -108.37 136.13 48.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.865 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.29 -178.9 20.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.52 ' CE1' ' HH ' ' P' ' 124' ' ' TYR . 3.2 t60 -140.23 43.53 1.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.443 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -130.07 156.13 45.02 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -27.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.617 0.246 . . . . 0.0 111.591 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.24 -58.84 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.386 . . . . 0.0 110.651 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . 0.823 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -72.48 -39.6 67.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.549 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.52 ' HH ' ' CE1' ' P' ' 119' ' ' HIS . 5.9 m-85 -57.82 -49.77 75.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.956 0.408 . . . . 0.0 110.531 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . 0.645 ' O ' ' NH2' ' P' ' 129' ' ' ARG . 8.3 t -62.7 -33.02 74.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.605 ' O ' ' CZ ' ' P' ' 129' ' ' ARG . 0.1 OUTLIER -75.83 -14.41 60.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.325 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -94.18 -24.45 17.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.457 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.6 mtp180 -77.11 91.11 3.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.645 ' NH2' ' O ' ' P' ' 125' ' ' SER . 0.0 OUTLIER -160.88 154.85 22.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.05 103.96 9.73 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.678 HG13 ' OG1' ' P' ' 31' ' ' THR . 2.6 t -82.03 109.44 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.82 100.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.28 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -98.0 123.08 41.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.92 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.915 179.707 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 77.2 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' P' ' 20' ' ' TYR . 40.4 m-85 -137.53 103.06 4.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.978 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.89 9.99 23.4 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.72 -1.229 . . . . 0.0 112.211 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.2 -33.89 2.71 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.651 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.821 ' HB2' HD21 ' P' ' 25' ' ' LEU . 18.0 m-85 -116.11 160.59 20.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.131 0.491 . . . . 0.0 112.286 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -97.56 142.0 29.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.327 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 t -40.86 -53.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.86 -16.54 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.393 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.29 -46.07 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 110.417 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' P' ' 20' ' ' TYR . 11.9 mt -56.12 -20.83 19.11 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.559 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -12.23 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -118.72 -28.15 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -117.13 -52.51 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -109.39 97.07 6.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.865 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -164.68 13.02 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 1.004 HG23 HG22 ' P' ' 131' ' ' VAL . 90.3 m -120.41 130.09 54.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.916 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.648 HG11 HG23 ' P' ' 41' ' ' ILE . 5.3 t -108.84 141.72 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.102 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.28 117.7 30.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 20.4 m-30 -96.26 167.76 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.925 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' P' ' 128' ' ' ARG . . . -100.74 -170.11 28.81 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.76 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.43 115.74 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.52 31.63 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.534 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.433 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 15.5 mmtm -91.58 141.66 28.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 17.3 t80 -126.55 57.71 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.701 0.762 . . . . 0.0 110.116 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -150.96 150.85 31.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.893 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.648 HG23 HG11 ' P' ' 32' ' ' VAL . 3.0 mt -100.81 160.33 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.467 ' O ' HG23 ' P' ' 46' ' ' VAL . 18.4 p -108.83 138.86 44.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 111.743 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.08 -28.64 1.35 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.926 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.35 -31.98 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.112 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.494 ' O ' HG13 ' P' ' 48' ' ' ILE . 65.9 m-85 -106.33 5.57 29.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' P' ' 42' ' ' THR . 80.4 t -76.26 -28.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.53 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -36.46 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.67 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.074 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -58.95 -46.32 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.172 0.51 . . . . 0.0 109.899 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.434 HD23 ' N ' ' P' ' 49' ' ' LEU . 3.3 mt -59.75 -39.01 83.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.767 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.72 -44.69 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.345 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 -50.08 66.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.967 0.413 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.074 ' CD2' HG22 ' P' ' 48' ' ' ILE . 60.0 m-70 -59.75 -35.8 75.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.85 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.686 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.97 80.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.977 0.418 . . . . 0.0 110.435 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -78.03 -34.21 50.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.0 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.823 ' CD2' HG11 ' P' ' 99' ' ' VAL . 1.0 OUTLIER -67.0 -40.57 87.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.874 -179.234 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.99 -34.35 66.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.61 -22.63 67.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.569 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -110.8 115.29 53.55 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.592 0.235 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.12 -62.1 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.878 2.385 . . . . 0.0 114.065 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.6 25.16 1.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.602 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -91.14 122.13 33.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.166 0.508 . . . . 0.0 110.98 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.2 mttp -128.29 132.68 48.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.533 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.9 p -95.38 146.41 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-O 121.392 0.615 . . . . 0.0 111.54 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.22 103.68 12.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.69 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.631 HG11 ' HB ' ' P' ' 90' ' ' VAL . 0.2 OUTLIER -84.32 95.02 3.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.542 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 22.3 tt0 -89.36 119.72 30.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.773 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.48 145.9 18.65 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.658 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.674 ' O ' HG23 ' P' ' 70' ' ' THR . 28.2 m120 -142.49 161.44 38.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.674 HG23 ' O ' ' P' ' 69' ' ' ASN . 2.2 p -165.23 -169.98 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.0 111.889 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.505 ' HB3' ' CE1' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -58.17 158.48 6.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.926 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -77.63 -30.95 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.324 0.583 . . . . 0.0 109.741 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.404 ' HD2' ' OH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -65.89 129.09 38.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.697 0.761 . . . . 0.0 112.653 -178.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -179.96 18.1 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.824 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.77 144.28 28.41 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.72 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.605 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 94.8 Cg_exo -39.39 -49.68 3.07 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.144 2.563 . . . . 0.0 113.603 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -43.41 76.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -71.79 -45.37 61.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' P' ' 80' ' ' ILE . 6.4 m120 -71.11 -76.59 0.1 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -31.94 -46.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -57.02 10.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.279 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.986 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -50.43 -46.59 56.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.037 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.986 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.9 -43.61 82.25 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.236 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -51.95 -37.38 52.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 109.842 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -51.1 63.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.708 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.58 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 0.8 OUTLIER -58.39 -39.59 80.06 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -59.96 -32.83 71.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.757 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -31.67 71.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.145 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.45 -55.43 33.59 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.604 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.631 ' HB ' HG11 ' P' ' 66' ' ' VAL . 17.4 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.878 0.371 . . . . 0.0 111.088 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.616 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.31 -39.75 91.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.651 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.91 -24.39 69.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.16 -58.3 7.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.515 ' CD1' HG11 ' P' ' 64' ' ' VAL . 95.3 mt -61.23 -32.46 72.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.686 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.46 98.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.389 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.32 -21.21 77.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.864 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -10.8 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.0 111.344 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -5.88 17.98 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.436 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.823 HG11 ' CD2' ' P' ' 56' ' ' LEU . 19.5 t -78.45 127.77 38.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.946 0.373 . . . . 0.0 111.097 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.4 143.08 57.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 111.494 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.81 -35.38 22.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.553 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -21.1 54.27 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.725 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.1 OUTLIER -94.02 -9.66 36.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.16 0.48 . . . . 0.0 111.387 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.616 HD13 ' O ' ' P' ' 91' ' ' LYS . 1.1 mt -106.76 140.13 40.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.674 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.402 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -149.09 143.44 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.55 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 15.9 p -115.7 159.87 20.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.676 0.274 . . . . 0.0 110.863 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.58 HG12 ' CE2' ' P' ' 109' ' ' TYR . 46.4 t -164.57 114.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.489 ' OG ' HG23 ' P' ' 80' ' ' ILE . 58.5 p -111.82 134.71 53.2 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.433 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.58 ' CE2' HG12 ' P' ' 107' ' ' VAL . 95.2 m-85 -124.21 19.01 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.58 -109.79 0.01 OUTLIER Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 114.445 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' HA ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -88.59 7.69 32.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.23 -60.35 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 110.327 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -142.09 89.18 8.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.941 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.99 166.99 9.6 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.692 2.261 . . . . 0.0 112.543 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.26 -63.08 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.46 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.775 HG21 ' HD2' ' P' ' 126' ' ' LYS . 36.7 t -89.04 112.19 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.812 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tp -65.0 137.97 58.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.14 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.37 176.19 14.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.82 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.407 ' CB ' ' OH ' ' P' ' 124' ' ' TYR . 17.8 p-80 -140.79 60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.886 0.343 . . . . 0.0 111.39 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.31 155.3 48.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.35 -30.79 0.11 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.78 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.11 79.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' P' ' 71' ' ' ASP . 5.2 m-85 -62.64 -39.29 93.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.054 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 14.2 m -65.14 -33.51 76.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.945 0.402 . . . . 0.0 109.971 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.775 ' HD2' HG21 ' P' ' 116' ' ' VAL . 21.1 mtmt -73.98 -24.49 59.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.493 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -90.53 -30.87 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 76.2 mtm-85 -67.44 88.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.53 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.15 156.95 29.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.69 99.21 5.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 1.004 HG22 HG23 ' P' ' 31' ' ' THR . 31.1 t -95.95 115.75 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.846 ' O ' HD12 ' P' ' 132' ' ' LEU . 2.9 pp -85.72 123.59 31.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -131.68 151.8 51.35 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . 0.48 ' HE2' HD12 ' P' ' 56' ' ' LEU . 57.1 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.015 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.94 0.4 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 67.2 m-85 -133.45 109.54 9.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.508 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.71 9.69 20.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.265 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.72 -36.06 2.23 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.593 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.403 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 5.7 m-85 -121.34 162.4 20.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.431 . . . . 0.0 111.459 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 11.0 p -101.49 156.76 17.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.822 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.696 HG13 ' OH ' ' P' ' 134' ' ' TYR . 38.0 t -45.89 -41.55 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' P' ' 27' ' ' GLN . . . -66.2 -18.49 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' NE2' ' P' ' 27' ' ' GLN . 0.3 OUTLIER -99.26 -43.88 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.338 0.59 . . . . 0.0 110.008 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.542 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 1.9 mt -63.59 -19.2 64.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.557 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . 0.41 ' HG3' ' HG3' ' P' ' 27' ' ' GLN . 0.0 OUTLIER -88.88 -25.04 22.35 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' P' ' 23' ' ' ALA . 2.9 pp0? -132.98 -8.66 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . 0.403 ' HD3' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -109.94 -66.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.403 ' CE2' ' HD3' ' P' ' 28' ' ' ARG . 67.3 m-85 -107.43 88.8 2.82 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.39 0.614 . . . . 0.0 111.513 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.2 OUTLIER -152.47 16.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.997 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 91.1 m -121.89 129.82 52.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.716 HG11 HG23 ' P' ' 41' ' ' ILE . 4.6 t -107.68 150.49 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.917 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -123.05 112.11 17.38 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.411 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 23.3 m-85 -93.22 170.74 9.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.714 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.45 179.81 30.78 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.531 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.53 119.94 10.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 110.715 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t0 61.44 37.46 16.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.045 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -121.31 137.92 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 29.9 p90 -127.4 56.79 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 110.719 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.2 150.92 32.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.716 HG23 HG11 ' P' ' 32' ' ' VAL . 1.4 mp -94.21 163.23 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.982 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.481 ' N ' HG22 ' P' ' 41' ' ' ILE . 43.2 p -113.41 149.27 34.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.312 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.77 -32.4 3.03 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.31 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -64.17 -33.36 75.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.689 0.281 . . . . 0.0 111.614 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.541 ' CB ' HG13 ' P' ' 32' ' ' VAL . 78.4 m-85 -100.61 -3.71 29.93 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.408 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 70.2 t -61.79 -42.97 96.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.609 0.242 . . . . 0.0 111.351 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.413 ' NE2' HG12 ' P' ' 48' ' ' ILE . 0.9 OUTLIER -43.83 -43.5 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.063 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.34 -46.8 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -58.27 -42.24 86.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.9 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -42.7 77.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.87 65.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.063 ' CD2' HG22 ' P' ' 48' ' ' ILE . 14.6 m-70 -62.5 -38.56 90.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 110.473 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -68.58 -41.68 79.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.927 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.84 98.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.733 0.302 . . . . 0.0 111.147 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . 0.605 ' HE2' ' HD1' ' P' ' 52' ' ' HIS . 0.2 OUTLIER -71.84 -36.5 70.21 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.776 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.71 HD21 ' HG3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -75.14 -34.21 61.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.617 -178.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.55 -30.16 64.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.011 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 -17.85 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.376 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -112.58 111.79 51.69 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.301 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.93 -63.27 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.949 2.433 . . . . 0.0 114.421 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 22.59 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.646 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.5 112.96 24.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.349 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -117.01 132.87 56.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.546 ' HB ' HD13 ' P' ' 56' ' ' LEU . 14.4 p -98.64 146.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.547 0.689 . . . . 0.0 111.474 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.461 HD22 HG21 ' P' ' 107' ' ' VAL . 0.3 OUTLIER -107.3 103.65 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.462 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.458 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.5 t -83.59 100.2 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.387 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 5.5 tt0 -90.96 121.54 32.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.306 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.13 146.42 20.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.265 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' HG23 ' P' ' 70' ' ' THR . 0.8 OUTLIER -145.33 161.08 40.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.632 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.447 HG23 ' NH1' ' P' ' 86' ' ' ARG . 0.5 OUTLIER -162.38 -172.99 3.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 111.638 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 6.0 p-10 -81.75 166.32 20.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.374 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 tm-20 -64.15 -39.0 93.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.932 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.434 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 4.1 mmm180 -39.37 106.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -173.91 15.49 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.056 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.21 146.79 32.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.527 0.203 . . . . 0.0 110.646 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.432 ' O ' HD12 ' P' ' 80' ' ' ILE . 88.1 Cg_exo -45.46 -40.89 18.01 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.479 2.119 . . . . 0.0 112.644 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.37 -41.27 89.68 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -69.42 -44.2 71.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' P' ' 80' ' ' ILE . 27.8 m120 -61.84 -75.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.618 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.6 OUTLIER -30.01 -45.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 O-C-N 123.185 0.303 . . . . 0.0 111.737 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.13 -60.65 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.607 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -44.21 -45.98 8.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.767 178.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.409 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.9 -38.24 92.76 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.82 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -44.01 63.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.865 0.364 . . . . 0.0 110.226 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -39.72 90.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.528 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 3.0 mtt180 -61.65 -39.85 92.84 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.52 81.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.143 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -32.01 73.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.495 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.53 -63.53 1.24 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.514 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.23 -37.09 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 111.403 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -61.73 2.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.8 -20.3 59.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.363 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.69 -58.78 5.83 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.519 HD12 HD22 ' P' ' 104' ' ' LEU . 24.2 mt -59.41 -30.04 68.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.373 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.63 94.82 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.243 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.12 -26.71 73.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.892 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 1.2 mtpm? -78.23 -9.92 59.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.68 0.276 . . . . 0.0 111.26 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.12 -3.2 23.98 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.152 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.839 HG11 HD21 ' P' ' 104' ' ' LEU . 16.8 t -74.68 126.14 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.766 0.283 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . 0.45 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.3 OUTLIER -62.37 139.23 58.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.0 111.566 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.862 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -62.99 -32.84 74.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.294 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.46 -19.99 58.39 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.189 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.71 ' HG3' HD21 ' P' ' 56' ' ' LEU . 0.0 OUTLIER -101.99 -4.32 26.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.198 0.523 . . . . 0.0 111.035 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' P' ' 101' ' ' ALA . 0.5 OUTLIER -110.8 120.48 42.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.458 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -124.94 -175.17 14.17 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.852 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.781 ' O ' HG13 ' P' ' 107' ' ' VAL . 15.8 p -149.21 163.12 38.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.885 0.374 . . . . 0.0 111.279 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.781 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -177.0 111.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.47 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 1.1 p -111.9 145.54 39.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 0.0 111.812 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' P' ' 110' ' ' GLY . 83.7 m-85 -121.16 23.83 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 11.56 -115.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.859 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.36 17.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.175 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -59.1 -54.42 47.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 110.113 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -141.33 89.74 9.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.364 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.53 165.73 10.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.712 2.275 . . . . 0.0 112.534 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -59.72 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.814 HG21 ' HB3' ' P' ' 126' ' ' LYS . 11.4 t -88.21 109.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -75.98 134.07 40.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.777 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.04 -179.15 27.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.616 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -142.51 73.89 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -168.53 161.89 11.84 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 0.0 OUTLIER -46.35 -24.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.83 -59.06 3.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 -40.29 67.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 25.4 m-85 -60.48 -43.26 97.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 95.4 p -68.21 -33.34 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.814 ' HB3' HG21 ' P' ' 116' ' ' VAL . 23.7 mtmt -71.89 -22.85 61.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.218 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -87.41 -29.21 21.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.357 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.8 mtp180 -66.35 90.2 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.246 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.8 OUTLIER -158.81 158.6 33.83 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.67 107.84 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.85 147.75 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -100.53 100.02 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.586 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' P' ' 65' ' ' LEU . . . -104.55 143.87 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . 0.696 ' OH ' HG13 ' P' ' 22' ' ' VAL . 8.1 m-85 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -89.74 106.48 18.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.75 9.4 26.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.552 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.26 -38.35 1.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.795 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 17.7 m-85 -121.67 170.93 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 111.822 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.36 150.69 23.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.887 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 t -38.26 -63.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.53 -13.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -46.35 5.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 12.5 mt -56.88 -22.24 35.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.506 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.64 -11.96 16.65 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -115.77 -27.32 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -55.91 2.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -108.21 81.83 1.54 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.174 0.512 . . . . 0.0 111.914 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' P' ' 132' ' ' LEU . 0.2 OUTLIER -140.39 13.71 2.37 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.918 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.665 ' OG1' HG13 ' P' ' 131' ' ' VAL . 53.8 m -134.56 136.63 43.15 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.722 HG11 HG23 ' P' ' 41' ' ' ILE . 10.5 t -108.6 150.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.077 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -123.75 114.54 20.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 22.3 m-30 -93.4 170.59 9.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.777 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.31 -172.25 31.01 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.98 126.34 27.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.27 0.535 . . . . 0.0 110.673 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 46.64 33.77 2.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -96.08 141.51 29.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.689 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 3.3 t80 -129.85 48.81 2.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.714 0.769 . . . . 0.0 109.767 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -150.29 151.01 32.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.955 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.722 HG23 HG11 ' P' ' 32' ' ' VAL . 2.5 mt -96.08 161.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.559 0.219 . . . . 0.0 110.661 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.465 ' N ' HG22 ' P' ' 41' ' ' ILE . 16.2 p -110.83 144.8 39.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.032 0.444 . . . . 0.0 111.755 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.58 -30.17 3.13 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 113.413 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . 0.438 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 0.6 OUTLIER -63.27 -31.34 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.689 0.281 . . . . 0.0 111.721 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.585 ' CB ' HG13 ' P' ' 32' ' ' VAL . 87.8 m-85 -105.7 4.71 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 72.0 t -70.9 -37.17 67.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' P' ' 44' ' ' GLU . 0.0 OUTLIER -52.42 -31.99 37.02 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.557 -178.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 0.986 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -62.86 -49.98 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.191 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.554 HD23 ' CD2' ' P' ' 93' ' ' TYR . 1.6 mp -53.57 -37.45 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.62 -39.24 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.708 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.48 -57.32 4.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 0.986 ' CD2' HG22 ' P' ' 48' ' ' ILE . 20.0 m-70 -54.31 -37.85 65.29 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' P' ' 49' ' ' LEU . . . -60.15 -43.49 95.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.729 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.98 96.81 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.865 0.364 . . . . 0.0 110.551 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -73.86 -38.33 64.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.825 ' CD2' HG11 ' P' ' 99' ' ' VAL . 4.5 tp -65.48 -43.12 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.352 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.06 -37.67 78.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.445 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.85 -24.04 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -115.37 114.88 42.69 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.52 -48.6 19.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 113.894 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.7 18.48 7.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.612 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.64 116.57 28.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 0.0 110.711 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -118.19 133.96 55.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.953 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.656 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.3 p -95.57 141.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.345 0.593 . . . . 0.0 111.259 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.841 HD21 ' CG2' ' P' ' 107' ' ' VAL . 5.1 tt -108.96 101.03 10.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.725 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.468 HG13 HD22 ' P' ' 132' ' ' LEU . 0.7 OUTLIER -79.27 112.24 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.329 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.517 ' HG3' HD22 ' P' ' 65' ' ' LEU . 8.2 mt-10 -99.72 117.56 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.1 22.15 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.997 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.691 ' O ' HG23 ' P' ' 70' ' ' THR . 0.9 OUTLIER -145.5 157.92 43.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.814 0.34 . . . . 0.0 110.32 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.691 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.5 p -168.03 -176.65 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.059 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 6.1 p-10 -72.42 155.58 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.49 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pm0 -62.4 -34.23 76.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.018 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -39.68 106.92 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.69 168.25 17.42 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.569 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' P' ' 79' ' ' ASN . 0.5 OUTLIER -83.03 146.16 51.11 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.653 0.263 . . . . 0.0 110.568 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.11 -36.36 84.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.957 2.438 . . . . 0.0 114.182 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . 0.416 ' O ' HG22 ' P' ' 80' ' ' ILE . 1.0 OUTLIER -64.12 -48.96 74.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.79 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -75.07 -30.25 60.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -65.38 -74.54 0.1 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.627 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.3 OUTLIER -32.27 -38.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 O-C-N 123.23 0.332 . . . . 0.0 111.231 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -61.41 -59.37 5.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.499 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -47.22 -50.85 20.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.922 178.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.478 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.72 -45.24 86.06 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.598 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 4.2 tp60 -49.25 -38.69 27.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.281 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -67.65 -46.65 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.715 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.579 ' NH1' HG21 ' P' ' 70' ' ' THR . 0.4 OUTLIER -58.27 -40.65 82.43 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.595 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.12 -31.98 70.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.124 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -32.13 70.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.429 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.53 -60.16 4.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.8 -35.62 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -42.83 97.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.502 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.77 -22.63 78.93 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . 0.554 ' CD2' HD23 ' P' ' 49' ' ' LEU . 5.2 t80 -63.88 -62.09 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.6 ' CD1' HG11 ' P' ' 64' ' ' VAL . 75.3 mt -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.501 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.62 92.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.753 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.37 -24.44 76.07 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -73.17 -10.06 59.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.79 36.41 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.934 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.825 HG11 ' CD2' ' P' ' 56' ' ' LEU . 22.2 t -75.8 128.8 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.24 138.64 57.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -53.28 -36.03 60.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.04 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.06 -15.53 60.71 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.043 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.686 ' HE3' HG13 ' P' ' 99' ' ' VAL . 7.0 mtpp -92.88 -11.44 33.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' P' ' 101' ' ' ALA . 1.8 mt -103.68 142.81 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.451 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -147.69 145.64 14.47 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.771 ' O ' HG13 ' P' ' 107' ' ' VAL . 15.2 p -123.27 162.57 22.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.956 0.407 . . . . 0.0 111.313 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.841 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER 179.05 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.599 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -98.69 142.55 30.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.902 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' P' ' 112' ' ' GLU . 34.7 m-85 -113.31 13.81 19.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.89 -109.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.045 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -107.96 15.31 24.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' P' ' 109' ' ' TYR . 0.2 OUTLIER -63.25 -45.02 93.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.633 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . 0.411 ' N ' ' OE2' ' P' ' 112' ' ' GLU . 20.9 mtmm -146.51 88.93 5.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.71 164.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 0.0 113.143 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.37 -61.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.507 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.776 HG21 ' HB3' ' P' ' 126' ' ' LYS . 15.3 t -88.41 109.79 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.27 136.12 47.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.109 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.56 173.17 13.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -140.88 92.89 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.068 0.434 . . . . 0.0 111.994 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -166.64 162.37 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . 0.416 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.2 OUTLIER -47.08 -25.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.578 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.02 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.725 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.64 69.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 12.9 m-85 -54.55 -50.52 67.73 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.072 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -65.99 -33.81 76.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.776 ' HB3' HG21 ' P' ' 116' ' ' VAL . 3.6 mtmt -68.04 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.915 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.46 -29.75 21.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 5.4 mtp180 -65.49 88.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -158.3 157.46 32.5 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.71 95.26 4.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.665 HG13 ' OG1' ' P' ' 31' ' ' THR . 13.6 t -82.44 112.62 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.468 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -63.8 105.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.565 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -100.55 128.41 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.482 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.831 179.732 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 54.9 m-85 -136.04 108.42 7.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 111.282 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 9.95 32.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.424 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 -31.66 3.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.563 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.628 ' HB2' HD21 ' P' ' 25' ' ' LEU . 33.5 m-85 -117.29 161.8 18.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 16.7 t -111.15 160.57 16.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.755 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.436 HG23 ' H ' ' P' ' 22' ' ' VAL . 17.2 t -40.06 -56.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.37 -19.94 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.76 -43.61 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.298 0.57 . . . . 0.0 110.283 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' P' ' 20' ' ' TYR . 47.1 mt -67.94 -22.0 65.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.44 -20.88 26.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -143.42 -3.57 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . 0.41 ' HD2' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -107.26 -69.87 0.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.41 ' CE2' ' HD2' ' P' ' 28' ' ' ARG . 58.3 m-85 -108.86 89.56 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 112.101 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -150.14 18.75 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 86.9 m -126.3 132.01 51.74 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.833 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 1.065 HG11 HG23 ' P' ' 41' ' ' ILE . 23.6 t -108.36 149.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -113.41 113.44 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.623 0.725 . . . . 0.0 112.301 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.802 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 7.1 m-30 -90.29 174.49 7.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.567 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.89 -177.85 15.06 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -62.34 136.45 57.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.82 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.0 28.21 0.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.269 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.447 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -105.5 127.75 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.704 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.45 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 23.3 p90 -128.11 43.56 3.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.478 . . . . 0.0 110.2 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -148.06 150.51 34.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.345 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 1.065 HG23 HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -89.06 166.32 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.78 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.467 ' H ' HG22 ' P' ' 41' ' ' ILE . 47.1 p -111.09 150.1 29.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.125 0.488 . . . . 0.0 111.568 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.56 -31.2 3.54 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.337 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . 0.425 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 2.2 mm-40 -63.03 -32.44 73.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.404 ' O ' HG13 ' P' ' 48' ' ' ILE . 92.1 m-85 -104.05 5.11 35.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.43 HG13 ' OH ' ' P' ' 93' ' ' TYR . 76.3 t -70.68 -39.92 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' P' ' 44' ' ' GLU . 0.0 OUTLIER -49.81 -33.74 17.51 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.681 -178.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.058 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -59.17 -52.56 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 110.065 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.753 HD11 HG13 ' P' ' 90' ' ' VAL . 3.1 mm? -55.57 -33.32 63.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.681 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.23 -43.04 68.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.9 -37.06 62.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.058 ' CD2' HG22 ' P' ' 48' ' ' ILE . 28.4 m-70 -69.04 -38.73 79.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.84 94.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.347 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.36 90.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.021 0.439 . . . . 0.0 110.311 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . 0.444 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 7.8 t80 -72.56 -40.4 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.768 ' CD2' HG11 ' P' ' 99' ' ' VAL . 1.8 tp -61.64 -44.24 97.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -65.95 -41.8 90.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.94 3.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -113.77 118.05 43.48 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.483 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.56 -56.5 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.715 2.277 . . . . 0.0 113.727 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 23.42 1.59 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.475 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -91.5 131.82 36.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 110.547 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -137.35 137.72 39.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.997 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.9 p -98.16 141.29 16.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.519 0.675 . . . . 0.0 111.533 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.878 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.9 tt -108.97 103.62 12.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.565 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.8 OUTLIER -81.32 113.62 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.02 118.72 37.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -104.06 139.54 14.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.582 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 127' ' ' ASN . 57.0 m-80 -145.76 104.62 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.915 HG22 ' NH1' ' P' ' 86' ' ' ARG . 39.2 p -86.21 -176.54 5.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 10.4 p-10 -71.09 165.47 23.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.442 ' O ' ' CD ' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -66.68 -35.68 80.73 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.94 114.08 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.66 -142.12 17.3 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.807 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.29 146.11 52.65 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.512 0.196 . . . . 0.0 110.614 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.483 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 87.8 Cg_exo -44.68 -43.95 14.27 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.589 2.192 . . . . 0.0 113.715 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.72 -46.36 88.48 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -72.83 -36.56 67.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.949 0.404 . . . . 0.0 110.006 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' P' ' 80' ' ' ILE . 5.4 m120 -67.99 -74.33 0.12 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.621 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -29.98 -44.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.911 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -57.89 11.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.224 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.2 OUTLIER -46.53 -44.36 17.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.245 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.464 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -65.73 -38.13 94.17 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.564 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.34 -43.49 43.82 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.2 ptm180 -67.98 -33.72 75.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.466 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.915 ' NH1' HG22 ' P' ' 70' ' ' THR . 56.0 mtt180 -65.11 -49.23 70.75 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.543 0.687 . . . . 0.0 109.277 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.14 -34.81 74.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.704 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.45 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -63.89 -67.51 0.42 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.691 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.753 HG13 HD11 ' P' ' 49' ' ' LEU . 59.0 t -53.16 -43.35 49.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.112 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -40.98 85.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.546 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.77 -15.58 80.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.914 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . 0.43 ' OH ' HG13 ' P' ' 46' ' ' VAL . 2.6 t80 -72.75 -64.27 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.58 ' CD1' HG11 ' P' ' 64' ' ' VAL . 28.7 mt -55.78 -32.62 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.396 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.75 89.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.828 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.13 -22.75 77.41 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.605 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -76.04 -10.03 59.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.806 0.336 . . . . 0.0 110.975 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.3 35.73 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.148 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' P' ' 56' ' ' LEU . 18.2 t -75.63 125.81 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.852 0.326 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' P' ' 103' ' ' LYS . 2.5 p30 -62.34 139.54 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.335 0.588 . . . . 0.0 111.565 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.48 -36.35 10.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.449 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.99 -17.1 60.55 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.078 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' P' ' 63' ' ' LYS . 24.3 mtpp -91.49 -14.51 30.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.036 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' P' ' 94' ' ' LEU . 1.3 mt -102.62 143.07 32.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.565 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -139.92 146.14 17.48 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.776 ' O ' HG13 ' P' ' 107' ' ' VAL . 19.4 p -128.78 152.04 48.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.783 0.325 . . . . 0.0 110.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -175.39 119.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -118.53 133.63 55.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.522 ' O ' ' C ' ' P' ' 110' ' ' GLY . 23.7 m-85 -102.01 32.48 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -103.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.539 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' P' ' 72' ' ' GLU . 41.7 mt-10 -113.89 16.87 18.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -47.21 66.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.66 89.34 11.78 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.6 163.39 15.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.683 2.255 . . . . 0.0 112.935 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.73 -64.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' P' ' 126' ' ' LYS . 2.4 t -88.85 108.74 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' P' ' 117' ' ' LEU . 3.6 mm? -66.89 135.83 54.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.46 173.94 14.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.085 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -140.74 60.95 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.05 152.14 51.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . 0.411 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.1 OUTLIER -37.78 -33.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.28 -61.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.84 -42.63 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.992 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.466 ' O ' ' HD3' ' P' ' 128' ' ' ARG . 4.7 m-85 -56.65 -54.0 51.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.196 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . 0.552 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 4.8 m -55.68 -35.59 66.2 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.664 ' HB3' HG21 ' P' ' 116' ' ' VAL . 33.9 mtmt -75.44 -21.22 58.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.56 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 69' ' ' ASN . 44.9 m-20 -80.95 -42.76 20.77 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.802 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.39 73.58 0.72 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.949 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.6 143.42 49.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.11 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.61 98.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.66 111.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 101.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.589 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -97.6 125.65 42.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.46 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.945 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 33.2 p . . . . . 0 C--O 1.232 0.132 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 45.5 m-85 -129.98 112.08 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.678 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.35 9.62 61.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.584 -0.817 . . . . 0.0 114.08 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 -27.4 3.86 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.137 -1.506 . . . . 0.0 114.529 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.15 173.89 8.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.285 0.542 . . . . 0.0 111.726 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.89 151.52 21.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' P' ' 25' ' ' LEU . 13.1 t -44.5 -35.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.898 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.59 -13.04 38.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.612 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' P' ' 29' ' ' TYR . 0.4 OUTLIER -98.16 -44.37 6.63 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.849 0.833 . . . . 0.0 108.891 177.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' P' ' 22' ' ' VAL . 7.5 mt -58.89 -23.36 60.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.348 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -111.87 -19.19 12.48 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 -32.23 2.99 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -141.57 59.92 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 0.5 OUTLIER 157.5 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.974 0.416 . . . . 0.0 110.691 178.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 172.95 15.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 57.3 m -120.4 126.82 51.41 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.628 0.649 . . . . 0.0 112.203 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.745 HG11 HG23 ' P' ' 41' ' ' ILE . 3.4 t -108.18 145.35 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.49 115.19 23.54 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.7 m-85 -96.04 168.28 10.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.766 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.53 -171.87 28.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.976 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -61.8 116.52 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.656 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 58.33 39.2 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.41 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 1.7 tptp -112.97 136.15 52.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.416 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 27.5 p90 -130.33 54.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.58 150.59 33.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.745 HG23 HG11 ' P' ' 32' ' ' VAL . 1.6 mp -96.76 161.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.781 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.468 ' N ' HG22 ' P' ' 41' ' ' ILE . 30.7 p -112.71 147.72 36.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.017 0.437 . . . . 0.0 111.385 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.77 -30.17 3.39 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.082 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.49 -33.89 75.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.562 0.22 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.403 ' CB ' HG13 ' P' ' 32' ' ' VAL . 96.9 m-85 -104.49 3.36 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.57 -41.14 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' P' ' 47' ' ' GLN . 6.5 pm0 -47.6 -35.05 8.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.711 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.003 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -64.37 -46.78 92.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.536 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.437 ' HB3' ' CE1' ' P' ' 93' ' ' TYR . 5.6 mp -56.87 -47.34 80.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.375 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . 0.449 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.3 OUTLIER -67.45 -33.52 75.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.428 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.9 -41.03 37.93 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.685 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.003 ' CD2' HG22 ' P' ' 48' ' ' ILE . 22.3 m-70 -64.21 -38.46 91.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.26 88.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . 0.448 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 21.6 t80 -79.2 -34.45 42.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 1.023 HD23 HG11 ' P' ' 99' ' ' VAL . 5.0 tp -66.51 -41.3 89.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -75.64 -34.54 60.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.653 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.93 -24.85 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.57 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -112.57 114.82 49.74 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.634 0.254 . . . . 0.0 110.389 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -48.94 -63.12 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.876 2.384 . . . . 0.0 114.039 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.27 18.85 2.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -84.56 113.57 21.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.9 mttp -115.59 128.46 55.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.51 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.7 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.6 p -96.2 139.98 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 121.305 0.574 . . . . 0.0 110.641 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.618 HD21 HG22 ' P' ' 107' ' ' VAL . 1.1 tt -112.45 103.09 11.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.956 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.689 HG13 HD22 ' P' ' 132' ' ' LEU . 0.6 OUTLIER -81.47 106.45 12.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.479 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.58 ' HA ' HG23 ' P' ' 107' ' ' VAL . 20.7 mt-10 -89.8 119.32 30.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.526 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 134.53 12.52 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.607 ' O ' HG23 ' P' ' 70' ' ' THR . 27.3 m120 -134.62 159.02 42.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.438 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.607 HG23 ' O ' ' P' ' 69' ' ' ASN . 7.6 p -164.42 -177.61 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.162 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.518 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 8.2 p-10 -73.55 155.6 38.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' P' ' 111' ' ' GLU . 2.6 pp20? -63.49 -34.86 78.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.962 0.41 . . . . 0.0 110.641 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -41.8 165.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.438 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . 0.529 ' O ' HG23 ' P' ' 75' ' ' THR . . . 78.4 -124.47 6.7 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.773 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . 0.529 HG23 ' O ' ' P' ' 74' ' ' GLY . 0.8 OUTLIER -163.62 145.53 7.52 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.437 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 2.4 Cg_endo -39.61 -53.13 2.36 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.297 2.664 . . . . 0.0 113.25 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -40.73 93.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -72.37 -35.16 68.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.453 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.74 ' HA ' HD12 ' P' ' 82' ' ' LEU . 5.6 m120 -76.94 -76.88 0.16 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.573 HD11 ' O ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.04 -43.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.3 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -68.86 -60.72 2.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 1.028 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.14 -38.42 73.49 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.272 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 1.028 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -68.46 -50.96 34.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.341 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.4 mt-30 -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -46.49 88.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.324 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.615 ' HD2' HD22 ' P' ' 82' ' ' LEU . 0.4 OUTLIER -57.27 -42.62 81.95 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -59.87 -37.44 79.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.147 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -64.63 -32.34 73.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.467 178.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.59 -47.59 84.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.697 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.01 -34.69 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.702 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.567 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -66.94 -38.69 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.525 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.96 -29.47 58.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . 0.451 ' CD1' ' HE3' ' P' ' 97' ' ' LYS . 7.6 t80 -62.87 -53.76 49.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.596 ' HB2' HD21 ' P' ' 104' ' ' LEU . 20.3 mt -59.48 -28.62 67.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.263 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.57 -36.63 65.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.914 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.45 58.01 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.092 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.575 ' HD2' ' HA ' ' P' ' 94' ' ' LEU . 0.0 OUTLIER -49.42 -34.76 17.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.92 28.94 1.6 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.386 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 1.023 HG11 HD23 ' P' ' 56' ' ' LEU . 23.1 t -90.71 145.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.567 0.223 . . . . 0.0 110.822 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . 0.405 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -61.5 160.45 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.283 0.563 . . . . 0.0 111.526 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.772 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.64 -32.52 16.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.1 -21.67 46.93 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.48 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.08 -4.57 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.22 0.533 . . . . 0.0 110.923 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' P' ' 101' ' ' ALA . 4.6 mt -85.74 150.51 24.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.206 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.619 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.9 139.67 8.12 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.685 ' O ' HG13 ' P' ' 107' ' ' VAL . 34.6 p -141.57 151.2 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.685 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -166.95 170.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.855 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.573 ' O ' HD11 ' P' ' 80' ' ' ILE . 1.3 t -157.38 126.93 6.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.726 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.3 m-85 -115.49 18.49 15.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -1.28 -113.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.597 -0.729 . . . . 0.0 114.804 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -85.35 2.54 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.91 -57.05 14.47 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 88.22 5.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.76 170.81 18.69 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.022 2.481 . . . . 0.0 112.838 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.46 -56.03 2.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.152 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.892 HG13 ' HB1' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -88.72 138.61 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.699 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.44 139.41 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.154 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.19 176.93 15.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.881 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.464 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 0.2 OUTLIER -141.06 62.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 0.249 . . . . 0.0 111.279 -179.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 1.4 p30 -132.92 154.91 49.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.81 -26.09 0.12 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . 0.517 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -72.69 -62.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.97 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . 0.892 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -69.79 -42.43 73.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 1.0 OUTLIER -55.65 -48.76 74.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.759 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 58.2 m -63.34 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.397 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -68.33 -27.13 66.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.325 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.443 ' ND2' HG12 ' P' ' 116' ' ' VAL . 92.0 m-20 -89.07 -28.95 19.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -70.16 86.89 0.57 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 7.6 ptt-85 -159.79 159.18 32.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -123.63 102.35 7.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -86.87 109.58 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.689 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -59.68 102.19 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.572 178.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 126.92 48.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.678 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.874 179.624 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 39.1 p . . . . . 0 CA--C 1.526 0.036 0 CA-C-O 120.805 0.336 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' P' ' 20' ' ' TYR . 63.4 m-85 -89.68 107.16 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.994 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.75 9.33 38.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.645 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.67 -37.1 1.87 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.349 -1.405 . . . . 0.0 114.037 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' P' ' 17' ' ' PHE . 5.3 m-85 -120.76 169.14 10.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.023 0.411 . . . . 0.0 111.586 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 26.0 t -102.78 152.99 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.439 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -40.07 -48.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.36 -17.27 28.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -42.61 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.284 0.564 . . . . 0.0 110.427 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.509 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 16.3 mt -59.27 -21.22 59.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.436 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . 0.45 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 4.5 mm-40 -103.26 -12.6 17.17 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -125.21 -22.72 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -109.78 -62.16 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -108.25 83.58 1.8 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.288 0.566 . . . . 0.0 112.162 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.603 HD22 ' HB2' ' P' ' 132' ' ' LEU . 0.1 OUTLIER -141.53 13.45 2.14 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.933 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.477 HG23 HG22 ' P' ' 131' ' ' VAL . 95.2 m -134.28 135.99 43.23 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.719 HG11 HG23 ' P' ' 41' ' ' ILE . 3.0 t -108.37 150.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.07 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.32 115.62 21.98 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.2 m-30 -96.18 169.87 9.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.512 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.56 -168.95 19.41 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.818 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.58 126.14 26.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 49.75 30.57 3.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.618 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.402 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -101.13 132.55 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.423 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 40.1 p90 -129.35 46.26 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 110.822 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.41 150.43 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.808 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.719 HG23 HG11 ' P' ' 32' ' ' VAL . 1.2 mp -90.9 164.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.259 . . . . 0.0 110.896 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.465 ' N ' HG22 ' P' ' 41' ' ' ILE . 67.2 p -112.8 149.98 32.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.213 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -43.48 -32.51 1.92 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.228 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.89 -33.06 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.415 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.502 ' CB ' HG13 ' P' ' 32' ' ' VAL . 81.4 m-85 -102.27 -1.02 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.59 -40.98 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -43.85 -43.44 6.3 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.008 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -57.39 -50.34 77.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 110.556 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' P' ' 53' ' ' ALA . 5.1 mt -53.32 -37.46 62.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -40.26 56.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.13 -54.22 11.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.03 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.008 ' CD2' HG22 ' P' ' 48' ' ' ILE . 22.7 m-70 -56.98 -36.8 70.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 109.904 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' P' ' 49' ' ' LEU . . . -60.76 -42.53 97.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.07 95.51 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.854 0.359 . . . . 0.0 110.751 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.33 -36.43 53.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.707 ' CD2' HG11 ' P' ' 99' ' ' VAL . 8.0 tp -68.93 -39.42 79.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.935 0.398 . . . . 0.0 111.174 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.05 -36.74 66.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.192 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.45 -23.28 67.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.22 111.24 58.04 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.602 0.239 . . . . 0.0 110.363 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.17 -58.67 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.863 2.375 . . . . 0.0 113.927 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.65 2.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.638 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.18 116.95 27.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.77 131.12 57.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.038 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.661 ' HB ' HD13 ' P' ' 56' ' ' LEU . 3.9 p -95.98 133.69 36.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.433 0.635 . . . . 0.0 111.15 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.452 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.2 tt -109.79 103.67 12.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.793 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.73 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -82.41 108.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.73 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.47 ' HA ' HG23 ' P' ' 107' ' ' VAL . 2.4 tt0 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.773 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.77 128.58 8.87 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.722 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.721 ' O ' HG23 ' P' ' 70' ' ' THR . 1.8 m-80 -130.93 158.0 41.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.721 HG23 ' O ' ' P' ' 69' ' ' ASN . 0.9 OUTLIER -170.25 -175.19 1.89 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 111.495 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.563 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 14.0 p-10 -77.43 149.39 35.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.302 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 9.2 pm0 -57.71 -31.63 66.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.883 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.423 ' N ' ' HG2' ' P' ' 72' ' ' GLU . 2.9 tpp180 -40.74 107.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.36 -173.69 15.03 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.163 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.76 145.52 30.87 Favored Pre-proline 0 N--CA 1.466 0.355 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 81.4 Cg_exo -39.97 -46.79 3.91 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.916 2.411 . . . . 0.0 113.063 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.84 -40.99 94.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -73.99 -39.01 63.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.457 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 0.4 OUTLIER -68.78 -76.75 0.09 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' P' ' 79' ' ' ASN . 1.0 OUTLIER -30.64 -45.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.433 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.37 -57.62 11.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -45.31 -51.86 10.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.779 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -62.23 -35.84 92.16 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.482 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -47.9 65.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.913 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 0.0 OUTLIER -68.1 -32.99 73.69 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.827 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.494 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 6.6 mtt180 -65.22 -45.99 82.46 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.555 0.693 . . . . 0.0 109.229 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' P' ' 106' ' ' THR . . . -60.35 -35.55 75.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.749 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.99 -30.74 71.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.87 -56.35 20.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.938 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.04 -36.17 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -43.77 98.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -72.21 -24.44 76.42 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.98 -64.04 1.0 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.464 ' CD1' HG11 ' P' ' 64' ' ' VAL . 85.2 mt -53.83 -32.82 54.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -59.02 -41.6 88.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.053 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.72 -21.08 77.85 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -79.85 -9.52 59.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 122.74 0.416 . . . . 0.0 110.974 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.94 0.18 36.01 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.776 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.707 HG11 ' CD2' ' P' ' 56' ' ' LEU . 48.6 t -73.63 123.71 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.36 148.61 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -68.48 -34.24 75.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.673 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.39 -22.1 55.44 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.045 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.622 ' HD3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -100.05 -4.43 29.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.229 0.537 . . . . 0.0 111.133 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' P' ' 101' ' ' ALA . 37.2 mt -95.91 150.12 20.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.298 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.616 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -148.42 142.07 9.66 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.755 ' O ' HG13 ' P' ' 107' ' ' VAL . 45.0 p -134.02 155.69 49.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.668 0.27 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.755 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -170.77 171.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.424 ' OG ' HG23 ' P' ' 80' ' ' ILE . 14.7 p -162.62 134.54 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.633 0.254 . . . . 0.0 111.48 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.509 ' O ' ' C ' ' P' ' 110' ' ' GLY . 29.5 m-85 -123.62 23.59 8.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 1.25 -110.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 114.622 0.609 . . . . 0.0 114.622 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -84.05 5.06 27.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -54.71 -59.57 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 88.78 7.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.98 166.96 13.05 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.79 2.327 . . . . 0.0 113.018 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.72 -61.64 1.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.27 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' P' ' 126' ' ' LYS . 5.6 t -88.84 108.86 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.83 136.53 56.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.199 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.06 174.98 14.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.981 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.457 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 7.2 p-80 -141.12 61.09 1.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.765 0.283 . . . . 0.0 111.462 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . 0.724 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 2.7 p30 -130.16 156.35 44.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -43.66 -25.82 0.19 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . 0.724 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -75.13 -56.66 4.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.89 -43.19 68.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.666 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 2.0 m-85 -59.48 -47.38 85.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 94.6 p -63.36 -33.44 75.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 110.241 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.784 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -69.79 -24.49 63.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.887 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.85 -30.8 18.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.335 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 3.0 mtp180 -65.82 87.25 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.2 OUTLIER -159.32 157.17 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.06 96.23 4.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.477 HG22 HG23 ' P' ' 31' ' ' THR . 21.5 t -82.02 109.71 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.73 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -60.92 101.81 0.17 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.031 178.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.22 127.84 46.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.755 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . 0.495 ' HH ' ' HD1' ' P' ' 52' ' ' HIS . 11.3 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.889 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.925 0.393 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -137.04 107.17 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.18 9.64 12.26 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.358 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.79 -41.41 1.32 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.819 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -126.65 172.59 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.967 0.413 . . . . 0.0 111.504 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -99.72 152.26 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.949 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.672 ' HA ' HD12 ' P' ' 25' ' ' LEU . 16.7 t -42.13 -53.85 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.315 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.46 -14.94 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -44.79 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 109.483 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' P' ' 22' ' ' VAL . 2.6 mt -59.06 -21.98 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.997 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -100.75 -11.93 19.51 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -121.86 -21.82 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . 0.483 ' HD3' ' CZ ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -118.39 -55.44 2.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.483 ' CZ ' ' HD3' ' P' ' 28' ' ' ARG . 53.0 m-85 -108.78 101.41 10.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.179 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 1.4 p30 -170.44 20.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.247 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 82.7 m -128.88 131.29 47.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 2.6 t -110.98 143.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.211 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -117.28 118.55 32.59 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.51 170.73 7.86 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.132 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.45 -165.77 15.34 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.433 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . 0.407 ' CE2' ' OD2' ' P' ' 37' ' ' ASP . 2.7 t80 -57.65 123.74 16.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.51 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . 0.407 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 3.2 p30 42.01 28.61 0.1 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.002 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -90.44 130.14 36.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.626 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 9.1 t80 -125.03 59.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.52 149.98 29.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.91 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.482 HG22 ' N ' ' P' ' 42' ' ' THR . 8.6 mt -96.83 161.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.482 ' N ' HG22 ' P' ' 41' ' ' ILE . 3.9 p -110.47 140.72 44.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 112.025 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.6 -30.03 3.1 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.095 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.84 -33.49 76.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.55 0.214 . . . . 0.0 111.552 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.403 ' O ' HG13 ' P' ' 48' ' ' ILE . 83.1 m-85 -101.26 0.17 36.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.42 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 75.6 t -66.87 -40.81 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.43 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -45.11 -43.52 9.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.423 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 0.953 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -54.08 -52.46 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.292 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' P' ' 53' ' ' ALA . 2.6 mp -50.92 -40.27 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.385 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -38.29 64.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.928 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.02 -58.89 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.821 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 0.953 ' CD2' HG22 ' P' ' 48' ' ' ILE . 18.8 m-70 -51.54 -37.0 47.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.171 0.51 . . . . 0.0 109.784 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . 0.566 ' HB1' ' NZ ' ' P' ' 97' ' ' LYS . . . -60.98 -48.16 83.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.289 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.85 76.86 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.926 0.394 . . . . 0.0 110.372 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -71.47 -42.12 68.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.676 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.75 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.301 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -67.29 -43.06 82.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.09 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.331 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -123.41 95.64 45.02 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.88 -24.61 39.58 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 113.29 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.9 5.27 51.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.55 127.03 36.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.8 mttp -121.51 130.56 53.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.046 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.1 p -97.38 147.34 6.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.502 0.668 . . . . 0.0 111.536 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.5 tt -119.78 104.24 10.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.665 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.683 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -83.15 109.87 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.618 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 1.6 mm-40 -89.7 121.55 31.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.54 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.25 133.84 11.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.881 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -145.82 100.98 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.778 0.323 . . . . 0.0 110.754 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.862 HG21 HD11 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -88.05 -168.68 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 13.0 p-10 -81.79 164.91 21.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.974 0.416 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 10.1 tm-20 -66.93 -40.59 87.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.246 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.432 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -44.97 106.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.037 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.27 -164.83 12.01 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.479 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.27 146.02 34.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.657 0.265 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.68 ' O ' HD12 ' P' ' 80' ' ' ILE . 71.8 Cg_exo -50.78 -38.22 56.39 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.13 2.553 . . . . 0.0 114.158 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.55 -42.8 83.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 40.5 t80 -81.73 -29.26 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.66 ' HA ' HD12 ' P' ' 82' ' ' LEU . 2.0 m-80 -90.62 -11.54 39.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.68 HD12 ' O ' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -87.58 -40.74 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.2 -48.67 64.59 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.269 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 1.029 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -60.24 -38.46 83.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.126 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 1.029 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.4 -44.52 64.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.139 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.7 OUTLIER -50.63 -41.3 54.88 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.477 ' HG3' ' CE1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.65 -35.42 80.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -64.24 -52.39 58.95 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.55 -34.98 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.476 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -29.43 69.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.49 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.75 -50.77 63.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.629 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.15 -38.76 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.424 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.97 -40.68 96.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.234 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 -28.3 68.66 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . 0.466 ' CD1' ' HD2' ' P' ' 97' ' ' LYS . 4.3 t80 -59.97 -62.24 2.02 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.639 ' HA ' ' HD3' ' P' ' 97' ' ' LYS . 95.4 mt -54.43 -32.42 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.55 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.18 76.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.169 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.78 -29.75 75.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.547 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.639 ' HD3' ' HA ' ' P' ' 94' ' ' LEU . 0.7 OUTLIER -74.13 -11.6 60.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.11 3.49 15.24 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.75 HG11 ' CD2' ' P' ' 56' ' ' LEU . 28.2 t -80.98 131.82 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.897 0.349 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . 0.438 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -60.31 158.02 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.333 0.587 . . . . 0.0 111.556 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.876 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -86.42 -29.94 22.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.71 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.53 50.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.807 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.631 ' HE3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -99.93 -3.77 31.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.145 0.497 . . . . 0.0 111.163 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.3 mt -91.68 149.21 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.336 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.634 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -145.89 139.79 8.45 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.488 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 43.5 p -138.45 151.43 47.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.767 0.318 . . . . 0.0 110.975 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.511 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -161.27 169.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.133 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.478 ' OG ' HG23 ' P' ' 80' ' ' ILE . 51.6 p -162.68 130.04 3.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.506 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.552 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.0 OUTLIER -114.19 31.55 6.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.234 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.77 -113.12 0.01 OUTLIER Glycine 0 C--N 1.34 0.796 0 O-C-N 123.679 0.612 . . . . 0.0 114.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 2.7 mp0 -97.71 13.18 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . 0.436 ' CG ' ' HB3' ' P' ' 76' ' ' PRO . 26.0 mt-10 -61.72 -55.23 32.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.679 0.276 . . . . 0.0 110.378 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -134.19 89.83 27.24 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 161.2 8.98 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.641 2.227 . . . . 0.0 112.967 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.92 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.712 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.878 HG21 ' HB3' ' P' ' 126' ' ' LYS . 3.6 t -88.61 108.82 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.98 135.04 57.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.388 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.93 173.3 14.72 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.787 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.487 ' HA ' ' CD1' ' P' ' 124' ' ' TYR . 0.6 OUTLIER -141.21 64.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.787 0.294 . . . . 0.0 111.492 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.82 152.88 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -38.0 -32.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -60.93 2.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -43.93 74.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' P' ' 119' ' ' HIS . 0.8 OUTLIER -57.71 -52.99 63.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.316 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . 0.403 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 11.2 t -59.33 -33.96 71.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.878 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -67.86 -27.84 67.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.572 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 69' ' ' ASN . 74.3 m-20 -82.96 -33.48 26.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.88 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.3 mpp_? -69.74 80.21 0.44 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.815 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 4.1 ptt180 -156.56 150.86 25.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.95 115.91 25.35 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.8 112.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.683 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -59.41 98.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.632 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -102.36 129.1 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.009 179.773 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.81 0.338 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.525 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 94.2 m-85 -89.48 108.1 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.498 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.97 9.14 38.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.333 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -32.97 2.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.488 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' P' ' 17' ' ' PHE . 2.1 m-85 -115.41 160.61 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.025 0.441 . . . . 0.0 111.611 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 9.4 t -103.2 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.262 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.614 ' HA ' HD12 ' P' ' 25' ' ' LEU . 21.5 t -43.3 -41.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -17.27 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 -40.58 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.568 0.699 . . . . 0.0 110.012 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' P' ' 22' ' ' VAL . 6.3 mt -64.27 -15.34 59.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.564 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . 0.491 ' HG3' ' CD2' ' P' ' 134' ' ' TYR . 2.0 tt0 -92.78 -25.47 18.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.39 -9.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -117.12 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 54.0 m-85 -107.12 99.49 9.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 111.961 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.622 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 1.3 p30 -178.38 27.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.22 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.508 HG23 HG22 ' P' ' 131' ' ' VAL . 78.6 m -126.48 127.08 44.81 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.791 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.745 HG11 HG23 ' P' ' 41' ' ' ILE . 1.9 t -104.19 150.13 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.157 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -124.63 112.64 17.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.243 0.544 . . . . 0.0 112.429 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -91.51 166.66 12.73 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.97 -167.64 19.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.064 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.54 126.32 26.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.016 0.436 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t0 53.09 27.92 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.568 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -100.97 136.8 40.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.485 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 46.4 p90 -135.72 36.05 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.22 150.63 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.799 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.745 HG23 HG11 ' P' ' 32' ' ' VAL . 0.8 OUTLIER -88.26 164.66 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.933 0.397 . . . . 0.0 111.069 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.456 ' H ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -114.38 149.06 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' P' ' 46' ' ' VAL . . . -41.18 -33.96 0.85 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.527 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.2 -31.79 72.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.644 0.259 . . . . 0.0 111.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.491 ' O ' HG13 ' P' ' 48' ' ' ILE . 71.2 m-85 -99.99 1.54 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' P' ' 43' ' ' GLY . 56.0 t -65.05 -44.72 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -40.01 -43.97 1.65 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 0.89 HG22 ' HD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -62.14 -47.4 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.066 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.41 HD22 HG13 ' P' ' 90' ' ' VAL . 16.2 mt -56.61 -51.77 67.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.801 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . 0.576 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.9 OUTLIER -61.13 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' P' ' 17' ' ' PHE . . . -71.14 -37.06 72.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 0.89 ' HD2' HG22 ' P' ' 48' ' ' ILE . 5.6 m-70 -66.21 -33.44 75.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.241 0.543 . . . . 0.0 110.321 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . 0.416 ' CB ' ' HG2' ' P' ' 97' ' ' LYS . . . -75.38 -31.14 60.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.826 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.25 69.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 111.356 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . 0.772 ' HH ' ' HE1' ' P' ' 134' ' ' TYR . 1.8 p90 -74.28 -34.41 63.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.577 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -72.4 -35.64 68.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -178.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.77 -31.7 65.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.98 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.89 61.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.38 111.79 57.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.819 0.342 . . . . 0.0 110.503 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.69 -62.49 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.079 2.519 . . . . 0.0 114.481 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.35 22.93 2.7 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.65 116.34 28.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.711 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -122.21 132.28 54.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.892 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.512 ' HB ' HD13 ' P' ' 56' ' ' LEU . 10.0 p -95.36 137.34 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 121.41 0.624 . . . . 0.0 111.466 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' P' ' 107' ' ' VAL . 0.6 OUTLIER -105.15 106.39 16.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.682 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.577 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.6 OUTLIER -84.88 104.39 12.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 10.4 mt-10 -89.59 119.88 30.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.596 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.16 95.92 1.88 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.094 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.708 ' O ' HG23 ' P' ' 70' ' ' THR . 2.4 m-20 -97.58 155.22 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.283 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.708 HG23 ' O ' ' P' ' 69' ' ' ASN . 0.7 OUTLIER -173.43 176.25 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.165 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -73.88 148.16 42.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.249 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' P' ' 114' ' ' PRO . 0.5 OUTLIER -55.36 -28.3 52.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.957 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.456 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 19.1 ttm180 -39.82 104.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.312 0.577 . . . . 0.0 112.263 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . 0.489 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.29 163.28 16.54 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.109 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.16 146.71 71.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.479 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 68.7 Cg_exo -50.53 -42.63 48.54 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.744 2.296 . . . . 0.0 113.95 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.99 -46.66 86.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . 0.576 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -77.49 -32.31 54.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.547 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 1.5 m120 -63.56 -74.94 0.09 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.445 HG23 ' OG ' ' P' ' 108' ' ' SER . 0.7 OUTLIER -32.16 -40.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 120.779 0.323 . . . . 0.0 110.707 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' P' ' 84' ' ' GLN . . . -62.16 -55.3 30.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.039 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.3 OUTLIER -43.72 -52.65 6.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.595 177.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.44 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -68.62 -34.4 78.49 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.108 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.442 ' HB2' ' HA ' ' P' ' 81' ' ' ALA . 0.0 OUTLIER -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -64.09 -40.26 95.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.571 ' NH1' HG21 ' P' ' 70' ' ' THR . 9.1 mtt180 -60.26 -39.58 87.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.64 94.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.431 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.29 -34.89 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.51 -61.06 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.429 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.41 HG13 HD22 ' P' ' 49' ' ' LEU . 26.3 t -64.88 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.354 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -47.17 87.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.634 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.56 -23.01 76.79 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.839 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' P' ' 97' ' ' LYS . 5.2 t80 -64.43 -63.69 1.07 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' P' ' 64' ' ' VAL . 33.5 mt -55.47 -31.68 62.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.12 95.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.82 -24.08 75.64 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.447 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -74.98 -9.49 58.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.068 179.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.21 6.04 48.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.868 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' P' ' 56' ' ' LEU . 39.3 t -76.86 130.39 36.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.064 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.47 140.68 58.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.456 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.0 70.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.35 -17.9 57.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.929 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 12.6 mtpp -91.65 -13.38 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.999 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.423 HD21 ' CG1' ' P' ' 99' ' ' VAL . 2.8 mt -101.99 143.83 31.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.355 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.577 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.23 147.07 17.77 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.812 ' O ' HG13 ' P' ' 107' ' ' VAL . 17.4 p -127.93 154.71 45.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.728 0.299 . . . . 0.0 110.663 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.812 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -176.02 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.769 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.445 ' OG ' HG23 ' P' ' 80' ' ' ILE . 52.5 p -112.79 137.46 51.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.771 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.531 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.7 m-85 -113.22 26.85 10.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.707 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 5.8 -111.37 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.224 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.479 ' HG3' ' HG3' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -101.38 14.89 30.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -62.52 -55.16 30.09 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.24 88.83 5.69 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . 0.433 ' HG2' ' HG2' ' P' ' 72' ' ' GLU . 21.6 Cg_exo -65.95 169.89 12.56 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.026 2.484 . . . . 0.0 112.928 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.84 -61.69 1.33 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.224 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.44 114.17 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.601 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.04 138.7 57.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.8 178.19 18.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.053 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.512 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 0.5 OUTLIER -142.04 67.53 1.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.639 0.219 . . . . 0.0 111.305 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.09 153.13 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -38.98 -32.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.14 -52.65 13.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.874 0.368 . . . . 0.0 111.291 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.53 67.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.512 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 2.1 m-30 -63.91 -40.5 96.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 91.5 p -65.85 -35.75 81.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.026 0.441 . . . . 0.0 109.888 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -69.59 -25.3 63.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.743 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.63 -30.68 19.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 7.4 mtp180 -66.18 82.41 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -159.23 162.42 36.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -128.42 102.45 6.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.508 HG22 HG23 ' P' ' 31' ' ' THR . 14.1 t -91.21 117.52 34.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.1 OUTLIER -71.48 104.92 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.081 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -115.21 145.19 42.66 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.543 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . 0.772 ' HE1' ' HH ' ' P' ' 55' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.922 0.391 . . . . 0.0 110.757 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' P' ' 20' ' ' TYR . 57.1 m-85 -91.06 108.71 20.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.32 9.38 42.46 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.818 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.51 2.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.02 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.551 ' HD2' HD21 ' P' ' 25' ' ' LEU . 0.5 OUTLIER -120.62 164.89 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.021 0.439 . . . . 0.0 111.58 -179.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.3 t -98.27 152.32 19.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 15.7 t -39.9 -49.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.72 -15.98 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' P' ' 29' ' ' TYR . 0.2 OUTLIER -99.6 -47.58 5.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.233 0.539 . . . . 0.0 110.233 178.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' P' ' 20' ' ' TYR . 42.0 mt -54.62 -22.64 14.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.783 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -12.93 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -111.9 -29.69 7.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -129.79 -38.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.415 ' HB2' ' OD1' ' P' ' 24' ' ' ASP . 27.7 m-85 -109.91 104.78 13.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.614 0.721 . . . . 0.0 112.366 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 179.44 22.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.464 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 91.7 m -126.88 128.79 47.05 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.065 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.738 HG11 HG23 ' P' ' 41' ' ' ILE . 16.7 t -108.95 150.29 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.309 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -122.46 116.19 23.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.0 m-85 -95.66 168.63 10.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.67 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.77 -166.84 29.49 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.185 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -58.68 114.89 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 50.12 30.46 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.6 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.416 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -95.97 142.84 27.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.984 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -130.0 55.77 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.09 150.39 31.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.562 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.738 HG23 HG11 ' P' ' 32' ' ' VAL . 1.5 mp -97.38 161.93 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 110.836 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.466 ' N ' HG22 ' P' ' 41' ' ' ILE . 42.6 p -112.59 147.11 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.394 . . . . 0.0 111.251 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.63 -31.13 2.43 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.0 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.76 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 111.259 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.439 ' CB ' HG13 ' P' ' 32' ' ' VAL . 94.5 m-85 -105.26 3.75 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.946 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.66 -38.4 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -52.27 -32.81 39.04 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.615 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 0.962 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -63.51 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.158 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -59.33 -34.13 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.194 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.68 -39.16 52.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.924 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.45 -46.45 39.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 0.962 ' CD2' HG22 ' P' ' 48' ' ' ILE . 19.5 m-70 -62.28 -38.23 88.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.04 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.007 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.88 95.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.063 0.459 . . . . 0.0 110.203 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -75.38 -35.82 61.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.903 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.852 HD23 HG11 ' P' ' 99' ' ' VAL . 0.8 OUTLIER -63.56 -43.22 97.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.036 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -69.97 -41.22 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.264 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.38 -26.56 61.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -111.73 110.49 54.84 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.447 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.55 -51.03 11.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.795 2.33 . . . . 0.0 114.0 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 18.32 6.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.2 112.79 23.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.451 . . . . 0.0 110.658 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 7.5 mttt -115.96 130.11 56.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.722 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.9 p -99.04 146.59 8.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.569 0.7 . . . . 0.0 111.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.724 HD21 ' CG2' ' P' ' 107' ' ' VAL . 2.8 tt -117.63 105.26 11.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.486 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.4 OUTLIER -82.38 103.46 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.153 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.44 119.38 31.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.787 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.64 143.28 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.098 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.535 ' O ' HG23 ' P' ' 70' ' ' THR . 1.5 m-80 -138.96 157.52 45.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.535 HG23 ' O ' ' P' ' 69' ' ' ASN . 68.1 p -164.73 -165.29 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.474 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' P' ' 124' ' ' TYR . 24.0 p30 -90.89 158.8 16.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.517 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 2.3 pm0 -60.85 -33.55 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.845 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.408 ' HG2' ' OH ' ' P' ' 124' ' ' TYR . 5.3 mmm180 -45.32 111.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.15 -174.84 15.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.052 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.82 145.09 31.28 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 111.639 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.466 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 85.1 Cg_exo -38.57 -46.92 2.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.117 2.545 . . . . 0.0 113.723 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.37 -44.47 92.72 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.743 0.306 . . . . 0.0 111.024 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -70.1 -44.83 68.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' P' ' 80' ' ' ILE . 7.1 m120 -70.94 -76.02 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.6 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.67 -43.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.39 -55.88 11.96 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.65 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 1.011 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -49.43 -50.36 41.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 178.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 1.011 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -63.07 -42.59 99.54 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.9 tp60 -47.84 -40.44 21.34 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.204 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.3 ptm180 -67.6 -37.71 82.95 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.578 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 15.9 mtt180 -62.72 -47.67 82.58 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.616 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.45 -33.24 69.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.829 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -32.66 73.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.497 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -59.62 -56.51 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.511 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.413 ' HB ' HG11 ' P' ' 66' ' ' VAL . 21.4 t -66.08 -34.61 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.248 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -44.81 96.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.763 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.46 -23.66 77.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.5 -60.81 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 91.0 mt -55.91 -31.93 63.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.25 -39.08 82.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.032 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.04 95.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.04 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -34.66 74.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.02 26.59 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.095 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.852 HG11 HD23 ' P' ' 56' ' ' LEU . 49.6 t -90.53 143.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.179 0.191 . . . . 0.0 110.572 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.8 162.6 10.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 111.455 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -91.13 -31.5 16.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.548 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.93 -23.82 47.39 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.829 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.558 ' HG3' HD21 ' P' ' 56' ' ' LEU . 0.0 OUTLIER -100.63 -4.32 28.66 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.114 0.483 . . . . 0.0 111.059 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' P' ' 101' ' ' ALA . 47.0 mt -96.92 147.26 24.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.486 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -150.87 144.13 11.43 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.812 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.616 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 39.8 p -124.21 157.46 34.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.727 0.298 . . . . 0.0 110.533 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.724 ' CG2' HD21 ' P' ' 65' ' ' LEU . 92.7 t -161.14 162.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.6 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 2.3 t -155.74 123.25 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.493 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' P' ' 110' ' ' GLY . 92.6 m-85 -116.75 17.76 15.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -3.68 -113.54 0.0 OUTLIER Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -78.77 -2.33 38.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.02 -63.39 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.679 0.275 . . . . 0.0 110.753 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 89.49 20.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.7 163.44 13.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.706 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.37 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.655 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.78 113.95 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.78 136.53 52.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.28 175.67 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.721 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.455 ' HB3' ' CE2' ' P' ' 124' ' ' TYR . 5.8 m80 -141.56 100.31 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.873 0.336 . . . . 0.0 111.629 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -170.83 161.56 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -47.33 -24.59 0.8 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.36 -60.73 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.934 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.05 77.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.817 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' P' ' 119' ' ' HIS . 13.2 m-85 -59.01 -50.38 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.239 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 8.4 t -62.38 -32.57 73.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -73.56 -24.36 60.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -88.94 -31.48 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.25 88.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.3 OUTLIER -158.78 157.88 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.86 100.68 7.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -84.32 113.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -62.63 102.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.662 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -106.91 132.95 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.086 179.694 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.831 0.348 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' P' ' 20' ' ' TYR . 81.9 m-85 -89.86 106.39 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.45 9.05 22.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.523 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.21 -40.71 1.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.518 ' OH ' ' HG2' ' P' ' 47' ' ' GLN . 0.1 OUTLIER -128.89 -179.7 5.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.262 0.553 . . . . 0.0 111.899 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -118.28 175.81 5.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 t -42.94 -53.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.07 -21.12 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.77 -43.95 6.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.961 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' P' ' 51' ' ' ALA . 30.0 mt -56.85 -21.77 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.657 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.63 -11.3 15.89 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.31 -25.35 4.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -111.14 -64.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -105.2 81.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.416 HD22 ' HB2' ' P' ' 132' ' ' LEU . 0.1 OUTLIER -139.68 9.61 2.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.989 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.612 HG23 HG22 ' P' ' 131' ' ' VAL . 67.8 m -135.21 138.32 43.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.738 HG11 HG23 ' P' ' 41' ' ' ILE . 10.3 t -109.62 149.89 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.031 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -117.42 116.46 27.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.804 0.811 . . . . 0.0 112.885 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.724 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -92.72 174.81 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.891 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.17 -176.45 14.83 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 2.7 t80 -61.84 131.8 51.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.703 0.751 . . . . 0.0 110.613 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 2.7 p30 44.68 29.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.445 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -94.53 119.86 33.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.65 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.766 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.4 OUTLIER -118.73 46.12 1.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.751 0.786 . . . . 0.0 110.053 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.41 150.47 31.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.433 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.741 HD11 HG22 ' P' ' 90' ' ' VAL . 2.6 mt -93.03 165.88 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.348 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.465 ' H ' HG22 ' P' ' 41' ' ' ILE . 0.3 OUTLIER -110.32 141.09 43.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.09 0.472 . . . . 0.0 111.828 -179.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.09 -31.72 4.53 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.055 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -33.01 74.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 111.015 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.5 ' CB ' HG13 ' P' ' 32' ' ' VAL . 74.8 m-85 -100.13 -6.85 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.865 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.3 -42.09 94.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 120.88 0.371 . . . . 0.0 111.44 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.518 ' HG2' ' OH ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -44.91 -42.55 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 0.965 HG22 ' CD2' ' P' ' 52' ' ' HIS . 5.6 mt -50.67 -55.5 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.368 0.604 . . . . 0.0 109.783 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.18 -32.93 25.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.906 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -41.21 67.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.682 0.277 . . . . 0.0 110.834 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -73.1 -42.68 62.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 0.965 ' CD2' HG22 ' P' ' 48' ' ' ILE . 46.3 m-70 -65.97 -39.31 90.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.921 0.391 . . . . 0.0 110.122 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.97 -50.63 71.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.47 -40.55 78.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -76.09 -38.34 57.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.72 HD13 ' HB ' ' P' ' 64' ' ' VAL . 1.2 tp -70.57 -35.73 73.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -73.67 -33.97 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.031 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.387 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -112.7 114.29 49.75 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.24 -50.17 11.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.611 2.207 . . . . 0.0 113.543 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.88 17.46 4.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.594 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.46 122.76 33.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.972 0.415 . . . . 0.0 110.182 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -124.78 135.71 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.583 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.72 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -100.88 150.05 5.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.489 0.661 . . . . 0.0 111.535 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.523 HD21 HG22 ' P' ' 107' ' ' VAL . 0.8 OUTLIER -121.76 107.81 12.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.763 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.2 OUTLIER -86.55 104.22 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' P' ' 133' ' ' ALA . 55.5 mt-10 -89.75 122.62 33.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.18 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -116.35 141.32 16.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.497 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.6 OUTLIER -148.32 113.99 5.68 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.972 HG22 ' NH1' ' P' ' 86' ' ' ARG . 45.5 p -99.69 176.28 5.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -58.96 138.62 57.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -50.48 -28.07 7.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.656 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.402 ' HE ' ' HH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -46.21 106.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 0.0 112.774 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.86 -178.94 18.62 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.46 143.89 27.12 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.983 0.391 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.614 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -48.02 -27.94 9.72 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.775 2.317 . . . . 0.0 113.22 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -45.38 92.84 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.299 0.571 . . . . 0.0 110.752 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . 0.474 ' CE2' HD23 ' P' ' 82' ' ' LEU . 14.1 t80 -90.12 -17.34 27.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.566 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' P' ' 76' ' ' PRO . 5.1 m-80 -85.6 -21.76 28.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.263 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -83.58 -35.59 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.81 -49.56 61.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.605 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.474 HD23 ' CE2' ' P' ' 78' ' ' TYR . 0.2 OUTLIER -52.32 -45.81 65.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.211 177.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.488 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -74.84 -53.91 6.13 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.282 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -46.0 -36.56 5.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.083 0.468 . . . . 0.0 109.875 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 34.8 mtp85 -67.68 -46.85 71.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.346 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.972 ' NH1' HG22 ' P' ' 70' ' ' THR . 31.1 mtt180 -58.07 -38.98 77.37 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.592 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -66.57 -37.18 84.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.107 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -30.68 71.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.325 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.31 -60.81 2.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.05 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.741 HG22 HD11 ' P' ' 41' ' ' ILE . 20.7 t -62.91 -41.41 92.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.601 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.603 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -58.44 -38.88 78.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.043 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.68 79.03 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.573 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.83 -60.19 2.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.582 ' HB3' HG21 ' P' ' 99' ' ' VAL . 90.3 mt -57.84 -34.13 69.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.053 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.64 81.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.988 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.17 -26.92 74.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.504 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.99 -9.03 59.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 111.366 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.77 -6.75 17.84 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.251 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.582 HG21 ' HB3' ' P' ' 94' ' ' LEU . 80.0 t -67.96 112.97 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.829 0.314 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.99 144.97 56.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.215 0.531 . . . . 0.0 111.401 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.51 -36.77 74.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.738 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.86 -24.95 55.31 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.766 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.12 -3.76 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.309 0.576 . . . . 0.0 110.798 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' P' ' 91' ' ' LYS . 0.7 OUTLIER -94.3 150.48 20.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.097 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.763 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -142.5 141.72 10.98 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.592 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 78.3 p -142.89 145.9 33.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.536 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -160.63 173.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.591 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -162.49 129.07 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.291 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.5 OUTLIER -114.21 27.12 9.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.683 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -4.59 -115.44 0.0 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.6 0.562 . . . . 0.0 114.23 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 3.2 mp0 -83.09 -2.05 54.38 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.761 -0.258 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.64 -63.1 1.31 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.662 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -139.96 89.4 11.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 164.77 11.28 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.652 2.235 . . . . 0.0 112.705 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.39 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.757 HG21 ' HB3' ' P' ' 126' ' ' LYS . 2.8 t -89.22 111.08 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.783 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.48 135.24 47.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.89 172.88 12.9 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.951 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.518 ' CE1' ' HH ' ' P' ' 124' ' ' TYR . 3.9 t60 -138.08 48.76 1.96 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.365 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.02 157.66 42.4 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 15.3 tp10 -42.99 -37.43 1.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.45 -60.29 3.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.94 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.26 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.518 ' HH ' ' CE1' ' P' ' 119' ' ' HIS . 2.8 m-85 -57.17 -56.21 24.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.381 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 0.3 OUTLIER -55.91 -35.55 66.7 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.757 ' HB3' HG21 ' P' ' 116' ' ' VAL . 25.5 mtmt -73.29 -22.52 60.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.201 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 69' ' ' ASN . 37.2 m-20 -81.21 -43.74 18.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.97 71.61 0.81 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.515 0.674 . . . . 0.0 110.804 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.13 145.29 51.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.225 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -117.33 93.21 4.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.612 HG22 HG23 ' P' ' 31' ' ' THR . 24.7 t -83.08 115.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.634 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -63.73 100.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.309 178.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.539 ' HB2' ' OE1' ' P' ' 67' ' ' GLU . . . -102.77 130.17 49.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 111.557 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.87 179.802 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 74.6 p . . . . . 0 C--O 1.231 0.101 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -88.82 102.91 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.569 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.26 10.09 56.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.145 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.98 17.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.336 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.644 ' HB2' HD21 ' P' ' 25' ' ' LEU . 1.7 m-85 -107.04 147.13 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -104.14 144.38 31.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -38.31 -56.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.23 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -45.38 5.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 0.0 110.628 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' P' ' 20' ' ' TYR . 34.3 mt -56.54 -20.82 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.956 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.58 -12.3 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -123.38 -25.38 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . 0.475 ' HG2' ' CZ ' ' P' ' 29' ' ' TYR . 4.7 tpm_? -110.9 -62.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' P' ' 20' ' ' TYR . 22.2 m-85 -107.19 91.66 3.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 19.2 p-10 -155.07 13.77 0.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.369 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -125.94 130.82 52.03 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.758 HG11 HG23 ' P' ' 41' ' ' ILE . 3.6 t -111.19 148.45 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.5 118.31 26.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' P' ' 86' ' ' ARG . 21.9 m-85 -95.49 168.28 10.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.604 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.64 -166.69 27.37 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.158 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -60.88 122.03 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.23 25.51 1.83 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.749 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.467 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -93.14 138.58 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.469 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.451 ' HA ' ' HB3' ' P' ' 86' ' ' ARG . 44.6 p90 -131.42 49.93 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -147.62 150.74 34.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.917 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.758 HG23 HG11 ' P' ' 32' ' ' VAL . 1.9 mt -95.36 161.8 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.647 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.478 ' N ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -109.96 135.58 50.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 111.327 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.73 -27.38 2.19 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.024 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -32.1 72.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.406 ' O ' HG13 ' P' ' 48' ' ' ILE . 31.1 m-85 -105.54 11.44 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.546 ' HA ' ' HG ' ' P' ' 49' ' ' LEU . 0.9 OUTLIER -72.7 -34.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.264 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.36 -45.58 6.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.95 0.405 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.121 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.11 -50.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 0.0 109.196 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' P' ' 93' ' ' TYR . 6.2 mt -53.4 -62.41 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.726 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.5 -49.67 71.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.47 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.588 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.121 ' CD2' HG22 ' P' ' 48' ' ' ILE . 7.5 m-70 -72.17 -42.87 65.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.75 0.31 . . . . 0.0 110.821 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' P' ' 94' ' ' LEU . . . -65.59 -25.79 67.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.18 -36.93 46.84 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.04 0.448 . . . . 0.0 109.926 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -75.91 -34.68 59.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.642 HD13 ' HB ' ' P' ' 64' ' ' VAL . 0.7 OUTLIER -72.18 -36.06 69.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -32.72 66.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.153 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.09 -19.7 63.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -110.02 111.7 58.21 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 120.615 0.245 . . . . 0.0 110.481 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.89 -63.09 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.884 2.389 . . . . 0.0 114.213 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.17 24.09 1.66 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.622 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.53 122.58 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.145 0.498 . . . . 0.0 110.777 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -126.38 131.29 51.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.84 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.642 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.7 p -96.05 143.74 11.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.62 0.724 . . . . 0.0 111.754 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.823 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.8 tt -116.7 104.49 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.518 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -84.47 113.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.675 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.6 mm-40 -89.53 119.87 30.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.638 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.7 86.96 1.47 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.817 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' P' ' 70' ' ' THR . 7.6 t30 -98.65 158.49 15.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 110.354 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 61.0 p -165.29 -165.55 0.88 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 19.8 p-10 -83.77 154.56 23.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.617 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 3.1 pp20? -64.85 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.624 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.91 110.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 -173.17 14.8 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.36 145.3 29.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.463 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 72.1 Cg_exo -48.16 -44.74 27.74 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.458 2.106 . . . . 0.0 112.465 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -41.1 98.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -68.24 -42.96 78.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.472 ' HB2' ' HA3' ' P' ' 110' ' ' GLY . 31.4 m120 -69.92 -75.49 0.11 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.385 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -29.63 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.62 11.34 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.796 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 1.03 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -54.22 -43.77 71.11 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.752 178.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 1.03 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -68.11 -41.9 85.71 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.959 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.96 -31.57 65.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' P' ' 88' ' ' ASP . 10.5 tpt85 -65.67 -60.35 2.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.38 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.646 ' HD3' ' HA2' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -56.42 -41.5 76.47 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.242 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.63 65.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.3 OUTLIER -65.27 -31.63 72.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.09 178.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.17 -42.49 98.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.011 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.477 ' O ' ' CD1' ' P' ' 93' ' ' TYR . 32.9 t -70.53 -38.65 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.925 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.595 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -74.22 -27.84 60.98 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.019 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -74.71 -53.94 6.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.48 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' P' ' 49' ' ' LEU . 0.7 OUTLIER -57.59 -44.16 85.2 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.543 ' HG ' ' CE1' ' P' ' 93' ' ' TYR . 4.5 mt -58.87 -35.19 72.57 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -61.45 -43.17 99.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.577 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.81 -13.07 78.71 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.393 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 15.1 mttm -88.98 -8.44 54.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.667 0.27 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.69 -12.62 11.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.763 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.589 HG13 ' CD2' ' P' ' 56' ' ' LEU . 60.9 t -70.65 114.64 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.593 0.235 . . . . 0.0 110.716 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.8 144.58 52.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.388 0.613 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -51.51 -37.48 49.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.807 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.35 45.12 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.8 mtmt -96.07 -6.08 39.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.161 0.505 . . . . 0.0 110.9 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' P' ' 91' ' ' LYS . 19.8 mt -89.4 149.88 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.916 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.41 135.37 4.69 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.765 ' O ' HG13 ' P' ' 107' ' ' VAL . 70.2 p -133.55 156.24 48.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.813 0.34 . . . . 0.0 110.645 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.823 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.1 OUTLIER -172.85 121.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -111.87 137.85 49.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.751 0.31 . . . . 0.0 110.976 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 90.3 m-85 -116.68 24.51 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -111.82 0.01 OUTLIER Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.569 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.89 14.4 31.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.506 0.193 . . . . 0.0 111.514 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -54.84 41.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.96 89.16 8.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.423 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . 0.415 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 35.2 Cg_exo -61.05 166.89 9.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.692 2.262 . . . . 0.0 112.756 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.48 -67.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.911 HG21 ' HD3' ' P' ' 126' ' ' LYS . 38.5 t -89.61 111.8 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.342 0.592 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.73 138.54 58.44 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.923 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.76 174.15 14.11 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.8 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.449 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 14.2 p-80 -140.39 58.77 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -127.04 157.85 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' P' ' 125' ' ' SER . 0.2 OUTLIER -43.39 -27.55 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.615 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' P' ' 126' ' ' LYS . . . -64.76 -59.38 4.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . 0.617 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -66.36 -42.44 88.02 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 11.9 m-30 -65.37 -44.28 88.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . 0.435 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 51.8 p -73.28 -38.92 65.75 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.623 0.249 . . . . 0.0 111.416 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.911 ' HD3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -82.05 -16.77 49.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.038 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' P' ' 123' ' ' ALA . 39.1 m-20 -85.33 -29.55 24.41 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.435 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.1 mtp180 -70.32 94.97 0.98 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.521 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.7 OUTLIER -158.85 156.02 28.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.11 99.78 7.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 15.1 t -83.08 110.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.518 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -61.31 98.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.19 178.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -101.21 126.67 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.623 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . 0.429 ' HH ' ' HD1' ' P' ' 52' ' ' HIS . 20.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.982 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 30.0 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' P' ' 55' ' ' TYR . 4.5 m-85 -92.27 106.86 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 8.99 32.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.388 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.98 -38.57 1.69 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.887 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' P' ' 17' ' ' PHE . 0.5 OUTLIER -124.15 171.76 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.359 . . . . 0.0 111.341 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.75 150.77 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.436 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.709 ' HA ' HD12 ' P' ' 25' ' ' LEU . 18.8 t -43.26 -43.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.15 -15.76 48.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.43 -40.05 8.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.559 0.695 . . . . 0.0 109.887 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.709 HD12 ' HA ' ' P' ' 22' ' ' VAL . 5.0 mt -61.96 -21.13 64.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . 0.621 ' OE1' HG12 ' P' ' 22' ' ' VAL . 55.3 mt-30 -98.32 -14.85 20.01 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.4 -18.32 3.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 -66.74 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -105.9 83.67 1.95 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.282 0.563 . . . . 0.0 111.836 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' P' ' 132' ' ' LEU . 0.1 OUTLIER -138.52 12.77 2.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.555 ' OG1' HG13 ' P' ' 131' ' ' VAL . 79.8 m -134.98 137.91 43.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 3.3 t -112.55 147.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.248 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -117.44 123.15 45.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.476 0.655 . . . . 0.0 112.573 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.454 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 75.3 m-85 -108.97 172.6 6.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.876 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.37 -169.27 16.4 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.488 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' P' ' 37' ' ' ASP . 2.0 t80 -60.17 125.9 25.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 110.748 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . 0.448 ' HB2' ' CE1' ' P' ' 36' ' ' PHE . 2.3 t0 44.59 29.43 0.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.86 126.65 41.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.738 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 11.2 t80 -125.9 57.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.731 0.777 . . . . 0.0 110.191 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -151.09 150.71 31.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.715 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.679 HD13 HD21 ' P' ' 49' ' ' LEU . 10.6 mt -98.64 162.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.604 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.517 ' N ' HG22 ' P' ' 41' ' ' ILE . 7.5 p -112.76 144.89 41.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.118 0.485 . . . . 0.0 111.574 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.63 -31.94 3.96 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.313 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -63.82 -33.89 76.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.432 ' CB ' HG13 ' P' ' 32' ' ' VAL . 78.0 m-85 -99.11 -2.52 36.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.441 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 77.0 t -63.07 -43.69 99.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -39.63 -45.64 1.68 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.638 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.004 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.58 -53.26 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.679 HD21 HD13 ' P' ' 41' ' ' ILE . 3.5 mp -47.14 -46.49 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.549 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 2.6 p30 -73.46 -33.22 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.657 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.32 -51.48 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.004 ' CD2' HG22 ' P' ' 48' ' ' ILE . 12.0 m-70 -57.57 -37.79 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 109.936 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' P' ' 94' ' ' LEU . . . -61.66 -45.3 94.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.24 84.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.523 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . 0.467 ' HA ' ' CE2' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -70.1 -43.01 71.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.604 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.684 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -69.57 -36.75 76.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.03 -178.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.83 -36.33 78.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.13 66.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.604 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -113.85 112.87 47.51 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 -44.0 45.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.653 2.235 . . . . 0.0 113.575 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 17.51 11.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.591 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.42 123.74 34.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.271 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 30.9 mttt -123.12 132.72 54.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.683 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.2 p -96.42 143.54 12.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.417 0.627 . . . . 0.0 110.983 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.64 HD21 HG22 ' P' ' 107' ' ' VAL . 0.5 OUTLIER -113.39 108.65 17.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.796 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.684 HG13 HD22 ' P' ' 132' ' ' LEU . 0.2 OUTLIER -88.39 109.67 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.7 mt-10 -99.39 120.24 39.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.392 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 146.34 18.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.354 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.722 ' O ' HG23 ' P' ' 70' ' ' THR . 52.9 m-80 -139.54 167.52 21.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.722 HG23 ' O ' ' P' ' 69' ' ' ASN . 2.4 p -168.98 174.8 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.983 0.42 . . . . 0.0 111.448 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.508 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 15.4 p-10 -60.01 151.8 25.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.617 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.53 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 1.4 pp20? -66.26 -31.83 72.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 111.666 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 113.61 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.67 -169.41 12.91 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.266 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' P' ' 77' ' ' GLU . 0.6 OUTLIER -107.82 146.72 34.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 111.48 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.657 ' HB3' HD13 ' P' ' 80' ' ' ILE . 41.0 Cg_exo -54.96 -35.98 91.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.793 2.329 . . . . 0.0 113.929 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' P' ' 77' ' ' GLU . 0.0 OUTLIER -44.12 -55.35 4.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 0.1 OUTLIER -93.69 -13.93 26.94 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.602 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.748 ' HA ' HD12 ' P' ' 82' ' ' LEU . 2.1 m-20 -84.17 -25.76 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.539 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.657 HD13 ' HB3' ' P' ' 76' ' ' PRO . 0.5 OUTLIER -90.89 -36.42 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.43 -49.93 61.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.434 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 1.05 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -68.9 -34.35 75.27 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.976 178.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 1.05 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.55 -56.72 8.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.796 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 45.6 tt0 -50.46 -33.53 21.46 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -49.31 78.2 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.532 ' HD2' HD22 ' P' ' 82' ' ' LEU . 0.1 OUTLIER -55.43 -38.19 68.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' P' ' 84' ' ' GLN . . . -63.0 -35.31 79.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.241 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -31.32 69.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.341 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' P' ' 39' ' ' TYR . . . -61.1 -46.84 88.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.968 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.33 -31.39 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.429 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.587 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -62.73 -44.03 97.26 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . 0.49 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -74.32 -26.86 67.09 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -59.52 -57.1 14.44 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' P' ' 53' ' ' ALA . 47.2 mt -61.04 -32.28 71.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.332 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -61.83 -42.53 99.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.561 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.96 -19.97 78.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.014 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -10.79 59.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.663 0.268 . . . . 0.0 111.269 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -7.52 16.96 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.065 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.684 HG11 ' CD2' ' P' ' 56' ' ' LEU . 31.8 t -78.8 127.41 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.732 0.301 . . . . 0.0 110.99 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . 0.425 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -58.58 163.53 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.548 . . . . 0.0 111.322 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.957 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -80.87 -31.65 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.198 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.18 -24.14 35.19 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.782 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -95.5 -4.55 44.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 111.224 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.957 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.2 mt -95.1 139.55 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.129 -0.228 . . . . 0.0 110.403 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.576 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -143.45 141.77 10.72 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.805 ' O ' HG13 ' P' ' 107' ' ' VAL . 68.4 p -133.21 153.22 51.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.929 0.395 . . . . 0.0 111.106 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.805 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -176.15 119.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.457 ' O ' HG12 ' P' ' 80' ' ' ILE . 90.3 p -117.51 140.11 50.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.416 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' P' ' 110' ' ' GLY . 33.1 m-85 -121.08 28.07 8.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.581 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -23.22 -71.07 0.01 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.874 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.53 ' OE1' ' HA ' ' P' ' 72' ' ' GLU . 4.4 mm-40 -106.78 -2.1 21.86 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.01 -57.01 6.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 118.474 0.579 . . . . 0.0 110.422 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -134.71 90.04 24.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -57.94 163.05 10.06 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.521 2.147 . . . . 0.0 112.564 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.45 -68.63 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.11 119.83 36.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.1 136.82 44.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.57 175.21 14.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.791 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' P' ' 119' ' ' HIS . 0.1 OUTLIER -140.53 97.52 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.825 0.312 . . . . 0.0 111.587 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -175.9 165.83 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -48.46 -26.29 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.05 -63.49 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.01 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.621 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 7.0 m-30 -56.97 -46.53 82.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.624 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -68.55 -36.85 79.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.329 . . . . 0.0 111.29 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -68.22 -26.93 65.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.292 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' P' ' 70' ' ' THR . 84.1 m-20 -87.19 -28.84 22.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.481 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 6.5 mtp180 -69.35 81.05 0.37 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.89 152.39 21.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.51 105.11 10.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.555 HG13 ' OG1' ' P' ' 31' ' ' THR . 16.0 t -86.73 113.41 24.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.684 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -61.05 99.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.194 178.178 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -99.55 124.39 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.635 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . 0.463 ' HE1' HD12 ' P' ' 56' ' ' LEU . 22.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.917 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.031 0.443 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' P' ' 20' ' ' TYR . 70.6 m-85 -90.55 107.08 18.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.611 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.81 9.87 35.5 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.297 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 134.21 -35.75 2.19 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.793 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.595 ' HB2' HD21 ' P' ' 25' ' ' LEU . 22.2 m-85 -117.81 161.9 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.715 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.15 153.65 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.425 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.414 HG23 ' H ' ' P' ' 22' ' ' VAL . 17.3 t -39.26 -51.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.43 16.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.38 -40.35 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.421 0.629 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' P' ' 20' ' ' TYR . 20.1 mt -69.32 -20.82 63.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.206 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -88.7 -20.89 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -142.71 -6.59 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -69.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -108.98 85.69 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.201 0.524 . . . . 0.0 112.244 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.2 19.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.329 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 98.4 m -126.42 129.35 48.56 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.754 HG11 HG23 ' P' ' 41' ' ' ILE . 3.2 t -107.86 150.38 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.978 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -121.39 116.16 24.25 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' HG2' ' P' ' 86' ' ' ARG . 21.7 m-85 -98.09 167.11 11.09 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.68 -167.38 17.23 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -66.18 123.34 19.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.079 0.439 . . . . 0.0 110.835 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.67 15.34 7.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.728 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.463 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 2.2 mptt -91.17 125.64 36.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.504 ' HB3' ' NH1' ' P' ' 86' ' ' ARG . 52.1 p90 -128.04 37.46 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.796 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.05 149.74 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.754 HG23 HG11 ' P' ' 32' ' ' VAL . 1.2 mp -87.57 164.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.283 . . . . 0.0 110.975 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . 0.444 ' N ' HG22 ' P' ' 41' ' ' ILE . 49.3 p -112.35 150.63 30.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.405 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -42.45 -32.95 1.32 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.14 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.05 -33.37 75.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.727 0.299 . . . . 0.0 111.416 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . 0.403 ' CB ' HG13 ' P' ' 32' ' ' VAL . 87.7 m-85 -102.82 3.6 36.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 74.2 t -69.16 -40.49 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.41 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.54 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -44.07 -44.35 7.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 1.035 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.6 OUTLIER -56.47 -51.1 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.818 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.581 HD23 ' CD2' ' P' ' 93' ' ' TYR . 2.1 mp -53.36 -34.5 57.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.595 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -39.04 53.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.867 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.79 26.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 1.035 ' CD2' HG22 ' P' ' 48' ' ' ILE . 54.6 m-70 -59.92 -35.95 75.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.987 0.422 . . . . 0.0 110.139 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.45 98.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.302 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.79 91.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.978 0.418 . . . . 0.0 110.723 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.38 -38.79 63.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.97 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 1.043 HD23 HG11 ' P' ' 99' ' ' VAL . 2.9 tp -62.2 -41.68 98.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.139 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.16 -40.92 71.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.73 -27.92 31.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.683 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.4 OUTLIER -109.6 115.1 56.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.566 0.222 . . . . 0.0 110.488 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.8 -59.03 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 113.858 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.72 22.91 2.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.633 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.76 123.38 34.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 110.707 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -128.07 134.16 49.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -97.0 146.13 7.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.502 0.668 . . . . 0.0 111.758 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.8 HD21 ' CG2' ' P' ' 107' ' ' VAL . 5.1 tt -117.41 105.37 12.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.452 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -83.14 108.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.636 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.3 tt0 -99.2 117.61 34.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -107.51 149.67 16.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.968 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.8 OUTLIER -152.96 108.57 3.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.811 0.339 . . . . 0.0 110.712 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -100.65 -171.67 2.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 21.2 p-10 -64.27 144.85 56.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.396 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -64.08 -27.09 68.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.542 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.9 OUTLIER -39.55 110.91 0.16 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.326 0.584 . . . . 0.0 112.037 -178.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.01 -150.91 18.65 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.902 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.05 148.46 51.71 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 122.0 0.12 . . . . 0.0 110.822 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 1.3 Cg_endo -41.85 -38.91 4.98 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.616 2.211 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' P' ' 81' ' ' ALA . 0.5 OUTLIER -61.9 -40.84 96.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.88 -47.53 45.18 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.681 178.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' P' ' 82' ' ' LEU . 11.1 m120 -64.62 -76.27 0.07 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.711 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -35.42 -38.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' P' ' 77' ' ' GLU . . . -66.37 -64.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.043 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.931 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -63.48 -33.63 75.99 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.285 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . 0.931 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.89 -52.47 28.58 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 1.2 tp-100 -50.79 -34.73 28.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -59.93 -43.02 95.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.617 ' CZ ' ' CD2' ' P' ' 82' ' ' LEU . 6.8 mtt85 -56.37 -43.41 79.16 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.05 -32.58 68.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.4 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.419 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.27 -56.67 18.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.642 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.34 -34.42 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.4 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.44 ' HD3' HD13 ' P' ' 104' ' ' LEU . 3.1 tmtt? -59.45 -51.81 68.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.39 -26.09 74.44 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.115 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . 0.581 ' CD2' HD23 ' P' ' 49' ' ' LEU . 5.8 t80 -59.96 -61.27 2.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.489 ' HB2' HD21 ' P' ' 104' ' ' LEU . 23.1 mt -59.83 -29.8 68.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.88 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.11 98.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.33 -21.08 78.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.626 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -11.29 59.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 111.179 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.28 -3.63 22.08 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.308 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 1.043 HG11 HD23 ' P' ' 56' ' ' LEU . 21.5 t -81.98 131.65 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.831 0.315 . . . . 0.0 111.423 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' CG ' ' P' ' 103' ' ' LYS . 31.3 p30 -58.95 166.37 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.208 0.527 . . . . 0.0 111.306 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . 0.803 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -77.87 -31.83 51.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.7 -21.36 62.85 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.297 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 23.4 mtpp -90.45 -12.65 36.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.064 0.459 . . . . 0.0 111.067 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.803 HD12 ' HA ' ' P' ' 101' ' ' ALA . 6.3 mt -92.23 149.76 21.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.93 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.444 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -145.78 137.01 6.7 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.573 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 18.7 p -117.63 156.24 28.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.065 0.46 . . . . 0.0 111.275 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.8 ' CG2' HD21 ' P' ' 65' ' ' LEU . 97.2 t -160.49 157.75 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.608 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.711 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 3.3 t -161.09 128.18 4.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.993 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.31 -68.46 0.79 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.349 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.7 -121.51 6.37 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.615 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 1.2 mm-40 -75.62 -19.89 58.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.859 0.33 . . . . 0.0 111.091 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.47 -74.09 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -142.09 102.45 5.71 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.323 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.34 167.49 20.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.745 2.297 . . . . 0.0 112.248 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . 0.779 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -88.55 -77.66 0.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.66 ' HB ' ' NZ ' ' P' ' 126' ' ' LYS . 2.0 t -96.94 130.6 45.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.461 0.648 . . . . 0.0 111.137 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 141.13 52.34 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.745 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.73 172.09 12.99 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.764 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -141.09 91.64 2.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.793 0.296 . . . . 0.0 111.411 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' P' ' 124' ' ' TYR . 37.5 t70 -178.86 167.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' P' ' 125' ' ' SER . 1.1 mm-40 -44.45 -26.83 0.38 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -66.54 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.672 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . 0.646 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -70.4 -35.67 73.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.7 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' P' ' 120' ' ' ASP . 2.2 m-85 -65.85 -46.43 78.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . 0.424 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 6.9 t -71.56 -37.06 71.11 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.66 ' NZ ' ' HB ' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -79.77 -16.16 56.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.993 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.779 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 7.9 m-20 -86.53 -31.51 21.23 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 120.581 0.229 . . . . 0.0 110.495 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.424 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.7 mtp180 -70.3 83.62 0.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.25 153.33 34.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -119.66 99.18 6.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.67 112.73 21.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.452 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -61.55 101.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.669 178.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.72 122.1 39.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.733 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.947 179.596 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.791 0.329 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' P' P ' 17' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' P' ' 20' ' ' TYR . 61.1 m-85 -88.83 105.87 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.992 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.82 10.33 38.02 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.129 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.96 -30.61 3.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.384 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' CE2' ' P' ' 29' ' ' TYR . 20.3 m-85 -114.22 158.75 20.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 150.98 23.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.014 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 22' ' ' VAL . . . . . 0.42 HG23 ' H ' ' P' ' 22' ' ' VAL . 16.5 t -39.5 -48.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.59 -17.89 57.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.42 -43.93 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.456 0.646 . . . . 0.0 110.441 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 17.5 mt -58.35 -21.38 49.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.152 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 26' ' ' GLN . . . . . 0.458 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 4.3 mt-30 -101.92 -12.4 18.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.93 -21.52 4.34 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -112.64 -60.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 29' ' ' TYR . . . . . 0.452 ' CE2' ' CE1' ' P' ' 20' ' ' TYR . 28.3 m-85 -102.29 85.9 2.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.933 0.397 . . . . 0.0 111.735 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 30' ' ' ASN . . . . . 0.535 HD22 ' HB2' ' P' ' 132' ' ' LEU . 0.0 OUTLIER -144.6 6.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 31' ' ' THR . . . . . 0.422 ' OG1' HG13 ' P' ' 131' ' ' VAL . 51.9 m -136.86 138.8 41.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 32' ' ' VAL . . . . . 0.694 HG11 HG23 ' P' ' 41' ' ' ILE . 12.0 t -111.82 150.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.507 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -120.37 119.11 32.13 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 34' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 16.3 m-85 -95.69 170.24 9.46 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.52 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 -179.65 23.01 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.634 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 36' ' ' PHE . . . . . 0.415 ' CE2' ' CE2' ' P' ' 124' ' ' TYR . 0.6 OUTLIER -64.22 117.3 6.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 111.049 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.51 24.77 7.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 38' ' ' LYS . . . . . 0.515 ' HD3' ' HB2' ' P' ' 40' ' ' ASP . 0.0 OUTLIER -111.06 127.33 55.51 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.903 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 39' ' ' TYR . . . . . 0.684 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -117.65 77.5 1.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.599 0.714 . . . . 0.0 111.058 -178.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 40' ' ' ASP . . . . . 0.515 ' HB2' ' HD3' ' P' ' 38' ' ' LYS . 0.2 OUTLIER -153.28 150.36 28.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.223 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 41' ' ' ILE . . . . . 0.694 HG23 HG11 ' P' ' 32' ' ' VAL . 7.5 mt -99.0 155.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -108.48 143.73 37.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.481 . . . . 0.0 112.056 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.59 -29.26 5.57 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.121 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 44' ' ' GLU . . . . . 0.43 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 3.4 mm-40 -66.16 -28.98 69.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.27 -1.06 29.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 94.8 t -65.26 -41.42 91.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 47' ' ' GLN . . . . . 0.434 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 0.0 OUTLIER -49.24 -29.49 5.82 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.588 -178.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 48' ' ' ILE . . . . . 0.939 HG22 ' CD2' ' P' ' 52' ' ' HIS . 2.9 mt -64.71 -52.85 49.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.391 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 49' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' P' ' 93' ' ' TYR . 2.7 mp -51.9 -47.83 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.3 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 50' ' ' ASP . . . . . 0.434 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -70.07 -35.75 74.45 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.609 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 51' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -73.43 -47.76 39.08 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.171 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 52' ' ' HIS . . . . . 0.939 ' CD2' HG22 ' P' ' 48' ' ' ILE . 8.9 m-70 -61.04 -38.04 84.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.8 92.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.019 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.93 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.935 0.397 . . . . 0.0 110.618 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -71.01 -40.28 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.691 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 56' ' ' LEU . . . . . 0.623 HD13 ' HB ' ' P' ' 64' ' ' VAL . 2.0 tp -62.88 -45.18 93.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.73 -40.49 96.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.336 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.39 9.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.669 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 59' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -115.5 115.74 41.86 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.601 0.239 . . . . 0.0 110.599 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.46 -50.91 11.24 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.694 2.263 . . . . 0.0 113.506 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 61' ' ' ALA . . . . . 0.406 ' O ' ' HD2' ' P' ' 63' ' ' LYS . . . -88.75 19.66 3.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 62' ' ' ALA . . . . . 0.594 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -92.61 134.74 34.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 63' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -138.02 141.49 40.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 64' ' ' VAL . . . . . 0.782 HG11 ' CD1' ' P' ' 94' ' ' LEU . 9.6 p -100.4 150.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.519 0.675 . . . . 0.0 111.795 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 65' ' ' LEU . . . . . 0.705 HD21 ' CG2' ' P' ' 107' ' ' VAL . 3.4 tt -120.69 101.45 7.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.342 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 66' ' ' VAL . . . . . 0.647 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.3 t -83.51 101.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 67' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 29.6 tt0 -90.41 123.47 34.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 68' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -106.71 148.05 16.34 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.521 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 69' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -160.91 106.19 1.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.317 . . . . 0.0 110.508 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 70' ' ' THR . . . . . 0.801 HG21 ' NH1' ' P' ' 86' ' ' ARG . 26.7 p -106.26 -170.85 1.79 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 71' ' ' ASP . . . . . 0.501 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 21.4 p-10 -57.28 138.12 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 72' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -59.83 -22.84 62.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.454 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -38.13 108.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.12 -144.69 18.34 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.635 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.97 146.82 60.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.727 0.264 . . . . 0.0 110.772 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 76' ' ' PRO . . . . . 0.526 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 1.9 Cg_endo -39.99 -44.79 3.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.009 2.473 . . . . 0.0 112.445 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -42.72 99.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -71.46 -40.25 70.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.679 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 79' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -67.15 -75.12 0.1 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 80' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -29.4 -41.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 123.254 0.346 . . . . 0.0 111.475 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -64.47 -59.74 3.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.597 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 82' ' ' LEU . . . . . 0.804 HD12 ' NH1' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -48.69 -46.71 40.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.256 178.35 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.83 -46.01 85.08 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.52 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 84' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -47.12 -43.14 20.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.388 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 85' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -65.54 -36.0 82.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.777 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 86' ' ' ARG . . . . . 0.804 ' NH1' HD12 ' P' ' 82' ' ' LEU . 17.0 mtt180 -68.5 -48.61 63.95 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.334 0.588 . . . . 0.0 109.445 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 87' ' ' ALA . . . . . 0.713 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -62.4 -40.31 96.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.562 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -56.21 -35.25 67.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.844 178.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 89' ' ' ALA . . . . . 0.51 ' HB2' ' HE1' ' P' ' 39' ' ' TYR . . . -64.33 -64.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 90' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' P' ' 93' ' ' TYR . 20.3 t -55.14 -39.67 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.371 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 91' ' ' LYS . . . . . 0.517 ' HA ' ' CD2' ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.49 -43.1 99.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 110.153 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 92' ' ' GLY . . . . . 0.432 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -71.81 -11.12 73.29 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 93' ' ' TYR . . . . . 0.43 ' CD2' HD23 ' P' ' 49' ' ' LEU . 4.4 t80 -75.95 -62.9 1.44 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 94' ' ' LEU . . . . . 0.782 ' CD1' HG11 ' P' ' 64' ' ' VAL . 72.2 mt -53.51 -31.38 45.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 95' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' P' ' 99' ' ' VAL . . . -63.38 -40.26 96.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.394 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.31 -24.7 75.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.455 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.33 -9.18 59.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 111.248 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.86 14.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.947 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 99' ' ' VAL . . . . . 0.577 ' CG1' HD23 ' P' ' 56' ' ' LEU . 21.8 t -70.57 114.88 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -55.84 141.63 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.89 40.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.246 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.88 64.99 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.689 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 103' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 2.1 mtpp -93.59 -19.13 21.46 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 120.522 0.201 . . . . 0.0 111.399 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 104' ' ' LEU . . . . . 0.73 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -136.27 132.01 35.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.782 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 105' ' ' GLY . . . . . 0.647 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -126.72 -169.07 12.68 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.534 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 106' ' ' THR . . . . . 0.713 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 49.6 p -147.36 168.53 21.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.087 0.47 . . . . 0.0 111.272 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 107' ' ' VAL . . . . . 0.705 ' CG2' HD21 ' P' ' 65' ' ' LEU . 48.7 t -158.32 163.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.509 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 108' ' ' SER . . . . . 0.542 ' N ' HG12 ' P' ' 107' ' ' VAL . 3.2 t -160.28 113.58 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.963 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 109' ' ' TYR . . . . . 0.599 ' CZ ' HG11 ' P' ' 107' ' ' VAL . 60.0 m-85 -108.36 27.33 9.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.194 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -12.08 -109.26 0.0 OUTLIER Glycine 0 CA--C 1.526 0.744 0 O-C-N 123.684 0.615 . . . . 0.0 114.581 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 111' ' ' GLU . . . . . 0.504 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 6.3 mt-10 -63.29 -18.31 63.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 112' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 3.7 tm-20 -48.18 -69.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.527 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -130.25 95.04 28.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.69 0.281 . . . . 0.0 111.034 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.34 155.93 54.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.705 2.27 . . . . 0.0 112.454 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 115' ' ' ALA . . . . . 0.661 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -101.97 -71.47 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 116' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' P' ' 126' ' ' LYS . 3.5 t -88.76 114.29 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.49 136.59 49.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.75 175.4 14.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.118 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 119' ' ' HIS . . . . . 0.463 ' CE1' ' OH ' ' P' ' 124' ' ' TYR . 18.5 t60 -140.16 52.94 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.627 0.251 . . . . 0.0 111.184 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 1.7 p30 -131.31 154.69 48.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -45.42 -26.41 0.55 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 122' ' ' ALA . . . . . 0.504 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -70.25 -58.18 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 110.72 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.59 -40.36 76.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.638 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 124' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -59.7 -49.89 76.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.462 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 125' ' ' SER . . . . . 0.414 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 3.3 t -64.26 -34.89 79.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 126' ' ' LYS . . . . . 0.977 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -68.74 -27.08 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' P' P ' 127' ' ' ASN . . . . . 0.661 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 1.7 m-20 -82.21 -31.82 30.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 128' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 1.8 mpp_? -68.85 85.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.051 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 129' ' ' ARG . . . . . 0.445 ' HG2' ' OD1' ' P' ' 69' ' ' ASN . 3.9 ptt180 -154.65 147.16 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 130' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -113.29 108.53 17.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 131' ' ' VAL . . . . . 0.422 HG13 ' OG1' ' P' ' 31' ' ' THR . 3.6 t -88.27 108.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 132' ' ' LEU . . . . . 0.596 HD22 HG13 ' P' ' 66' ' ' VAL . 1.2 mm? -62.51 101.92 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.571 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.93 135.14 45.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 111.48 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.932 179.818 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.795 0.331 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 12.1 p 58.7 163.26 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 12.7 p 58.73 38.41 24.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.92 -28.55 32.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.023 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.59 138.83 44.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.61 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -120.41 130.24 54.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.965 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -75.66 -66.33 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.757 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' P' ' 9' ' ' ALA . . . -143.24 17.95 1.9 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.337 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' P' ' 8' ' ' ALA . . . 81.94 -17.75 0.52 Allowed 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.27 -67.74 1.73 Allowed Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.823 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -178.33 168.69 1.87 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.982 0.42 . . . . 0.0 111.268 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.08 -11.78 62.7 Favored Glycine 0 CA--C 1.519 0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.839 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' P' ' 14' ' ' ALA . . . -43.57 -24.26 0.1 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' P' ' 13' ' ' ALA . . . -30.53 142.61 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -67.41 105.47 1.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.527 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 29.4 p -149.76 92.27 1.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.043 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -89.54 105.87 18.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 111.537 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.33 9.39 30.0 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.631 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.64 -36.56 2.02 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.442 -1.361 . . . . 0.0 113.817 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -121.08 169.88 10.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.083 0.468 . . . . 0.0 111.74 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.12 155.15 20.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.576 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.406 HG23 ' H ' ' P' ' 22' ' ' VAL . 20.7 t -39.25 -53.83 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.21 -18.24 9.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.36 -43.31 6.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 110.463 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.523 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 9.4 mt -63.18 -22.13 66.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.236 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -95.78 -14.92 22.92 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -131.61 -15.13 3.16 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.54 -62.74 1.51 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 96.6 6.29 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.475 ' HA ' HG21 ' P' ' 48' ' ' ILE . 1.6 p30 -160.77 18.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.749 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.454 ' OG1' HG13 ' P' ' 131' ' ' VAL . 85.0 m -125.81 130.58 51.71 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.84 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.436 HG11 HG23 ' P' ' 41' ' ' ILE . 15.8 t -108.41 148.88 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.747 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -114.86 119.1 35.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.416 0.627 . . . . 0.0 112.185 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 73.1 m-85 -103.63 169.22 8.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.823 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.54 -169.54 19.49 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.881 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' P' ' 36' ' ' PHE . 1.5 t80 -57.01 112.85 1.46 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.855 0.36 . . . . 0.0 110.809 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 45.79 38.64 4.48 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.181 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -89.93 138.32 31.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -122.14 49.96 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.96 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -153.38 150.37 28.78 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.521 HG22 ' N ' ' P' ' 42' ' ' THR . 5.7 mt -98.01 163.18 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.521 ' N ' HG22 ' P' ' 41' ' ' ILE . 11.1 p -110.65 143.41 41.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.091 0.472 . . . . 0.0 111.839 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.451 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.87 -32.21 8.46 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 113.225 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -33.97 74.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.626 0.25 . . . . 0.0 111.497 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.421 ' CD1' ' HA ' ' P' ' 32' ' ' VAL . 77.2 m-85 -100.42 -0.24 38.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.451 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 48.1 t -65.22 -43.04 95.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-O 120.548 0.214 . . . . 0.0 111.444 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.458 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 1.0 OUTLIER -42.22 -43.45 3.4 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.002 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.7 -49.73 79.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.919 0.39 . . . . 0.0 110.41 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 5.6 mp -50.98 -45.76 61.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.474 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 3.9 p30 -73.9 -32.21 63.47 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.59 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . 0.437 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.41 -49.48 22.32 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.002 ' CD2' HG22 ' P' ' 48' ' ' ILE . 20.0 m-70 -60.78 -36.47 79.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.532 . . . . 0.0 109.643 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . 0.411 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -61.18 -44.42 97.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.844 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.19 -41.58 98.48 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.79 0.328 . . . . 0.0 110.587 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -73.75 -40.1 63.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.9 HD23 HG11 ' P' ' 99' ' ' VAL . 5.5 tp -63.95 -42.82 97.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.417 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.14 -39.84 78.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.484 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.68 -25.89 55.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.543 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.4 OUTLIER -112.47 113.6 50.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.63 0.252 . . . . 0.0 110.419 179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.5 -46.81 27.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.627 2.218 . . . . 0.0 113.535 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.46 16.82 9.52 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.593 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.73 118.69 30.35 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.634 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -120.15 134.4 55.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.213 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.625 ' HB ' HD13 ' P' ' 56' ' ' LEU . 4.5 p -97.43 134.39 35.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 121.404 0.621 . . . . 0.0 111.496 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.481 HD21 HG22 ' P' ' 107' ' ' VAL . 1.1 tt -109.56 103.32 12.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.685 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.648 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.5 OUTLIER -79.8 120.08 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.031 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.5 mt-10 -103.69 117.63 34.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.609 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -103.29 140.91 15.07 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.582 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.581 ' O ' ' O ' ' P' ' 127' ' ' ASN . 77.4 m-20 -157.24 104.81 2.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.714 0.293 . . . . 0.0 110.824 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.566 HG22 ' NH1' ' P' ' 86' ' ' ARG . 72.1 p -101.9 -172.05 2.08 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.343 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -62.62 143.81 56.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.844 0.354 . . . . 0.0 110.191 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 1.2 pp20? -63.43 -29.36 70.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.881 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' U' ' 7' ' ' DAL . 0.0 OUTLIER -41.64 119.59 1.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . 0.577 ' O ' HG23 ' P' ' 75' ' ' THR . . . 115.09 -113.46 2.95 Favored Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.085 -0.961 . . . . 0.0 112.96 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . 0.577 HG23 ' O ' ' P' ' 74' ' ' GLY . 0.6 OUTLIER -167.21 147.56 4.84 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.157 0.479 . . . . 0.0 111.036 -179.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 82.2 Cg_exo -41.68 -45.94 6.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.522 2.148 . . . . 0.0 112.919 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.12 -42.45 94.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.762 0.315 . . . . 0.0 110.761 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 1.6 t80 -71.27 -46.39 60.99 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.927 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' P' ' 80' ' ' ILE . 12.5 m120 -67.66 -75.45 0.1 Allowed 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.695 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -29.7 -43.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 O-C-N 123.141 0.276 . . . . 0.0 111.515 179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.24 -59.75 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.436 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' P' ' 86' ' ' ARG . 0.3 OUTLIER -49.76 -44.6 48.84 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.922 178.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.438 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -71.54 -55.28 7.69 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.077 -0.582 . . . . 0.0 113.125 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.52 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 1.0 OUTLIER -45.51 -36.44 4.55 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 110.533 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.557 ' HB3' ' CE2' ' P' ' 39' ' ' TYR . 5.2 mtp180 -69.64 -51.84 31.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.102 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.566 ' NH1' HG22 ' P' ' 70' ' ' THR . 0.2 OUTLIER -52.82 -39.8 62.77 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.44 -35.58 77.98 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.261 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.09 -29.13 69.98 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.334 178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.35 -52.0 56.71 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.417 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -70.75 -39.08 75.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.231 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.494 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -60.78 -42.28 97.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.859 0.362 . . . . 0.0 110.204 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.94 -24.96 75.84 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -61.24 -61.18 2.74 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.556 ' HB2' HD21 ' P' ' 104' ' ' LEU . 39.9 mt -58.27 -30.83 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.445 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.23 96.17 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.363 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.48 -25.05 75.87 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.794 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.411 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 2.9 mtpm? -76.84 -9.43 58.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.611 0.243 . . . . 0.0 111.207 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.67 -1.98 23.25 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.493 -0.86 . . . . 0.0 113.193 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.9 HG11 HD23 ' P' ' 56' ' ' LEU . 25.0 t -75.58 127.26 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 0.0 111.418 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.9 146.57 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.253 0.549 . . . . 0.0 111.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.89 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -64.1 -36.15 83.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.569 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.46 -21.9 50.14 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.666 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.6 mtpp -94.21 -5.84 46.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.096 0.474 . . . . 0.0 110.85 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.89 HD12 ' HA ' ' P' ' 101' ' ' ALA . 5.3 mt -96.73 149.08 22.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.648 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -149.57 140.99 8.47 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.505 ' O ' HG13 ' P' ' 107' ' ' VAL . 35.1 p -136.21 153.41 51.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.505 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -163.5 171.66 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.041 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.695 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.5 OUTLIER -162.04 131.12 4.38 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 121.029 -0.269 . . . . 0.0 111.302 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.533 ' O ' ' C ' ' P' ' 110' ' ' GLY . 65.7 m-85 -115.84 23.11 12.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.847 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.533 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -8.47 -106.38 0.0 OUTLIER Glycine 0 C--N 1.34 0.779 0 O-C-N 123.474 0.484 . . . . 0.0 113.971 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 3.8 mt-10 -71.16 -18.52 62.49 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.703 0.252 . . . . 0.0 111.282 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.65 -70.24 0.1 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.133 -178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mmtm -130.66 89.62 42.99 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 122.312 -0.242 . . . . 0.0 110.541 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.0 156.27 39.98 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.599 2.199 . . . . 0.0 112.461 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . 0.712 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -97.68 -74.75 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.095 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.673 HG21 ' CB ' ' P' ' 126' ' ' LYS . 2.6 t -88.79 114.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.056 0.455 . . . . 0.0 110.999 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.63 138.32 57.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.024 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 119.02 176.66 16.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.874 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.468 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 7.1 p80 -141.64 65.55 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.904 0.352 . . . . 0.0 111.566 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -137.8 150.28 47.07 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -38.44 -30.94 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.1 -59.73 2.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.987 0.422 . . . . 0.0 110.875 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.66 -42.44 82.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 1.0 OUTLIER -60.66 -45.08 95.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.161 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 26.9 m -62.92 -36.83 84.67 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.801 0.334 . . . . 0.0 110.509 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.673 ' CB ' HG21 ' P' ' 116' ' ' VAL . 27.0 mtmt -69.21 -25.02 64.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.549 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.712 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 4.6 m-20 -82.49 -33.89 28.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.72 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 4.7 mtp180 -69.64 83.22 0.43 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.954 0.407 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -158.02 148.29 20.39 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -121.12 109.29 14.83 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.454 HG13 ' OG1' ' P' ' 31' ' ' THR . 4.4 t -87.78 115.6 28.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.587 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -59.19 102.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.744 178.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.441 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -100.76 127.04 47.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.307 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.973 179.807 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.923 0.392 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.451 ' HB3' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.597 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.597 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.844 0.354 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 72.4 m -77.96 -32.89 51.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 99.5 p -61.14 -173.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.928 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 5.1 t -82.59 -57.35 3.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -121.1 110.7 16.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.997 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -150.08 132.3 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.05 -49.55 6.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.809 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' P' ' 9' ' ' ALA . . . -174.57 -88.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.756 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' P' ' 8' ' ' ALA . . . 69.81 -55.96 0.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.19 -23.64 31.51 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.618 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.2 135.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.14 -12.76 61.33 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.917 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.21 -72.48 0.05 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.831 0.348 . . . . 0.0 111.543 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 61.74 69.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . 0.452 ' O ' ' CZ ' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -118.66 -109.57 0.35 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.975 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . 0.531 HG22 ' HB3' ' P' ' 21' ' ' SER . 15.3 p -88.86 150.34 22.94 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.822 0.344 . . . . 0.0 110.719 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 0.1 OUTLIER -151.48 135.86 16.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.219 0.533 . . . . 0.0 112.283 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.0 2.88 33.27 Favored Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.374 -0.83 . . . . 0.0 114.205 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.95 -34.36 2.86 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 119.399 -1.381 . . . . 0.0 114.154 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -114.69 161.71 17.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.186 0.517 . . . . 0.0 111.826 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . 0.531 ' HB3' HG22 ' P' ' 16' ' ' THR . 0.8 OUTLIER -97.72 145.76 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.395 179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.428 HG23 ' O ' ' P' ' 15' ' ' GLN . 14.5 t -37.12 -58.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.84 -16.01 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -99.19 -43.02 6.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.324 0.583 . . . . 0.0 110.056 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.503 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 25.5 mt -54.67 -21.69 11.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.224 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.41 -12.85 16.91 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -121.32 -23.63 5.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 3.8 ptm85 -122.89 -48.22 2.02 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.27 102.87 12.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.285 0.564 . . . . 0.0 112.354 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.522 ' HA ' HG21 ' P' ' 48' ' ' ILE . 1.1 p30 179.66 22.65 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.405 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.773 HG23 HG22 ' P' ' 131' ' ' VAL . 72.8 m -125.22 126.84 45.83 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 122.103 -0.373 . . . . 0.0 111.386 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.676 HG11 HG23 ' P' ' 41' ' ' ILE . 0.8 OUTLIER -105.18 150.64 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.913 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -117.93 112.7 20.67 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.374 0.606 . . . . 0.0 112.167 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.56 ' CD2' ' CZ ' ' P' ' 86' ' ' ARG . 15.3 m-30 -92.13 167.0 12.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.226 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.14 174.05 15.47 Favored Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.89 ' CE1' ' HB2' ' U' ' 7' ' ' DAL . 0.3 OUTLIER -61.76 142.45 57.27 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.54 -0.388 . . . . 0.0 110.946 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 p30 49.67 26.0 1.66 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.771 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.451 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -108.97 135.25 50.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.656 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.669 ' HA ' ' NE ' ' P' ' 86' ' ' ARG . 47.4 p90 -132.86 30.46 4.02 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 110.672 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.32 150.83 44.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.774 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.757 HD11 HG22 ' P' ' 90' ' ' VAL . 1.5 mt -87.7 166.38 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.589 0.233 . . . . 0.0 110.616 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.479 ' N ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -111.07 144.56 40.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.09 0.472 . . . . 0.0 111.779 -179.151 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.454 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.73 -31.95 2.82 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.624 -0.716 . . . . 0.0 113.606 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.07 -30.5 71.03 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.712 0.291 . . . . 0.0 111.497 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.591 ' HB3' HG13 ' P' ' 32' ' ' VAL . 72.6 m-85 -104.9 3.52 30.98 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.454 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 54.3 t -69.1 -37.22 76.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.589 0.233 . . . . 0.0 111.38 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -46.21 -42.44 14.2 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.035 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.8 OUTLIER -55.96 -49.71 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.002 0.43 . . . . 0.0 110.412 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.77 -39.68 74.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.11 -45.79 72.7 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.04 -34.51 68.83 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 110.382 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.035 ' CD2' HG22 ' P' ' 48' ' ' ILE . 16.5 m-70 -72.27 -40.64 67.49 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.973 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.05 -31.9 73.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.182 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.05 -36.05 59.19 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-O 120.679 0.276 . . . . 0.0 110.481 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . 0.456 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 13.8 t80 -74.26 -38.89 63.31 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.153 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.736 HD23 ' CG1' ' P' ' 99' ' ' VAL . 1.2 tp -65.08 -43.95 90.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.841 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -69.96 -39.98 75.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.24 -24.43 59.25 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.055 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.97 89.92 51.86 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.009 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.46 -21.67 10.82 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.792 2.328 . . . . 0.0 113.354 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.78 -1.2 55.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.659 0.266 . . . . 0.0 111.679 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.81 125.88 35.85 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.182 0.515 . . . . 0.0 110.598 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 2.6 pttp -121.85 132.29 54.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.836 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.508 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -97.6 146.61 7.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.484 0.659 . . . . 0.0 111.713 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.509 HD21 HG22 ' P' ' 107' ' ' VAL . 0.9 OUTLIER -118.89 103.73 9.87 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.406 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.613 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.6 OUTLIER -79.17 112.74 17.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.842 -179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.5 tt0 -101.3 114.99 29.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.104 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -106.35 146.54 16.08 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.878 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 127' ' ' ASN . 11.3 m-80 -155.76 107.49 2.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 79.1 p -105.35 -173.91 2.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.446 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 24.0 p-10 -54.76 139.1 40.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.509 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -61.51 -27.15 68.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.204 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 -39.59 108.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.67 -175.17 15.9 Favored Glycine 0 CA--C 1.52 0.4 0 CA-C-N 115.406 -0.815 . . . . 0.0 113.437 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -101.6 147.69 34.18 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 122.223 0.209 . . . . 0.0 111.224 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.449 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 92.9 Cg_exo -39.56 -45.22 3.33 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.881 2.387 . . . . 0.0 113.172 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -40.88 90.84 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 120.902 0.382 . . . . 0.0 110.438 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 5.7 t80 -75.53 -37.45 60.04 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.841 178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -70.51 -76.85 0.09 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.543 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -31.93 -40.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 O-C-N 123.101 0.251 . . . . 0.0 111.343 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.21 -56.91 11.41 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.324 179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.534 ' HA ' ' HD3' ' P' ' 85' ' ' ARG . 0.4 OUTLIER -47.32 -53.45 13.58 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.54 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' P' ' 86' ' ' ARG . . . -69.16 -42.62 75.44 Favored Glycine 0 C--N 1.335 0.496 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.334 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' P' ' 80' ' ' ILE . 7.3 tp-100 -45.68 -44.65 13.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.637 0.256 . . . . 0.0 110.656 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.534 ' HD3' ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -72.19 -32.88 67.2 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.552 178.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.669 ' NE ' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -62.04 -49.81 74.52 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.504 0.669 . . . . 0.0 109.302 177.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -56.33 -35.34 67.48 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.5 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -29.64 70.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -62.94 -59.69 4.49 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.537 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.757 HG22 HD11 ' P' ' 41' ' ' ILE . 23.1 t -64.9 -37.69 80.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.491 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -61.16 -47.39 86.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.299 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.9 -19.03 73.16 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -67.5 -64.18 0.91 Allowed 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.44 ' O ' HG23 ' P' ' 99' ' ' VAL . 75.6 mt -52.54 -33.71 46.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.095 178.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.1 -40.91 97.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.201 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -61.47 -32.4 81.01 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -8.63 56.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.531 -0.334 . . . . 0.0 110.948 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 101.44 14.33 30.47 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.51 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.736 ' CG1' HD23 ' P' ' 56' ' ' LEU . 48.1 t -80.46 130.42 35.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 0.0 111.402 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.07 165.69 6.76 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.259 0.552 . . . . 0.0 111.127 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.34 -30.07 17.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.474 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -60.27 -22.32 58.27 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.813 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.644 ' HD3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -101.87 -4.32 26.44 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.212 0.529 . . . . 0.0 111.093 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.616 HD12 ' HA ' ' P' ' 101' ' ' ALA . 38.4 mt -96.37 150.38 20.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.133 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.613 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -151.15 142.99 10.01 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 121.054 -0.594 . . . . 0.0 111.651 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.74 ' O ' HG13 ' P' ' 107' ' ' VAL . 30.4 p -133.26 156.76 46.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.585 0.231 . . . . 0.0 110.451 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.74 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -171.13 129.22 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.347 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -119.25 130.55 55.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.736 -179.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 82.6 m-85 -110.94 25.66 11.53 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.083 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.47 -112.36 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.718 -0.674 . . . . 0.0 114.445 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.509 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.03 6.88 47.84 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -53.89 -58.97 5.32 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.72 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 89.36 11.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.265 179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.84 164.36 14.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.568 2.179 . . . . 0.0 112.424 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.38 -62.7 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.64 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' P' ' 126' ' ' LYS . 7.9 t -89.49 112.22 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.975 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -62.8 137.77 58.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.143 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 116.85 174.56 17.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.992 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.438 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 15.3 p-80 -141.99 68.73 1.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.689 0.28 . . . . 0.0 111.369 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -139.42 152.5 47.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -37.93 -32.36 0.06 Allowed 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.58 -61.89 1.6 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.987 0.423 . . . . 0.0 110.994 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.24 79.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -56.81 -50.17 73.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.252 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 87.7 p -60.66 -37.04 80.24 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.133 0.492 . . . . 0.0 110.056 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.856 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -62.47 -32.92 73.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.294 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' P' ' 69' ' ' ASN . 98.7 m-20 -81.58 -30.45 33.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.415 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 4.5 mtp180 -69.79 74.61 0.43 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.089 0.471 . . . . 0.0 110.869 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.17 146.18 40.26 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.509 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.77 90.01 3.24 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.773 HG22 HG23 ' P' ' 31' ' ' THR . 15.4 t -80.2 114.17 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.468 HD22 HG13 ' P' ' 66' ' ' VAL . 0.2 OUTLIER -63.08 104.95 0.63 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.206 178.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.427 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -102.25 126.75 49.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 111.491 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.088 179.652 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.451 ' O4 ' ' N2 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.712 0.292 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.488 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.89 ' HB2' ' CE1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.906 0.384 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 87.0 p -107.14 -22.12 12.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t 67.92 61.44 0.42 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.7 m -88.02 -58.74 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.753 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -116.26 90.29 3.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.65 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -96.93 143.59 27.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.161 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . 0.545 ' O ' ' HB3' ' P' ' 8' ' ' ALA . 2.4 m-20 -69.17 -12.71 61.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' P' ' 7' ' ' ASP . . . 77.55 -166.77 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 65.51 126.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.95 -73.06 0.41 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.84 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . 0.41 HD22 ' HB2' ' P' ' 14' ' ' ALA . 7.4 p-10 -160.48 134.0 6.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.883 0.373 . . . . 0.0 110.952 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.03 -71.38 1.24 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.538 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.42 -47.12 9.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.828 0.347 . . . . 0.0 111.193 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.41 ' HB2' HD22 ' P' ' 11' ' ' ASN . . . 63.41 31.56 14.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.08 17.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 2.6 t -88.83 152.29 21.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.498 ' C ' ' H ' ' P' ' 19' ' ' GLY . 47.8 m-85 -137.92 85.62 2.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.771 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 50.6 4.98 0.07 OUTLIER Glycine 0 CA--C 1.525 0.68 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.726 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . 0.72 ' O ' HD21 ' P' ' 25' ' ' LEU . . . 171.53 97.2 0.11 Allowed Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' P' ' 19' ' ' GLY . 0.8 OUTLIER 60.57 -178.34 0.1 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.246 0.546 . . . . 0.0 112.106 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 6.9 p -107.99 160.49 15.74 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.49 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.404 HG12 ' HG3' ' P' ' 26' ' ' GLN . 20.6 t -39.13 -53.46 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 -15.92 3.72 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.7 -38.64 8.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.452 0.644 . . . . 0.0 110.142 178.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.72 HD21 ' O ' ' P' ' 19' ' ' GLY . 14.4 mt -70.27 -22.47 62.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.464 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . 0.404 ' HG3' HG12 ' P' ' 22' ' ' VAL . 12.6 mt-30 -85.25 -26.72 26.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -140.6 -3.49 1.3 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' P' ' 24' ' ' ASP . 5.4 mtm-85 -107.54 -68.03 0.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -109.52 96.39 6.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.099 0.476 . . . . 0.0 112.061 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.579 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -162.77 27.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.024 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.571 HG23 HG22 ' P' ' 131' ' ' VAL . 95.3 m -128.33 129.61 46.55 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.813 0.339 . . . . 0.0 111.882 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.483 HG11 HG23 ' P' ' 41' ' ' ILE . 1.0 OUTLIER -110.77 150.72 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.481 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -120.94 118.05 28.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.7 m-30 -100.99 171.65 7.51 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.383 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.76 -166.64 23.41 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.903 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -59.68 117.71 5.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.944 0.372 . . . . 0.0 110.926 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 t70 45.45 29.04 0.55 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.342 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.404 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 24.5 mmtm -94.81 130.9 41.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.882 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.779 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -119.57 67.08 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.606 0.717 . . . . 0.0 110.037 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -152.15 150.67 30.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.475 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.483 HG23 HG11 ' P' ' 32' ' ' VAL . 3.6 mt -107.98 156.84 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 10.9 p -109.85 150.16 28.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.15 0.5 . . . . 0.0 112.065 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.449 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -48.92 -31.27 10.16 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.458 -0.792 . . . . 0.0 113.264 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.75 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.69 0.281 . . . . 0.0 111.389 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.464 ' CB ' HG13 ' P' ' 32' ' ' VAL . 77.0 m-85 -99.68 -4.61 30.46 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.449 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 64.9 t -62.82 -41.95 94.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.432 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -44.46 -45.38 9.09 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.008 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -52.59 -49.67 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.941 0.401 . . . . 0.0 110.22 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.859 HD11 HG13 ' P' ' 90' ' ' VAL . 2.7 mm? -54.06 -45.36 71.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.904 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.76 -40.29 96.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.908 0.385 . . . . 0.0 110.343 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . 0.444 ' HB2' ' HA3' ' P' ' 19' ' ' GLY . . . -68.95 -46.66 67.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.856 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.008 ' CD2' HG22 ' P' ' 48' ' ' ILE . 59.7 m-70 -68.17 -41.47 81.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.116 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.03 99.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.437 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.72 -39.86 94.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.66 0.267 . . . . 0.0 110.482 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -73.38 -36.88 66.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.646 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 1.074 HD23 HG11 ' P' ' 99' ' ' VAL . 5.0 tp -60.01 -47.9 83.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.191 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -68.27 -43.08 78.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.594 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.64 -26.38 22.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.684 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -114.88 113.63 44.35 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.491 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.14 -49.08 17.66 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.771 2.314 . . . . 0.0 113.849 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.64 17.5 8.75 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.39 114.6 26.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.094 0.473 . . . . 0.0 110.662 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.518 ' CG ' ' HA ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -117.32 133.45 55.96 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.806 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.537 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.2 p -98.88 143.53 13.11 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-O 121.43 0.633 . . . . 0.0 111.476 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.765 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.5 tt -113.55 101.16 9.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.627 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.63 HG11 ' HB ' ' P' ' 90' ' ' VAL . 0.8 OUTLIER -80.13 106.81 11.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.234 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.477 ' OE2' HG11 ' P' ' 107' ' ' VAL . 0.9 OUTLIER -100.59 119.37 38.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.058 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' P' ' 130' ' ' ALA . . . -96.68 144.04 17.09 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.621 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 127' ' ' ASN . 1.4 m-20 -140.19 102.43 4.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.828 0.347 . . . . 0.0 110.625 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 1.081 HG21 HD11 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -95.0 -169.97 2.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.573 179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -73.61 158.49 34.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 0.0 110.999 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 pp20? -74.44 -33.96 63.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.259 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.03 116.18 1.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.13 -161.82 12.56 Favored Glycine 0 C--N 1.331 0.295 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.532 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.48 148.15 35.3 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.489 0.185 . . . . 0.0 110.751 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.431 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 46.6 Cg_exo -54.77 -31.87 74.0 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.231 1.954 . . . . 0.0 112.162 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -67.44 -43.02 82.14 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.706 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.492 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 29.2 t80 -73.89 -39.74 63.67 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.256 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -67.83 -76.7 0.08 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.58 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 1.8 tt -33.1 -38.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.07 -56.87 6.41 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.749 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 1.081 HD11 HG21 ' P' ' 70' ' ' THR . 0.0 OUTLIER -55.4 -42.14 73.63 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 1.011 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -66.76 -40.51 93.83 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -52.55 -43.56 65.27 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.132 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.521 ' HD3' ' CD1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.12 -35.87 81.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.637 ' NH1' HG23 ' P' ' 70' ' ' THR . 0.0 OUTLIER -65.22 -44.65 87.6 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.745 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -57.79 -36.85 72.75 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.219 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . 0.53 ' HA ' ' HB3' ' P' ' 91' ' ' LYS . 0.2 OUTLIER -67.57 -28.89 68.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.211 178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -58.46 -66.36 0.5 Allowed 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.731 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.859 HG13 HD11 ' P' ' 49' ' ' LEU . 84.3 t -57.11 -31.75 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.385 0.612 . . . . 0.0 109.892 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.53 ' HB3' ' HA ' ' P' ' 88' ' ' ASP . 0.3 OUTLIER -60.93 -47.62 85.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.351 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.1 -18.85 79.39 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.112 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -68.04 -61.13 2.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.849 ' HB2' HD11 ' P' ' 104' ' ' LEU . 63.4 mt -57.02 -31.3 64.98 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.283 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.57 -38.43 84.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.591 178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -59.09 -39.63 94.62 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -60.86 -35.23 76.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.88 27.43 1.9 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.556 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 1.074 HG11 HD23 ' P' ' 56' ' ' LEU . 45.4 t -89.92 143.42 11.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.524 0.202 . . . . 0.0 110.483 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.31 165.22 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.245 0.545 . . . . 0.0 111.493 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.11 -29.91 18.01 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.297 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.97 -29.68 55.82 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.386 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.518 ' HA ' ' CG ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.14 -4.87 26.47 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 110.421 179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.849 HD11 ' HB2' ' P' ' 94' ' ' LEU . 0.2 OUTLIER -106.91 121.32 44.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.122 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.557 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -129.61 178.36 17.47 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.606 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.745 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 70.7 p -149.95 163.44 38.08 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.765 ' CG2' HD21 ' P' ' 65' ' ' LEU . 93.5 t -160.85 161.14 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.21 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 5.6 t -159.66 129.05 5.29 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.471 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.433 ' CZ ' ' HG2' ' P' ' 67' ' ' GLU . 25.9 m-85 -88.85 -63.26 1.32 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.12 -127.92 8.17 Favored Glycine 0 N--CA 1.44 -1.092 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.079 -178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' P' ' 72' ' ' GLU . 0.3 OUTLIER -93.14 2.62 56.62 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.029 178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -54.45 -66.14 0.45 Allowed 'General case' 0 C--N 1.34 0.164 0 CA-C-O 120.831 0.348 . . . . 0.0 110.429 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -141.03 88.97 9.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.057 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . 0.4 ' CG ' ' HB3' ' P' ' 72' ' ' GLU . 24.2 Cg_exo -64.27 165.78 18.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.737 2.291 . . . . 0.0 112.434 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.54 -58.33 1.95 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.674 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.886 HG13 ' HB1' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -91.11 142.83 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.874 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.27 139.8 31.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.96 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 118.21 175.81 16.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.936 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.448 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 9.5 p-80 -141.3 68.27 1.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.749 0.274 . . . . 0.0 111.457 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -141.25 153.65 45.34 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 3.7 tp10 -40.37 -30.3 0.1 Allowed 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -67.56 -65.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.992 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . 0.886 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -68.13 -41.42 81.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.698 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' P' ' 119' ' ' HIS . 1.6 m-85 -54.7 -52.96 60.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 89.3 p -59.09 -37.35 76.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 110.185 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 22.8 mtmt -61.53 -31.62 71.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.292 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' P' ' 69' ' ' ASN . 58.3 m-20 -84.42 -34.31 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.896 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 5.0 mtp180 -68.97 79.64 0.31 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.158 0.504 . . . . 0.0 111.135 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' P' ' 69' ' ' ASN . 0.1 OUTLIER -150.59 149.76 30.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -179.114 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.43 ' HA ' ' HA2' ' P' ' 68' ' ' GLY . . . -119.73 98.48 6.13 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.571 HG22 HG23 ' P' ' 31' ' ' THR . 21.8 t -83.9 115.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -176.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.467 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -65.39 103.13 0.77 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.549 178.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -99.47 128.59 45.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.937 0.398 . . . . 0.0 111.511 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.051 179.624 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.599 ' O10' ' HB2' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . 0.599 ' HB2' ' O10' ' U' ' 2' ' ' AMU . . . . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.492 ' HB3' ' CE2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.768 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.768 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 120.627 0.251 . . . . 0.0 111.371 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 31.9 p -126.79 30.72 5.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.814 0.34 . . . . 0.0 110.841 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 4.2 m -138.01 20.06 2.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.158 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 3.5 t -90.15 -54.94 3.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.772 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -140.85 117.87 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -142.74 141.39 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.03 -62.65 1.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -172.95 -176.46 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.39 138.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.103 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.05 85.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.332 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . 0.49 ' HB3' ' HB2' ' P' ' 14' ' ' ALA . 1.1 t-20 178.68 124.25 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.357 . . . . 0.0 110.711 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.46 -57.4 3.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.659 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.75 -24.8 24.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 111.356 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' P' ' 11' ' ' ASN . . . -55.64 133.27 50.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 111.221 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -109.16 -164.51 0.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.564 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -130.49 90.54 2.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.78 0.324 . . . . 0.0 111.12 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -89.51 106.65 18.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.994 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.77 10.01 35.98 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.535 -0.84 . . . . 0.0 113.412 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.41 -35.03 2.17 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.16 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -129.92 176.77 7.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.051 0.453 . . . . 0.0 111.709 -178.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . 0.431 ' OG ' ' HB1' ' P' ' 14' ' ' ALA . 8.9 t -103.3 157.37 17.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.131 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.795 ' HA ' HD12 ' P' ' 25' ' ' LEU . 17.4 t -46.4 -51.38 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.18 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.53 -13.34 2.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.436 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.11 -44.66 6.53 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' P' ' 22' ' ' VAL . 3.9 mt -58.07 -19.78 34.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.703 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -109.02 -11.27 14.98 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.06 -31.08 5.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -122.83 -50.17 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -105.72 103.8 13.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.529 0.68 . . . . 0.0 112.403 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.601 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -176.08 11.05 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.301 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.426 ' O ' ' CD1' ' P' ' 45' ' ' TYR . 85.0 m -113.77 128.12 56.29 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.838 -0.539 . . . . 0.0 112.097 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.631 ' CG1' HG23 ' P' ' 41' ' ' ILE . 5.3 t -108.06 151.16 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.386 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . 0.456 ' C ' ' CD1' ' P' ' 34' ' ' PHE . 6.9 m-85 -112.48 163.32 14.61 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.456 ' CD1' ' C ' ' P' ' 33' ' ' TYR . 73.4 m-85 -152.06 168.55 24.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.221 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.49 -175.74 23.27 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.567 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -59.35 128.43 37.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 117.084 0.442 . . . . 0.0 110.884 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 p30 43.59 29.76 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.801 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.431 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 2.3 tttp -101.02 137.71 39.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.48 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' P' ' 39' ' ' TYR . 48.5 p90 -125.37 60.71 1.23 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.985 0.421 . . . . 0.0 111.306 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -150.63 150.85 31.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.232 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.631 HG23 ' CG1' ' P' ' 32' ' ' VAL . 3.3 mt -94.76 163.44 2.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 120.652 0.263 . . . . 0.0 110.736 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.518 ' N ' HG22 ' P' ' 41' ' ' ILE . 72.8 p -112.61 142.67 44.92 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.057 0.456 . . . . 0.0 111.308 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.9 -29.74 4.6 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.346 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -64.05 -32.87 74.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.675 0.274 . . . . 0.0 111.61 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.429 ' CE2' ' HB2' ' P' ' 33' ' ' TYR . 68.2 m-85 -102.8 3.65 36.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 22.0 t -67.82 -41.23 84.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.46 ' NE2' HG12 ' P' ' 48' ' ' ILE . 6.1 pm0 -45.77 -37.77 6.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.0 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.3 mt -57.74 -52.83 52.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.452 . . . . 0.0 110.081 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.4 mp -52.85 -33.09 48.01 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.437 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.09 -40.78 62.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.3 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . 0.573 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -74.45 -43.93 53.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.037 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.0 ' CD2' HG22 ' P' ' 48' ' ' ILE . 59.9 m-70 -62.9 -38.82 92.44 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.28 -45.14 94.62 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.026 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.12 -43.36 87.18 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . 0.47 ' HD2' ' HH ' ' P' ' 134' ' ' TYR . 8.9 t80 -73.63 -41.51 62.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 1.069 HD23 HG11 ' P' ' 99' ' ' VAL . 5.6 tp -61.02 -45.06 96.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.397 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -70.79 -40.74 72.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.564 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.96 -26.64 37.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.57 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.627 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -114.54 114.33 44.95 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.374 179.707 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.03 -51.58 10.35 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.859 2.373 . . . . 0.0 113.931 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.06 19.69 5.52 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.627 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.19 119.68 30.72 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.895 0.379 . . . . 0.0 109.994 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.503 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -119.5 132.51 55.79 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.724 -179.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.691 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.8 p -98.65 144.87 10.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 CA-C-O 121.294 0.569 . . . . 0.0 110.904 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.634 HD21 HG22 ' P' ' 107' ' ' VAL . 0.6 OUTLIER -116.56 108.31 15.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.943 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.652 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.2 OUTLIER -85.53 113.96 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.416 ' HA ' HG23 ' P' ' 107' ' ' VAL . 21.0 tt0 -99.07 120.36 39.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.734 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.29 144.01 21.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.708 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.743 ' O ' HG23 ' P' ' 70' ' ' THR . 0.3 OUTLIER -144.3 159.8 42.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.736 0.303 . . . . 0.0 110.315 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.743 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.1 p -170.26 -173.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.445 ' CB ' ' CE2' ' P' ' 124' ' ' TYR . 10.0 p-10 -63.72 157.25 24.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.379 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.519 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 0.2 OUTLIER -70.55 -31.35 68.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.798 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.441 ' HB2' ' OH ' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -49.86 119.74 3.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -178.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.37 -173.82 15.33 Favored Glycine 0 C--N 1.33 0.24 0 CA-C-N 114.933 -1.03 . . . . 0.0 113.225 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.17 143.15 26.56 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.713 0.292 . . . . 0.0 111.135 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.537 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -40.2 -43.1 3.73 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.017 2.478 . . . . 0.0 113.667 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -59.82 -45.17 93.21 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.511 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 14.1 t80 -70.89 -41.97 70.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 0.0 110.406 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 4.3 m-80 -67.5 -75.44 0.1 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.9 OUTLIER -29.48 -44.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.779 0.323 . . . . 0.0 111.525 179.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.37 4.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.91 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.572 HD12 ' NH1' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -47.9 -51.9 21.42 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.279 -0.569 . . . . 0.0 109.92 178.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.452 ' HA2' ' CG ' ' P' ' 86' ' ' ARG . . . -61.52 -40.74 99.12 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.511 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -51.39 -40.51 59.4 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.523 HH12 HD22 ' P' ' 82' ' ' LEU . 8.1 ttp-105 -64.73 -38.82 92.29 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.572 ' NH1' HD12 ' P' ' 82' ' ' LEU . 0.3 OUTLIER -59.05 -40.08 84.0 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' P' ' 106' ' ' THR . . . -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.776 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.5 OUTLIER -65.87 -34.69 78.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.789 178.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.1 68.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.753 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.86 -38.06 43.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.809 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.583 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.2 -39.66 91.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.988 0.423 . . . . 0.0 110.236 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.79 -27.43 64.91 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -59.87 -57.02 14.67 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.463 ' HB2' HD21 ' P' ' 104' ' ' LEU . 23.2 mt -61.45 -32.25 72.23 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.39 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -39.96 95.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.103 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.12 -26.97 74.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.759 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -72.38 -11.44 60.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.793 0.33 . . . . 0.0 111.038 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.99 2.0 25.24 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.13 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 1.069 HG11 HD23 ' P' ' 56' ' ' LEU . 26.9 t -81.95 131.95 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.368 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . 0.427 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.5 OUTLIER -60.9 164.28 5.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.271 0.557 . . . . 0.0 111.324 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.921 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -84.26 -30.02 25.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.37 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.58 -22.78 53.37 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.895 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.644 ' HE3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -98.84 -3.86 34.46 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.092 0.473 . . . . 0.0 111.25 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.921 HD12 ' HA ' ' P' ' 101' ' ' ALA . 8.7 mt -89.2 150.44 22.67 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 122.254 -0.279 . . . . 0.0 110.342 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.652 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.16 138.82 7.72 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.827 ' O ' HG13 ' P' ' 107' ' ' VAL . 66.3 p -132.14 153.37 50.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.693 0.282 . . . . 0.0 111.014 -179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.827 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -175.38 170.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.493 ' OG ' HG23 ' P' ' 80' ' ' ILE . 32.4 p -162.47 139.18 7.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.406 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.482 ' O ' ' C ' ' P' ' 110' ' ' GLY . 74.6 m-85 -123.57 19.77 9.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 7.4 -110.34 0.01 OUTLIER Glycine 0 C--N 1.336 0.58 0 N-CA-C 115.116 0.806 . . . . 0.0 115.116 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.519 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -86.18 8.07 22.51 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 8.4 tp10 -51.43 -59.74 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.923 0.392 . . . . 0.0 109.961 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.17 89.81 22.72 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.686 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.18 160.11 11.32 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.709 2.273 . . . . 0.0 112.991 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -69.13 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.674 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.69 HG21 ' HB3' ' P' ' 126' ' ' LYS . 19.6 t -87.67 106.23 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.044 0.449 . . . . 0.0 110.923 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 mp -69.24 134.9 49.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.1 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.69 174.68 13.56 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.379 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.61 87.02 2.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.145 0.473 . . . . 0.0 111.692 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -173.2 165.98 4.87 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -47.79 -22.3 0.52 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.57 -60.84 2.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.912 0.386 . . . . 0.0 111.444 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -40.09 72.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.075 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.445 ' CE2' ' CB ' ' P' ' 71' ' ' ASP . 2.9 m-85 -60.55 -45.75 92.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.749 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 25.2 t -65.34 -32.02 73.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.387 . . . . 0.0 110.174 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.69 ' HB3' HG21 ' P' ' 116' ' ' VAL . 1.9 mtmt -75.06 -24.69 58.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.369 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -87.89 -29.0 21.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.657 0.265 . . . . 0.0 111.262 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -67.25 87.42 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 3.3 ptt-85 -159.08 160.31 35.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -125.37 106.53 9.9 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 t -84.25 111.24 19.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.646 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -61.58 101.94 0.22 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.209 178.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.92 130.51 48.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.279 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . 0.47 ' HH ' ' HD2' ' P' ' 55' ' ' TYR . 5.8 m-85 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.025 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.466 H5'2 ' O4 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.466 ' O4 ' H5'2 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.668 0.747 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.511 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 21.9 p . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.804 0.335 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 90.9 p -172.33 -172.33 0.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.04 89.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.82 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 37.8 p -88.39 -27.6 21.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 148.31 23.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.712 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.95 146.94 24.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -91.09 -55.29 3.6 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.719 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 63.27 137.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.194 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.83 3.24 38.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.584 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.38 -28.23 72.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.418 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 11.7 p30 43.09 31.73 0.37 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 111.405 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.91 -45.81 40.49 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.426 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.02 -73.22 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 111.185 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -179.86 176.0 0.79 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.235 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . 0.41 ' O ' ' CB ' ' P' ' 21' ' ' SER . 0.0 OUTLIER -129.85 148.05 51.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.493 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.5 p -129.24 150.35 50.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 111.688 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -141.94 106.38 4.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.169 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.66 8.51 47.36 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.3 -0.953 . . . . 0.0 113.288 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.54 -35.67 2.24 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 119.575 -1.297 . . . . 0.0 114.127 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.71 ' HB2' HD21 ' P' ' 25' ' ' LEU . 2.9 m-85 -119.43 169.26 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.124 0.462 . . . . 0.0 111.468 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' P' ' 15' ' ' GLN . 5.0 m -101.27 145.3 29.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.992 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.508 ' HA ' HD12 ' P' ' 25' ' ' LEU . 10.3 t -43.27 -30.38 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.106 0.479 . . . . 0.0 111.468 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . 0.625 ' O ' ' HG2' ' P' ' 27' ' ' GLN . . . -61.67 -21.96 64.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' P' ' 28' ' ' ARG . 0.5 OUTLIER -99.69 -54.05 3.02 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-O 121.726 0.774 . . . . 0.0 109.604 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.71 HD21 ' HB2' ' P' ' 20' ' ' TYR . 7.1 mt -44.59 -28.05 0.55 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -97.89 -31.22 12.31 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 121.157 0.503 . . . . 0.0 110.725 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . 0.634 ' O ' ' HB2' ' P' ' 28' ' ' ARG . 0.1 OUTLIER -148.5 77.68 1.4 Allowed 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.532 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . 0.634 ' HB2' ' O ' ' P' ' 27' ' ' GLN . 0.0 OUTLIER 164.47 -68.87 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.205 177.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.449 ' CD1' ' HD3' ' P' ' 28' ' ' ARG . 6.7 m-85 -109.13 90.09 3.19 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.61 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 2.0 p30 -168.29 64.69 0.07 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.411 ' O ' ' CE1' ' P' ' 45' ' ' TYR . 97.6 m -164.11 126.68 2.44 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.818 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.921 HG11 HG23 ' P' ' 41' ' ' ILE . 1.2 t -99.75 150.0 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.652 0.263 . . . . 0.0 111.215 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -116.33 108.35 15.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.535 0.683 . . . . 0.0 111.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -89.31 172.94 8.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.612 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -111.16 -173.98 19.92 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.431 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 3.0 t80 -58.36 122.56 13.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 117.457 0.628 . . . . 0.0 110.901 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . 0.411 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 2.7 p30 43.92 30.84 0.44 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.744 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.75 141.58 28.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.467 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 31.2 p90 -130.76 52.55 2.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.145 0.497 . . . . 0.0 110.833 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -149.97 150.14 31.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.448 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.921 HG23 HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -100.27 163.52 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.924 -179.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 69.4 p -109.45 150.59 27.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.409 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.86 -29.72 1.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.205 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -65.2 -30.47 71.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 0.0 111.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.503 ' CB ' HG13 ' P' ' 32' ' ' VAL . 68.0 m-85 -104.12 1.17 30.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.981 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.409 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 82.4 t -73.22 -37.56 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.41 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -52.62 -40.7 63.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 0.407 ' CG1' ' O ' ' P' ' 45' ' ' TYR . 4.6 pt -67.25 -35.72 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.344 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 13.3 mt -62.88 -40.12 96.55 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.95 -34.19 62.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.792 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.76 -53.58 8.27 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.463 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 0.651 ' CE1' ' HB3' ' P' ' 25' ' ' LEU . 23.0 m-70 -53.59 -35.35 60.75 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.04 85.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.065 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.35 85.96 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.123 0.487 . . . . 0.0 110.201 179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.23 -37.87 63.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.73 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 1.017 HD23 HG11 ' P' ' 99' ' ' VAL . 1.7 tp -62.47 -42.74 99.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.294 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -70.64 -42.06 71.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.461 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.27 -27.07 54.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.534 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.3 OUTLIER -113.15 112.22 49.84 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.94 -48.74 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.842 2.361 . . . . 0.0 114.154 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.61 17.61 8.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.585 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.35 117.91 29.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.085 0.469 . . . . 0.0 110.901 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -118.7 130.41 55.81 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.765 -179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.638 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.4 p -94.44 140.23 17.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-O 121.347 0.594 . . . . 0.0 111.422 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.407 ' CB ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.14 104.31 13.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.786 -179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -85.09 108.12 16.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.083 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.6 tt0 -102.01 118.06 36.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.605 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.03 152.34 20.67 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.52 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -148.55 170.7 17.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.871 0.367 . . . . 0.0 110.926 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' P' ' 128' ' ' ARG . 0.1 OUTLIER 176.2 174.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.147 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.533 ' HB2' ' CZ ' ' P' ' 124' ' ' TYR . 37.7 p-10 -54.46 142.64 26.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.253 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.467 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 2.2 pp20? -62.79 -25.98 68.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.071 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.429 ' HD3' ' CE1' ' P' ' 119' ' ' HIS . 0.7 OUTLIER -39.33 110.74 0.15 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.362 0.601 . . . . 0.0 112.545 -178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.22 -168.87 12.71 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.336 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.57 144.83 29.45 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.674 0.273 . . . . 0.0 111.066 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.06 -39.28 14.66 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.634 2.223 . . . . 0.0 112.488 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.8 -43.02 97.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.679 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 12.3 t80 -68.18 -41.81 80.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.467 ' OD1' HG23 ' P' ' 70' ' ' THR . 3.1 m-80 -70.68 -75.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.823 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -30.15 -40.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -69.89 -57.06 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.82 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 1.016 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.4 -42.0 81.42 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.056 178.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 1.016 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.86 -52.32 20.19 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.765 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 1.9 tt0 -48.03 -35.67 11.52 Favored 'General case' 0 N--CA 1.461 0.109 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -61.92 -48.71 79.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.082 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 0.3 OUTLIER -54.98 -40.89 70.55 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.556 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.78 -34.24 74.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.44 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -32.99 74.57 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.235 178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.33 -53.44 57.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.426 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.37 -34.02 60.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.055 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 2.1 tmtt? -60.84 -52.75 63.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.509 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -65.06 -27.1 71.86 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -59.16 -58.4 8.83 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.485 ' CD1' HG11 ' P' ' 64' ' ' VAL . 92.6 mt -56.73 -29.91 62.98 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -69.84 -38.99 76.68 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.84 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.31 -35.17 87.61 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.68 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -63.87 -36.56 84.32 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.63 26.15 2.22 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.247 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 1.017 HG11 HD23 ' P' ' 56' ' ' LEU . 24.4 t -91.15 146.16 6.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.568 0.223 . . . . 0.0 110.726 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.28 161.76 1.25 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.172 0.51 . . . . 0.0 111.562 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.29 -31.32 17.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.381 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.67 -12.91 65.11 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.021 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 12.9 mtpp -94.37 -10.91 31.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.07 0.462 . . . . 0.0 111.27 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' P' ' 101' ' ' ALA . 1.9 mt -99.79 150.01 22.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.607 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.74 144.58 11.8 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.777 ' O ' HG13 ' P' ' 107' ' ' VAL . 17.6 p -124.57 159.09 31.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.722 0.296 . . . . 0.0 110.85 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.777 HG13 ' O ' ' P' ' 106' ' ' THR . 0.0 OUTLIER -175.28 117.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.151 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.823 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -99.77 143.78 29.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.805 0.336 . . . . 0.0 111.526 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' P' ' 110' ' ' GLY . 2.8 m-85 -105.45 7.8 33.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.962 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 16.87 -127.25 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.276 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -101.08 12.75 37.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.53 0.205 . . . . 0.0 111.106 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -59.1 5.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 109.95 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.36 89.03 16.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 31.9 Cg_exo -61.19 164.07 15.57 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.804 2.336 . . . . 0.0 112.982 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.3 -67.4 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.277 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.769 HG21 ' HG3' ' P' ' 126' ' ' LYS . 18.8 t -88.52 108.76 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 32.9 mt -67.89 138.75 56.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.503 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.28 177.03 14.99 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.999 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.537 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 14.8 t-160 -141.03 61.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.815 0.34 . . . . 0.0 111.21 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . 0.824 ' OD2' ' HB3' ' P' ' 122' ' ' ALA . 7.9 p-10 -127.14 154.69 44.44 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -49.38 -23.02 1.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.547 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . 0.824 ' HB3' ' OD2' ' P' ' 120' ' ' ASP . . . -76.07 -58.1 3.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.025 0.44 . . . . 0.0 110.938 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -63.77 -42.21 97.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.674 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.537 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 3.2 m-30 -66.59 -37.21 84.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.37 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . 0.444 ' HA ' ' NE ' ' P' ' 128' ' ' ARG . 22.5 p -62.06 -37.61 85.64 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.778 0.323 . . . . 0.0 110.682 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.769 ' HG3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -83.07 -11.84 57.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.713 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -80.71 -37.07 31.3 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.628 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -78.65 92.63 4.76 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.821 0.82 . . . . 0.0 110.756 179.378 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 8.9 ptt-85 -146.68 146.35 30.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.362 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -115.53 93.91 4.48 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.9 t -78.03 112.84 16.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 1.4 mm? -63.71 100.14 0.27 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.282 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -97.38 122.53 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 111.806 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.053 179.568 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.441 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . 0.763 ' O ' ' O ' ' U' ' 4' ' ' DGL . . . . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.763 ' O ' ' O ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.709 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.431 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.709 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.839 0.352 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 13.5 t -174.69 133.7 0.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 5.8 p -98.62 35.02 1.9 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 7.2 t -74.75 -23.25 58.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -105.33 139.11 40.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.856 0.36 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -110.35 150.03 29.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -75.42 -42.21 54.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 65.52 -76.37 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.02 124.78 24.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.8 -72.74 0.37 Allowed Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.162 -0.542 . . . . 0.0 113.096 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 61.9 31.1 18.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.895 0.379 . . . . 0.0 110.823 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.3 -21.33 53.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.727 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.09 -28.96 42.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.807 0.337 . . . . 0.0 111.291 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.21 106.71 18.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.007 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -151.41 103.74 3.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.996 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.46 123.57 50.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.739 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.43 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 7.0 m-85 -90.96 107.02 18.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.112 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.9 10.66 33.48 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.396 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.24 -35.43 2.18 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.593 -1.289 . . . . 0.0 113.466 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.21 132.87 43.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.599 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 92.5 p -60.07 152.37 24.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.528 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' P' ' 25' ' ' LEU . 21.5 t -44.3 -40.07 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.903 0.382 . . . . 0.0 112.029 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.96 -14.83 25.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.316 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.54 -41.03 8.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.561 0.696 . . . . 0.0 109.895 178.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.522 HD21 ' HB1' ' P' ' 51' ' ' ALA . 14.7 mt -61.86 -19.8 63.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.185 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -98.66 -14.61 19.76 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.99 -17.9 2.11 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.57 -67.96 0.93 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -105.36 81.89 1.76 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.634 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -139.24 10.17 2.54 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.006 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.678 ' OG1' HG13 ' P' ' 131' ' ' VAL . 23.5 m -134.81 137.12 43.05 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.65 HG11 HG23 ' P' ' 41' ' ' ILE . 11.3 t -106.89 149.71 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.437 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . 0.548 ' CE2' ' NH2' ' P' ' 129' ' ' ARG . 3.3 m-85 -113.39 115.51 28.2 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.275 0.559 . . . . 0.0 111.778 -178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.462 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 82.4 m-85 -104.69 168.9 8.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.078 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.99 179.73 19.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.384 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.65 ' CZ ' ' HB1' ' U' ' 3' ' ' ALA . 3.6 t80 -61.4 137.48 58.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.765 0.317 . . . . 0.0 111.117 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . 0.415 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 0.5 OUTLIER 46.91 28.05 0.8 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.293 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.407 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 5.5 mttm -109.12 136.07 49.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.847 0.356 . . . . 0.0 110.742 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -130.86 49.82 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -150.75 150.44 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.958 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.65 HG23 HG11 ' P' ' 32' ' ' VAL . 2.2 mp -92.98 164.09 2.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.519 0.199 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.529 ' N ' HG22 ' P' ' 41' ' ' ILE . 28.0 p -109.5 144.22 38.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.98 0.419 . . . . 0.0 111.299 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.414 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -43.84 -29.58 1.43 Allowed Glycine 0 CA--C 1.523 0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.219 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.43 -31.96 73.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.618 0.247 . . . . 0.0 111.655 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.562 ' CB ' HG13 ' P' ' 32' ' ' VAL . 76.0 m-85 -104.39 3.31 32.18 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.414 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 98.5 t -70.31 -38.32 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.318 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.24 -40.25 11.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.298 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.05 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.4 mt -55.39 -55.87 14.69 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 120.945 0.402 . . . . 0.0 110.333 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.687 HD11 HG13 ' P' ' 90' ' ' VAL . 2.8 mm? -52.04 -31.89 31.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.697 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.72 -38.69 62.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.688 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . 0.522 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -75.36 -45.98 35.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.024 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.05 ' CD2' HG22 ' P' ' 48' ' ' ILE . 65.8 m-70 -64.41 -37.73 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.67 95.3 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.76 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.6 -41.22 98.34 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 121.032 0.444 . . . . 0.0 110.14 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . 0.43 ' HB2' ' CD2' ' P' ' 17' ' ' PHE . 24.2 t80 -75.82 -37.6 58.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.66 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.944 HD23 HG11 ' P' ' 99' ' ' VAL . 10.1 tp -60.68 -49.02 79.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.21 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -70.1 -40.31 75.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.51 -27.29 37.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.423 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -113.63 115.37 46.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 120.667 0.27 . . . . 0.0 110.423 179.656 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.83 -59.6 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.915 2.41 . . . . 0.0 113.902 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 20.52 2.82 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.663 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -88.46 114.6 25.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.017 0.437 . . . . 0.0 110.374 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.588 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.4 129.7 56.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.44 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.687 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.4 p -95.56 126.37 48.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-O 121.428 0.632 . . . . 0.0 110.921 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.588 HD21 HG22 ' P' ' 107' ' ' VAL . 0.8 OUTLIER -99.54 105.51 17.41 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.721 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.557 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.4 t -82.19 120.17 33.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.047 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.1 tt0 -106.52 116.05 31.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.361 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -86.97 142.97 18.69 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.735 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.726 ' O ' HG23 ' P' ' 70' ' ' THR . 0.6 OUTLIER -141.39 161.52 37.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.959 0.409 . . . . 0.0 110.751 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.726 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.3 p -170.16 -173.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.538 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.48 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 4.3 p30 -74.92 152.79 38.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.617 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.414 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pp20? -63.56 -32.63 74.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.935 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.404 ' HB3' ' OD1' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -39.75 109.41 0.11 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.96 178.62 19.17 Favored Glycine 0 C--N 1.331 0.252 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.14 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.97 146.51 31.43 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.511 0.196 . . . . 0.0 110.853 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.437 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 71.8 Cg_exo -41.23 -42.6 5.15 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.741 2.294 . . . . 0.0 113.197 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.34 -43.62 98.56 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.881 0.372 . . . . 0.0 110.568 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.558 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 0.3 OUTLIER -67.94 -43.56 78.83 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.6 OUTLIER -69.51 -76.05 0.1 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.687 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.635 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.46 -43.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.72 -56.49 9.09 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.573 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.766 HD12 ' C ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -48.9 -56.19 9.53 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.262 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.99 -39.34 97.45 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.526 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.445 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 3.8 mt-30 -48.41 -51.12 28.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.832 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 13.0 ptp180 -62.2 -32.67 73.35 Favored 'General case' 0 CA--C 1.523 -0.074 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 0.4 OUTLIER -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.03 -38.74 76.79 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.982 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.5 OUTLIER -63.35 -29.73 70.99 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.638 178.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -64.9 -43.22 93.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.154 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.687 HG13 HD11 ' P' ' 49' ' ' LEU . 39.2 t -75.47 -42.7 42.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.365 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' P' ' 88' ' ' ASP . 0.0 OUTLIER -63.1 -38.93 93.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.517 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -71.75 -31.29 65.09 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.32 -57.01 14.79 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' P' ' 64' ' ' VAL . 83.5 mt -57.63 -30.48 65.41 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.285 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -68.9 -39.71 79.55 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.945 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.66 -36.21 91.15 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.056 -0.592 . . . . 0.0 111.873 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -35.36 78.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.05 26.53 2.05 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.944 HG11 HD23 ' P' ' 56' ' ' LEU . 57.5 t -90.77 144.98 7.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.595 0.236 . . . . 0.0 110.54 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . 0.457 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -63.94 161.56 15.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.45 0.643 . . . . 0.0 111.504 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.571 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.97 -32.3 16.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.423 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.41 -23.93 36.25 Favored Glycine 0 CA--C 1.518 0.251 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.689 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.67 -3.25 33.48 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.29 0.567 . . . . 0.0 110.858 179.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.571 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.8 mt -89.24 148.88 23.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.846 178.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.557 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -148.68 140.84 8.53 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.637 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.806 ' O ' HG13 ' P' ' 107' ' ' VAL . 14.8 p -131.12 153.44 49.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.679 0.276 . . . . 0.0 110.832 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.806 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -174.26 117.56 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.635 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -105.65 137.8 42.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.368 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.513 ' O ' ' C ' ' P' ' 110' ' ' GLY . 91.9 m-85 -121.4 15.97 11.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.996 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.513 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -5.03 -106.3 0.0 OUTLIER Glycine 0 C--N 1.34 0.761 0 O-C-N 123.758 0.662 . . . . 0.0 114.523 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -89.61 0.7 56.76 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.589 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -54.73 -59.87 4.13 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.46 88.7 7.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -60.96 168.29 7.52 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.893 2.395 . . . . 0.0 113.163 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.51 -66.01 0.93 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.236 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.823 HG13 ' HB1' ' P' ' 123' ' ' ALA . 2.5 p -88.6 151.05 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.669 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -108.37 136.13 48.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.865 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.29 -178.9 20.56 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.52 ' CE1' ' HH ' ' P' ' 124' ' ' TYR . 3.2 t60 -140.23 43.53 1.9 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.443 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.1 p30 -130.07 156.13 45.02 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -44.71 -27.31 0.48 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.617 0.246 . . . . 0.0 111.591 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.24 -58.84 6.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.386 . . . . 0.0 110.651 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . 0.823 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -72.48 -39.6 67.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.549 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.52 ' HH ' ' CE1' ' P' ' 119' ' ' HIS . 5.9 m-85 -57.82 -49.77 75.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.956 0.408 . . . . 0.0 110.531 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . 0.645 ' O ' ' NH2' ' P' ' 129' ' ' ARG . 8.3 t -62.7 -33.02 74.24 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.029 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.605 ' O ' ' CZ ' ' P' ' 129' ' ' ARG . 0.1 OUTLIER -75.83 -14.41 60.29 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.325 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -94.18 -24.45 17.51 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.457 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.6 mtp180 -77.11 91.11 3.66 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.645 ' NH2' ' O ' ' P' ' 125' ' ' SER . 0.0 OUTLIER -160.88 154.85 22.65 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.05 103.96 9.73 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 175.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.678 HG13 ' OG1' ' P' ' 31' ' ' THR . 2.6 t -82.03 109.44 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.82 100.28 0.06 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.28 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -98.0 123.08 41.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.92 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.915 179.707 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.513 ' O2 ' H5'2 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.738 ' O10' ' HB2' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.42 0.629 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.548 ' C ' ' H ' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.631 ' HD2' HD23 ' P' ' 82' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.738 ' HB2' ' O10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.45 ' C ' ' HB2' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.796 0.331 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -143.64 85.49 1.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 31.4 p -177.48 -64.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.59 -23.01 22.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.124 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -106.31 149.96 26.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.844 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -111.64 150.73 29.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . 0.617 ' O ' ' HB3' ' P' ' 8' ' ' ALA . 1.2 p30 -62.83 -12.85 27.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.431 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' P' ' 7' ' ' ASP . . . 84.81 -178.66 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.217 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.88 -19.64 20.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.788 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.65 -69.39 1.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.678 -0.772 . . . . 0.0 113.258 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 64.14 129.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 110.531 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -47.77 -73.3 0.34 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.57 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' P' ' 14' ' ' ALA . . . -90.45 -73.26 0.53 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.859 0.361 . . . . 0.0 110.775 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' P' ' 13' ' ' ALA . . . 174.05 53.17 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.728 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 61.35 110.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.269 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 77.2 p -123.74 149.61 45.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.135 0.493 . . . . 0.0 111.995 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.454 ' N ' ' O ' ' P' ' 20' ' ' TYR . 40.4 m-85 -137.53 103.06 4.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.978 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.89 9.99 23.4 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.72 -1.229 . . . . 0.0 112.211 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.2 -33.89 2.71 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.651 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.821 ' HB2' HD21 ' P' ' 25' ' ' LEU . 18.0 m-85 -116.11 160.59 20.14 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.131 0.491 . . . . 0.0 112.286 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -97.56 142.0 29.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.327 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 t -40.86 -53.24 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.86 -16.54 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.393 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.29 -46.07 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 110.417 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.821 HD21 ' HB2' ' P' ' 20' ' ' TYR . 11.9 mt -56.12 -20.83 19.11 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.559 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.52 -12.23 15.67 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -118.72 -28.15 5.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 8.5 mtm180 -117.13 -52.51 2.51 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -109.39 97.07 6.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.865 ' HA ' HG21 ' P' ' 48' ' ' ILE . 0.3 OUTLIER -164.68 13.02 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 179.171 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 1.004 HG23 HG22 ' P' ' 131' ' ' VAL . 90.3 m -120.41 130.09 54.2 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.916 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.648 HG11 HG23 ' P' ' 41' ' ' ILE . 5.3 t -108.84 141.72 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.102 178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -116.28 117.7 30.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 20.4 m-30 -96.26 167.76 10.99 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.925 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' P' ' 128' ' ' ARG . . . -100.74 -170.11 28.81 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.76 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.515 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 1.8 t80 -56.43 115.74 2.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.877 0.37 . . . . 0.0 111.324 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 46.52 31.63 1.39 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.534 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.433 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 15.5 mmtm -91.58 141.66 28.47 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.891 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 17.3 t80 -126.55 57.71 1.42 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.701 0.762 . . . . 0.0 110.116 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -150.96 150.85 31.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.893 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.648 HG23 HG11 ' P' ' 32' ' ' VAL . 3.0 mt -100.81 160.33 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.467 ' O ' HG23 ' P' ' 46' ' ' VAL . 18.4 p -108.83 138.86 44.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 111.743 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.08 -28.64 1.35 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.926 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -66.35 -31.98 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.112 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.494 ' O ' HG13 ' P' ' 48' ' ' ILE . 65.9 m-85 -106.33 5.57 29.75 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' P' ' 42' ' ' THR . 80.4 t -76.26 -28.76 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.53 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.18 -36.46 70.82 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.67 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.074 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -58.95 -46.32 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.172 0.51 . . . . 0.0 109.899 179.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.434 HD23 ' N ' ' P' ' 49' ' ' LEU . 3.3 mt -59.75 -39.01 83.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.767 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.72 -44.69 40.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.345 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 -50.08 66.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.967 0.413 . . . . 0.0 110.529 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.074 ' CD2' HG22 ' P' ' 48' ' ' ILE . 60.0 m-70 -59.75 -35.8 75.32 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.959 178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.11 -36.85 80.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.686 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.47 -40.97 80.81 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.977 0.418 . . . . 0.0 110.435 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -78.03 -34.21 50.7 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.0 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.823 ' CD2' HG11 ' P' ' 99' ' ' VAL . 1.0 OUTLIER -67.0 -40.57 87.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.874 -179.234 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -72.99 -34.35 66.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.144 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.61 -22.63 67.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.569 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -110.8 115.29 53.55 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-O 120.592 0.235 . . . . 0.0 110.593 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.12 -62.1 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.878 2.385 . . . . 0.0 114.065 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.6 25.16 1.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -178.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.602 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -91.14 122.13 33.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.166 0.508 . . . . 0.0 110.98 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.2 mttp -128.29 132.68 48.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.533 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.9 p -95.38 146.41 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-O 121.392 0.615 . . . . 0.0 111.54 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' P' ' 133' ' ' ALA . 0.6 OUTLIER -110.22 103.68 12.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.69 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.631 HG11 ' HB ' ' P' ' 90' ' ' VAL . 0.2 OUTLIER -84.32 95.02 3.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.542 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 22.3 tt0 -89.36 119.72 30.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.773 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.48 145.9 18.65 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.658 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.674 ' O ' HG23 ' P' ' 70' ' ' THR . 28.2 m120 -142.49 161.44 38.05 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.674 HG23 ' O ' ' P' ' 69' ' ' ASN . 2.2 p -165.23 -169.98 1.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.177 0.513 . . . . 0.0 111.889 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.505 ' HB3' ' CE1' ' P' ' 124' ' ' TYR . 0.0 OUTLIER -58.17 158.48 6.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.926 179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -77.63 -30.95 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.324 0.583 . . . . 0.0 109.741 178.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.419 ' NE ' ' H82' ' U' ' 2' ' ' AMU . 0.0 OUTLIER -65.89 129.09 38.59 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.697 0.761 . . . . 0.0 112.653 -178.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.81 -179.96 18.1 Favored Glycine 0 C--N 1.334 0.44 0 CA-C-N 114.023 -1.444 . . . . 0.0 112.824 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.77 144.28 28.41 Favored Pre-proline 0 N--CA 1.464 0.26 0 CA-C-O 120.703 0.287 . . . . 0.0 111.72 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.605 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 94.8 Cg_exo -39.39 -49.68 3.07 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.144 2.563 . . . . 0.0 113.603 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -43.41 76.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.774 0.321 . . . . 0.0 111.417 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -71.79 -45.37 61.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.077 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' P' ' 80' ' ' ILE . 6.4 m120 -71.11 -76.59 0.1 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -31.94 -46.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -57.02 10.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.279 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.986 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -50.43 -46.59 56.58 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.037 178.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.986 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.9 -43.61 82.25 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.236 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -51.95 -37.38 52.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.039 0.447 . . . . 0.0 109.842 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -51.1 63.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.708 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.58 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 0.8 OUTLIER -58.39 -39.59 80.06 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -59.96 -32.83 71.18 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.289 -0.869 . . . . 0.0 108.757 177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.63 -31.67 71.85 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.145 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.45 -55.43 33.59 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.604 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.631 ' HB ' HG11 ' P' ' 66' ' ' VAL . 17.4 t -64.6 -35.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.878 0.371 . . . . 0.0 111.088 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.616 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.31 -39.75 91.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.651 179.841 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.91 -24.39 69.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.16 -58.3 7.68 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.515 ' CD1' HG11 ' P' ' 64' ' ' VAL . 95.3 mt -61.23 -32.46 72.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.686 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.67 -43.46 98.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.389 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.32 -21.21 77.27 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.864 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 -10.8 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.598 0.237 . . . . 0.0 111.344 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -5.88 17.98 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.436 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.823 HG11 ' CD2' ' P' ' 56' ' ' LEU . 19.5 t -78.45 127.77 38.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.946 0.373 . . . . 0.0 111.097 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.4 143.08 57.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.44 0.638 . . . . 0.0 111.494 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.81 -35.38 22.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.553 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.68 -21.1 54.27 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.11 -0.566 . . . . 0.0 113.725 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.1 OUTLIER -94.02 -9.66 36.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.16 0.48 . . . . 0.0 111.387 -179.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.616 HD13 ' O ' ' P' ' 91' ' ' LYS . 1.1 mt -106.76 140.13 40.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.674 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.402 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -149.09 143.44 10.89 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.55 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 15.9 p -115.7 159.87 20.81 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.676 0.274 . . . . 0.0 110.863 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.58 HG12 ' CE2' ' P' ' 109' ' ' TYR . 46.4 t -164.57 114.73 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.489 ' OG ' HG23 ' P' ' 80' ' ' ILE . 58.5 p -111.82 134.71 53.2 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.433 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.58 ' CE2' HG12 ' P' ' 107' ' ' VAL . 95.2 m-85 -124.21 19.01 9.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.644 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.524 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.58 -109.79 0.01 OUTLIER Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 114.445 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.534 ' OE1' ' HA ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -88.59 7.69 32.05 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -53.23 -60.35 3.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.817 0.342 . . . . 0.0 110.327 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -142.09 89.18 8.85 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.941 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -60.99 166.99 9.6 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.692 2.261 . . . . 0.0 112.543 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.26 -63.08 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.46 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.775 HG21 ' HD2' ' P' ' 126' ' ' LYS . 36.7 t -89.04 112.19 23.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.812 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tp -65.0 137.97 58.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.14 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.37 176.19 14.73 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.82 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.407 ' CB ' ' OH ' ' P' ' 124' ' ' TYR . 17.8 p-80 -140.79 60.51 1.52 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.886 0.343 . . . . 0.0 111.39 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.31 155.3 48.61 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -40.35 -30.79 0.11 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.55 -56.78 5.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.913 0.387 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.11 79.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.713 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' P' ' 71' ' ' ASP . 5.2 m-85 -62.64 -39.29 93.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.054 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 14.2 m -65.14 -33.51 76.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.945 0.402 . . . . 0.0 109.971 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.775 ' HD2' HG21 ' P' ' 116' ' ' VAL . 21.1 mtmt -73.98 -24.49 59.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.493 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -90.53 -30.87 17.0 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 76.2 mtm-85 -67.44 88.67 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.53 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.15 156.95 29.95 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -178.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -125.69 99.21 5.88 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 1.004 HG22 HG23 ' P' ' 31' ' ' THR . 31.1 t -95.95 115.75 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -176.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.846 ' O ' HD12 ' P' ' 132' ' ' LEU . 2.9 pp -85.72 123.59 31.28 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -131.68 151.8 51.35 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.963 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . 0.48 ' HE2' HD12 ' P' ' 56' ' ' LEU . 57.1 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.015 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.563 ' H9 ' ' HB2' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.482 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.563 ' HB2' ' H9 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.482 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.784 0.326 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -121.5 -47.2 2.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -76.4 63.45 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 34.2 p -90.05 -48.43 7.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -150.97 99.3 2.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.933 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.59 124.07 30.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.12 -38.83 13.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.051 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 62.92 -80.66 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.991 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.66 28.06 5.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.904 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.96 -42.7 60.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.625 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -178.95 -178.86 0.56 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.859 0.362 . . . . 0.0 110.853 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.71 -28.13 67.53 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.487 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -67.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.77 0.319 . . . . 0.0 111.093 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.21 56.3 5.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.152 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -137.49 161.02 37.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.992 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.08 150.87 44.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.861 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 67.2 m-85 -133.45 109.54 9.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.508 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.71 9.69 20.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.265 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.72 -36.06 2.23 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.866 -1.159 . . . . 0.0 113.593 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.403 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 5.7 m-85 -121.34 162.4 20.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.006 0.431 . . . . 0.0 111.459 -179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 11.0 p -101.49 156.76 17.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.822 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.696 HG13 ' OH ' ' P' ' 134' ' ' TYR . 38.0 t -45.89 -41.55 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' P' ' 27' ' ' GLN . . . -66.2 -18.49 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' NE2' ' P' ' 27' ' ' GLN . 0.3 OUTLIER -99.26 -43.88 6.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.338 0.59 . . . . 0.0 110.008 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.542 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 1.9 mt -63.59 -19.2 64.64 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.557 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . 0.41 ' HG3' ' HG3' ' P' ' 27' ' ' GLN . 0.0 OUTLIER -88.88 -25.04 22.35 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' P' ' 23' ' ' ALA . 2.9 pp0? -132.98 -8.66 3.06 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . 0.403 ' HD3' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -109.94 -66.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.403 ' CE2' ' HD3' ' P' ' 28' ' ' ARG . 67.3 m-85 -107.43 88.8 2.82 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.39 0.614 . . . . 0.0 111.513 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.2 OUTLIER -152.47 16.35 0.61 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.997 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 91.1 m -121.89 129.82 52.87 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.716 HG11 HG23 ' P' ' 41' ' ' ILE . 4.6 t -107.68 150.49 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.917 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -123.05 112.11 17.38 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.411 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 23.3 m-85 -93.22 170.74 9.4 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.714 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.45 179.81 30.78 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.531 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.924 ' CD1' ' HB2' ' U' ' 7' ' ' DAL . 0.6 OUTLIER -63.53 119.94 10.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.936 0.398 . . . . 0.0 110.715 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t0 61.44 37.46 16.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.045 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.408 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -121.31 137.92 54.48 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 29.9 p90 -127.4 56.79 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 110.719 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -150.2 150.92 32.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.947 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.716 HG23 HG11 ' P' ' 32' ' ' VAL . 1.4 mp -94.21 163.23 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.743 0.306 . . . . 0.0 110.982 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.481 ' N ' HG22 ' P' ' 41' ' ' ILE . 43.2 p -113.41 149.27 34.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.312 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -44.77 -32.4 3.03 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.31 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -64.17 -33.36 75.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.689 0.281 . . . . 0.0 111.614 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.541 ' CB ' HG13 ' P' ' 32' ' ' VAL . 78.4 m-85 -100.61 -3.71 29.93 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.408 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 70.2 t -61.79 -42.97 96.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.609 0.242 . . . . 0.0 111.351 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.413 ' NE2' HG12 ' P' ' 48' ' ' ILE . 0.9 OUTLIER -43.83 -43.5 6.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.063 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.34 -46.8 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.874 0.368 . . . . 0.0 110.419 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 7.6 mt -58.27 -42.24 86.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.9 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.72 -42.7 77.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.186 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.34 -41.87 65.99 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.954 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.063 ' CD2' HG22 ' P' ' 48' ' ' ILE . 14.6 m-70 -62.5 -38.56 90.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 110.473 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' P' ' 97' ' ' LYS . . . -68.58 -41.68 79.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.927 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -43.84 98.14 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.733 0.302 . . . . 0.0 111.147 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . 0.605 ' HE2' ' HD1' ' P' ' 52' ' ' HIS . 0.2 OUTLIER -71.84 -36.5 70.21 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.776 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.71 HD21 ' HG3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -75.14 -34.21 61.61 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.617 -178.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -72.55 -30.16 64.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.011 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.32 -17.85 61.26 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.376 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -112.58 111.79 51.69 Favored Pre-proline 0 CA--C 1.53 0.188 0 CA-C-O 120.702 0.287 . . . . 0.0 110.301 179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.93 -63.27 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.949 2.433 . . . . 0.0 114.421 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 22.59 2.14 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.646 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.5 112.96 24.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.349 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -117.01 132.87 56.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.095 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.546 ' HB ' HD13 ' P' ' 56' ' ' LEU . 14.4 p -98.64 146.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 121.547 0.689 . . . . 0.0 111.474 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.461 HD22 HG21 ' P' ' 107' ' ' VAL . 0.3 OUTLIER -107.3 103.65 13.07 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.462 179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.458 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.5 t -83.59 100.2 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.387 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' P' ' 107' ' ' VAL . 5.5 tt0 -90.96 121.54 32.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.306 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.13 146.42 20.34 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.265 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.445 ' O ' HG23 ' P' ' 70' ' ' THR . 0.8 OUTLIER -145.33 161.08 40.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.632 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.447 HG23 ' NH1' ' P' ' 86' ' ' ARG . 0.5 OUTLIER -162.38 -172.99 3.39 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.232 0.539 . . . . 0.0 111.638 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 6.0 p-10 -81.75 166.32 20.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.374 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' P' ' 111' ' ' GLU . 2.3 tm-20 -64.15 -39.0 93.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.932 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.434 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 4.1 mmm180 -39.37 106.2 0.05 Allowed 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -173.91 15.49 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.056 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.21 146.79 32.57 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.527 0.203 . . . . 0.0 110.646 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.432 ' O ' HD12 ' P' ' 80' ' ' ILE . 88.1 Cg_exo -45.46 -40.89 18.01 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.479 2.119 . . . . 0.0 112.644 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -66.37 -41.27 89.68 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.498 ' CZ ' ' C ' ' U' ' 4' ' ' DGL . 3.1 t80 -69.42 -44.2 71.83 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' P' ' 80' ' ' ILE . 27.8 m120 -61.84 -75.12 0.07 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.618 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.6 OUTLIER -30.01 -45.75 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 O-C-N 123.185 0.303 . . . . 0.0 111.737 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.13 -60.65 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.607 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -44.21 -45.98 8.7 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.767 178.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.409 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.9 -38.24 92.76 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.697 -0.764 . . . . 0.0 111.82 178.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -44.01 63.8 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.865 0.364 . . . . 0.0 110.226 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -39.72 90.33 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.528 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 3.0 mtt180 -61.65 -39.85 92.84 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.52 81.92 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.143 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.04 -32.01 73.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.495 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.53 -63.53 1.24 Allowed 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.514 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.23 -37.09 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.872 0.368 . . . . 0.0 111.403 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -61.73 2.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.813 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -61.8 -20.3 59.54 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.363 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -63.69 -58.78 5.83 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.519 HD12 HD22 ' P' ' 104' ' ' LEU . 24.2 mt -59.41 -30.04 68.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.373 178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.63 94.82 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.243 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.12 -26.71 73.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.892 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.438 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 1.2 mtpm? -78.23 -9.92 59.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.68 0.276 . . . . 0.0 111.26 179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.12 -3.2 23.98 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.181 -1.009 . . . . 0.0 113.152 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.839 HG11 HD21 ' P' ' 104' ' ' LEU . 16.8 t -74.68 126.14 35.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.766 0.283 . . . . 0.0 110.837 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . 0.45 ' CB ' ' HD2' ' P' ' 103' ' ' LYS . 0.3 OUTLIER -62.37 139.23 58.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.0 111.566 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.862 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -62.99 -32.84 74.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.294 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.46 -19.99 58.39 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.189 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.71 ' HG3' HD21 ' P' ' 56' ' ' LEU . 0.0 OUTLIER -101.99 -4.32 26.28 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.198 0.523 . . . . 0.0 111.035 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.862 HD12 ' HA ' ' P' ' 101' ' ' ALA . 0.5 OUTLIER -110.8 120.48 42.55 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.458 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -124.94 -175.17 14.17 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.852 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.781 ' O ' HG13 ' P' ' 107' ' ' VAL . 15.8 p -149.21 163.12 38.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.885 0.374 . . . . 0.0 111.279 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.781 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -177.0 111.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.47 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.618 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 1.1 p -111.9 145.54 39.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.954 0.407 . . . . 0.0 111.812 -178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.475 ' O ' ' C ' ' P' ' 110' ' ' GLY . 83.7 m-85 -121.16 23.83 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.619 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 11.56 -115.75 0.01 OUTLIER Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.541 -0.754 . . . . 0.0 114.859 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.5 ' HB2' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -95.36 17.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.691 0.281 . . . . 0.0 111.175 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -59.1 -54.42 47.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.853 0.359 . . . . 0.0 110.113 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -141.33 89.74 9.35 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.364 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.53 165.73 10.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.712 2.275 . . . . 0.0 112.534 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.03 -59.72 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.814 HG21 ' HB3' ' P' ' 126' ' ' LYS . 11.4 t -88.21 109.18 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 28.5 mt -75.98 134.07 40.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.777 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 150.04 -179.15 27.03 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.616 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -142.51 73.89 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -168.53 161.89 11.84 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . 0.419 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 0.0 OUTLIER -46.35 -24.97 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -179.246 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.83 -59.06 3.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.2 -40.29 67.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 25.4 m-85 -60.48 -43.26 97.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 95.4 p -68.21 -33.34 74.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.873 0.368 . . . . 0.0 110.524 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.814 ' HB3' HG21 ' P' ' 116' ' ' VAL . 23.7 mtmt -71.89 -22.85 61.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.218 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -87.41 -29.21 21.64 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.357 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.411 ' HB3' ' O ' ' P' ' 34' ' ' PHE . 3.8 mtp180 -66.35 90.2 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.246 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.8 OUTLIER -158.81 158.6 33.83 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.67 107.84 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 1.2 t -82.85 147.75 5.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.54 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -100.53 100.02 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.586 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' P' ' 65' ' ' LEU . . . -104.55 143.87 32.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . 0.696 ' OH ' HG13 ' P' ' 22' ' ' VAL . 8.1 m-85 . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.891 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.621 ' O10' ' CB ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . 0.621 ' CB ' ' O10' ' U' ' 2' ' ' AMU . . . . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.534 ' HB3' ' O ' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.464 ' CZ ' ' CE1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.924 ' HB2' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.829 0.347 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.16 154.74 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 10.1 m -84.58 114.25 21.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 20.3 m -90.08 -54.1 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.032 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -150.23 150.21 31.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -89.88 137.55 32.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.29 -23.14 21.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.201 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.63 -81.33 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.99 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.83 163.12 3.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.827 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.46 -57.98 1.49 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.418 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 43.95 56.06 4.91 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.901 0.381 . . . . 0.0 111.335 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.24 -66.71 1.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.604 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.15 -54.67 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 0.0 111.374 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.94 151.4 6.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.05 109.85 21.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 76.8 p -132.04 118.82 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.742 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -89.74 106.48 18.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.75 9.4 26.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.552 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.26 -38.35 1.74 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.795 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.42 ' HB2' ' CD2' ' P' ' 25' ' ' LEU . 17.7 m-85 -121.67 170.93 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.096 0.475 . . . . 0.0 111.822 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.36 150.69 23.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.887 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 14.0 t -38.26 -63.62 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.53 -13.99 1.83 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -46.35 5.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 177.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.57 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 12.5 mt -56.88 -22.24 35.63 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.506 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.64 -11.96 16.65 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -115.77 -27.32 7.08 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.36 -55.91 2.47 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -108.21 81.83 1.54 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.174 0.512 . . . . 0.0 111.914 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' P' ' 132' ' ' LEU . 0.2 OUTLIER -140.39 13.71 2.37 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.918 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.665 ' OG1' HG13 ' P' ' 131' ' ' VAL . 53.8 m -134.56 136.63 43.15 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.722 HG11 HG23 ' P' ' 41' ' ' ILE . 10.5 t -108.6 150.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.077 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -123.75 114.54 20.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.432 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 22.3 m-30 -93.4 170.59 9.49 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.777 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.31 -172.25 31.01 Favored Glycine 0 C--N 1.334 0.453 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.725 ' CD1' ' HB2' ' U' ' 7' ' ' DAL . 1.0 OUTLIER -60.98 126.34 27.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.27 0.535 . . . . 0.0 110.673 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 46.64 33.77 2.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -96.08 141.51 29.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.027 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.689 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 3.3 t80 -129.85 48.81 2.34 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.714 0.769 . . . . 0.0 109.767 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -150.29 151.01 32.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.955 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.722 HG23 HG11 ' P' ' 32' ' ' VAL . 2.5 mt -96.08 161.81 2.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.559 0.219 . . . . 0.0 110.661 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.465 ' N ' HG22 ' P' ' 41' ' ' ILE . 16.2 p -110.83 144.8 39.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.032 0.444 . . . . 0.0 111.755 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.428 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.58 -30.17 3.13 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.747 -0.661 . . . . 0.0 113.413 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . 0.438 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 0.6 OUTLIER -63.27 -31.34 72.46 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.689 0.281 . . . . 0.0 111.721 -179.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.585 ' CB ' HG13 ' P' ' 32' ' ' VAL . 87.8 m-85 -105.7 4.71 30.35 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.428 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 72.0 t -70.9 -37.17 67.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.438 ' NE2' ' O ' ' P' ' 44' ' ' GLU . 0.0 OUTLIER -52.42 -31.99 37.02 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.557 -178.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 0.986 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -62.86 -49.98 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.191 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.554 HD23 ' CD2' ' P' ' 93' ' ' TYR . 1.6 mp -53.57 -37.45 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.011 0.434 . . . . 0.0 109.999 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.62 -39.24 58.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.708 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.48 -57.32 4.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.01 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 0.986 ' CD2' HG22 ' P' ' 48' ' ' ILE . 20.0 m-70 -54.31 -37.85 65.29 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.029 0.442 . . . . 0.0 109.944 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' P' ' 49' ' ' LEU . . . -60.15 -43.49 95.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.729 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.98 96.81 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.865 0.364 . . . . 0.0 110.551 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -73.86 -38.33 64.49 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.825 ' CD2' HG11 ' P' ' 99' ' ' VAL . 4.5 tp -65.48 -43.12 91.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.352 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -69.06 -37.67 78.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.445 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.85 -24.04 55.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.644 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -115.37 114.88 42.69 Favored Pre-proline 0 C--N 1.331 -0.211 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.52 -48.6 19.58 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.76 2.307 . . . . 0.0 113.894 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.7 18.48 7.51 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.612 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.64 116.57 28.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.995 0.426 . . . . 0.0 110.711 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -118.19 133.96 55.43 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.953 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.656 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.3 p -95.57 141.56 15.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 121.345 0.593 . . . . 0.0 111.259 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.841 HD21 ' CG2' ' P' ' 107' ' ' VAL . 5.1 tt -108.96 101.03 10.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.725 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.468 HG13 HD22 ' P' ' 132' ' ' LEU . 0.7 OUTLIER -79.27 112.24 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.329 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.517 ' HG3' HD22 ' P' ' 65' ' ' LEU . 8.2 mt-10 -99.72 117.56 34.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.653 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.77 143.1 22.15 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.997 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.691 ' O ' HG23 ' P' ' 70' ' ' THR . 0.9 OUTLIER -145.5 157.92 43.92 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.814 0.34 . . . . 0.0 110.32 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.691 HG23 ' O ' ' P' ' 69' ' ' ASN . 1.5 p -168.03 -176.65 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.059 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.41 ' CB ' ' CD1' ' P' ' 124' ' ' TYR . 6.1 p-10 -72.42 155.58 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.49 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 1.6 pm0 -62.4 -34.23 76.32 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.018 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -39.68 106.92 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.69 168.25 17.42 Favored Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.569 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' P' ' 79' ' ' ASN . 0.5 OUTLIER -83.03 146.16 51.11 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.653 0.263 . . . . 0.0 110.568 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.11 -36.36 84.89 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.957 2.438 . . . . 0.0 114.182 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . 0.416 ' O ' HG22 ' P' ' 80' ' ' ILE . 1.0 OUTLIER -64.12 -48.96 74.05 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.79 -178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.52 ' C ' ' CD1' ' P' ' 78' ' ' TYR . 0.0 OUTLIER -75.07 -30.25 60.92 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -65.38 -74.54 0.1 Allowed 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.627 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.3 OUTLIER -32.27 -38.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.192 0 O-C-N 123.23 0.332 . . . . 0.0 111.231 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -61.41 -59.37 5.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.499 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -47.22 -50.85 20.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.922 178.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.478 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -66.72 -45.24 86.06 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.598 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 4.2 tp60 -49.25 -38.69 27.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.916 0.388 . . . . 0.0 110.281 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -67.65 -46.65 71.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.715 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.579 ' NH1' HG21 ' P' ' 70' ' ' THR . 0.4 OUTLIER -58.27 -40.65 82.43 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.595 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.12 -31.98 70.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.124 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.4 -32.13 70.93 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.429 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.53 -60.16 4.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.8 -35.62 73.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.293 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -42.83 97.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.502 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.77 -22.63 78.93 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.501 -0.639 . . . . 0.0 111.501 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . 0.554 ' CD2' HD23 ' P' ' 49' ' ' LEU . 5.2 t80 -63.88 -62.09 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.6 ' CD1' HG11 ' P' ' 64' ' ' VAL . 75.3 mt -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.501 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.06 -41.62 92.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.753 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.37 -24.44 76.07 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -73.17 -10.06 59.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.862 0.363 . . . . 0.0 110.848 179.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.92 1.79 36.41 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.934 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.825 HG11 ' CD2' ' P' ' 56' ' ' LEU . 22.2 t -75.8 128.8 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.73 0.3 . . . . 0.0 111.29 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -60.24 138.64 57.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.093 0.473 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -53.28 -36.03 60.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.04 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.06 -15.53 60.71 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.043 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.686 ' HE3' HG13 ' P' ' 99' ' ' VAL . 7.0 mtpp -92.88 -11.44 33.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.09 0.471 . . . . 0.0 110.884 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' P' ' 101' ' ' ALA . 1.8 mt -103.68 142.81 33.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.757 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.451 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -147.69 145.64 14.47 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.771 ' O ' HG13 ' P' ' 107' ' ' VAL . 15.2 p -123.27 162.57 22.37 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.956 0.407 . . . . 0.0 111.313 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.841 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER 179.05 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.599 179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.627 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -98.69 142.55 30.1 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.902 -178.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.563 ' O ' ' HG3' ' P' ' 112' ' ' GLU . 34.7 m-85 -113.31 13.81 19.15 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.699 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.482 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 2.89 -109.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.271 -0.877 . . . . 0.0 115.045 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -107.96 15.31 24.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' P' ' 109' ' ' TYR . 0.2 OUTLIER -63.25 -45.02 93.49 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.633 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . 0.411 ' N ' ' OE2' ' P' ' 112' ' ' GLU . 20.9 mtmm -146.51 88.93 5.97 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.71 164.74 12.97 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.758 2.305 . . . . 0.0 113.143 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.37 -61.92 1.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.507 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.776 HG21 ' HB3' ' P' ' 126' ' ' LYS . 15.3 t -88.41 109.79 20.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.078 0.466 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 52.8 mt -71.27 136.12 47.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.109 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.56 173.17 13.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.7 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -140.88 92.89 2.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.068 0.434 . . . . 0.0 111.994 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -166.64 162.37 16.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . 0.416 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.2 OUTLIER -47.08 -25.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.794 -0.362 . . . . 0.0 111.578 -179.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.08 -60.02 2.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.96 0.409 . . . . 0.0 110.725 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.06 -42.64 69.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.41 ' CD1' ' CB ' ' P' ' 71' ' ' ASP . 12.9 m-85 -54.55 -50.52 67.73 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.072 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 1.9 t -65.99 -33.81 76.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.735 0.302 . . . . 0.0 110.589 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.776 ' HB3' HG21 ' P' ' 116' ' ' VAL . 3.6 mtmt -68.04 -29.49 68.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.915 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -87.46 -29.75 21.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.089 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 5.4 mtp180 -65.49 88.33 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.191 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -158.3 157.46 32.5 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -178.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.71 95.26 4.28 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.665 HG13 ' OG1' ' P' ' 31' ' ' THR . 13.6 t -82.44 112.62 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.468 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -63.8 105.35 0.81 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.565 178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -100.55 128.41 46.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.482 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.831 179.732 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.457 ' O2 ' H5'2 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.422 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.855 0.359 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.422 ' N ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.49 ' HA ' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.725 ' HB2' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.842 0.353 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 89.9 p -161.32 -173.0 3.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m 70.35 -63.47 0.4 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.099 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 8.5 t -47.53 -59.93 2.89 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.283 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -139.58 123.29 17.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.916 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -147.75 134.97 20.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -90.91 -70.41 0.68 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.858 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -179.08 168.0 1.57 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.128 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.53 24.83 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.123 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.32 -29.43 49.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.563 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . 0.417 ' CG ' ' HB3' ' P' ' 14' ' ' ALA . 2.5 t30 -178.08 49.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.82 -56.53 3.29 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.414 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.75 -13.12 37.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 111.404 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.417 ' HB3' ' CG ' ' P' ' 11' ' ' ASN . . . -62.44 82.04 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.854 0.359 . . . . 0.0 111.318 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 53.33 48.56 21.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.289 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.13 147.61 52.11 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.444 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 54.9 m-85 -136.04 108.42 7.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 111.282 -179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.29 9.95 32.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.469 -0.872 . . . . 0.0 113.424 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 -31.66 3.62 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.563 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.628 ' HB2' HD21 ' P' ' 25' ' ' LEU . 33.5 m-85 -117.29 161.8 18.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.104 0.478 . . . . 0.0 111.771 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 16.7 t -111.15 160.57 16.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.755 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.436 HG23 ' H ' ' P' ' 22' ' ' VAL . 17.2 t -40.06 -56.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -54.37 -19.94 6.45 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.76 -43.61 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.298 0.57 . . . . 0.0 110.283 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.628 HD21 ' HB2' ' P' ' 20' ' ' TYR . 47.1 mt -67.94 -22.0 65.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.994 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.44 -20.88 26.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -143.42 -3.57 0.92 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . 0.41 ' HD2' ' CE2' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -107.26 -69.87 0.82 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.41 ' CE2' ' HD2' ' P' ' 28' ' ' ARG . 58.3 m-85 -108.86 89.56 3.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 112.101 -178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 41.2 p-10 -150.14 18.75 0.86 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 86.9 m -126.3 132.01 51.74 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 120.781 -0.367 . . . . 0.0 111.833 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 1.065 HG11 HG23 ' P' ' 41' ' ' ILE . 23.6 t -108.36 149.74 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.922 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -113.41 113.44 25.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.623 0.725 . . . . 0.0 112.301 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.802 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 7.1 m-30 -90.29 174.49 7.56 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.695 -1.139 . . . . 0.0 112.567 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -125.89 -177.85 15.06 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.514 ' CZ ' ' HA ' ' U' ' 7' ' ' DAL . 12.9 t80 -62.34 136.45 57.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.427 0.613 . . . . 0.0 110.82 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.0 28.21 0.6 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.269 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.447 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -105.5 127.75 53.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.704 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.45 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 23.3 p90 -128.11 43.56 3.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.103 0.478 . . . . 0.0 110.2 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -148.06 150.51 34.04 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.345 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 1.065 HG23 HG11 ' P' ' 32' ' ' VAL . 1.0 OUTLIER -89.06 166.32 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.639 0.257 . . . . 0.0 110.78 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.467 ' H ' HG22 ' P' ' 41' ' ' ILE . 47.1 p -111.09 150.1 29.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.125 0.488 . . . . 0.0 111.568 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.425 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.56 -31.2 3.54 Favored Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.532 -0.758 . . . . 0.0 113.337 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . 0.425 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 2.2 mm-40 -63.03 -32.44 73.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.404 ' O ' HG13 ' P' ' 48' ' ' ILE . 92.1 m-85 -104.05 5.11 35.08 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.43 HG13 ' OH ' ' P' ' 93' ' ' TYR . 76.3 t -70.68 -39.92 76.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' P' ' 44' ' ' GLU . 0.0 OUTLIER -49.81 -33.74 17.51 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.681 -178.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.058 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.2 mt -59.17 -52.56 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.018 0.437 . . . . 0.0 110.065 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.753 HD11 HG13 ' P' ' 90' ' ' VAL . 3.1 mm? -55.57 -33.32 63.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.681 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.23 -43.04 68.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.742 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.9 -37.06 62.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.058 ' CD2' HG22 ' P' ' 48' ' ' ILE . 28.4 m-70 -69.04 -38.73 79.3 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.84 94.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.347 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.36 90.31 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.021 0.439 . . . . 0.0 110.311 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . 0.444 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 7.8 t80 -72.56 -40.4 66.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.444 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.768 ' CD2' HG11 ' P' ' 99' ' ' VAL . 1.8 tp -61.64 -44.24 97.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.165 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -65.95 -41.8 90.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.365 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.68 -28.94 3.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.75 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -113.77 118.05 43.48 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.566 0.222 . . . . 0.0 110.483 179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.56 -56.5 2.8 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.715 2.277 . . . . 0.0 113.727 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 23.42 1.59 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.475 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -91.5 131.82 36.69 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.991 0.424 . . . . 0.0 110.547 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.49 ' HB3' ' HA ' ' P' ' 103' ' ' LYS . 0.1 OUTLIER -137.35 137.72 39.18 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.997 179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.599 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.9 p -98.16 141.29 16.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 121.519 0.675 . . . . 0.0 111.533 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.878 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.9 tt -108.97 103.62 12.7 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.426 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.565 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.8 OUTLIER -81.32 113.62 20.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.024 0.44 . . . . 0.0 110.94 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.02 118.72 37.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.377 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -104.06 139.54 14.58 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.582 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 127' ' ' ASN . 57.0 m-80 -145.76 104.62 3.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.853 0.358 . . . . 0.0 110.773 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.915 HG22 ' NH1' ' P' ' 86' ' ' ARG . 39.2 p -86.21 -176.54 5.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.44 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 10.4 p-10 -71.09 165.47 23.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.442 ' O ' ' CD ' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -66.68 -35.68 80.73 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.122 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.94 114.08 0.66 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.66 -142.12 17.3 Favored Glycine 0 C--N 1.334 0.469 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.807 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.29 146.11 52.65 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.512 0.196 . . . . 0.0 110.614 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.483 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 87.8 Cg_exo -44.68 -43.95 14.27 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.589 2.192 . . . . 0.0 113.715 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.72 -46.36 88.48 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.53 ' CE1' ' HB3' ' U' ' 3' ' ' ALA . 22.7 t80 -72.83 -36.56 67.52 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 120.949 0.404 . . . . 0.0 110.006 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.482 ' O ' ' C ' ' P' ' 80' ' ' ILE . 5.4 m120 -67.99 -74.33 0.12 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.621 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.5 OUTLIER -29.98 -44.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.775 0.321 . . . . 0.0 110.911 179.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.3 -57.89 11.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.034 -0.667 . . . . 0.0 110.224 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.2 OUTLIER -46.53 -44.36 17.76 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.245 177.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.464 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -65.73 -38.13 94.17 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.564 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -49.34 -43.49 43.82 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.2 ptm180 -67.98 -33.72 75.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.466 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.915 ' NH1' HG22 ' P' ' 70' ' ' THR . 56.0 mtt180 -65.11 -49.23 70.75 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.543 0.687 . . . . 0.0 109.277 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.584 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -60.14 -34.81 74.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.704 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -33.45 74.44 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -63.89 -67.51 0.42 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.691 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.753 HG13 HD11 ' P' ' 49' ' ' LEU . 59.0 t -53.16 -43.35 49.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.112 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -40.98 85.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.546 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.77 -15.58 80.71 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.914 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . 0.43 ' OH ' HG13 ' P' ' 46' ' ' VAL . 2.6 t80 -72.75 -64.27 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.58 ' CD1' HG11 ' P' ' 64' ' ' VAL . 28.7 mt -55.78 -32.62 63.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.396 178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.75 89.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.828 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.13 -22.75 77.41 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.605 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.447 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -76.04 -10.03 59.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.806 0.336 . . . . 0.0 110.975 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 107.01 -0.3 35.73 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.148 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' P' ' 56' ' ' LEU . 18.2 t -75.63 125.81 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.852 0.326 . . . . 0.0 110.836 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' P' ' 103' ' ' LYS . 2.5 p30 -62.34 139.54 58.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.335 0.588 . . . . 0.0 111.565 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.48 -36.35 10.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.449 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.99 -17.1 60.55 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.94 -0.647 . . . . 0.0 113.078 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.49 ' HA ' ' HB3' ' P' ' 63' ' ' LYS . 24.3 mtpp -91.49 -14.51 30.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 111.036 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' P' ' 94' ' ' LEU . 1.3 mt -102.62 143.07 32.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.65 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.565 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -139.92 146.14 17.48 Favored Glycine 0 N--CA 1.441 -0.985 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.776 ' O ' HG13 ' P' ' 107' ' ' VAL . 19.4 p -128.78 152.04 48.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.783 0.325 . . . . 0.0 110.652 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -175.39 119.0 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.621 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.1 OUTLIER -118.53 133.63 55.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.91 -179.555 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.522 ' O ' ' C ' ' P' ' 110' ' ' GLY . 23.7 m-85 -102.01 32.48 3.44 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.522 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -103.27 0.01 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-N 115.361 -0.836 . . . . 0.0 114.539 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.442 ' CD ' ' O ' ' P' ' 72' ' ' GLU . 41.7 mt-10 -113.89 16.87 18.28 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -47.21 66.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.092 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.66 89.34 11.78 Favored Pre-proline 0 C--N 1.332 -0.161 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.6 163.39 15.63 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.683 2.255 . . . . 0.0 112.935 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.73 -64.91 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.674 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' P' ' 126' ' ' LYS . 2.4 t -88.85 108.74 19.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' P' ' 117' ' ' LEU . 3.6 mm? -66.89 135.83 54.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.275 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.46 173.94 14.11 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.085 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -140.74 60.95 1.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.664 0.269 . . . . 0.0 111.383 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.05 152.14 51.42 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . 0.411 ' OE1' ' CA ' ' P' ' 121' ' ' GLU . 0.1 OUTLIER -37.78 -33.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.28 -61.58 1.94 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 0.0 110.634 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.84 -42.63 94.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.992 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.466 ' O ' ' HD3' ' P' ' 128' ' ' ARG . 4.7 m-85 -56.65 -54.0 51.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.196 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . 0.552 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 4.8 m -55.68 -35.59 66.2 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.948 0.404 . . . . 0.0 110.848 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.664 ' HB3' HG21 ' P' ' 116' ' ' VAL . 33.9 mtmt -75.44 -21.22 58.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.56 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' P' ' 69' ' ' ASN . 44.9 m-20 -80.95 -42.76 20.77 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.802 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.39 73.58 0.72 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.199 -0.6 . . . . 0.0 110.949 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.6 143.42 49.68 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.11 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -114.61 98.06 6.65 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.66 111.51 20.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.75 101.67 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.589 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -97.6 125.65 42.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.46 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.945 179.705 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.447 ' PB ' ' O7 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.515 H111 ' H3 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . 0.53 ' HB3' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.657 ' CG ' ' H2 ' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.657 ' H2 ' ' CG ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.514 ' HA ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.73 0.3 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 28.3 t 63.07 -79.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.039 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 92.1 p -156.29 168.9 25.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.934 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 50.6 m -72.61 -51.24 20.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -122.25 104.29 9.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.25 109.2 16.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -84.67 -15.47 45.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 63.83 22.92 13.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.787 0.327 . . . . 0.0 111.188 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . 0.785 ' CB ' ' HB2' ' P' ' 23' ' ' ALA . . . 53.16 32.51 13.36 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.308 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . 0.639 ' HA2' ' HB2' ' P' ' 14' ' ' ALA . . . -91.55 -71.34 1.2 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.329 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 16.1 m120 64.85 -107.36 0.15 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.184 0.194 . . . . 0.0 111.4 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.12 -73.64 1.27 Allowed Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.665 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' P' ' 14' ' ' ALA . . . -90.45 -55.24 3.67 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.639 ' HB2' ' HA2' ' P' ' 10' ' ' GLY . . . 76.48 124.14 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.431 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -143.46 -178.4 5.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.087 0.47 . . . . 0.0 111.763 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 33.2 p -125.88 151.43 46.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.237 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.448 ' CD2' ' HA ' ' P' ' 55' ' ' TYR . 45.5 m-85 -129.98 112.08 13.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.86 0.362 . . . . 0.0 111.678 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 69.35 9.62 61.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.584 -0.817 . . . . 0.0 114.08 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 -27.4 3.86 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 119.137 -1.506 . . . . 0.0 114.529 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.15 173.89 8.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.285 0.542 . . . . 0.0 111.726 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.89 151.52 21.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.706 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.704 ' HA ' HD12 ' P' ' 25' ' ' LEU . 13.1 t -44.5 -35.55 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.898 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . 0.785 ' HB2' ' CB ' ' P' ' 9' ' ' ALA . . . -63.59 -13.04 38.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.612 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' P' ' 29' ' ' TYR . 0.4 OUTLIER -98.16 -44.37 6.63 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.849 0.833 . . . . 0.0 108.891 177.385 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' P' ' 22' ' ' VAL . 7.5 mt -58.89 -23.36 60.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.348 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -111.87 -19.19 12.48 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.2 -32.23 2.99 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -141.57 59.92 1.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 0.5 OUTLIER 157.5 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.974 0.416 . . . . 0.0 110.691 178.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 172.95 15.97 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 57.3 m -120.4 126.82 51.41 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.628 0.649 . . . . 0.0 112.203 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.745 HG11 HG23 ' P' ' 41' ' ' ILE . 3.4 t -108.18 145.35 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.875 178.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -119.49 115.19 23.54 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.4 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.7 m-85 -96.04 168.28 10.71 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.766 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.53 -171.87 28.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.976 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.454 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 12.0 t80 -61.8 116.52 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.846 0.355 . . . . 0.0 110.656 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 58.33 39.2 25.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.061 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.41 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 1.7 tptp -112.97 136.15 52.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.416 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 27.5 p90 -130.33 54.56 1.86 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.079 0.466 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -148.58 150.59 33.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.644 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.745 HG23 HG11 ' P' ' 32' ' ' VAL . 1.6 mp -96.76 161.55 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.703 0.287 . . . . 0.0 110.781 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.468 ' N ' HG22 ' P' ' 41' ' ' ILE . 30.7 p -112.71 147.72 36.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.017 0.437 . . . . 0.0 111.385 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.77 -30.17 3.39 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.082 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.49 -33.89 75.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.562 0.22 . . . . 0.0 111.355 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.403 ' CB ' HG13 ' P' ' 32' ' ' VAL . 96.9 m-85 -104.49 3.36 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.57 -41.14 82.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.452 ' OE1' ' N ' ' P' ' 47' ' ' GLN . 6.5 pm0 -47.6 -35.05 8.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.711 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.003 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -64.37 -46.78 92.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.536 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.437 ' HB3' ' CE1' ' P' ' 93' ' ' TYR . 5.6 mp -56.87 -47.34 80.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.375 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . 0.449 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.3 OUTLIER -67.45 -33.52 75.31 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.428 -179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.9 -41.03 37.93 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.685 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.003 ' CD2' HG22 ' P' ' 48' ' ' ILE . 22.3 m-70 -64.21 -38.46 91.12 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.81 -38.26 88.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.021 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.57 97.19 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.074 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . 0.448 ' HA ' ' CD2' ' P' ' 17' ' ' PHE . 21.6 t80 -79.2 -34.45 42.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.822 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 1.023 HD23 HG11 ' P' ' 99' ' ' VAL . 5.0 tp -66.51 -41.3 89.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -75.64 -34.54 60.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.653 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.93 -24.85 67.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.57 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -112.57 114.82 49.74 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.634 0.254 . . . . 0.0 110.389 179.573 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -48.94 -63.12 0.33 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.876 2.384 . . . . 0.0 114.039 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.27 18.85 2.96 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -84.56 113.57 21.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.9 mttp -115.59 128.46 55.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.51 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.7 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.6 p -96.2 139.98 18.12 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-O 121.305 0.574 . . . . 0.0 110.641 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.618 HD21 HG22 ' P' ' 107' ' ' VAL . 1.1 tt -112.45 103.09 11.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.956 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.689 HG13 HD22 ' P' ' 132' ' ' LEU . 0.6 OUTLIER -81.47 106.45 12.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.479 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.58 ' HA ' HG23 ' P' ' 107' ' ' VAL . 20.7 mt-10 -89.8 119.32 30.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.526 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.67 134.53 12.52 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.472 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.607 ' O ' HG23 ' P' ' 70' ' ' THR . 27.3 m120 -134.62 159.02 42.53 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.438 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.607 HG23 ' O ' ' P' ' 69' ' ' ASN . 7.6 p -164.42 -177.61 4.98 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.162 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.518 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 8.2 p-10 -73.55 155.6 38.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.955 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' P' ' 111' ' ' GLU . 2.6 pp20? -63.49 -34.86 78.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.962 0.41 . . . . 0.0 110.641 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -41.8 165.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.438 -179.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . 0.529 ' O ' HG23 ' P' ' 75' ' ' THR . . . 78.4 -124.47 6.7 Favored Glycine 0 CA--C 1.521 0.424 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.773 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . 0.529 HG23 ' O ' ' P' ' 74' ' ' GLY . 0.8 OUTLIER -163.62 145.53 7.52 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.437 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 2.4 Cg_endo -39.61 -53.13 2.36 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.297 2.664 . . . . 0.0 113.25 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.67 -40.73 93.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.72 0.295 . . . . 0.0 111.088 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.621 ' OH ' ' HB3' ' U' ' 4' ' ' DGL . 1.1 t80 -72.37 -35.16 68.42 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.453 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.74 ' HA ' HD12 ' P' ' 82' ' ' LEU . 5.6 m120 -76.94 -76.88 0.16 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.573 HD11 ' O ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.04 -43.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.847 -0.161 . . . . 0.0 111.3 179.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -68.86 -60.72 2.18 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.934 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 1.028 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -57.14 -38.42 73.49 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.272 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 1.028 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -68.46 -50.96 34.29 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.341 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.4 mt-30 -46.73 -39.26 11.28 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.73 -46.49 88.97 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.324 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.615 ' HD2' HD22 ' P' ' 82' ' ' LEU . 0.4 OUTLIER -57.27 -42.62 81.95 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.57 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -59.87 -37.44 79.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.147 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . 0.407 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -64.63 -32.34 73.96 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.467 178.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.59 -47.59 84.81 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.697 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.01 -34.69 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.702 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.567 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -66.94 -38.69 86.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 0.0 110.525 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.96 -29.47 58.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . 0.451 ' CD1' ' HE3' ' P' ' 97' ' ' LYS . 7.6 t80 -62.87 -53.76 49.21 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.596 ' HB2' HD21 ' P' ' 104' ' ' LEU . 20.3 mt -59.48 -28.62 67.17 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.263 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.57 -36.63 65.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.914 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -57.81 -51.45 58.01 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.092 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.575 ' HD2' ' HA ' ' P' ' 94' ' ' LEU . 0.0 OUTLIER -49.42 -34.76 17.26 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.92 28.94 1.6 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.386 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 1.023 HG11 HD23 ' P' ' 56' ' ' LEU . 23.1 t -90.71 145.65 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.567 0.223 . . . . 0.0 110.822 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . 0.405 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.2 OUTLIER -61.5 160.45 11.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.283 0.563 . . . . 0.0 111.526 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.772 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -90.64 -32.52 16.2 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.316 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -58.1 -21.67 46.93 Favored Glycine 0 CA--C 1.518 0.247 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.48 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -99.08 -4.57 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.22 0.533 . . . . 0.0 110.923 179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.772 HD12 ' HA ' ' P' ' 101' ' ' ALA . 4.6 mt -85.74 150.51 24.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.206 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.619 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.9 139.67 8.12 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.685 ' O ' HG13 ' P' ' 107' ' ' VAL . 34.6 p -141.57 151.2 42.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.923 0.392 . . . . 0.0 110.954 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.685 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -166.95 170.98 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.855 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.573 ' O ' HD11 ' P' ' 80' ' ' ILE . 1.3 t -157.38 126.93 6.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.726 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.497 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.3 m-85 -115.49 18.49 15.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.69 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.497 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -1.28 -113.46 0.01 OUTLIER Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.597 -0.729 . . . . 0.0 114.804 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -85.35 2.54 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.91 -57.05 14.47 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.93 88.22 5.99 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -72.76 170.81 18.69 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 123.022 2.481 . . . . 0.0 112.838 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -103.46 -56.03 2.29 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.152 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.892 HG13 ' HB1' ' P' ' 123' ' ' ALA . 0.3 OUTLIER -88.72 138.61 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.699 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 70.9 mt -97.44 139.41 33.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.154 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.19 176.93 15.92 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.881 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.464 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 0.2 OUTLIER -141.06 62.96 1.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.699 0.249 . . . . 0.0 111.279 -179.36 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 1.4 p30 -132.92 154.91 49.97 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -42.81 -26.09 0.12 Allowed 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . 0.517 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -72.69 -62.28 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.957 0.408 . . . . 0.0 110.97 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . 0.892 ' HB1' HG13 ' P' ' 116' ' ' VAL . . . -69.79 -42.43 73.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.636 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 1.0 OUTLIER -55.65 -48.76 74.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.759 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 58.2 m -63.34 -32.41 73.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.397 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 16.2 mtmt -68.33 -27.13 66.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.325 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.443 ' ND2' HG12 ' P' ' 116' ' ' VAL . 92.0 m-20 -89.07 -28.95 19.78 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -70.16 86.89 0.57 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' P' ' 69' ' ' ASN . 7.6 ptt-85 -159.79 159.18 32.38 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -123.63 102.35 7.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -86.87 109.58 19.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.689 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -59.68 102.19 0.14 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.572 178.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -101.27 126.92 48.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 111.678 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.874 179.624 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.595 ' PA ' ' HB2' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.499 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . 0.595 ' HB2' ' PA ' ' U' ' 1' ' ' UDP . . . . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 120.867 0.365 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.621 ' HB3' ' OH ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.696 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.454 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.696 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 36.7 p -104.19 -54.22 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.62 68.63 4.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -90.0 -36.35 15.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -150.17 127.97 11.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.837 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -90.01 149.43 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.09 -52.96 4.58 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.754 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.03 116.03 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -137.89 15.72 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.392 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.57 -38.33 80.49 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.583 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 68.34 -68.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.843 0.354 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.37 -26.79 68.41 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.56 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -54.5 46.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 0.0 111.186 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -100.24 -168.65 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.202 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -102.33 176.23 5.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.82 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 39.1 p -127.68 110.68 12.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.944 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.444 ' N ' ' O ' ' P' ' 20' ' ' TYR . 63.4 m-85 -89.68 107.16 18.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.994 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.75 9.33 38.53 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.537 -0.84 . . . . 0.0 113.645 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.67 -37.1 1.87 Allowed Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.349 -1.405 . . . . 0.0 114.037 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' P' ' 17' ' ' PHE . 5.3 m-85 -120.76 169.14 10.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.023 0.411 . . . . 0.0 111.586 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 26.0 t -102.78 152.99 20.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.439 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -40.07 -48.96 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.36 -17.27 28.38 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 -42.61 6.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.284 0.564 . . . . 0.0 110.427 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.509 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 16.3 mt -59.27 -21.22 59.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.436 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . 0.45 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 4.5 mm-40 -103.26 -12.6 17.17 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -125.21 -22.72 4.33 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 17.8 mtt85 -109.78 -62.16 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -108.25 83.58 1.8 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.288 0.566 . . . . 0.0 112.162 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.603 HD22 ' HB2' ' P' ' 132' ' ' LEU . 0.1 OUTLIER -141.53 13.45 2.14 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.933 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.477 HG23 HG22 ' P' ' 131' ' ' VAL . 95.2 m -134.28 135.99 43.23 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.719 HG11 HG23 ' P' ' 41' ' ' ILE . 3.0 t -108.37 150.73 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.07 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -123.32 115.62 21.98 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 21.2 m-30 -96.18 169.87 9.65 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.512 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -110.56 -168.95 19.41 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.818 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.418 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 4.0 t80 -61.58 126.14 26.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.5 t70 49.75 30.57 3.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.618 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.402 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -101.13 132.55 46.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.77 0.319 . . . . 0.0 110.679 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.423 ' HA ' ' HG2' ' P' ' 86' ' ' ARG . 40.1 p90 -129.35 46.26 2.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 110.822 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -150.41 150.43 31.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.808 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.719 HG23 HG11 ' P' ' 32' ' ' VAL . 1.2 mp -90.9 164.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.645 0.259 . . . . 0.0 110.896 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.465 ' N ' HG22 ' P' ' 41' ' ' ILE . 67.2 p -112.8 149.98 32.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.934 0.397 . . . . 0.0 111.213 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -43.48 -32.51 1.92 Allowed Glycine 0 CA--C 1.521 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 113.228 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -63.89 -33.06 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.722 0.296 . . . . 0.0 111.415 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.502 ' CB ' HG13 ' P' ' 32' ' ' VAL . 81.4 m-85 -102.27 -1.02 31.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 79.4 t -65.59 -40.98 89.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -43.85 -43.44 6.3 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.008 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.9 OUTLIER -57.39 -50.34 77.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.975 0.417 . . . . 0.0 110.556 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' P' ' 53' ' ' ALA . 5.1 mt -53.32 -37.46 62.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.601 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -40.26 56.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.981 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.13 -54.22 11.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.03 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.008 ' CD2' HG22 ' P' ' 48' ' ' ILE . 22.7 m-70 -56.98 -36.8 70.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 109.904 179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' P' ' 49' ' ' LEU . . . -60.76 -42.53 97.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.903 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.02 -40.07 95.51 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.854 0.359 . . . . 0.0 110.751 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -77.33 -36.43 53.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.075 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.707 ' CD2' HG11 ' P' ' 99' ' ' VAL . 8.0 tp -68.93 -39.42 79.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.935 0.398 . . . . 0.0 111.174 -179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -73.05 -36.74 66.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.192 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.45 -23.28 67.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.563 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.22 111.24 58.04 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 120.602 0.239 . . . . 0.0 110.363 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.17 -58.67 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.863 2.375 . . . . 0.0 113.927 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.35 19.65 2.68 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.638 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.18 116.95 27.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.125 0.488 . . . . 0.0 110.14 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -115.77 131.12 57.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.038 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.661 ' HB ' HD13 ' P' ' 56' ' ' LEU . 3.9 p -95.98 133.69 36.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.433 0.635 . . . . 0.0 111.15 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.452 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.2 tt -109.79 103.67 12.52 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.793 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.73 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -82.41 108.94 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.73 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.47 ' HA ' HG23 ' P' ' 107' ' ' VAL . 2.4 tt0 -91.3 120.08 31.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.773 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.77 128.58 8.87 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.722 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.721 ' O ' HG23 ' P' ' 70' ' ' THR . 1.8 m-80 -130.93 158.0 41.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.721 HG23 ' O ' ' P' ' 69' ' ' ASN . 0.9 OUTLIER -170.25 -175.19 1.89 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 111.495 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.563 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 14.0 p-10 -77.43 149.39 35.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.302 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' P' ' 111' ' ' GLU . 9.2 pm0 -57.71 -31.63 66.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.883 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.423 ' N ' ' HG2' ' P' ' 72' ' ' GLU . 2.9 tpp180 -40.74 107.43 0.07 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.36 -173.69 15.03 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.163 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.76 145.52 30.87 Favored Pre-proline 0 N--CA 1.466 0.355 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.411 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 81.4 Cg_exo -39.97 -46.79 3.91 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.916 2.411 . . . . 0.0 113.063 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.84 -40.99 94.9 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.508 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.4 t80 -73.99 -39.01 63.95 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.145 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.457 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 0.4 OUTLIER -68.78 -76.75 0.09 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' P' ' 79' ' ' ASN . 1.0 OUTLIER -30.64 -45.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.433 179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.37 -57.62 11.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.473 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.494 HD22 ' HA ' ' P' ' 82' ' ' LEU . 0.2 OUTLIER -45.31 -51.86 10.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.779 177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.475 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -62.23 -35.84 92.16 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.482 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.1 -47.9 65.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.55 0.214 . . . . 0.0 110.913 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' P' ' 82' ' ' LEU . 0.0 OUTLIER -68.1 -32.99 73.69 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.827 179.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.494 ' O ' ' HB3' ' P' ' 89' ' ' ALA . 6.6 mtt180 -65.22 -45.99 82.46 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.555 0.693 . . . . 0.0 109.229 178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' P' ' 106' ' ' THR . . . -60.35 -35.55 75.94 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.749 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.99 -30.74 71.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 178.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.87 -56.35 20.28 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.938 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.04 -36.17 72.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.017 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -43.77 98.27 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.566 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -72.21 -24.44 76.42 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.98 -64.04 1.0 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.464 ' CD1' HG11 ' P' ' 64' ' ' VAL . 85.2 mt -53.83 -32.82 54.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.378 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -59.02 -41.6 88.15 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.053 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -70.72 -21.08 77.85 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.416 ' N ' ' HD2' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -79.85 -9.52 59.68 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 122.74 0.416 . . . . 0.0 110.974 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.94 0.18 36.01 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.776 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.707 HG11 ' CD2' ' P' ' 56' ' ' LEU . 48.6 t -73.63 123.71 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.36 148.61 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.19 0.519 . . . . 0.0 111.255 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.604 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -68.48 -34.24 75.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.673 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.39 -22.1 55.44 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 121.099 -0.572 . . . . 0.0 113.045 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.622 ' HD3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -100.05 -4.43 29.9 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.229 0.537 . . . . 0.0 111.133 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' P' ' 101' ' ' ALA . 37.2 mt -95.91 150.12 20.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.298 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.616 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -148.42 142.07 9.66 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.755 ' O ' HG13 ' P' ' 107' ' ' VAL . 45.0 p -134.02 155.69 49.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.668 0.27 . . . . 0.0 110.887 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.755 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -170.77 171.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.424 ' OG ' HG23 ' P' ' 80' ' ' ILE . 14.7 p -162.62 134.54 5.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.633 0.254 . . . . 0.0 111.48 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.509 ' O ' ' C ' ' P' ' 110' ' ' GLY . 29.5 m-85 -123.62 23.59 8.78 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.078 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 1.25 -110.97 0.01 OUTLIER Glycine 0 C--N 1.338 0.644 0 N-CA-C 114.622 0.609 . . . . 0.0 114.622 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.531 ' HB3' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -84.05 5.06 27.36 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -54.71 -59.57 4.53 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.23 88.78 7.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.98 166.96 13.05 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.79 2.327 . . . . 0.0 113.018 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.72 -61.64 1.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.27 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' P' ' 126' ' ' LYS . 5.6 t -88.84 108.86 19.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.76 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 35.3 mt -64.83 136.53 56.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.199 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.06 174.98 14.42 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.981 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.457 ' CB ' ' CZ ' ' P' ' 124' ' ' TYR . 7.2 p-80 -141.12 61.09 1.5 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.765 0.283 . . . . 0.0 111.462 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . 0.724 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 2.7 p30 -130.16 156.35 44.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -43.66 -25.82 0.19 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . 0.724 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -75.13 -56.66 4.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.89 -43.19 68.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.666 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 2.0 m-85 -59.48 -47.38 85.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.066 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 94.6 p -63.36 -33.44 75.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 110.241 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.784 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -69.79 -24.49 63.5 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.887 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.85 -30.8 18.66 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.335 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 3.0 mtp180 -65.82 87.25 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.2 OUTLIER -159.32 157.17 29.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.248 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.06 96.23 4.86 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 176.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.477 HG22 HG23 ' P' ' 31' ' ' THR . 21.5 t -82.02 109.71 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.73 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -60.92 101.81 0.17 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.031 178.144 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -100.22 127.84 46.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.831 0.348 . . . . 0.0 111.755 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . 0.495 ' HH ' ' HD1' ' P' ' 52' ' ' HIS . 11.3 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.889 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.568 ' H6 ' " O5'" ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.576 ' C10' ' H ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.576 ' H ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.536 ' OH1' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.418 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.536 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.822 0.344 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 77.5 p -143.27 98.47 3.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 28.9 t -141.6 -77.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 5.0 t -90.14 -31.5 17.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.97 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -150.9 150.36 30.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -89.68 138.65 31.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.959 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.33 -12.31 61.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.396 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.29 121.14 32.78 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.974 0.416 . . . . 0.0 111.112 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.08 -154.1 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.54 -69.82 1.21 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.436 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' P' ' 13' ' ' ALA . 0.7 OUTLIER -177.59 111.51 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.872 0.367 . . . . 0.0 110.77 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.34 -28.61 73.19 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.681 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . 0.476 ' HB3' ' ND2' ' P' ' 11' ' ' ASN . . . -58.14 -64.5 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 111.232 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.65 43.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.146 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 166.77 22.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 5.5 p -130.59 150.62 51.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.097 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -137.04 107.17 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.47 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.18 9.64 12.26 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.26 -0.971 . . . . 0.0 113.358 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.79 -41.41 1.32 Allowed Glycine 0 CA--C 1.52 0.364 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.819 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -126.65 172.59 10.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.967 0.413 . . . . 0.0 111.504 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 4.2 t -99.72 152.26 20.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.949 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.672 ' HA ' HD12 ' P' ' 25' ' ' LEU . 16.7 t -42.13 -53.85 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 112.315 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.46 -14.94 5.61 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -44.79 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.381 0.61 . . . . 0.0 109.483 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' P' ' 22' ' ' VAL . 2.6 mt -59.06 -21.98 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.997 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -100.75 -11.93 19.51 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -121.86 -21.82 5.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . 0.483 ' HD3' ' CZ ' ' P' ' 29' ' ' TYR . 0.0 OUTLIER -118.39 -55.44 2.22 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.483 ' CZ ' ' HD3' ' P' ' 28' ' ' ARG . 53.0 m-85 -108.78 101.41 10.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 112.179 -178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 1.4 p30 -170.44 20.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.479 -0.782 . . . . 0.0 112.247 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 82.7 m -128.88 131.29 47.61 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.178 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 2.6 t -110.98 143.25 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.211 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -117.28 118.55 32.59 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.51 170.73 7.86 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.132 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.45 -165.77 15.34 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.433 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.523 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 2.7 t80 -57.65 123.74 16.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.974 0.416 . . . . 0.0 111.51 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . 0.407 ' OD2' ' CE2' ' P' ' 36' ' ' PHE . 3.2 p30 42.01 28.61 0.1 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.002 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -90.44 130.14 36.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.771 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.626 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 9.1 t80 -125.03 59.1 1.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.536 0.684 . . . . 0.0 110.261 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.52 149.98 29.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.91 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.482 HG22 ' N ' ' P' ' 42' ' ' THR . 8.6 mt -96.83 161.32 2.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.482 ' N ' HG22 ' P' ' 41' ' ' ILE . 3.9 p -110.47 140.72 44.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 112.025 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.6 -30.03 3.1 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.095 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -64.84 -33.49 76.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.55 0.214 . . . . 0.0 111.552 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.403 ' O ' HG13 ' P' ' 48' ' ' ILE . 83.1 m-85 -101.26 0.17 36.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.42 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 75.6 t -66.87 -40.81 86.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.43 ' OE1' HG13 ' P' ' 48' ' ' ILE . 0.0 OUTLIER -45.11 -43.52 9.79 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.423 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 0.953 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -54.08 -52.46 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 110.292 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' P' ' 53' ' ' ALA . 2.6 mp -50.92 -40.27 56.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.385 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.04 -38.29 64.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.928 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.02 -58.89 3.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.821 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 0.953 ' CD2' HG22 ' P' ' 48' ' ' ILE . 18.8 m-70 -51.54 -37.0 47.39 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.171 0.51 . . . . 0.0 109.784 178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . 0.566 ' HB1' ' NZ ' ' P' ' 97' ' ' LYS . . . -60.98 -48.16 83.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.289 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.96 -42.85 76.86 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.926 0.394 . . . . 0.0 110.372 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -71.47 -42.12 68.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.676 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.75 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -62.57 -43.25 99.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.301 -179.279 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 19.6 t30 -67.29 -43.06 82.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.39 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.5 -26.09 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.331 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -123.41 95.64 45.02 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.88 -24.61 39.58 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.681 2.254 . . . . 0.0 113.29 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.9 5.27 51.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.55 127.03 36.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.049 0.452 . . . . 0.0 110.212 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 1.8 mttp -121.51 130.56 53.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.046 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.468 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.1 p -97.38 147.34 6.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.502 0.668 . . . . 0.0 111.536 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.511 HD21 ' CG2' ' P' ' 107' ' ' VAL . 1.5 tt -119.78 104.24 10.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.665 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.683 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -83.15 109.87 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.618 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 1.6 mm-40 -89.7 121.55 31.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.54 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.25 133.84 11.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.881 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -145.82 100.98 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.778 0.323 . . . . 0.0 110.754 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.862 HG21 HD11 ' P' ' 82' ' ' LEU . 0.0 OUTLIER -88.05 -168.68 2.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.837 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 13.0 p-10 -81.79 164.91 21.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.974 0.416 . . . . 0.0 111.409 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 10.1 tm-20 -66.93 -40.59 87.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.246 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.432 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.0 OUTLIER -44.97 106.89 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.037 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.27 -164.83 12.01 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.483 -0.781 . . . . 0.0 113.479 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.27 146.02 34.04 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-O 120.657 0.265 . . . . 0.0 111.418 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.68 ' O ' HD12 ' P' ' 80' ' ' ILE . 71.8 Cg_exo -50.78 -38.22 56.39 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.13 2.553 . . . . 0.0 114.158 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.55 -42.8 83.73 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.477 ' O ' ' HB3' ' P' ' 82' ' ' LEU . 40.5 t80 -81.73 -29.26 32.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.244 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.66 ' HA ' HD12 ' P' ' 82' ' ' LEU . 2.0 m-80 -90.62 -11.54 39.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.752 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.68 HD12 ' O ' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -87.58 -40.74 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.2 -48.67 64.59 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.193 -1.367 . . . . 0.0 110.269 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 1.029 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -60.24 -38.46 83.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.126 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 1.029 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.4 -44.52 64.55 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.228 -0.986 . . . . 0.0 111.139 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.7 OUTLIER -50.63 -41.3 54.88 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.477 ' HG3' ' CE1' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -63.65 -35.42 80.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -64.24 -52.39 58.95 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.55 -34.98 71.62 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.476 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.03 -29.43 69.79 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.49 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.75 -50.77 63.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.629 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.15 -38.76 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.228 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.424 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.97 -40.68 96.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.234 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.09 -28.3 68.66 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . 0.466 ' CD1' ' HD2' ' P' ' 97' ' ' LYS . 4.3 t80 -59.97 -62.24 2.02 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.639 ' HA ' ' HD3' ' P' ' 97' ' ' LYS . 95.4 mt -54.43 -32.42 57.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.55 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.74 -38.18 76.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.169 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -65.78 -29.75 75.75 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.547 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.639 ' HD3' ' HA ' ' P' ' 94' ' ' LEU . 0.7 OUTLIER -74.13 -11.6 60.35 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.507 0.188 . . . . 0.0 111.507 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.11 3.49 15.24 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.478 -0.867 . . . . 0.0 113.234 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.75 HG11 ' CD2' ' P' ' 56' ' ' LEU . 28.2 t -80.98 131.82 33.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.897 0.349 . . . . 0.0 111.085 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . 0.438 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -60.31 158.02 12.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.333 0.587 . . . . 0.0 111.556 -179.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.876 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -86.42 -29.94 22.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.71 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -59.12 -20.53 50.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.807 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.631 ' HE3' HG13 ' P' ' 99' ' ' VAL . 0.0 OUTLIER -99.93 -3.77 31.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.145 0.497 . . . . 0.0 111.163 179.317 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.3 mt -91.68 149.21 21.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.336 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.634 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -145.89 139.79 8.45 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.488 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 43.5 p -138.45 151.43 47.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.767 0.318 . . . . 0.0 110.975 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.511 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.0 OUTLIER -161.27 169.35 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.133 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.478 ' OG ' HG23 ' P' ' 80' ' ' ILE . 51.6 p -162.68 130.04 3.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.782 0.325 . . . . 0.0 111.506 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.552 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.0 OUTLIER -114.19 31.55 6.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.234 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.552 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.77 -113.12 0.01 OUTLIER Glycine 0 C--N 1.34 0.796 0 O-C-N 123.679 0.612 . . . . 0.0 114.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.632 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 2.7 mp0 -97.71 13.18 31.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.614 0.245 . . . . 0.0 111.307 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . 0.436 ' CG ' ' HB3' ' P' ' 76' ' ' PRO . 26.0 mt-10 -61.72 -55.23 32.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.679 0.276 . . . . 0.0 110.378 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -134.19 89.83 27.24 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 161.2 8.98 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.641 2.227 . . . . 0.0 112.967 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -107.92 -70.07 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.712 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.878 HG21 ' HB3' ' P' ' 126' ' ' LYS . 3.6 t -88.61 108.82 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.094 0.473 . . . . 0.0 110.82 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -60.98 135.04 57.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.388 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.93 173.3 14.72 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.787 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.487 ' HA ' ' CD1' ' P' ' 124' ' ' TYR . 0.6 OUTLIER -141.21 64.54 1.41 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.787 0.294 . . . . 0.0 111.492 -179.384 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.82 152.88 49.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -38.0 -32.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.4 -60.93 2.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.75 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.94 -43.93 74.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.723 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' P' ' 119' ' ' HIS . 0.8 OUTLIER -57.71 -52.99 63.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.316 -179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . 0.403 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 11.2 t -59.33 -33.96 71.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 110.208 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.878 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -67.86 -27.84 67.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.572 179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.514 ' O ' ' O ' ' P' ' 69' ' ' ASN . 74.3 m-20 -82.96 -33.48 26.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.88 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.403 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.3 mpp_? -69.74 80.21 0.44 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.95 0.405 . . . . 0.0 110.815 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 4.1 ptt180 -156.56 150.86 25.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.95 115.91 25.35 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.8 112.05 25.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.683 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -59.41 98.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.632 178.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -102.36 129.1 48.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.841 0.353 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.261 -0.876 . . . . 0.0 111.009 179.773 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.483 ' O2B' ' HB3' ' U' ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . 0.483 ' HB3' ' O2B' ' U' ' 1' ' ' UDP . . . . . . . . 0 C--O 1.23 0.078 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.66 ' CG ' ' H2 ' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.68 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.523 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.68 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.833 0.349 . . . . 0.0 111.229 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 65.9 m 61.43 114.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 1.3 m -97.09 145.5 25.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 31.6 p -87.04 -45.48 10.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -119.9 114.86 22.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -91.59 100.35 13.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' P' ' 8' ' ' ALA . 12.7 t70 -90.94 -23.71 20.37 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' P' ' 7' ' ' ASP . . . 67.78 -170.96 0.19 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.086 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.33 126.97 31.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.194 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.06 -39.96 5.96 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.444 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.16 11.55 7.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.547 0.213 . . . . 0.0 111.441 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.68 -24.98 26.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.566 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -73.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 111.372 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 46.08 52.86 9.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.006 0.432 . . . . 0.0 110.99 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.0 -177.49 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.358 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 41.7 p -119.5 106.24 12.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.213 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.525 ' CD2' ' HB2' ' P' ' 55' ' ' TYR . 94.2 m-85 -89.48 108.1 19.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.498 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.97 9.14 38.8 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.333 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.78 -32.97 2.93 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 119.788 -1.196 . . . . 0.0 113.488 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.4 ' O ' ' N ' ' P' ' 17' ' ' PHE . 2.1 m-85 -115.41 160.61 19.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.025 0.441 . . . . 0.0 111.611 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 9.4 t -103.2 154.05 19.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.262 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.614 ' HA ' HD12 ' P' ' 25' ' ' LEU . 21.5 t -43.3 -41.51 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.82 -17.27 55.64 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.27 -40.58 8.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.568 0.699 . . . . 0.0 110.012 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.614 HD12 ' HA ' ' P' ' 22' ' ' VAL . 6.3 mt -64.27 -15.34 59.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.564 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . 0.491 ' HG3' ' CD2' ' P' ' 134' ' ' TYR . 2.0 tt0 -92.78 -25.47 18.15 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -141.39 -9.89 0.96 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -117.12 -60.95 1.78 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' P' ' 25' ' ' LEU . 54.0 m-85 -107.12 99.49 9.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 111.961 -178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.622 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 1.3 p30 -178.38 27.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.22 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.508 HG23 HG22 ' P' ' 131' ' ' VAL . 78.6 m -126.48 127.08 44.81 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.791 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.745 HG11 HG23 ' P' ' 41' ' ' ILE . 1.9 t -104.19 150.13 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.157 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -124.63 112.64 17.03 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.243 0.544 . . . . 0.0 112.429 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -91.51 166.66 12.73 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.441 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -109.97 -167.64 19.82 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.064 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.54 126.32 26.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.016 0.436 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t0 53.09 27.92 6.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.568 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 4.9 mptt -100.97 136.8 40.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.758 0.313 . . . . 0.0 110.849 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.485 ' HA ' ' CG ' ' P' ' 86' ' ' ARG . 46.4 p90 -135.72 36.05 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.609 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.22 150.63 38.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.799 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.745 HG23 HG11 ' P' ' 32' ' ' VAL . 0.8 OUTLIER -88.26 164.66 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.933 0.397 . . . . 0.0 111.069 -179.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.456 ' H ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -114.38 149.06 36.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.941 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' P' ' 46' ' ' VAL . . . -41.18 -33.96 0.85 Allowed Glycine 0 C--N 1.334 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.527 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -62.2 -31.79 72.36 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.644 0.259 . . . . 0.0 111.656 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.491 ' O ' HG13 ' P' ' 48' ' ' ILE . 71.2 m-85 -99.99 1.54 42.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' P' ' 43' ' ' GLY . 56.0 t -65.05 -44.72 95.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.077 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.609 ' NE2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -40.01 -43.97 1.65 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 0.89 HG22 ' HD2' ' P' ' 52' ' ' HIS . 0.1 OUTLIER -62.14 -47.4 93.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.066 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.41 HD22 HG13 ' P' ' 90' ' ' VAL . 16.2 mt -56.61 -51.77 67.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.801 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . 0.576 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.9 OUTLIER -61.13 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.824 0.345 . . . . 0.0 111.227 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' P' ' 17' ' ' PHE . . . -71.14 -37.06 72.28 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 0.89 ' HD2' HG22 ' P' ' 48' ' ' ILE . 5.6 m-70 -66.21 -33.44 75.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.241 0.543 . . . . 0.0 110.321 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . 0.416 ' CB ' ' HG2' ' P' ' 97' ' ' LYS . . . -75.38 -31.14 60.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.826 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.25 69.9 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 111.356 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . 0.772 ' HH ' ' HE1' ' P' ' 134' ' ' TYR . 1.8 p90 -74.28 -34.41 63.55 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.739 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.577 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -72.4 -35.64 68.46 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -178.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.77 -31.7 65.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.98 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.74 -17.89 61.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.524 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.7 OUTLIER -110.38 111.79 57.35 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.819 0.342 . . . . 0.0 110.503 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.69 -62.49 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.079 2.519 . . . . 0.0 114.481 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.35 22.93 2.7 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.609 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.65 116.34 28.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.113 0.482 . . . . 0.0 110.711 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -122.21 132.28 54.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.892 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.512 ' HB ' HD13 ' P' ' 56' ' ' LEU . 10.0 p -95.36 137.34 23.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 121.41 0.624 . . . . 0.0 111.466 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.541 HD21 ' CG2' ' P' ' 107' ' ' VAL . 0.6 OUTLIER -105.15 106.39 16.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.682 -179.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.577 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.6 OUTLIER -84.88 104.39 12.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 10.4 mt-10 -89.59 119.88 30.4 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.596 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -83.16 95.92 1.88 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.094 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.708 ' O ' HG23 ' P' ' 70' ' ' THR . 2.4 m-20 -97.58 155.22 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.775 0.321 . . . . 0.0 110.283 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.708 HG23 ' O ' ' P' ' 69' ' ' ASN . 0.7 OUTLIER -173.43 176.25 2.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.165 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.1 p-10 -73.88 148.16 42.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.249 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.433 ' HG2' ' HG2' ' P' ' 114' ' ' PRO . 0.5 OUTLIER -55.36 -28.3 52.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.957 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.897 ' HD3' ' HB2' ' U' ' 7' ' ' DAL . 19.1 ttm180 -39.82 104.75 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.312 0.577 . . . . 0.0 112.263 -178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . 0.489 ' HA3' ' CE2' ' P' ' 78' ' ' TYR . . . 112.29 163.28 16.54 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.109 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.16 146.71 71.63 Favored Pre-proline 0 N--CA 1.467 0.401 0 CA-C-N 116.802 0.301 . . . . 0.0 110.51 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.479 ' HG3' ' HG3' ' P' ' 111' ' ' GLU . 68.7 Cg_exo -50.53 -42.63 48.54 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.744 2.296 . . . . 0.0 113.95 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.99 -46.66 86.64 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.591 ' CE1' ' HA ' ' U' ' 5' ' ' 6CL . 0.0 OUTLIER -77.49 -32.31 54.18 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.547 ' HB3' ' HA3' ' P' ' 110' ' ' GLY . 1.5 m120 -63.56 -74.94 0.09 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.445 HG23 ' OG ' ' P' ' 108' ' ' SER . 0.7 OUTLIER -32.16 -40.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-O 120.779 0.323 . . . . 0.0 110.707 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' P' ' 84' ' ' GLN . . . -62.16 -55.3 30.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.039 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' P' ' 79' ' ' ASN . 0.3 OUTLIER -43.72 -52.65 6.4 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.595 177.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.44 ' HA2' ' CD ' ' P' ' 86' ' ' ARG . . . -68.62 -34.4 78.49 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.108 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.442 ' HB2' ' HA ' ' P' ' 81' ' ' ALA . 0.0 OUTLIER -54.54 -45.25 73.37 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.472 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -64.09 -40.26 95.85 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.571 ' NH1' HG21 ' P' ' 70' ' ' THR . 9.1 mtt180 -60.26 -39.58 87.29 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.3 -39.64 94.33 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.431 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -60.29 -34.89 74.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.506 178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.51 -61.06 2.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.429 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.41 HG13 HD22 ' P' ' 49' ' ' LEU . 26.3 t -64.88 -37.02 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.354 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -47.17 87.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.634 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.56 -23.01 76.79 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.839 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . 0.454 ' CE1' ' HD3' ' P' ' 97' ' ' LYS . 5.2 t80 -64.43 -63.69 1.07 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.447 ' CD1' HG11 ' P' ' 64' ' ' VAL . 33.5 mt -55.47 -31.68 62.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -42.12 95.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.006 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -68.82 -24.08 75.64 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.447 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' P' ' 97' ' ' LYS . 0.0 OUTLIER -74.98 -9.49 58.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.779 0.323 . . . . 0.0 111.068 179.384 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 102.21 6.04 48.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.868 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' P' ' 56' ' ' LEU . 39.3 t -76.86 130.39 36.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.064 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -61.47 140.68 58.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.152 0.501 . . . . 0.0 111.456 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.0 70.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.756 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.35 -17.9 57.28 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.929 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 12.6 mtpp -91.65 -13.38 31.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.999 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.423 HD21 ' CG1' ' P' ' 99' ' ' VAL . 2.8 mt -101.99 143.83 31.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.355 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.577 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -146.23 147.07 17.77 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.812 ' O ' HG13 ' P' ' 107' ' ' VAL . 17.4 p -127.93 154.71 45.23 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.728 0.299 . . . . 0.0 110.663 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.812 HG13 ' O ' ' P' ' 106' ' ' THR . 0.1 OUTLIER -176.02 114.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.769 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.445 ' OG ' HG23 ' P' ' 80' ' ' ILE . 52.5 p -112.79 137.46 51.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.771 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.531 ' O ' ' C ' ' P' ' 110' ' ' GLY . 50.7 m-85 -113.22 26.85 10.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.707 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' P' ' 79' ' ' ASN . . . 5.8 -111.37 0.01 OUTLIER Glycine 0 C--N 1.337 0.637 0 CA-C-N 115.549 -0.75 . . . . 0.0 114.224 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.479 ' HG3' ' HG3' ' P' ' 76' ' ' PRO . 0.4 OUTLIER -101.38 14.89 30.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.785 0.326 . . . . 0.0 110.975 179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -62.52 -55.16 30.09 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.24 88.83 5.69 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . 0.433 ' HG2' ' HG2' ' P' ' 72' ' ' GLU . 21.6 Cg_exo -65.95 169.89 12.56 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.026 2.484 . . . . 0.0 112.928 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -99.84 -61.69 1.33 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.224 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.44 114.17 27.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.601 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.04 138.7 57.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.075 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 115.8 178.19 18.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.053 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.512 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 0.5 OUTLIER -142.04 67.53 1.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.639 0.219 . . . . 0.0 111.305 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.09 153.13 50.77 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -38.98 -32.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.14 -52.65 13.41 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.874 0.368 . . . . 0.0 111.291 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.53 67.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.187 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.512 ' CE1' ' HA ' ' P' ' 119' ' ' HIS . 2.1 m-30 -63.91 -40.5 96.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.361 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 91.5 p -65.85 -35.75 81.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.026 0.441 . . . . 0.0 109.888 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -69.59 -25.3 63.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.743 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -88.63 -30.68 19.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.115 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 7.4 mtp180 -66.18 82.41 0.08 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.0 OUTLIER -159.23 162.42 36.18 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -178.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -128.42 102.45 6.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.508 HG22 HG23 ' P' ' 31' ' ' THR . 14.1 t -91.21 117.52 34.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.1 OUTLIER -71.48 104.92 3.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.081 178.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' P' ' 65' ' ' LEU . . . -115.21 145.19 42.66 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.543 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . 0.772 ' HE1' ' HH ' ' P' ' 55' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.701 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.576 ' O2 ' H5'2 ' U' ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.465 ' C10' ' N ' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . 0.409 ' N ' ' O1B' ' U' ' 1' ' ' UDP . . . . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.818 0.342 . . . . 0.0 111.623 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.465 ' N ' ' C10' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.591 ' HA ' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.897 ' HB2' ' HD3' ' P' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.82 0.343 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 96.0 p -93.35 86.11 5.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 59.8 p -174.47 -41.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 19.5 m -71.82 -55.87 6.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.864 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -145.98 111.76 5.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -149.99 130.68 14.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.36 -52.61 4.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 59.12 103.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.164 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -175.32 60.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.62 -73.19 1.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.463 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 62.89 127.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.968 0.413 . . . . 0.0 111.023 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.05 -46.7 4.09 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.04 -50.45 33.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.882 0.372 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -103.12 -160.25 0.77 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.971 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 67.14 154.46 0.09 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.828 0.347 . . . . 0.0 111.194 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.9 121.17 29.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.757 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' P' ' 20' ' ' TYR . 57.1 m-85 -91.06 108.71 20.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.32 9.38 42.46 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.564 -0.826 . . . . 0.0 113.818 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.39 -35.51 2.11 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 119.333 -1.413 . . . . 0.0 114.02 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.551 ' HD2' HD21 ' P' ' 25' ' ' LEU . 0.5 OUTLIER -120.62 164.89 15.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.021 0.439 . . . . 0.0 111.58 -179.272 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 8.3 t -98.27 152.32 19.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.21 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 15.7 t -39.9 -49.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.72 -15.98 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' P' ' 29' ' ' TYR . 0.2 OUTLIER -99.6 -47.58 5.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.233 0.539 . . . . 0.0 110.233 178.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.551 HD21 ' HD2' ' P' ' 20' ' ' TYR . 42.0 mt -54.62 -22.64 14.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.783 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -12.93 14.5 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -111.9 -29.69 7.56 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.523 0.935 . . . . 0.0 113.523 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -129.79 -38.53 1.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.415 ' HB2' ' OD1' ' P' ' 24' ' ' ASP . 27.7 m-85 -109.91 104.78 13.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.614 0.721 . . . . 0.0 112.366 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' P' ' 132' ' ' LEU . 0.3 OUTLIER 179.44 22.34 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.464 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 91.7 m -126.88 128.79 47.05 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 120.668 -0.413 . . . . 0.0 112.065 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.738 HG11 HG23 ' P' ' 41' ' ' ILE . 16.7 t -108.95 150.29 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.309 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -122.46 116.19 23.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.442 ' CE2' ' HB3' ' P' ' 86' ' ' ARG . 23.0 m-85 -95.66 168.63 10.56 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.67 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -99.77 -166.84 29.49 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.185 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -58.68 114.89 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.879 0.371 . . . . 0.0 111.23 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 t70 50.12 30.46 4.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.6 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.416 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.1 OUTLIER -95.97 142.84 27.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.984 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -130.0 55.77 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.906 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.09 150.39 31.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.562 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.738 HG23 HG11 ' P' ' 32' ' ' VAL . 1.5 mp -97.38 161.93 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 110.836 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.466 ' N ' HG22 ' P' ' 41' ' ' ILE . 42.6 p -112.59 147.11 37.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.926 0.394 . . . . 0.0 111.251 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -44.63 -31.13 2.43 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.0 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.76 -34.26 75.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 111.259 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.439 ' CB ' HG13 ' P' ' 32' ' ' VAL . 94.5 m-85 -105.26 3.75 30.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.946 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 24.7 t -70.66 -38.4 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 pm0 -52.27 -32.81 39.04 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.615 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 0.962 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -63.51 -45.94 96.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.158 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 8.2 mt -59.33 -34.13 71.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.194 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.68 -39.16 52.97 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.924 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.45 -46.45 39.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.949 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 0.962 ' CD2' HG22 ' P' ' 48' ' ' ILE . 19.5 m-70 -62.28 -38.23 88.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.04 99.18 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.007 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.3 -39.88 95.79 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.063 0.459 . . . . 0.0 110.203 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -75.38 -35.82 61.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.903 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.852 HD23 HG11 ' P' ' 99' ' ' VAL . 0.8 OUTLIER -63.56 -43.22 97.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.862 0.363 . . . . 0.0 111.036 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -69.97 -41.22 74.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.264 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.38 -26.56 61.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.406 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.62 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -111.73 110.49 54.84 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.447 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.55 -51.03 11.82 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.795 2.33 . . . . 0.0 114.0 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.98 18.32 6.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.62 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -89.2 112.79 23.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.451 . . . . 0.0 110.658 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' P' ' 103' ' ' LYS . 7.5 mttt -115.96 130.11 56.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.722 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.478 ' HB ' ' CD1' ' P' ' 56' ' ' LEU . 9.9 p -99.04 146.59 8.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.569 0.7 . . . . 0.0 111.936 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.724 HD21 ' CG2' ' P' ' 107' ' ' VAL . 2.8 tt -117.63 105.26 11.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.756 -1.111 . . . . 0.0 110.494 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.486 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.4 OUTLIER -82.38 103.46 9.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.153 179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.44 119.38 31.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.913 0.387 . . . . 0.0 110.787 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -85.64 143.28 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.098 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.535 ' O ' HG23 ' P' ' 70' ' ' THR . 1.5 m-80 -138.96 157.52 45.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.934 0.397 . . . . 0.0 110.629 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.535 HG23 ' O ' ' P' ' 69' ' ' ASN . 68.1 p -164.73 -165.29 0.9 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.474 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.416 ' OD2' ' CD1' ' P' ' 124' ' ' TYR . 24.0 p30 -90.89 158.8 16.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.014 0.435 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.517 ' HA ' ' CB ' ' P' ' 111' ' ' GLU . 2.3 pm0 -60.85 -33.55 73.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.845 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.408 ' HG2' ' OH ' ' P' ' 124' ' ' TYR . 5.3 mmm180 -45.32 111.79 0.37 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.15 -174.84 15.83 Favored Glycine 0 CA--C 1.521 0.411 0 CA-C-N 114.875 -1.057 . . . . 0.0 113.052 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.82 145.09 31.28 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 111.639 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.466 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 85.1 Cg_exo -38.57 -46.92 2.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.117 2.545 . . . . 0.0 113.723 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -59.37 -44.47 92.72 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 120.743 0.306 . . . . 0.0 111.024 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.548 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.7 t80 -70.1 -44.83 68.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.356 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.447 ' O ' ' C ' ' P' ' 80' ' ' ILE . 7.1 m120 -70.94 -76.02 0.11 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.6 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.0 OUTLIER -30.67 -43.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.39 -55.88 11.96 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.28 -0.568 . . . . 0.0 110.65 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 1.011 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -49.43 -50.36 41.17 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.555 178.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 1.011 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -63.07 -42.59 99.54 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 120.346 -0.93 . . . . 0.0 111.323 178.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 7.9 tp60 -47.84 -40.44 21.34 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.204 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 1.3 ptm180 -67.6 -37.71 82.95 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.578 ' HD2' ' HA2' ' P' ' 83' ' ' GLY . 15.9 mtt180 -62.72 -47.67 82.58 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.616 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.45 -33.24 69.5 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.829 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -32.66 73.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.497 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -59.62 -56.51 20.94 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.511 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.413 ' HB ' HG11 ' P' ' 66' ' ' VAL . 21.4 t -66.08 -34.61 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.248 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -44.81 96.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.763 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.46 -23.66 77.56 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.5 -60.81 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . . . . . . . . . 91.0 mt -55.91 -31.93 63.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.25 -39.08 82.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.032 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.04 95.15 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.04 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.3 -34.66 74.09 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.02 26.59 2.04 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.095 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.852 HG11 HD23 ' P' ' 56' ' ' LEU . 49.6 t -90.53 143.47 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 122.179 0.191 . . . . 0.0 110.572 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.8 162.6 10.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.356 0.598 . . . . 0.0 111.455 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.543 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -91.13 -31.5 16.2 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.548 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -56.93 -23.82 47.39 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.829 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.558 ' HG3' HD21 ' P' ' 56' ' ' LEU . 0.0 OUTLIER -100.63 -4.32 28.66 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.114 0.483 . . . . 0.0 111.059 179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.543 HD12 ' HA ' ' P' ' 101' ' ' ALA . 47.0 mt -96.92 147.26 24.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.486 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -150.87 144.13 11.43 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.812 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.616 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 39.8 p -124.21 157.46 34.73 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.727 0.298 . . . . 0.0 110.533 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.724 ' CG2' HD21 ' P' ' 65' ' ' LEU . 92.7 t -161.14 162.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.6 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 2.3 t -155.74 123.25 5.54 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.821 -0.351 . . . . 0.0 111.493 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.499 ' O ' ' C ' ' P' ' 110' ' ' GLY . 92.6 m-85 -116.75 17.76 15.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.98 178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -3.68 -113.54 0.0 OUTLIER Glycine 0 C--N 1.339 0.739 0 N-CA-C 114.783 0.673 . . . . 0.0 114.783 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.517 ' CB ' ' HA ' ' P' ' 72' ' ' GLU . 0.0 OUTLIER -78.77 -2.33 38.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.02 -63.39 1.15 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.679 0.275 . . . . 0.0 110.753 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.87 89.49 20.93 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.7 163.44 13.33 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.633 2.222 . . . . 0.0 112.706 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -104.37 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.655 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 46.5 t -88.78 113.95 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.772 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.78 136.53 52.92 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.089 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 120.28 175.67 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.721 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.455 ' HB3' ' CE2' ' P' ' 124' ' ' TYR . 5.8 m80 -141.56 100.31 3.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.873 0.336 . . . . 0.0 111.629 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -170.83 161.56 7.25 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -47.33 -24.59 0.8 Allowed 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.36 -60.73 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.934 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.05 77.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.817 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' P' ' 119' ' ' HIS . 13.2 m-85 -59.01 -50.38 74.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.239 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 8.4 t -62.38 -32.57 73.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.331 . . . . 0.0 110.405 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -73.56 -24.36 60.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.411 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -88.94 -31.48 18.15 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -70.25 88.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.802 0.334 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.3 OUTLIER -158.78 157.88 32.49 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.86 100.68 7.02 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 11.9 t -84.32 113.64 23.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' P' ' 30' ' ' ASN . 0.4 OUTLIER -62.63 102.1 0.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.662 178.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.51 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -106.91 132.95 52.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.343 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.178 -0.915 . . . . 0.0 111.086 179.694 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.123 0.487 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.548 ' HB3' ' CE1' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.544 ' HB2' ' OH1' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.815 0.341 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 5.1 t -113.15 -35.73 5.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 7.4 t 60.16 109.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.894 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -90.04 -39.76 12.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.073 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -150.98 150.07 30.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -100.35 131.33 46.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -90.21 -28.12 19.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.242 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 62.95 32.08 15.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.875 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.49 -157.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.534 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.45 -73.17 1.26 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.673 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.01 165.97 33.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.826 0.346 . . . . 0.0 111.047 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.15 -12.91 61.12 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.758 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.48 -29.38 4.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.78 0.324 . . . . 0.0 111.489 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.88 170.45 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.055 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 62.72 134.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.97 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 44.0 p -132.3 104.76 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' P' ' 20' ' ' TYR . 81.9 m-85 -89.86 106.39 18.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.45 9.05 22.43 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.523 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.21 -40.71 1.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.957 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.518 ' OH ' ' HG2' ' P' ' 47' ' ' GLN . 0.1 OUTLIER -128.89 -179.7 5.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.262 0.553 . . . . 0.0 111.899 -179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -118.28 175.81 5.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.839 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 20.3 t -42.94 -53.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -53.07 -21.12 4.28 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.77 -43.95 6.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.195 0.522 . . . . 0.0 110.961 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.516 HD21 ' HB1' ' P' ' 51' ' ' ALA . 30.0 mt -56.85 -21.77 31.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.657 -179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -106.63 -11.3 15.89 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.31 -25.35 4.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -111.14 -64.72 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -105.2 81.76 1.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.416 HD22 ' HB2' ' P' ' 132' ' ' LEU . 0.1 OUTLIER -139.68 9.61 2.42 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.989 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.612 HG23 HG22 ' P' ' 131' ' ' VAL . 67.8 m -135.21 138.32 43.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.738 HG11 HG23 ' P' ' 41' ' ' ILE . 10.3 t -109.62 149.89 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.031 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -117.42 116.46 27.22 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.804 0.811 . . . . 0.0 112.885 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.724 ' O ' ' HG3' ' P' ' 128' ' ' ARG . 9.6 m-30 -92.72 174.81 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.282 -1.326 . . . . 0.0 112.891 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -123.17 -176.45 14.83 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' P' ' 37' ' ' ASP . 2.7 t80 -61.84 131.8 51.0 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.703 0.751 . . . . 0.0 110.613 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . 0.448 ' N ' ' CD1' ' P' ' 36' ' ' PHE . 2.7 p30 44.68 29.61 0.44 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.449 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.445 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -94.53 119.86 33.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.65 179.779 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.766 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.4 OUTLIER -118.73 46.12 1.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.751 0.786 . . . . 0.0 110.053 -179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -150.41 150.47 31.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.433 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.741 HD11 HG22 ' P' ' 90' ' ' VAL . 2.6 mt -93.03 165.88 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.348 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.465 ' H ' HG22 ' P' ' 41' ' ' ILE . 0.3 OUTLIER -110.32 141.09 43.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.09 0.472 . . . . 0.0 111.828 -179.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -46.09 -31.72 4.53 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.575 -0.739 . . . . 0.0 113.055 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -63.47 -33.01 74.63 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.757 0.313 . . . . 0.0 111.015 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.5 ' CB ' HG13 ' P' ' 32' ' ' VAL . 74.8 m-85 -100.13 -6.85 25.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.865 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . . . . . . . . . 43.9 t -62.3 -42.09 94.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 120.88 0.371 . . . . 0.0 111.44 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.518 ' HG2' ' OH ' ' P' ' 20' ' ' TYR . 0.0 OUTLIER -44.91 -42.55 8.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 -179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 0.965 HG22 ' CD2' ' P' ' 52' ' ' HIS . 5.6 mt -50.67 -55.5 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 121.368 0.604 . . . . 0.0 109.783 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.18 -32.93 25.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.906 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -41.21 67.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.682 0.277 . . . . 0.0 110.834 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . 0.516 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -73.1 -42.68 62.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.713 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 0.965 ' CD2' HG22 ' P' ' 48' ' ' ILE . 46.3 m-70 -65.97 -39.31 90.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.921 0.391 . . . . 0.0 110.122 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.97 -50.63 71.34 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.415 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.47 -40.55 78.81 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.926 0.393 . . . . 0.0 110.637 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -76.09 -38.34 57.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.72 HD13 ' HB ' ' P' ' 64' ' ' VAL . 1.2 tp -70.57 -35.73 73.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.256 -179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -73.67 -33.97 64.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.031 179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.83 -23.3 67.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.387 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -112.7 114.29 49.75 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.24 -50.17 11.9 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.611 2.207 . . . . 0.0 113.543 -178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.88 17.46 4.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.594 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.46 122.76 33.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.972 0.415 . . . . 0.0 110.182 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -124.78 135.71 53.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.583 -179.365 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.72 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -100.88 150.05 5.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.489 0.661 . . . . 0.0 111.535 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.523 HD21 HG22 ' P' ' 107' ' ' VAL . 0.8 OUTLIER -121.76 107.81 12.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.784 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.763 HG23 ' O ' ' P' ' 105' ' ' GLY . 0.2 OUTLIER -86.55 104.22 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.834 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' P' ' 133' ' ' ALA . 55.5 mt-10 -89.75 122.62 33.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.18 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -116.35 141.32 16.73 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.497 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.6 OUTLIER -148.32 113.99 5.68 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.972 HG22 ' NH1' ' P' ' 86' ' ' ARG . 45.5 p -99.69 176.28 5.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . . . . . . . . . 42.5 p30 -58.96 138.62 57.38 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.457 ' HA ' ' HG3' ' P' ' 111' ' ' GLU . 0.0 OUTLIER -50.48 -28.07 7.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.656 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.907 ' HG2' ' HB3' ' U' ' 7' ' ' DAL . 0.0 OUTLIER -46.21 106.62 0.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 0.0 112.774 -178.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.86 -178.94 18.62 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.871 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.46 143.89 27.12 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.983 0.391 . . . . 0.0 111.447 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.614 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 82.6 Cg_exo -48.02 -27.94 9.72 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.775 2.317 . . . . 0.0 113.22 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -45.38 92.84 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.299 0.571 . . . . 0.0 110.752 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.517 ' CZ ' ' HB3' ' U' ' 4' ' ' DGL . 14.1 t80 -90.12 -17.34 27.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.566 177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' P' ' 76' ' ' PRO . 5.1 m-80 -85.6 -21.76 28.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.263 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -83.58 -35.59 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 175.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.81 -49.56 61.64 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.418 -1.264 . . . . 0.0 109.605 177.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.474 HD23 ' CE2' ' P' ' 78' ' ' TYR . 0.2 OUTLIER -52.32 -45.81 65.76 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.211 177.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.488 ' HA2' ' HD2' ' P' ' 86' ' ' ARG . . . -74.84 -53.91 6.13 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.282 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -46.0 -36.56 5.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.083 0.468 . . . . 0.0 109.875 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 34.8 mtp85 -67.68 -46.85 71.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.346 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.972 ' NH1' HG22 ' P' ' 70' ' ' THR . 31.1 mtt180 -58.07 -38.98 77.37 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.592 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -66.57 -37.18 84.41 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.107 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -30.68 71.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.325 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -65.31 -60.81 2.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.05 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.741 HG22 HD11 ' P' ' 41' ' ' ILE . 20.7 t -62.91 -41.41 92.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.601 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.603 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -58.44 -38.88 78.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 110.043 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.35 -18.68 79.03 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.573 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.83 -60.19 2.46 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.582 ' HB3' HG21 ' P' ' 99' ' ' VAL . 90.3 mt -57.84 -34.13 69.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.053 178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.64 81.18 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.988 178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.17 -26.92 74.26 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.504 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 mtpp -81.99 -9.03 59.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.589 0.233 . . . . 0.0 111.366 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.77 -6.75 17.84 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.251 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.582 HG21 ' HB3' ' P' ' 94' ' ' LEU . 80.0 t -67.96 112.97 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.829 0.314 . . . . 0.0 111.115 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.99 144.97 56.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.215 0.531 . . . . 0.0 111.401 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.51 -36.77 74.32 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.738 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -57.86 -24.95 55.31 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.766 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -101.12 -3.76 28.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.309 0.576 . . . . 0.0 110.798 179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.603 HD22 ' HA ' ' P' ' 91' ' ' LYS . 0.7 OUTLIER -94.3 150.48 20.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.097 179.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.763 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -142.5 141.72 10.98 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.592 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 78.3 p -142.89 145.9 33.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.536 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -160.63 173.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.591 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 0.3 OUTLIER -162.49 129.07 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.291 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.521 ' O ' ' C ' ' P' ' 110' ' ' GLY . 0.5 OUTLIER -114.21 27.12 9.73 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.683 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -4.59 -115.44 0.0 OUTLIER Glycine 0 C--N 1.339 0.718 0 O-C-N 123.6 0.562 . . . . 0.0 114.23 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.496 ' N ' ' CD ' ' P' ' 111' ' ' GLU . 3.2 mp0 -83.09 -2.05 54.38 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.761 -0.258 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -56.64 -63.1 1.31 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.662 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 4.1 mtmt -139.96 89.4 11.32 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.87 164.77 11.28 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.652 2.235 . . . . 0.0 112.705 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -106.39 -63.61 1.25 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.773 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.757 HG21 ' HB3' ' P' ' 126' ' ' LYS . 2.8 t -89.22 111.08 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.783 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.48 135.24 47.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.89 172.88 12.9 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.951 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.518 ' CE1' ' HH ' ' P' ' 124' ' ' TYR . 3.9 t60 -138.08 48.76 1.96 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 121.072 -0.251 . . . . 0.0 111.365 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -131.02 157.66 42.4 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' P' ' 121' ' ' GLU . 15.3 tp10 -42.99 -37.43 1.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -57.45 -60.29 3.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.107 0.479 . . . . 0.0 110.832 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.9 -40.94 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.26 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.518 ' HH ' ' CE1' ' P' ' 119' ' ' HIS . 2.8 m-85 -57.17 -56.21 24.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.381 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . 0.481 ' HA ' ' HD3' ' P' ' 128' ' ' ARG . 0.3 OUTLIER -55.91 -35.55 66.7 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.757 ' HB3' HG21 ' P' ' 116' ' ' VAL . 25.5 mtmt -73.29 -22.52 60.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.201 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' P' ' 69' ' ' ASN . 37.2 m-20 -81.21 -43.74 18.83 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.724 ' HG3' ' O ' ' P' ' 34' ' ' PHE . 0.0 OUTLIER -71.97 71.61 0.81 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.515 0.674 . . . . 0.0 110.804 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.13 145.29 51.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.225 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -117.33 93.21 4.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.612 HG22 HG23 ' P' ' 31' ' ' THR . 24.7 t -83.08 115.46 25.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.634 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -63.73 100.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.309 178.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.539 ' HB2' ' OE1' ' P' ' 67' ' ' GLU . . . -102.77 130.17 49.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.741 0.305 . . . . 0.0 111.557 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.87 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.858 0.361 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.517 ' HB3' ' CZ ' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.493 ' HD3' ' O ' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.907 ' HB3' ' HG2' ' P' ' 73' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.772 0.32 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -99.04 -64.35 1.04 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.812 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.3 -177.26 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.935 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 33.5 t -66.27 -27.84 68.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -108.47 113.36 26.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.908 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -93.92 137.07 33.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -90.01 -51.26 5.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.005 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 179.83 143.61 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.1 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . 61.19 153.59 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.199 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.32 -12.56 62.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.94 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 10.8 m120 62.95 -177.71 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.713 0.292 . . . . 0.0 111.006 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.19 -73.28 1.27 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.043 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -45.68 -45.2 14.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.702 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.471 ' O ' ' CG ' ' P' ' 15' ' ' GLN . . . -64.11 -139.76 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.051 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . 0.471 ' CG ' ' O ' ' P' ' 14' ' ' ALA . 15.0 pt20 50.0 53.73 12.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 121.165 0.507 . . . . 0.0 111.721 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 74.6 p -130.94 93.47 3.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.695 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -88.82 102.91 15.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.569 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.26 10.09 56.1 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.145 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.38 -18.98 17.5 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.336 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.644 ' HB2' HD21 ' P' ' 25' ' ' LEU . 1.7 m-85 -107.04 147.13 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.795 0.331 . . . . 0.0 111.525 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -104.14 144.38 31.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.962 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . . . . . . . . . 18.6 t -38.31 -56.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.64 -19.23 9.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.15 -45.38 5.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.275 0.56 . . . . 0.0 110.628 178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' P' ' 20' ' ' TYR . 34.3 mt -56.54 -20.82 22.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.956 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.58 -12.3 15.3 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -123.38 -25.38 4.44 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . 0.475 ' HG2' ' CZ ' ' P' ' 29' ' ' TYR . 4.7 tpm_? -110.9 -62.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.501 ' CD2' ' CE2' ' P' ' 20' ' ' TYR . 22.2 m-85 -107.19 91.66 3.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' P' ' 25' ' ' LEU . 19.2 p-10 -155.07 13.77 0.39 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.369 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 34.3 m -125.94 130.82 52.03 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.758 HG11 HG23 ' P' ' 41' ' ' ILE . 3.6 t -111.19 148.45 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.986 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -124.5 118.31 26.33 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' P' ' 86' ' ' ARG . 21.9 m-85 -95.49 168.28 10.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.604 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -101.64 -166.69 27.37 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.158 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.445 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 8.2 t80 -60.88 122.03 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.935 0.398 . . . . 0.0 111.012 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 50.23 25.51 1.83 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.749 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.467 ' O ' ' NE ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -93.14 138.58 31.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.469 179.702 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.451 ' HA ' ' HB3' ' P' ' 86' ' ' ARG . 44.6 p90 -131.42 49.93 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.0 110.909 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -147.62 150.74 34.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.917 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.758 HG23 HG11 ' P' ' 32' ' ' VAL . 1.9 mt -95.36 161.8 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.61 0.243 . . . . 0.0 110.647 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.478 ' N ' HG22 ' P' ' 41' ' ' ILE . 0.2 OUTLIER -109.96 135.58 50.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.117 0.484 . . . . 0.0 111.327 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.73 -27.38 2.19 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.682 -0.69 . . . . 0.0 113.024 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -32.1 72.37 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.406 ' O ' HG13 ' P' ' 48' ' ' ILE . 31.1 m-85 -105.54 11.44 32.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.546 ' HA ' ' HG ' ' P' ' 49' ' ' LEU . 0.9 OUTLIER -72.7 -34.06 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.264 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.36 -45.58 6.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.95 0.405 . . . . 0.0 109.978 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.121 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.0 OUTLIER -56.11 -50.36 70.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.591 0.71 . . . . 0.0 109.196 178.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.584 ' HB3' ' CE2' ' P' ' 93' ' ' TYR . 6.2 mt -53.4 -62.41 1.67 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.726 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.5 -49.67 71.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.506 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.47 75.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.588 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.121 ' CD2' HG22 ' P' ' 48' ' ' ILE . 7.5 m-70 -72.17 -42.87 65.4 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.75 0.31 . . . . 0.0 110.821 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' P' ' 94' ' ' LEU . . . -65.59 -25.79 67.56 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.016 -179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.18 -36.93 46.84 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.04 0.448 . . . . 0.0 109.926 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -75.91 -34.68 59.93 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.528 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.642 HD13 ' HB ' ' P' ' 64' ' ' VAL . 0.7 OUTLIER -72.18 -36.06 69.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.03 -179.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -32.72 66.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.153 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.09 -19.7 63.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.633 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.6 OUTLIER -110.02 111.7 58.21 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-O 120.615 0.245 . . . . 0.0 110.481 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.89 -63.09 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.884 2.389 . . . . 0.0 114.213 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.17 24.09 1.66 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.622 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.53 122.58 33.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.145 0.498 . . . . 0.0 110.777 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -126.38 131.29 51.79 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.84 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.642 ' HB ' HD13 ' P' ' 56' ' ' LEU . 8.7 p -96.05 143.74 11.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.62 0.724 . . . . 0.0 111.754 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.823 HD21 ' CG2' ' P' ' 107' ' ' VAL . 4.8 tt -116.7 104.49 11.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.949 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.518 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -84.47 113.51 23.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.675 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 2.6 mm-40 -89.53 119.87 30.34 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.638 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.7 86.96 1.47 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.817 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.501 ' O ' ' CG2' ' P' ' 70' ' ' THR . 7.6 t30 -98.65 158.49 15.58 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.661 0.267 . . . . 0.0 110.354 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' P' ' 69' ' ' ASN . 61.0 p -165.29 -165.55 0.88 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.857 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.455 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 19.8 p-10 -83.77 154.56 23.5 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.617 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' P' ' 114' ' ' PRO . 3.1 pp20? -64.85 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.624 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -39.91 110.03 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.79 -173.17 14.8 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.463 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.36 145.3 29.62 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.463 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 72.1 Cg_exo -48.16 -44.74 27.74 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.458 2.106 . . . . 0.0 112.465 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.66 -41.1 98.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.054 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.476 ' CE1' ' HB3' ' U' ' 5' ' ' 6CL . 6.6 t80 -68.24 -42.96 78.96 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.472 ' HB2' ' HA3' ' P' ' 110' ' ' GLY . 31.4 m120 -69.92 -75.49 0.11 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.385 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.463 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.6 OUTLIER -29.63 -45.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.62 11.34 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.796 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 1.03 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -54.22 -43.77 71.11 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.752 178.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 1.03 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -68.11 -41.9 85.71 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.959 178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -56.96 -31.57 65.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' P' ' 88' ' ' ASP . 10.5 tpt85 -65.67 -60.35 2.99 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.38 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.646 ' HD3' ' HA2' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -56.42 -41.5 76.47 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.242 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.38 -33.63 65.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.3 OUTLIER -65.27 -31.63 72.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.09 178.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -61.17 -42.49 98.67 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.011 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.477 ' O ' ' CD1' ' P' ' 93' ' ' TYR . 32.9 t -70.53 -38.65 74.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.925 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.595 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -74.22 -27.84 60.98 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.019 -179.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' P' ' 95' ' ' ALA . . . -74.71 -53.94 6.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.48 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . 0.584 ' CE2' ' HB3' ' P' ' 49' ' ' LEU . 0.7 OUTLIER -57.59 -44.16 85.2 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.543 ' HG ' ' CE1' ' P' ' 93' ' ' TYR . 4.5 mt -58.87 -35.19 72.57 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -61.45 -43.17 99.34 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.577 179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -72.81 -13.07 78.71 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.393 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . 0.407 ' HD3' ' CB ' ' P' ' 53' ' ' ALA . 15.1 mttm -88.98 -8.44 54.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.667 0.27 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.69 -12.62 11.96 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.763 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.589 HG13 ' CD2' ' P' ' 56' ' ' LEU . 60.9 t -70.65 114.64 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.593 0.235 . . . . 0.0 110.716 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.8 144.58 52.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.388 0.613 . . . . 0.0 111.099 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -51.51 -37.48 49.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.807 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -54.23 -29.35 45.12 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.818 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 5.8 mtmt -96.07 -6.08 39.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.161 0.505 . . . . 0.0 110.9 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' P' ' 91' ' ' LYS . 19.8 mt -89.4 149.88 22.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.916 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.41 135.37 4.69 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.765 ' O ' HG13 ' P' ' 107' ' ' VAL . 70.2 p -133.55 156.24 48.16 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.813 0.34 . . . . 0.0 110.645 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.823 ' CG2' HD21 ' P' ' 65' ' ' LEU . 0.1 OUTLIER -172.85 121.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . . . . . . . . . 52.8 p -111.87 137.85 49.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.751 0.31 . . . . 0.0 110.976 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.515 ' O ' ' C ' ' P' ' 110' ' ' GLY . 90.3 m-85 -116.68 24.51 11.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.838 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.515 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . 4.48 -111.82 0.01 OUTLIER Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.576 -0.738 . . . . 0.0 114.569 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.89 14.4 31.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.506 0.193 . . . . 0.0 111.514 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.7 -54.84 41.67 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.028 0.442 . . . . 0.0 109.812 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.96 89.16 8.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.423 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . 0.415 ' HG3' ' HB3' ' P' ' 72' ' ' GLU . 35.2 Cg_exo -61.05 166.89 9.87 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.692 2.262 . . . . 0.0 112.756 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -105.48 -67.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.356 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.911 HG21 ' HD3' ' P' ' 126' ' ' LYS . 38.5 t -89.61 111.8 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.342 0.592 . . . . 0.0 110.765 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.73 138.54 58.44 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.923 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 123.76 174.15 14.11 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.8 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.449 ' HA ' ' CE1' ' P' ' 124' ' ' TYR . 14.2 p-80 -140.39 58.77 1.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.789 0.328 . . . . 0.0 111.2 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.3 p30 -127.04 157.85 38.53 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' P' ' 125' ' ' SER . 0.2 OUTLIER -43.39 -27.55 0.27 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.615 -179.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' P' ' 126' ' ' LYS . . . -64.76 -59.38 4.3 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.926 0.393 . . . . 0.0 110.387 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . 0.617 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -66.36 -42.44 88.02 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.359 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.455 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 11.9 m-30 -65.37 -44.28 88.08 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . 0.435 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 51.8 p -73.28 -38.92 65.75 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.623 0.249 . . . . 0.0 111.416 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.911 ' HD3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -82.05 -16.77 49.02 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.038 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' P' ' 123' ' ' ALA . 39.1 m-20 -85.33 -29.55 24.41 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.435 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.1 mtp180 -70.32 94.97 0.98 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.521 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' P' ' 32' ' ' VAL . 0.7 OUTLIER -158.85 156.02 28.87 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -118.11 99.78 7.1 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 15.1 t -83.08 110.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.518 HD22 HG13 ' P' ' 66' ' ' VAL . 0.3 OUTLIER -61.31 98.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.19 178.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' P' ' 65' ' ' LEU . . . -101.21 126.67 47.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.623 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . 0.429 ' HH ' ' HD1' ' P' ' 52' ' ' HIS . 20.1 m-85 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.982 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.42 ' O4 ' ' N2 ' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 120.477 0.18 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.629 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.445 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.629 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.607 0.241 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -146.64 117.67 7.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.908 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.14 -174.65 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.948 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 4.7 t -83.15 -30.78 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.96 92.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.906 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -139.74 139.57 36.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.714 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.19 -60.44 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.139 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' P' ' 9' ' ' ALA . . . 57.69 163.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.054 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' P' ' 8' ' ' ALA . . . 75.33 -53.96 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.53 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . 0.871 ' CA ' ' HB3' ' P' ' 14' ' ' ALA . . . -90.19 -66.55 1.21 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.617 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' P' ' 10' ' ' GLY . 76.0 m-20 66.81 -65.86 0.2 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.172 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' P' ' 10' ' ' GLY . . . -90.02 -64.07 1.25 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.91 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.11 -73.23 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 111.69 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.871 ' HB3' ' CA ' ' P' ' 10' ' ' GLY . . . -50.16 144.46 7.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.611 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.09 110.02 3.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 30.0 p -122.35 115.83 22.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' P' ' 55' ' ' TYR . 4.5 m-85 -92.27 106.86 18.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.934 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.1 8.99 32.65 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.388 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.98 -38.57 1.69 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 119.513 -1.327 . . . . 0.0 113.887 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.44 ' O ' ' N ' ' P' ' 17' ' ' PHE . 0.5 OUTLIER -124.15 171.76 9.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.855 0.359 . . . . 0.0 111.341 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.75 150.77 21.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.436 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.709 ' HA ' HD12 ' P' ' 25' ' ' LEU . 18.8 t -43.26 -43.31 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.15 -15.76 48.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.43 -40.05 8.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.559 0.695 . . . . 0.0 109.887 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.709 HD12 ' HA ' ' P' ' 22' ' ' VAL . 5.0 mt -61.96 -21.13 64.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . 0.621 ' OE1' HG12 ' P' ' 22' ' ' VAL . 55.3 mt-30 -98.32 -14.85 20.01 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.4 -18.32 3.61 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.11 -66.74 1.0 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -105.9 83.67 1.95 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.282 0.563 . . . . 0.0 111.836 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' P' ' 132' ' ' LEU . 0.1 OUTLIER -138.52 12.77 2.76 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.639 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.555 ' OG1' HG13 ' P' ' 131' ' ' VAL . 79.8 m -134.98 137.91 43.5 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' P' ' 129' ' ' ARG . 3.3 t -112.55 147.93 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.248 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -117.44 123.15 45.69 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.476 0.655 . . . . 0.0 112.573 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.454 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 75.3 m-85 -108.97 172.6 6.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.876 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.37 -169.27 16.4 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.488 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.45 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 2.0 t80 -60.17 125.9 25.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.811 0.338 . . . . 0.0 110.748 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . 0.448 ' HB2' ' CE1' ' P' ' 36' ' ' PHE . 2.3 t0 44.59 29.43 0.41 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.86 126.65 41.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.738 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 11.2 t80 -125.9 57.79 1.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.731 0.777 . . . . 0.0 110.191 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -151.09 150.71 31.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.715 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.679 HD13 HD21 ' P' ' 49' ' ' LEU . 10.6 mt -98.64 162.28 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.174 -0.21 . . . . 0.0 110.604 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.517 ' N ' HG22 ' P' ' 41' ' ' ILE . 7.5 p -112.76 144.89 41.52 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.118 0.485 . . . . 0.0 111.574 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -45.63 -31.94 3.96 Favored Glycine 0 CA--C 1.522 0.474 0 CA-C-N 115.542 -0.754 . . . . 0.0 113.313 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -63.82 -33.89 76.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.432 ' CB ' HG13 ' P' ' 32' ' ' VAL . 78.0 m-85 -99.11 -2.52 36.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.441 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 77.0 t -63.07 -43.69 99.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 120.694 0.283 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -39.63 -45.64 1.68 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.638 -179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.004 HG22 ' CD2' ' P' ' 52' ' ' HIS . 1.1 mt -57.58 -53.26 46.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.829 0.347 . . . . 0.0 110.838 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.679 HD21 HD13 ' P' ' 41' ' ' ILE . 3.5 mp -47.14 -46.49 23.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.549 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 2.6 p30 -73.46 -33.22 64.76 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.657 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . 0.405 ' N ' ' OD1' ' P' ' 50' ' ' ASP . . . -74.32 -51.48 15.04 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.064 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.004 ' CD2' HG22 ' P' ' 48' ' ' ILE . 12.0 m-70 -57.57 -37.79 73.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 0.0 109.936 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' P' ' 94' ' ' LEU . . . -61.66 -45.3 94.6 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.553 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.24 84.95 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.012 0.434 . . . . 0.0 110.523 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . 0.467 ' HA ' ' CE2' ' P' ' 17' ' ' PHE . 0.3 OUTLIER -70.1 -43.01 71.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.604 -179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.684 ' CD2' HG11 ' P' ' 99' ' ' VAL . 0.4 OUTLIER -69.57 -36.75 76.58 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.03 -178.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -68.83 -36.33 78.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.99 0.424 . . . . 0.0 110.293 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.0 -24.13 66.85 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.604 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.5 OUTLIER -113.85 112.87 47.51 Favored Pre-proline 0 CA--C 1.53 0.197 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -57.56 -44.0 45.8 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.653 2.235 . . . . 0.0 113.575 -179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.35 17.51 11.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.591 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.42 123.74 34.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 110.271 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' P' ' 103' ' ' LYS . 30.9 mttt -123.12 132.72 54.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.683 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.2 p -96.42 143.54 12.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 CA-C-O 121.417 0.627 . . . . 0.0 110.983 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.64 HD21 HG22 ' P' ' 107' ' ' VAL . 0.5 OUTLIER -113.39 108.65 17.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.796 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.684 HG13 HD22 ' P' ' 132' ' ' LEU . 0.2 OUTLIER -88.39 109.67 20.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 21.7 mt-10 -99.39 120.24 39.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.392 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 146.34 18.2 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.354 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.722 ' O ' HG23 ' P' ' 70' ' ' THR . 52.9 m-80 -139.54 167.52 21.91 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.722 HG23 ' O ' ' P' ' 69' ' ' ASN . 2.4 p -168.98 174.8 6.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.983 0.42 . . . . 0.0 111.448 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.508 ' HB2' ' CD1' ' P' ' 124' ' ' TYR . 15.4 p-10 -60.01 151.8 25.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.617 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.53 ' HA ' ' OE1' ' P' ' 111' ' ' GLU . 1.4 pp20? -66.26 -31.83 72.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.853 0.359 . . . . 0.0 111.666 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.11 113.61 1.07 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 113.67 -169.41 12.91 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.266 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . 0.452 ' HB ' ' HG3' ' P' ' 77' ' ' GLU . 0.6 OUTLIER -107.82 146.72 34.01 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 111.48 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.657 ' HB3' HD13 ' P' ' 80' ' ' ILE . 41.0 Cg_exo -54.96 -35.98 91.15 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.793 2.329 . . . . 0.0 113.929 -179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' P' ' 77' ' ' GLU . 0.0 OUTLIER -44.12 -55.35 4.83 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -177.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.497 ' CD2' ' CG ' ' U' ' 4' ' ' DGL . 0.1 OUTLIER -93.69 -13.93 26.94 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.602 179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.748 ' HA ' HD12 ' P' ' 82' ' ' LEU . 2.1 m-20 -84.17 -25.76 29.33 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.539 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.657 HD13 ' HB3' ' P' ' 76' ' ' PRO . 0.5 OUTLIER -90.89 -36.42 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.43 -49.93 61.56 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.434 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 1.05 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -68.9 -34.35 75.27 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.976 178.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 1.05 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -69.55 -56.72 8.12 Favored Glycine 0 C--N 1.34 0.799 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.796 177.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.524 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 45.6 tt0 -50.46 -33.53 21.46 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -49.31 78.2 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.318 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.532 ' HD2' HD22 ' P' ' 82' ' ' LEU . 0.1 OUTLIER -55.43 -38.19 68.67 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 177.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' P' ' 84' ' ' GLN . . . -63.0 -35.31 79.79 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.241 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.67 -31.32 69.3 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.341 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' P' ' 39' ' ' TYR . . . -61.1 -46.84 88.96 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.968 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -75.33 -31.39 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.429 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.587 ' HA ' HD22 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -62.73 -44.03 97.26 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.006 179.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . 0.49 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -74.32 -26.86 67.09 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -59.52 -57.1 14.44 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' P' ' 53' ' ' ALA . 47.2 mt -61.04 -32.28 71.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.332 178.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' P' ' 92' ' ' GLY . . . -61.83 -42.53 99.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.561 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.96 -19.97 78.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.014 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.21 -10.79 59.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.663 0.268 . . . . 0.0 111.269 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.96 -7.52 16.96 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.065 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.684 HG11 ' CD2' ' P' ' 56' ' ' LEU . 31.8 t -78.8 127.41 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.732 0.301 . . . . 0.0 110.99 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . 0.425 ' CB ' ' HD3' ' P' ' 103' ' ' LYS . 0.4 OUTLIER -58.58 163.53 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.548 . . . . 0.0 111.322 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.957 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -80.87 -31.65 35.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.198 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -55.18 -24.14 35.19 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.782 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.544 ' HB2' ' HA ' ' P' ' 63' ' ' LYS . 0.0 OUTLIER -95.5 -4.55 44.67 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 111.224 179.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.957 HD12 ' HA ' ' P' ' 101' ' ' ALA . 7.2 mt -95.1 139.55 31.28 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 121.129 -0.228 . . . . 0.0 110.403 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.576 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -143.45 141.77 10.72 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.805 ' O ' HG13 ' P' ' 107' ' ' VAL . 68.4 p -133.21 153.22 51.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.929 0.395 . . . . 0.0 111.106 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.805 HG13 ' O ' ' P' ' 106' ' ' THR . 0.2 OUTLIER -176.15 119.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.457 ' O ' HG12 ' P' ' 80' ' ' ILE . 90.3 p -117.51 140.11 50.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.963 0.411 . . . . 0.0 111.416 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' P' ' 110' ' ' GLY . 33.1 m-85 -121.08 28.07 8.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.581 179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -23.22 -71.07 0.01 OUTLIER Glycine 0 C--N 1.337 0.595 0 CA-C-N 115.064 -0.971 . . . . 0.0 114.874 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.53 ' OE1' ' HA ' ' P' ' 72' ' ' GLU . 4.4 mm-40 -106.78 -2.1 21.86 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -178.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.01 -57.01 6.86 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 118.474 0.579 . . . . 0.0 110.422 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -134.71 90.04 24.13 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.505 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -57.94 163.05 10.06 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.521 2.147 . . . . 0.0 112.564 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . . . . . . . . . . . -100.45 -68.63 0.8 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.065 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . . . . . . . . . 61.1 t -89.11 119.83 36.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -73.1 136.82 44.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 124.57 175.21 14.25 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.791 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.434 ' ND1' ' N ' ' P' ' 119' ' ' HIS . 0.1 OUTLIER -140.53 97.52 3.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.825 0.312 . . . . 0.0 111.587 -178.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -175.9 165.83 3.0 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -48.46 -26.29 2.06 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -70.05 -63.49 1.07 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.98 -41.01 83.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.621 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.508 ' CD1' ' HB2' ' P' ' 71' ' ' ASP . 7.0 m-30 -56.97 -46.53 82.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.624 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . . . . . . . . . 52.3 p -68.55 -36.85 79.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.79 0.329 . . . . 0.0 111.29 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -68.22 -26.93 65.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.292 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' P' ' 70' ' ' THR . 84.1 m-20 -87.19 -28.84 22.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.481 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 6.5 mtp180 -69.35 81.05 0.37 Allowed 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' P' ' 69' ' ' ASN . 0.0 OUTLIER -159.89 152.39 21.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.122 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -120.51 105.11 10.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 175.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.555 HG13 ' OG1' ' P' ' 31' ' ' THR . 16.0 t -86.73 113.41 24.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.684 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -61.05 99.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.194 178.178 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' P' ' 65' ' ' LEU . . . -99.55 124.39 44.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.635 -179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . 0.463 ' HE1' HD12 ' P' ' 56' ' ' LEU . 22.0 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.917 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.465 ' H82' ' HB3' ' U' ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 120.891 0.377 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.497 ' CG ' ' CD2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.561 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.45 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.561 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.813 0.34 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.45 139.87 1.03 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -156.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.608 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -68.52 -35.7 77.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.511 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -149.91 116.82 5.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 111.462 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.32 150.13 31.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.713 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -73.41 -52.37 13.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.754 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . 46.49 -169.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.625 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' P' ' 14' ' ' ALA . . . -131.38 65.16 1.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.957 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.64 -20.52 31.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.843 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.5 128.7 44.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.862 0.363 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.53 -22.2 51.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.23 -28.82 59.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.834 0.35 . . . . 0.0 111.251 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . 0.58 ' HB3' ' HB1' ' P' ' 9' ' ' ALA . . . -78.15 97.43 5.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -176.72 114.83 0.1 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.711 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.76 119.82 30.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.031 0.443 . . . . 0.0 111.184 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' P' ' 20' ' ' TYR . 70.6 m-85 -90.55 107.08 18.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.611 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.81 9.87 35.5 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.297 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 134.21 -35.75 2.19 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 119.579 -1.296 . . . . 0.0 113.793 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.595 ' HB2' HD21 ' P' ' 25' ' ' LEU . 22.2 m-85 -117.81 161.9 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.976 0.417 . . . . 0.0 111.715 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.15 153.65 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.425 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.414 HG23 ' H ' ' P' ' 22' ' ' VAL . 17.3 t -39.26 -51.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.86 -17.43 16.25 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.38 -40.35 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.421 0.629 . . . . 0.0 110.048 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' P' ' 20' ' ' TYR . 20.1 mt -69.32 -20.82 63.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.206 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -88.7 -20.89 24.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -142.71 -6.59 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -69.12 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -108.98 85.69 2.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.201 0.524 . . . . 0.0 112.244 -178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.2 19.26 0.86 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.329 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . . . . . . . . . 98.4 m -126.42 129.35 48.56 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.754 HG11 HG23 ' P' ' 41' ' ' ILE . 3.2 t -107.86 150.38 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.978 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -121.39 116.16 24.25 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.502 ' CE2' ' HG2' ' P' ' 86' ' ' ARG . 21.7 m-85 -98.09 167.11 11.09 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.359 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -112.68 -167.38 17.23 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.603 ' CZ ' ' O ' ' U' ' 6' ' ' DAL . 6.2 t80 -66.18 123.34 19.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.079 0.439 . . . . 0.0 110.835 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.67 15.34 7.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.728 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.463 ' O ' ' NH2' ' P' ' 86' ' ' ARG . 2.2 mptt -91.17 125.64 36.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.504 ' HB3' ' NH1' ' P' ' 86' ' ' ARG . 52.1 p90 -128.04 37.46 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.796 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.05 149.74 33.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.052 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.754 HG23 HG11 ' P' ' 32' ' ' VAL . 1.2 mp -87.57 164.14 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.693 0.283 . . . . 0.0 110.975 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . 0.444 ' N ' HG22 ' P' ' 41' ' ' ILE . 49.3 p -112.35 150.63 30.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.405 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -42.45 -32.95 1.32 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.14 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.05 -33.37 75.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.727 0.299 . . . . 0.0 111.416 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . 0.403 ' CB ' HG13 ' P' ' 32' ' ' VAL . 87.7 m-85 -102.82 3.6 36.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 74.2 t -69.16 -40.49 80.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.068 -0.253 . . . . 0.0 111.41 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.54 HE21 ' HA ' ' P' ' 47' ' ' GLN . 0.0 OUTLIER -44.07 -44.35 7.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 1.035 HG22 ' CD2' ' P' ' 52' ' ' HIS . 0.6 OUTLIER -56.47 -51.1 69.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.818 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.581 HD23 ' CD2' ' P' ' 93' ' ' TYR . 2.1 mp -53.36 -34.5 57.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.595 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.7 -39.04 53.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.867 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.79 -50.79 26.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.979 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 1.035 ' CD2' HG22 ' P' ' 48' ' ' ILE . 54.6 m-70 -59.92 -35.95 75.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.987 0.422 . . . . 0.0 110.139 179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.75 -41.45 98.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.302 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -39.79 91.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.978 0.418 . . . . 0.0 110.723 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -74.38 -38.79 63.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.97 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 1.043 HD23 HG11 ' P' ' 99' ' ' VAL . 2.9 tp -62.2 -41.68 98.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.139 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -71.16 -40.92 71.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.638 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.73 -27.92 31.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.683 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.4 OUTLIER -109.6 115.1 56.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.566 0.222 . . . . 0.0 110.488 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.8 -59.03 1.32 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.822 2.348 . . . . 0.0 113.858 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.72 22.91 2.13 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.633 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -90.76 123.38 34.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.144 0.497 . . . . 0.0 110.707 179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -128.07 134.16 49.13 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.934 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.615 ' HB ' HD13 ' P' ' 56' ' ' LEU . 9.8 p -97.0 146.13 7.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.502 0.668 . . . . 0.0 111.758 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.8 HD21 ' CG2' ' P' ' 107' ' ' VAL . 5.1 tt -117.41 105.37 12.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.452 HG13 HD22 ' P' ' 132' ' ' LEU . 0.3 OUTLIER -83.14 108.61 16.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.636 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 3.3 tt0 -99.2 117.61 34.05 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.728 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -107.51 149.67 16.73 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.968 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.455 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.8 OUTLIER -152.96 108.57 3.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.811 0.339 . . . . 0.0 110.712 179.66 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . . . . . . . . . 52.0 p -100.65 -171.67 2.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.764 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' P' ' 73' ' ' ARG . 21.2 p-10 -64.27 144.85 56.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.396 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' P' ' 111' ' ' GLU . 0.9 OUTLIER -64.08 -27.09 68.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.542 -179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . 0.439 ' HB2' ' OD2' ' P' ' 71' ' ' ASP . 0.9 OUTLIER -39.55 110.91 0.16 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.326 0.584 . . . . 0.0 112.037 -178.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 115.01 -150.91 18.65 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.902 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.05 148.46 51.71 Favored Pre-proline 0 C--N 1.331 -0.228 0 C-N-CA 122.0 0.12 . . . . 0.0 110.822 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' P' ' 111' ' ' GLU . 1.3 Cg_endo -41.85 -38.91 4.98 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.616 2.211 . . . . 0.0 111.99 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' P' ' 81' ' ' ALA . 0.5 OUTLIER -61.9 -40.84 96.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.88 -47.53 45.18 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.681 178.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' P' ' 82' ' ' LEU . 11.1 m120 -64.62 -76.27 0.07 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.711 ' HA ' ' OG ' ' P' ' 108' ' ' SER . 0.1 OUTLIER -35.42 -38.5 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' P' ' 77' ' ' GLU . . . -66.37 -64.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.636 -0.426 . . . . 0.0 112.043 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.931 HD13 ' N ' ' P' ' 83' ' ' GLY . 0.0 OUTLIER -63.48 -33.63 75.99 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.285 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . 0.931 ' N ' HD13 ' P' ' 82' ' ' LEU . . . -67.89 -52.47 28.58 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' P' ' 87' ' ' ALA . 1.2 tp-100 -50.79 -34.73 28.62 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -59.93 -43.02 95.18 Favored 'General case' 0 N--CA 1.456 -0.136 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.388 178.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.617 ' CZ ' ' CD2' ' P' ' 82' ' ' LEU . 6.8 mtt85 -56.37 -43.41 79.16 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.573 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -58.05 -32.58 68.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.4 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -32.63 72.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.419 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' P' ' 86' ' ' ARG . . . -60.27 -56.67 18.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.642 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.34 -34.42 65.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.4 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.44 ' HD3' HD13 ' P' ' 104' ' ' LEU . 3.1 tmtt? -59.45 -51.81 68.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.883 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.39 -26.09 74.44 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.115 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . 0.581 ' CD2' HD23 ' P' ' 49' ' ' LEU . 5.8 t80 -59.96 -61.27 2.73 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.489 ' HB2' HD21 ' P' ' 104' ' ' LEU . 23.1 mt -59.83 -29.8 68.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.88 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.52 -42.11 98.47 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.363 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.33 -21.08 78.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.626 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.85 -11.29 59.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.693 0.282 . . . . 0.0 111.179 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.28 -3.63 22.08 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.308 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 1.043 HG11 HD23 ' P' ' 56' ' ' LEU . 21.5 t -81.98 131.65 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.831 0.315 . . . . 0.0 111.423 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . 0.416 ' OD1' ' CG ' ' P' ' 103' ' ' LYS . 31.3 p30 -58.95 166.37 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.208 0.527 . . . . 0.0 111.306 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . 0.803 ' HA ' HD12 ' P' ' 104' ' ' LEU . . . -77.87 -31.83 51.62 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.7 -21.36 62.85 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.297 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' P' ' 63' ' ' LYS . 23.4 mtpp -90.45 -12.65 36.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.064 0.459 . . . . 0.0 111.067 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.803 HD12 ' HA ' ' P' ' 101' ' ' ALA . 6.3 mt -92.23 149.76 21.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.93 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.444 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -145.78 137.01 6.7 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.573 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 18.7 p -117.63 156.24 28.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.065 0.46 . . . . 0.0 111.275 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.8 ' CG2' HD21 ' P' ' 65' ' ' LEU . 97.2 t -160.49 157.75 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.608 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.711 ' OG ' ' HA ' ' P' ' 80' ' ' ILE . 3.3 t -161.09 128.18 4.11 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.993 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.31 -68.46 0.79 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.349 179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.7 -121.51 6.37 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.615 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 1.2 mm-40 -75.62 -19.89 58.91 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.859 0.33 . . . . 0.0 111.091 178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.47 -74.09 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -142.09 102.45 5.71 Favored Pre-proline 0 CA--C 1.531 0.242 0 C-N-CA 120.912 -0.315 . . . . 0.0 111.323 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.34 167.49 20.31 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.745 2.297 . . . . 0.0 112.248 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . 0.779 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -88.55 -77.66 0.36 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.226 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.66 ' HB ' ' NZ ' ' P' ' 126' ' ' LYS . 2.0 t -96.94 130.6 45.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.461 0.648 . . . . 0.0 111.137 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.32 141.13 52.34 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.745 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.73 172.09 12.99 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.764 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -141.09 91.64 2.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.793 0.296 . . . . 0.0 111.411 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' P' ' 124' ' ' TYR . 37.5 t70 -178.86 167.37 1.67 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' P' ' 125' ' ' SER . 1.1 mm-40 -44.45 -26.83 0.38 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . . . . . . . . . . . -64.62 -66.54 0.53 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.672 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . 0.646 ' HA ' ' CE ' ' P' ' 126' ' ' LYS . . . -70.4 -35.67 73.59 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.7 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.485 ' HE2' ' HB3' ' U' ' 7' ' ' DAL . 2.2 m-85 -65.85 -46.43 78.54 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . 0.424 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 6.9 t -71.56 -37.06 71.11 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.66 ' NZ ' ' HB ' ' P' ' 116' ' ' VAL . 0.0 OUTLIER -79.77 -16.16 56.09 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.993 -179.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.779 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 7.9 m-20 -86.53 -31.51 21.23 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 120.581 0.229 . . . . 0.0 110.495 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.424 ' CZ ' ' HA ' ' P' ' 125' ' ' SER . 2.7 mtp180 -70.3 83.62 0.56 Allowed 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.068 0.461 . . . . 0.0 110.18 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.25 153.33 34.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -119.66 99.18 6.5 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . . . . . . . . . 17.1 t -83.67 112.73 21.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.452 HD22 HG13 ' P' ' 66' ' ' VAL . 0.4 OUTLIER -61.55 101.62 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.669 178.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.72 122.1 39.28 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.733 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.947 179.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.815 0.34 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.59 ' OH2' ' HB2' ' U' ' 7' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.603 ' O ' ' CZ ' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.59 ' HB2' ' OH2' ' U' ' 5' ' ' 6CL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 1' ' ' CYS . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.881 0.372 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' P' P ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -139.8 90.43 2.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.84 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 3' ' ' SER . . . . . . . . . . . . . 68.6 p -163.81 -176.67 4.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.963 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 4' ' ' SER . . . . . . . . . . . . . 1.6 t -70.77 -45.22 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 5' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -150.2 136.56 18.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.878 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 6' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.74 150.04 52.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 7' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.82 -66.79 0.88 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.25 -76.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.39 174.73 14.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.188 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.48 -44.71 7.25 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.269 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 11' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -163.32 30.27 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 12' ' ' GLY . . . . . . . . . . . . . . . -90.17 -12.83 61.19 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.808 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.73 -27.4 2.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.7 0.286 . . . . 0.0 111.513 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 14' ' ' ALA . . . . . . . . . . . . . . . 65.73 -165.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.158 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.86 162.77 18.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.023 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 16' ' ' THR . . . . . . . . . . . . . 75.5 p -129.42 115.03 16.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.676 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 17' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' P' ' 20' ' ' TYR . 61.1 m-85 -88.83 105.87 18.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.992 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.82 10.33 38.02 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.129 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.96 -30.61 3.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 119.868 -1.158 . . . . 0.0 113.384 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 20' ' ' TYR . . . . . 0.452 ' CE1' ' CE2' ' P' ' 29' ' ' TYR . 20.3 m-85 -114.22 158.75 20.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.239 0.543 . . . . 0.0 112.058 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.7 150.98 23.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.014 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 22' ' ' VAL . . . . . 0.42 HG23 ' H ' ' P' ' 22' ' ' VAL . 16.5 t -39.5 -48.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.59 -17.89 57.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.42 -43.93 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.456 0.646 . . . . 0.0 110.441 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 25' ' ' LEU . . . . . 0.481 ' HB3' ' CE1' ' P' ' 52' ' ' HIS . 17.5 mt -58.35 -21.38 49.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.152 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 26' ' ' GLN . . . . . 0.458 ' HA ' ' OD1' ' P' ' 30' ' ' ASN . 4.3 mt-30 -101.92 -12.4 18.25 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 27' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.93 -21.52 4.34 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 28' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -112.64 -60.26 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 29' ' ' TYR . . . . . 0.452 ' CE2' ' CE1' ' P' ' 20' ' ' TYR . 28.3 m-85 -102.29 85.9 2.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.933 0.397 . . . . 0.0 111.735 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 30' ' ' ASN . . . . . 0.535 HD22 ' HB2' ' P' ' 132' ' ' LEU . 0.0 OUTLIER -144.6 6.78 1.26 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 31' ' ' THR . . . . . 0.422 ' OG1' HG13 ' P' ' 131' ' ' VAL . 51.9 m -136.86 138.8 41.13 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 32' ' ' VAL . . . . . 0.694 HG11 HG23 ' P' ' 41' ' ' ILE . 12.0 t -111.82 150.9 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.507 178.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 33' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -120.37 119.11 32.13 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 34' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' P' ' 128' ' ' ARG . 16.3 m-85 -95.69 170.24 9.46 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.52 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 35' ' ' GLY . . . . . . . . . . . . . . . -106.48 -179.65 23.01 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.634 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 36' ' ' PHE . . . . . 0.806 ' CD1' ' HB2' ' U' ' 7' ' ' DAL . 0.6 OUTLIER -64.22 117.3 6.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.874 0.369 . . . . 0.0 111.049 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 55.51 24.77 7.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.01 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 38' ' ' LYS . . . . . 0.515 ' HD3' ' HB2' ' P' ' 40' ' ' ASP . 0.0 OUTLIER -111.06 127.33 55.51 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.903 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 39' ' ' TYR . . . . . 0.684 ' CG ' ' O ' ' P' ' 39' ' ' TYR . 0.0 OUTLIER -117.65 77.5 1.15 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.599 0.714 . . . . 0.0 111.058 -178.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 40' ' ' ASP . . . . . 0.515 ' HB2' ' HD3' ' P' ' 38' ' ' LYS . 0.2 OUTLIER -153.28 150.36 28.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.223 179.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 41' ' ' ILE . . . . . 0.694 HG23 HG11 ' P' ' 32' ' ' VAL . 7.5 mt -99.0 155.35 3.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 42' ' ' THR . . . . . . . . . . . . . 3.0 p -108.48 143.73 37.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.109 0.481 . . . . 0.0 112.056 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 43' ' ' GLY . . . . . 0.44 ' HA2' ' CG2' ' P' ' 46' ' ' VAL . . . -47.59 -29.26 5.57 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.121 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 44' ' ' GLU . . . . . 0.43 ' O ' ' NE2' ' P' ' 47' ' ' GLN . 3.4 mm-40 -66.16 -28.98 69.19 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 45' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.27 -1.06 29.43 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 46' ' ' VAL . . . . . 0.44 ' CG2' ' HA2' ' P' ' 43' ' ' GLY . 94.8 t -65.26 -41.42 91.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 47' ' ' GLN . . . . . 0.434 ' HA ' ' OD2' ' P' ' 50' ' ' ASP . 0.0 OUTLIER -49.24 -29.49 5.82 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.588 -178.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 48' ' ' ILE . . . . . 0.939 HG22 ' CD2' ' P' ' 52' ' ' HIS . 2.9 mt -64.71 -52.85 49.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.962 0.411 . . . . 0.0 110.391 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 49' ' ' LEU . . . . . 0.43 HD23 ' CD2' ' P' ' 93' ' ' TYR . 2.7 mp -51.9 -47.83 64.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.3 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 50' ' ' ASP . . . . . 0.434 ' OD2' ' HA ' ' P' ' 47' ' ' GLN . 0.5 OUTLIER -70.07 -35.75 74.45 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.609 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 51' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' P' ' 25' ' ' LEU . . . -73.43 -47.76 39.08 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.171 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 52' ' ' HIS . . . . . 0.939 ' CD2' HG22 ' P' ' 48' ' ' ILE . 8.9 m-70 -61.04 -38.04 84.72 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.8 92.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.019 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.2 92.93 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-O 120.935 0.397 . . . . 0.0 110.618 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 55' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -71.01 -40.28 71.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.691 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 56' ' ' LEU . . . . . 0.623 HD13 ' HB ' ' P' ' 64' ' ' VAL . 2.0 tp -62.88 -45.18 93.75 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.312 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -63.73 -40.49 96.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.336 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.33 -25.39 9.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.669 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 59' ' ' THR . . . . . 0.594 ' HB ' ' HB2' ' P' ' 62' ' ' ALA . 0.2 OUTLIER -115.5 115.74 41.86 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-O 120.601 0.239 . . . . 0.0 110.599 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.46 -50.91 11.24 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.694 2.263 . . . . 0.0 113.506 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 61' ' ' ALA . . . . . 0.406 ' O ' ' HD2' ' P' ' 63' ' ' LYS . . . -88.75 19.66 3.9 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 62' ' ' ALA . . . . . 0.594 ' HB2' ' HB ' ' P' ' 59' ' ' THR . . . -92.61 134.74 34.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.885 0.374 . . . . 0.0 110.468 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 63' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' P' ' 103' ' ' LYS . 0.0 OUTLIER -138.02 141.49 40.38 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.088 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 64' ' ' VAL . . . . . 0.782 HG11 ' CD1' ' P' ' 94' ' ' LEU . 9.6 p -100.4 150.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.095 0 CA-C-O 121.519 0.675 . . . . 0.0 111.795 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 65' ' ' LEU . . . . . 0.705 HD21 ' CG2' ' P' ' 107' ' ' VAL . 3.4 tt -120.69 101.45 7.74 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.342 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 66' ' ' VAL . . . . . 0.647 HG23 ' O ' ' P' ' 105' ' ' GLY . 1.3 t -83.51 101.37 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.881 0.372 . . . . 0.0 110.725 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 67' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' P' ' 130' ' ' ALA . 29.6 tt0 -90.41 123.47 34.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.769 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 68' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' P' ' 108' ' ' SER . . . -106.71 148.05 16.34 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.521 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 69' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' P' ' 127' ' ' ASN . 0.3 OUTLIER -160.91 106.19 1.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.767 0.317 . . . . 0.0 110.508 179.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 70' ' ' THR . . . . . 0.801 HG21 ' NH1' ' P' ' 86' ' ' ARG . 26.7 p -106.26 -170.85 1.79 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 71' ' ' ASP . . . . . 0.501 ' HB2' ' CE2' ' P' ' 124' ' ' TYR . 21.4 p-10 -57.28 138.12 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.742 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 72' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' P' ' 111' ' ' GLU . 0.7 OUTLIER -59.83 -22.84 62.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.454 -179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 73' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -38.13 108.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 74' ' ' GLY . . . . . . . . . . . . . . . 114.12 -144.69 18.34 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.635 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 75' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.97 146.82 60.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.727 0.264 . . . . 0.0 110.772 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 76' ' ' PRO . . . . . 0.526 ' O ' ' HB ' ' P' ' 80' ' ' ILE . 1.9 Cg_endo -39.99 -44.79 3.79 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 123.009 2.473 . . . . 0.0 112.445 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -42.72 99.31 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.645 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 78' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' U' ' 4' ' ' DGL . 9.8 t80 -71.46 -40.25 70.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.679 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 79' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' P' ' 80' ' ' ILE . 0.4 OUTLIER -67.15 -75.12 0.1 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 80' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' P' ' 76' ' ' PRO . 0.0 OUTLIER -29.4 -41.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 O-C-N 123.254 0.346 . . . . 0.0 111.475 179.658 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 81' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' P' ' 79' ' ' ASN . . . -64.47 -59.74 3.98 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.597 179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 82' ' ' LEU . . . . . 0.804 HD12 ' NH1' ' P' ' 86' ' ' ARG . 0.2 OUTLIER -48.69 -46.71 40.88 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.256 178.35 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.83 -46.01 85.08 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.368 -0.92 . . . . 0.0 111.52 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 84' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' P' ' 80' ' ' ILE . 0.0 OUTLIER -47.12 -43.14 20.34 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.388 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 85' ' ' ARG . . . . . 0.477 ' HG2' ' N ' ' P' ' 86' ' ' ARG . 0.0 OUTLIER -65.54 -36.0 82.51 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.777 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 86' ' ' ARG . . . . . 0.804 ' NH1' HD12 ' P' ' 82' ' ' LEU . 17.0 mtt180 -68.5 -48.61 63.95 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.334 0.588 . . . . 0.0 109.445 178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 87' ' ' ALA . . . . . 0.713 ' HB1' ' HB ' ' P' ' 106' ' ' THR . . . -62.4 -40.31 96.09 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.562 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 88' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' P' ' 91' ' ' LYS . 0.4 OUTLIER -56.21 -35.25 67.1 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.844 178.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 89' ' ' ALA . . . . . 0.51 ' HB2' ' HE1' ' P' ' 39' ' ' TYR . . . -64.33 -64.62 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.5 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 90' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' P' ' 93' ' ' TYR . 20.3 t -55.14 -39.67 51.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.371 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 91' ' ' LYS . . . . . 0.517 ' HA ' ' CD2' ' P' ' 104' ' ' LEU . 0.0 OUTLIER -61.49 -43.1 99.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.171 0.51 . . . . 0.0 110.153 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 92' ' ' GLY . . . . . 0.432 ' N ' ' HG3' ' P' ' 91' ' ' LYS . . . -71.81 -11.12 73.29 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 93' ' ' TYR . . . . . 0.43 ' CD2' HD23 ' P' ' 49' ' ' LEU . 4.4 t80 -75.95 -62.9 1.44 Allowed 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 94' ' ' LEU . . . . . 0.782 ' CD1' HG11 ' P' ' 64' ' ' VAL . 72.2 mt -53.51 -31.38 45.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 95' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' P' ' 99' ' ' VAL . . . -63.38 -40.26 96.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.394 178.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 96' ' ' GLY . . . . . . . . . . . . . . . -69.31 -24.7 75.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.455 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.33 -9.18 59.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.769 0.319 . . . . 0.0 111.248 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.94 -7.86 14.83 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.947 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 99' ' ' VAL . . . . . 0.577 ' CG1' HD23 ' P' ' 56' ' ' LEU . 21.8 t -70.57 114.88 9.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.674 0.273 . . . . 0.0 110.836 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 100' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -55.84 141.63 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.387 . . . . 0.0 111.14 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.89 40.9 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.246 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.25 -11.88 64.99 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.689 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 103' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' P' ' 63' ' ' LYS . 2.1 mtpp -93.59 -19.13 21.46 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 120.522 0.201 . . . . 0.0 111.399 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 104' ' ' LEU . . . . . 0.73 ' O ' HD13 ' P' ' 104' ' ' LEU . 0.0 OUTLIER -136.27 132.01 35.21 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.023 -0.671 . . . . 0.0 111.782 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 105' ' ' GLY . . . . . 0.647 ' O ' HG23 ' P' ' 66' ' ' VAL . . . -126.72 -169.07 12.68 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.534 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 106' ' ' THR . . . . . 0.713 ' HB ' ' HB1' ' P' ' 87' ' ' ALA . 49.6 p -147.36 168.53 21.56 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.087 0.47 . . . . 0.0 111.272 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 107' ' ' VAL . . . . . 0.705 ' CG2' HD21 ' P' ' 65' ' ' LEU . 48.7 t -158.32 163.55 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.509 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 108' ' ' SER . . . . . 0.542 ' N ' HG12 ' P' ' 107' ' ' VAL . 3.2 t -160.28 113.58 2.12 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.963 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 109' ' ' TYR . . . . . 0.599 ' CZ ' HG11 ' P' ' 107' ' ' VAL . 60.0 m-85 -108.36 27.33 9.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.194 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 110' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' P' ' 109' ' ' TYR . . . -12.08 -109.26 0.0 OUTLIER Glycine 0 CA--C 1.526 0.744 0 O-C-N 123.684 0.615 . . . . 0.0 114.581 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 111' ' ' GLU . . . . . 0.504 ' HB2' ' HD3' ' P' ' 76' ' ' PRO . 6.3 mt-10 -63.29 -18.31 63.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 112' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' P' ' 109' ' ' TYR . 3.7 tm-20 -48.18 -69.04 0.13 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.527 -178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 113' ' ' LYS . . . . . . . . . . . . . 6.8 tptm -130.25 95.04 28.7 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.69 0.281 . . . . 0.0 111.034 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 114' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.34 155.93 54.26 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.705 2.27 . . . . 0.0 112.454 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 115' ' ' ALA . . . . . 0.661 ' HB3' ' OD1' ' P' ' 127' ' ' ASN . . . -101.97 -71.47 0.72 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.117 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 116' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' P' ' 126' ' ' LYS . 3.5 t -88.76 114.29 26.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.989 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 117' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.49 136.59 49.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.152 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.75 175.4 14.0 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.118 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 119' ' ' HIS . . . . . 0.463 ' CE1' ' OH ' ' P' ' 124' ' ' TYR . 18.5 t60 -140.16 52.94 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.627 0.251 . . . . 0.0 111.184 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 120' ' ' ASP . . . . . 0.504 ' OD1' ' HB3' ' P' ' 122' ' ' ALA . 1.7 p30 -131.31 154.69 48.27 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 121' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -45.42 -26.41 0.55 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 122' ' ' ALA . . . . . 0.504 ' HB3' ' OD1' ' P' ' 120' ' ' ASP . . . -70.25 -58.18 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.014 0.435 . . . . 0.0 110.72 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.59 -40.36 76.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.638 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 124' ' ' TYR . . . . . 0.501 ' CE2' ' HB2' ' P' ' 71' ' ' ASP . 0.7 OUTLIER -59.7 -49.89 76.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.462 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 125' ' ' SER . . . . . 0.414 ' HA ' ' CZ ' ' P' ' 128' ' ' ARG . 3.3 t -64.26 -34.89 79.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.902 0.382 . . . . 0.0 110.416 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 126' ' ' LYS . . . . . 0.977 ' HB3' HG21 ' P' ' 116' ' ' VAL . 0.0 OUTLIER -68.74 -27.08 65.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.599 179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' P' P ' 127' ' ' ASN . . . . . 0.661 ' OD1' ' HB3' ' P' ' 115' ' ' ALA . 1.7 m-20 -82.21 -31.82 30.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.387 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 128' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' P' ' 70' ' ' THR . 1.8 mpp_? -68.85 85.07 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.82 0.343 . . . . 0.0 111.051 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 129' ' ' ARG . . . . . 0.445 ' HG2' ' OD1' ' P' ' 69' ' ' ASN . 3.9 ptt180 -154.65 147.16 24.08 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 130' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' P' ' 67' ' ' GLU . . . -113.29 108.53 17.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 131' ' ' VAL . . . . . 0.422 HG13 ' OG1' ' P' ' 31' ' ' THR . 3.6 t -88.27 108.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 132' ' ' LEU . . . . . 0.596 HD22 HG13 ' P' ' 66' ' ' VAL . 1.2 mm? -62.51 101.92 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.571 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' P' P ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.93 135.14 45.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 111.48 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' P' P ' 134' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.932 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' U' U ' 1' ' ' UDP . . . . . 0.465 " H3'" ' H83' ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' U' U ' 2' ' ' AMU . . . . . 0.686 H113 ' CB ' ' U' ' 6' ' ' DAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' U' U ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' U' U ' 4' ' ' DGL . . . . . 0.433 ' HB3' ' CE2' ' P' ' 78' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' U' U ' 5' ' ' 6CL . . . . . 0.422 ' CZ ' ' OD1' ' P' ' 71' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' U' U ' 6' ' ' DAL . . . . . 0.686 ' CB ' H113 ' U' ' 2' ' ' AMU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' U' U ' 7' ' ' DAL . . . . . 0.806 ' HB2' ' CD1' ' P' ' 36' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_